EU-1-04-273,"{'atc_code': 'L01XX23', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lysodren', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/273', 'active_substance': 'Mitotane', 'eu_mah_current': 'HRA Pharma Rare Diseases', 'orphan_status': 'h', 'eu_aut_date': '04-28-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/521', 'ema_number_certainty': '0.8181818181818182'}"
EU-1-04-274,"{'atc_code': 'L01XG01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'VELCADE', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/274', 'active_substance': 'bortezomib', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '04-26-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/539', 'ema_number_certainty': '0.9117647058823529'}"
EU-1-04-275,"{'atc_code': 'L01BB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Litak', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/275', 'active_substance': 'Cladribine', 'eu_mah_current': 'Lipomed GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-14-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/504', 'ema_number_certainty': '1.0'}"
EU-1-98-091,"{'atc_code': 'C09CA07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kinzalmono', 'status_type': 'a', 'eu_pnumber': 'EU/1/98/091', 'active_substance': 'telmisartan', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '12-16-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/211', 'ema_number_certainty': '0.9883720930232558'}"
EU-1-04-278,"{'atc_code': 'A10AE05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Levemir', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/278', 'active_substance': 'insulin detemir', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '06-01-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/528', 'ema_number_certainty': '0.96875'}"
EU-1-04-276,"{'atc_code': 'N05AX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Abilify', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/276', 'active_substance': 'aripiprazole', 'eu_mah_current': 'Otsuka Pharmaceutical Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-04-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/471', 'ema_number_certainty': '0.9375'}"
EU-1-04-277,"{'atc_code': 'B02BC30', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'TachoSil', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/277', 'active_substance': 'Human Fibrinogen / Human Thrombin', 'eu_mah_current': 'Corza Medical GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-08-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/505', 'ema_number_certainty': '0.9444444444444444'}"
EU-1-04-281,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Erbitux', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/281', 'active_substance': 'cetuximab', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/558', 'ema_number_certainty': '0.9259259259259259'}"
EU-1-04-282,"{'atc_code': 'J05AE07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Telzir', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/282', 'active_substance': 'Fosamprenavir', 'eu_mah_current': 'ViiV Healthcare BV', 'orphan_status': 'h', 'eu_aut_date': '07-12-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/534', 'ema_number_certainty': '0.9102564102564102'}"
EU-1-04-279,"{'atc_code': 'N03AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lyrica', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/279', 'active_substance': 'pregabalin', 'eu_mah_current': 'Upjohn EESV', 'orphan_status': 'h', 'eu_aut_date': '07-06-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/546', 'ema_number_certainty': '0.7362637362637363'}"
EU-1-04-280,"{'atc_code': 'N06AX21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Yentreve', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/280', 'active_substance': 'duloxetine hydrochloride', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-11-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/545', 'ema_number_certainty': '0.9111111111111111'}"
EU-1-04-284,"{'atc_code': 'C01EB16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pedea', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/284', 'active_substance': 'Ibuprofen', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'h', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/549', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-04-285,"{'atc_code': 'A10AB06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Apidra', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/285', 'active_substance': 'Insulin glulisine', 'eu_mah_current': 'Sanofi-Aventis Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-27-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/557', 'ema_number_certainty': '0.9'}"
EU-1-04-286,"{'atc_code': 'A16AX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Wilzin', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/286', 'active_substance': 'Zinc acetate dihydrate', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'h', 'eu_aut_date': '10-13-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/535', 'ema_number_certainty': '1.0'}"
EU-1-04-290,"{'atc_code': 'L01BA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Alimta', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/290', 'active_substance': 'pemetrexed', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/564', 'ema_number_certainty': '0.9130434782608695'}"
EU-1-04-292,"{'atc_code': 'H05BX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mimpara', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/292', 'active_substance': 'Cinacalcet', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-22-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/570', 'ema_number_certainty': '0.9069767441860465'}"
EU-1-04-294,"{'atc_code': 'G04BD10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Emselex', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/294', 'active_substance': 'darifenacin hydrobromide', 'eu_mah_current': 'zr pharma&amp; GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-22-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/554', 'ema_number_certainty': '0.9215686274509803'}"
EU-1-04-295,"{'atc_code': 'L01XX35', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xagrid', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/295', 'active_substance': 'anagrelide', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'h', 'eu_aut_date': '11-16-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/480', 'ema_number_certainty': '0.9'}"
EU-1-04-296,"{'atc_code': 'N06AX21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cymbalta', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/296', 'active_substance': 'duloxetine hydrochloride', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-17-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/572', 'ema_number_certainty': '0.9375'}"
EU-1-04-298,"{'atc_code': 'J05AR02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kivexa', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/298', 'active_substance': 'abacavir / Lamivudine', 'eu_mah_current': 'ViiV Healthcare BV', 'orphan_status': 'h', 'eu_aut_date': '12-17-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/581', 'ema_number_certainty': '0.8947368421052632'}"
EU-1-04-299,"{'atc_code': 'J07BC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fendrix', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/299', 'active_substance': 'Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '02-02-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/550', 'ema_number_certainty': '0.9565217391304348'}"
EU-1-04-300,"{'atc_code': 'L01XC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Avastin', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/300', 'active_substance': 'bevacizumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-12-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/582', 'ema_number_certainty': '0.9125'}"
EU-1-04-302,"{'atc_code': 'N02BG08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Prialt', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/302', 'active_substance': 'ziconotide', 'eu_mah_current': 'Esteve Pharmaceuticals GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-21-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/551', 'ema_number_certainty': '0.8913043478260869'}"
EU-1-04-303,"{'atc_code': 'A16AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Orfadin', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/303', 'active_substance': 'Nitisinone', 'eu_mah_current': 'Swedish Orphan Biovitrum International AB', 'orphan_status': 'h', 'eu_aut_date': '02-21-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/555', 'ema_number_certainty': '0.926829268292683'}"
EU-1-04-305,"{'atc_code': 'J05AR03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Truvada', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/305', 'active_substance': 'emtricitabine / tenofovir disoproxil fumarate', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '02-21-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/594', 'ema_number_certainty': '0.9494949494949495'}"
EU-1-04-304,"{'atc_code': 'N04BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Azilect', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/304', 'active_substance': 'rasagiline', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-21-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/574', 'ema_number_certainty': '0.9672131147540983'}"
EU-1-04-306,"{'atc_code': 'A04AA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aloxi', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/306', 'active_substance': 'Palonosetron', 'eu_mah_current': 'Helsinn Birex Pharmaceuticals Ltd', 'orphan_status': 'h', 'eu_aut_date': '03-22-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/563', 'ema_number_certainty': '1.0'}"
EU-1-04-307,"{'atc_code': 'N03AX15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zonegran', 'status_type': 'a', 'eu_pnumber': 'EU/1/04/307', 'active_substance': 'zonisamide', 'eu_mah_current': 'Amdipharm Limited', 'orphan_status': 'h', 'eu_aut_date': '03-10-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/577', 'ema_number_certainty': '0.8648648648648649'}"
EU-1-05-308,"{'atc_code': 'M05BA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aclasta', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/308', 'active_substance': 'zoledronic acid', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '04-15-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/595', 'ema_number_certainty': '0.9130434782608695'}"
EU-1-05-310,"{'atc_code': 'M05BB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fosavance', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/310', 'active_substance': 'Alendronate Sodium / Colecalciferol', 'eu_mah_current': 'N.V. Organon', 'orphan_status': 'h', 'eu_aut_date': '08-24-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/619', 'ema_number_certainty': '0.85'}"
EU-1-05-311,"{'atc_code': 'L01EB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tarceva', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/311', 'active_substance': 'Erlotinib', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-19-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/618', 'ema_number_certainty': '0.9302325581395349'}"
EU-1-05-312,"{'atc_code': 'N07XX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xyrem', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/312', 'active_substance': 'Sodium oxybate', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '10-13-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/593', 'ema_number_certainty': '0.8666666666666667'}"
EU-1-05-315,"{'atc_code': 'J05AE09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'APTIVUS', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/315', 'active_substance': 'Tipranavir', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-25-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/631', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-05-316,"{'atc_code': 'C01EB17', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Procoralan', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/316', 'active_substance': 'Ivabradine', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'h', 'eu_aut_date': '10-25-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/597', 'ema_number_certainty': '0.9166666666666666'}"
EU-1-05-317,"{'atc_code': 'C01EB17', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Corlentor', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/317', 'active_substance': 'Ivabradine', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'h', 'eu_aut_date': '10-25-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/598', 'ema_number_certainty': '0.9444444444444444'}"
EU-1-05-320,"{'atc_code': 'J02AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Noxafil', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/320', 'active_substance': 'Posaconazole', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-25-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/610', 'ema_number_certainty': '0.8409090909090909'}"
EU-1-05-319,"{'atc_code': 'R03DX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xolair', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/319', 'active_substance': 'omalizumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '10-25-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/606', 'ema_number_certainty': '0.92'}"
EU-1-05-318,"{'atc_code': 'G04BE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Revatio', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/318', 'active_substance': 'sildenafil', 'eu_mah_current': 'Upjohn EESV', 'orphan_status': 'h', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/638', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-05-322,"{'atc_code': 'V10X', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Yttriga', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/322', 'active_substance': 'Yttrium (90Y) Chloride', 'eu_mah_current': 'Eckert &amp; Ziegler Radiopharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-19-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/596', 'ema_number_certainty': '0.9230769230769231'}"
EU-1-05-323,"{'atc_code': 'J07BD54', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ProQuad', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/323', 'active_substance': 'Measles, Mumps, Rubella and Varicella Vaccine (Live)', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-06-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/622', 'ema_number_certainty': '0.8840579710144928'}"
EU-1-05-324,"{'atc_code': 'A16AB08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Naglazyme', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/324', 'active_substance': 'galsulfase', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'h', 'eu_aut_date': '01-24-2006', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/640', 'ema_number_certainty': '0.8367346938775511'}"
EU-1-05-328,"{'atc_code': 'J01XX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cubicin', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/328', 'active_substance': 'Daptomycin', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-19-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/637', 'ema_number_certainty': '0.9090909090909091'}"
EU-1-05-329,"{'atc_code': 'J06BA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kiovig', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/329', 'active_substance': 'Human normal immunoglobulin (IVIg)', 'eu_mah_current': 'Baxter AG', 'orphan_status': 'h', 'eu_aut_date': '01-19-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/628', 'ema_number_certainty': '0.8823529411764706'}"
EU-1-05-330,"{'atc_code': 'J07BH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rotarix', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/330', 'active_substance': 'Rotavirus vaccine, live', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '02-21-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/639', 'ema_number_certainty': '0.8936170212765957'}"
EU-1-05-331,"{'atc_code': 'N04BC09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Neupro', 'status_type': 'a', 'eu_pnumber': 'EU/1/05/331', 'active_substance': 'Rotigotine', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '02-15-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/626', 'ema_number_certainty': '0.9577464788732394'}"
EU-1-06-332,"{'atc_code': 'H01AC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Omnitrope', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/332', 'active_substance': 'Somatropin', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-12-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/607', 'ema_number_certainty': '0.9032258064516129'}"
EU-1-06-333,"{'atc_code': 'A16AB07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Myozyme', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/333', 'active_substance': 'alglucosidase alfa', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-29-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/636', 'ema_number_certainty': '0.7674418604651163'}"
EU-1-06-336,"{'atc_code': 'J01AA12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tygacil', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/336', 'active_substance': 'Tigecycline', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/644', 'ema_number_certainty': '0.9259259259259259'}"
EU-1-06-337,"{'atc_code': 'J07BD52', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'M-M-RVAXPRO', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/337', 'active_substance': 'Measles, Mumps and Rubella Vaccine (Live)', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-05-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/604', 'ema_number_certainty': '0.7755102040816326'}"
EU-1-06-334,"{'atc_code': 'L01BB06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Evoltra', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/334', 'active_substance': 'clofarabine', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-29-2006', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/613', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-06-338,"{'atc_code': 'S01ED51', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'DuoTrav', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/338', 'active_substance': 'Travoprost / Timolol', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '04-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/665', 'ema_number_certainty': '0.9411764705882353'}"
EU-1-06-340,"{'atc_code': 'S01ED51', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ganfort', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/340', 'active_substance': 'bimatoprost / timolol', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '05-19-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/668', 'ema_number_certainty': '0.7741935483870968'}"
EU-1-06-341,"{'atc_code': 'J07BK02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zostavax', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/341', 'active_substance': 'shingles (herpes zoster) vaccine (live)', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-19-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/674', 'ema_number_certainty': '0.8412698412698413'}"
EU-1-06-342,"{'atc_code': 'L01EX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nexavar', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/342', 'active_substance': 'Sorafenib', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '07-19-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/690', 'ema_number_certainty': '0.9090909090909091'}"
EU-1-06-346,"{'atc_code': 'L04AA23', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tysabri', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/346', 'active_substance': 'Natalizumab', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-27-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/603', 'ema_number_certainty': '0.8354430379746836'}"
EU-1-06-347,"{'atc_code': 'L01EX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sutent', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/347', 'active_substance': 'sunitinib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '07-19-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/687', 'ema_number_certainty': '0.896551724137931'}"
EU-1-06-343,"{'atc_code': 'J05AF10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Baraclude', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/343', 'active_substance': 'entecavir', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-26-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/623', 'ema_number_certainty': '0.8679245283018868'}"
EU-1-06-348,"{'atc_code': 'J07BH02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'RotaTeq', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/348', 'active_substance': 'Rotavirus vaccine (live, oral)', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-27-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/669', 'ema_number_certainty': '0.8'}"
EU-1-06-350,"{'atc_code': 'V03AF02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Savene', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/350', 'active_substance': 'Dexrazoxane', 'eu_mah_current': 'Clinigen Healthcare B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/682', 'ema_number_certainty': '0.9583333333333334'}"
EU-1-06-354,"{'atc_code': 'A10BD05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Competact', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/354', 'active_substance': 'Pioglitazone / metformin', 'eu_mah_current': 'CHEPLAPHARM Arzneimittel GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/655', 'ema_number_certainty': '0.975609756097561'}"
EU-1-06-356,"{'atc_code': 'V03AC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Exjade', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/356', 'active_substance': 'deferasirox', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/670', 'ema_number_certainty': '0.7692307692307693'}"
EU-1-06-357,"{'atc_code': 'J07BM01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Gardasil', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/357', 'active_substance': 'Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-20-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/703', 'ema_number_certainty': '0.8666666666666667'}"
EU-1-06-359,"{'atc_code': 'N07BC51', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Suboxone', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/359', 'active_substance': 'buprenorphine / naloxone', 'eu_mah_current': 'Indivior Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '09-26-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/697', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-06-360,"{'atc_code': 'N07BA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Champix', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/360', 'active_substance': 'varenicline tartrate', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '09-26-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/699', 'ema_number_certainty': '0.9354838709677419'}"
EU-1-06-361,"{'atc_code': 'V08DA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Luminity', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/361', 'active_substance': 'perflutren', 'eu_mah_current': 'Lantheus EU Limited', 'orphan_status': 'h', 'eu_aut_date': '09-20-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/654', 'ema_number_certainty': '0.84'}"
EU-1-06-362,"{'atc_code': 'A10BJ01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Byetta', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/362', 'active_substance': 'exenatide', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '11-20-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/698', 'ema_number_certainty': '0.8444444444444444'}"
EU-1-06-363,"{'atc_code': 'L01XE06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sprycel', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/363', 'active_substance': 'Dasatinib', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '11-20-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/709', 'ema_number_certainty': '0.8431372549019608'}"
EU-1-06-367,"{'atc_code': 'N03AX17', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Diacomit', 'status_type': 'a', 'eu_pnumber': 'EU/1/06/367', 'active_substance': 'Stiripentol', 'eu_mah_current': 'Biocodex', 'orphan_status': 'h', 'eu_aut_date': '01-04-2007', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/664', 'ema_number_certainty': '0.8947368421052632'}"
EU-1-07-387,"{'atc_code': 'L04AD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Advagraf', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/387', 'active_substance': 'Tacrolimus', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-23-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/712', 'ema_number_certainty': '0.7894736842105263'}"
EU-1-07-386,"{'atc_code': 'G04BD11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Toviaz', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/386', 'active_substance': 'fesoterodine', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/723', 'ema_number_certainty': '0.8536585365853658'}"
EU-1-07-389,"{'atc_code': 'L04AA24', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Orencia', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/389', 'active_substance': 'abatacept', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '05-21-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/701', 'ema_number_certainty': '0.8983050847457628'}"
EU-1-07-391,"{'atc_code': 'L04AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Revlimid', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/391', 'active_substance': 'Lenalidomide', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/717', 'ema_number_certainty': '0.8705882352941177'}"
EU-1-07-392,"{'atc_code': 'N05CH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Circadin', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/392', 'active_substance': 'Melatonin', 'eu_mah_current': 'RAD Neurim Pharmaceuticals EEC SARL', 'orphan_status': 'h', 'eu_aut_date': '06-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/695', 'ema_number_certainty': '0.9166666666666666'}"
EU-1-07-393,"{'atc_code': 'L04AA25', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Soliris', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/393', 'active_substance': 'Eculizumab', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'h', 'eu_aut_date': '06-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/791', 'ema_number_certainty': '0.8620689655172413'}"
EU-1-07-396,"{'atc_code': 'G03GA30', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pergoveris', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/396', 'active_substance': 'follitropin alfa / lutropin alfa', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-25-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/714', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-07-395,"{'atc_code': 'N05AX13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Invega', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/395', 'active_substance': 'paliperidone', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '06-25-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/746', 'ema_number_certainty': '0.975609756097561'}"
EU-1-07-397,"{'atc_code': 'L01XX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Siklos', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/397', 'active_substance': 'hydroxycarbamide', 'eu_mah_current': 'Addmedica', 'orphan_status': 'h', 'eu_aut_date': '06-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/689', 'ema_number_certainty': '0.8285714285714286'}"
EU-1-07-400,"{'atc_code': 'B03XA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mircera', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/400', 'active_substance': 'methoxy polyethylene glycol-epoetin beta', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/739', 'ema_number_certainty': '0.9361702127659575'}"
EU-1-07-399,"{'atc_code': 'R06AX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aerinaze', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/399', 'active_substance': 'desloratadine; pseudoephedrine sulphate', 'eu_mah_current': 'N.V. Organon', 'orphan_status': 'h', 'eu_aut_date': '07-30-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/772', 'ema_number_certainty': '0.7666666666666667'}"
EU-1-07-401,"{'atc_code': 'A08AB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'alli', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/401', 'active_substance': 'Orlistat', 'eu_mah_current': 'GlaxoSmithKline Dungarvan Limited', 'orphan_status': 'h', 'eu_aut_date': '07-23-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/854', 'ema_number_certainty': '0.9487179487179487'}"
EU-1-07-402,"{'atc_code': 'H01AC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'INCRELEX', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/402', 'active_substance': 'Mecasermin', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'h', 'eu_aut_date': '08-03-2007', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/704', 'ema_number_certainty': '0.8'}"
EU-1-07-403,"{'atc_code': 'L01BB07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Atriance', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/403', 'active_substance': 'nelarabine', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-22-2007', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/752', 'ema_number_certainty': '0.7894736842105263'}"
EU-1-07-404,"{'atc_code': 'J06BA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Flebogamma DIF', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/404', 'active_substance': 'Human normal immunoglobulin (IVIg)', 'eu_mah_current': 'Instituto Grifols, S.A.', 'orphan_status': 'h', 'eu_aut_date': '08-23-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/781', 'ema_number_certainty': '0.9583333333333334'}"
EU-1-07-412,"{'atc_code': 'B03XA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Abseamed', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/412', 'active_substance': 'epoetin alfa', 'eu_mah_current': 'Medice Arzneimittel P&#252;tter GmbH &amp; Co KG', 'orphan_status': 'h', 'eu_aut_date': '08-28-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/727', 'ema_number_certainty': '0.9111111111111111'}"
EU-1-07-405,"{'atc_code': 'C09XA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rasilez', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/405', 'active_substance': 'aliskiren', 'eu_mah_current': 'Noden Pharma DAC', 'orphan_status': 'h', 'eu_aut_date': '08-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/780', 'ema_number_certainty': '0.9833333333333333'}"
EU-1-07-410,"{'atc_code': 'B03XA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Binocrit', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/410', 'active_substance': 'epoetin alfa', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-28-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/725', 'ema_number_certainty': '1.0'}"
EU-1-07-411,"{'atc_code': 'B03XA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Epoetin alfa Hexal', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/411', 'active_substance': 'epoetin alfa', 'eu_mah_current': 'Hexal AG', 'orphan_status': 'h', 'eu_aut_date': '08-28-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/726', 'ema_number_certainty': '0.9534883720930233'}"
EU-1-07-413,"{'atc_code': 'L01XD04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Gliolan', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/413', 'active_substance': '5-aminolevulinic acid hydrochloride', 'eu_mah_current': 'photonamic GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '09-07-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/744', 'ema_number_certainty': '0.7272727272727273'}"
EU-1-07-420,"{'atc_code': 'V03AB33', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cyanokit', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/420', 'active_substance': 'hydroxocobalamin', 'eu_mah_current': 'SERB S.A.', 'orphan_status': 'h', 'eu_aut_date': '11-23-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/806', 'ema_number_certainty': '1.0'}"
EU-1-07-425,"{'atc_code': 'A10BD08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Eucreas', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/425', 'active_substance': 'vildagliptin / metformin hydrochloride', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/807', 'ema_number_certainty': '0.7837837837837838'}"
EU-1-07-422,"{'atc_code': 'L01XE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tasigna', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/422', 'active_substance': 'Nilotinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-19-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/798', 'ema_number_certainty': '0.8714285714285714'}"
EU-1-07-423,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vectibix', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/423', 'active_substance': 'panitumumab', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-03-2007', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/741', 'ema_number_certainty': '0.8947368421052632'}"
EU-1-07-427,"{'atc_code': 'N05AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Olanzapine Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/427', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-12-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/810', 'ema_number_certainty': '0.90625'}"
EU-1-07-431,"{'atc_code': 'B03XA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Retacrit', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/431', 'active_substance': 'epoetin zeta', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '12-18-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/872', 'ema_number_certainty': '0.8870967741935484'}"
EU-1-07-432,"{'atc_code': 'B03XA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Silapo', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/432', 'active_substance': 'epoetin zeta', 'eu_mah_current': 'STADA Arzneimittel AG', 'orphan_status': 'h', 'eu_aut_date': '12-18-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/760', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-07-433,"{'atc_code': 'S01BC10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nevanac', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/433', 'active_substance': 'nepafenac', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '12-11-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/818', 'ema_number_certainty': '0.9565217391304348'}"
EU-1-07-428,"{'atc_code': 'L01CD01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Abraxane', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/428', 'active_substance': 'paclitaxel', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '01-11-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/778', 'ema_number_certainty': '0.8823529411764706'}"
EU-1-07-434,"{'atc_code': 'R01AD12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Avamys', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/434', 'active_substance': 'Fluticasone furoate', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '01-11-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/770', 'ema_number_certainty': '0.8518518518518519'}"
EU-1-07-436,"{'atc_code': 'J05AX08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Isentress', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/436', 'active_substance': 'raltegravir', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-20-2007', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/860', 'ema_number_certainty': '0.9'}"
EU-1-07-438,"{'atc_code': 'L04AA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Myfenax', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/438', 'active_substance': 'Mycophenolate mofetil', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-21-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/884', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-07-439,"{'atc_code': 'L04AA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mycophenolate mofetil Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/439', 'active_substance': 'Mycophenolate mofetil', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-21-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/882', 'ema_number_certainty': '0.7941176470588235'}"
EU-1-07-440,"{'atc_code': 'L01XE07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tyverb', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/440', 'active_substance': 'lapatinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '06-10-2008', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/795', 'ema_number_certainty': '0.8775510204081632'}"
EU-1-08-441,"{'atc_code': 'N02AB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Effentora', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/441', 'active_substance': 'fentanyl citrate', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-04-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/833', 'ema_number_certainty': '0.7428571428571429'}"
EU-1-08-442,"{'atc_code': 'B01AE07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pradaxa', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/442', 'active_substance': 'dabigatran etexilate mesilate', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-18-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/829', 'ema_number_certainty': '0.8356164383561644'}"
EU-1-08-446,"{'atc_code': 'J06BA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Privigen', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/446', 'active_substance': 'Human normal immunoglobulin (IVIg)', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-25-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/831', 'ema_number_certainty': '0.9117647058823529'}"
EU-1-08-447,"{'atc_code': 'M04AA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Adenuric', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/447', 'active_substance': 'febuxostat', 'eu_mah_current': 'Menarini International Operations Luxembourg S.A.', 'orphan_status': 'h', 'eu_aut_date': '04-21-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/777', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-95-003,"{'atc_code': 'L03AB08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Betaferon', 'status_type': 'a', 'eu_pnumber': 'EU/1/95/003', 'active_substance': 'Interferon beta-1b', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '11-30-1995', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/81', 'ema_number_certainty': '0.9625'}"
EU-1-95-002,"{'atc_code': 'L01CD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Taxotere', 'status_type': 'a', 'eu_pnumber': 'EU/1/95/002', 'active_substance': 'Docetaxel', 'eu_mah_current': 'Sanofi Mature IP', 'orphan_status': 'h', 'eu_aut_date': '11-27-1995', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/73', 'ema_number_certainty': '0.9652173913043478'}"
EU-1-96-005,"{'atc_code': 'L04AA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'CellCept', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/005', 'active_substance': 'Mycophenolate mofetil', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-14-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/82', 'ema_number_certainty': '0.912621359223301'}"
EU-1-96-004,"{'atc_code': 'L02BA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fareston', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/004', 'active_substance': 'Toremifene', 'eu_mah_current': 'Orion Corporation', 'orphan_status': 'h', 'eu_aut_date': '02-14-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/91', 'ema_number_certainty': '0.9'}"
EU-1-96-006,"{'atc_code': 'B02BD08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NovoSeven', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/006', 'active_substance': 'Eptacog alfa (activated)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '02-23-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/74', 'ema_number_certainty': '0.9365079365079365'}"
EU-1-96-007,"{'atc_code': 'A10AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Humalog', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/007', 'active_substance': 'Insulin lispro', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-30-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/88', 'ema_number_certainty': '0.9734513274336283'}"
EU-1-96-008,"{'atc_code': 'G03GA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Puregon', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/008', 'active_substance': 'follitropin beta', 'eu_mah_current': 'N.V. Organon', 'orphan_status': 'h', 'eu_aut_date': '05-03-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/86', 'ema_number_certainty': '0.8987341772151899'}"
EU-1-96-012,"{'atc_code': 'M05BA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bondronat', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/012', 'active_substance': 'Ibandronic acid', 'eu_mah_current': 'Atnahs Pharma Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-25-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/101', 'ema_number_certainty': '0.8833333333333333'}"
EU-1-97-033,"{'atc_code': 'L03AB07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Avonex', 'status_type': 'a', 'eu_pnumber': 'EU/1/97/033', 'active_substance': 'Interferon Beta - 1a', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-13-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/102', 'ema_number_certainty': '0.9478260869565217'}"
EU-1-96-018,"{'atc_code': 'B01AD07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rapilysin', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/018', 'active_substance': 'Reteplase', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '08-29-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/105', 'ema_number_certainty': '0.9791666666666666'}"
EU-1-96-010,"{'atc_code': 'N07XX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rilutek', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/010', 'active_substance': 'Riluzole', 'eu_mah_current': 'Sanofi Mature IP', 'orphan_status': 'h', 'eu_aut_date': '06-10-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/109', 'ema_number_certainty': '0.9148936170212766'}"
EU-1-96-020,"{'atc_code': 'J07BC20', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Twinrix Adult', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/020', 'active_substance': 'Hepatitis A and hepatitis B vaccine', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '09-20-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/112', 'ema_number_certainty': '0.9459459459459459'}"
EU-1-96-022,"{'atc_code': 'N05AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zyprexa', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/022', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-27-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/115', 'ema_number_certainty': '0.9732142857142857'}"
EU-1-97-045,"{'atc_code': 'V04CX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Helicobacter Test INFAI', 'status_type': 'a', 'eu_pnumber': 'EU/1/97/045', 'active_substance': '&#185;&#179;C - urea', 'eu_mah_current': 'INFAI GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-14-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/140', 'ema_number_certainty': '0.9166666666666666'}"
EU-1-97-046,"{'atc_code': 'C09CA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aprovel', 'status_type': 'a', 'eu_pnumber': 'EU/1/97/046', 'active_substance': 'Irbesartan', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '08-27-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/141', 'ema_number_certainty': '0.9428571428571428'}"
EU-1-97-047,"{'atc_code': 'B02BD04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'BeneFIX', 'status_type': 'a', 'eu_pnumber': 'EU/1/97/047', 'active_substance': 'Nonacog alfa', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '08-27-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/139', 'ema_number_certainty': '0.9523809523809523'}"
EU-1-97-049,"{'atc_code': 'C09CA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Karvea', 'status_type': 'a', 'eu_pnumber': 'EU/1/97/049', 'active_substance': 'Irbesartan', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '08-27-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/142', 'ema_number_certainty': '0.9214285714285714'}"
EU-1-97-051,"{'atc_code': 'N04BC05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mirapexin', 'status_type': 'a', 'eu_pnumber': 'EU/1/97/051', 'active_substance': 'pramipexole', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-23-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/134', 'ema_number_certainty': '0.9358974358974359'}"
EU-1-97-050,"{'atc_code': 'N04BC05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sifrol', 'status_type': 'a', 'eu_pnumber': 'EU/1/97/050', 'active_substance': 'pramipexole', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-14-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/133', 'ema_number_certainty': '0.9027777777777778'}"
EU-1-97-053,"{'atc_code': 'A16AB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cerezyme', 'status_type': 'a', 'eu_pnumber': 'EU/1/97/053', 'active_substance': 'imiglucerase', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-17-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/157', 'ema_number_certainty': '0.8955223880597015'}"
EU-1-97-057,"{'atc_code': 'V10BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Quadramet', 'status_type': 'a', 'eu_pnumber': 'EU/1/97/057', 'active_substance': 'Samarium [153 Sm] lexidronam pentasodium', 'eu_mah_current': 'CIS bio international', 'orphan_status': 'h', 'eu_aut_date': '02-05-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/150', 'ema_number_certainty': '1.0'}"
EU-1-97-055,"{'atc_code': 'J05AG01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Viramune', 'status_type': 'a', 'eu_pnumber': 'EU/1/97/055', 'active_substance': 'nevirapine', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-05-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/183', 'ema_number_certainty': '0.9368421052631579'}"
EU-1-00-135,"{'atc_code': 'V09AB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'DaTSCAN', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/135', 'active_substance': 'Ioflupane (123I)', 'eu_mah_current': 'GE Healthcare B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-27-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/266', 'ema_number_certainty': '0.9545454545454546'}"
EU-1-00-140,"{'atc_code': 'S01LA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Visudyne', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/140', 'active_substance': 'verteporfin', 'eu_mah_current': 'CHEPLAPHARM Arzneimittel GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-27-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/305', 'ema_number_certainty': '0.961038961038961'}"
EU-1-00-142,"{'atc_code': 'A10AD05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NovoMix', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/142', 'active_substance': 'Insulin aspart', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '08-01-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/308', 'ema_number_certainty': '0.9722222222222222'}"
EU-1-00-143,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'KOGENATE Bayer', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/143', 'active_substance': 'Recombinant coagulation factor VIII (octocog alfa)', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '08-04-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/275', 'ema_number_certainty': '1.0'}"
EU-1-00-145,"{'atc_code': 'L01XC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Herceptin', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/145', 'active_substance': 'trastuzumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-28-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/278', 'ema_number_certainty': '0.9069767441860465'}"
EU-1-00-146,"{'atc_code': 'N03AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Keppra', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/146', 'active_substance': 'levetiracetam', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '09-29-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/277', 'ema_number_certainty': '0.9465648854961832'}"
EU-1-00-149,"{'atc_code': 'L01XX22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Panretin', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/149', 'active_substance': 'alitretinoin', 'eu_mah_current': 'Amdipharm Limited', 'orphan_status': 'h', 'eu_aut_date': '10-11-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/279', 'ema_number_certainty': '0.8709677419354839'}"
EU-1-00-152,"{'atc_code': 'J07CA09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Infanrix hexa', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/152', 'active_substance': 'diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine (adsorbed)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '10-23-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/296', 'ema_number_certainty': '0.968503937007874'}"
EU-1-00-150,"{'atc_code': 'A10BG03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Actos', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/150', 'active_substance': 'pioglitazone', 'eu_mah_current': 'CHEPLAPHARM Arzneimittel GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-13-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/285', 'ema_number_certainty': '0.9636363636363636'}"
EU-1-00-155,"{'atc_code': 'G03GA07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Luveris', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/155', 'active_substance': 'Lutropin alfa', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-29-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/292', 'ema_number_certainty': '0.9622641509433962'}"
EU-1-00-156,"{'atc_code': 'J05AR02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trizivir', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/156', 'active_substance': 'abacavir, lamivudine, zidovudine', 'eu_mah_current': 'ViiV Healthcare BV', 'orphan_status': 'h', 'eu_aut_date': '12-28-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/338', 'ema_number_certainty': '0.8902439024390244'}"
EU-1-00-157,"{'atc_code': 'R06AX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Azomyr', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/157', 'active_substance': 'desloratadine', 'eu_mah_current': 'N.V. Organon', 'orphan_status': 'h', 'eu_aut_date': '01-15-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/310', 'ema_number_certainty': '0.8767123287671232'}"
EU-1-00-160,"{'atc_code': 'R06AX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aerius', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/160', 'active_substance': 'desloratadine', 'eu_mah_current': 'N.V. Organon', 'orphan_status': 'h', 'eu_aut_date': '01-15-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/313', 'ema_number_certainty': '0.8695652173913043'}"
EU-1-00-161,"{'atc_code': 'R06AX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Neoclarityn', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/161', 'active_substance': 'desloratadine', 'eu_mah_current': 'N.V. Organon', 'orphan_status': 'h', 'eu_aut_date': '01-15-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/314', 'ema_number_certainty': '0.8507462686567164'}"
EU-1-00-162,"{'atc_code': 'A10BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Prandin', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/162', 'active_substance': 'Repaglinide', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '01-29-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/362', 'ema_number_certainty': '1.0'}"
EU-1-00-163,"{'atc_code': 'L01BC06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xeloda', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/163', 'active_substance': 'capecitabine', 'eu_mah_current': 'CHEPLAPHARM Arzneimittel GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-02-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/316', 'ema_number_certainty': '0.855072463768116'}"
EU-1-00-166,"{'atc_code': 'M03AX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NeuroBloc', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/166', 'active_substance': 'Botulinum Toxin Type B', 'eu_mah_current': 'Sloan Pharma S.a.r.l.', 'orphan_status': 'h', 'eu_aut_date': '01-22-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/301', 'ema_number_certainty': '0.9459459459459459'}"
EU-1-00-165,"{'atc_code': 'G03GA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ovitrelle', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/165', 'active_substance': 'Choriogonadotrophin alfa', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-02-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/320', 'ema_number_certainty': '0.9387755102040817'}"
EU-1-00-164,"{'atc_code': 'H01AC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NutropinAq', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/164', 'active_substance': 'Somatropin', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'h', 'eu_aut_date': '02-16-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/315', 'ema_number_certainty': '0.9318181818181818'}"
EU-1-00-169,"{'atc_code': 'B01AD11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Metalyse', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/169', 'active_substance': 'tenecteplase', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-23-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/306', 'ema_number_certainty': '0.9130434782608695'}"
EU-1-00-170,"{'atc_code': 'V03AF07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fasturtec', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/170', 'active_substance': 'rasburicase', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '02-23-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/331', 'ema_number_certainty': '0.9361702127659575'}"
EU-1-01-171,"{'atc_code': 'L04AA10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rapamune', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/171', 'active_substance': 'sirolimus', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-13-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/273', 'ema_number_certainty': '0.935251798561151'}"
EU-1-01-172,"{'atc_code': 'J05AR10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kaletra', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/172', 'active_substance': 'lopinavir / Ritonavir', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '03-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/368', 'ema_number_certainty': '0.9323308270676691'}"
EU-1-01-173,"{'atc_code': 'D11AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vaniqa', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/173', 'active_substance': 'eflornithine', 'eu_mah_current': 'Almirall, S.A.', 'orphan_status': 'h', 'eu_aut_date': '03-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/325', 'ema_number_certainty': '0.9333333333333333'}"
EU-1-01-176,"{'atc_code': 'M05BA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zometa', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/176', 'active_substance': 'zoledronic acid', 'eu_mah_current': 'Phoenix Labs Unlimited Company', 'orphan_status': 'h', 'eu_aut_date': '03-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/336', 'ema_number_certainty': '0.9183673469387755'}"
EU-1-01-177,"{'atc_code': 'V08DA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'SonoVue', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/177', 'active_substance': 'sulphur hexafluoride', 'eu_mah_current': 'Bracco International B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-26-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/303', 'ema_number_certainty': '0.8518518518518519'}"
EU-1-01-178,"{'atc_code': 'L01XF03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Targretin', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/178', 'active_substance': 'bexarotene', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-29-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/326', 'ema_number_certainty': '0.9285714285714286'}"
EU-1-01-183,"{'atc_code': 'J07BC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'HBVAXPRO', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/183', 'active_substance': 'Recombinant Hepatitis B virus small surface antigen (HbsAg)', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-27-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/373', 'ema_number_certainty': '0.8627450980392157'}"
EU-1-01-185,"{'atc_code': 'B03XA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aranesp', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/185', 'active_substance': 'darbepoetin alfa', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-08-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/332', 'ema_number_certainty': '0.9711538461538461'}"
EU-1-01-190,"{'atc_code': 'B01AD12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ceprotin', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/190', 'active_substance': 'Protein C', 'eu_mah_current': 'Baxter AG', 'orphan_status': 'h', 'eu_aut_date': '07-16-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/334', 'ema_number_certainty': '0.9047619047619048'}"
EU-1-01-188,"{'atc_code': 'A16AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fabrazyme', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/188', 'active_substance': 'Agalsidase beta', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-03-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/370', 'ema_number_certainty': '0.8939393939393939'}"
EU-1-01-189,"{'atc_code': 'A16AB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Replagal', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/189', 'active_substance': 'Agalsidase alfa', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'h', 'eu_aut_date': '08-03-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/369', 'ema_number_certainty': '0.8974358974358975'}"
EU-1-01-194,"{'atc_code': 'R07AX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'INOmax', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/194', 'active_substance': 'Nitric oxide', 'eu_mah_current': 'Linde Healthcare AB', 'orphan_status': 'h', 'eu_aut_date': '08-01-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/337', 'ema_number_certainty': '0.9210526315789473'}"
EU-1-01-195,"{'atc_code': 'A10AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Liprolog', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/195', 'active_substance': 'Insulin lispro', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-01-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/393', 'ema_number_certainty': '0.9382716049382716'}"
EU-1-01-196,"{'atc_code': 'J02AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'CANCIDAS', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/196', 'active_substance': 'caspofungin', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-24-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/379', 'ema_number_certainty': '0.9444444444444444'}"
EU-1-01-197,"{'atc_code': 'L01XD05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Foscan', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/197', 'active_substance': 'temoporfin', 'eu_mah_current': 'biolitec Pharma Ltd', 'orphan_status': 'h', 'eu_aut_date': '10-24-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/318', 'ema_number_certainty': '1.0'}"
EU-1-01-198,"{'atc_code': 'L01EA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Glivec', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/198', 'active_substance': 'Imatinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-07-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/406', 'ema_number_certainty': '0.8941176470588236'}"
EU-1-01-199,"{'atc_code': 'S01EE04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Travatan', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/199', 'active_substance': 'Travoprost', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-27-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/390', 'ema_number_certainty': '0.9791666666666666'}"
EU-1-01-200,"{'atc_code': 'J05AF07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Viread', 'status_type': 'a', 'eu_pnumber': 'EU/1/01/200', 'active_substance': 'tenofovir disoproxil fumarate', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '02-05-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/419', 'ema_number_certainty': '0.9612403100775194'}"
EU-1-02-201,"{'atc_code': 'D11AH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Protopic', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/201', 'active_substance': 'Tacrolimus', 'eu_mah_current': 'Leo Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '02-28-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/374', 'ema_number_certainty': '0.9444444444444444'}"
EU-1-02-205,"{'atc_code': 'S01EE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lumigan', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/205', 'active_substance': 'Bimatoprost', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '03-08-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/391', 'ema_number_certainty': '0.8181818181818182'}"
EU-1-02-203,"{'atc_code': 'L04AC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kineret', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/203', 'active_substance': 'Anakinra', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'h', 'eu_aut_date': '03-08-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/363', 'ema_number_certainty': '0.851063829787234'}"
EU-1-02-209,"{'atc_code': 'M01AH04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dynastat', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/209', 'active_substance': 'Parecoxib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/381', 'ema_number_certainty': '0.8833333333333333'}"
EU-1-02-216,"{'atc_code': 'J01DH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Invanz', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/216', 'active_substance': 'Ertapenem', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-18-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/389', 'ema_number_certainty': '0.9148936170212766'}"
EU-1-02-217,"{'atc_code': 'S01GX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Opatanol', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/217', 'active_substance': 'Olopatadine', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '05-17-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/407', 'ema_number_certainty': '0.8518518518518519'}"
EU-1-02-219,"{'atc_code': 'N06DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ebixa', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/219', 'active_substance': 'Memantine', 'eu_mah_current': 'H. Lundbeck A/S', 'orphan_status': 'h', 'eu_aut_date': '05-15-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/463', 'ema_number_certainty': '0.9444444444444444'}"
EU-1-02-218,"{'atc_code': 'N06DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Axura', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/218', 'active_substance': 'Memantine', 'eu_mah_current': 'Merz Pharmaceuticals GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-17-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/378', 'ema_number_certainty': '0.9807692307692307'}"
EU-1-02-220,"{'atc_code': 'C02KX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tracleer', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/220', 'active_substance': 'bosentan', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '05-15-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/401', 'ema_number_certainty': '0.9066666666666666'}"
EU-1-02-221,"{'atc_code': 'L03AB11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pegasys', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/221', 'active_substance': 'peginterferon alfa-2a', 'eu_mah_current': 'zr pharma&amp; GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-20-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/395', 'ema_number_certainty': '0.9066666666666666'}"
EU-1-02-222,"{'atc_code': 'J05AH02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tamiflu', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/222', 'active_substance': 'Oseltamivir', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-20-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/402', 'ema_number_certainty': '0.9191919191919192'}"
EU-1-02-224,"{'atc_code': 'J07BC20', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ambirix', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/224', 'active_substance': 'Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '08-30-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/426', 'ema_number_certainty': '0.9545454545454546'}"
EU-1-02-223,"{'atc_code': 'G03AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Evra', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/223', 'active_substance': 'Norelgestromin / Ethinyl estradiol', 'eu_mah_current': 'Gedeon Richter Plc.', 'orphan_status': 'h', 'eu_aut_date': '08-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/410', 'ema_number_certainty': '0.8611111111111112'}"
EU-1-02-226,"{'atc_code': 'M05BC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'InductOs', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/226', 'active_substance': 'Dibotermin alfa', 'eu_mah_current': 'Medtronic BioPharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-09-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/408', 'ema_number_certainty': '0.9841269841269841'}"
EU-1-02-227,"{'atc_code': 'L03AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Neulasta', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/227', 'active_substance': 'Pegfilgrastim', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/420', 'ema_number_certainty': '0.9264705882352942'}"
EU-1-02-229,"{'atc_code': 'A10AD01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Actraphane', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/229', 'active_substance': 'Insulin human (rDNA)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '10-07-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/427', 'ema_number_certainty': '0.9629629629629629'}"
EU-1-02-230,"{'atc_code': 'A10AB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Actrapid', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/230', 'active_substance': 'Insulin human (rDNA)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '10-07-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/424', 'ema_number_certainty': '0.9791666666666666'}"
EU-1-02-234,"{'atc_code': 'A10AC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Protaphane', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/234', 'active_substance': 'Insulin human (rDNA)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '10-07-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/442', 'ema_number_certainty': '0.9807692307692307'}"
EU-1-02-233,"{'atc_code': 'A10AC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Insulatard', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/233', 'active_substance': 'Insulin human (rDNA)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '10-07-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/441', 'ema_number_certainty': '0.9807692307692307'}"
EU-1-02-231,"{'atc_code': 'A10AD01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mixtard', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/231', 'active_substance': 'Insulin human (rDNA)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '10-07-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/428', 'ema_number_certainty': '0.9814814814814815'}"
EU-1-02-237,"{'atc_code': 'G04BE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cialis', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/237', 'active_substance': 'tadalafil', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-12-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/436', 'ema_number_certainty': '0.9605263157894737'}"
EU-1-02-240,"{'atc_code': 'H01AX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Somavert', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/240', 'active_substance': 'Pegvisomant', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '11-13-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/409', 'ema_number_certainty': '0.8955223880597015'}"
EU-1-02-238,"{'atc_code': 'A16AX06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zavesca', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/238', 'active_substance': 'Miglustat', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '11-20-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/435', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-02-246,"{'atc_code': 'A16AA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Carbaglu', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/246', 'active_substance': 'Carglumic acid', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'h', 'eu_aut_date': '01-24-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/461', 'ema_number_certainty': '0.92'}"
EU-1-03-248,"{'atc_code': 'G04BE09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Levitra', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/248', 'active_substance': 'Vardenafil', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '03-06-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/475', 'ema_number_certainty': '0.92'}"
EU-1-03-251,"{'atc_code': 'J05AF08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hepsera', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/251', 'active_substance': 'adefovir dipivoxil', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '03-06-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/485', 'ema_number_certainty': '0.95'}"
EU-1-03-249,"{'atc_code': 'G04BE09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vivanza', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/249', 'active_substance': 'Vardenafil', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '03-04-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/488', 'ema_number_certainty': '0.9166666666666666'}"
EU-1-03-247,"{'atc_code': 'H05AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Forsteo', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/247', 'active_substance': 'Teriparatide', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-10-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/425', 'ema_number_certainty': '0.9230769230769231'}"
EU-1-03-252,"{'atc_code': 'J05AX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fuzeon', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/252', 'active_substance': 'Enfuvirtide', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-27-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/514', 'ema_number_certainty': '0.9565217391304348'}"
EU-1-03-253,"{'atc_code': 'A16AB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aldurazyme', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/253', 'active_substance': 'Laronidase', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-10-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/477', 'ema_number_certainty': '0.9387755102040817'}"
EU-1-03-254,"{'atc_code': 'L01AB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Busilvex', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/254', 'active_substance': 'busulfan', 'eu_mah_current': 'PIERRE FABRE MEDICAMENT', 'orphan_status': 'h', 'eu_aut_date': '07-09-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/472', 'ema_number_certainty': '0.8636363636363636'}"
EU-1-03-255,"{'atc_code': 'B01AC11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ventavis', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/255', 'active_substance': 'Iloprost', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '09-16-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/474', 'ema_number_certainty': '0.92'}"
EU-1-03-256,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Humira', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/256', 'active_substance': 'Adalimumab', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '09-08-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/481', 'ema_number_certainty': '0.9343065693430657'}"
EU-1-03-260,"{'atc_code': 'N04BA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Stalevo', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/260', 'active_substance': 'Levodopa,carbidopa,entacapone', 'eu_mah_current': 'Orion Corporation', 'orphan_status': 'h', 'eu_aut_date': '10-17-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/511', 'ema_number_certainty': '0.9420289855072463'}"
EU-1-03-262,"{'atc_code': 'A04AD12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Emend', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/262', 'active_substance': 'aprepitant', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-11-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/527', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-03-263,"{'atc_code': 'J07AE01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dukoral', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/263', 'active_substance': 'Oral cholera vaccine', 'eu_mah_current': 'Valneva Sweden AB', 'orphan_status': 'h', 'eu_aut_date': '04-28-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/476', 'ema_number_certainty': '0.9032258064516129'}"
EU-1-03-261,"{'atc_code': 'J05AF09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Emtriva', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/261', 'active_substance': 'Emtricitabine', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '10-24-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/533', 'ema_number_certainty': '0.9888888888888889'}"
EU-1-03-264,"{'atc_code': 'V10XX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zevalin', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/264', 'active_substance': 'Ibritumomab tiuxetan', 'eu_mah_current': 'Ceft Biopharma s.r.o', 'orphan_status': 'h', 'eu_aut_date': '01-16-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/547', 'ema_number_certainty': '0.925'}"
EU-1-03-265,"{'atc_code': 'M05BA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bonviva', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/265', 'active_substance': 'Ibandronic acid', 'eu_mah_current': 'Atnahs Pharma Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-23-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/501', 'ema_number_certainty': '0.8604651162790697'}"
EU-1-03-269,"{'atc_code': 'L02BA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Faslodex', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/269', 'active_substance': 'Fulvestrant', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '03-10-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/540', 'ema_number_certainty': '0.8837209302325582'}"
EU-1-03-270,"{'atc_code': 'G04BD04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kentera', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/270', 'active_substance': 'Oxybutynin', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-15-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/532', 'ema_number_certainty': '0.8484848484848485'}"
EU-1-03-267,"{'atc_code': 'J05AE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Reyataz', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/267', 'active_substance': 'atazanavir sulphate', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-02-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/494', 'ema_number_certainty': '0.9278350515463918'}"
EU-1-03-268,"{'atc_code': 'C10AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cholestagel', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/268', 'active_substance': 'colesevelam hydrochloride', 'eu_mah_current': 'CHEPLAPHARM Arzneimittel GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-10-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/512', 'ema_number_certainty': '0.8648648648648649'}"
EU-1-10-639,"{'atc_code': 'C09CA07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Telmisartan Actavis', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/639', 'active_substance': 'telmisartan', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '09-30-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1168', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-10-642,"{'atc_code': 'M05BA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ibandronic Acid Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/642', 'active_substance': 'Ibandronic acid', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1195', 'ema_number_certainty': '0.8125'}"
EU-1-10-641,"{'atc_code': 'B06AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ruconest', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/641', 'active_substance': 'Conestat alfa', 'eu_mah_current': 'Pharming Group N.V.', 'orphan_status': 'h', 'eu_aut_date': '10-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1223', 'ema_number_certainty': '0.8'}"
EU-1-10-640,"{'atc_code': 'N05AH05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sycrest', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/640', 'active_substance': 'asenapine', 'eu_mah_current': 'Organon N.V.', 'orphan_status': 'h', 'eu_aut_date': '09-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1177', 'ema_number_certainty': '0.6956521739130435'}"
EU-1-10-643,"{'atc_code': 'C01EB21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rapiscan', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/643', 'active_substance': 'regadenoson', 'eu_mah_current': 'GE Healthcare AS', 'orphan_status': 'h', 'eu_aut_date': '09-06-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1176', 'ema_number_certainty': '0.7'}"
EU-1-10-644,"{'atc_code': 'N02AB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'PecFent', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/644', 'active_substance': 'Fentanyl', 'eu_mah_current': 'Kyowa Kirin Holdings B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-31-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1164', 'ema_number_certainty': '0.7586206896551724'}"
EU-1-10-646,"{'atc_code': 'A16AB10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'VPRIV', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/646', 'active_substance': 'Velaglucerase alfa', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'h', 'eu_aut_date': '08-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1249', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-10-645,"{'atc_code': 'C01BG11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Brinavess', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/645', 'active_substance': 'vernakalant hydrochloride', 'eu_mah_current': 'Correvio', 'orphan_status': 'h', 'eu_aut_date': '09-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1215', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-10-647,"{'atc_code': 'L04AA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Myclausen', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/647', 'active_substance': 'mycophenolate mofetil', 'eu_mah_current': 'Passauer Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-07-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1218', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-10-648,"{'atc_code': 'C09DB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Twynsta', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/648', 'active_substance': 'telmisartan / amlodipine', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-07-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1224', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-10-654,"{'atc_code': 'L04AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Leflunomide ratiopharm', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/654', 'active_substance': 'leflunomide', 'eu_mah_current': 'ratiopharm GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-29-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2035', 'ema_number_certainty': '0.8421052631578947'}"
EU-1-10-652,"{'atc_code': 'J01GB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'TOBI Podhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/652', 'active_substance': 'Tobramycin', 'eu_mah_current': 'Mylan IRE Healthcare Ltd', 'orphan_status': 'h', 'eu_aut_date': '07-20-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2155', 'ema_number_certainty': '0.7894736842105263'}"
EU-1-10-655,"{'atc_code': 'B01AC24', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Brilique', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/655', 'active_substance': 'ticagrelor', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '12-03-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1241', 'ema_number_certainty': '0.7391304347826086'}"
EU-1-10-658,"{'atc_code': 'J07BB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aflunov', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/658', 'active_substance': 'Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)', 'eu_mah_current': 'Seqirus S.r.l.', 'orphan_status': 'h', 'eu_aut_date': '11-29-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2094', 'ema_number_certainty': '0.65'}"
EU-1-10-659,"{'atc_code': 'M05BA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Iasibon', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/659', 'active_substance': 'Ibandronic acid', 'eu_mah_current': 'Pharmathen S.A.', 'orphan_status': 'h', 'eu_aut_date': '01-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2025', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-10-660,"{'atc_code': 'L01CE01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Potactasol', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/660', 'active_substance': 'topotecan', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '01-06-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2282', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-10-663,"{'atc_code': 'J05AR01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lamivudine / Zidovudine Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/663', 'active_substance': 'Lamivudine / Zidovudine', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-28-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1236', 'ema_number_certainty': '0.6842105263157895'}"
EU-1-10-665,"{'atc_code': 'N04BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Entacapone Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/665', 'active_substance': 'entacapone', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-18-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2075', 'ema_number_certainty': '0.8'}"
EU-1-11-667,"{'atc_code': 'L04AX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Esbriet', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/667', 'active_substance': 'Pirfenidone', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-28-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2154', 'ema_number_certainty': '0.7714285714285715'}"
EU-1-11-672,"{'atc_code': 'N05AX13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xeplion', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/672', 'active_substance': 'paliperidone', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '03-04-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2105', 'ema_number_certainty': '1.0'}"
EU-1-11-669,"{'atc_code': 'L01BC53', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Teysuno', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/669', 'active_substance': 'Tegafur / gimeracil / oteracil', 'eu_mah_current': 'Nordic Group B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-14-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1242', 'ema_number_certainty': '0.76'}"
EU-1-13-870,"{'atc_code': 'A05AA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Orphacol', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/870', 'active_substance': 'Cholic acid', 'eu_mah_current': 'Laboratoires CTRS', 'orphan_status': 'h', 'eu_aut_date': '05-25-2012', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/1250', 'ema_number_certainty': '0.65'}"
EU-1-11-673,"{'atc_code': 'C09DA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ifirmacombi', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/673', 'active_substance': 'Irbesartan / hydrochlorothiazide', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '03-04-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2302', 'ema_number_certainty': '0.5789473684210527'}"
EU-1-10-637,"{'atc_code': 'L04AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Leflunomide medac', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/637', 'active_substance': 'leflunomide', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'h', 'eu_aut_date': '07-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1227', 'ema_number_certainty': '0.9047619047619048'}"
EU-1-11-676,"{'atc_code': 'L01CD04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'JEVTANA', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/676', 'active_substance': 'cabazitaxel', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '03-17-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2018', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-11-677,"{'atc_code': 'L04AA27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Gilenya', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/677', 'active_substance': 'Fingolimod', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '03-17-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2202', 'ema_number_certainty': '0.8085106382978723'}"
EU-1-11-678,"{'atc_code': 'L01XX41', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'HALAVEN', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/678', 'active_substance': 'eribulin', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-17-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2084', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-11-679,"{'atc_code': 'C10BA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pravafenix', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/679', 'active_substance': 'fenofibrate / pravastatin', 'eu_mah_current': 'LABORATOIRES SMB SA', 'orphan_status': 'h', 'eu_aut_date': '04-14-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1243', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-11-682,"{'atc_code': 'V03AB17', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Methylthioninium chloride Proveblue', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/682', 'active_substance': 'methylthioninium chloride', 'eu_mah_current': 'Provepharm S.A.S.', 'orphan_status': 'h', 'eu_aut_date': '05-06-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2108', 'ema_number_certainty': '0.8214285714285714'}"
EU-1-11-685,"{'atc_code': 'M05BA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ibandronic acid Sandoz', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/685', 'active_substance': 'Ibandronic acid', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-26-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2367', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-11-687,"{'atc_code': 'J06BA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hizentra', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/687', 'active_substance': 'human normal immunoglobulin', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-14-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2127', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-11-690,"{'atc_code': 'G03AA14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zoely', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/690', 'active_substance': 'nomegestrol / estradiol', 'eu_mah_current': 'Theramex Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '07-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1213', 'ema_number_certainty': '0.8611111111111112'}"
EU-1-11-692,"{'atc_code': 'S01BC11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Yellox', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/692', 'active_substance': 'bromfenac', 'eu_mah_current': 'BAUSCH + LOMB IRELAND LIMITED', 'orphan_status': 'h', 'eu_aut_date': '05-18-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1198', 'ema_number_certainty': '0.75'}"
EU-1-11-691,"{'atc_code': 'B01AF02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Eliquis', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/691', 'active_substance': 'apixaban', 'eu_mah_current': 'Bristol-Myers Squibb/Pfizer EEIG', 'orphan_status': 'h', 'eu_aut_date': '05-18-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2148', 'ema_number_certainty': '0.6829268292682927'}"
EU-1-11-693,"{'atc_code': 'N06DA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rivastigmine Actavis', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/693', 'active_substance': 'Rivastigmine', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '06-16-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2036', 'ema_number_certainty': '0.7894736842105263'}"
EU-1-11-688,"{'atc_code': 'B06AC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cinryze', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/688', 'active_substance': 'C1 inhibitor, human', 'eu_mah_current': 'Takeda Manufacturing Austria AG', 'orphan_status': 'h', 'eu_aut_date': '06-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1207', 'ema_number_certainty': '0.75'}"
EU-1-11-694,"{'atc_code': 'L04AA28', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NULOJIX', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/694', 'active_substance': 'belatacept', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-17-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2098', 'ema_number_certainty': '0.6818181818181818'}"
EU-1-11-697,"{'atc_code': 'L01AX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Temozolomide SUN', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/697', 'active_substance': 'temozolomide', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe BV', 'orphan_status': 'h', 'eu_aut_date': '07-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2198', 'ema_number_certainty': '0.7727272727272727'}"
EU-1-11-698,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'YERVOY', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/698', 'active_substance': 'ipilimumab', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '07-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2213', 'ema_number_certainty': '0.62'}"
EU-1-11-699,"{'atc_code': 'N07XX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fampyra', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/699', 'active_substance': 'fampridine', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-20-2011', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2097', 'ema_number_certainty': '0.8076923076923077'}"
EU-1-11-700,"{'atc_code': 'L04AA26', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Benlysta', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/700', 'active_substance': 'belimumab', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '07-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2015', 'ema_number_certainty': '0.696969696969697'}"
EU-1-11-701,"{'atc_code': 'N03AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Levetiracetam Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/701', 'active_substance': 'levetiracetam', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-26-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2316', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-11-702,"{'atc_code': 'N03AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Levetiracetam ratiopharm', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/702', 'active_substance': 'levetiracetam', 'eu_mah_current': 'ratiopharm GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-26-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2244', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-11-703,"{'atc_code': 'M05BX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xgeva', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/703', 'active_substance': 'denosumab', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2173', 'ema_number_certainty': '0.8787878787878788'}"
EU-1-11-707,"{'atc_code': 'A10BH05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trajenta', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/707', 'active_substance': 'linagliptin', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-24-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2110', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-11-706,"{'atc_code': 'N04BA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Levodopa/Carbidopa/Entacapone Orion', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/706', 'active_substance': 'Levodopa,carbidopa,entacapone', 'eu_mah_current': 'Orion Corporation', 'orphan_status': 'h', 'eu_aut_date': '08-24-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2441', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-11-708,"{'atc_code': 'N04BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Entacapone Orion', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/708', 'active_substance': 'entacapone', 'eu_mah_current': 'Orion Corporation', 'orphan_status': 'h', 'eu_aut_date': '08-18-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2440', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-11-709,"{'atc_code': 'N05CD08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Buccolam', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/709', 'active_substance': 'midazolam', 'eu_mah_current': 'Laboratorios Lesvi, S.L.', 'orphan_status': 'h', 'eu_aut_date': '09-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2267', 'ema_number_certainty': '0.5294117647058824'}"
EU-1-11-710,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Votubia', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/710', 'active_substance': 'Everolimus', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '09-02-2011', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2311', 'ema_number_certainty': '0.8'}"
EU-1-11-713,"{'atc_code': 'N03AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Levetiracetam Actavis', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/713', 'active_substance': 'levetiracetam', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '10-03-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2355', 'ema_number_certainty': '0.7727272727272727'}"
EU-1-11-712,"{'atc_code': 'N03AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Levetiracetam Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/712', 'active_substance': 'levetiracetam', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '10-03-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2290', 'ema_number_certainty': '0.6842105263157895'}"
EU-1-11-711,"{'atc_code': 'N03AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Matever', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/711', 'active_substance': 'levetiracetam', 'eu_mah_current': 'Pharmathen S.A.', 'orphan_status': 'h', 'eu_aut_date': '10-03-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2024', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-11-714,"{'atc_code': 'L02BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zytiga', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/714', 'active_substance': 'abiraterone', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '09-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2321', 'ema_number_certainty': '0.8064516129032258'}"
EU-1-11-716,"{'atc_code': 'P01BF05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Eurartesim', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/716', 'active_substance': 'piperaquine tetraphosphate/artenimol', 'eu_mah_current': 'Alfasigma S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1199', 'ema_number_certainty': '0.7'}"
EU-1-11-719,"{'atc_code': 'C09CA07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Telmisartan Teva Pharma', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/719', 'active_substance': 'telmisartan', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-03-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2511', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-11-717,"{'atc_code': 'N07XX08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vyndaqel', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/717', 'active_substance': 'tafamidis', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '11-16-2011', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2294', 'ema_number_certainty': '0.6571428571428571'}"
EU-1-11-718,"{'atc_code': 'N05CM18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dexdor', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/718', 'active_substance': 'dexmedetomidine', 'eu_mah_current': 'Orion Corporation', 'orphan_status': 'h', 'eu_aut_date': '09-16-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2268', 'ema_number_certainty': '0.7058823529411765'}"
EU-1-11-722,"{'atc_code': 'A10BG03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pioglitazone Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/722', 'active_substance': 'pioglitazone', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '03-21-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2277', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-11-727,"{'atc_code': 'L01BB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xaluprine', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/727', 'active_substance': 'Mercaptopurine', 'eu_mah_current': 'Nova Laboratories Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '03-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2022', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-11-715,"{'atc_code': 'H02AB09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Plenadren', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/715', 'active_substance': 'hydrocortisone', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'h', 'eu_aut_date': '11-03-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2185', 'ema_number_certainty': '0.8'}"
EU-1-11-732,"{'atc_code': 'R06AX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Desloratadine Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/732', 'active_substance': 'desloratadine', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-24-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2419', 'ema_number_certainty': '0.7619047619047619'}"
EU-1-11-731,"{'atc_code': 'A10BD10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Komboglyze', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/731', 'active_substance': 'saxagliptin / metformin', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '11-24-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2059', 'ema_number_certainty': '0.8'}"
EU-1-11-734,"{'atc_code': 'C09CA09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Edarbi', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/734', 'active_substance': 'azilsartan medoxomil', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '12-07-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2293', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-11-736,"{'atc_code': 'J05AG05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EDURANT', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/736', 'active_substance': 'rilpivirine', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '11-28-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2264', 'ema_number_certainty': '0.8181818181818182'}"
EU-1-11-737,"{'atc_code': 'J05AR08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Eviplera', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/737', 'active_substance': 'emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as fumarate)', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '11-28-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2312', 'ema_number_certainty': '0.9393939393939394'}"
EU-1-11-733,"{'atc_code': 'A07AA12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dificlir', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/733', 'active_substance': 'fidaxomicin', 'eu_mah_current': 'Tillotts Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2087', 'ema_number_certainty': '0.7058823529411765'}"
EU-1-11-738,"{'atc_code': 'N03AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Levetiracetam Actavis Group', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/738', 'active_substance': 'levetiracetam', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '12-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2305', 'ema_number_certainty': '0.631578947368421'}"
EU-1-11-739,"{'atc_code': 'R06AX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dasselta', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/739', 'active_substance': 'desloratadine', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '11-28-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2310', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-11-740,"{'atc_code': 'L01XD04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ameluz', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/740', 'active_substance': '5-Aminolaevulinic acid', 'eu_mah_current': 'Biofrontera Bioscience GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-14-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2204', 'ema_number_certainty': '0.7368421052631579'}"
EU-1-11-741,"{'atc_code': 'N03AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Levetiracetam SUN', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/741', 'active_substance': 'levetiracetam', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe BV', 'orphan_status': 'h', 'eu_aut_date': '12-14-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2051', 'ema_number_certainty': '0.6842105263157895'}"
EU-1-11-742,"{'atc_code': 'J05AG03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Efavirenz Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/742', 'active_substance': 'efavirenz', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2352', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-11-743,"{'atc_code': 'A10BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Repaglinide Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/743', 'active_substance': 'Repaglinide', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '12-22-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2318', 'ema_number_certainty': '0.625'}"
EU-1-11-745,"{'atc_code': 'R06AX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Desloratadine Actavis', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/745', 'active_substance': 'desloratadine', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '01-13-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2435', 'ema_number_certainty': '0.7894736842105263'}"
EU-1-11-746,"{'atc_code': 'R06AX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Desloratadine ratiopharm', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/746', 'active_substance': 'desloratadine', 'eu_mah_current': 'ratiopharm GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-13-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2404', 'ema_number_certainty': '0.6470588235294118'}"
EU-1-11-749,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Caprelsa', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/749', 'active_substance': 'vandetanib', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-17-2012', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/2315', 'ema_number_certainty': '0.6875'}"
EU-1-11-747,"{'atc_code': 'J01XB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Colobreathe', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/747', 'active_substance': 'Colistimethate sodium', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-13-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1225', 'ema_number_certainty': '0.85'}"
EU-1-12-750,"{'atc_code': 'G03XB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Esmya', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/750', 'active_substance': 'Ulipristal Acetate', 'eu_mah_current': 'Gedeon Richter Plc.', 'orphan_status': 'h', 'eu_aut_date': '02-23-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2041', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-12-751,"{'atc_code': 'L01EC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zelboraf', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/751', 'active_substance': 'vemurafenib', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2409', 'ema_number_certainty': '0.90625'}"
EU-1-12-753,"{'atc_code': 'H01CB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Signifor', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/753', 'active_substance': 'pasireotide', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'h', 'eu_aut_date': '04-24-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2052', 'ema_number_certainty': '0.8'}"
EU-1-12-755,"{'atc_code': 'A10BG03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pioglitazone Actavis', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/755', 'active_substance': 'pioglitazone', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '03-15-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2324', 'ema_number_certainty': '0.75'}"
EU-1-12-757,"{'atc_code': 'A10BG03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pioglitazone Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/757', 'active_substance': 'pioglitazone', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2297', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-12-759,"{'atc_code': 'M05BA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zoledronic acid Actavis', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/759', 'active_substance': 'zoledronic acid', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '04-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2488', 'ema_number_certainty': '0.8125'}"
EU-1-12-762,"{'atc_code': 'L01BC06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Capecitabine Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/762', 'active_substance': 'capecitabine', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '04-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2386', 'ema_number_certainty': '0.5909090909090909'}"
EU-1-12-761,"{'atc_code': 'L01BC06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Capecitabine Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/761', 'active_substance': 'capecitabine', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2362', 'ema_number_certainty': '0.6842105263157895'}"
EU-1-12-763,"{'atc_code': 'L01BC06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ecansya', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/763', 'active_substance': 'capecitabine', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '04-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2605', 'ema_number_certainty': '0.7647058823529411'}"
EU-1-12-760,"{'atc_code': 'R05CB16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bronchitol', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/760', 'active_substance': 'Mannitol', 'eu_mah_current': 'Pharmaxis Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '04-13-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1252', 'ema_number_certainty': '0.6923076923076923'}"
EU-1-12-764,"{'atc_code': 'L01DB11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pixuvri', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/764', 'active_substance': 'pixantrone', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'h', 'eu_aut_date': '05-10-2012', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2055', 'ema_number_certainty': '0.7692307692307693'}"
EU-1-12-766,"{'atc_code': 'A04AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'SANCUSO', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/766', 'active_substance': 'granisetron', 'eu_mah_current': 'Kyowa Kirin Holdings B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2296', 'ema_number_certainty': '0.8666666666666667'}"
EU-1-12-767,"{'atc_code': 'J07AH08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nimenrix', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/767', 'active_substance': 'Meningococcal group A, C, W-135 and Y conjugate vaccine', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2226', 'ema_number_certainty': '0.6363636363636364'}"
EU-1-12-768,"{'atc_code': 'N07XX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Riluzole Zentiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/768', 'active_substance': 'Riluzole', 'eu_mah_current': 'Zentiva k.s.', 'orphan_status': 'h', 'eu_aut_date': '05-07-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2622', 'ema_number_certainty': '0.8666666666666667'}"
EU-1-12-771,"{'atc_code': 'M05BA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zoledronic acid Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/771', 'active_substance': 'zoledronic acid', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-16-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2439', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-12-769,"{'atc_code': 'L01CD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Docetaxel Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/769', 'active_substance': 'Docetaxel', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '05-22-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2539', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-12-770,"{'atc_code': 'L01CD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Docetaxel Kabi', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/770', 'active_substance': 'Docetaxel', 'eu_mah_current': 'Fresenius Kabi Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-22-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2325', 'ema_number_certainty': '0.875'}"
EU-1-12-773,"{'atc_code': 'L01EJ01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Jakavi', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/773', 'active_substance': 'ruxolitinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-23-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2464', 'ema_number_certainty': '0.71875'}"
EU-1-12-775,"{'atc_code': 'B02BD11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NovoThirteen', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/775', 'active_substance': 'catridecacog', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '09-03-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2284', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-12-776,"{'atc_code': 'N03AX22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fycompa', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/776', 'active_substance': 'Perampanel', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-23-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2434', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-12-777,"{'atc_code': 'L01EK01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Inlyta', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/777', 'active_substance': 'Axitinib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '09-03-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2406', 'ema_number_certainty': '0.75'}"
EU-1-12-778,"{'atc_code': 'R03BB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Eklira Genuair', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/778', 'active_substance': 'aclidinium bromide', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '07-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2211', 'ema_number_certainty': '1.0'}"
EU-1-12-779,"{'atc_code': 'M05BA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zoledronic acid medac', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/779', 'active_substance': 'zoledronic acid', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'h', 'eu_aut_date': '08-03-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2359', 'ema_number_certainty': '0.625'}"
EU-1-12-780,"{'atc_code': 'A10BD11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Jentadueto', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/780', 'active_substance': 'linagliptin/metformin hydrochloride', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2279', 'ema_number_certainty': '0.7037037037037037'}"
EU-1-12-781,"{'atc_code': 'R03BB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bretaris Genuair', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/781', 'active_substance': 'aclidinium bromide', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '07-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2706', 'ema_number_certainty': '1.0'}"
EU-1-12-782,"{'atc_code': 'R07AX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kalydeco', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/782', 'active_substance': 'ivacaftor', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '07-23-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2494', 'ema_number_certainty': '0.675'}"
EU-1-12-783,"{'atc_code': 'D06BB10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zyclara', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/783', 'active_substance': 'imiquimod', 'eu_mah_current': 'Meda AB', 'orphan_status': 'h', 'eu_aut_date': '08-23-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2387', 'ema_number_certainty': '0.6428571428571429'}"
EU-1-12-784,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cuprymina', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/784', 'active_substance': 'Copper 64Cu chloride', 'eu_mah_current': 'A.C.O.M. -ADVANCED CENTER ONCOLOGY MACERATA -S.R.L.', 'orphan_status': 'h', 'eu_aut_date': '08-23-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2136', 'ema_number_certainty': '0.8'}"
EU-1-12-785,"{'atc_code': 'J01DI02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zinforo', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/785', 'active_substance': 'ceftaroline fosamil', 'eu_mah_current': 'Pfizer Ireland Pharmaceuticals', 'orphan_status': 'h', 'eu_aut_date': '08-23-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2252', 'ema_number_certainty': '0.7931034482758621'}"
EU-1-12-786,"{'atc_code': 'M05BA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zoledronic acid Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/786', 'active_substance': 'zoledronic acid', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '08-23-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2482', 'ema_number_certainty': '0.6470588235294118'}"
EU-1-12-787,"{'atc_code': 'A16AX08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Revestive', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/787', 'active_substance': 'teduglutide', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'h', 'eu_aut_date': '08-30-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2345', 'ema_number_certainty': '0.8181818181818182'}"
EU-1-12-788,"{'atc_code': 'R03BB06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Seebri Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/788', 'active_substance': 'glycopyrronium bromide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '09-28-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2430', 'ema_number_certainty': '0.8666666666666667'}"
EU-1-12-789,"{'atc_code': 'R03BB06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Enurev Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/789', 'active_substance': 'glycopyrronium bromide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '09-28-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2691', 'ema_number_certainty': '0.8666666666666667'}"
EU-1-12-790,"{'atc_code': 'R03BB06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tovanor Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/790', 'active_substance': 'glycopyrronium bromide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '09-28-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2690', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-12-792,"{'atc_code': 'L01BC08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dacogen', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/792', 'active_substance': 'Decitabine', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '09-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2221', 'ema_number_certainty': '0.6'}"
EU-1-12-793,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'XALKORI', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/793', 'active_substance': 'crizotinib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '10-23-2012', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2489', 'ema_number_certainty': '0.9'}"
EU-1-12-794,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ADCETRIS', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/794', 'active_substance': 'Brentuximab vedotin', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '10-25-2012', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/2455', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-12-795,"{'atc_code': 'A10BX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Forxiga', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/795', 'active_substance': 'dapagliflozin', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '11-12-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2322', 'ema_number_certainty': '0.6388888888888888'}"
EU-1-12-797,"{'atc_code': 'S01LA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Eylea', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/797', 'active_substance': 'aflibercept', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '11-22-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2392', 'ema_number_certainty': '0.5185185185185185'}"
EU-1-12-800,"{'atc_code': 'M05BA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zoledronic acid Hospira', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/800', 'active_substance': 'zoledronic acid', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '11-19-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2365', 'ema_number_certainty': '0.8076923076923077'}"
EU-1-12-801,"{'atc_code': 'A06AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Constella', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/801', 'active_substance': 'linaclotide', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '11-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2490', 'ema_number_certainty': '0.68'}"
EU-1-12-798,"{'atc_code': 'M05BA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ibandronic acid Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/798', 'active_substance': 'Ibandronic acid', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '11-19-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2638', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-12-799,"{'atc_code': 'N06DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Memantine Merz', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/799', 'active_substance': 'Memantine', 'eu_mah_current': 'Merz Pharmaceuticals GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-22-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2711', 'ema_number_certainty': '1.0'}"
EU-1-12-802,"{'atc_code': 'L01BC06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Capecitabine medac', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/802', 'active_substance': 'capecitabine', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'h', 'eu_aut_date': '11-19-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2568', 'ema_number_certainty': '0.65'}"
EU-1-12-803,"{'atc_code': 'D03BA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NexoBrid', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/803', 'active_substance': 'Concentrate of proteolytic enzymes enriched in bromelain', 'eu_mah_current': 'MediWound Germany GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-18-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2246', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-12-805,"{'atc_code': 'V09AX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Amyvid', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/805', 'active_substance': 'Florbetapir (18F)', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-14-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2422', 'ema_number_certainty': '0.8947368421052632'}"
EU-1-12-806,"{'atc_code': 'A10AD06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ryzodeg', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/806', 'active_substance': 'Insulin degludec/insulin aspart', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '01-21-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2499', 'ema_number_certainty': '0.9333333333333333'}"
EU-1-12-808,"{'atc_code': 'L01EA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Imatinib Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/808', 'active_substance': 'imatinib', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-08-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2585', 'ema_number_certainty': '0.7272727272727273'}"
EU-1-12-807,"{'atc_code': 'A10AE06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tresiba', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/807', 'active_substance': 'Insulin degludec', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '01-21-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2498', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-08-448,"{'atc_code': 'J02AX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mycamine', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/448', 'active_substance': 'micafungin', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-25-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/734', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-08-451,"{'atc_code': 'C02KX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Volibris', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/451', 'active_substance': 'Ambrisentan', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '04-21-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/839', 'ema_number_certainty': '0.868421052631579'}"
EU-1-08-444,"{'atc_code': 'L03AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ratiograstim', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/444', 'active_substance': 'filgrastim', 'eu_mah_current': 'ratiopharm GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-15-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/825', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-08-445,"{'atc_code': 'L03AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tevagrastim', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/445', 'active_substance': 'filgrastim', 'eu_mah_current': 'Teva GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-15-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/827', 'ema_number_certainty': '0.896551724137931'}"
EU-1-08-454,"{'atc_code': 'L03AB08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Extavia', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/454', 'active_substance': 'Interferon beta-1b', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '05-20-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/933', 'ema_number_certainty': '0.9347826086956522'}"
EU-1-08-462,"{'atc_code': 'C01EB18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ranexa', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/462', 'active_substance': 'ranolazine', 'eu_mah_current': 'Menarini International Operations Luxembourg S.A.', 'orphan_status': 'h', 'eu_aut_date': '07-09-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/805', 'ema_number_certainty': '0.9130434782608695'}"
EU-1-08-463,"{'atc_code': 'A06AH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Relistor', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/463', 'active_substance': 'methylnaltrexone bromide', 'eu_mah_current': 'Bausch Health Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '07-02-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/870', 'ema_number_certainty': '0.9142857142857143'}"
EU-1-08-461,"{'atc_code': 'B06AC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Firazyr', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/461', 'active_substance': 'icatibant', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'h', 'eu_aut_date': '07-11-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/899', 'ema_number_certainty': '0.7241379310344828'}"
EU-1-08-457,"{'atc_code': 'A10BD07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Efficib', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/457', 'active_substance': 'sitagliptin / metformin hydrochloride', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-16-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/896', 'ema_number_certainty': '0.8490566037735849'}"
EU-1-08-455,"{'atc_code': 'A10BD07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Janumet', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/455', 'active_substance': 'sitagliptin / metformin hydrochloride', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-16-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/861', 'ema_number_certainty': '0.8627450980392157'}"
EU-1-08-456,"{'atc_code': 'A10BD07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Velmetia', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/456', 'active_substance': 'sitagliptin / metformin hydrochloride', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-16-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/862', 'ema_number_certainty': '0.8421052631578947'}"
EU-1-08-465,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Clopidogrel Zentiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/465', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Zentiva, k.s.', 'orphan_status': 'h', 'eu_aut_date': '07-16-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/975', 'ema_number_certainty': '0.8596491228070176'}"
EU-1-08-466,"{'atc_code': 'V03AB35', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bridion', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/466', 'active_substance': 'sugammadex', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-25-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/885', 'ema_number_certainty': '0.8518518518518519'}"
EU-1-08-468,"{'atc_code': 'J05AG04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Intelence', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/468', 'active_substance': 'etravirine', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '08-28-2008', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/900', 'ema_number_certainty': '0.9487179487179487'}"
EU-1-08-469,"{'atc_code': 'N04BC05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Oprymea', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/469', 'active_substance': 'pramipexole', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '09-12-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/941', 'ema_number_certainty': '0.875'}"
EU-1-08-470,"{'atc_code': 'N03AX18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vimpat', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/470', 'active_substance': 'lacosamide', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '08-29-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/863', 'ema_number_certainty': '0.8409090909090909'}"
EU-1-08-475,"{'atc_code': 'N05AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Olanzapine Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/475', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '10-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/961', 'ema_number_certainty': '0.9024390243902439'}"
EU-1-08-472,"{'atc_code': 'B01AF01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xarelto', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/472', 'active_substance': 'rivaroxaban', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '09-30-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/944', 'ema_number_certainty': '0.8666666666666667'}"
EU-1-08-473,"{'atc_code': 'B02BC30', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Evicel', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/473', 'active_substance': 'human fibrinogen / human thrombin', 'eu_mah_current': 'Omrix Biopharmaceuticals N.V.', 'orphan_status': 'h', 'eu_aut_date': '10-06-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/898', 'ema_number_certainty': '0.9230769230769231'}"
EU-1-08-476,"{'atc_code': 'G04BE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Adcirca', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/476', 'active_substance': 'tadalafil', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1021', 'ema_number_certainty': '0.9090909090909091'}"
EU-1-08-477,"{'atc_code': 'L03AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ceplene', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/477', 'active_substance': 'Histamine dihydrochloride', 'eu_mah_current': 'Laboratoires Delbert', 'orphan_status': 'h', 'eu_aut_date': '10-07-2008', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/796', 'ema_number_certainty': '0.896551724137931'}"
EU-1-08-479,"{'atc_code': 'N05AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zypadhera', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/479', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-19-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/890', 'ema_number_certainty': '0.9032258064516129'}"
EU-1-08-480,"{'atc_code': 'C09CA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ifirmasta', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/480', 'active_substance': 'Irbesartan', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '12-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/962', 'ema_number_certainty': '0.65'}"
EU-1-08-481,"{'atc_code': 'A16AX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kuvan', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/481', 'active_substance': 'sapropterin dihydrochloride', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'h', 'eu_aut_date': '12-02-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/943', 'ema_number_certainty': '0.9259259259259259'}"
EU-1-08-483,"{'atc_code': 'A10BD08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zomarist', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/483', 'active_substance': 'vildagliptin / metformin hydrochloride', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '12-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1049', 'ema_number_certainty': '0.7894736842105263'}"
EU-1-08-482,"{'atc_code': 'S01ED51', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Azarga', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/482', 'active_substance': 'brinzolamide / timolol', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-25-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/960', 'ema_number_certainty': '0.9090909090909091'}"
EU-1-08-485,"{'atc_code': 'A10BH02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Jalra', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/485', 'active_substance': 'vildagliptin', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-19-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1048', 'ema_number_certainty': '0.8'}"
EU-1-08-486,"{'atc_code': 'A10BH02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xiliarx', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/486', 'active_substance': 'vildagliptin', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-19-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1051', 'ema_number_certainty': '0.7575757575757576'}"
EU-1-08-484,"{'atc_code': 'A10BD08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Icandra', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/484', 'active_substance': 'vildagliptin / metformin hydrochloride', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '12-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1050', 'ema_number_certainty': '0.7380952380952381'}"
EU-1-08-490,"{'atc_code': 'N04BC05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pramipexole Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/490', 'active_substance': 'pramipexole', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-18-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/940', 'ema_number_certainty': '0.8076923076923077'}"
EU-1-08-488,"{'atc_code': 'L01BC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vidaza', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/488', 'active_substance': 'Azacitidine', 'eu_mah_current': 'Bristol Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '12-17-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/978', 'ema_number_certainty': '0.8285714285714286'}"
EU-1-08-492,"{'atc_code': 'L04AC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'RoActemra', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/492', 'active_substance': 'tocilizumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-16-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/955', 'ema_number_certainty': '0.75'}"
EU-1-08-494,"{'atc_code': 'L04AC05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Stelara', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/494', 'active_substance': 'ustekinumab', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '01-16-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/958', 'ema_number_certainty': '0.7962962962962963'}"
EU-1-08-495,"{'atc_code': 'L03AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zarzio', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/495', 'active_substance': 'Filgrastim', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-06-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/917', 'ema_number_certainty': '0.96'}"
EU-1-08-497,"{'atc_code': 'B02BX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nplate', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/497', 'active_substance': 'romiplostim', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-04-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/942', 'ema_number_certainty': '0.868421052631579'}"
EU-1-08-496,"{'atc_code': 'L03AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Filgrastim Hexal', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/496', 'active_substance': 'Filgrastim', 'eu_mah_current': 'Hexal AG', 'orphan_status': 'h', 'eu_aut_date': '02-06-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/918', 'ema_number_certainty': '0.9583333333333334'}"
EU-1-08-498,"{'atc_code': 'N06AX22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Thymanax', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/498', 'active_substance': 'agomelatine', 'eu_mah_current': 'Servier (Ireland) Industries Limited', 'orphan_status': 'h', 'eu_aut_date': '02-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/916', 'ema_number_certainty': '0.896551724137931'}"
EU-1-08-499,"{'atc_code': 'N06AX22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Valdoxan', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/499', 'active_substance': 'agomelatine', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'h', 'eu_aut_date': '02-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/915', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-08-501,"{'atc_code': 'J07BA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ixiaro', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/501', 'active_substance': 'Japanese Encephalitis vaccine (inactivated, adsorbed)', 'eu_mah_current': 'Valneva Austria GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-31-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/963', 'ema_number_certainty': '0.868421052631579'}"
EU-1-08-502,"{'atc_code': 'L03AX15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mepact', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/502', 'active_substance': 'mifamurtide', 'eu_mah_current': 'Takeda France SAS', 'orphan_status': 'h', 'eu_aut_date': '03-06-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/802', 'ema_number_certainty': '0.896551724137931'}"
EU-1-08-503,"{'atc_code': 'B01AC22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Efient', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/503', 'active_substance': 'prasugrel', 'eu_mah_current': 'SUBSTIPHARM', 'orphan_status': 'h', 'eu_aut_date': '02-25-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/984', 'ema_number_certainty': '0.6428571428571429'}"
EU-1-08-504,"{'atc_code': 'L02BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Firmagon', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/504', 'active_substance': 'degarelix (as acetate)', 'eu_mah_current': 'Amager Strandvej 405, 2770 Kastrup, Danmark', 'orphan_status': 'h', 'eu_aut_date': '02-17-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/986', 'ema_number_certainty': '0.8'}"
EU-1-09-508,"{'atc_code': 'J07AL52', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Synflorix', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/508', 'active_substance': 'Pneumococcal polysaccharide conjugate vaccine (adsorbed)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '03-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/973', 'ema_number_certainty': '0.9803921568627451'}"
EU-1-09-511,"{'atc_code': 'G03XC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Conbriza', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/511', 'active_substance': 'bazedoxifene', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-17-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/913', 'ema_number_certainty': '0.8709677419354839'}"
EU-1-09-514,"{'atc_code': 'N03AF04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zebinix', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/514', 'active_substance': 'eslicarbazepine acetate', 'eu_mah_current': 'Bial - Portela &amp; C&#170;, SA', 'orphan_status': 'h', 'eu_aut_date': '04-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/988', 'ema_number_certainty': '0.8936170212765957'}"
EU-1-09-515,"{'atc_code': 'A02BC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'CONTROLOC Control', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/515', 'active_substance': 'pantoprazole', 'eu_mah_current': 'Takeda GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-12-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1097', 'ema_number_certainty': '0.85'}"
EU-1-09-516,"{'atc_code': 'A02BC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'SOMAC Control', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/516', 'active_substance': 'pantoprazole', 'eu_mah_current': 'Takeda GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-12-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1098', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-09-517,"{'atc_code': 'A02BC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'PANTOZOL Control', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/517', 'active_substance': 'pantoprazole', 'eu_mah_current': 'Takeda GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-12-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1013', 'ema_number_certainty': '0.8636363636363636'}"
EU-1-09-523,"{'atc_code': 'L04AD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Modigraf', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/523', 'active_substance': 'Tacrolimus', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/954', 'ema_number_certainty': '0.7727272727272727'}"
EU-1-09-524,"{'atc_code': 'N01BX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Qutenza', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/524', 'active_substance': 'Capsaicin', 'eu_mah_current': 'Gr&#252;nenthal GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/909', 'ema_number_certainty': '0.8387096774193549'}"
EU-1-09-525,"{'atc_code': 'N06DA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nimvastid', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/525', 'active_substance': 'Rivastigmine', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '05-11-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1029', 'ema_number_certainty': '0.9411764705882353'}"
EU-1-09-521,"{'atc_code': 'V03AE02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Renvela', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/521', 'active_substance': 'sevelamer (carbonate)', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-10-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/993', 'ema_number_certainty': '0.8787878787878788'}"
EU-1-09-522,"{'atc_code': 'G03AD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ellaOne', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/522', 'active_substance': 'ulipristal acetate', 'eu_mah_current': 'Laboratoire HRA Pharma', 'orphan_status': 'h', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1027', 'ema_number_certainty': '0.775'}"
EU-1-09-526,"{'atc_code': 'L01EB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Iressa', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/526', 'active_substance': 'gefitinib', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '06-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1016', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-09-528,"{'atc_code': 'N06BC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Peyona', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/528', 'active_substance': 'Caffeine citrate', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '07-02-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1014', 'ema_number_certainty': '0.8125'}"
EU-1-09-529,"{'atc_code': 'A10BJ02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Victoza', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/529', 'active_substance': 'liraglutide', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '06-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1026', 'ema_number_certainty': '0.9655172413793104'}"
EU-1-09-530,"{'atc_code': 'A10BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Repaglinide Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/530', 'active_substance': 'Repaglinide', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-29-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1067', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-09-531,"{'atc_code': 'N02AB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Instanyl', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/531', 'active_substance': 'Fentanyl', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '07-20-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/959', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-09-533,"{'atc_code': 'A11HA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vedrop', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/533', 'active_substance': 'tocofersolan', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'h', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/920', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-09-535,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Grepid', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/535', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Pharmathen S.A.', 'orphan_status': 'h', 'eu_aut_date': '07-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1059', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-09-538,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Afinitor', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/538', 'active_substance': 'everolimus', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-03-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1038', 'ema_number_certainty': '0.775'}"
EU-1-09-537,"{'atc_code': 'L03AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mozobil', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/537', 'active_substance': 'Plerixafor', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-31-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1030', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-09-539,"{'atc_code': 'C03XA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Samsca', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/539', 'active_substance': 'tolvaptan', 'eu_mah_current': 'Otsuka Pharmaceutical Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-03-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/980', 'ema_number_certainty': '0.8095238095238095'}"
EU-1-09-540,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Clopidogrel Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/540', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1053', 'ema_number_certainty': '0.8157894736842105'}"
EU-1-09-546,"{'atc_code': 'L04AB06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Simponi', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/546', 'active_substance': 'golimumab', 'eu_mah_current': 'Janssen Biologics B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-01-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/992', 'ema_number_certainty': '0.8421052631578947'}"
EU-1-09-545,"{'atc_code': 'A10BH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Onglyza', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/545', 'active_substance': 'saxagliptin', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '10-01-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1039', 'ema_number_certainty': '0.896551724137931'}"
EU-1-09-544,"{'atc_code': 'L04AB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cimzia', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/544', 'active_substance': 'certolizumab pegol', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'h', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1037', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-09-553,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zyllt', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/553', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '09-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1058', 'ema_number_certainty': '0.7307692307692307'}"
EU-1-09-558,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Clopidogrel BGR', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/558', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Laboratoires BIOGARAN', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1138', 'ema_number_certainty': '0.8'}"
EU-1-09-562,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Clopidogrel Krka d.d.', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/562', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1137', 'ema_number_certainty': '0.7307692307692307'}"
EU-1-09-556,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Clopidogrel Krka', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/556', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '09-23-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1056', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-09-543,"{'atc_code': 'J01DF01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cayston', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/543', 'active_substance': 'aztreonam', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/996', 'ema_number_certainty': '0.9411764705882353'}"
EU-1-09-555,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Clopidogrel TAD', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/555', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'TAD Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-23-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1136', 'ema_number_certainty': '0.8275862068965517'}"
EU-1-09-550,"{'atc_code': 'L01CA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Javlor', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/550', 'active_substance': 'vinflunine ditartrate', 'eu_mah_current': 'PIERRE FABRE MEDICAMENT', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/983', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-09-551,"{'atc_code': 'G04BE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vizarsin', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/551', 'active_substance': 'sildenafil', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1076', 'ema_number_certainty': '0.875'}"
EU-1-09-565,"{'atc_code': 'B03XA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Biopoin', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/565', 'active_substance': 'epoetin theta', 'eu_mah_current': 'Teva GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-23-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1036', 'ema_number_certainty': '0.9473684210526315'}"
EU-1-09-566,"{'atc_code': 'J05AF05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lamivudine Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/566', 'active_substance': 'Lamivudine', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-23-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1113', 'ema_number_certainty': '0.75'}"
EU-1-09-564,"{'atc_code': 'L04AC08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ilaris', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/564', 'active_substance': 'Canakinumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '10-23-2009', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1109', 'ema_number_certainty': '0.9142857142857143'}"
EU-1-09-573,"{'atc_code': 'B03XA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Eporatio', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/573', 'active_substance': 'epoetin theta', 'eu_mah_current': 'ratiopharm GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-29-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1033', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-09-576,"{'atc_code': 'C09CA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Irbesartan Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/576', 'active_substance': 'Irbesartan', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1093', 'ema_number_certainty': '0.75'}"
EU-1-09-577,"{'atc_code': 'J07BB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Foclivia', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/577', 'active_substance': 'A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen', 'eu_mah_current': 'Seqirus S.r.l.,', 'orphan_status': 'h', 'eu_aut_date': '10-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1208', 'ema_number_certainty': '0.75'}"
EU-1-09-575,"{'atc_code': 'C09DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Copalia HCT', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/575', 'active_substance': 'amlodipine besylate / valsartan / hydrochlorothiazide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-04-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1159', 'ema_number_certainty': '0.717948717948718'}"
EU-1-09-574,"{'atc_code': 'C09DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dafiro HCT', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/574', 'active_substance': 'amlodipine besylate / valsartan / hydrochlorothiazide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-04-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1160', 'ema_number_certainty': '0.7317073170731707'}"
EU-1-09-579,"{'atc_code': 'A10BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Repaglinide Krka', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/579', 'active_substance': 'Repaglinide', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '11-04-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1066', 'ema_number_certainty': '0.8'}"
EU-1-09-569,"{'atc_code': 'C09DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Exforge HCT', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/569', 'active_substance': 'amlodipine besylate / valsartan / hydrochlorothiazide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '10-16-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1068', 'ema_number_certainty': '0.6052631578947368'}"
EU-1-09-572,"{'atc_code': 'M05BB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vantavo', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/572', 'active_substance': 'alendronic acid / colecalciferol', 'eu_mah_current': 'N.V. Organon', 'orphan_status': 'h', 'eu_aut_date': '10-16-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1180', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-09-578,"{'atc_code': 'J07BB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Adjupanrix', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/578', 'active_substance': 'Purified antigen fractions of inactivated split virions A/VietNam/1194/2004 NIBRG-14 (H5N1)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '10-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1206', 'ema_number_certainty': '0.9473684210526315'}"
EU-1-09-571,"{'atc_code': 'J07BB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pandemic influenza vaccine H5N1 BAXTER', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/571', 'active_substance': 'Pandemic influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)', 'eu_mah_current': 'Ology Bioservices Ireland LTD', 'orphan_status': 'h', 'eu_aut_date': '10-16-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1200', 'ema_number_certainty': '0.9090909090909091'}"
EU-1-09-580,"{'atc_code': 'A10BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Enyglid', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/580', 'active_substance': 'Repaglinide', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '10-14-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1065', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-09-581,"{'atc_code': 'A06AX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Resolor', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/581', 'active_substance': 'prucalopride', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'h', 'eu_aut_date': '10-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1012', 'ema_number_certainty': '0.8787878787878788'}"
EU-1-09-583,"{'atc_code': 'C09DA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Irbesartan / Hydrochlorothiazide Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/583', 'active_substance': 'irbesartan / hydrochlorothiazide', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-26-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1112', 'ema_number_certainty': '0.6857142857142857'}"
EU-1-09-589,"{'atc_code': 'N06DA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rivastigmine HEXAL', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/589', 'active_substance': 'Rivastigmine', 'eu_mah_current': 'Hexal AG', 'orphan_status': 'h', 'eu_aut_date': '12-11-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1182', 'ema_number_certainty': '0.6875'}"
EU-1-09-584,"{'atc_code': 'G04BE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sildenafil Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/584', 'active_substance': 'sildenafil', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1073', 'ema_number_certainty': '0.7727272727272727'}"
EU-1-09-586,"{'atc_code': 'R03AC18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Oslif Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/586', 'active_substance': 'indacaterol', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1210', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-09-590,"{'atc_code': 'J07AL02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Prevenar 13', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/590', 'active_substance': 'Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '12-09-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1104', 'ema_number_certainty': '0.863013698630137'}"
EU-1-09-585,"{'atc_code': 'N06DA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rivastigmine 1 A Pharma', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/585', 'active_substance': 'Rivastigmine', 'eu_mah_current': '1 A Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-11-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1181', 'ema_number_certainty': '0.6470588235294118'}"
EU-1-09-587,"{'atc_code': 'N05AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Olanzapine Glenmark', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/587', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Glenmark Arzneimittel GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-03-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1085', 'ema_number_certainty': '0.9523809523809523'}"
EU-1-09-588,"{'atc_code': 'N05AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Olanzapine Glenmark Europe', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/588', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Glenmark Arzneimittel GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-03-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1086', 'ema_number_certainty': '0.9473684210526315'}"
EU-1-09-591,"{'atc_code': 'C01BD07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Multaq', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/591', 'active_substance': 'dronedarone', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '11-26-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1043', 'ema_number_certainty': '0.8529411764705882'}"
EU-1-09-592,"{'atc_code': 'N05AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Olazax Disperzi', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/592', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Glenmark Pharmaceuticals s.r.o.', 'orphan_status': 'h', 'eu_aut_date': '12-10-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1088', 'ema_number_certainty': '0.8235294117647058'}"
EU-1-09-597,"{'atc_code': 'N05AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Olazax', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/597', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Glenmark Pharmaceuticals s.r.o.', 'orphan_status': 'h', 'eu_aut_date': '12-11-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1087', 'ema_number_certainty': '1.0'}"
EU-1-09-598,"{'atc_code': 'J05AG01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nevirapine Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/598', 'active_substance': 'nevirapine', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1119', 'ema_number_certainty': '0.8'}"
EU-1-09-593,"{'atc_code': 'R03AC18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Onbrez Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/593', 'active_substance': 'indacaterol', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1114', 'ema_number_certainty': '0.7916666666666666'}"
EU-1-09-599,"{'atc_code': 'N06DA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rivastigmine Sandoz', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/599', 'active_substance': 'Rivastigmine', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-11-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1183', 'ema_number_certainty': '0.8'}"
EU-1-09-594,"{'atc_code': 'R03AC18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hirobriz Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/594', 'active_substance': 'indacaterol', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1211', 'ema_number_certainty': '0.88'}"
EU-1-09-600,"{'atc_code': 'J06BB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zutectra', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/600', 'active_substance': 'Human Hepatitis B Immunoglobulin', 'eu_mah_current': 'Biotest Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1089', 'ema_number_certainty': '0.8421052631578947'}"
EU-1-09-596,"{'atc_code': 'J05AF05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lamivudine Teva Pharma B.V.', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/596', 'active_substance': 'Lamivudine', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-10-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1111', 'ema_number_certainty': '0.7727272727272727'}"
EU-1-09-595,"{'atc_code': 'G04BE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sildenafil Actavis', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/595', 'active_substance': 'Sildenafil', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '12-10-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1090', 'ema_number_certainty': '0.8125'}"
EU-1-09-601,"{'atc_code': 'N07XX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Firdapse', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/601', 'active_substance': 'amifampridine', 'eu_mah_current': 'SERB S.A.', 'orphan_status': 'h', 'eu_aut_date': '12-23-2009', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/1032', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-09-603,"{'atc_code': 'G04BE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sildenafil ratiopharm', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/603', 'active_substance': 'Sildenafil', 'eu_mah_current': 'ratiopharm GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-23-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1080', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-09-602,"{'atc_code': 'V09HA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Scintimun', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/602', 'active_substance': 'besilesomab', 'eu_mah_current': 'CIS bio international', 'orphan_status': 'h', 'eu_aut_date': '01-11-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1045', 'ema_number_certainty': '1.0'}"
EU-1-09-604,"{'atc_code': 'L04AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Leflunomide Zentiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/604', 'active_substance': 'leflunomide', 'eu_mah_current': 'Zentiva k.s.', 'orphan_status': 'h', 'eu_aut_date': '01-08-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1129', 'ema_number_certainty': '0.8636363636363636'}"
EU-1-09-605,"{'atc_code': 'L01AX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Temomedac', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/605', 'active_substance': 'temozolomide', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'h', 'eu_aut_date': '01-25-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1124', 'ema_number_certainty': '0.7619047619047619'}"
EU-1-09-609,"{'atc_code': 'G03GA09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Elonva', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/609', 'active_substance': 'corifollitropin alfa', 'eu_mah_current': 'N.V. Organon', 'orphan_status': 'h', 'eu_aut_date': '01-25-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1106', 'ema_number_certainty': '0.68'}"
EU-1-09-606,"{'atc_code': 'L01AX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Temozolomide Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/606', 'active_substance': 'temozolomide', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1126', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-09-607,"{'atc_code': 'G04CA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Silodyx', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/607', 'active_substance': 'silodosin', 'eu_mah_current': 'Recordati Ireland Ltd', 'orphan_status': 'h', 'eu_aut_date': '01-29-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1209', 'ema_number_certainty': '0.8823529411764706'}"
EU-1-09-608,"{'atc_code': 'G04CA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Urorec', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/608', 'active_substance': 'silodosin', 'eu_mah_current': 'Recordati Ireland Ltd', 'orphan_status': 'h', 'eu_aut_date': '01-29-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1092', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-10-612,"{'atc_code': 'B02BX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Revolade', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/612', 'active_substance': 'Eltrombopag', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '03-11-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1110', 'ema_number_certainty': '0.7045454545454546'}"
EU-1-10-614,"{'atc_code': 'J07AH08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Menveo', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/614', 'active_substance': 'Meningococcal Group A, C, W135 and Y Conjugate Vaccine', 'eu_mah_current': 'GSK Vaccines S.r.l.', 'orphan_status': 'h', 'eu_aut_date': '03-15-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1095', 'ema_number_certainty': '0.875'}"
EU-1-10-618,"{'atc_code': 'M05BX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Prolia', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/618', 'active_substance': 'denosumab', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1120', 'ema_number_certainty': '0.8292682926829268'}"
EU-1-10-619,"{'atc_code': 'B01AC30', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'DuoPlavin', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/619', 'active_substance': 'clopidogrel / acetylsalicylic acid', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '03-15-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1143', 'ema_number_certainty': '0.8372093023255814'}"
EU-1-10-622,"{'atc_code': 'L01AC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tepadina', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/622', 'active_substance': 'Thiotepa', 'eu_mah_current': 'ADIENNE S.r.l.S.U.', 'orphan_status': 'h', 'eu_aut_date': '03-15-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1046', 'ema_number_certainty': '0.7083333333333334'}"
EU-1-10-620,"{'atc_code': 'A10BD07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ristfor', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/620', 'active_substance': 'sitagliptin / metformin hydrochloride', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-15-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1235', 'ema_number_certainty': '0.7954545454545454'}"
EU-1-10-621,"{'atc_code': 'A10BH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ristaben', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/621', 'active_substance': 'sitagliptin', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-15-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1234', 'ema_number_certainty': '0.7894736842105263'}"
EU-1-10-627,"{'atc_code': 'G03XC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Raloxifene Teva', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/627', 'active_substance': 'Raloxifene hydrochloride', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-29-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1075', 'ema_number_certainty': '0.8125'}"
EU-1-10-628,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Votrient', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/628', 'active_substance': 'Pazopanib hydrochloride', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '06-14-2010', 'eu_aut_type_initial': 'exceptional_conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1141', 'ema_number_certainty': '0.7073170731707317'}"
EU-1-10-631,"{'atc_code': 'L03AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nivestim', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/631', 'active_substance': 'Filgrastim', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-08-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1142', 'ema_number_certainty': '0.78125'}"
EU-1-10-632,"{'atc_code': 'C09CA07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tolura', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/632', 'active_substance': 'telmisartan', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '06-04-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1196', 'ema_number_certainty': '0.875'}"
EU-1-10-635,"{'atc_code': 'N05AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Olanzapine Apotex', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/635', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Apotex Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1178', 'ema_number_certainty': '0.6842105263157895'}"
EU-1-10-633,"{'atc_code': 'L01CE01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Topotecan Hospira', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/633', 'active_substance': 'topotecan', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1192', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-10-636,"{'atc_code': 'R03DX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Daxas', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/636', 'active_substance': 'roflumilast', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '07-05-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1179', 'ema_number_certainty': '0.6896551724137931'}"
EU-1-10-638,"{'atc_code': 'S01BA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ozurdex', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/638', 'active_substance': 'dexamethasone', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '07-27-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1140', 'ema_number_certainty': '0.84'}"
EU-1-15-1076,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kovaltry', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1076', 'active_substance': 'octocog alfa', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '02-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3825', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-15-1078,"{'atc_code': 'H05AA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Natpar', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1078', 'active_substance': 'parathyroid hormone', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'h', 'eu_aut_date': '04-24-2017', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/003861', 'ema_number_certainty': '0.5'}"
EU-1-15-1056,"{'atc_code': 'V03AB37', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Praxbind', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1056', 'active_substance': 'idarucizumab', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-20-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3986', 'ema_number_certainty': '0.6'}"
EU-1-16-1086,"{'atc_code': 'L01XE35', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'TAGRISSO', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1086', 'active_substance': 'osimertinib', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '02-02-2016', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4124', 'ema_number_certainty': '0.52'}"
EU-1-18-1298,"{'atc_code': 'B02BD10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'VEYVONDI', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1298', 'active_substance': 'vonicog alfa', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004454', 'ema_number_certainty': '0.8'}"
EU-1-15-1025,"{'atc_code': 'J05AR15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EVOTAZ', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1025', 'active_substance': 'atazanavir / cobicistat', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '07-13-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3904', 'ema_number_certainty': '0.5333333333333333'}"
EU-1-18-1273,"{'atc_code': 'B01AC22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Prasugrel Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1273', 'active_substance': 'prasugrel', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '05-16-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004644', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-12-809,"{'atc_code': 'G04BD12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Betmiga', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/809', 'active_substance': 'mirabegron', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-20-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2388', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-14-945,"{'atc_code': 'L01EL01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'IMBRUVICA', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/945', 'active_substance': 'Ibrutinib', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '10-21-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3791', 'ema_number_certainty': '0.5116279069767442'}"
EU-1-14-946,"{'atc_code': 'L03AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Accofil', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/946', 'active_substance': 'Filgrastim', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '09-18-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3956', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-12-812,"{'atc_code': 'J07AH09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bexsero', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/812', 'active_substance': 'Meningococcal group B Vaccine (rDNA, component, adsorbed)', 'eu_mah_current': 'GlaxoSmithKline Vaccines S.r.l.', 'orphan_status': 'h', 'eu_aut_date': '01-14-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2333', 'ema_number_certainty': '0.7692307692307693'}"
EU-1-13-819,"{'atc_code': 'S01XA22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'JETREA', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/819', 'active_substance': 'ocriplasmin', 'eu_mah_current': 'Inceptua AB', 'orphan_status': 'h', 'eu_aut_date': '03-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2381', 'ema_number_certainty': '0.7894736842105263'}"
EU-1-13-884,"{'atc_code': 'A10BX11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Invokana', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/884', 'active_substance': 'canagliflozin', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '11-15-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2649', 'ema_number_certainty': '0.43478260869565216'}"
EU-1-13-894,"{'atc_code': 'J05AX15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sovaldi', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/894', 'active_substance': 'sofosbuvir', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2798', 'ema_number_certainty': '0.6'}"
EU-1-14-918,"{'atc_code': 'A10BD16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vokanamet', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/918', 'active_substance': 'canagliflozin / metformin hydrochloride', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '04-23-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2656', 'ema_number_certainty': '0.6521739130434783'}"
EU-1-13-842,"{'atc_code': 'A10BD09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Incresync', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/842', 'active_substance': 'alogliptin / pioglitazone', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '09-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2178', 'ema_number_certainty': '0.6428571428571429'}"
EU-1-13-841,"{'atc_code': 'G04BE10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Spedra', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/841', 'active_substance': 'avanafil', 'eu_mah_current': 'Menarini International Operations Luxembourg S.A.', 'orphan_status': 'h', 'eu_aut_date': '06-21-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2581', 'ema_number_certainty': '0.875'}"
EU-1-13-843,"{'atc_code': 'A10BD13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vipdomet', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/843', 'active_substance': 'alogliptin / metformin', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '09-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2654', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-13-844,"{'atc_code': 'A10BH04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vipidia', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/844', 'active_substance': 'alogliptin', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '09-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2182', 'ema_number_certainty': '0.75'}"
EU-1-13-862,"{'atc_code': 'R03AL04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ultibro Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/862', 'active_substance': 'indacaterol/glycopyrronium bromide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '09-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2679', 'ema_number_certainty': '0.8'}"
EU-1-13-863,"{'atc_code': 'R03AL04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xoterna Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/863', 'active_substance': 'indacaterol/glycopyrronium bromide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '09-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3755', 'ema_number_certainty': '0.9473684210526315'}"
EU-1-13-878,"{'atc_code': 'B01AX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Defitelio', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/878', 'active_substance': 'defibrotide', 'eu_mah_current': 'Gentium S.r.I.', 'orphan_status': 'h', 'eu_aut_date': '10-18-2013', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/2393', 'ema_number_certainty': '0.5'}"
EU-1-13-865,"{'atc_code': 'L01XE23', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tafinlar', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/865', 'active_substance': 'DABRAFENIB', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2604', 'ema_number_certainty': '0.696969696969697'}"
EU-1-13-904,"{'atc_code': 'D11AX21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mirvaso', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/904', 'active_substance': 'brimonidine', 'eu_mah_current': 'Galderma International', 'orphan_status': 'h', 'eu_aut_date': '02-21-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2642', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-13-858,"{'atc_code': 'L01EX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Stivarga', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/858', 'active_substance': 'regorafenib', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '08-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2573', 'ema_number_certainty': '0.7083333333333334'}"
EU-1-13-882,"{'atc_code': 'N05AX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ABILIFY MAINTENA', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/882', 'active_substance': 'Aripiprazole', 'eu_mah_current': 'Otsuka Pharmaceutical Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-15-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2755', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-14-981,"{'atc_code': 'L04AA32', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Otezla', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/981', 'active_substance': 'apremilast', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003746', 'ema_number_certainty': '0.5789473684210527'}"
EU-1-14-980,"{'atc_code': 'L04AC10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cosentyx', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/980', 'active_substance': 'secukinumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003729', 'ema_number_certainty': '0.5'}"
EU-1-13-888,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NovoEight', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/888', 'active_substance': 'turoctocog alfa', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2719', 'ema_number_certainty': '0.7692307692307693'}"
EU-1-14-915,"{'atc_code': 'J05AH02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ebilfumin', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/915', 'active_substance': 'oseltamivir', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '05-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3717', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-13-875,"{'atc_code': 'J04AK06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Deltyba', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/875', 'active_substance': 'delamanid', 'eu_mah_current': 'Otsuka Novel Products GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-28-2014', 'eu_aut_type_initial': 'exceptional_conditional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/2552', 'ema_number_certainty': '0.5172413793103449'}"
EU-1-13-877,"{'atc_code': 'L03AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Grastofil', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/877', 'active_substance': 'filgrastim', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '10-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2150', 'ema_number_certainty': '0.7647058823529411'}"
EU-1-14-913,"{'atc_code': 'N05AE05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Latuda', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/913', 'active_substance': 'lurasidone', 'eu_mah_current': 'Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '03-21-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2713', 'ema_number_certainty': '0.6206896551724138'}"
EU-1-14-920,"{'atc_code': 'R03AK07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'DuoResp Spiromax', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/920', 'active_substance': 'budesonide / formoterol', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-28-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2348', 'ema_number_certainty': '0.5'}"
EU-1-13-837,"{'atc_code': 'L04AX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tecfidera', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/837', 'active_substance': 'Dimethyl fumarate', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-30-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2601', 'ema_number_certainty': '0.6551724137931034'}"
EU-1-13-838,"{'atc_code': 'L04AA31', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'AUBAGIO', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/838', 'active_substance': 'Teriflunomide', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '08-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/002514', 'ema_number_certainty': '0.46153846153846156'}"
EU-1-14-923,"{'atc_code': 'L04AA33', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Entyvio', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/923', 'active_substance': 'vedolizumab', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '05-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2782', 'ema_number_certainty': '0.5769230769230769'}"
EU-1-14-929,"{'atc_code': 'R03AK10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Revinty Ellipta', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/929', 'active_substance': 'fluticasone furoate / vilanterol', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '05-02-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2745', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-13-901,"{'atc_code': 'J04AK05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sirturo', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/901', 'active_substance': 'bedaquiline', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '03-05-2014', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/2614', 'ema_number_certainty': '0.6538461538461539'}"
EU-1-14-931,"{'atc_code': 'L01EE01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mekinist', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/931', 'active_substance': 'trametinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '06-30-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2643', 'ema_number_certainty': '0.53125'}"
EU-1-13-834,"{'atc_code': 'M05BA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zoledronic acid Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/834', 'active_substance': 'zoledronic acid', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2667', 'ema_number_certainty': '0.5454545454545454'}"
EU-1-13-839,"{'atc_code': 'L01EA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Iclusig', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/839', 'active_substance': 'ponatinib', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-01-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2695', 'ema_number_certainty': '0.7631578947368421'}"
EU-1-13-873,"{'atc_code': 'V10XX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xofigo', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/873', 'active_substance': 'Radium Ra 223 dichloride', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2653', 'ema_number_certainty': '0.8125'}"
EU-1-14-969,"{'atc_code': 'D02BB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'SCENESSE', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/969', 'active_substance': 'afamelanotide', 'eu_mah_current': 'Clinuvel Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '12-22-2014', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2548', 'ema_number_certainty': '0.5882352941176471'}"
EU-1-13-820,"{'atc_code': 'N06DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Marixino', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/820', 'active_substance': 'Memantine', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '04-29-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2658', 'ema_number_certainty': '0.8'}"
EU-1-13-817,"{'atc_code': 'C09DA07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Actelsar HCT', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/817', 'active_substance': 'telmisartan / hydrochlorothiazide', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '03-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2676', 'ema_number_certainty': '0.5263157894736842'}"
EU-1-13-832,"{'atc_code': 'C02KX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Stayveer', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/832', 'active_substance': 'bosentan', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '06-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2644', 'ema_number_certainty': '0.8'}"
EU-1-13-824,"{'atc_code': 'N06DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nemdatine', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/824', 'active_substance': 'Memantine', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '04-22-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2680', 'ema_number_certainty': '0.75'}"
EU-1-13-840,"{'atc_code': 'J06BA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'HyQvia', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/840', 'active_substance': 'human normal immunoglobulin', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-16-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2491', 'ema_number_certainty': '0.6521739130434783'}"
EU-1-13-892,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tivicay', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/892', 'active_substance': 'dolutegravir', 'eu_mah_current': 'ViiV Healthcare BV', 'orphan_status': 'h', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2753', 'ema_number_certainty': '0.6052631578947368'}"
EU-1-13-856,"{'atc_code': 'L03AA14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lonquex', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/856', 'active_substance': 'lipegfilgrastim', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-25-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2556', 'ema_number_certainty': '0.6363636363636364'}"
EU-1-13-829,"{'atc_code': 'J07CA09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hexyon', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/829', 'active_substance': 'diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)', 'eu_mah_current': 'Sanofi Pasteur', 'orphan_status': 'h', 'eu_aut_date': '04-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2796', 'ema_number_certainty': '0.7272727272727273'}"
EU-1-13-828,"{'atc_code': 'J07CA09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hexacima', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/828', 'active_substance': 'Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)', 'eu_mah_current': 'Sanofi Pasteur', 'orphan_status': 'h', 'eu_aut_date': '04-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2702', 'ema_number_certainty': '0.7'}"
EU-1-13-818,"{'atc_code': 'L01XE14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bosulif', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/818', 'active_substance': 'Bosutinib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-27-2013', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/2373', 'ema_number_certainty': '0.7272727272727273'}"
EU-1-12-811,"{'atc_code': 'A10BJ03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lyxumia', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/811', 'active_substance': 'lixisenatide', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '02-01-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2445', 'ema_number_certainty': '0.5882352941176471'}"
EU-1-13-879,"{'atc_code': 'L01EB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Giotrif', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/879', 'active_substance': 'afatinib', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-25-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2280', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-13-880,"{'atc_code': 'N06DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Memantine Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/880', 'active_substance': 'memantine', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '12-04-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2766', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-13-881,"{'atc_code': 'N01BB20', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fortacin', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/881', 'active_substance': 'lidocaine / prilocaine', 'eu_mah_current': 'Recordati Ireland Ltd', 'orphan_status': 'h', 'eu_aut_date': '11-15-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2693', 'ema_number_certainty': '0.6923076923076923'}"
EU-1-14-930,"{'atc_code': 'A10BK03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Jardiance', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/930', 'active_substance': 'Empagliflozin', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2677', 'ema_number_certainty': '0.41935483870967744'}"
EU-1-14-943,"{'atc_code': 'V03AE05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Velphoro', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/943', 'active_substance': 'mixture of polynuclear iron(iii)-oxyhydroxide, sucrose and starches', 'eu_mah_current': 'Vifor Fresenius Medical Care Renal Pharma France', 'orphan_status': 'h', 'eu_aut_date': '08-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2705', 'ema_number_certainty': '0.7'}"
EU-1-12-814,"{'atc_code': 'L01XX44', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ZALTRAP', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/814', 'active_substance': 'aflibercept', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '02-01-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2532', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-13-822,"{'atc_code': 'A16AX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'PHEBURANE', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/822', 'active_substance': 'Sodium Phenylbutyrate', 'eu_mah_current': 'Eurocept International BV', 'orphan_status': 'h', 'eu_aut_date': '07-31-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2500', 'ema_number_certainty': '0.6923076923076923'}"
EU-1-13-902,"{'atc_code': 'M09AX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Translarna', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/902', 'active_substance': 'ataluren', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'h', 'eu_aut_date': '07-31-2014', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/2720', 'ema_number_certainty': '0.6785714285714286'}"
EU-1-14-963,"{'atc_code': 'R03AL05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Brimica Genuair', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/963', 'active_substance': 'aclidinium bromide / formoterol fumarate dihydrate', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3969', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-14-964,"{'atc_code': 'R03AL05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Duaklir Genuair', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/964', 'active_substance': 'aclidinium bromide / formoterol fumarate dihydrate', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3745', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-13-848,"{'atc_code': 'L01XX43', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Erivedge', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/848', 'active_substance': 'vismodegib', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-12-2013', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2602', 'ema_number_certainty': '0.7727272727272727'}"
EU-1-13-860,"{'atc_code': 'A02BC05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nexium Control', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/860', 'active_substance': 'esomeprazole', 'eu_mah_current': 'GlaxoSmithKline Dungarvan Limited', 'orphan_status': 'h', 'eu_aut_date': '08-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2618', 'ema_number_certainty': '0.6842105263157895'}"
EU-1-13-861,"{'atc_code': 'A16AA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Procysbi', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/861', 'active_substance': 'mercaptamine (cysteamine bitartrate)', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '09-06-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2465', 'ema_number_certainty': '0.7894736842105263'}"
EU-1-13-887,"{'atc_code': 'J07BB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fluenz Tetra', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/887', 'active_substance': 'influenza vaccine (live attenuated, nasal)', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '12-04-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2617', 'ema_number_certainty': '0.76'}"
EU-1-13-896,"{'atc_code': 'J04AA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Granupas', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/896', 'active_substance': 'Para-aminosalicylic acid', 'eu_mah_current': 'Eurocept International B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-07-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2709', 'ema_number_certainty': '0.8'}"
EU-1-14-899,"{'atc_code': 'R03AL03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Laventair Ellipta', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/899', 'active_substance': 'umeclidinium bromide / vilanterol trifenatate', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '05-08-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3754', 'ema_number_certainty': '0.6956521739130435'}"
EU-1-13-821,"{'atc_code': 'C09DA07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tolucombi', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/821', 'active_substance': 'telmisartan/hydrochlorothiazide', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '03-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2549', 'ema_number_certainty': '0.7333333333333333'}"
EU-1-13-852,"{'atc_code': 'G02CX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Atosiban SUN', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/852', 'active_substance': 'atosiban', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe BV', 'orphan_status': 'h', 'eu_aut_date': '07-31-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2329', 'ema_number_certainty': '0.6'}"
EU-1-14-914,"{'atc_code': 'A16AB12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vimizim', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/914', 'active_substance': 'elosulfase alfa', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'h', 'eu_aut_date': '04-28-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2779', 'ema_number_certainty': '1.0'}"
EU-1-14-940,"{'atc_code': 'J05AR13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Triumeq', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/940', 'active_substance': 'dolutegravir / abacavir / lamivudine', 'eu_mah_current': 'ViiV Healthcare BV', 'orphan_status': 'h', 'eu_aut_date': '09-01-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2754', 'ema_number_certainty': '0.5675675675675675'}"
EU-1-14-957,"{'atc_code': 'L01XC21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cyramza', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/957', 'active_substance': 'ramucirumab', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2829', 'ema_number_certainty': '0.6818181818181818'}"
EU-1-14-967,"{'atc_code': 'J05AR14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rezolsta', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/967', 'active_substance': 'Darunavir/Cobicistat', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2819', 'ema_number_certainty': '0.47058823529411764'}"
EU-1-13-859,"{'atc_code': 'N04BA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Corbilta', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/859', 'active_substance': 'levodopa / carbidopa / entacapone', 'eu_mah_current': 'Orion Corporation', 'orphan_status': 'h', 'eu_aut_date': '11-11-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2785', 'ema_number_certainty': '0.6'}"
EU-1-13-866,"{'atc_code': 'C10BA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cholib', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/866', 'active_substance': 'fenofibrate / simvastatin', 'eu_mah_current': 'Mylan IRE Healthcare Ltd', 'orphan_status': 'h', 'eu_aut_date': '08-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2559', 'ema_number_certainty': '0.75'}"
EU-1-14-919,"{'atc_code': 'C07AA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hemangiol', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/919', 'active_substance': 'propranolol', 'eu_mah_current': 'Pierre Fabre Dermatologie', 'orphan_status': 'h', 'eu_aut_date': '04-23-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2621', 'ema_number_certainty': '0.75'}"
EU-1-14-952,"{'atc_code': 'V03AE02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sevelamer carbonate Winthrop', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/952', 'active_substance': 'Sevelamer carbonate', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3971', 'ema_number_certainty': '0.6'}"
EU-1-14-954,"{'atc_code': 'L01EX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vargatef', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/954', 'active_substance': 'nintedanib', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-21-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2569', 'ema_number_certainty': '0.38461538461538464'}"
EU-1-14-955,"{'atc_code': 'V09IA09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lymphoseek', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/955', 'active_substance': 'tilmanocept', 'eu_mah_current': 'Navidea Biopharmaceuticals Europe Ltd.', 'orphan_status': 'h', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2085', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-13-855,"{'atc_code': 'J07BX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Imvanex', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/855', 'active_substance': 'Smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara)', 'eu_mah_current': 'Bavarian Nordic A/S', 'orphan_status': 'h', 'eu_aut_date': '07-31-2013', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2596', 'ema_number_certainty': '0.6296296296296297'}"
EU-1-14-935,"{'atc_code': 'L04AD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Envarsus', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/935', 'active_substance': 'tacrolimus', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '07-18-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2655', 'ema_number_certainty': '0.6153846153846154'}"
EU-1-13-850,"{'atc_code': 'L04AX06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Imnovid', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/850', 'active_substance': 'Pomalidomide', 'eu_mah_current': 'Bristol Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2682', 'ema_number_certainty': '0.6451612903225806'}"
EU-1-14-974,"{'atc_code': 'A16AX10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cerdelga', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/974', 'active_substance': 'eliglustat', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3724', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-14-975,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Clopidogrel ratiopharm', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/975', 'active_substance': 'clopidogrel', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4006', 'ema_number_certainty': '0.5882352941176471'}"
EU-1-12-815,"{'atc_code': 'N07BB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Selincro', 'status_type': 'a', 'eu_pnumber': 'EU/1/12/815', 'active_substance': 'nalmefene', 'eu_mah_current': 'H. Lundbeck A/S', 'orphan_status': 'h', 'eu_aut_date': '02-25-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2583', 'ema_number_certainty': '0.5294117647058824'}"
EU-1-13-889,"{'atc_code': 'N03AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Levetiracetam Hospira', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/889', 'active_substance': 'levetiracetam', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '01-08-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2783', 'ema_number_certainty': '0.5909090909090909'}"
EU-1-14-916,"{'atc_code': 'N03AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pregabalin Pfizer', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/916', 'active_substance': 'pregabalin', 'eu_mah_current': 'Upjohn EESV', 'orphan_status': 'h', 'eu_aut_date': '04-10-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3880', 'ema_number_certainty': '0.4857142857142857'}"
EU-1-13-823,"{'atc_code': 'N05AH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Adasuve', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/823', 'active_substance': 'loxapine', 'eu_mah_current': 'Ferrer Internacional S.A.', 'orphan_status': 'h', 'eu_aut_date': '02-20-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2400', 'ema_number_certainty': '0.9166666666666666'}"
EU-1-13-813,"{'atc_code': 'L01XC13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Perjeta', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/813', 'active_substance': 'pertuzumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-04-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2547', 'ema_number_certainty': '0.76'}"
EU-1-13-857,"{'atc_code': 'B02BD06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Voncento', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/857', 'active_substance': 'human coagulation factor VIII / human von Willebrand factor', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2493', 'ema_number_certainty': '0.9230769230769231'}"
EU-1-13-890,"{'atc_code': 'L01EX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cometriq', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/890', 'active_substance': 'cabozantinib', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'h', 'eu_aut_date': '03-21-2014', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2640', 'ema_number_certainty': '0.5757575757575758'}"
EU-1-13-830,"{'atc_code': 'J05AR09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Stribild', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/830', 'active_substance': 'elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '05-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2574', 'ema_number_certainty': '0.9142857142857143'}"
EU-1-13-891,"{'atc_code': 'N06AX26', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Brintellix', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/891', 'active_substance': 'vortioxetine', 'eu_mah_current': 'H. Lundbeck A/S', 'orphan_status': 'h', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2717', 'ema_number_certainty': '0.6842105263157895'}"
EU-1-14-965,"{'atc_code': 'J02AB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ketoconazole HRA', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/965', 'active_substance': 'ketoconazole', 'eu_mah_current': 'HRA Pharma Rare Diseases', 'orphan_status': 'h', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3906', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-13-906,"{'atc_code': 'V09AX06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Neuraceq', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/906', 'active_substance': 'florbetaben (18F)', 'eu_mah_current': 'Life Radiopharma Berlin GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-20-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2553', 'ema_number_certainty': '0.7727272727272727'}"
EU-1-14-956,"{'atc_code': 'A10BJ05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trulicity', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/956', 'active_substance': 'dulaglutide', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-21-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2825', 'ema_number_certainty': '0.625'}"
EU-1-14-951,"{'atc_code': 'L01AB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Busulfan Fresenius Kabi', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/951', 'active_substance': 'busulfan', 'eu_mah_current': 'Fresenius Kabi Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2806', 'ema_number_certainty': '0.5'}"
EU-1-14-970,"{'atc_code': 'B02BD04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rixubis', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/970', 'active_substance': 'nonacog gamma', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3771', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-14-973,"{'atc_code': 'J01MA12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Quinsair', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/973', 'active_substance': 'levofloxacin', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '03-26-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2789', 'ema_number_certainty': '0.5625'}"
EU-1-13-893,"{'atc_code': 'C02KX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Opsumit', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/893', 'active_substance': 'macitentan', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '12-20-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2697', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-13-826,"{'atc_code': 'N06DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Memantine LEK', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/826', 'active_substance': 'Memantine', 'eu_mah_current': 'Pharmathen S.A.', 'orphan_status': 'h', 'eu_aut_date': '04-22-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2630', 'ema_number_certainty': '0.875'}"
EU-1-14-972,"{'atc_code': 'N06AX21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Duloxetine Lilly', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/972', 'active_substance': 'duloxetine', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-08-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4000', 'ema_number_certainty': '0.5'}"
EU-1-14-977,"{'atc_code': 'N04BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rasagiline ratiopharm', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/977', 'active_substance': 'rasagiline', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3957', 'ema_number_certainty': '0.7'}"
EU-1-14-978,"{'atc_code': 'G03XC05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Senshio', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/978', 'active_substance': 'ospemifene', 'eu_mah_current': 'Shionogi B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2780', 'ema_number_certainty': '0.6'}"
EU-1-14-979,"{'atc_code': 'L01EX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ofev', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/979', 'active_substance': 'Nintedanib', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3821', 'ema_number_certainty': '0.39285714285714285'}"
EU-1-13-869,"{'atc_code': 'L04AA34', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lemtrada', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/869', 'active_substance': 'Alemtuzumab', 'eu_mah_current': 'Sanofi Belgium', 'orphan_status': 'h', 'eu_aut_date': '09-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3718', 'ema_number_certainty': '0.4090909090909091'}"
EU-1-14-933,"{'atc_code': 'S01EC54', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Simbrinza', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/933', 'active_substance': 'Brinzolamide / Brimonidine tartrate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '07-18-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3698', 'ema_number_certainty': '0.7'}"
EU-1-14-934,"{'atc_code': 'L03AB13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Plegridy', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/934', 'active_substance': 'peginterferon beta-1a', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-18-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2827', 'ema_number_certainty': '0.7619047619047619'}"
EU-1-14-936,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nuwiq', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/936', 'active_substance': 'simoctocog alfa', 'eu_mah_current': 'Octapharma AB', 'orphan_status': 'h', 'eu_aut_date': '07-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2813', 'ema_number_certainty': '0.8'}"
EU-1-13-845,"{'atc_code': 'L01EA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Imatinib Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/845', 'active_substance': 'Imatinib', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '07-01-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2681', 'ema_number_certainty': '0.782608695652174'}"
EU-1-13-846,"{'atc_code': 'L02BB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xtandi', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/846', 'active_substance': 'enzalutamide', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-21-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2639', 'ema_number_certainty': '0.7241379310344828'}"
EU-1-13-836,"{'atc_code': 'N06DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Memantine ratiopharm', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/836', 'active_substance': 'memantine', 'eu_mah_current': 'ratiopharm GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2671', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-14-928,"{'atc_code': 'L04AC11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sylvant', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/928', 'active_substance': 'siltuximab', 'eu_mah_current': 'EUSA Pharma (Netherlands) B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3708', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-13-853,"{'atc_code': 'L04AB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Remsima', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/853', 'active_substance': 'Infliximab', 'eu_mah_current': 'Celltrion Healthcare Hungary Kft.', 'orphan_status': 'h', 'eu_aut_date': '09-10-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2576', 'ema_number_certainty': '0.5681818181818182'}"
EU-1-13-854,"{'atc_code': 'L04AB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Inflectra', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/854', 'active_substance': 'Infliximab', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '09-10-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2778', 'ema_number_certainty': '0.7894736842105263'}"
EU-1-14-960,"{'atc_code': 'G03CC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'DUAVIVE', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/960', 'active_substance': 'oestrogens conjugated / bazedoxifene', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2314', 'ema_number_certainty': '0.6111111111111112'}"
EU-1-14-961,"{'atc_code': 'G04BE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tadalafil Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/961', 'active_substance': 'tadalafil', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '11-21-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3787', 'ema_number_certainty': '0.5625'}"
EU-1-14-959,"{'atc_code': 'L01XK01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lynparza', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/959', 'active_substance': 'Olaparib', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003726', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-14-958,"{'atc_code': 'J05AP51', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Harvoni', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/958', 'active_substance': 'ledipasvir/sofosbuvir', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '11-17-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3850', 'ema_number_certainty': '0.7631578947368421'}"
EU-1-13-871,"{'atc_code': 'G03GA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ovaleap', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/871', 'active_substance': 'Follitropin alfa', 'eu_mah_current': 'Theramex Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '09-27-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2608', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-13-827,"{'atc_code': 'N06DX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Memantine Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/827', 'active_substance': 'Memantine', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '04-22-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2660', 'ema_number_certainty': '0.5'}"
EU-1-14-938,"{'atc_code': 'L01EM01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zydelig', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/938', 'active_substance': 'idelalisib', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '09-18-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3843', 'ema_number_certainty': '0.8076923076923077'}"
EU-1-14-947,"{'atc_code': 'A10AE56', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xultophy', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/947', 'active_substance': 'insulin degludec / liraglutide', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '09-18-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2647', 'ema_number_certainty': '0.7222222222222222'}"
EU-1-13-885,"{'atc_code': 'L01XC14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kadcyla', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/885', 'active_substance': 'Trastuzumab emtansine', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-15-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2389', 'ema_number_certainty': '0.6470588235294118'}"
EU-1-13-886,"{'atc_code': 'R03AK10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Relvar Ellipta', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/886', 'active_substance': 'fluticasone furoate/vilanterol', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2673', 'ema_number_certainty': '0.7407407407407407'}"
EU-1-13-900,"{'atc_code': 'A10BD15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xigduo', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/900', 'active_substance': 'dapagliflozin/metformin', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2672', 'ema_number_certainty': '0.7083333333333334'}"
EU-1-14-917,"{'atc_code': 'R03AL04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ulunar Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/917', 'active_substance': 'indacaterol/glycopyrronium bromide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '04-23-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3875', 'ema_number_certainty': '0.875'}"
EU-1-14-921,"{'atc_code': 'R03AK07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'BiResp Spiromax', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/921', 'active_substance': 'budesonide / formoterol', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-28-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3890', 'ema_number_certainty': '0.5384615384615384'}"
EU-1-14-937,"{'atc_code': 'L01XC15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Gazyvaro', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/937', 'active_substance': 'obinutuzumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-23-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2799', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-13-851,"{'atc_code': 'C10AX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lojuxta', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/851', 'active_substance': 'Lomitapide', 'eu_mah_current': 'Amryt Pharmaceuticals DAC', 'orphan_status': 'h', 'eu_aut_date': '07-31-2013', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2578', 'ema_number_certainty': '0.6538461538461539'}"
EU-1-13-872,"{'atc_code': 'V03AX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tybost', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/872', 'active_substance': 'cobicistat', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '09-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2572', 'ema_number_certainty': '0.7'}"
EU-1-13-905,"{'atc_code': 'S01EE04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Izba', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/905', 'active_substance': 'travoprost', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '02-20-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2738', 'ema_number_certainty': '0.875'}"
EU-1-13-907,"{'atc_code': 'C02KX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Adempas', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/907', 'active_substance': 'riociguat', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '03-27-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2737', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-13-909,"{'atc_code': 'G03GA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bemfola', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/909', 'active_substance': 'follitropin alfa', 'eu_mah_current': 'Gedeon Richter Plc.', 'orphan_status': 'h', 'eu_aut_date': '03-27-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2615', 'ema_number_certainty': '0.9'}"
EU-1-14-962,"{'atc_code': 'A06AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Moventig', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/962', 'active_substance': 'naloxegol', 'eu_mah_current': 'Kyowa Kirin Holdings B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-08-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2810', 'ema_number_certainty': '0.6470588235294118'}"
EU-1-13-835,"{'atc_code': 'J02AC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Voriconazole Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/13/835', 'active_substance': 'voriconazole', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '05-16-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2669', 'ema_number_certainty': '0.6842105263157895'}"
EU-1-14-941,"{'atc_code': 'V09AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vizamyl', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/941', 'active_substance': 'flutemetamol (18F)', 'eu_mah_current': 'GE Healthcare AS', 'orphan_status': 'h', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2557', 'ema_number_certainty': '0.6875'}"
EU-1-15-999,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zykadia', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/999', 'active_substance': 'ceritinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '05-06-2015', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3819', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-15-1009,"{'atc_code': 'N05AX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aripiprazole Zentiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1009', 'active_substance': 'aripiprazole', 'eu_mah_current': 'Zentiva, k.s.', 'orphan_status': 'h', 'eu_aut_date': '06-25-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3899', 'ema_number_certainty': '0.5454545454545454'}"
EU-1-15-1015,"{'atc_code': 'A16AB13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Strensiq', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1015', 'active_substance': 'asfotase alfa', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'h', 'eu_aut_date': '08-28-2015', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3794', 'ema_number_certainty': '0.6'}"
EU-1-15-1016,"{'atc_code': 'C10AX13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Repatha', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1016', 'active_substance': 'evolocumab', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-17-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003766', 'ema_number_certainty': '0.4583333333333333'}"
EU-1-15-997,"{'atc_code': 'N03AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pregabalin Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/997', 'active_substance': 'pregabalin', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '06-25-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004078', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-15-1013,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lumark', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1013', 'active_substance': 'lutetium, isotope of mass 177', 'eu_mah_current': 'IDB Holland B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2749', 'ema_number_certainty': '0.5454545454545454'}"
EU-1-15-1010,"{'atc_code': 'N06AX21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Duloxetine Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1010', 'active_substance': 'Duloxetine', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3981', 'ema_number_certainty': '0.55'}"
EU-1-15-1014,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'OPDIVO', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1014', 'active_substance': 'nivolumab', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3985', 'ema_number_certainty': '0.5205479452054794'}"
EU-1-15-1053,"{'atc_code': 'H02AB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Neofordex', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1053', 'active_substance': 'dexamethasone', 'eu_mah_current': 'Laboratoires CTRS', 'orphan_status': 'h', 'eu_aut_date': '03-16-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4071', 'ema_number_certainty': '0.45454545454545453'}"
EU-1-00-133,"{'atc_code': 'A10AE04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Toujeo', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/133', 'active_substance': 'insulin glargine', 'eu_mah_current': 'Sanofi-Aventis Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-27-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/309', 'ema_number_certainty': '0.935064935064935'}"
EU-1-15-1005,"{'atc_code': 'N05AX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aripiprazole Mylan Pharma', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1005', 'active_substance': 'aripiprazole', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '06-30-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3803', 'ema_number_certainty': '0.6470588235294118'}"
EU-1-15-1006,"{'atc_code': 'B02AB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Respreeza', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1006', 'active_substance': 'human alpha1-proteinase inhibitor', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-20-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2739', 'ema_number_certainty': '0.6'}"
EU-1-15-1007,"{'atc_code': 'J07BM03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Gardasil 9', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1007', 'active_substance': 'human papillomavirus 9-valent vaccine (recombinant, adsorbed)', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3852', 'ema_number_certainty': '0.6363636363636364'}"
EU-1-15-1011,"{'atc_code': 'N03AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pregabalin Sandoz', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1011', 'active_substance': 'pregabalin', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004010', 'ema_number_certainty': '0.6428571428571429'}"
EU-1-15-1012,"{'atc_code': 'N03AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pregabalin Sandoz GmbH', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1012', 'active_substance': 'pregabalin', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004070', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-15-1000,"{'atc_code': 'C03XA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Jinarc', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1000', 'active_substance': 'tolvaptan', 'eu_mah_current': 'Otsuka Pharmaceutical Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-27-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2788', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-15-1001,"{'atc_code': 'A04AA55', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Akynzeo', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1001', 'active_substance': 'netupitant/palonosetron or fosnetupitant/palonosetron', 'eu_mah_current': 'Helsinn Birex Pharmaceuticals Ltd', 'orphan_status': 'h', 'eu_aut_date': '05-27-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003728', 'ema_number_certainty': '0.6428571428571429'}"
EU-1-15-1002,"{'atc_code': 'L01XE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lenvima', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1002', 'active_substance': 'lenvatinib', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3727', 'ema_number_certainty': '0.5'}"
EU-1-15-1003,"{'atc_code': 'A10BD20', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Synjardy', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1003', 'active_substance': 'empagliflozin / metformin', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-27-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3770', 'ema_number_certainty': '0.4482758620689655'}"
EU-1-15-1018,"{'atc_code': 'S01FB51', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Omidria', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1018', 'active_substance': 'phenylephrine / ketorolac', 'eu_mah_current': 'Omeros Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3702', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-15-1019,"{'atc_code': 'L01XX32', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bortezomib Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1019', 'active_substance': 'bortezomib', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '07-20-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3984', 'ema_number_certainty': '0.47058823529411764'}"
EU-1-15-1020,"{'atc_code': 'N06BX13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Raxone', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1020', 'active_substance': 'idebenone', 'eu_mah_current': 'Santhera Pharmaceuticals (Deutschland) GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-08-2015', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/003834', 'ema_number_certainty': '0.625'}"
EU-1-15-1043,"{'atc_code': 'R03DX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nucala', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1043', 'active_substance': 'mepolizumab', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'h', 'eu_aut_date': '12-02-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3860', 'ema_number_certainty': '0.5'}"
EU-1-15-1045,"{'atc_code': 'N05AX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aripiprazole Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1045', 'active_substance': 'aripiprazole', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '11-16-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4021', 'ema_number_certainty': '0.5882352941176471'}"
EU-1-15-1046,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Elocta', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1046', 'active_substance': 'efmoroctocog alfa', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'h', 'eu_aut_date': '11-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3964', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-15-1047,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'BLINCYTO', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1047', 'active_substance': 'blinatumomab', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-23-2015', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3731', 'ema_number_certainty': '0.65'}"
EU-1-15-1048,"{'atc_code': 'L01EE02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cotellic', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1048', 'active_substance': 'cobimetinib', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-20-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3960', 'ema_number_certainty': '0.4666666666666667'}"
EU-1-15-1049,"{'atc_code': 'S01XA21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cystadrops', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1049', 'active_substance': 'mercaptamine', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'h', 'eu_aut_date': '01-19-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003769', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-15-1051,"{'atc_code': 'A10BD15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ebymect', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1051', 'active_substance': 'dapagliflozin / metformin', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '11-16-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4162', 'ema_number_certainty': '0.75'}"
EU-1-15-1052,"{'atc_code': 'A10BK01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Edistride', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1052', 'active_substance': 'dapagliflozin', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '11-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4161', 'ema_number_certainty': '0.391304347826087'}"
EU-1-14-984,"{'atc_code': 'N04BD03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xadago', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/984', 'active_substance': 'safinamide', 'eu_mah_current': 'Zambon S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '02-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2396', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-15-989,"{'atc_code': 'J01XA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Orbactiv', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/989', 'active_substance': 'oritavancin', 'eu_mah_current': 'Menarini International Operations Luxembourg S.A.', 'orphan_status': 'h', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3785', 'ema_number_certainty': '0.5'}"
EU-1-15-1008,"{'atc_code': 'N05CH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hetlioz', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1008', 'active_substance': 'tasimelteon', 'eu_mah_current': 'Vanda Pharmaceuticals Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-03-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3870', 'ema_number_certainty': '0.5'}"
EU-1-10-615,"{'atc_code': 'L01AX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Temozolomide Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/10/615', 'active_substance': 'temozolomide', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '03-15-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1125', 'ema_number_certainty': '0.7666666666666667'}"
EU-1-16-1097,"{'atc_code': 'L03AX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Strimvelis', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1097', 'active_substance': 'autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence', 'eu_mah_current': 'Orchard Therapeutics (Netherlands) B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-26-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003854', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-15-1067,"{'atc_code': 'J05AR10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lopinavir/Ritonavir Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1067', 'active_substance': 'lopinavir / ritonavir', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '01-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4025', 'ema_number_certainty': '0.6875'}"
EU-1-15-1061,"{'atc_code': 'J05AR18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Genvoya', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1061', 'active_substance': 'elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '11-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4042', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-15-1065,"{'atc_code': 'B01AC16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Eptifibatide Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1065', 'active_substance': 'eptifibatide', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '01-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004104', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-15-991,"{'atc_code': 'J01XX11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sivextro', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/991', 'active_substance': 'tedizolid phosphate', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-23-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2846', 'ema_number_certainty': '0.6'}"
EU-1-14-986,"{'atc_code': 'J01XA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xydalba', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/986', 'active_substance': 'Dalbavancin', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '02-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/002840', 'ema_number_certainty': '0.5294117647058824'}"
EU-1-14-987,"{'atc_code': 'S01XA19', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Holoclar', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/987', 'active_substance': 'Ex vivo expanded autologous human corneal epithelial cells containing stem cells', 'eu_mah_current': 'Holostem Terapie Avanzate S.r.l.', 'orphan_status': 'h', 'eu_aut_date': '02-17-2015', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/2450', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-15-994,"{'atc_code': 'B01AC25', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kengrexal', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/994', 'active_substance': 'cangrelor', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '03-23-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3773', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-15-1071,"{'atc_code': 'L01BA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pemetrexed Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1071', 'active_substance': 'pemetrexed', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '01-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4072', 'ema_number_certainty': '0.5'}"
EU-1-15-1072,"{'atc_code': 'L01XX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Spectrila', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1072', 'active_substance': 'asparaginase', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'h', 'eu_aut_date': '01-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2661', 'ema_number_certainty': '0.6'}"
EU-1-15-1073,"{'atc_code': 'N03AX23', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Briviact', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1073', 'active_substance': 'brivaracetam', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '01-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3898', 'ema_number_certainty': '0.6153846153846154'}"
EU-1-16-1092,"{'atc_code': 'C09DB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Amlodipine/Valsartan Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1092', 'active_substance': 'amlodipine/valsartan', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '03-22-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004037', 'ema_number_certainty': '0.5384615384615384'}"
EU-1-16-1103,"{'atc_code': 'C09DX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Neparvis', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1103', 'active_substance': 'sacubitril / valsartan', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '05-26-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4343', 'ema_number_certainty': '0.47058823529411764'}"
EU-1-15-1055,"{'atc_code': 'L01BA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ciambra', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1055', 'active_substance': 'pemetrexed', 'eu_mah_current': 'Menarini International Operations Luxembourg S.A.', 'orphan_status': 'h', 'eu_aut_date': '12-02-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3788', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-16-1098,"{'atc_code': 'B02BD04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ALPROLIX', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1098', 'active_substance': 'eftrenonacog alfa', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'h', 'eu_aut_date': '05-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4142', 'ema_number_certainty': '0.4'}"
EU-1-15-1036,"{'atc_code': 'J02AC05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cresemba', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1036', 'active_substance': 'isavuconazole', 'eu_mah_current': 'Basilea Pharmaceutica Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2734', 'ema_number_certainty': '0.5882352941176471'}"
EU-1-16-1102,"{'atc_code': 'L01XX32', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bortezomib SUN', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1102', 'active_substance': 'bortezomib', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe BV', 'orphan_status': 'h', 'eu_aut_date': '07-22-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4076', 'ema_number_certainty': '0.4666666666666667'}"
EU-1-14-944,"{'atc_code': 'A10AE04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Abasaglar', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/944', 'active_substance': 'Insulin glargine', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-09-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2835', 'ema_number_certainty': '0.625'}"
EU-1-15-1031,"{'atc_code': 'C10AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Praluent', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1031', 'active_substance': 'alirocumab', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '09-23-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3882', 'ema_number_certainty': '0.5789473684210527'}"
EU-1-15-1032,"{'atc_code': 'J01DI54', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zerbaxa', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1032', 'active_substance': 'ceftolozane / tazobactam', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-18-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3772', 'ema_number_certainty': '0.6'}"
EU-1-15-1058,"{'atc_code': 'C09DX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Entresto', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1058', 'active_substance': 'sacubitril / valsartan', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4062', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-15-1059,"{'atc_code': 'R07AX30', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Orkambi', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1059', 'active_substance': 'Lumacaftor/Ivacaftor', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '11-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3954', 'ema_number_certainty': '0.5416666666666666'}"
EU-1-15-1060,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kyprolis', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1060', 'active_substance': 'carfilzomib', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3790', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-15-1074,"{'atc_code': 'L04AB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Benepali', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1074', 'active_substance': 'etanercept', 'eu_mah_current': 'Samsung Bioepis NL B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4007', 'ema_number_certainty': '0.52'}"
EU-1-15-1064,"{'atc_code': 'L01XX51', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Imlygic', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1064', 'active_substance': 'talimogene laherparepvec', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-16-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2771', 'ema_number_certainty': '0.5882352941176471'}"
EU-1-16-1099,"{'atc_code': 'J05AR17', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Descovy', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1099', 'active_substance': 'emtricitabine / tenofovir alafenamide', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '04-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4094', 'ema_number_certainty': '0.8181818181818182'}"
EU-1-15-1029,"{'atc_code': 'N05AX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aripiprazole Sandoz', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1029', 'active_substance': 'Aripiprazole', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-20-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4008', 'ema_number_certainty': '0.5454545454545454'}"
EU-1-15-1068,"{'atc_code': 'N07XX11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Wakix', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1068', 'active_substance': 'Pitolisant hydrochloride', 'eu_mah_current': 'Bioprojet Pharma', 'orphan_status': 'h', 'eu_aut_date': '03-31-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2616', 'ema_number_certainty': '0.5333333333333333'}"
EU-1-15-1040,"{'atc_code': 'C02AC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Intuniv', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1040', 'active_substance': 'guanfacine', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'h', 'eu_aut_date': '09-17-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3759', 'ema_number_certainty': '0.5'}"
EU-1-16-1094,"{'atc_code': 'L01XG03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ninlaro', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1094', 'active_substance': 'ixazomib', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '11-21-2016', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/003844', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-16-1087,"{'atc_code': 'B02BD13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Coagadex', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1087', 'active_substance': 'human coagulation factor X', 'eu_mah_current': 'BPL Bioproducts Laboratory GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-16-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3855', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-16-1088,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Empliciti', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1088', 'active_substance': 'elotuzumab', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '05-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003967', 'ema_number_certainty': '0.6363636363636364'}"
EU-1-16-1093,"{'atc_code': 'N03AX15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zonisamide Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1093', 'active_substance': 'zonisamide', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '03-31-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004127', 'ema_number_certainty': '0.6'}"
EU-1-16-1090,"{'atc_code': 'N04BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rasagiline Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1090', 'active_substance': 'rasagiline', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '04-04-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004064', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-16-1096,"{'atc_code': 'L01BC59', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lonsurf', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1096', 'active_substance': 'trifluridine / tipiracil', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'h', 'eu_aut_date': '04-25-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3897', 'ema_number_certainty': '0.6'}"
EU-1-14-988,"{'atc_code': 'A08AA62', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mysimba', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/988', 'active_substance': 'naltrexone / bupropion', 'eu_mah_current': 'Orexigen Therapeutics Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '03-26-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3687', 'ema_number_certainty': '0.5806451612903226'}"
EU-1-15-1063,"{'atc_code': 'L01BA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Armisarte', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1063', 'active_substance': 'pemetrexed', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '01-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4109', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-15-992,"{'atc_code': 'A10BX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Saxenda', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/992', 'active_substance': 'liraglutide', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '03-23-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3780', 'ema_number_certainty': '0.6153846153846154'}"
EU-1-15-993,"{'atc_code': 'B01AF03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lixiana', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/993', 'active_substance': 'edoxaban', 'eu_mah_current': 'Daiichi Sankyo Europe GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2629', 'ema_number_certainty': '0.6470588235294118'}"
EU-1-16-1091,"{'atc_code': 'J05AE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Atazanavir Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1091', 'active_substance': 'atazanavir', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '08-22-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4048', 'ema_number_certainty': '0.5'}"
EU-1-15-1027,"{'atc_code': 'N03AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pregabalin Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1027', 'active_substance': 'pregabalin', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '08-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4024', 'ema_number_certainty': '0.5'}"
EU-1-15-1028,"{'atc_code': 'N06AX21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Duloxetine Zentiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1028', 'active_substance': 'duloxetine', 'eu_mah_current': 'Zentiva, k.s.', 'orphan_status': 'h', 'eu_aut_date': '08-20-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003935', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-15-1037,"{'atc_code': 'L01BA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pemetrexed Sandoz', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1037', 'active_substance': 'pemetrexed', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-18-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4011', 'ema_number_certainty': '0.5'}"
EU-1-15-1038,"{'atc_code': 'L01BA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pemetrexed medac', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1038', 'active_substance': 'Pemetrexed', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'h', 'eu_aut_date': '11-27-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003905', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-15-1030,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Odomzo', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1030', 'active_substance': 'sonidegib', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe BV', 'orphan_status': 'h', 'eu_aut_date': '08-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2839', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-15-1083,"{'atc_code': 'B01AC27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Uptravi', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1083', 'active_substance': 'selexipag', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '05-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3774', 'ema_number_certainty': '0.6470588235294118'}"
EU-1-16-1095,"{'atc_code': 'B02BD04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'IDELVION', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1095', 'active_substance': 'albutrepenonacog alfa', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3955', 'ema_number_certainty': '0.5384615384615384'}"
EU-1-15-1024,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'KEYTRUDA', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1024', 'active_substance': 'pembrolizumab', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-17-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003820', 'ema_number_certainty': '0.5342465753424658'}"
EU-1-15-1054,"{'atc_code': 'H05BX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cinacalcet Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1054', 'active_substance': 'cinacalcet', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '11-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004014', 'ema_number_certainty': '0.8'}"
EU-1-15-1082,"{'atc_code': 'A16AX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Galafold', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1082', 'active_substance': 'migalastat', 'eu_mah_current': 'Amicus Therapeutics Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '05-26-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4059', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-15-1066,"{'atc_code': 'N04BX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ongentys', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1066', 'active_substance': 'opicapone', 'eu_mah_current': 'Bial - Portela &amp; C&#170;, SA', 'orphan_status': 'h', 'eu_aut_date': '06-24-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/002790', 'ema_number_certainty': '0.5'}"
EU-1-15-990,"{'atc_code': 'S01XA18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'IKERVIS', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/990', 'active_substance': 'Ciclosporin', 'eu_mah_current': 'Santen Oy', 'orphan_status': 'h', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2066', 'ema_number_certainty': '0.6'}"
EU-1-15-1070,"{'atc_code': 'L01XX24', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Oncaspar', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1070', 'active_substance': 'pegaspargase', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'h', 'eu_aut_date': '01-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3789', 'ema_number_certainty': '0.65'}"
EU-1-15-1021,"{'atc_code': 'N03AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pregabalin Zentiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1021', 'active_substance': 'pregabalin', 'eu_mah_current': 'Zentiva, k.s.', 'orphan_status': 'h', 'eu_aut_date': '07-17-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003900', 'ema_number_certainty': '0.6'}"
EU-1-15-1023,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Farydak', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1023', 'active_substance': 'panobinostat', 'eu_mah_current': 'Secura Bio Limited', 'orphan_status': 'h', 'eu_aut_date': '08-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3725', 'ema_number_certainty': '0.5'}"
EU-1-15-1085,"{'atc_code': 'L04AC13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Taltz', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1085', 'active_substance': 'ixekizumab', 'eu_mah_current': 'Eli Lilly and Company (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '04-25-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003943', 'ema_number_certainty': '0.5263157894736842'}"
EU-1-16-1101,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Darzalex', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1101', 'active_substance': 'daratumumab', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '05-20-2016', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004077', 'ema_number_certainty': '0.65625'}"
EU-1-15-1075,"{'atc_code': 'B03AB10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Feraccru', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1075', 'active_substance': 'ferric maltol', 'eu_mah_current': 'Norgine B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2733', 'ema_number_certainty': '0.47368421052631576'}"
EU-1-15-1079,"{'atc_code': 'J07CA09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vaxelis', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1079', 'active_substance': 'Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)', 'eu_mah_current': 'MCM Vaccine B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-15-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3982', 'ema_number_certainty': '0.5'}"
EU-1-15-1062,"{'atc_code': 'A16AX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ravicti', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1062', 'active_substance': 'Glycerol phenylbutyrate', 'eu_mah_current': 'Immedica Pharma AB', 'orphan_status': 'h', 'eu_aut_date': '11-27-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3822', 'ema_number_certainty': '0.6'}"
EU-1-14-982,"{'atc_code': 'J05AP53', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Viekirax', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/982', 'active_substance': 'ombitasvir / paritaprevir / ritonavir', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3839', 'ema_number_certainty': '0.75'}"
EU-1-14-983,"{'atc_code': 'J05AP09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Exviera', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/983', 'active_substance': 'dasabuvir', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3837', 'ema_number_certainty': '0.84375'}"
EU-1-16-1104,"{'atc_code': 'A04AA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Palonosetron Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1104', 'active_substance': 'palonosetron', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '05-26-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4129', 'ema_number_certainty': '0.5'}"
EU-1-15-1033,"{'atc_code': 'A16AB14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kanuma', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1033', 'active_substance': 'sebelipase alfa', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'h', 'eu_aut_date': '08-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4004', 'ema_number_certainty': '0.5'}"
EU-1-16-1119,"{'atc_code': 'J05AP54', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zepatier', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1119', 'active_substance': 'elbasvir / grazoprevir', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-22-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4126', 'ema_number_certainty': '0.5333333333333333'}"
EU-1-16-1125,"{'atc_code': 'R03DX08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cinqaero', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1125', 'active_substance': 'reslizumab', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-16-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3912', 'ema_number_certainty': '0.4444444444444444'}"
EU-1-16-1152,"{'atc_code': 'B01AF03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Roteas', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1152', 'active_substance': 'edoxaban', 'eu_mah_current': 'Berlin-Chemie AG', 'orphan_status': 'h', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4339', 'ema_number_certainty': '0.4'}"
EU-1-17-1182,"{'atc_code': 'J05AR03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Emtricitabine /Tenofovir disoproxil Krka d.d.', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1182', 'active_substance': 'emtricitabine / tenofovir disoproxil', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '04-28-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004686', 'ema_number_certainty': '0.6153846153846154'}"
EU-1-17-1184,"{'atc_code': 'L01XC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Riximyo', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1184', 'active_substance': 'rituximab', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-15-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004729', 'ema_number_certainty': '0.75'}"
EU-1-17-1187,"{'atc_code': 'J07AH09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trumenba', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1187', 'active_substance': 'meningococcal group B vaccine (recombinant, adsorbed)', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '05-24-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004051', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-17-1197,"{'atc_code': 'S01XA24', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'OXERVATE', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1197', 'active_substance': 'cenegermin', 'eu_mah_current': 'Domp&#233; farmaceutici S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '07-06-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004209', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-17-1234,"{'atc_code': 'L04AC', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tremfya', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1234', 'active_substance': 'Guselkumab', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '11-10-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004271', 'ema_number_certainty': '0.8'}"
EU-1-17-1255,"{'atc_code': 'G03XX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Intrarosa', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1255', 'active_substance': 'prasterone', 'eu_mah_current': 'Endoceutics S.A.', 'orphan_status': 'h', 'eu_aut_date': '01-08-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004138', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-17-1229,"{'atc_code': 'D11AH05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dupixent', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1229', 'active_substance': 'dupilumab', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '09-26-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004390', 'ema_number_certainty': '0.78125'}"
EU-1-17-1230,"{'atc_code': 'N03AX18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lacosamide Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1230', 'active_substance': 'lacosamide', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '09-18-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004443', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-17-1262,"{'atc_code': 'M05BX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'CRYSVITA', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1262', 'active_substance': 'Burosumab', 'eu_mah_current': 'Kyowa Kirin Holdings B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-19-2018', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004275', 'ema_number_certainty': '0.8235294117647058'}"
EU-1-16-1124,"{'atc_code': 'L04AX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nordimet', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1124', 'active_substance': 'methotrexate', 'eu_mah_current': 'Nordic Group B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003983', 'ema_number_certainty': '0.4444444444444444'}"
EU-1-16-1141,"{'atc_code': 'V09IX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'SomaKit TOC', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1141', 'active_substance': 'edotreotide', 'eu_mah_current': 'Advanced Accelerator Applications', 'orphan_status': 'h', 'eu_aut_date': '12-08-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004140', 'ema_number_certainty': '0.4375'}"
EU-1-16-1146,"{'atc_code': 'A10BD19', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Glyxambi', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1146', 'active_substance': 'empagliflozin/linagliptin', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003833', 'ema_number_certainty': '0.5263157894736842'}"
EU-1-16-1147,"{'atc_code': 'L01XE33', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'IBRANCE', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1147', 'active_substance': 'palbociclib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '11-09-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003853', 'ema_number_certainty': '0.6190476190476191'}"
EU-1-17-1215,"{'atc_code': 'L01EK03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fotivda', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1215', 'active_substance': 'tivozanib', 'eu_mah_current': 'EUSA Pharma (Netherlands) B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-24-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004131', 'ema_number_certainty': '0.625'}"
EU-1-17-1216,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Imraldi', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1216', 'active_substance': 'adalimumab', 'eu_mah_current': 'Samsung Bioepis NL B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-24-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4279', 'ema_number_certainty': '0.56'}"
EU-1-17-1218,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rydapt', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1218', 'active_substance': 'Midostaurin', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '09-18-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004095', 'ema_number_certainty': '0.5454545454545454'}"
EU-1-16-1110,"{'atc_code': 'A05AA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Chenodeoxycholic acid Leadiant', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1110', 'active_substance': 'chenodeoxycholic acid', 'eu_mah_current': 'Leadiant GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-10-2017', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4061', 'ema_number_certainty': '0.5'}"
EU-1-17-1212,"{'atc_code': 'L01BB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'MAVENCLAD', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1212', 'active_substance': 'cladribine', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004230', 'ema_number_certainty': '0.625'}"
EU-1-17-1222,"{'atc_code': 'J05AR06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1222', 'active_substance': 'Efavirenz / emtricitabine / tenofovir disoproxil', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '09-05-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004240', 'ema_number_certainty': '0.8823529411764706'}"
EU-1-16-1134,"{'atc_code': 'G04BE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mysildecard', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1134', 'active_substance': 'sildenafil', 'eu_mah_current': 'Viatris Limited', 'orphan_status': 'h', 'eu_aut_date': '09-15-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004186', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-14-971,"{'atc_code': 'N05AX13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trevicta', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/971', 'active_substance': 'paliperidone', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '12-05-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4066', 'ema_number_certainty': '0.9090909090909091'}"
EU-1-16-1137,"{'atc_code': 'G04BE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Granpidam', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1137', 'active_substance': 'sildenafil', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '11-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004289', 'ema_number_certainty': '0.6'}"
EU-1-16-1140,"{'atc_code': 'J05AE10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Darunavir Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1140', 'active_substance': 'darunavir', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '01-04-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004068', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-16-1148,"{'atc_code': 'J05AR03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Emtricitabine/Tenofovir disoproxil Zentiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1148', 'active_substance': 'emtricitabine / tenofovir disoproxil', 'eu_mah_current': 'Zentiva, k.s.', 'orphan_status': 'h', 'eu_aut_date': '11-09-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004137', 'ema_number_certainty': '0.625'}"
EU-1-16-1132,"{'atc_code': 'B01AB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Inhixa', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1132', 'active_substance': 'enoxaparin sodium', 'eu_mah_current': 'Techdow Pharma Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-15-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4264', 'ema_number_certainty': '0.5294117647058824'}"
EU-1-16-1142,"{'atc_code': 'H05BX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Parsabiv', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1142', 'active_substance': 'etelcalcetide', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3995', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-16-1127,"{'atc_code': 'J05AF07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tenofovir disoproxil Zentiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1127', 'active_substance': 'tenofovir disoproxil', 'eu_mah_current': 'Zentiva, k.s.', 'orphan_status': 'h', 'eu_aut_date': '09-15-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004120', 'ema_number_certainty': '0.4666666666666667'}"
EU-1-16-1105,"{'atc_code': 'V10X', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EndolucinBeta', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1105', 'active_substance': 'Lutetium (177 Lu) chloride', 'eu_mah_current': 'ITM Medical Isotopes GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-06-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/PSUSA', 'ema_number_certainty': '0.4444444444444444'}"
EU-1-16-1114,"{'atc_code': 'L01XG01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bortezomib Hospira', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1114', 'active_substance': 'bortezomib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '07-22-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4207', 'ema_number_certainty': '0.5882352941176471'}"
EU-1-16-1154,"{'atc_code': 'J05AF13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vemlidy', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1154', 'active_substance': 'tenofovir alafenamide', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '01-09-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004169', 'ema_number_certainty': '0.4666666666666667'}"
EU-1-16-1160,"{'atc_code': 'A10AB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fiasp', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1160', 'active_substance': 'insulin aspart', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '01-09-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004046', 'ema_number_certainty': '0.5'}"
EU-1-16-1161,"{'atc_code': 'H05AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Movymia', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1161', 'active_substance': 'teriparatide', 'eu_mah_current': 'STADA Arzneimittel AG', 'orphan_status': 'h', 'eu_aut_date': '01-11-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4368', 'ema_number_certainty': '0.5'}"
EU-1-17-1178,"{'atc_code': 'L04AA29', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xeljanz', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1178', 'active_substance': 'Tofacitinib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004214', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-16-1151,"{'atc_code': 'J05AR03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Emtricitabine/Tenofovir disoproxil Krka', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1151', 'active_substance': 'emtricitabine / tenofovir disoproxil', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '12-08-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4215', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-17-1172,"{'atc_code': 'L01BA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Jylamvo', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1172', 'active_substance': 'methotrexate', 'eu_mah_current': 'Therakind (Europe) Limited', 'orphan_status': 'h', 'eu_aut_date': '03-29-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003756', 'ema_number_certainty': '0.4375'}"
EU-1-17-1214,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bavencio', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1214', 'active_substance': 'avelumab', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-18-2017', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004338', 'ema_number_certainty': '0.6470588235294118'}"
EU-1-16-1153,"{'atc_code': 'G04BE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Talmanco', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1153', 'active_substance': 'tadalafil', 'eu_mah_current': 'Viatris Limited', 'orphan_status': 'h', 'eu_aut_date': '01-09-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004297', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-16-1128,"{'atc_code': 'L01XE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kisplyx', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1128', 'active_substance': 'lenvatinib', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-25-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4224', 'ema_number_certainty': '0.4782608695652174'}"
EU-1-16-1144,"{'atc_code': 'C01EB17', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ivabradine Zentiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1144', 'active_substance': 'ivabradine', 'eu_mah_current': 'Zentiva, k.s.', 'orphan_status': 'h', 'eu_aut_date': '11-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004117', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-16-1116,"{'atc_code': 'J05AX69', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Epclusa', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1116', 'active_substance': 'sofosbuvir/velpatasvir', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '07-06-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004210', 'ema_number_certainty': '0.4782608695652174'}"
EU-1-17-1193,"{'atc_code': 'B02BD04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Refixia', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1193', 'active_substance': 'nonacog beta pegol', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '06-02-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4178', 'ema_number_certainty': '0.5'}"
EU-1-17-1199,"{'atc_code': 'A16AX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cuprior', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1199', 'active_substance': 'trientine', 'eu_mah_current': 'Orphalan', 'orphan_status': 'h', 'eu_aut_date': '09-05-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004005', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-17-1200,"{'atc_code': 'L01XC26', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Besponsa', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1200', 'active_substance': 'inotuzumab ozogamicin', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-29-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4119', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-17-1201,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Skilarence', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1201', 'active_substance': 'dimethyl fumarate', 'eu_mah_current': 'Almirall, S.A.', 'orphan_status': 'h', 'eu_aut_date': '06-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/002157', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-17-1211,"{'atc_code': 'J05AF10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Entecavir Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1211', 'active_substance': 'entecavir', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '09-26-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004458', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-17-1223,"{'atc_code': 'J05AP56', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vosevi', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1223', 'active_substance': 'sofosbuvir / velpatasvir / voxilaprevir', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '07-26-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4350', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-17-1227,"{'atc_code': 'J05AF10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Entecavir Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1227', 'active_substance': 'entecavir', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '09-18-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004377', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-17-1195,"{'atc_code': 'L04AB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Erelzi', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1195', 'active_substance': 'etanercept', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004192', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-17-1196,"{'atc_code': 'L04AC14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kevzara', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1196', 'active_substance': 'sarilumab', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '06-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004254', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-17-1225,"{'atc_code': 'J05AR22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Symtuza', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1225', 'active_substance': 'darunavir / cobicistat / emtricitabine / tenofovir alafenamide', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '09-21-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4391', 'ema_number_certainty': '0.5625'}"
EU-1-17-1228,"{'atc_code': 'L01XD07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'TOOKAD', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1228', 'active_substance': 'padeliporfin', 'eu_mah_current': 'Steba Biotech S.A', 'orphan_status': 'h', 'eu_aut_date': '11-10-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004182', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-18-1265,"{'atc_code': 'A10BD23', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Segluromet', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1265', 'active_substance': 'ertugliflozin / metformin hydrochloride', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-23-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4314', 'ema_number_certainty': '0.875'}"
EU-1-18-1266,"{'atc_code': 'A10BD24', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Steglujan', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1266', 'active_substance': 'ertugliflozin / sitagliptin', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-23-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4313', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-18-1267,"{'atc_code': 'A10BK04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Steglatro', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1267', 'active_substance': 'ertugliflozin', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4315', 'ema_number_certainty': '0.75'}"
EU-1-18-1270,"{'atc_code': 'A10AE04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Semglee', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1270', 'active_substance': 'Insulin glargine', 'eu_mah_current': 'Viatris Limited', 'orphan_status': 'h', 'eu_aut_date': '03-23-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004280', 'ema_number_certainty': '0.6363636363636364'}"
EU-1-18-1276,"{'atc_code': 'A16AA07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Myalepta', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1276', 'active_substance': 'metreleptin', 'eu_mah_current': 'Amryt Pharmaceuticals DAC', 'orphan_status': 'h', 'eu_aut_date': '07-30-2018', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004218', 'ema_number_certainty': '0.7272727272727273'}"
EU-1-17-1219,"{'atc_code': 'S01XA18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Verkazia', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1219', 'active_substance': 'ciclosporin', 'eu_mah_current': 'Santen Oy', 'orphan_status': 'h', 'eu_aut_date': '07-06-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4411', 'ema_number_certainty': '0.5'}"
EU-1-17-1220,"{'atc_code': 'L01XC32', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tecentriq', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1220', 'active_substance': 'atezolizumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-21-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004143', 'ema_number_certainty': '0.6222222222222222'}"
EU-1-17-1221,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kisqali', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1221', 'active_substance': 'ribociclib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004213', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-17-1236,"{'atc_code': 'R03AL08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trelegy Ellipta', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1236', 'active_substance': 'fluticasone furoate/umeclidinium/vilanterol', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'h', 'eu_aut_date': '11-15-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004363', 'ema_number_certainty': '0.45454545454545453'}"
EU-1-17-1237,"{'atc_code': 'R03AL08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Elebrato Ellipta', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1237', 'active_substance': 'fluticasone furoate/umeclidinium/vilanterol', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'h', 'eu_aut_date': '11-15-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004781', 'ema_number_certainty': '0.5'}"
EU-1-17-1238,"{'atc_code': 'V03AB15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nyxoid', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1238', 'active_substance': 'naloxone', 'eu_mah_current': 'Mundipharma Corporation (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '11-10-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004325', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-16-1168,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vihuma', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1168', 'active_substance': 'simoctocog alfa', 'eu_mah_current': 'Octapharma AB', 'orphan_status': 'h', 'eu_aut_date': '02-13-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4459', 'ema_number_certainty': '0.6'}"
EU-1-17-1175,"{'atc_code': 'J01XX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Daptomycin Hospira', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1175', 'active_substance': 'daptomycin', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004310', 'ema_number_certainty': '0.5294117647058824'}"
EU-1-16-1169,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Alecensa', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1169', 'active_substance': 'alectinib', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-16-2017', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4164', 'ema_number_certainty': '0.625'}"
EU-1-16-1133,"{'atc_code': 'J05AR03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Emtricitabine/Tenofovir disoproxil Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1133', 'active_substance': 'emtricitabine / tenofovir disoproxil', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '12-16-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004050', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-17-1188,"{'atc_code': 'M09AX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Spinraza', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1188', 'active_substance': 'nusinersen', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-30-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4312', 'ema_number_certainty': '0.5'}"
EU-1-17-1173,"{'atc_code': 'V03AE10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lokelma', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1173', 'active_substance': 'sodium zirconium cyclosilicate', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '03-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004029', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-17-1205,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Blitzima', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1205', 'active_substance': 'rituximab', 'eu_mah_current': 'Celltrion Healthcare Hungary Kft.', 'orphan_status': 'h', 'eu_aut_date': '07-13-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004723', 'ema_number_certainty': '0.47619047619047616'}"
EU-1-17-1226,"{'atc_code': 'V10XX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lutathera', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1226', 'active_substance': 'lutetium (177Lu) oxodotreotide', 'eu_mah_current': 'Advanced Accelerator Applications', 'orphan_status': 'h', 'eu_aut_date': '09-26-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004123', 'ema_number_certainty': '0.6'}"
EU-1-16-1106,"{'atc_code': 'L04AB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Flixabi', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1106', 'active_substance': 'infliximab', 'eu_mah_current': 'Samsung Bioepis NL B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-26-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4020', 'ema_number_certainty': '0.6296296296296297'}"
EU-1-16-1108,"{'atc_code': 'A10BD21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Qtern', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1108', 'active_substance': 'saxagliptin / dapagliflozin', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '07-15-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004057', 'ema_number_certainty': '0.46153846153846156'}"
EU-1-16-1109,"{'atc_code': 'J01DD52', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zavicefta', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1109', 'active_substance': 'ceftazidime/avibactam', 'eu_mah_current': 'Pfizer Ireland Pharmaceuticals', 'orphan_status': 'h', 'eu_aut_date': '06-24-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4027', 'ema_number_certainty': '0.5333333333333333'}"
EU-1-16-1155,"{'atc_code': 'L04AC12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kyntheum', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1155', 'active_substance': 'brodalumab', 'eu_mah_current': 'Leo Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003959', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-16-1157,"{'atc_code': 'A10AE54', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Suliqua', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1157', 'active_substance': 'insulin glargine / lixisenatide', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '01-11-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004243', 'ema_number_certainty': '0.45454545454545453'}"
EU-1-17-1176,"{'atc_code': 'A16AX06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Yargesa', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1176', 'active_substance': 'miglustat', 'eu_mah_current': 'Piramal Critical Care B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4016', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-16-1138,"{'atc_code': 'L01XX52', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Venclyxto', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1138', 'active_substance': 'venetoclax', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '12-05-2016', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4106', 'ema_number_certainty': '0.5789473684210527'}"
EU-1-16-1164,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'AMGEVITA', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1164', 'active_substance': 'adalimumab', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4212', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-17-1194,"{'atc_code': 'M04AA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Febuxostat Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1194', 'active_substance': 'febuxostat', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '06-15-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004374', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-17-1203,"{'atc_code': 'A10AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Insulin lispro Sanofi', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1203', 'active_substance': 'insulin lispro', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '07-19-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4303', 'ema_number_certainty': '0.5'}"
EU-1-17-1202,"{'atc_code': 'A16AA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ucedane', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1202', 'active_substance': 'carglumic acid', 'eu_mah_current': 'Eurocept International B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004019', 'ema_number_certainty': '0.7'}"
EU-1-17-1224,"{'atc_code': 'A16AX15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xermelo', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1224', 'active_substance': 'telotristat', 'eu_mah_current': 'SERB SAS', 'orphan_status': 'h', 'eu_aut_date': '09-18-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003937', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-17-1251,"{'atc_code': 'A10BJ06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ozempic', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1251', 'active_substance': 'semaglutide', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '02-08-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004174', 'ema_number_certainty': '0.5'}"
EU-1-16-1150,"{'atc_code': 'G03GA10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rekovelle', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1150', 'active_substance': 'follitropin delta', 'eu_mah_current': 'Ferring Pharmaceuticals A/S', 'orphan_status': 'h', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003994', 'ema_number_certainty': '0.75'}"
EU-1-16-1158,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'AFSTYLA', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1158', 'active_substance': 'lonoctocog alfa', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-04-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4075', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-16-1159,"{'atc_code': 'H05AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Terrosa', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1159', 'active_substance': 'teriparatide', 'eu_mah_current': 'Gedeon Richter Plc.', 'orphan_status': 'h', 'eu_aut_date': '01-04-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3916', 'ema_number_certainty': '0.5'}"
EU-1-17-1179,"{'atc_code': 'V03AE09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Veltassa', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1179', 'active_substance': 'patiromer', 'eu_mah_current': 'Vifor Fresenius Medical Care Renal Pharma France', 'orphan_status': 'h', 'eu_aut_date': '07-19-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004180', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-17-1213,"{'atc_code': 'J05AP57', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Maviret', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1213', 'active_substance': 'glecaprevir / pibrentasvir', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '07-26-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004430', 'ema_number_certainty': '0.68'}"
EU-1-16-1112,"{'atc_code': 'J05AR19', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Odefsey', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1112', 'active_substance': 'emtricitabine / rilpivirine / tenofovir alafenamide', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '06-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4156', 'ema_number_certainty': '0.6818181818181818'}"
EU-1-16-1129,"{'atc_code': 'J05AF07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tenofovir disoproxil Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1129', 'active_substance': 'Tenofovir disoproxil', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '12-08-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004049', 'ema_number_certainty': '0.6111111111111112'}"
EU-1-16-1135,"{'atc_code': 'A03AB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sialanar', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1135', 'active_substance': 'glycopyrronium bromide', 'eu_mah_current': 'Proveca Pharma Limited', 'orphan_status': 'h', 'eu_aut_date': '09-15-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3883', 'ema_number_certainty': '0.5'}"
EU-1-17-1185,"{'atc_code': 'L01XC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rixathon', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1185', 'active_substance': 'rituximab', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-15-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003903', 'ema_number_certainty': '0.42857142857142855'}"
EU-1-17-1210,"{'atc_code': 'J05AR06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1210', 'active_substance': 'efavirenz / emtricitabine / tenofovir disoproxil', 'eu_mah_current': 'Zentiva, k.s.', 'orphan_status': 'h', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004250', 'ema_number_certainty': '0.6923076923076923'}"
EU-1-17-1253,"{'atc_code': 'L02BA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fulvestrant Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1253', 'active_substance': 'fulvestrant', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '01-08-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004649', 'ema_number_certainty': '0.75'}"
EU-1-17-1256,"{'atc_code': 'L01XX35', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Anagrelide Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1256', 'active_substance': 'anagrelide', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '02-15-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004585', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-16-1156,"{'atc_code': 'J06BB21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ZINPLAVA', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1156', 'active_substance': 'bezlotoxumab', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-18-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4136', 'ema_number_certainty': '0.625'}"
EU-1-17-1177,"{'atc_code': 'G04BE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tadalafil Lilly', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1177', 'active_substance': 'tadalafil', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4666', 'ema_number_certainty': '0.6'}"
EU-1-17-1181,"{'atc_code': 'M09AX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Spherox', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1181', 'active_substance': 'spheroids of human autologous matrix-associated chondrocytes', 'eu_mah_current': 'CO.DON AG', 'orphan_status': 'h', 'eu_aut_date': '07-10-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/002736', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-17-1232,"{'atc_code': 'A16AX06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Miglustat Gen.Orph', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1232', 'active_substance': 'Miglustat', 'eu_mah_current': 'Gen.Orph', 'orphan_status': 'h', 'eu_aut_date': '04-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4366', 'ema_number_certainty': '0.5'}"
EU-1-17-1233,"{'atc_code': 'N07BC51', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zubsolv', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1233', 'active_substance': 'buprenorphine / naloxone', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '11-10-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004407', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-17-1235,"{'atc_code': 'L01XK02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zejula', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1235', 'active_substance': 'niraparib', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '11-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004249', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-16-1166,"{'atc_code': 'N03AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pregabalin Zentiva k.s', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1166', 'active_substance': 'pregabalin', 'eu_mah_current': 'Zentiva, k.s.', 'orphan_status': 'h', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004277', 'ema_number_certainty': '0.6153846153846154'}"
EU-1-16-1170,"{'atc_code': 'L04AA37', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Olumiant', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1170', 'active_substance': 'baricitinib', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-13-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004085', 'ema_number_certainty': '0.42857142857142855'}"
EU-1-16-1171,"{'atc_code': 'L01AA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ledaga', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1171', 'active_substance': 'chlormethine', 'eu_mah_current': 'Helsinn Birex Pharmaceuticals Ltd.', 'orphan_status': 'h', 'eu_aut_date': '03-03-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/002826', 'ema_number_certainty': '0.6'}"
EU-1-17-1244,"{'atc_code': 'L04AD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tacforius', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1244', 'active_substance': 'tacrolimus', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004435', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-17-1263,"{'atc_code': 'J05AR06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Efavirenz/Emtricitabine/Tenofovir disoproxil Krka', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1263', 'active_substance': 'efavirenz / emtricitabine / tenofovir disoproxil', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '02-08-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004274', 'ema_number_certainty': '0.5454545454545454'}"
EU-1-18-1274,"{'atc_code': 'R03AL', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trydonis', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1274', 'active_substance': 'beclometasone / formoterol / glycopyrronium bromide', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '04-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004702', 'ema_number_certainty': '0.6'}"
EU-1-18-1275,"{'atc_code': 'R03AL', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Riarify', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1275', 'active_substance': 'beclometasone / formoterol / glycopyrronium bromide', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '04-23-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4836', 'ema_number_certainty': '0.5'}"
EU-1-17-1239,"{'atc_code': 'B02BC', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'VeraSeal', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1239', 'active_substance': 'human fibrinogen / human thrombin', 'eu_mah_current': 'Instituto Grifols, S.A.', 'orphan_status': 'h', 'eu_aut_date': '11-10-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004446', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-17-1245,"{'atc_code': 'J05AX18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'PREVYMIS', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1245', 'active_substance': 'letermovir', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-08-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004536', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-17-1246,"{'atc_code': 'L01XC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mvasi', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1246', 'active_substance': 'bevacizumab', 'eu_mah_current': 'Amgen Technology (Ireland) UC', 'orphan_status': 'h', 'eu_aut_date': '01-15-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004728', 'ema_number_certainty': '0.7333333333333333'}"
EU-1-17-1250,"{'atc_code': 'L01XK03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rubraca', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1250', 'active_substance': 'rucaparib', 'eu_mah_current': 'Clovis Oncology Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '05-24-2018', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004272', 'ema_number_certainty': '0.5'}"
EU-1-17-1257,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Herzuma', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1257', 'active_substance': 'trastuzumab', 'eu_mah_current': 'Celltrion Healthcare Hungary Kft.', 'orphan_status': 'h', 'eu_aut_date': '02-09-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/002575', 'ema_number_certainty': '0.5652173913043478'}"
EU-1-17-1258,"{'atc_code': 'A16AB', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lamzede', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1258', 'active_substance': 'velmanase alfa', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '03-23-2018', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003922', 'ema_number_certainty': '0.7'}"
EU-1-17-1260,"{'atc_code': 'H02AB09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Alkindi', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1260', 'active_substance': 'hydrocortisone', 'eu_mah_current': 'Diurnal Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-09-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4416', 'ema_number_certainty': '0.5'}"
EU-1-17-1261,"{'atc_code': 'L04AX08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Alofisel', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1261', 'active_substance': 'Darvadstrocel', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '03-23-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004258', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-17-1190,"{'atc_code': 'C01EB17', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ivabradine Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1190', 'active_substance': 'ivabradine', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '05-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004241', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-17-1254,"{'atc_code': 'A07EA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Jorveza', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1254', 'active_substance': 'budesonide', 'eu_mah_current': 'Dr Falk Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-08-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004655', 'ema_number_certainty': '0.5'}"
EU-1-17-1208,"{'atc_code': 'R03AL09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trimbow', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1208', 'active_substance': 'beclometasone / formoterol / glycopyrronium bromide', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004257', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-16-1089,"{'atc_code': 'J07BB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pandemic influenza vaccine H5N1 AstraZeneca', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1089', 'active_substance': 'Pandemic influenza vaccine (H5N1) (live attenuated, nasal)', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '05-20-2016', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/3963', 'ema_number_certainty': '0.5'}"
EU-1-17-1231,"{'atc_code': 'L04AA36', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ocrevus', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1231', 'active_substance': 'ocrelizumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-08-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004043', 'ema_number_certainty': '0.5625'}"
EU-1-17-1241,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ontruzant', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1241', 'active_substance': 'trastuzumab', 'eu_mah_current': 'Samsung Bioepis NL B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-15-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004323', 'ema_number_certainty': '0.631578947368421'}"
EU-1-17-1242,"{'atc_code': 'J05AE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ritonavir Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1242', 'active_substance': 'ritonavir', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '11-10-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004549', 'ema_number_certainty': '0.6428571428571429'}"
EU-1-17-1186,"{'atc_code': 'V09IX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Axumin', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1186', 'active_substance': 'fluciclovine (18F)', 'eu_mah_current': 'Blue Earth Diagnostics Ireland Ltd', 'orphan_status': 'h', 'eu_aut_date': '05-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004197', 'ema_number_certainty': '0.5625'}"
EU-1-18-1264,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Alunbrig', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1264', 'active_substance': 'brigatinib', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '11-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004248', 'ema_number_certainty': '0.9'}"
EU-1-18-1271,"{'atc_code': 'B02BX06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hemlibra', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1271', 'active_substance': 'emicizumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-23-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004406', 'ema_number_certainty': '0.5625'}"
EU-1-18-1272,"{'atc_code': 'J07BK03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Shingrix', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1272', 'active_substance': 'herpes zoster vaccine (recombinant, adjuvanted)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004336', 'ema_number_certainty': '0.875'}"
EU-1-15-1004,"{'atc_code': 'J02AC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Voriconazole Hikma', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1004', 'active_substance': 'voriconazole', 'eu_mah_current': 'Hikma Farmac&#234;utica (Portugal), S.A.', 'orphan_status': 'h', 'eu_aut_date': '05-27-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003737', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-17-1209,"{'atc_code': 'N05AX15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Reagila', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1209', 'active_substance': 'cariprazine', 'eu_mah_current': 'Gedeon Richter Plc.', 'orphan_status': 'h', 'eu_aut_date': '07-13-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/002770', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-17-1249,"{'atc_code': 'J05AE10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Darunavir Krka', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1249', 'active_substance': 'darunavir', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '01-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004273', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-17-1252,"{'atc_code': 'R03DX10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fasenra', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1252', 'active_substance': 'benralizumab', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '01-08-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4433', 'ema_number_certainty': '0.5384615384615384'}"
EU-1-16-1167,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Truxima', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1167', 'active_substance': 'rituximab', 'eu_mah_current': 'Celltrion Healthcare Hungary Kft.', 'orphan_status': 'h', 'eu_aut_date': '02-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4112', 'ema_number_certainty': '0.6086956521739131'}"
EU-1-17-1247,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ADYNOVI', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1247', 'active_substance': 'rurioctocog alfa pegol', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-08-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004195', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-18-1269,"{'atc_code': 'J05AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Alpivab', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1269', 'active_substance': 'peramivir', 'eu_mah_current': 'BioCryst Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '04-13-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4299', 'ema_number_certainty': '1.0'}"
EU-1-16-1115,"{'atc_code': 'L01BA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pemetrexed Fresenius Kabi', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1115', 'active_substance': 'pemetrexed', 'eu_mah_current': 'Fresenius Kabi Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-22-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003895', 'ema_number_certainty': '0.5625'}"
EU-1-16-1136,"{'atc_code': 'L01EX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'CABOMETYX', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1136', 'active_substance': 'cabozantinib', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'h', 'eu_aut_date': '09-09-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004163', 'ema_number_certainty': '0.6842105263157895'}"
EU-1-17-1192,"{'atc_code': 'A16AB', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Brineura', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1192', 'active_substance': 'cerliponase alfa', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'h', 'eu_aut_date': '05-30-2017', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004065', 'ema_number_certainty': '0.5454545454545454'}"
EU-1-17-1217,"{'atc_code': 'A16AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nitisinone MDK', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1217', 'active_substance': 'nitisinone', 'eu_mah_current': 'MendeliKABS Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '08-24-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004281', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-18-1278,"{'atc_code': 'L01AD01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Carmustine Obvius', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1278', 'active_substance': 'carmustine', 'eu_mah_current': 'Obvius Investment B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004326', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-18-1279,"{'atc_code': 'A10BB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'AMGLIDIA', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1279', 'active_substance': 'glibenclamide', 'eu_mah_current': 'AMMTeK', 'orphan_status': 'h', 'eu_aut_date': '05-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004379', 'ema_number_certainty': '0.6'}"
EU-1-18-1277,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mylotarg', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1277', 'active_substance': 'gemtuzumab ozogamicin', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004204', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-18-1281,"{'atc_code': 'L01XC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'KANJINTI', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1281', 'active_substance': 'trastuzumab', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-16-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4361', 'ema_number_certainty': '0.7272727272727273'}"
EU-1-18-1282,"{'atc_code': 'J05AR21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Juluca', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1282', 'active_substance': 'dolutegravir / rilpivirine', 'eu_mah_current': 'ViiV Healthcare B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-16-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004427', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-18-1280,"{'atc_code': 'L04AB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zessly', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1280', 'active_substance': 'infliximab', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-18-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004647', 'ema_number_certainty': '0.6'}"
EU-1-18-1283,"{'atc_code': 'L01BA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pemetrexed Krka', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1283', 'active_substance': 'pemetrexed', 'eu_mah_current': 'KRKA, d.d.', 'orphan_status': 'h', 'eu_aut_date': '05-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003958', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-19-1410,"{'atc_code': 'N06AX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Spravato', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1410', 'active_substance': 'esketamine', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '12-18-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004535', 'ema_number_certainty': '1.0'}"
EU-1-20-1459,"{'atc_code': 'J05AB16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Veklury', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1459', 'active_substance': 'remdesivir', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '07-03-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005622', 'ema_number_certainty': '0.9230769230769231'}"
EU-1-19-1404,"{'atc_code': 'L04AA44', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rinvoq', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1404', 'active_substance': 'upadacitinib', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004760', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-19-1405,"{'atc_code': 'B02BX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'TAVLESSE', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1405', 'active_substance': 'fostamatinib', 'eu_mah_current': 'Instituto Grifols, S.A.', 'orphan_status': 'h', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005012', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-19-1393,"{'atc_code': 'J01MA23', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Quofenix', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1393', 'active_substance': 'delafloxacin', 'eu_mah_current': 'A. Menarini - Industrie Farmaceutiche Riunite - s.r.l.', 'orphan_status': 'h', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004860', 'ema_number_certainty': '1.0'}"
EU-1-19-1394,"{'atc_code': 'J01AA12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tigecycline Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1394', 'active_substance': 'tigecycline', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '04-17-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005114', 'ema_number_certainty': '1.0'}"
EU-1-20-1447,"{'atc_code': 'A10AB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Insulin aspart Sanofi', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1447', 'active_substance': 'insulin aspart', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '06-25-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005033', 'ema_number_certainty': '1.0'}"
EU-1-19-1396,"{'atc_code': 'L01BB06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ivozall', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1396', 'active_substance': 'clofarabine', 'eu_mah_current': 'ORPHELIA Pharma SAS', 'orphan_status': 'h', 'eu_aut_date': '11-14-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005039', 'ema_number_certainty': '0.75'}"
EU-1-19-1397,"{'atc_code': 'L01XG01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bortezomib Fresenius Kabi', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1397', 'active_substance': 'bortezomib', 'eu_mah_current': 'Fresenius Kabi Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-14-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005074', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-20-1460,"{'atc_code': 'L01EX14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rozlytrek', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1460', 'active_substance': 'entrectinib', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-31-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004936', 'ema_number_certainty': '1.0'}"
EU-1-20-1474,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'BLENREP', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1474', 'active_substance': 'belantamab mafodotin', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '08-25-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004935', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-20-1475,"{'atc_code': 'L01XX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Arsenic trioxide medac', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1475', 'active_substance': 'arsenic trioxide', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'h', 'eu_aut_date': '09-17-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005218', 'ema_number_certainty': '1.0'}"
EU-1-20-1476,"{'atc_code': 'B06AX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Adakveo', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1476', 'active_substance': 'crizanlizumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '10-28-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004874', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-19-1371,"{'atc_code': 'L04AA', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ultomiris', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1371', 'active_substance': 'Ravulizumab', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'h', 'eu_aut_date': '07-02-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004954', 'ema_number_certainty': '0.9166666666666666'}"
EU-1-19-1372,"{'atc_code': 'V09AB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Striascan', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1372', 'active_substance': 'ioflupane (123I)', 'eu_mah_current': 'CIS bio international', 'orphan_status': 'h', 'eu_aut_date': '06-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4745', 'ema_number_certainty': '0.5'}"
EU-1-19-1373,"{'atc_code': 'B02BX08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Doptelet', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1373', 'active_substance': 'avatrombopag', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'h', 'eu_aut_date': '06-20-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004722', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-19-1374,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Esperoct', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1374', 'active_substance': 'turoctocog alfa pegol', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '06-20-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004883', 'ema_number_certainty': '1.0'}"
EU-1-19-1375,"{'atc_code': 'L03AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Grasustek', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1375', 'active_substance': 'pegfilgrastim', 'eu_mah_current': 'Juta Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-20-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004556', 'ema_number_certainty': '1.0'}"
EU-1-19-1376,"{'atc_code': 'L01XC33', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'LIBTAYO', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1376', 'active_substance': 'cemiplimab', 'eu_mah_current': 'Regeneron Ireland Designated Activity Company (DAC)', 'orphan_status': 'h', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004844', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-19-1356,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Idacio', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1356', 'active_substance': 'adalimumab', 'eu_mah_current': 'Fresenius Kabi Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-02-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004475', 'ema_number_certainty': '1.0'}"
EU-1-19-1365,"{'atc_code': 'A16AX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cufence', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1365', 'active_substance': 'trientine dihydrochloride', 'eu_mah_current': 'Univar Solutions B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004111', 'ema_number_certainty': '0.75'}"
EU-1-19-1377,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Talzenna', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1377', 'active_substance': 'talazoparib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-20-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004674', 'ema_number_certainty': '1.0'}"
EU-1-19-1370,"{'atc_code': 'J05AR25', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dovato', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1370', 'active_substance': 'dolutegravir/lamivudine', 'eu_mah_current': 'ViiV Healthcare BV', 'orphan_status': 'h', 'eu_aut_date': '07-01-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004909', 'ema_number_certainty': '0.7333333333333333'}"
EU-1-20-1450,"{'atc_code': 'L04AA27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fingolimod Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1450', 'active_substance': 'fingolimod', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '06-25-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005191', 'ema_number_certainty': '1.0'}"
EU-1-18-1334,"{'atc_code': 'J01DH52', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vaborem', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1334', 'active_substance': 'meropenem/vaborbactam', 'eu_mah_current': 'Menarini International Operations Luxembourg S.A.', 'orphan_status': 'h', 'eu_aut_date': '11-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004669', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-17-1174,"{'atc_code': 'R03BB07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rolufta Ellipta', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1174', 'active_substance': 'umeclidinium', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'h', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4654', 'ema_number_certainty': '0.7692307692307693'}"
EU-1-20-1454,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aybintio', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1454', 'active_substance': 'bevacizumab', 'eu_mah_current': 'Samsung Bioepis NL B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005106', 'ema_number_certainty': '1.0'}"
EU-1-20-1455,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Piqray', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1455', 'active_substance': 'alpelisib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004804', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-20-1456,"{'atc_code': 'L01XC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zercepac', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1456', 'active_substance': 'trastuzumab', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005209', 'ema_number_certainty': '1.0'}"
EU-1-19-1368,"{'atc_code': 'C02KX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ambrisentan Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1368', 'active_substance': 'ambrisentan', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '06-20-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004985', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-19-1408,"{'atc_code': 'N06BA14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sunosi', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1408', 'active_substance': 'solriamfetol', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'h', 'eu_aut_date': '01-16-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004893', 'ema_number_certainty': '1.0'}"
EU-1-20-1473,"{'atc_code': 'L01EX18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'AYVAKYT', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1473', 'active_substance': 'avapritinib', 'eu_mah_current': 'Blueprint Medicines (Netherlands) B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-24-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005208', 'ema_number_certainty': '1.0'}"
EU-1-19-1364,"{'atc_code': 'M03AX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NUCEIVA', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1364', 'active_substance': 'botulinum toxin type A', 'eu_mah_current': 'Evolus Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-27-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004587', 'ema_number_certainty': '1.0'}"
EU-1-20-1471,"{'atc_code': 'L04AA', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Idefirix', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1471', 'active_substance': 'imlifidase', 'eu_mah_current': 'Hansa Biopharma AB', 'orphan_status': 'h', 'eu_aut_date': '08-25-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004849', 'ema_number_certainty': '1.0'}"
EU-1-19-1366,"{'atc_code': 'L01XX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xromi', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1366', 'active_substance': 'hydroxycarbamide', 'eu_mah_current': 'Nova Laboratories Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '07-01-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004837', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-19-1400,"{'atc_code': 'S01EX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rhokiinsa', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1400', 'active_substance': 'netarsudil', 'eu_mah_current': 'Santen Oy', 'orphan_status': 'h', 'eu_aut_date': '11-19-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004583', 'ema_number_certainty': '1.0'}"
EU-1-19-1406,"{'atc_code': 'H04AA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Baqsimi', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1406', 'active_substance': 'Glucagon', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003848', 'ema_number_certainty': '1.0'}"
EU-1-20-1462,"{'atc_code': 'H05AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Livogiva', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1462', 'active_substance': 'teriparatide', 'eu_mah_current': 'Theramex Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '08-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005087', 'ema_number_certainty': '1.0'}"
EU-1-19-1411,"{'atc_code': 'M05BX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Evenity', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1411', 'active_substance': 'romosozumab', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '12-09-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004465', 'ema_number_certainty': '1.0'}"
EU-1-20-1465,"{'atc_code': 'N06BC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Gencebok', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1465', 'active_substance': 'caffeine citrate', 'eu_mah_current': 'Gennisium Pharma', 'orphan_status': 'h', 'eu_aut_date': '08-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005435', 'ema_number_certainty': '1.0'}"
EU-1-20-1451,"{'atc_code': 'L01XJ03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Daurismo', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1451', 'active_substance': 'glasdegib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004878', 'ema_number_certainty': '1.0'}"
EU-1-20-1452,"{'atc_code': 'B03XA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Reblozyl', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1452', 'active_substance': 'luspatercept', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-25-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004444', 'ema_number_certainty': '1.0'}"
EU-1-20-1468,"{'atc_code': 'R07AX32', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kaftrio', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1468', 'active_substance': 'ivacaftor / tezacaftor / elexacaftor', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005269', 'ema_number_certainty': '1.0'}"
EU-1-19-1362,"{'atc_code': 'A16AB19', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Palynziq', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1362', 'active_substance': 'pegvaliase', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'h', 'eu_aut_date': '05-03-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/PSUSA', 'ema_number_certainty': '0.5'}"
EU-1-20-1480,"{'atc_code': 'L04AA45', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Jyseleca', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1480', 'active_substance': 'filgotinib', 'eu_mah_current': 'Galapagos NV', 'orphan_status': 'h', 'eu_aut_date': '09-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005113', 'ema_number_certainty': '1.0'}"
EU-1-18-1292,"{'atc_code': 'L01CD01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Apealea', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1292', 'active_substance': 'paclitaxel', 'eu_mah_current': 'Inceptua AB', 'orphan_status': 'h', 'eu_aut_date': '11-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004154', 'ema_number_certainty': '0.625'}"
EU-1-19-1398,"{'atc_code': 'L01XX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Arsenic Trioxide Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1398', 'active_substance': 'arsenic trioxide', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '11-14-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005175', 'ema_number_certainty': '1.0'}"
EU-1-20-1448,"{'atc_code': 'L01CD04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cabazitaxel Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1448', 'active_substance': 'cabazitaxel', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '08-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005178', 'ema_number_certainty': '0.75'}"
EU-1-19-1390,"{'atc_code': 'N04BA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Inbrija', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1390', 'active_substance': 'levodopa', 'eu_mah_current': 'Acorda Therapeutics Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '09-19-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004786', 'ema_number_certainty': '0.6'}"
EU-1-19-1409,"{'atc_code': 'L03AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cegfila', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1409', 'active_substance': 'pegfilgrastim', 'eu_mah_current': 'Mundipharma Corporation (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '12-19-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005312', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-20-1469,"{'atc_code': 'J01GB06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ARIKAYCE liposomal', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1469', 'active_substance': 'amikacin', 'eu_mah_current': 'Insmed Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005264', 'ema_number_certainty': '1.0'}"
EU-1-19-1395,"{'atc_code': 'B01AC30', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Clopidogrel/Acetylsalicylic acid Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1395', 'active_substance': 'clopidogrel / acetylsalicylic acid', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004996', 'ema_number_certainty': '1.0'}"
EU-1-19-1361,"{'atc_code': 'L04AC', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Skyrizi', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1361', 'active_substance': 'risankizumab', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'h', 'eu_aut_date': '04-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004759', 'ema_number_certainty': '1.0'}"
EU-1-19-1385,"{'atc_code': 'L01EX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'VITRAKVI', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1385', 'active_substance': 'larotrectinib', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '09-19-2019', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004919', 'ema_number_certainty': '1.0'}"
EU-1-19-1386,"{'atc_code': 'V03AC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Deferasirox Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1386', 'active_substance': 'deferasirox', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '09-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005014', 'ema_number_certainty': '1.0'}"
EU-1-21-1539,"{'atc_code': 'L01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Abecma', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1539', 'active_substance': 'idecabtagene vicleucel', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '08-18-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004662', 'ema_number_certainty': '1.0'}"
EU-1-21-1540,"{'atc_code': 'L01EA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dasatinib Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1540', 'active_substance': 'dasatinib', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '03-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005446', 'ema_number_certainty': '1.0'}"
EU-1-21-1541,"{'atc_code': 'L01EA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dasatinib Accordpharma', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1541', 'active_substance': 'dasatinib', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '03-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005317', 'ema_number_certainty': '1.0'}"
EU-1-19-1389,"{'atc_code': 'N03AX24', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Epidyolex', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1389', 'active_substance': 'cannabidiol', 'eu_mah_current': 'GW Pharma (International) B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-19-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004675', 'ema_number_certainty': '1.0'}"
EU-1-18-1284,"{'atc_code': 'N01AH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dzuveo', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1284', 'active_substance': 'sufentanil', 'eu_mah_current': 'Laboratoire Aguettant', 'orphan_status': 'h', 'eu_aut_date': '06-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004335', 'ema_number_certainty': '0.5'}"
EU-1-19-1388,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Polivy', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1388', 'active_substance': 'polatuzumab vedotin', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-16-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004870', 'ema_number_certainty': '1.0'}"
EU-1-95-001,"{'atc_code': 'G03GA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'GONAL-f', 'status_type': 'a', 'eu_pnumber': 'EU/1/95/001', 'active_substance': 'Follitropin alfa', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-20-1995', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/71', 'ema_number_certainty': '0.9807692307692307'}"
EU-1-18-1302,"{'atc_code': 'N03AG04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kigabeq', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1302', 'active_substance': 'vigabatrin', 'eu_mah_current': 'ORPHELIA Pharma SAS', 'orphan_status': 'h', 'eu_aut_date': '09-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004534', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-19-1358,"{'atc_code': 'N02CD03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'AJOVY', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1358', 'active_substance': 'fremanezumab', 'eu_mah_current': 'Teva GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004833', 'ema_number_certainty': '0.7'}"
EU-1-19-1360,"{'atc_code': 'C10AX18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Waylivra', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1360', 'active_substance': 'volanesorsen', 'eu_mah_current': 'Akcea Therapeutics Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '05-03-2019', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004538', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-19-1387,"{'atc_code': 'N01BB20', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Senstend', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1387', 'active_substance': 'lidocaine / prilocaine', 'eu_mah_current': 'Plethora Pharma Solutions Ltd.', 'orphan_status': 'h', 'eu_aut_date': '11-14-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005298', 'ema_number_certainty': '1.0'}"
EU-1-18-1290,"{'atc_code': 'A16AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nityr', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1290', 'active_substance': 'nitisinone', 'eu_mah_current': 'Cycle Pharmaceuticals (Europe) Ltd', 'orphan_status': 'h', 'eu_aut_date': '07-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004582', 'ema_number_certainty': '0.75'}"
EU-1-18-1296,"{'atc_code': 'N07XX15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tegsedi', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1296', 'active_substance': 'inotersen', 'eu_mah_current': 'Akcea Therapeutics Ireland Ltd', 'orphan_status': 'h', 'eu_aut_date': '07-06-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004782', 'ema_number_certainty': '0.6923076923076923'}"
EU-1-18-1297,"{'atc_code': 'L01XX71', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kymriah', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1297', 'active_substance': 'tisagenlecleucel', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-23-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004090', 'ema_number_certainty': '0.9333333333333333'}"
EU-1-19-1353,"{'atc_code': 'J05AE08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Atazanavir Krka', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1353', 'active_substance': 'atazanavir', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '03-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004859', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-19-1354,"{'atc_code': 'L01EB07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vizimpro', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1354', 'active_substance': 'dacomitinib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-02-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004779', 'ema_number_certainty': '0.75'}"
EU-1-19-1355,"{'atc_code': 'L01ED05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lorviqua', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1355', 'active_substance': 'lorlatinib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '05-06-2019', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004646', 'ema_number_certainty': '0.9230769230769231'}"
EU-1-20-1477,"{'atc_code': 'N07XX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fampridine Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1477', 'active_substance': 'fampridine', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '09-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005359', 'ema_number_certainty': '1.0'}"
EU-1-20-1479,"{'atc_code': 'L01XE', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Calquence', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1479', 'active_substance': 'acalabrutinib', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '11-05-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005299', 'ema_number_certainty': '1.0'}"
EU-1-19-1359,"{'atc_code': 'J05AX23', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trogarzo', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1359', 'active_substance': 'ibalizumab', 'eu_mah_current': 'Theratechnologies Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '09-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004961', 'ema_number_certainty': '1.0'}"
EU-1-18-1289,"{'atc_code': 'J05AR20', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Biktarvy', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1289', 'active_substance': 'bictegravir / emtricitabine / tenofovir alafenamide', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '06-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004449', 'ema_number_certainty': '0.5625'}"
EU-1-18-1294,"{'atc_code': 'N05AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'RXULTI', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1294', 'active_substance': 'brexpiprazole', 'eu_mah_current': 'Otsuka Pharmaceutical Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003841', 'ema_number_certainty': '0.6'}"
EU-1-18-1299,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Yescarta', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1299', 'active_substance': 'axicabtagene ciloleucel', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-23-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004480', 'ema_number_certainty': '0.5714285714285714'}"
EU-1-19-1399,"{'atc_code': 'L01EX13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xospata', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1399', 'active_substance': 'gilteritinib', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-24-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004752', 'ema_number_certainty': '1.0'}"
EU-1-19-1407,"{'atc_code': 'H02CA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Isturisa', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1407', 'active_substance': 'osilodrostat', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'h', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004821', 'ema_number_certainty': '1.0'}"
EU-1-18-1287,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hefiya', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1287', 'active_substance': 'adalimumab', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004865', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-19-1369,"{'atc_code': 'N07BC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sixmo', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1369', 'active_substance': 'buprenorphine', 'eu_mah_current': 'L. Molteni &amp; C. dei F.lli Alitti Soc.Es.S.p.A', 'orphan_status': 'h', 'eu_aut_date': '06-20-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004743', 'ema_number_certainty': '0.75'}"
EU-1-20-1457,"{'atc_code': 'J01XX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xenleta', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1457', 'active_substance': 'lefamulin', 'eu_mah_current': 'Nabriva Therapeutics Ireland DAC', 'orphan_status': 'h', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005048', 'ema_number_certainty': '1.0'}"
EU-1-20-1458,"{'atc_code': 'B01AF02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Apixaban Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1458', 'active_substance': 'apixaban', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '07-23-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005358', 'ema_number_certainty': '1.0'}"
EU-1-19-1403,"{'atc_code': 'R03AK07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Budesonide/Formoterol Teva Pharma B.V.', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1403', 'active_substance': 'budesonide / formoterol fumarate dihydrate', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-03-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004882', 'ema_number_certainty': '1.0'}"
EU-1-20-1478,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zynrelef', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1478', 'active_substance': 'bupivacaine/meloxicam', 'eu_mah_current': 'Heron Therapeutics, B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005205', 'ema_number_certainty': '1.0'}"
EU-1-18-1328,"{'atc_code': 'L03AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pelmeg', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1328', 'active_substance': 'pegfilgrastim', 'eu_mah_current': 'Mundipharma Corporation (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '11-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004700', 'ema_number_certainty': '0.7'}"
EU-1-18-1329,"{'atc_code': 'L03AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fulphila', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1329', 'active_substance': 'pegfilgrastim', 'eu_mah_current': 'Viatris Limited', 'orphan_status': 'h', 'eu_aut_date': '11-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004915', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-18-1330,"{'atc_code': 'N02CD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Emgality', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1330', 'active_substance': 'galcanezumab', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004648', 'ema_number_certainty': '0.6'}"
EU-1-18-1351,"{'atc_code': 'L01AB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trecondi', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1351', 'active_substance': 'treosulfan', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'h', 'eu_aut_date': '06-20-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004751', 'ema_number_certainty': '0.75'}"
EU-1-18-1352,"{'atc_code': 'L03AB15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Besremi', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1352', 'active_substance': 'ropeginterferon alfa-2b', 'eu_mah_current': 'AOP Orphan Pharmaceuticals GmbH,', 'orphan_status': 'h', 'eu_aut_date': '02-15-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004128', 'ema_number_certainty': '0.8'}"
EU-1-20-1442,"{'atc_code': 'L04AA38', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zeposia', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1442', 'active_substance': 'ozanimod', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '05-20-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004835', 'ema_number_certainty': '1.0'}"
EU-1-20-1492,"{'atc_code': 'L01X', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tecartus', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1492', 'active_substance': 'brexucabtagene autoleucel', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-14-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005102', 'ema_number_certainty': '0.875'}"
EU-1-20-1493,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Libmeldy', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1493', 'active_substance': 'atidarsagene autotemcel', 'eu_mah_current': 'Orchard Therapeutics (Netherlands) B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-17-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005321', 'ema_number_certainty': '1.0'}"
EU-1-21-1535,"{'atc_code': 'L01EX20', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pemazyre', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1535', 'active_substance': 'pemigatinib', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005266', 'ema_number_certainty': '1.0'}"
EU-1-21-1536,"{'atc_code': 'L01AC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Thiotepa Riemser', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1536', 'active_substance': 'thiotepa', 'eu_mah_current': 'Esteve Pharmaceuticals GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005434', 'ema_number_certainty': '1.0'}"
EU-1-18-1312,"{'atc_code': 'J01AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xerava', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1312', 'active_substance': 'Eravacycline', 'eu_mah_current': 'PAION Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004237', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-18-1324,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Jivi', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1324', 'active_substance': 'damoctocog alfa pegol', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '11-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004054', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-19-1417,"{'atc_code': 'S01LA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Beovu', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1417', 'active_substance': 'brolucizumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '02-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004913', 'ema_number_certainty': '1.0'}"
EU-1-18-1348,"{'atc_code': 'B02BX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mulpleo', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1348', 'active_substance': 'lusutrombopag', 'eu_mah_current': 'Shionogi B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-18-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004720', 'ema_number_certainty': '0.7142857142857143'}"
EU-1-19-1418,"{'atc_code': 'N05CM18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dexmedetomidine Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1418', 'active_substance': 'dexmedetomidine', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '02-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005152', 'ema_number_certainty': '1.0'}"
EU-1-18-1318,"{'atc_code': 'N05CH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Slenyto', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1318', 'active_substance': 'melatonin', 'eu_mah_current': 'RAD Neurim Pharmaceuticals EEC SARL', 'orphan_status': 'h', 'eu_aut_date': '09-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004425', 'ema_number_certainty': '0.5384615384615384'}"
EU-1-18-1321,"{'atc_code': 'L01EB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Gefitinib Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1321', 'active_substance': 'gefitinib', 'eu_mah_current': 'Mylan Pharmaceuticals Limited', 'orphan_status': 'h', 'eu_aut_date': '09-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004826', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-18-1344,"{'atc_code': 'L01XC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zirabev', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1344', 'active_substance': 'bevacizumab', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '02-14-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004697', 'ema_number_certainty': '0.9230769230769231'}"
EU-1-18-1345,"{'atc_code': 'V03AB38', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ondexxya', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1345', 'active_substance': 'andexanet alfa', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '04-26-2019', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004108', 'ema_number_certainty': '1.0'}"
EU-1-20-1499,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Onbevzi', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1499', 'active_substance': 'bevacizumab', 'eu_mah_current': 'Samsung Bioepis NL B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-11-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005640', 'ema_number_certainty': '1.0'}"
EU-1-20-1496,"{'atc_code': 'A16AX18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Oxlumo', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1496', 'active_substance': 'lumasiran', 'eu_mah_current': 'Alnylam Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005040', 'ema_number_certainty': '1.0'}"
EU-1-20-1518,"{'atc_code': 'J05AX29', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rukobia', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1518', 'active_substance': 'fostemsavir', 'eu_mah_current': 'ViiV Healthcare BV', 'orphan_status': 'h', 'eu_aut_date': '02-04-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005011', 'ema_number_certainty': '0.75'}"
EU-1-18-1313,"{'atc_code': 'L03AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pelgraz', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1313', 'active_substance': 'pegfilgrastim', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '09-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003961', 'ema_number_certainty': '0.625'}"
EU-1-18-1331,"{'atc_code': 'S01XA27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Luxturna', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1331', 'active_substance': 'voretigene neparvovec', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4451', 'ema_number_certainty': '0.375'}"
EU-1-18-1332,"{'atc_code': 'J05AG06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pifeltro', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1332', 'active_substance': 'doravirine', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004747', 'ema_number_certainty': '0.625'}"
EU-1-18-1333,"{'atc_code': 'J05AR24', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Delstrigo', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1333', 'active_substance': 'doravirine / lamivudine / tenofovir disoproxil', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004746', 'ema_number_certainty': '0.5454545454545454'}"
EU-1-20-1424,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nustendi', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1424', 'active_substance': 'bempedoic acid / ezetimibe', 'eu_mah_current': 'Daiichi Sankyo Europe GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004959', 'ema_number_certainty': '1.0'}"
EU-1-20-1425,"{'atc_code': 'C10AX15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nilemdo', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1425', 'active_substance': 'bempedoic acid', 'eu_mah_current': 'Daiichi Sankyo Europe GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-01-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004958', 'ema_number_certainty': '1.0'}"
EU-1-20-1482,"{'atc_code': 'J05AG05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'REKAMBYS', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1482', 'active_substance': 'rilpivirine', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '12-17-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005060', 'ema_number_certainty': '1.0'}"
EU-1-18-1311,"{'atc_code': 'L01EH02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nerlynx', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1311', 'active_substance': 'neratinib', 'eu_mah_current': 'Pierre Fabre M&#233;dicament', 'orphan_status': 'h', 'eu_aut_date': '08-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004030', 'ema_number_certainty': '0.7692307692307693'}"
EU-1-18-1293,"{'atc_code': 'N02C', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Aimovig', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1293', 'active_substance': 'erenumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '07-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004447', 'ema_number_certainty': '0.45454545454545453'}"
EU-1-19-1379,"{'atc_code': 'J02AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Posaconazole Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1379', 'active_substance': 'posaconazole', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005005', 'ema_number_certainty': '1.0'}"
EU-1-19-1380,"{'atc_code': 'J02AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Posaconazole AHCL', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1380', 'active_substance': 'posaconazole', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005028', 'ema_number_certainty': '0.8'}"
EU-1-21-1538,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'JEMPERLI', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1538', 'active_substance': 'dostarlimab', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '04-21-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005204', 'ema_number_certainty': '1.0'}"
EU-1-18-1325,"{'atc_code': 'C01BB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Namuscla', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1325', 'active_substance': 'Mexiletine', 'eu_mah_current': 'Lupin Europe GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-18-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4584', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-18-1326,"{'atc_code': 'J07BB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Flucelvax Tetra', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1326', 'active_substance': 'influenza vaccine (surface antigen, inactivated, prepared in cell cultures)', 'eu_mah_current': 'Seqirus Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '12-12-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004814', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-18-1340,"{'atc_code': 'B06AC05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'TAKHZYRO', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1340', 'active_substance': 'lanadelumab', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'h', 'eu_aut_date': '11-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004806', 'ema_number_certainty': '0.9090909090909091'}"
EU-1-18-1341,"{'atc_code': 'L01XC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ogivri', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1341', 'active_substance': 'trastuzumab', 'eu_mah_current': 'Viatris Limited', 'orphan_status': 'h', 'eu_aut_date': '12-12-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004916', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-18-1306,"{'atc_code': 'R07AX31', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Symkevi', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1306', 'active_substance': 'tezacaftor/ivacaftor', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '10-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004682', 'ema_number_certainty': '0.5454545454545454'}"
EU-1-18-1307,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Verzenios', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1307', 'active_substance': 'abemaciclib', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004302', 'ema_number_certainty': '0.7272727272727273'}"
EU-1-14-922,"{'atc_code': 'R03BB07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Incruse Ellipta', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/922', 'active_substance': 'umeclidinium bromide', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '04-28-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2809', 'ema_number_certainty': '0.5'}"
EU-1-18-1349,"{'atc_code': 'J05AH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dectova', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1349', 'active_substance': 'zanamivir', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'h', 'eu_aut_date': '04-26-2019', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004102', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-20-1426,"{'atc_code': 'L01BC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Azacitidine Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1426', 'active_substance': 'Azacitidine', 'eu_mah_current': 'Mylan Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '03-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004984', 'ema_number_certainty': '1.0'}"
EU-1-20-1427,"{'atc_code': 'L01XX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Arsenic trioxide Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1427', 'active_substance': 'arsenic trioxide', 'eu_mah_current': 'Mylan Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '04-01-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005235', 'ema_number_certainty': '1.0'}"
EU-1-16-1130,"{'atc_code': 'L01CE02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Onivyde pegylated liposomal', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1130', 'active_substance': 'irinotecan', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'h', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4125', 'ema_number_certainty': '0.42857142857142855'}"
EU-1-96-011,"{'atc_code': 'L01DB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Caelyx pegylated liposomal', 'status_type': 'a', 'eu_pnumber': 'EU/1/96/011', 'active_substance': 'Doxorubicin hydrochloride', 'eu_mah_current': 'Baxter Holding B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-21-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/89', 'ema_number_certainty': '0.9242424242424242'}"
EU-1-20-1515,"{'atc_code': 'L01XC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Abevmy', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1515', 'active_substance': 'bevacizumab', 'eu_mah_current': 'Mylan IRE Healthcare Limited', 'orphan_status': 'h', 'eu_aut_date': '04-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005327', 'ema_number_certainty': '1.0'}"
EU-1-20-1488,"{'atc_code': 'B01AF01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rivaroxaban Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1488', 'active_substance': 'rivaroxaban', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '11-16-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005279', 'ema_number_certainty': '1.0'}"
EU-1-20-1490,"{'atc_code': 'L04AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lenalidomide Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1490', 'active_substance': 'lenalidomide', 'eu_mah_current': 'Mylan Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '12-18-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005306', 'ema_number_certainty': '0.9090909090909091'}"
EU-1-20-1527,"{'atc_code': 'L01EX22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Retsevmo', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1527', 'active_substance': 'selpercatinib', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-11-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005375', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-02-204,"{'atc_code': 'L01XX27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'TRISENOX', 'status_type': 'a', 'eu_pnumber': 'EU/1/02/204', 'active_substance': 'Arsenic trioxide', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-05-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/388', 'ema_number_certainty': '0.8727272727272727'}"
EU-1-19-1412,"{'atc_code': 'V03AC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Deferasirox Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1412', 'active_substance': 'deferasirox', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005156', 'ema_number_certainty': '1.0'}"
EU-1-20-1486,"{'atc_code': 'L03AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nyvepria', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1486', 'active_substance': 'pegfilgrastim', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '11-18-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005085', 'ema_number_certainty': '1.0'}"
EU-1-20-1487,"{'atc_code': 'L01AA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'PHELINUN', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1487', 'active_substance': 'melphalan', 'eu_mah_current': 'ADIENNE S.r.l.S.U.', 'orphan_status': 'h', 'eu_aut_date': '11-16-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005173', 'ema_number_certainty': '1.0'}"
EU-1-14-898,"{'atc_code': 'R03AL03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Anoro Ellipta', 'status_type': 'a', 'eu_pnumber': 'EU/1/14/898', 'active_substance': 'umeclidinium bromide / vilanterol trifenatate', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '05-08-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2751', 'ema_number_certainty': '0.8421052631578947'}"
EU-1-20-1497,"{'atc_code': 'L01XY02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Phesgo', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1497', 'active_substance': 'pertuzumab / trastuzumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005386', 'ema_number_certainty': '1.0'}"
EU-1-20-1495,"{'atc_code': 'V01AA08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Palforzia', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1495', 'active_substance': 'defatted powder of Arachis hypogaea L., semen (peanuts)', 'eu_mah_current': 'Aimmune Therapeutics Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '12-17-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004917', 'ema_number_certainty': '1.0'}"
EU-1-20-1524,"{'atc_code': 'C10AX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vazkepa', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1524', 'active_substance': 'icosapent ethyl', 'eu_mah_current': 'Amarin Pharmaceuticals Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005398', 'ema_number_certainty': '0.75'}"
EU-1-18-1295,"{'atc_code': 'L01XC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trazimera', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1295', 'active_substance': 'trastuzumab', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '07-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004463', 'ema_number_certainty': '0.6153846153846154'}"
EU-1-17-1191,"{'atc_code': 'L01XC16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Qarziba', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1191', 'active_substance': 'dinutuximab beta', 'eu_mah_current': 'EUSA Pharma (Netherlands) B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-08-2017', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3918', 'ema_number_certainty': '0.5'}"
EU-1-20-1501,"{'atc_code': 'H01AC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sogroya', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1501', 'active_substance': 'somapacitan', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '03-31-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005030', 'ema_number_certainty': '1.0'}"
EU-1-18-1319,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hulio', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1319', 'active_substance': 'adalimumab', 'eu_mah_current': 'Viatris Limited', 'orphan_status': 'h', 'eu_aut_date': '09-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004429', 'ema_number_certainty': '0.9411764705882353'}"
EU-1-19-1413,"{'atc_code': 'L01BC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Azacitidine Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1413', 'active_substance': 'Azacitidine', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '02-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005147', 'ema_number_certainty': '1.0'}"
EU-1-19-1416,"{'atc_code': 'L01BC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Azacitidine Betapharm', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1416', 'active_substance': 'Azacitidine', 'eu_mah_current': 'betapharm Arzneimittel GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005075', 'ema_number_certainty': '1.0'}"
EU-1-20-1437,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dovprela', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1437', 'active_substance': 'pretomanid', 'eu_mah_current': 'Mylan IRE Healthcare Limited', 'orphan_status': 'h', 'eu_aut_date': '07-31-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005167', 'ema_number_certainty': '1.0'}"
EU-1-21-1533,"{'atc_code': 'R03AK06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Seffalair Spiromax', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1533', 'active_substance': 'salmeterol / fluticasone propionate', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004881', 'ema_number_certainty': '1.0'}"
EU-1-21-1534,"{'atc_code': 'R03AK06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'BroPair Spiromax', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1534', 'active_substance': 'salmeterol / fluticasone propionate', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005591', 'ema_number_certainty': '1.0'}"
EU-1-21-1537,"{'atc_code': 'L01XX66', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NEXPOVIO', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1537', 'active_substance': 'selinexor', 'eu_mah_current': 'Stemline Therapeutics B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005127', 'ema_number_certainty': '1.0'}"
EU-1-18-1314,"{'atc_code': 'L01EC03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Braftovi', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1314', 'active_substance': 'encorafenib', 'eu_mah_current': 'Pierre Fabre M&#233;dicament', 'orphan_status': 'h', 'eu_aut_date': '09-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004580', 'ema_number_certainty': '0.8181818181818182'}"
EU-1-18-1315,"{'atc_code': 'L01EE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mektovi', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1315', 'active_substance': 'binimetinib', 'eu_mah_current': 'Pierre Fabre M&#233;dicament', 'orphan_status': 'h', 'eu_aut_date': '09-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004579', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-18-1316,"{'atc_code': 'L04AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lenalidomide Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1316', 'active_substance': 'lenalidomide', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '09-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004857', 'ema_number_certainty': '0.5833333333333334'}"
EU-1-18-1338,"{'atc_code': 'J07BX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dengvaxia', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1338', 'active_substance': 'dengue tetravalent vaccine (live, attenuated)', 'eu_mah_current': 'Sanofi Pasteur', 'orphan_status': 'h', 'eu_aut_date': '12-12-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004171', 'ema_number_certainty': '0.8'}"
EU-1-18-1342,"{'atc_code': 'L02BB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Erleada', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1342', 'active_substance': 'apalutamide', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '01-14-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004452', 'ema_number_certainty': '0.9'}"
EU-1-20-1526,"{'atc_code': 'L01EH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'TUKYSA', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1526', 'active_substance': 'tucatinib', 'eu_mah_current': 'Seagen B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-11-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005263', 'ema_number_certainty': '1.0'}"
EU-1-19-1381,"{'atc_code': 'V03AF11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'LysaKare', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1381', 'active_substance': 'arginine/lysine', 'eu_mah_current': 'Advanced Accelerator Applications', 'orphan_status': 'h', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004541', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-19-1383,"{'atc_code': 'N03AX18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lacosamide UCB', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1383', 'active_substance': 'lacosamide', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '08-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005243', 'ema_number_certainty': '0.6'}"
EU-1-20-1438,"{'atc_code': 'R03AL12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Enerzair Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1438', 'active_substance': 'indacaterol / glycopyrronium / mometasone furoate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '07-03-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005061', 'ema_number_certainty': '1.0'}"
EU-1-20-1439,"{'atc_code': 'R03AK14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Atectura Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1439', 'active_substance': 'indacaterol / mometasone furoate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '05-30-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005067', 'ema_number_certainty': '1.0'}"
EU-1-20-1440,"{'atc_code': 'R03AL12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zimbus Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1440', 'active_substance': 'indacaterol / glycopyrronium / mometasone furoate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '07-03-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005518', 'ema_number_certainty': '0.75'}"
EU-1-20-1441,"{'atc_code': 'R03AK', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bemrist Breezhaler', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1441', 'active_substance': 'indacaterol / mometasone furoate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '05-30-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005516', 'ema_number_certainty': '0.8'}"
EU-1-18-1310,"{'atc_code': 'V03AC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Deferiprone Lipomed', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1310', 'active_substance': 'Deferiprone', 'eu_mah_current': 'Lipomed GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004710', 'ema_number_certainty': '0.625'}"
EU-1-18-1343,"{'atc_code': 'G04CA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Silodosin Recordati', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1343', 'active_substance': 'silodosin', 'eu_mah_current': 'Recordati Ireland Ltd', 'orphan_status': 'h', 'eu_aut_date': '01-07-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4964', 'ema_number_certainty': '1.0'}"
EU-1-19-1419,"{'atc_code': 'B01AC21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trepulmix', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1419', 'active_substance': 'treprostinil sodium', 'eu_mah_current': 'SciPharm S&#224;rl', 'orphan_status': 'h', 'eu_aut_date': '04-03-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005207', 'ema_number_certainty': '1.0'}"
EU-1-20-1423,"{'atc_code': 'J07AE02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vaxchora', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1423', 'active_substance': 'Cholera vaccine (recombinant, live, oral)', 'eu_mah_current': 'Emergent Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-01-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003876', 'ema_number_certainty': '1.0'}"
EU-1-20-1517,"{'atc_code': 'A12BA30', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sibnayal', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1517', 'active_substance': 'potassium citrate/potassium hydrogen carbonate', 'eu_mah_current': 'ADVICENNE', 'orphan_status': 'h', 'eu_aut_date': '04-30-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005407', 'ema_number_certainty': '1.0'}"
EU-1-20-1528,"{'atc_code': 'J07BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Comirnaty', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1528', 'active_substance': 'tozinameran, COVID-19 mRNA vaccine (nucleoside-modified)', 'eu_mah_current': 'BioNTech Manufacturing GmbH', 'orphan_status': 'h', 'eu_aut_date': '12-21-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005735', 'ema_number_certainty': '1.0'}"
EU-1-18-1320,"{'atc_code': 'N07XX12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Onpattro', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1320', 'active_substance': 'patisiran', 'eu_mah_current': 'Alnylam Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004699', 'ema_number_certainty': '0.7'}"
EU-1-20-1429,"{'atc_code': 'H05BX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cinacalcet Accordpharma', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1429', 'active_substance': 'cinacalcet', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '04-03-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005236', 'ema_number_certainty': '1.0'}"
EU-1-20-1430,"{'atc_code': 'A10BJ06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rybelsus', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1430', 'active_substance': 'semaglutide', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '04-03-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004953', 'ema_number_certainty': '1.0'}"
EU-1-20-1433,"{'atc_code': 'J07BB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fluad Tetra', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1433', 'active_substance': 'influenza vaccine (surface antigen, inactivated, adjuvanted)', 'eu_mah_current': 'Seqirus Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-20-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004993', 'ema_number_certainty': '1.0'}"
EU-1-20-1502,"{'atc_code': 'S01EE51', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Roclanda', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1502', 'active_substance': 'Latanoprost / netarsudil', 'eu_mah_current': 'Santen Oy', 'orphan_status': 'h', 'eu_aut_date': '01-07-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005107', 'ema_number_certainty': '1.0'}"
EU-1-20-1504,"{'atc_code': 'L01XX67', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ELZONRIS', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1504', 'active_substance': 'tagraxofusp', 'eu_mah_current': 'Stemline Therapeutics B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-07-2021', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005031', 'ema_number_certainty': '1.0'}"
EU-1-18-1335,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Poteligeo', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1335', 'active_substance': 'Mogamulizumab', 'eu_mah_current': 'Kyowa Kirin Holdings B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004232', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-20-1503,"{'atc_code': 'J07BC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Heplisav B', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1503', 'active_substance': 'hepatitis B surface antigen', 'eu_mah_current': 'Dynavax GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-18-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005063', 'ema_number_certainty': '1.0'}"
EU-1-18-1286,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hyrimoz', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1286', 'active_substance': 'adalimumab', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004320', 'ema_number_certainty': '0.7692307692307693'}"
EU-1-20-1498,"{'atc_code': 'R03AL11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'TRIXEO AEROSPHERE', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1498', 'active_substance': 'Formoterol / glycopyrronium bromide / budesonide', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004983', 'ema_number_certainty': '1.0'}"
EU-1-16-1139,"{'atc_code': 'A05AA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ocaliva', 'status_type': 'a', 'eu_pnumber': 'EU/1/16/1139', 'active_substance': 'obeticholic acid', 'eu_mah_current': 'Intercept Pharma International Limited', 'orphan_status': 'h', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/4093', 'ema_number_certainty': '0.5625'}"
EU-1-20-1435,"{'atc_code': 'L01XC38', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sarclisa', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1435', 'active_substance': 'isatuximab', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '05-30-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004977', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-18-1322,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Imfinzi', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1322', 'active_substance': 'durvalumab', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '09-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004771', 'ema_number_certainty': '0.7619047619047619'}"
EU-1-20-1446,"{'atc_code': 'J05AX28', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hepcludex', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1446', 'active_substance': 'bulevirtide', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '07-31-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004854', 'ema_number_certainty': '1.0'}"
EU-1-20-1505,"{'atc_code': 'N05CD14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Byfavo', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1505', 'active_substance': 'remimazolam', 'eu_mah_current': 'PAION Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005246', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-20-1508,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Enhertu', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1508', 'active_substance': 'trastuzumab deruxtecan', 'eu_mah_current': 'Daiichi Sankyo Europe GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-18-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005124', 'ema_number_certainty': '1.0'}"
EU-1-20-1509,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Alymsys', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1509', 'active_substance': 'bevacizumab', 'eu_mah_current': 'Mabxience Research SL', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005286', 'ema_number_certainty': '1.0'}"
EU-1-20-1510,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Oyavas', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1510', 'active_substance': 'bevacizumab', 'eu_mah_current': 'STADA Arzneimittel AG', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005556', 'ema_number_certainty': '1.0'}"
EU-1-20-1511,"{'atc_code': 'L01EX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sunitinib Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1511', 'active_substance': 'sunitinib', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '02-11-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005419', 'ema_number_certainty': '1.0'}"
EU-1-20-1512,"{'atc_code': 'L02BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Abiraterone Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1512', 'active_substance': 'abiraterone acetate', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '04-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005408', 'ema_number_certainty': '1.0'}"
EU-1-18-1323,"{'atc_code': 'L04AC17', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ilumetri', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1323', 'active_substance': 'tildrakizumab', 'eu_mah_current': 'Almirall, S.A.', 'orphan_status': 'h', 'eu_aut_date': '09-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004514', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-00-141,"{'atc_code': 'L01DB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Myocet liposomal', 'status_type': 'a', 'eu_pnumber': 'EU/1/00/141', 'active_substance': 'Doxorubicin', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-13-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/297', 'ema_number_certainty': '0.9534883720930233'}"
EU-1-21-1530,"{'atc_code': 'N03AX25', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ontozry', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1530', 'active_substance': 'cenobamate', 'eu_mah_current': 'Angelini Pharma S.p.A', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005377', 'ema_number_certainty': '1.0'}"
EU-1-18-1339,"{'atc_code': 'R03AL07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bevespi Aerosphere', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1339', 'active_substance': 'glycopyrronium bromide / formoterol', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '12-18-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004245', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-20-1489,"{'atc_code': 'N01BB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EXPAREL liposomal', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1489', 'active_substance': 'bupivacaine', 'eu_mah_current': 'Pacira Ireland Ltd', 'orphan_status': 'h', 'eu_aut_date': '11-16-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004586', 'ema_number_certainty': '1.0'}"
EU-1-20-1521,"{'atc_code': 'L04AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lenalidomide Krka d.d.', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1521', 'active_substance': 'lenalidomide', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '02-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005729', 'ema_number_certainty': '1.0'}"
EU-1-20-1523,"{'atc_code': 'H04AA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ogluo', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1523', 'active_substance': 'glucagon', 'eu_mah_current': 'Tetris Pharma B.V', 'orphan_status': 'h', 'eu_aut_date': '02-11-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005391', 'ema_number_certainty': '1.0'}"
EU-1-18-1346,"{'atc_code': 'A16AX06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Miglustat Dipharma', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1346', 'active_substance': 'miglustat', 'eu_mah_current': 'Dipharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-18-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004904', 'ema_number_certainty': '1.0'}"
EU-1-19-1384,"{'atc_code': 'C01CX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Giapreza', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1384', 'active_substance': 'angiotensin II acetate', 'eu_mah_current': 'PAION Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-23-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004930', 'ema_number_certainty': '0.75'}"
EU-1-19-1421,"{'atc_code': 'D11AH06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Staquis', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1421', 'active_substance': 'crisaborole', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004863', 'ema_number_certainty': '1.0'}"
EU-1-20-1422,"{'atc_code': 'A10AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lyumjev', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1422', 'active_substance': 'Insulin lispro', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005037', 'ema_number_certainty': '1.0'}"
EU-1-18-1301,"{'atc_code': 'A16AB18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mepsevii', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1301', 'active_substance': 'vestronidase alfa', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-23-2018', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004438', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-20-1513,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Yuflyma', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1513', 'active_substance': 'adalimumab', 'eu_mah_current': 'Celltrion Healthcare Hungary Kft.', 'orphan_status': 'h', 'eu_aut_date': '02-11-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005188', 'ema_number_certainty': '1.0'}"
EU-1-18-1327,"{'atc_code': 'L03AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ziextenzo', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1327', 'active_substance': 'pegfilgrastim', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004802', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-20-1436,"{'atc_code': 'L04AB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nepexto', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1436', 'active_substance': 'etanercept', 'eu_mah_current': 'Mylan IRE Healthcare Limited', 'orphan_status': 'h', 'eu_aut_date': '05-20-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004711', 'ema_number_certainty': '1.0'}"
EU-1-20-1491,"{'atc_code': 'N03AX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fintepla', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1491', 'active_substance': 'fenfluramine', 'eu_mah_current': 'Zogenix ROI Limited', 'orphan_status': 'h', 'eu_aut_date': '12-18-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003933', 'ema_number_certainty': '1.0'}"
EU-1-19-1414,"{'atc_code': 'L04AA42', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mayzent', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1414', 'active_substance': 'siponimod', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '01-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004712', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-20-1500,"{'atc_code': 'J05AX25', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xofluza', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1500', 'active_substance': 'baloxavir marboxil', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-07-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004974', 'ema_number_certainty': '1.0'}"
EU-1-20-1514,"{'atc_code': 'L01EJ02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Inrebic', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1514', 'active_substance': 'fedratinib', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '02-08-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005026', 'ema_number_certainty': '1.0'}"
EU-1-19-1415,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Amsparity', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1415', 'active_substance': 'adalimumab', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '02-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004879', 'ema_number_certainty': '1.0'}"
EU-1-18-1305,"{'atc_code': 'B01AX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cablivi', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1305', 'active_substance': 'caplacizumab', 'eu_mah_current': 'Ablynx N.V.', 'orphan_status': 'h', 'eu_aut_date': '08-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004426', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-18-1317,"{'atc_code': 'L01CD01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pazenir', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1317', 'active_substance': 'paclitaxel', 'eu_mah_current': 'ratiopharm GmbH', 'orphan_status': 'h', 'eu_aut_date': '05-06-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004441', 'ema_number_certainty': '1.0'}"
EU-1-18-1347,"{'atc_code': 'M04AA03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Febuxostat Krka', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1347', 'active_substance': 'febuxostat', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '03-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004773', 'ema_number_certainty': '0.75'}"
EU-1-20-1483,"{'atc_code': 'J07AH08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'MenQuadfi', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1483', 'active_substance': 'Meningococcal group A, C, W and Y conjugate vaccine', 'eu_mah_current': 'Sanofi Pasteur', 'orphan_status': 'h', 'eu_aut_date': '11-18-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005084', 'ema_number_certainty': '1.0'}"
EU-1-20-1484,"{'atc_code': 'J07BB02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Supemtek', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1484', 'active_substance': 'quadrivalent influenza vaccine (recombinant, prepared in cell culture)', 'eu_mah_current': 'Sanofi Pasteur', 'orphan_status': 'h', 'eu_aut_date': '11-16-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005159', 'ema_number_certainty': '1.0'}"
EU-1-20-1485,"{'atc_code': 'J06BB22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Obiltoxaximab SFL', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1485', 'active_substance': 'obiltoxaximab', 'eu_mah_current': 'SFL Pharmaceuticals Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-18-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005169', 'ema_number_certainty': '1.0'}"
EU-1-20-1470,"{'atc_code': 'V04CX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lumeblue', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1470', 'active_substance': 'methylthioninium chloride', 'eu_mah_current': 'Alfasigma S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '08-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/002776', 'ema_number_certainty': '1.0'}"
EU-1-21-1531,"{'atc_code': 'M09AX10', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Evrysdi', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1531', 'active_substance': 'risdiplam', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005145', 'ema_number_certainty': '1.0'}"
EU-1-21-1532,"{'atc_code': 'L04AA52', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kesimpta', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1532', 'active_substance': 'ofatumumab', 'eu_mah_current': 'Novartis Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005410', 'ema_number_certainty': '1.0'}"
EU-1-18-1336,"{'atc_code': 'N07BC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Buvidal', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1336', 'active_substance': 'buprenorphine', 'eu_mah_current': 'Camurus AB', 'orphan_status': 'h', 'eu_aut_date': '11-20-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004651', 'ema_number_certainty': '0.75'}"
EU-1-11-696,"{'atc_code': 'A10BJ01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bydureon', 'status_type': 'a', 'eu_pnumber': 'EU/1/11/696', 'active_substance': 'exenatide', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '06-17-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2020', 'ema_number_certainty': '0.8181818181818182'}"
EU-1-20-1428,"{'atc_code': 'A16AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Givlaari', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1428', 'active_substance': 'givosiran', 'eu_mah_current': 'Alnylam Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-02-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004775', 'ema_number_certainty': '0.8'}"
EU-1-20-1481,"{'atc_code': 'J05AJ04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vocabria', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1481', 'active_substance': 'cabotegravir', 'eu_mah_current': 'ViiV Healthcare BV', 'orphan_status': 'h', 'eu_aut_date': '12-17-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004976', 'ema_number_certainty': '0.8'}"
EU-1-18-1308,"{'atc_code': 'L01XY01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vyxeos liposomal', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1308', 'active_substance': 'daunorubicin / cytarabine', 'eu_mah_current': 'Jazz Pharmaceuticals Ireland Ltd', 'orphan_status': 'h', 'eu_aut_date': '08-23-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004282', 'ema_number_certainty': '0.875'}"
EU-1-19-1420,"{'atc_code': 'J01DH56', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Recarbrio', 'status_type': 'a', 'eu_pnumber': 'EU/1/19/1420', 'active_substance': 'imipenem / cilastatin / relebactam', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004808', 'ema_number_certainty': '1.0'}"
EU-1-20-1431,"{'atc_code': 'L01XC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ruxience', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1431', 'active_substance': 'rituximab', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-01-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004696', 'ema_number_certainty': '0.75'}"
EU-1-20-1434,"{'atc_code': 'J01DI04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fetcroja', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1434', 'active_substance': 'cefiderocol', 'eu_mah_current': 'Shionogi B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-23-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004829', 'ema_number_certainty': '0.8'}"
EU-1-20-1444,"{'atc_code': 'J07BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zabdeno', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1444', 'active_substance': 'Ebola vaccine (Ad26.ZEBOV-GP [recombinant])', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '07-01-2020', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005337', 'ema_number_certainty': '1.0'}"
EU-1-20-1445,"{'atc_code': 'J07BX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mvabea', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1445', 'active_substance': 'Ebola vaccine (MVA-BN-Filo [recombinant])', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '07-01-2020', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005343', 'ema_number_certainty': '1.0'}"
EU-1-20-1432,"{'atc_code': 'L02BB06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NUBEQA', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1432', 'active_substance': 'darolutamide', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '03-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004790', 'ema_number_certainty': '1.0'}"
EU-1-20-1443,"{'atc_code': 'M09AX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zolgensma', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1443', 'active_substance': 'onasemnogene abeparvovec', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '05-18-2020', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/004750', 'ema_number_certainty': '0.8461538461538461'}"
EU-1-20-1494,"{'atc_code': 'C10AX16', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Leqvio', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1494', 'active_substance': 'inclisiran', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005333', 'ema_number_certainty': '1.0'}"
EU-1-18-1291,"{'atc_code': 'A06AH05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rizmoic', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1291', 'active_substance': 'naldemedine', 'eu_mah_current': 'Shionogi B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-18-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004256', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-21-1589,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Hukyndra', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1589', 'active_substance': 'adalimumab', 'eu_mah_current': 'STADA Arzneimittel AG', 'orphan_status': 'h', 'eu_aut_date': '11-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005548', 'ema_number_certainty': '1.0'}"
EU-1-21-1590,"{'atc_code': 'L04AB04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Libmyris', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1590', 'active_substance': 'adalimumab', 'eu_mah_current': 'STADA Arzneimittel AG', 'orphan_status': 'h', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005947', 'ema_number_certainty': '1.0'}"
EU-1-22-1644,"{'atc_code': 'A10AB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Inpremzia', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1644', 'active_substance': 'insulin human (rDNA)', 'eu_mah_current': 'Baxter Holding B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005331', 'ema_number_certainty': '1.0'}"
EU-1-08-443,"{'atc_code': 'L04AX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Thalidomide BMS', 'status_type': 'a', 'eu_pnumber': 'EU/1/08/443', 'active_substance': 'Thalidomide', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-16-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/823', 'ema_number_certainty': '0.7708333333333334'}"
EU-1-21-1561,"{'atc_code': 'C01DX22', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Verquvo', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1561', 'active_substance': 'vericiguat', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '07-16-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005319', 'ema_number_certainty': '1.0'}"
EU-1-21-1588,"{'atc_code': 'B01AF01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rivaroxaban Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1588', 'active_substance': 'rivaroxaban', 'eu_mah_current': 'Mylan Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005600', 'ema_number_certainty': '1.0'}"
EU-1-20-1519,"{'atc_code': 'L04AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lenalidomide Krka', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1519', 'active_substance': 'lenalidomide', 'eu_mah_current': 'KRKA, d.d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '02-11-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005348', 'ema_number_certainty': '1.0'}"
EU-1-20-1520,"{'atc_code': 'L04AX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lenalidomide Krka d.d. Novo mesto', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1520', 'active_substance': 'lenalidomide', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '02-11-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005734', 'ema_number_certainty': '1.0'}"
EU-1-21-1597,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Regkirona', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1597', 'active_substance': 'regdanvimab', 'eu_mah_current': 'Celltrion Healthcare Hungary Kft.', 'orphan_status': 'h', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005854', 'ema_number_certainty': '1.0'}"
EU-1-21-1598,"{'atc_code': 'A10BH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sitagliptin SUN', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1598', 'active_substance': 'sitagliptin fumarate', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe BV', 'orphan_status': 'h', 'eu_aut_date': '12-09-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005741', 'ema_number_certainty': '1.0'}"
EU-1-21-1612,"{'atc_code': 'J07AL02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Apexxnar', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1612', 'active_substance': 'pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '02-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005451', 'ema_number_certainty': '1.0'}"
EU-1-21-1542,"{'atc_code': 'L01EM04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Copiktra', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1542', 'active_substance': 'duvelisib', 'eu_mah_current': 'Secura Bio Limited', 'orphan_status': 'h', 'eu_aut_date': '05-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005381', 'ema_number_certainty': '1.0'}"
EU-1-21-1547,"{'atc_code': 'G03AA18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Drovelis', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1547', 'active_substance': 'drospirenone / estetrol', 'eu_mah_current': 'Gedeon Richter Plc.', 'orphan_status': 'h', 'eu_aut_date': '05-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005336', 'ema_number_certainty': '1.0'}"
EU-1-21-1548,"{'atc_code': 'G03AA18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lydisilka', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1548', 'active_substance': 'drospirenone / estetrol', 'eu_mah_current': 'Estetra SRL', 'orphan_status': 'h', 'eu_aut_date': '05-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005382', 'ema_number_certainty': '1.0'}"
EU-1-21-1593,"{'atc_code': 'D11AH', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cibinqo', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1593', 'active_substance': 'abrocitinib', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '12-09-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005452', 'ema_number_certainty': '1.0'}"
EU-1-21-1594,"{'atc_code': 'L01FX18', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Rybrevant', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1594', 'active_substance': 'amivantamab', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '12-09-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005454', 'ema_number_certainty': '1.0'}"
EU-1-21-1600,"{'atc_code': 'J05AX24', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tecovirimat SIGA', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1600', 'active_substance': 'tecovirimat', 'eu_mah_current': 'SIGA Technologies Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-06-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005248', 'ema_number_certainty': '1.0'}"
EU-1-21-1608,"{'atc_code': 'A10BJ06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Wegovy', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1608', 'active_substance': 'semaglutide', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '01-06-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005422', 'ema_number_certainty': '1.0'}"
EU-1-21-1546,"{'atc_code': 'N07XX11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ozawade', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1546', 'active_substance': 'pitolisant', 'eu_mah_current': 'Bioprojet Pharma', 'orphan_status': 'h', 'eu_aut_date': '07-22-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005117', 'ema_number_certainty': '1.0'}"
EU-1-21-1550,"{'atc_code': 'L04AA', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ponvory', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1550', 'active_substance': 'ponesimod', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '05-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005163', 'ema_number_certainty': '1.0'}"
EU-1-21-1551,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Evkeeza', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1551', 'active_substance': 'evinacumab', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-17-2021', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005449', 'ema_number_certainty': '1.0'}"
EU-1-21-1596,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tepmetko', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1596', 'active_substance': 'tepotinib', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005524', 'ema_number_certainty': '1.0'}"
EU-1-03-271,"{'atc_code': 'B02BD02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ADVATE', 'status_type': 'a', 'eu_pnumber': 'EU/1/03/271', 'active_substance': 'octocog alfa', 'eu_mah_current': 'Takeda Manufacturing Austria AG', 'orphan_status': 'h', 'eu_aut_date': '03-02-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/520', 'ema_number_certainty': '0.8852459016393442'}"
EU-1-21-1555,"{'atc_code': 'L01EX23', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'GAVRETO', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1555', 'active_substance': 'pralsetinib', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-18-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005413', 'ema_number_certainty': '1.0'}"
EU-1-21-1556,"{'atc_code': 'L01BC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Onureg', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1556', 'active_substance': 'azacitidine', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '06-17-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004761', 'ema_number_certainty': '1.0'}"
EU-1-21-1576,"{'atc_code': 'L01EL03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Brukinsa', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1576', 'active_substance': 'zanubrutinib', 'eu_mah_current': 'BeiGene Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '11-22-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004978', 'ema_number_certainty': '1.0'}"
EU-1-21-1601,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ronapreve', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1601', 'active_substance': 'casirivimab / imdevimab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005814', 'ema_number_certainty': '1.0'}"
EU-1-21-1602,"{'atc_code': 'L04AA', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Uplizna', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1602', 'active_substance': 'inebilizumab', 'eu_mah_current': 'Horizon Therapeutics Ireland DAC', 'orphan_status': 'h', 'eu_aut_date': '04-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005818', 'ema_number_certainty': '1.0'}"
EU-1-21-1587,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'RAYVOW', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1587', 'active_substance': 'lasmiditan', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-17-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005332', 'ema_number_certainty': '1.0'}"
EU-1-21-1606,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Yselty', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1606', 'active_substance': 'linzagolix choline', 'eu_mah_current': 'ObsEva Ireland Ltd.', 'orphan_status': 'h', 'eu_aut_date': '06-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005442', 'ema_number_certainty': '1.0'}"
EU-1-21-1607,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lonapegsomatropin Ascendis Pharma', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1607', 'active_substance': 'Lonapegsomatropin', 'eu_mah_current': 'Ascendis Pharma Endocrinology Division A/S', 'orphan_status': 'h', 'eu_aut_date': '01-11-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005367', 'ema_number_certainty': '1.0'}"
EU-1-22-1634,"{'atc_code': 'L04AX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dimethyl fumarate Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1634', 'active_substance': 'dimethyl fumarate', 'eu_mah_current': 'Mylan Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '05-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005956', 'ema_number_certainty': '1.0'}"
EU-1-22-1637,"{'atc_code': 'L04AX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Dimethyl fumarate Neuraxpharm', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1637', 'active_substance': 'dimethyl fumarate', 'eu_mah_current': 'Laboratorios Lesvi, S.L.', 'orphan_status': 'h', 'eu_aut_date': '05-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/006039', 'ema_number_certainty': '1.0'}"
EU-1-22-1638,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'QUVIVIQ', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1638', 'active_substance': 'daridorexant', 'eu_mah_current': 'Idorsia Pharmaceuticals Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-29-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005634', 'ema_number_certainty': '1.0'}"
EU-1-22-1645,"{'atc_code': 'N02CD', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vydura', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1645', 'active_substance': 'rimegepant', 'eu_mah_current': 'Biohaven Pharmaceutical Ireland DAC', 'orphan_status': 'h', 'eu_aut_date': '04-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005725', 'ema_number_certainty': '1.0'}"
EU-1-21-1553,"{'atc_code': 'L02BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Abiraterone Krka', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1553', 'active_substance': 'abiraterone acetate', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '06-24-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005649', 'ema_number_certainty': '1.0'}"
EU-1-21-1554,"{'atc_code': 'D11AH07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Adtralza', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1554', 'active_substance': 'tralokinumab', 'eu_mah_current': 'Leo Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '06-17-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005255', 'ema_number_certainty': '1.0'}"
EU-1-17-1189,"{'atc_code': 'G04BX15', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'elmiron', 'status_type': 'a', 'eu_pnumber': 'EU/1/17/1189', 'active_substance': 'pentosan polysulfate sodium', 'eu_mah_current': 'bene-Arzneimittel GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-02-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4246', 'ema_number_certainty': '0.47058823529411764'}"
EU-1-21-1604,"{'atc_code': 'R03AL11', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Riltrava Aerosphere', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1604', 'active_substance': 'formoterol / glycopyrronium bromide / budesonide', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '01-06-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005311', 'ema_number_certainty': '1.0'}"
EU-1-21-1605,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tavneos', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1605', 'active_substance': 'avacopan', 'eu_mah_current': 'Vifor Fresenius Medical Care Renal Pharma France', 'orphan_status': 'h', 'eu_aut_date': '01-11-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005523', 'ema_number_certainty': '1.0'}"
EU-1-21-1618,"{'atc_code': 'J07BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nuvaxovid', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1618', 'active_substance': 'COVID-19 Vaccine (recombinant, adjuvanted)', 'eu_mah_current': 'Novavax CZ, a.s.', 'orphan_status': 'h', 'eu_aut_date': '12-20-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005808', 'ema_number_certainty': '1.0'}"
EU-1-21-1573,"{'atc_code': 'L04AA27', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Fingolimod Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1573', 'active_substance': 'fingolimod', 'eu_mah_current': 'Mylan Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '08-18-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005661', 'ema_number_certainty': '1.0'}"
EU-1-21-1615,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Padcev', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1615', 'active_substance': 'enfortumab vedotin', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005392', 'ema_number_certainty': '1.0'}"
EU-1-21-1616,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kerendia', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1616', 'active_substance': 'finerenone', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '02-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005200', 'ema_number_certainty': '1.0'}"
EU-1-21-1617,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ngenla', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1617', 'active_substance': 'somatrogon', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '02-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005633', 'ema_number_certainty': '1.0'}"
EU-1-21-1622,"{'atc_code': 'B06AX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Oxbryta', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1622', 'active_substance': 'voxelotor', 'eu_mah_current': 'Global Blood Therapeutics Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004869', 'ema_number_certainty': '1.0'}"
EU-1-22-1663,"{'atc_code': 'V03AB35', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sugammadex Fresenius Kabi', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1663', 'active_substance': 'sugammadex', 'eu_mah_current': 'Fresenius Kabi Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005760', 'ema_number_certainty': '1.0'}"
EU-1-21-1552,"{'atc_code': 'L01EE04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Koselugo', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1552', 'active_substance': 'selumetinib', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '06-17-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005244', 'ema_number_certainty': '1.0'}"
EU-1-21-1568,"{'atc_code': 'L01EA01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Imatinib Koanaa', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1568', 'active_substance': 'imatinib', 'eu_mah_current': 'Koanaa Healthcare GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-22-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005595', 'ema_number_certainty': '1.0'}"
EU-1-21-1569,"{'atc_code': 'L01EX19', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'QINLOCK', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1569', 'active_substance': 'ripretinib', 'eu_mah_current': 'Deciphera Pharmaceuticals (Netherlands) B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-18-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005614', 'ema_number_certainty': '1.0'}"
EU-1-21-1572,"{'atc_code': 'S01LA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Byooviz', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1572', 'active_substance': 'ranibizumab', 'eu_mah_current': 'Samsung Bioepis NL B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-18-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005545', 'ema_number_certainty': '1.0'}"
EU-1-21-1599,"{'atc_code': 'N02CD05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vyepti', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1599', 'active_substance': 'eptinezumab', 'eu_mah_current': 'H. Lundbeck A/S', 'orphan_status': 'h', 'eu_aut_date': '01-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005287', 'ema_number_certainty': '1.0'}"
EU-1-18-1337,"{'atc_code': 'V04CD06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'GHRYVELIN', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1337', 'active_substance': 'macimorelin', 'eu_mah_current': 'Consilient Health Ltd', 'orphan_status': 'h', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004660', 'ema_number_certainty': '0.75'}"
EU-1-21-1624,"{'atc_code': 'J07BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'COVID-19 Vaccine (inactivated, adjuvanted) Valneva', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1624', 'active_substance': 'COVID-19 vaccine (inactivated, adjuvanted, adsorbed)', 'eu_mah_current': 'Valneva Austria GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/006019', 'ema_number_certainty': '1.0'}"
EU-1-22-1656,"{'atc_code': 'J01DH03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ertapenem SUN', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1656', 'active_substance': 'ertapenem', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005815', 'ema_number_certainty': '1.0'}"
EU-1-21-1574,"{'atc_code': 'B03XA05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Evrenzo', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1574', 'active_substance': 'roxadustat', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-18-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004871', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-21-1577,"{'atc_code': 'M05BX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Voxzogo', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1577', 'active_substance': 'vosoritide', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'h', 'eu_aut_date': '08-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005475', 'ema_number_certainty': '1.0'}"
EU-1-21-1623,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Saphnelo', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1623', 'active_substance': 'anifrolumab', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '02-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004975', 'ema_number_certainty': '1.0'}"
EU-1-22-1631,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Breyanzi', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1631', 'active_substance': 'lisocabtagene maraleucel', 'eu_mah_current': 'Bristol Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-04-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004731', 'ema_number_certainty': '1.0'}"
EU-1-22-1632,"{'atc_code': 'L03AA13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Stimufend', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1632', 'active_substance': 'pegfilgrastim', 'eu_mah_current': 'Fresenius Kabi Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-28-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004780', 'ema_number_certainty': '1.0'}"
EU-1-22-1633,"{'atc_code': 'A10BH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sitagliptin Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1633', 'active_substance': 'Sitagliptin', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '04-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005598', 'ema_number_certainty': '1.0'}"
EU-1-22-1639,"{'atc_code': 'A10AD05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Truvelog Mix 30', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1639', 'active_substance': 'insulin aspart', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '04-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005635', 'ema_number_certainty': '1.0'}"
EU-1-22-1640,"{'atc_code': 'A16AA06', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Amversio', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1640', 'active_substance': 'betaine anhydrous', 'eu_mah_current': 'SERB S.A.', 'orphan_status': 'h', 'eu_aut_date': '05-05-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005637', 'ema_number_certainty': '1.0'}"
EU-1-21-1583,"{'atc_code': 'V03AB35', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sugammadex Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1583', 'active_substance': 'sugammadex', 'eu_mah_current': 'Mylan Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '11-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005403', 'ema_number_certainty': '1.0'}"
EU-1-20-1453,"{'atc_code': 'N05AX13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'BYANNLI', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1453', 'active_substance': 'paliperidone', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '06-18-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005486', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-21-1603,"{'atc_code': 'L01XX73', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lumykras', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1603', 'active_substance': 'sotorasib', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-06-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005522', 'ema_number_certainty': '1.0'}"
EU-1-21-1621,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'OKEDI', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1621', 'active_substance': 'risperidone', 'eu_mah_current': 'Laboratorios Farmac&#233;uticos Rovi, S.A.', 'orphan_status': 'h', 'eu_aut_date': '02-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005406', 'ema_number_certainty': '1.0'}"
EU-1-22-1641,"{'atc_code': 'J07BC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'PreHevbri', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1641', 'active_substance': 'Hepatitis B vaccine (recombinant, adsorbed)', 'eu_mah_current': 'VBI Vaccines B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005466', 'ema_number_certainty': '1.0'}"
EU-1-22-1642,"{'atc_code': 'L02BX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Orgovyx', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1642', 'active_substance': 'relugolix', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '04-29-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005353', 'ema_number_certainty': '1.0'}"
EU-1-20-1507,"{'atc_code': 'J07BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Spikevax', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1507', 'active_substance': 'elasomeran', 'eu_mah_current': 'MODERNA BIOTECH SPAIN, S.L.', 'orphan_status': 'h', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005791', 'ema_number_certainty': '0.95'}"
EU-1-22-1643,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kapruvia', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1643', 'active_substance': 'difelikefalin', 'eu_mah_current': 'Vifor Fresenius Medical Care Renal Pharma France', 'orphan_status': 'h', 'eu_aut_date': '04-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005612', 'ema_number_certainty': '1.0'}"
EU-1-22-1664,"{'atc_code': 'B02BD08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Cevenfacta', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1664', 'active_substance': 'eptacog beta (activated)', 'eu_mah_current': 'Laboratoire fran&#231;ais du Fractionnement et des Biotechnologies', 'orphan_status': 'h', 'eu_aut_date': '07-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005655', 'ema_number_certainty': '1.0'}"
EU-1-21-1570,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Minjuvi', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1570', 'active_substance': 'tafasitamab', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-26-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005436', 'ema_number_certainty': '1.0'}"
EU-1-21-1571,"{'atc_code': 'L02BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Abiraterone Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1571', 'active_substance': 'abiraterone acetate', 'eu_mah_current': 'Mylan Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005368', 'ema_number_certainty': '1.0'}"
EU-1-22-1666,"{'atc_code': 'L01DB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Celdoxome pegylated liposomal', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1666', 'active_substance': 'doxorubicin hydrochloride', 'eu_mah_current': 'YES Pharmaceutical Development Services GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005330', 'ema_number_certainty': '1.0'}"
EU-1-22-1667,"{'atc_code': 'L01XC07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'VEGZELMA', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1667', 'active_substance': 'bevacizumab', 'eu_mah_current': 'Celltrion Healthcare Hungary Kft.', 'orphan_status': 'h', 'eu_aut_date': '08-17-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005534', 'ema_number_certainty': '1.0'}"
EU-1-22-1668,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Roctavian', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1668', 'active_substance': 'valoctocogene roxaparvovec', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'h', 'eu_aut_date': '08-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005830', 'ema_number_certainty': '1.0'}"
EU-1-22-1669,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pepaxti', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1669', 'active_substance': 'melphalan flufenamide', 'eu_mah_current': 'Oncopeptides AB (publ)', 'orphan_status': 'h', 'eu_aut_date': '08-17-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005681', 'ema_number_certainty': '1.0'}"
EU-1-22-1670,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Scemblix', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1670', 'active_substance': 'asciminib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005605', 'ema_number_certainty': '1.0'}"
EU-1-21-1611,"{'atc_code': 'A10BD08', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vildagliptin/Metformin hydrochloride Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1611', 'active_substance': 'vildagliptin / metformin hydrochloride', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '03-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005738', 'ema_number_certainty': '1.0'}"
EU-1-22-1652,"{'atc_code': 'D03AX13', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Filsuvez', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1652', 'active_substance': 'birch bark extract', 'eu_mah_current': 'Amryt Pharmaceuticals DAC', 'orphan_status': 'h', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005035', 'ema_number_certainty': '1.0'}"
EU-1-22-1653,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Upstaza', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1653', 'active_substance': 'eladocagene exuparvovec', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'h', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005352', 'ema_number_certainty': '1.0'}"
EU-1-07-437,"{'atc_code': 'A04AD12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'IVEMEND', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/437', 'active_substance': 'fosaprepitant', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-11-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/743', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-22-1658,"{'atc_code': 'H01CC01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ganirelix Gedeon Richter', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1658', 'active_substance': 'ganirelix', 'eu_mah_current': 'Gedeon Richter Plc.', 'orphan_status': 'h', 'eu_aut_date': '07-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005641', 'ema_number_certainty': '1.0'}"
EU-1-21-1582,"{'atc_code': 'P01BE03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Artesunate Amivas', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1582', 'active_substance': 'artesunate', 'eu_mah_current': 'Amivas Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '11-22-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005550', 'ema_number_certainty': '1.0'}"
EU-1-21-1592,"{'atc_code': 'L01FX17', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Trodelvy', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1592', 'active_substance': 'sacituzumab govitecan', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '11-22-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005182', 'ema_number_certainty': '1.0'}"
EU-1-21-1549,"{'atc_code': 'H02AB09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Efmody', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1549', 'active_substance': 'hydrocortisone', 'eu_mah_current': 'Diurnal Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-27-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005105', 'ema_number_certainty': '1.0'}"
EU-1-21-1564,"{'atc_code': 'A08AA12', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Imcivree', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1564', 'active_substance': 'setmelanotide', 'eu_mah_current': 'Rhythm Pharmaceuticals Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-16-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005089', 'ema_number_certainty': '1.0'}"
EU-1-21-1575,"{'atc_code': 'L04AC21', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bimzelx', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1575', 'active_substance': 'bimekizumab', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005316', 'ema_number_certainty': '1.0'}"
EU-1-22-1629,"{'atc_code': 'L01DB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ZOLSKETIL pegylated liposomal', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1629', 'active_substance': 'doxorubicin', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '05-31-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005320', 'ema_number_certainty': '1.0'}"
EU-1-22-1630,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'KIMMTRAK', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1630', 'active_substance': 'tebentafusp', 'eu_mah_current': 'Immunocore Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '04-01-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004929', 'ema_number_certainty': '1.0'}"
EU-1-22-1651,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EVUSHELD', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1651', 'active_substance': 'tixagevimab / cilgavimab', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '03-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005788', 'ema_number_certainty': '1.0'}"
EU-1-21-1595,"{'atc_code': 'L04AA54', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ASPAVELI', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1595', 'active_substance': 'pegcetacoplan', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'h', 'eu_aut_date': '12-13-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005553', 'ema_number_certainty': '1.0'}"
EU-1-21-1619,"{'atc_code': 'A10BD07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sitagliptin/Metformin hydrochloride Mylan', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1619', 'active_substance': 'sitagliptin/metformin hydrochloride', 'eu_mah_current': 'Mylan Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '02-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005678', 'ema_number_certainty': '1.0'}"
EU-1-21-1620,"{'atc_code': 'A16AX07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sapropterin Dipharma', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1620', 'active_substance': 'sapropterin', 'eu_mah_current': 'Dipharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005646', 'ema_number_certainty': '1.0'}"
EU-1-21-1544,"{'atc_code': 'B06AC', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Orladeyo', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1544', 'active_substance': 'berotralstat', 'eu_mah_current': 'Biocryst Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '04-30-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005138', 'ema_number_certainty': '1.0'}"
EU-1-21-1557,"{'atc_code': 'L04AX01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Jayempi', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1557', 'active_substance': 'azathioprine', 'eu_mah_current': 'Nova Laboratories Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005055', 'ema_number_certainty': '1.0'}"
EU-1-21-1558,"{'atc_code': 'D06BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Klisyri', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1558', 'active_substance': 'tirbanibulin', 'eu_mah_current': 'Almirall, S.A.', 'orphan_status': 'h', 'eu_aut_date': '07-16-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005183', 'ema_number_certainty': '1.0'}"
EU-1-21-1578,"{'atc_code': 'N04BX04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ontilyv', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1578', 'active_substance': 'opicapone', 'eu_mah_current': 'Bial - Portela &amp; C&#170;, SA', 'orphan_status': 'h', 'eu_aut_date': '02-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005782', 'ema_number_certainty': '1.0'}"
EU-1-09-568,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Clopidogrel Viatris', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/568', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Viatris Limited', 'orphan_status': 'h', 'eu_aut_date': '10-16-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1189', 'ema_number_certainty': '0.6578947368421053'}"
EU-1-09-559,"{'atc_code': 'B01AC04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Clopidogrel Taw Pharma', 'status_type': 'a', 'eu_pnumber': 'EU/1/09/559', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Taw Pharma (Ireland) Limited', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1134', 'ema_number_certainty': '0.7631578947368421'}"
EU-1-22-1646,"{'atc_code': 'N07XX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Amifampridine SERB', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1646', 'active_substance': 'amifampridine', 'eu_mah_current': 'SERB S.A.', 'orphan_status': 'h', 'eu_aut_date': '05-19-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005839', 'ema_number_certainty': '1.0'}"
EU-1-20-1525,"{'atc_code': 'J07BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'JCOVDEN', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1525', 'active_substance': 'COVID-19 vaccine (Ad26.COV2-S [recombinant])', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '03-11-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005737', 'ema_number_certainty': '1.0'}"
EU-1-21-1565,"{'atc_code': 'H01CC54', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ryeqo', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1565', 'active_substance': 'relugolix / estradiol / norethisterone acetate', 'eu_mah_current': 'Gedeon Richter Plc.', 'orphan_status': 'h', 'eu_aut_date': '07-16-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005267', 'ema_number_certainty': '1.0'}"
EU-1-21-1529,"{'atc_code': 'J07BX03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vaxzevria', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1529', 'active_substance': 'COVID-19 Vaccine (ChAdOx1-S [recombinant])', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '01-29-2021', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/005675', 'ema_number_certainty': '0.9696969696969697'}"
EU-1-22-1625,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Paxlovid', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1625', 'active_substance': '(1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide / ritonavir', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '01-28-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005973', 'ema_number_certainty': '1.0'}"
EU-1-22-1657,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kinpeygo', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1657', 'active_substance': 'budesonide', 'eu_mah_current': 'STADA Arzneimittel AG', 'orphan_status': 'h', 'eu_aut_date': '07-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005653', 'ema_number_certainty': '1.0'}"
EU-1-21-1559,"{'atc_code': 'L04AC19', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Enspryng', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1559', 'active_substance': 'satralizumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-24-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004788', 'ema_number_certainty': '1.0'}"
EU-1-21-1560,"{'atc_code': 'V09AB03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Celsunax', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1560', 'active_substance': 'ioflupane (123I)', 'eu_mah_current': 'Pinax Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-17-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005135', 'ema_number_certainty': '1.0'}"
EU-1-21-1579,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Nexviadyme', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1579', 'active_substance': 'avalglucosidase alfa', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005501', 'ema_number_certainty': '1.0'}"
EU-1-22-1628,"{'atc_code': 'H05AA02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sondelbay', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1628', 'active_substance': 'teriparatide', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '03-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005827', 'ema_number_certainty': '1.0'}"
EU-1-22-1659,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xenpozyme', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1659', 'active_substance': 'olipudase alfa', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004850', 'ema_number_certainty': '1.0'}"
EU-1-22-1660,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Zokinvy', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1660', 'active_substance': 'lonafarnib', 'eu_mah_current': 'EigerBio Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005271', 'ema_number_certainty': '1.0'}"
EU-1-22-1661,"{'atc_code': 'A10BD07', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sitagliptin/Metformin hydrochloride Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1661', 'active_substance': 'sitagliptin/metformin hydrochloride', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '07-22-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005850', 'ema_number_certainty': '1.0'}"
EU-1-18-1350,"{'atc_code': 'J01GB01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vantobra', 'status_type': 'a', 'eu_pnumber': 'EU/1/18/1350', 'active_substance': 'tobramycin', 'eu_mah_current': 'PARI Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-18-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005086', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-21-1562,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Xevudy', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1562', 'active_substance': 'sotrovimab', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'h', 'eu_aut_date': '12-17-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005676', 'ema_number_certainty': '1.0'}"
EU-1-15-1035,"{'atc_code': 'B02BD14', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'OBIZUR', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1035', 'active_substance': 'susoctocog alfa', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/002792', 'ema_number_certainty': '0.5294117647058824'}"
EU-1-21-1585,"{'atc_code': 'L04AX09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vumerity', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1585', 'active_substance': 'diroximel fumarate', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005437', 'ema_number_certainty': '1.0'}"
EU-1-21-1586,"{'atc_code': 'V03AF09', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Voraxaze', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1586', 'active_substance': 'glucarpidase', 'eu_mah_current': 'SERB SAS', 'orphan_status': 'h', 'eu_aut_date': '01-11-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005467', 'ema_number_certainty': '1.0'}"
EU-1-22-1648,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'CARVYKTI', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1648', 'active_substance': 'ciltacabtagene autoleucel', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '05-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005095', 'ema_number_certainty': '1.0'}"
EU-1-22-1650,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tabrecta', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1650', 'active_substance': 'capmatinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '06-20-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004845', 'ema_number_certainty': '1.0'}"
EU-1-21-1566,"{'atc_code': 'A05AX05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Bylvay', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1566', 'active_substance': 'odevixibat', 'eu_mah_current': 'Albireo AB', 'orphan_status': 'h', 'eu_aut_date': '07-16-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004691', 'ema_number_certainty': '1.0'}"
EU-1-22-1649,"{'atc_code': 'L01XC', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lunsumio', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1649', 'active_substance': 'mosunetuzumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-03-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005680', 'ema_number_certainty': '1.0'}"
EU-1-21-1567,"{'atc_code': 'B06AC02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Icatibant Accord', 'status_type': 'a', 'eu_pnumber': 'EU/1/21/1567', 'active_substance': 'icatibant', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '07-16-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005083', 'ema_number_certainty': '1.0'}"
EU-1-22-1647,"{'atc_code': 'L02AE02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Camcevi', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1647', 'active_substance': 'leuprorelin', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '05-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005034', 'ema_number_certainty': '1.0'}"
EU-1-20-1506,"{'atc_code': 'A10AB05', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Kirsty', 'status_type': 'a', 'eu_pnumber': 'EU/1/20/1506', 'active_substance': 'Insulin aspart', 'eu_mah_current': 'Mylan IRE Healthcare Limited', 'orphan_status': 'h', 'eu_aut_date': '02-05-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004965', 'ema_number_certainty': '1.0'}"
EU-1-22-1684,"{'atc_code': 'A16AX', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'NULIBRY', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1684', 'active_substance': 'fosdenopterin', 'eu_mah_current': 'Comharsa Life Sciences Limited', 'orphan_status': 'h', 'eu_aut_date': '09-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005378', 'ema_number_certainty': '1.0'}"
EU-1-22-1677,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tezspire', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1677', 'active_substance': 'tezepelumab', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '09-19-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005588', 'ema_number_certainty': '1.0'}"
EU-1-22-1678,"{'atc_code': 'L04AD03', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Lupkynis', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1678', 'active_substance': 'voclosporin', 'eu_mah_current': 'Otsuka Pharmaceutical Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005256', 'ema_number_certainty': '1.0'}"
EU-1-22-1679,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Opdualag', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1679', 'active_substance': 'nivolumab/relatlimab', 'eu_mah_current': 'Bristol Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '09-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005481', 'ema_number_certainty': '1.0'}"
EU-1-22-1681,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Amvuttra', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1681', 'active_substance': 'vutrisiran', 'eu_mah_current': 'Alnylam Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005852', 'ema_number_certainty': '1.0'}"
EU-1-22-1683,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vabysmo', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1683', 'active_substance': 'Faricimab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005642', 'ema_number_certainty': '1.0'}"
EU-1-22-1676,"{'atc_code': 'L04AX02', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Thalidomide Lipomed', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1676', 'active_substance': 'Thalidomide', 'eu_mah_current': 'Lipomed GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-19-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005715', 'ema_number_certainty': '1.0'}"
EU-1-15-1057,"{'atc_code': 'L01BA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pemetrexed Pfizer', 'status_type': 'a', 'eu_pnumber': 'EU/1/15/1057', 'active_substance': 'pemetrexed', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '11-20-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3970', 'ema_number_certainty': '0.5882352941176471'}"
EU-1-22-1685,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Mounjaro', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1685', 'active_substance': 'tirzepatide', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005620', 'ema_number_certainty': '1.0'}"
EU-1-22-1655,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Pirfenidone axunio', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1655', 'active_substance': 'pirfenidone', 'eu_mah_current': 'axunio Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-20-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005873', 'ema_number_certainty': '1.0'}"
EU-1-22-1671,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Sunlenca', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1671', 'active_substance': 'lenacapavir', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '08-17-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005638', 'ema_number_certainty': '1.0'}"
EU-1-22-1675,"{'atc_code': 'L01F', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'TECVAYLI', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1675', 'active_substance': 'teclistamab', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '08-23-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005865', 'ema_number_certainty': '1.0'}"
EU-1-22-1680,"{'atc_code': 'V10X', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'ilLuzyce', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1680', 'active_substance': 'lutetium (177Lu) chloride', 'eu_mah_current': 'Billev Pharma ApS', 'orphan_status': 'h', 'eu_aut_date': '09-15-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005859', 'ema_number_certainty': '1.0'}"
EU-1-07-435,"{'atc_code': 'A10BH01', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Tesavel', 'status_type': 'a', 'eu_pnumber': 'EU/1/07/435', 'active_substance': 'sitagliptin', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-10-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/910', 'ema_number_certainty': '0.926829268292683'}"
EU-1-22-1674,"{'atc_code': '', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Vyvgart', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1674', 'active_substance': 'efgartigimod alfa', 'eu_mah_current': 'argenx BV', 'orphan_status': 'h', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005849', 'ema_number_certainty': '1.0'}"
EU-1-22-1673,"{'atc_code': 'S01LA04', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'Ranivisio', 'status_type': 'a', 'eu_pnumber': 'EU/1/22/1673', 'active_substance': 'ranibizumab', 'eu_mah_current': 'Midas Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-25-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005019', 'ema_number_certainty': '1.0'}"
EU-1-04-283,"{'atc_code': 'N06AX21', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ariclaim', 'status_type': 'w', 'eu_pnumber': 'EU/1/04/283', 'active_substance': 'duloxetine hydrochloride', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-11-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/552', 'ema_number_certainty': '0.9821428571428571'}"
EU-1-04-287,"{'atc_code': 'M05BX03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Osseor', 'status_type': 'w', 'eu_pnumber': 'EU/1/04/287', 'active_substance': 'Strontium ranelate', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'h', 'eu_aut_date': '09-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/561', 'ema_number_certainty': '0.95'}"
EU-1-04-289,"{'atc_code': 'B01AE06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Angiox', 'status_type': 'w', 'eu_pnumber': 'EU/1/04/289', 'active_substance': 'Bivalirudin', 'eu_mah_current': 'The Medicines Company UK Ltd', 'orphan_status': 'h', 'eu_aut_date': '09-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/562', 'ema_number_certainty': '1.0'}"
EU-1-04-291,"{'atc_code': 'L04AA21', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Raptiva', 'status_type': 'w', 'eu_pnumber': 'EU/1/04/291', 'active_substance': 'Efalizumab', 'eu_mah_current': 'Serono Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '09-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/542', 'ema_number_certainty': '1.0'}"
EU-1-04-293,"{'atc_code': 'H05BX01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Parareg', 'status_type': 'w', 'eu_pnumber': 'EU/1/04/293', 'active_substance': 'Cinacalcet', 'eu_mah_current': 'Domp&#233; Biotec S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '10-22-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/575', 'ema_number_certainty': '1.0'}"
EU-1-04-288,"{'atc_code': 'M05BX03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Protelos', 'status_type': 'w', 'eu_pnumber': 'EU/1/04/288', 'active_substance': 'Strontium ranelate', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'h', 'eu_aut_date': '09-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/560', 'ema_number_certainty': '0.9555555555555556'}"
EU-1-04-301,"{'atc_code': 'J07CA10', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Quintanrix', 'status_type': 'w', 'eu_pnumber': 'EU/1/04/301', 'active_substance': 'Diphtheria, tetanus, pertussis (whole cell), hepatitis B (rDNA) and Haemophilus type b conjugate vaccine (adsorbed)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '02-17-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/556', 'ema_number_certainty': '1.0'}"
EU-1-05-313,"{'atc_code': 'V08CA11', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ablavar', 'status_type': 'w', 'eu_pnumber': 'EU/1/05/313', 'active_substance': 'Gadofosveset Trisodium', 'eu_mah_current': 'TMC Pharma Services Ltd', 'orphan_status': 'h', 'eu_aut_date': '10-03-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/601', 'ema_number_certainty': '1.0'}"
EU-1-05-314,"{'atc_code': 'V03AF08', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Kepivance', 'status_type': 'w', 'eu_pnumber': 'EU/1/05/314', 'active_substance': 'Palifermin', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'h', 'eu_aut_date': '10-25-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/609', 'ema_number_certainty': '1.0'}"
EU-1-05-321,"{'atc_code': 'J02AC04', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Posaconazole SP', 'status_type': 'w', 'eu_pnumber': 'EU/1/05/321', 'active_substance': 'Posaconazole', 'eu_mah_current': 'SP Europe', 'orphan_status': 'h', 'eu_aut_date': '10-25-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/611', 'ema_number_certainty': '1.0'}"
EU-1-05-326,"{'atc_code': 'N02AB03', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Ionsys', 'status_type': 'w', 'eu_pnumber': 'EU/1/05/326', 'active_substance': 'Fentanyl', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '01-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/612', 'ema_number_certainty': '1.0'}"
EU-1-05-327,"{'atc_code': 'A10AF01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Exubera', 'status_type': 'w', 'eu_pnumber': 'EU/1/05/327', 'active_substance': 'Insulin human', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'h', 'eu_aut_date': '01-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/588', 'ema_number_certainty': '1.0'}"
EU-1-06-335,"{'atc_code': 'H01AC01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Valtropin', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/335', 'active_substance': 'Somatropin', 'eu_mah_current': 'BioPartners GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/602', 'ema_number_certainty': '1.0'}"
EU-1-06-339,"{'atc_code': 'H05AA03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Preotact', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/339', 'active_substance': 'Parathyroid hormone', 'eu_mah_current': 'NPS Pharma Holdings Limited', 'orphan_status': 'h', 'eu_aut_date': '04-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/659', 'ema_number_certainty': '1.0'}"
EU-1-06-355,"{'atc_code': 'B01AB02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'ATryn', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/355', 'active_substance': 'antithrombin alfa', 'eu_mah_current': 'Laboratoire fran&#231;ais du Fractionnement et des Biotechnologies', 'orphan_status': 'h', 'eu_aut_date': '07-28-2006', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/587', 'ema_number_certainty': '1.0'}"
EU-1-06-349,"{'atc_code': 'A10BD04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Avaglim', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/349', 'active_substance': 'Rosiglitazone / glimepiride', 'eu_mah_current': 'SmithKline Beecham Ltd', 'orphan_status': 'h', 'eu_aut_date': '06-27-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/675', 'ema_number_certainty': '1.0'}"
EU-1-06-344,"{'atc_code': 'A08AX01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'ACOMPLIA', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/344', 'active_substance': 'Rimonabant', 'eu_mah_current': 'Sanofi-Aventis', 'orphan_status': 'h', 'eu_aut_date': '06-19-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/666', 'ema_number_certainty': '1.0'}"
EU-1-06-345,"{'atc_code': 'A08AX01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zimulti', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/345', 'active_substance': 'Rimonabant', 'eu_mah_current': 'Sanofi-Aventis', 'orphan_status': 'h', 'eu_aut_date': '06-19-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/691', 'ema_number_certainty': '1.0'}"
EU-1-06-353,"{'atc_code': 'C02KX03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Thelin', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/353', 'active_substance': 'Sitaxentan sodium', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'h', 'eu_aut_date': '08-10-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/679', 'ema_number_certainty': '1.0'}"
EU-1-06-352,"{'atc_code': 'G03BA03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Intrinsa', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/352', 'active_substance': 'testosterone', 'eu_mah_current': 'Warner Chilcott UK Ltd', 'orphan_status': 'h', 'eu_aut_date': '07-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/634', 'ema_number_certainty': '1.0'}"
EU-1-06-351,"{'atc_code': 'G03BA03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Livensa', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/351', 'active_substance': 'testosterone', 'eu_mah_current': 'Warner Chilcott Deutschland Gmbh', 'orphan_status': 'h', 'eu_aut_date': '07-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/630', 'ema_number_certainty': '1.0'}"
EU-1-06-358,"{'atc_code': 'J07BM01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Silgard', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/358', 'active_substance': 'Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'h', 'eu_aut_date': '09-20-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/732', 'ema_number_certainty': '0.9787234042553191'}"
EU-1-06-368,"{'atc_code': 'A10AB01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Insulin Human Winthrop', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/368', 'active_substance': 'Insulin human', 'eu_mah_current': 'Sanofi-Aventis Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '01-17-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/761', 'ema_number_certainty': '0.9672131147540983'}"
EU-1-06-369,"{'atc_code': 'C09DA04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Irbesartan HCT BMS', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/369', 'active_substance': 'irbesartan / hydrochlorothiazide', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '01-19-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/784', 'ema_number_certainty': '1.0'}"
EU-1-06-375,"{'atc_code': 'C09CA04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Irbesartan BMS', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/375', 'active_substance': 'Irbesartan', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '01-19-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/786', 'ema_number_certainty': '1.0'}"
EU-1-06-373,"{'atc_code': 'C09DB01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Imprida', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/373', 'active_substance': 'amlodipine / valsartan', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '01-17-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/775', 'ema_number_certainty': '1.0'}"
EU-1-06-381,"{'atc_code': 'J07BB01', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Daronrix', 'status_type': 'w', 'eu_pnumber': 'EU/1/06/381', 'active_substance': 'A/Viet Nam/1194/2004 (H5N1) whole virus inactivated antigen', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '03-21-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/706', 'ema_number_certainty': '1.0'}"
EU-1-07-385,"{'atc_code': 'J07BB02', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Focetria', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/385', 'active_substance': 'Pandemic influenza vaccine (H1N1) (surface antigen, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-181)', 'eu_mah_current': 'Novartis Vaccines and Diagnostics S.r.l.', 'orphan_status': 'h', 'eu_aut_date': '05-02-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/710', 'ema_number_certainty': '1.0'}"
EU-1-07-388,"{'atc_code': 'J05AF11', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Sebivo', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/388', 'active_substance': 'telbivudine', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '04-24-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/713', 'ema_number_certainty': '0.967741935483871'}"
EU-1-07-390,"{'atc_code': 'D06AX13', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Altargo', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/390', 'active_substance': 'retapamulin', 'eu_mah_current': 'Glaxo Group Ltd', 'orphan_status': 'h', 'eu_aut_date': '05-24-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/757', 'ema_number_certainty': '1.0'}"
EU-1-07-394,"{'atc_code': 'J07BB02', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Optaflu', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/394', 'active_substance': 'Influenza vaccine (surface antigen, inactivated, prepared in cell culture)', 'eu_mah_current': 'Seqirus GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-01-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/758', 'ema_number_certainty': '0.9761904761904762'}"
EU-1-07-398,"{'atc_code': 'V08CA06', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Optimark', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/398', 'active_substance': 'Gadoversetamide', 'eu_mah_current': 'Guerbet', 'orphan_status': 'h', 'eu_aut_date': '07-23-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/745', 'ema_number_certainty': '0.9545454545454546'}"
EU-1-07-407,"{'atc_code': 'C09XA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Sprimeo', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/407', 'active_substance': 'aliskiren', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/851', 'ema_number_certainty': '1.0'}"
EU-1-07-409,"{'atc_code': 'C09XA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Riprazo', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/409', 'active_substance': 'aliskiren', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/853', 'ema_number_certainty': '1.0'}"
EU-1-07-406,"{'atc_code': 'C09XA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Enviage', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/406', 'active_substance': 'aliskiren', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/850', 'ema_number_certainty': '1.0'}"
EU-1-07-408,"{'atc_code': 'C09XA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Tekturna', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/408', 'active_substance': 'aliskiren', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '08-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/852', 'ema_number_certainty': '1.0'}"
EU-1-07-426,"{'atc_code': 'N05AH03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Olanzapine Cipla', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/426', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Cipla (EU) Limited', 'orphan_status': 'h', 'eu_aut_date': '11-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/793', 'ema_number_certainty': '1.0'}"
EU-1-07-421,"{'atc_code': 'A10BD05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Glubrava', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/421', 'active_substance': 'Pioglitazone / metformin hydrochloride', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '12-11-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/893', 'ema_number_certainty': '0.9230769230769231'}"
EU-1-07-430,"{'atc_code': 'J05AR06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Atripla', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/430', 'active_substance': 'efavirenz / emtricitabine / tenofovir disoproxil fumarate', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'h', 'eu_aut_date': '12-13-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/797', 'ema_number_certainty': '0.9176470588235294'}"
EU-1-96-014,"{'atc_code': 'J07CA05', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Tritanrix HepB', 'status_type': 'w', 'eu_pnumber': 'EU/1/96/014', 'active_substance': 'DTPW-Hepatitis B', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '07-19-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/93', 'ema_number_certainty': '1.0'}"
EU-1-96-025,"{'atc_code': 'V09IB03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Indimacis 125', 'status_type': 'w', 'eu_pnumber': 'EU/1/96/025', 'active_substance': 'Igovomab', 'eu_mah_current': 'CIS bio international', 'orphan_status': 'h', 'eu_aut_date': '10-04-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/65', 'ema_number_certainty': '1.0'}"
EU-1-96-023,"{'atc_code': 'V09IA01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'CEA-Scan', 'status_type': 'w', 'eu_pnumber': 'EU/1/96/023', 'active_substance': 'Arcitumomab', 'eu_mah_current': 'Immunomedics GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-04-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/41', 'ema_number_certainty': '1.0'}"
EU-1-97-041,"{'atc_code': 'N07BC03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Orlaam', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/041', 'active_substance': 'Levacetylmethadol', 'eu_mah_current': 'Sipaco Internacional Lda', 'orphan_status': 'h', 'eu_aut_date': '07-01-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/77', 'ema_number_certainty': '1.0'}"
EU-1-96-019,"{'atc_code': 'V09IA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Tecnemab-K-1', 'status_type': 'w', 'eu_pnumber': 'EU/1/96/019', 'active_substance': 'Anti-melanoma Mab fragments', 'eu_mah_current': 'Sorin Radiofarmaci S.r.l.', 'orphan_status': 'h', 'eu_aut_date': '09-05-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/68', 'ema_number_certainty': '1.0'}"
EU-1-96-013,"{'atc_code': 'M05BA06', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Destara', 'status_type': 'w', 'eu_pnumber': 'EU/1/96/013', 'active_substance': 'Ibandronic acid', 'eu_mah_current': 'Roche Registration Limited', 'orphan_status': 'h', 'eu_aut_date': '06-25-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/103', 'ema_number_certainty': '1.0'}"
EU-1-97-043,"{'atc_code': 'B01AE01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Revasc', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/043', 'active_substance': 'Desirudin', 'eu_mah_current': 'Canyon Pharmaceuticals Ltd', 'orphan_status': 'h', 'eu_aut_date': '07-09-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/104', 'ema_number_certainty': '1.0'}"
EU-1-96-017,"{'atc_code': 'B01AD07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ecokinase', 'status_type': 'w', 'eu_pnumber': 'EU/1/96/017', 'active_substance': 'Reteplase', 'eu_mah_current': 'Galenus Mannheim GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-29-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/106', 'ema_number_certainty': '1.0'}"
EU-1-96-009,"{'atc_code': 'J05AF04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zerit', 'status_type': 'w', 'eu_pnumber': 'EU/1/96/009', 'active_substance': 'Stavudine', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '05-08-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/110', 'ema_number_certainty': '0.9879518072289156'}"
EU-1-97-032,"{'atc_code': 'V09HA04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'LeukoScan', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/032', 'active_substance': 'Sulesomab', 'eu_mah_current': 'Immunomedics GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-14-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/111', 'ema_number_certainty': '1.0'}"
EU-1-96-021,"{'atc_code': 'N05AH03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Olansek', 'status_type': 'w', 'eu_pnumber': 'EU/1/96/021', 'active_substance': 'Olanzapine', 'eu_mah_current': 'Eli Lilly UK Ltd', 'orphan_status': 'h', 'eu_aut_date': '10-07-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/114', 'ema_number_certainty': '1.0'}"
EU-1-97-034,"{'atc_code': 'J05AB06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Vitrasert implant', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/034', 'active_substance': 'ganciclovir', 'eu_mah_current': 'Dr Gerhard Mann Chem.-pharm. Fabrik GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-18-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/120', 'ema_number_certainty': '1.0'}"
EU-1-97-037,"{'atc_code': 'J05AB12', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Vistide', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/037', 'active_substance': 'Cidofovir', 'eu_mah_current': 'Gilead Sciences International Limited', 'orphan_status': 'h', 'eu_aut_date': '04-23-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/121', 'ema_number_certainty': '1.0'}"
EU-1-97-035,"{'atc_code': 'B01AE02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Refludan', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/035', 'active_substance': 'Lepirudin', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '03-13-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/122', 'ema_number_certainty': '1.0'}"
EU-1-96-028,"{'atc_code': 'L01XX17', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Evotopin', 'status_type': 'w', 'eu_pnumber': 'EU/1/96/028', 'active_substance': 'Topotecan hydrochloride', 'eu_mah_current': 'SmithKline Beecham plc', 'orphan_status': 'h', 'eu_aut_date': '12-09-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/124', 'ema_number_certainty': '1.0'}"
EU-1-97-048,"{'atc_code': 'J07CA05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Infanrix HepB', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/048', 'active_substance': 'Diphteria, tetanus, acellular pertussis and hepatitis B', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '07-30-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/126', 'ema_number_certainty': '1.0'}"
EU-1-96-024,"{'atc_code': 'J05AE02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Crixivan', 'status_type': 'w', 'eu_pnumber': 'EU/1/96/024', 'active_substance': 'Indinavir', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-04-1996', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/128', 'ema_number_certainty': '0.9886363636363636'}"
EU-1-97-038,"{'atc_code': 'A10AB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Liprolog', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/038', 'active_substance': 'Insulin lispro', 'eu_mah_current': 'Eli Lilly UK Ltd', 'orphan_status': 'h', 'eu_aut_date': '05-07-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/143', 'ema_number_certainty': '1.0'}"
EU-1-97-040,"{'atc_code': 'V08CA05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Teslascan', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/040', 'active_substance': 'Mangafodipir', 'eu_mah_current': 'GE Healthcare AS', 'orphan_status': 'h', 'eu_aut_date': '05-22-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/137', 'ema_number_certainty': '1.0'}"
EU-1-97-042,"{'atc_code': 'A10AB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Humalog-Pen', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/042', 'active_substance': 'Insulin lispro', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-16-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/153', 'ema_number_certainty': '1.0'}"
EU-1-97-052,"{'atc_code': 'N04BC05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Daquiran', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/052', 'active_substance': 'pramipexole', 'eu_mah_current': 'Dr Karl Thomae GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-27-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/135', 'ema_number_certainty': '1.0'}"
EU-1-97-036,"{'atc_code': 'A10AB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Humalog-Humaject', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/036', 'active_substance': 'Insulin lispro', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-16-1997', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/138', 'ema_number_certainty': '1.0'}"
EU-1-97-054,"{'atc_code': 'J05AE04', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Viracept', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/054', 'active_substance': 'Nelfinavir', 'eu_mah_current': 'Roche Registration Limited', 'orphan_status': 'h', 'eu_aut_date': '01-22-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/164', 'ema_number_certainty': '1.0'}"
EU-1-97-056,"{'atc_code': 'J07CA07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Primavax', 'status_type': 'w', 'eu_pnumber': 'EU/1/97/056', 'active_substance': 'diphteria, tetanus and hepatitis B (recombinant) vaccine, adsorbed', 'eu_mah_current': 'Aventis Pasteur MSD', 'orphan_status': 'h', 'eu_aut_date': '02-05-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/156', 'ema_number_certainty': '1.0'}"
EU-1-98-059,"{'atc_code': 'J01MA13', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Trovan', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/059', 'active_substance': 'trovafloxacin', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'h', 'eu_aut_date': '07-03-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/160', 'ema_number_certainty': '1.0'}"
EU-1-98-060,"{'atc_code': 'J01MA13', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Trovan IV', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/060', 'active_substance': 'alatrofloxacin', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'h', 'eu_aut_date': '07-03-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/161', 'ema_number_certainty': '1.0'}"
EU-1-98-061,"{'atc_code': 'J01MA13', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Turvel', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/061', 'active_substance': 'trovafloxacin', 'eu_mah_current': 'Roerig Farmaceutici Italiana S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '07-08-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/158', 'ema_number_certainty': '1.0'}"
EU-1-98-062,"{'atc_code': 'J01MA', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Turvel IV', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/062', 'active_substance': 'alatrofloxacin', 'eu_mah_current': 'Roerig Farmaceutici Italiana S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '07-03-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/159', 'ema_number_certainty': '1.0'}"
EU-1-98-068,"{'atc_code': 'V04CX', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Pylori-Chek', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/068', 'active_substance': '&#185;&#179;C-urea', 'eu_mah_current': 'Alimentarics B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-15-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/182', 'ema_number_certainty': '1.0'}"
EU-1-98-075,"{'atc_code': 'J05AE01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Fortovase', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/075', 'active_substance': 'Saquinavir', 'eu_mah_current': 'Roche Registration Limited', 'orphan_status': 'h', 'eu_aut_date': '08-20-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/178', 'ema_number_certainty': '1.0'}"
EU-1-98-072,"{'atc_code': 'V08DA', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EchoGen', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/072', 'active_substance': 'Dodecafluoropentane', 'eu_mah_current': 'Sonus Pharmaceuticals Ltd', 'orphan_status': 'h', 'eu_aut_date': '07-17-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/149', 'ema_number_certainty': '1.0'}"
EU-1-98-078,"{'atc_code': 'G04BE03', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Patrex', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/078', 'active_substance': 'sildenafil', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'h', 'eu_aut_date': '09-15-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/204', 'ema_number_certainty': '1.0'}"
EU-1-98-079,"{'atc_code': 'D06BB10', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zartra', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/079', 'active_substance': 'Imiquimod', 'eu_mah_current': 'Laboratoires 3M Sant&#233;', 'orphan_status': 'h', 'eu_aut_date': '09-18-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/180', 'ema_number_certainty': '1.0'}"
EU-1-98-083,"{'atc_code': 'V09IA01', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'HumaSPECT', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/083', 'active_substance': 'votumumab', 'eu_mah_current': 'KS Biomedix Llmited', 'orphan_status': 'h', 'eu_aut_date': '09-25-1998', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/145', 'ema_number_certainty': '1.0'}"
EU-1-98-087,"{'atc_code': 'L03AB09', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Infergen', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/087', 'active_substance': 'Interferon alfacon-1', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-01-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/186', 'ema_number_certainty': '1.0'}"
EU-1-98-093,"{'atc_code': 'H05BA01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Forcaltonin', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/093', 'active_substance': 'Calcitonin (salmon)', 'eu_mah_current': 'Unigene UK Limited', 'orphan_status': 'h', 'eu_aut_date': '01-11-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/197', 'ema_number_certainty': '1.0'}"
EU-1-98-088,"{'atc_code': 'J07CA01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Triacelluvax', 'status_type': 'w', 'eu_pnumber': 'EU/1/98/088', 'active_substance': 'combined diphtheria, tetanus, and acellular pertussis vaccine', 'eu_mah_current': 'Chiron spa', 'orphan_status': 'h', 'eu_aut_date': '01-11-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/181', 'ema_number_certainty': '1.0'}"
EU-1-99-098,"{'atc_code': 'L04AC01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zenapax', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/098', 'active_substance': 'daclizumab', 'eu_mah_current': 'Roche Registration Limited', 'orphan_status': 'h', 'eu_aut_date': '02-26-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/198', 'ema_number_certainty': '1.0'}"
EU-1-99-102,"{'atc_code': 'N05CF03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Sonata', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/102', 'active_substance': 'Zaleplon', 'eu_mah_current': 'Meda AB', 'orphan_status': 'h', 'eu_aut_date': '03-12-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/227', 'ema_number_certainty': '0.9310344827586207'}"
EU-1-99-099,"{'atc_code': 'N05CF03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zerene', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/099', 'active_substance': 'Zaleplon', 'eu_mah_current': 'Meda AB', 'orphan_status': 'h', 'eu_aut_date': '03-12-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/228', 'ema_number_certainty': '1.0'}"
EU-1-99-101,"{'atc_code': 'D03AX06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Regranex', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/101', 'active_substance': 'becaplermin', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '03-29-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/212', 'ema_number_certainty': '1.0'}"
EU-1-99-104,"{'atc_code': 'J07CA08', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Procomvax', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/104', 'active_substance': 'Haemophilus b conjugate (Meningococcal Protein conjugate) and Hepatitis B vaccine', 'eu_mah_current': 'Sanofi Pasteur MSD, SNC', 'orphan_status': 'h', 'eu_aut_date': '05-07-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/231', 'ema_number_certainty': '1.0'}"
EU-1-99-105,"{'atc_code': 'J07BH01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'RotaShield', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/105', 'active_substance': 'Rotavirus vaccine', 'eu_mah_current': 'Wyeth-Lederle Vaccines S.A.', 'orphan_status': 'h', 'eu_aut_date': '05-07-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/192', 'ema_number_certainty': '1.0'}"
EU-1-99-106,"{'atc_code': 'J05AB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Cotronak', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/106', 'active_substance': 'ribavirin', 'eu_mah_current': 'Schering-Plough Europe', 'orphan_status': 'h', 'eu_aut_date': '05-07-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/247', 'ema_number_certainty': '0.9230769230769231'}"
EU-1-99-115,"{'atc_code': 'S01AD08', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Vitravene', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/115', 'active_substance': 'Fomivirsen', 'eu_mah_current': 'Novartis Ophtalmics Europe Ltd', 'orphan_status': 'h', 'eu_aut_date': '07-29-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/244', 'ema_number_certainty': '1.0'}"
EU-1-99-113,"{'atc_code': 'L01CD01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Paxene', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/113', 'active_substance': 'paclitaxel', 'eu_mah_current': 'Norton Healthcare Limited', 'orphan_status': 'h', 'eu_aut_date': '07-19-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/216', 'ema_number_certainty': '1.0'}"
EU-1-99-121,"{'atc_code': 'C01BD04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Tikosyn', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/121', 'active_substance': 'Dofetilide', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'h', 'eu_aut_date': '11-29-1999', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/238', 'ema_number_certainty': '1.0'}"
EU-1-99-127,"{'atc_code': 'L03AB05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'IntronA', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/127', 'active_substance': 'Interferon alfa-2b', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-09-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/281', 'ema_number_certainty': '0.9611650485436893'}"
EU-1-99-128,"{'atc_code': 'L03AB05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Viraferon', 'status_type': 'w', 'eu_pnumber': 'EU/1/99/128', 'active_substance': 'Interferon alfa-2b', 'eu_mah_current': 'Schering-Plough Europe', 'orphan_status': 'h', 'eu_aut_date': '03-09-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/282', 'ema_number_certainty': '1.0'}"
EU-1-00-131,"{'atc_code': 'L03AB10', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'PegIntron', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/131', 'active_substance': 'Peginterferon alfa-2b', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-25-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/280', 'ema_number_certainty': '1.0'}"
EU-1-00-132,"{'atc_code': 'L03AB10', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'ViraferonPeg', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/132', 'active_substance': 'Peginterferon alfa-2b', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-29-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/329', 'ema_number_certainty': '1.0'}"
EU-1-00-137,"{'atc_code': 'A10BG02', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Avandia', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/137', 'active_substance': 'Rosiglitazone', 'eu_mah_current': 'SmithKline Beecham Ltd', 'orphan_status': 'h', 'eu_aut_date': '07-11-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/268', 'ema_number_certainty': '0.9846153846153847'}"
EU-1-00-138,"{'atc_code': 'A10BG02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'VENVIA', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/138', 'active_substance': 'Rosiglitazone', 'eu_mah_current': 'SmithKline Beecham plc', 'orphan_status': 'h', 'eu_aut_date': '07-11-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/269', 'ema_number_certainty': '1.0'}"
EU-1-00-139,"{'atc_code': 'A10BG02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Nyracta', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/139', 'active_substance': 'Rosiglitazone', 'eu_mah_current': 'SmithKline Beecham plc', 'orphan_status': 'h', 'eu_aut_date': '07-11-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/270', 'ema_number_certainty': '1.0'}"
EU-1-00-136,"{'atc_code': 'J07BC01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Hepacare', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/136', 'active_substance': 'Triple antigen hepatitis B vaccine (recombinant)', 'eu_mah_current': 'Medeva Pharma Limited', 'orphan_status': 'h', 'eu_aut_date': '08-04-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/261', 'ema_number_certainty': '1.0'}"
EU-1-00-144,"{'atc_code': 'B02BD02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Helixate NexGen', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/144', 'active_substance': 'Recombinant coagulation factor VIII (octocog alfa)', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '08-04-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/276', 'ema_number_certainty': '0.9829059829059829'}"
EU-1-00-153,"{'atc_code': 'J07CA12', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Infanrix penta', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/153', 'active_substance': 'Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis vaccine', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '10-23-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/295', 'ema_number_certainty': '1.0'}"
EU-1-00-151,"{'atc_code': 'A10BG03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Glustin', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/151', 'active_substance': 'pioglitazone', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '10-10-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/286', 'ema_number_certainty': '0.98'}"
EU-1-00-147,"{'atc_code': 'J07CA09', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Hexavac', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/147', 'active_substance': 'diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted', 'eu_mah_current': 'Aventis Pasteur MSD', 'orphan_status': 'h', 'eu_aut_date': '10-23-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/298', 'ema_number_certainty': '1.0'}"
EU-1-00-148,"{'atc_code': 'J05AE05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Agenerase', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/148', 'active_substance': 'amprenavir', 'eu_mah_current': 'Glaxo Group Limited', 'orphan_status': 'h', 'eu_aut_date': '10-20-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/264', 'ema_number_certainty': '1.0'}"
EU-1-00-154,"{'atc_code': 'V09IA05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'NeoSpect', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/154', 'active_substance': 'Depreotide', 'eu_mah_current': 'CIS bio international', 'orphan_status': 'h', 'eu_aut_date': '11-29-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/263', 'ema_number_certainty': '1.0'}"
EU-1-00-158,"{'atc_code': 'R06AX27', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Opulis', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/158', 'active_substance': 'desloratadine', 'eu_mah_current': 'Schering-Plough Europe', 'orphan_status': 'h', 'eu_aut_date': '01-15-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/311', 'ema_number_certainty': '1.0'}"
EU-1-00-159,"{'atc_code': 'R06AX27', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Allex', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/159', 'active_substance': 'desloratadine', 'eu_mah_current': 'Schering-Plough Europe', 'orphan_status': 'h', 'eu_aut_date': '01-15-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/312', 'ema_number_certainty': '1.0'}"
EU-1-00-167,"{'atc_code': 'J07AL02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Prevenar', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/167', 'active_substance': 'pneumoccocal saccharide conjugated vaccine, adsorbed', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'h', 'eu_aut_date': '02-02-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/323', 'ema_number_certainty': '1.0'}"
EU-1-00-168,"{'atc_code': 'B01AD11', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Tenecteplase Boehringer Ingelheim Pharma GmbH &amp; Co. KG', 'status_type': 'w', 'eu_pnumber': 'EU/1/00/168', 'active_substance': 'tenecteplase', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-23-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/307', 'ema_number_certainty': '1.0'}"
EU-1-01-174,"{'atc_code': 'A10BX03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Starlix', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/174', 'active_substance': 'nateglinide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '04-03-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/335', 'ema_number_certainty': '0.9642857142857143'}"
EU-1-01-175,"{'atc_code': 'A10BX03', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Trazec', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/175', 'active_substance': 'nateglinide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '04-03-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/383', 'ema_number_certainty': '1.0'}"
EU-1-01-179,"{'atc_code': 'M05BC02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Osigraft', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/179', 'active_substance': 'eptotermin alfa', 'eu_mah_current': 'Olympus Biotech International Limited', 'orphan_status': 'h', 'eu_aut_date': '05-17-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/293', 'ema_number_certainty': '1.0'}"
EU-1-01-180,"{'atc_code': 'G04BE07', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Uprima', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/180', 'active_substance': 'apomorphine hydrochloride', 'eu_mah_current': 'Abbott Laboratories Ltd', 'orphan_status': 'h', 'eu_aut_date': '05-28-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/327', 'ema_number_certainty': '1.0'}"
EU-1-01-181,"{'atc_code': 'G04BE07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ixense', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/181', 'active_substance': 'apomorphine hydrochloride', 'eu_mah_current': 'Takeda Europe R&amp;D Centre Ltd', 'orphan_status': 'h', 'eu_aut_date': '05-28-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/328', 'ema_number_certainty': '1.0'}"
EU-1-01-182,"{'atc_code': 'G04BE07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Taluvian', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/182', 'active_substance': 'apomorphine hydrochloride', 'eu_mah_current': 'Abbott SpA', 'orphan_status': 'h', 'eu_aut_date': '05-28-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/386', 'ema_number_certainty': '1.0'}"
EU-1-01-184,"{'atc_code': 'B03XA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Nespo', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/184', 'active_substance': 'darbepoetin alfa', 'eu_mah_current': 'Domp&#233; Biotec S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '06-08-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/333', 'ema_number_certainty': '1.0'}"
EU-1-01-186,"{'atc_code': 'B02BD04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Nonafact', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/186', 'active_substance': 'Human coagulation factor IX', 'eu_mah_current': 'Sanquin Plasma Products B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-03-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/348', 'ema_number_certainty': '1.0'}"
EU-1-01-187,"{'atc_code': 'L01BC01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'DepoCyte', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/187', 'active_substance': 'Cytarabine', 'eu_mah_current': 'Pacira Limited', 'orphan_status': 'h', 'eu_aut_date': '07-11-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/317', 'ema_number_certainty': '1.0'}"
EU-1-01-191,"{'atc_code': 'J01FA15', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ketek', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/191', 'active_substance': 'telithromycin', 'eu_mah_current': 'Aventis Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '07-09-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/354', 'ema_number_certainty': '1.0'}"
EU-1-01-193,"{'atc_code': 'L01XC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'MabCampath', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/193', 'active_substance': 'Alemtuzumab', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-06-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/353', 'ema_number_certainty': '1.0'}"
EU-1-01-192,"{'atc_code': 'J01FA15', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Levviax', 'status_type': 'w', 'eu_pnumber': 'EU/1/01/192', 'active_substance': 'telithromycin', 'eu_mah_current': 'Aventis Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '07-09-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/355', 'ema_number_certainty': '0.9459459459459459'}"
EU-1-02-202,"{'atc_code': 'D11AH01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Protopy', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/202', 'active_substance': 'Tacrolimus', 'eu_mah_current': 'Astellas Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-28-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/375', 'ema_number_certainty': '1.0'}"
EU-1-02-208,"{'atc_code': 'M01AH04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Xapit', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/208', 'active_substance': 'Parecoxib', 'eu_mah_current': 'Pharmacia Europe EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/380', 'ema_number_certainty': '1.0'}"
EU-1-02-211,"{'atc_code': 'B03XA', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Dynepo', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/211', 'active_substance': 'Epoetin delta', 'eu_mah_current': 'Shire Pharmaceutical Contracts Ltd', 'orphan_status': 'h', 'eu_aut_date': '03-18-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/372', 'ema_number_certainty': '1.0'}"
EU-1-02-210,"{'atc_code': 'M01AH04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Rayzon', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/210', 'active_substance': 'Parecoxib', 'eu_mah_current': 'Pharmacia Europe EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/382', 'ema_number_certainty': '1.0'}"
EU-1-02-207,"{'atc_code': 'B01AX05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Quixidar', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/207', 'active_substance': 'Fondaparinux sodium', 'eu_mah_current': 'Glaxo Group Ltd', 'orphan_status': 'h', 'eu_aut_date': '03-21-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/404', 'ema_number_certainty': '1.0'}"
EU-1-02-225,"{'atc_code': 'B01AD10', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Xigris', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/225', 'active_substance': 'Drotrecogin alfa (activated)', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/396', 'ema_number_certainty': '1.0'}"
EU-1-02-228,"{'atc_code': 'L03AA13', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Neupopeg', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/228', 'active_substance': 'Pegfilgrastim', 'eu_mah_current': 'Domp&#233; Biotec S.p.A.', 'orphan_status': 'h', 'eu_aut_date': '08-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/422', 'ema_number_certainty': '1.0'}"
EU-1-02-232,"{'atc_code': 'A10AB01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Velosulin', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/232', 'active_substance': 'Insulin human (rDNA)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '10-07-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/423', 'ema_number_certainty': '1.0'}"
EU-1-02-235,"{'atc_code': 'A10AC01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Monotard', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/235', 'active_substance': 'Insulin human (rDNA)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '10-07-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/440', 'ema_number_certainty': '1.0'}"
EU-1-02-236,"{'atc_code': 'A10AC01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ultratard', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/236', 'active_substance': 'Insulin human (rDNA)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'h', 'eu_aut_date': '10-07-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/439', 'ema_number_certainty': '1.0'}"
EU-1-02-242,"{'atc_code': 'M01AH03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Valdyn', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/242', 'active_substance': 'Valdecoxib', 'eu_mah_current': 'Pharmacia Europe EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-27-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/432', 'ema_number_certainty': '1.0'}"
EU-1-02-244,"{'atc_code': 'M01AH03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Valdyn (ex Kudeq)', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/244', 'active_substance': 'Valdecoxib', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'h', 'eu_aut_date': '03-27-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/437', 'ema_number_certainty': '1.0'}"
EU-1-02-239,"{'atc_code': 'M01AH03', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Bextra', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/239', 'active_substance': 'Valdecoxib', 'eu_mah_current': 'Pharmacia Europe EEIG', 'orphan_status': 'h', 'eu_aut_date': '03-27-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/431', 'ema_number_certainty': '1.0'}"
EU-1-02-245,"{'atc_code': '', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Theryttrex', 'status_type': 'w', 'eu_pnumber': 'EU/1/02/245', 'active_substance': 'Yttrium (90Y) Chloride', 'eu_mah_current': 'MDS Nordion S.A.', 'orphan_status': 'h', 'eu_aut_date': '01-07-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/445', 'ema_number_certainty': '1.0'}"
EU-1-03-250,"{'atc_code': '', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ytracis', 'status_type': 'w', 'eu_pnumber': 'EU/1/03/250', 'active_substance': 'Yttrium (90Y) Chloride', 'eu_mah_current': 'CIS bio international', 'orphan_status': 'h', 'eu_aut_date': '03-24-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/460', 'ema_number_certainty': '1.0'}"
EU-1-03-257,"{'atc_code': 'L04AB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Trudexa', 'status_type': 'w', 'eu_pnumber': 'EU/1/03/257', 'active_substance': 'Adalimumab', 'eu_mah_current': 'Abbott Laboratories Ltd', 'orphan_status': 'h', 'eu_aut_date': '09-01-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/482', 'ema_number_certainty': '1.0'}"
EU-1-03-258,"{'atc_code': 'A10BD03', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Avandamet', 'status_type': 'w', 'eu_pnumber': 'EU/1/03/258', 'active_substance': 'rosiglitazone / metformin', 'eu_mah_current': 'SmithKline Beecham Ltd', 'orphan_status': 'h', 'eu_aut_date': '10-20-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/522', 'ema_number_certainty': '1.0'}"
EU-1-03-259,"{'atc_code': 'L01XX33', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Onsenal', 'status_type': 'w', 'eu_pnumber': 'EU/1/03/259', 'active_substance': 'Celecoxib', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'h', 'eu_aut_date': '10-17-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/466', 'ema_number_certainty': '1.0'}"
EU-1-03-266,"{'atc_code': 'M05BA06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Bondenza', 'status_type': 'w', 'eu_pnumber': 'EU/1/03/266', 'active_substance': 'Ibandronic acid', 'eu_mah_current': 'Roche Registration Limited', 'orphan_status': 'h', 'eu_aut_date': '02-23-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/502', 'ema_number_certainty': '1.0'}"
EU-1-04-272,"{'atc_code': 'L01XD01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'PhotoBarr', 'status_type': 'w', 'eu_pnumber': 'EU/1/04/272', 'active_substance': 'Porfimer sodium', 'eu_mah_current': 'Pinnacle Biologics B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-25-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/493', 'ema_number_certainty': '1.0'}"
EU-1-10-649,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel Teva Pharma B.V.', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/649', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '06-16-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1226', 'ema_number_certainty': '1.0'}"
EU-1-10-650,"{'atc_code': 'B01AC04', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Clopidogrel Teva Generics B.V.', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/650', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Teva Generics B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2254', 'ema_number_certainty': '1.0'}"
EU-1-10-651,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel HCS', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/651', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'HCS bvba', 'orphan_status': 'h', 'eu_aut_date': '10-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2255', 'ema_number_certainty': '1.0'}"
EU-1-10-656,"{'atc_code': 'B01AC24', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Possia', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/656', 'active_substance': 'ticagrelor', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '12-03-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2303', 'ema_number_certainty': '1.0'}"
EU-1-10-657,"{'atc_code': 'J07BB02', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Prepandemic Influenza', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/657', 'active_substance': 'Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)', 'eu_mah_current': 'Novartis Vaccines and Diagnostics S.r.l.', 'orphan_status': 'h', 'eu_aut_date': '11-29-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2269', 'ema_number_certainty': '1.0'}"
EU-1-10-661,"{'atc_code': 'J07BB03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'FLUENZ', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/661', 'active_substance': 'influenza vaccine (live attenuated, nasal)', 'eu_mah_current': 'MedImmune, LLC', 'orphan_status': 'h', 'eu_aut_date': '01-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1101', 'ema_number_certainty': '1.0'}"
EU-1-10-662,"{'atc_code': 'L01CD02', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Docetaxel Teva Pharma', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/662', 'active_substance': 'Docetaxel', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2032', 'ema_number_certainty': '1.0'}"
EU-1-10-664,"{'atc_code': 'J07BB02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Pumarix', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/664', 'active_substance': 'Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '03-04-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1212', 'ema_number_certainty': '1.0'}"
EU-1-11-666,"{'atc_code': 'R03DX07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Libertek', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/666', 'active_substance': 'roflumilast', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '02-28-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2399', 'ema_number_certainty': '0.8235294117647058'}"
EU-1-11-668,"{'atc_code': 'R03DX07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Daliresp', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/668', 'active_substance': 'roflumilast', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '02-28-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2398', 'ema_number_certainty': '0.9375'}"
EU-1-11-671,"{'atc_code': 'M09AB02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Xiapex', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/671', 'active_substance': 'collagenase clostridium histolyticum', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'h', 'eu_aut_date': '02-28-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2048', 'ema_number_certainty': '0.96'}"
EU-1-11-675,"{'atc_code': 'L04AA13', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Leflunomide Teva', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/675', 'active_substance': 'leflunomide', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-10-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2356', 'ema_number_certainty': '1.0'}"
EU-1-11-674,"{'atc_code': 'L04AA13', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Repso', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/674', 'active_substance': 'leflunomide', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-14-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1222', 'ema_number_certainty': '1.0'}"
EU-1-11-681,"{'atc_code': 'N03AX21', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Trobalt', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/681', 'active_substance': 'retigabine', 'eu_mah_current': 'Glaxo Group Ltd', 'orphan_status': 'h', 'eu_aut_date': '03-28-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1245', 'ema_number_certainty': '1.0'}"
EU-1-11-680,"{'atc_code': 'C09XA52', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Riprazo HCT', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/680', 'active_substance': 'aliskiren / hydrochlorothiazide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '04-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2420', 'ema_number_certainty': '1.0'}"
EU-1-11-683,"{'atc_code': 'C09XA52', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Sprimeo HCT', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/683', 'active_substance': 'aliskiren / hydrochlorothiazide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '06-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2421', 'ema_number_certainty': '1.0'}"
EU-1-11-686,"{'atc_code': 'C09XA53', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Rasilamlo', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/686', 'active_substance': 'aliskiren / amlodipine', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '04-14-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2073', 'ema_number_certainty': '1.0'}"
EU-1-11-689,"{'atc_code': 'G03AA14', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'IOA', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/689', 'active_substance': 'nomegestrol / estradiol', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'h', 'eu_aut_date': '11-16-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2068', 'ema_number_certainty': '1.0'}"
EU-1-11-695,"{'atc_code': 'N04BC09', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Leganto', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/695', 'active_substance': 'Rotigotine', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'h', 'eu_aut_date': '06-16-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2380', 'ema_number_certainty': '0.9565217391304348'}"
EU-1-11-704,"{'atc_code': 'J05AE12', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Victrelis', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/704', 'active_substance': 'boceprevir', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'h', 'eu_aut_date': '07-18-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2332', 'ema_number_certainty': '1.0'}"
EU-1-11-705,"{'atc_code': 'J01XA03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Vibativ', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/705', 'active_substance': 'telavancin', 'eu_mah_current': 'Theravance Biopharma Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '09-02-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1240', 'ema_number_certainty': '1.0'}"
EU-1-11-720,"{'atc_code': 'J05AE11', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Incivo', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/720', 'active_substance': 'telaprevir', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '09-19-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2313', 'ema_number_certainty': '1.0'}"
EU-1-11-721,"{'atc_code': 'A10BG03', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Paglitaz', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/721', 'active_substance': 'pioglitazone', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '03-21-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2309', 'ema_number_certainty': '1.0'}"
EU-1-11-723,"{'atc_code': 'A10BG03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Pioglitazone Krka', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/723', 'active_substance': 'pioglitazone', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '03-21-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2453', 'ema_number_certainty': '1.0'}"
EU-1-11-728,"{'atc_code': 'N04BC05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Pramipexole Accord', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/728', 'active_substance': 'pramipexole', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '09-30-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2291', 'ema_number_certainty': '0.7857142857142857'}"
EU-1-11-729,"{'atc_code': 'C09DB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Onduarp', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/729', 'active_substance': 'telmisartan / amlodipine', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-24-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2118', 'ema_number_certainty': '1.0'}"
EU-1-11-730,"{'atc_code': 'C09XA54', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Rasitrio', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/730', 'active_substance': 'aliskiren / amlodipine / hydrochlorothiazide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '11-22-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2017', 'ema_number_certainty': '0.9230769230769231'}"
EU-1-11-735,"{'atc_code': 'C09CA09', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ipreziv', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/735', 'active_substance': 'azilsartan medoxomil', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '12-07-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2517', 'ema_number_certainty': '1.0'}"
EU-1-12-791,"{'atc_code': 'C10AX10', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Glybera', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/791', 'active_substance': 'Alipogene tiparvovec', 'eu_mah_current': 'uniQure biopharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '10-25-2012', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/2145', 'ema_number_certainty': '1.0'}"
EU-1-11-744,"{'atc_code': 'L01XX17', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Topotecan Eagle', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/744', 'active_substance': 'topotecan', 'eu_mah_current': 'Eagle Laboratories Limited', 'orphan_status': 'h', 'eu_aut_date': '12-22-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2261', 'ema_number_certainty': '1.0'}"
EU-1-11-748,"{'atc_code': 'L01CD02', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Docetaxel Mylan', 'status_type': 'w', 'eu_pnumber': 'EU/1/11/748', 'active_substance': 'Docetaxel', 'eu_mah_current': 'Mylan S.A.S.', 'orphan_status': 'h', 'eu_aut_date': '01-31-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2317', 'ema_number_certainty': '1.0'}"
EU-1-12-752,"{'atc_code': 'J07BB01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Vepacel', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/752', 'active_substance': 'Prepandemic influenza vaccine (A/H5N1) (whole virion, Vero cell derived, inactivated)', 'eu_mah_current': 'Ology Bioservices Ireland LTD', 'orphan_status': 'h', 'eu_aut_date': '02-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2089', 'ema_number_certainty': '1.0'}"
EU-1-12-754,"{'atc_code': 'A10BG03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Sepioglin', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/754', 'active_substance': 'pioglitazone', 'eu_mah_current': 'Vaia S.A.', 'orphan_status': 'h', 'eu_aut_date': '03-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2021', 'ema_number_certainty': '1.0'}"
EU-1-12-756,"{'atc_code': 'A10BG03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Glidipion', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/756', 'active_substance': 'pioglitazone', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '03-15-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2558', 'ema_number_certainty': '0.8'}"
EU-1-12-758,"{'atc_code': 'A10BG03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Pioglitazone Teva Pharma', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/758', 'active_substance': 'pioglitazone', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2410', 'ema_number_certainty': '0.8235294117647058'}"
EU-1-12-765,"{'atc_code': 'C09CA04', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Sabervel', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/765', 'active_substance': 'Irbesartan', 'eu_mah_current': 'Pharmathen S.A.', 'orphan_status': 'h', 'eu_aut_date': '04-13-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2510', 'ema_number_certainty': '1.0'}"
EU-1-12-772,"{'atc_code': 'M05BA08', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zoledronic acid Teva Pharma', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/772', 'active_substance': 'zoledronic acid', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-16-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2437', 'ema_number_certainty': '1.0'}"
EU-1-12-774,"{'atc_code': 'B03AC', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Rienso', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/774', 'active_substance': 'Ferumoxytol', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'h', 'eu_aut_date': '06-15-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2215', 'ema_number_certainty': '1.0'}"
EU-1-12-796,"{'atc_code': 'D06BX02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Picato', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/796', 'active_substance': 'ingenol mebutate', 'eu_mah_current': 'LEO Laboratories Ltd', 'orphan_status': 'h', 'eu_aut_date': '11-15-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2275', 'ema_number_certainty': '0.6153846153846154'}"
EU-1-08-449,"{'atc_code': 'L03AA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Filgrastim ratiopharm', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/449', 'active_substance': 'filgrastim', 'eu_mah_current': 'ratiopharm GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-15-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/824', 'ema_number_certainty': '1.0'}"
EU-1-08-450,"{'atc_code': 'L03AA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Biograstim', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/450', 'active_substance': 'filgrastim', 'eu_mah_current': 'AbZ-Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-15-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/826', 'ema_number_certainty': '1.0'}"
EU-1-08-452,"{'atc_code': 'J07BB02', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Pandemrix', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/452', 'active_substance': 'Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-179A)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '05-20-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/832', 'ema_number_certainty': '1.0'}"
EU-1-08-453,"{'atc_code': 'J07BB02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Prepandrix', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/453', 'active_substance': 'Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '05-14-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/822', 'ema_number_certainty': '0.9722222222222222'}"
EU-1-08-458,"{'atc_code': 'C10AD52', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Trevaclyn', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/458', 'active_substance': 'nicotinic acid / laropiprant', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'h', 'eu_aut_date': '07-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/897', 'ema_number_certainty': '1.0'}"
EU-1-08-459,"{'atc_code': 'C10AD52', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Tredaptive', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/459', 'active_substance': 'nicotinic acid / laropiprant', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'h', 'eu_aut_date': '07-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/889', 'ema_number_certainty': '1.0'}"
EU-1-08-460,"{'atc_code': 'C10AD52', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Pelzont', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/460', 'active_substance': 'nicotinic acid / laropiprant', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'h', 'eu_aut_date': '07-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/903', 'ema_number_certainty': '1.0'}"
EU-1-08-464,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel BMS', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/464', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '07-16-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/974', 'ema_number_certainty': '1.0'}"
EU-1-08-467,"{'atc_code': 'J01DH04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Doribax', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/467', 'active_substance': 'doripenem', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '07-25-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/891', 'ema_number_certainty': '1.0'}"
EU-1-08-471,"{'atc_code': 'N06AX21', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Duloxetine Boehringer Ingelheim', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/471', 'active_substance': 'Duloxetine', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '10-08-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1007', 'ema_number_certainty': '1.0'}"
EU-1-08-474,"{'atc_code': 'R01AD12', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Alisade', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/474', 'active_substance': 'Fluticasone furoate', 'eu_mah_current': 'Glaxo Group Ltd', 'orphan_status': 'h', 'eu_aut_date': '10-06-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1019', 'ema_number_certainty': '1.0'}"
EU-1-08-478,"{'atc_code': 'J07BB02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/478', 'active_substance': 'Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '09-26-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1015', 'ema_number_certainty': '1.0'}"
EU-1-08-489,"{'atc_code': 'M05BC02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Opgenra', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/489', 'active_substance': 'eptotermin alfa', 'eu_mah_current': 'Olympus Biotech International Limited', 'orphan_status': 'h', 'eu_aut_date': '02-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/819', 'ema_number_certainty': '1.0'}"
EU-1-08-491,"{'atc_code': 'C09XA52', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Rasilez HCT', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/491', 'active_substance': 'aliskiren hemifumarate / hydrochlorothiazide', 'eu_mah_current': 'Noden Pharma DAC', 'orphan_status': 'h', 'eu_aut_date': '01-16-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/964', 'ema_number_certainty': '0.9130434782608695'}"
EU-1-08-505,"{'atc_code': 'J07BB02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Intanza', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/505', 'active_substance': 'Influenza Vaccine (split virion, inactivated)', 'eu_mah_current': 'Sanofi Pasteur Europe', 'orphan_status': 'h', 'eu_aut_date': '02-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/957', 'ema_number_certainty': '1.0'}"
EU-1-08-500,"{'atc_code': 'G03XC03', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Fablyn', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/500', 'active_substance': 'lasofoxifene', 'eu_mah_current': 'Dr Friedrich Eberth Arzneimittel GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/977', 'ema_number_certainty': '1.0'}"
EU-1-08-506,"{'atc_code': 'J07BB01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Celvapan', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/506', 'active_substance': 'Pandemic influenza vaccine (H1N1) (whole virion, Vero cell derived, inactivated) A/California/07/2009 (H1N1)v', 'eu_mah_current': 'Nanotherapeutics Bohumil, s.r.o.', 'orphan_status': 'h', 'eu_aut_date': '03-04-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/982', 'ema_number_certainty': '1.0'}"
EU-1-08-507,"{'atc_code': 'J07BB02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'IDflu', 'status_type': 'w', 'eu_pnumber': 'EU/1/08/507', 'active_substance': 'Influenza Vaccine (split virion, inactivated)', 'eu_mah_current': 'Sanofi Pasteur SA', 'orphan_status': 'h', 'eu_aut_date': '02-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/966', 'ema_number_certainty': '1.0'}"
EU-1-09-510,"{'atc_code': 'G03GA06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Fertavid', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/510', 'active_substance': 'follitropin beta', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1042', 'ema_number_certainty': '1.0'}"
EU-1-09-509,"{'atc_code': 'J05AP01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ribavirin Teva', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/509', 'active_substance': 'Ribavirin', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-31-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1018', 'ema_number_certainty': '0.9'}"
EU-1-09-512,"{'atc_code': 'L01XC09', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Removab', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/512', 'active_substance': 'Catumaxomab', 'eu_mah_current': 'Neovii Biotech GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-20-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/972', 'ema_number_certainty': '1.0'}"
EU-1-09-513,"{'atc_code': 'N06DA03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Rivastigmine Teva', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/513', 'active_substance': 'Rivastigmine', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-17-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1044', 'ema_number_certainty': '1.0'}"
EU-1-09-520,"{'atc_code': 'N03AF04', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Exalief', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/520', 'active_substance': 'eslicarbazepine acetate', 'eu_mah_current': 'Bial - Portela &amp; C&#170;, SA', 'orphan_status': 'h', 'eu_aut_date': '04-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/987', 'ema_number_certainty': '1.0'}"
EU-1-09-519,"{'atc_code': 'A02BC02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'PANTOLOC Control', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/519', 'active_substance': 'pantoprazole', 'eu_mah_current': 'Takeda GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-12-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1100', 'ema_number_certainty': '0.875'}"
EU-1-09-518,"{'atc_code': 'A02BC02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'PANTECTA Control', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/518', 'active_substance': 'pantoprazole', 'eu_mah_current': 'Takeda GmbH', 'orphan_status': 'h', 'eu_aut_date': '06-12-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1099', 'ema_number_certainty': '1.0'}"
EU-1-09-527,"{'atc_code': 'J05AP01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ribavirin Teva Pharma BV', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/527', 'active_substance': 'Ribavirin', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-01-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1064', 'ema_number_certainty': '0.9444444444444444'}"
EU-1-09-532,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel Acino', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/532', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Acino AG', 'orphan_status': 'h', 'eu_aut_date': '07-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1166', 'ema_number_certainty': '1.0'}"
EU-1-09-534,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel Hexal', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/534', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Acino Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1139', 'ema_number_certainty': '1.0'}"
EU-1-09-536,"{'atc_code': 'L01XX17', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Topotecan Actavis', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/536', 'active_substance': 'topotecan', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1031', 'ema_number_certainty': '1.0'}"
EU-1-09-541,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel ratiopharm GmbH', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/541', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Archie Samuel s.r.o.', 'orphan_status': 'h', 'eu_aut_date': '07-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1165', 'ema_number_certainty': '0.9333333333333333'}"
EU-1-09-542,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel 1A Pharma', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/542', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Acino Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1054', 'ema_number_certainty': '1.0'}"
EU-1-09-549,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel Acino Pharma', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/549', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Acino Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1172', 'ema_number_certainty': '1.0'}"
EU-1-09-547,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel Sandoz', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/547', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Acino Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1174', 'ema_number_certainty': '1.0'}"
EU-1-09-548,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel Acino Pharma GmbH', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/548', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Acino Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1175', 'ema_number_certainty': '1.0'}"
EU-1-09-560,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel DURA', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/560', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Mylan dura GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1132', 'ema_number_certainty': '1.0'}"
EU-1-09-554,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel ratiopharm', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/554', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Archie Samuel s.r.o.', 'orphan_status': 'h', 'eu_aut_date': '09-23-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1173', 'ema_number_certainty': '0.9375'}"
EU-1-09-561,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel Teva Pharma', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/561', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1133', 'ema_number_certainty': '1.0'}"
EU-1-09-557,"{'atc_code': 'B01AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel Qualimed', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/557', 'active_substance': 'Clopidogrel', 'eu_mah_current': 'Qualimed', 'orphan_status': 'h', 'eu_aut_date': '09-23-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1135', 'ema_number_certainty': '1.0'}"
EU-1-09-552,"{'atc_code': 'L01XX17', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Topotecan Teva', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/552', 'active_substance': 'topotecan', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-21-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1071', 'ema_number_certainty': '1.0'}"
EU-1-09-563,"{'atc_code': 'M09AX02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'ChondroCelect', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/563', 'active_substance': 'Characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins', 'eu_mah_current': 'TiGenix NV', 'orphan_status': 'h', 'eu_aut_date': '10-05-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/878', 'ema_number_certainty': '1.0'}"
EU-1-09-570,"{'atc_code': 'C09DX01', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Imprida HCT', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/570', 'active_substance': 'amlodipine besylate / valsartan / hydrochlorothiazide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '10-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1161', 'ema_number_certainty': '1.0'}"
EU-1-09-582,"{'atc_code': 'L04AC04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Rilonacept Regeneron', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/582', 'active_substance': 'Rilonacept', 'eu_mah_current': 'Regeneron UK Limited', 'orphan_status': 'h', 'eu_aut_date': '10-23-2009', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'exceptional', 'ema_number': 'EMEA/H/C/1047', 'ema_number_certainty': '1.0'}"
EU-1-09-610,"{'atc_code': 'C09CA07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Telmisartan Teva', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/610', 'active_substance': 'telmisartan', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1146', 'ema_number_certainty': '0.8666666666666667'}"
EU-1-09-611,"{'atc_code': 'L01CD02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Docetaxel Teva', 'status_type': 'w', 'eu_pnumber': 'EU/1/09/611', 'active_substance': 'Docetaxel', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1107', 'ema_number_certainty': '0.9130434782608695'}"
EU-1-10-613,"{'atc_code': 'J06BB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'ImmunoGam', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/613', 'active_substance': 'Human Hepatitis B Immunoglobulin', 'eu_mah_current': 'Cangene Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '03-15-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1055', 'ema_number_certainty': '1.0'}"
EU-1-10-616,"{'atc_code': 'L01AX03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Temozolomide HEXAL', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/616', 'active_substance': 'temozolomide', 'eu_mah_current': 'Hexal AG', 'orphan_status': 'h', 'eu_aut_date': '03-15-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1127', 'ema_number_certainty': '0.8695652173913043'}"
EU-1-10-617,"{'atc_code': 'L01AX03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Temozolomide Sandoz', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/617', 'active_substance': 'temozolomide', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-15-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1128', 'ema_number_certainty': '0.8695652173913043'}"
EU-1-10-623,"{'atc_code': 'B01AC30', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Clopidogrel/Acetylsalicylic acid Zentiva', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/623', 'active_substance': 'clopidogrel / acetylsalicylic acid', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'h', 'eu_aut_date': '03-15-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1144', 'ema_number_certainty': '1.0'}"
EU-1-10-624,"{'atc_code': 'J07BB02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Arepanrix', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/624', 'active_substance': 'Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-179A)', 'eu_mah_current': 'GlaxoSmithKline Biologicals S.A.', 'orphan_status': 'h', 'eu_aut_date': '03-23-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1201', 'ema_number_certainty': '1.0'}"
EU-1-10-625,"{'atc_code': 'L01XC10', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Arzerra', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/625', 'active_substance': 'Ofatumumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'h', 'eu_aut_date': '04-19-2010', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1131', 'ema_number_certainty': '1.0'}"
EU-1-10-626,"{'atc_code': 'J05AB04', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Ribavirin BioPartners', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/626', 'active_substance': 'Ribavirin', 'eu_mah_current': 'BioPartners GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-06-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1184', 'ema_number_certainty': '1.0'}"
EU-1-10-629,"{'atc_code': 'J07BB02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Humenza', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/629', 'active_substance': 'Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-179A)', 'eu_mah_current': 'Sanofi Pasteur SA', 'orphan_status': 'h', 'eu_aut_date': '06-08-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1202', 'ema_number_certainty': '1.0'}"
EU-1-10-630,"{'atc_code': 'L01CD02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Docefrez', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/630', 'active_substance': 'Docetaxel', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe BV', 'orphan_status': 'h', 'eu_aut_date': '05-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1074', 'ema_number_certainty': '1.0'}"
EU-1-10-634,"{'atc_code': 'J05AB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ribavirin Mylan', 'status_type': 'w', 'eu_pnumber': 'EU/1/10/634', 'active_substance': 'Ribavirin', 'eu_mah_current': 'Mylan S.A.S.', 'orphan_status': 'h', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/1185', 'ema_number_certainty': '1.0'}"
EU-1-15-1077,"{'atc_code': 'B02BD02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Iblias', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1077', 'active_substance': 'octocog alfa', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'h', 'eu_aut_date': '02-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4147', 'ema_number_certainty': '1.0'}"
EU-1-12-810,"{'atc_code': 'M04AX02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Krystexxa', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/810', 'active_substance': 'pegloticase', 'eu_mah_current': 'Crealta Pharmaceuticals Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '01-08-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2208', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-13-883,"{'atc_code': 'J05AX11', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Vitekta', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/883', 'active_substance': 'elvitegravir', 'eu_mah_current': 'Gilead Sciences International Limited', 'orphan_status': 'h', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2577', 'ema_number_certainty': '1.0'}"
EU-1-13-876,"{'atc_code': 'L01EA01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Imatinib Medac', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/876', 'active_substance': 'Imatinib', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'h', 'eu_aut_date': '09-25-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2692', 'ema_number_certainty': '1.0'}"
EU-1-13-825,"{'atc_code': 'L01EA01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Imatinib Actavis', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/825', 'active_substance': 'Imatinib', 'eu_mah_current': 'Actavis Group PTC ehf.', 'orphan_status': 'h', 'eu_aut_date': '04-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2594', 'ema_number_certainty': '0.7647058823529411'}"
EU-1-13-831,"{'atc_code': 'L01BC06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Capecitabine SUN', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/831', 'active_substance': 'Capecitabine', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe BV', 'orphan_status': 'h', 'eu_aut_date': '06-21-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2050', 'ema_number_certainty': '1.0'}"
EU-1-14-912,"{'atc_code': 'M05BA08', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zoledronic acid Teva Generics', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/912', 'active_substance': 'Zoledronic Acid', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-27-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2805', 'ema_number_certainty': '1.0'}"
EU-1-13-895,"{'atc_code': 'A05AA03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Kolbam', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/895', 'active_substance': 'cholic acid', 'eu_mah_current': 'Retrophin Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '04-04-2014', 'eu_aut_type_initial': 'exceptional', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2081', 'ema_number_certainty': '0.75'}"
EU-1-14-942,"{'atc_code': 'B01AC30', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Clopidogrel / Acetylsalicylic acid Teva', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/942', 'active_substance': 'clopidogrel / acetylsalicylic acid', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-01-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2272', 'ema_number_certainty': '1.0'}"
EU-1-14-939,"{'atc_code': 'J05AP07', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Daklinza', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/939', 'active_substance': 'daclatasvir', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3768', 'ema_number_certainty': '1.0'}"
EU-1-14-948,"{'atc_code': 'R03AK07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Budesonide/Formoterol Teva', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/948', 'active_substance': 'budesonide / formoterol', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3951', 'ema_number_certainty': '1.0'}"
EU-1-14-949,"{'atc_code': 'R03AK07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Vylaer Spiromax', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/949', 'active_substance': 'budesonide / formoterol', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3952', 'ema_number_certainty': '0.75'}"
EU-1-14-950,"{'atc_code': 'R03AK07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Budesonide/Formoterol Teva Pharma B.V.', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/950', 'active_substance': 'budesonide / formoterol', 'eu_mah_current': 'Teva Pharma B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3953', 'ema_number_certainty': '1.0'}"
EU-1-13-867,"{'atc_code': 'L03AX17', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Provenge', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/867', 'active_substance': 'Autologous peripheral blood mononuclear cells activated with PAP-GM-CSF (Sipuleucel-T)', 'eu_mah_current': 'Dendreon UK Limited', 'orphan_status': 'h', 'eu_aut_date': '09-06-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2513', 'ema_number_certainty': '1.0'}"
EU-1-14-953,"{'atc_code': 'V03AE02', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Tasermity', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/953', 'active_substance': 'sevelamer hydrochloride', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-26-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3968', 'ema_number_certainty': '0.8'}"
EU-1-14-976,"{'atc_code': 'B01AC26', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zontivity', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/976', 'active_substance': 'vorapaxar', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'h', 'eu_aut_date': '01-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2814', 'ema_number_certainty': '1.0'}"
EU-1-13-849,"{'atc_code': 'H01AC01', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Somatropin Biopartners', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/849', 'active_substance': 'somatropin', 'eu_mah_current': 'BioPartners GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2196', 'ema_number_certainty': '1.0'}"
EU-1-13-847,"{'atc_code': 'M09AX02', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'MACI', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/847', 'active_substance': 'Matrix applied characterised autologous cultured chondrocytes', 'eu_mah_current': 'Vericel Denmark ApS', 'orphan_status': 'h', 'eu_aut_date': '06-27-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2522', 'ema_number_certainty': '1.0'}"
EU-1-13-833,"{'atc_code': 'N07XX59', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Nuedexta', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/833', 'active_substance': 'Dextromethorphan / quinidine', 'eu_mah_current': 'Jenson Pharmaceutical Services Ltd', 'orphan_status': 'h', 'eu_aut_date': '06-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/833', 'ema_number_certainty': '1.0'}"
EU-1-14-924,"{'atc_code': 'J05AE14', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'OLYSIO', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/924', 'active_substance': 'simeprevir', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'h', 'eu_aut_date': '05-14-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2777', 'ema_number_certainty': '0.85'}"
EU-1-13-868,"{'atc_code': 'B02BC30', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EVARREST', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/868', 'active_substance': 'Human fibrinogen/Human thrombin', 'eu_mah_current': 'Omrix Biopharmaceuticals N.V.', 'orphan_status': 'h', 'eu_aut_date': '09-25-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2515', 'ema_number_certainty': '1.0'}"
EU-1-14-932,"{'atc_code': 'J01GB01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Vantobra', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/932', 'active_substance': 'Tobramycin', 'eu_mah_current': 'PARI Pharma GmbH', 'orphan_status': 'h', 'eu_aut_date': '03-18-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2633', 'ema_number_certainty': '1.0'}"
EU-1-14-911,"{'atc_code': 'N06DA03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Rivastigmine 3M Health Care Ltd.', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/911', 'active_substance': 'rivastigmine', 'eu_mah_current': '3M Health Care Limited', 'orphan_status': 'h', 'eu_aut_date': '04-03-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3824', 'ema_number_certainty': '1.0'}"
EU-1-13-908,"{'atc_code': 'A10BX13', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Eperzan', 'status_type': 'w', 'eu_pnumber': 'EU/1/13/908', 'active_substance': 'albiglutide', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'h', 'eu_aut_date': '03-21-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2735', 'ema_number_certainty': '1.0'}"
EU-1-12-804,"{'atc_code': 'V03AE06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'BindRen', 'status_type': 'w', 'eu_pnumber': 'EU/1/12/804', 'active_substance': 'colestilan', 'eu_mah_current': 'Mitsubishi Tanabe Pharma Europe Ltd', 'orphan_status': 'h', 'eu_aut_date': '01-21-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2377', 'ema_number_certainty': '1.0'}"
EU-1-15-998,"{'atc_code': 'N03AX16', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Pregabalin Mylan Pharma', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/998', 'active_substance': 'pregabalin', 'eu_mah_current': 'Mylan S.A.S.', 'orphan_status': 'h', 'eu_aut_date': '06-25-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3962', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-15-996,"{'atc_code': 'L03AA13', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ristempa', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/996', 'active_substance': 'pegfilgrastim', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-13-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3910', 'ema_number_certainty': '1.0'}"
EU-1-15-1017,"{'atc_code': 'L01CD02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Taxespira', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1017', 'active_substance': 'docetaxel', 'eu_mah_current': 'Hospira UK Limited', 'orphan_status': 'h', 'eu_aut_date': '08-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3925', 'ema_number_certainty': '1.0'}"
EU-1-15-1044,"{'atc_code': 'N04BA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Numient', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1044', 'active_substance': 'levodopa / carbidopa', 'eu_mah_current': 'Amneal Pharma Europe Ltd', 'orphan_status': 'h', 'eu_aut_date': '11-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2611', 'ema_number_certainty': '1.0'}"
EU-1-15-1050,"{'atc_code': 'N02AB03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'IONSYS', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1050', 'active_substance': 'fentanyl', 'eu_mah_current': 'Incline Therapeutics Europe Ltd', 'orphan_status': 'h', 'eu_aut_date': '11-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2715', 'ema_number_certainty': '1.0'}"
EU-1-14-985,"{'atc_code': 'B02BC30', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Raplixa', 'status_type': 'w', 'eu_pnumber': 'EU/1/14/985', 'active_substance': 'human fibrinogen / human thrombin', 'eu_mah_current': 'Mallinckrodt Pharmaceuticals Ireland Limited', 'orphan_status': 'h', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2807', 'ema_number_certainty': '1.0'}"
EU-1-15-1069,"{'atc_code': 'D03AX13', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Episalvan', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1069', 'active_substance': 'birch bark extract', 'eu_mah_current': 'Amryt GMBH', 'orphan_status': 'h', 'eu_aut_date': '01-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3938', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-15-1084,"{'atc_code': 'L01XC22', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Portrazza', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1084', 'active_substance': 'necitumumab', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '02-15-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3886', 'ema_number_certainty': '1.0'}"
EU-1-15-995,"{'atc_code': 'J05AR16', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'DUTREBIS', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/995', 'active_substance': 'lamivudine / raltegravir', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'h', 'eu_aut_date': '03-26-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3823', 'ema_number_certainty': '1.0'}"
EU-1-15-1034,"{'atc_code': 'L01BA04', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Pemetrexed Lilly', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1034', 'active_substance': 'pemetrexed', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4114', 'ema_number_certainty': '0.6'}"
EU-1-15-1026,"{'atc_code': 'L01XC17', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Nivolumab BMS', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1026', 'active_substance': 'nivolumab', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'h', 'eu_aut_date': '07-20-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3840', 'ema_number_certainty': '1.0'}"
EU-1-15-1039,"{'atc_code': 'V03AE', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Fexeric', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1039', 'active_substance': 'ferric citrate coordination complex', 'eu_mah_current': 'Akebia Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '09-23-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3776', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-15-1042,"{'atc_code': 'N01AH03', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zalviso', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1042', 'active_substance': 'Sufentanil', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-18-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2784', 'ema_number_certainty': '0.75'}"
EU-1-16-1100,"{'atc_code': 'A04AA05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Palonosetron Hospira', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1100', 'active_substance': 'palonosetron', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-08-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4069', 'ema_number_certainty': '1.0'}"
EU-1-15-1080,"{'atc_code': 'M04AB05', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zurampic', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1080', 'active_substance': 'lesinurad', 'eu_mah_current': 'Gr&#252;nenthal GmbH', 'orphan_status': 'h', 'eu_aut_date': '02-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3932', 'ema_number_certainty': '1.0'}"
EU-1-15-1081,"{'atc_code': 'J02AX04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Caspofungin Accord', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1081', 'active_substance': 'caspofungin', 'eu_mah_current': 'Accord Healthcare S.L.U.', 'orphan_status': 'h', 'eu_aut_date': '02-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4134', 'ema_number_certainty': '0.8571428571428571'}"
EU-1-15-1022,"{'atc_code': 'L01XC16', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Unituxin', 'status_type': 'w', 'eu_pnumber': 'EU/1/15/1022', 'active_substance': 'dinutuximab', 'eu_mah_current': 'United Therapeutics Europe Ltd', 'orphan_status': 'h', 'eu_aut_date': '08-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2800', 'ema_number_certainty': '1.0'}"
EU-1-17-1183,"{'atc_code': 'L01BA04', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Pemetrexed Pfizer', 'status_type': 'w', 'eu_pnumber': 'EU/1/17/1183', 'active_substance': 'pemetrexed', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '04-24-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4488', 'ema_number_certainty': '0.8888888888888888'}"
EU-1-16-1162,"{'atc_code': 'A10AE04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Lusduna', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1162', 'active_substance': 'insulin glargine', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'h', 'eu_aut_date': '01-04-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4101', 'ema_number_certainty': '1.0'}"
EU-1-16-1122,"{'atc_code': 'R03AK06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Aerivio Spiromax', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1122', 'active_substance': 'salmeterol/fluticasone propionate', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2752', 'ema_number_certainty': '1.0'}"
EU-1-16-1123,"{'atc_code': 'R03AK06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Airexar Spiromax', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1123', 'active_substance': 'salmeterol/fluticasone propionate', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4267', 'ema_number_certainty': '1.0'}"
EU-1-16-1145,"{'atc_code': 'C01EB17', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ivabradine JensonR', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1145', 'active_substance': 'ivabradine', 'eu_mah_current': 'JensonR+ Limited', 'orphan_status': 'h', 'eu_aut_date': '11-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4217', 'ema_number_certainty': '1.0'}"
EU-1-16-1165,"{'atc_code': 'L04AB01', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'LIFMIOR', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1165', 'active_substance': 'etanercept', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'h', 'eu_aut_date': '02-13-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4167', 'ema_number_certainty': '0.75'}"
EU-1-16-1131,"{'atc_code': 'B01AB05', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Thorinane', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1131', 'active_substance': 'enoxaparin sodium', 'eu_mah_current': 'Techdow Pharma Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '09-15-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3795', 'ema_number_certainty': '1.0'}"
EU-1-16-1126,"{'atc_code': 'A07DA06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Truberzi', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1126', 'active_substance': 'eluxadoline', 'eu_mah_current': 'Allergan Pharmaceuticals International Limited', 'orphan_status': 'h', 'eu_aut_date': '09-19-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4098', 'ema_number_certainty': '0.42857142857142855'}"
EU-1-17-1206,"{'atc_code': 'L01XC02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Rituzena', 'status_type': 'w', 'eu_pnumber': 'EU/1/17/1206', 'active_substance': 'rituximab', 'eu_mah_current': 'Celltrion Healthcare Hungary Kft.', 'orphan_status': 'h', 'eu_aut_date': '07-13-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4724', 'ema_number_certainty': '1.0'}"
EU-1-17-1207,"{'atc_code': 'L01XC02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ritemvia', 'status_type': 'w', 'eu_pnumber': 'EU/1/17/1207', 'active_substance': 'rituximab', 'eu_mah_current': 'Celltrion Healthcare Hungary Kft.', 'orphan_status': 'h', 'eu_aut_date': '07-13-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4725', 'ema_number_certainty': '0.46153846153846156'}"
EU-1-16-1143,"{'atc_code': 'L01XC27', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Lartruvo', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1143', 'active_substance': 'olaratumab', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-09-2016', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/4216', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-16-1163,"{'atc_code': 'L04AB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'SOLYMBIC', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1163', 'active_substance': 'adalimumab', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '03-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/IG', 'ema_number_certainty': '0.4'}"
EU-1-16-1107,"{'atc_code': 'L04AC01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zinbryta', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1107', 'active_substance': 'daclizumab beta', 'eu_mah_current': 'Biogen Idec Limited', 'orphan_status': 'h', 'eu_aut_date': '07-01-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/3862', 'ema_number_certainty': '0.9'}"
EU-1-16-1113,"{'atc_code': 'A09AA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Enzepi', 'status_type': 'w', 'eu_pnumber': 'EU/1/16/1113', 'active_substance': 'pancreas powder', 'eu_mah_current': 'Allergan Pharmaceuticals International Limited', 'orphan_status': 'h', 'eu_aut_date': '06-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/2070', 'ema_number_certainty': '1.0'}"
EU-1-17-1240,"{'atc_code': 'L04AB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Cyltezo', 'status_type': 'w', 'eu_pnumber': 'EU/1/17/1240', 'active_substance': 'adalimumab', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'h', 'eu_aut_date': '11-10-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4319', 'ema_number_certainty': '1.0'}"
EU-1-17-1243,"{'atc_code': 'L01EA01', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Imatinib Teva B.V.', 'status_type': 'w', 'eu_pnumber': 'EU/1/17/1243', 'active_substance': 'imatinib', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'h', 'eu_aut_date': '11-15-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4748', 'ema_number_certainty': '1.0'}"
EU-1-17-1248,"{'atc_code': 'J05AE10', 'eu_aut_status': 'NOT RENEWED', 'eu_brand_name_current': 'Darunavir Krka d.d.', 'status_type': 'w', 'eu_pnumber': 'EU/1/17/1248', 'active_substance': 'darunavir', 'eu_mah_current': 'KRKA d d., Novo mesto', 'orphan_status': 'h', 'eu_aut_date': '01-18-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004891', 'ema_number_certainty': '0.5555555555555556'}"
EU-1-17-1180,"{'atc_code': 'A04AD14', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Varuby', 'status_type': 'w', 'eu_pnumber': 'EU/1/17/1180', 'active_substance': 'rolapitant', 'eu_mah_current': 'TESARO Bio Netherlands B.V.', 'orphan_status': 'h', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4196', 'ema_number_certainty': '1.0'}"
EU-1-19-1357,"{'atc_code': 'L04AB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Kromeya', 'status_type': 'w', 'eu_pnumber': 'EU/1/19/1357', 'active_substance': 'adalimumab', 'eu_mah_current': 'Fresenius Kabi Deutschland GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-02-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005158', 'ema_number_certainty': '1.0'}"
EU-1-19-1378,"{'atc_code': 'R03AL08', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'Temybric Ellipta', 'status_type': 'w', 'eu_pnumber': 'EU/1/19/1378', 'active_substance': 'fluticasone furoate / umeclidinium / vilanterol', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'h', 'eu_aut_date': '06-12-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005254', 'ema_number_certainty': '0.8333333333333334'}"
EU-1-20-1463,"{'atc_code': 'H05AA02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Qutavina', 'status_type': 'w', 'eu_pnumber': 'EU/1/20/1463', 'active_substance': 'teriparatide', 'eu_mah_current': 'EuroGenerics Holdings BV', 'orphan_status': 'h', 'eu_aut_date': '08-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005388', 'ema_number_certainty': '1.0'}"
EU-1-19-1363,"{'atc_code': 'A10BK06', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zynquista', 'status_type': 'w', 'eu_pnumber': 'EU/1/19/1363', 'active_substance': 'sotagliflozin', 'eu_mah_current': 'Guidehouse Germany GmbH', 'orphan_status': 'h', 'eu_aut_date': '04-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004889', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-19-1401,"{'atc_code': 'A10BD25', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Qtrilmet', 'status_type': 'w', 'eu_pnumber': 'EU/1/19/1401', 'active_substance': 'metformin hydrochloride / saxagliptin / dapagliflozin', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '11-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004910', 'ema_number_certainty': '1.0'}"
EU-1-20-1472,"{'atc_code': 'L01XC07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Equidacent', 'status_type': 'w', 'eu_pnumber': 'EU/1/20/1472', 'active_substance': 'bevacizumab', 'eu_mah_current': 'Centus Biotherapeutics Europe Limited', 'orphan_status': 'h', 'eu_aut_date': '09-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005181', 'ema_number_certainty': '1.0'}"
EU-1-19-1367,"{'atc_code': '', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Zynteglo', 'status_type': 'w', 'eu_pnumber': 'EU/1/19/1367', 'active_substance': 'betibeglogene autotemcel', 'eu_mah_current': 'bluebird bio (Netherlands) B.V.', 'orphan_status': 'h', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'conditional', 'eu_aut_type_current': 'conditional', 'ema_number': 'EMEA/H/C/003691', 'ema_number_certainty': '0.7777777777777778'}"
EU-1-18-1300,"{'atc_code': 'M04AA51', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Duzallo', 'status_type': 'w', 'eu_pnumber': 'EU/1/18/1300', 'active_substance': 'allopurinol / lesinurad', 'eu_mah_current': 'Gr&#252;nenthal GmbH', 'orphan_status': 'h', 'eu_aut_date': '08-23-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/4412', 'ema_number_certainty': '0.5'}"
EU-1-18-1288,"{'atc_code': 'L04AB04', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Halimatoz', 'status_type': 'w', 'eu_pnumber': 'EU/1/18/1288', 'active_substance': 'adalimumab', 'eu_mah_current': 'Sandoz GmbH', 'orphan_status': 'h', 'eu_aut_date': '07-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004866', 'ema_number_certainty': '0.5'}"
EU-1-07-384,"{'atc_code': 'L01CD02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Docetaxel Zentiva', 'status_type': 'w', 'eu_pnumber': 'EU/1/07/384', 'active_substance': 'Docetaxel', 'eu_mah_current': 'Zentiva k.s.', 'orphan_status': 'h', 'eu_aut_date': '04-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/808', 'ema_number_certainty': '0.9130434782608695'}"
EU-1-20-1516,"{'atc_code': 'L01XC07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Lextemy', 'status_type': 'w', 'eu_pnumber': 'EU/1/20/1516', 'active_substance': 'bevacizumab', 'eu_mah_current': 'Mylan IRE Healthcare Limited', 'orphan_status': 'h', 'eu_aut_date': '04-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005611', 'ema_number_certainty': '1.0'}"
EU-1-04-297,"{'atc_code': 'N06AX21', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Nodetrip', 'status_type': 'w', 'eu_pnumber': 'EU/1/04/297', 'active_substance': 'duloxetine hydrochloride', 'eu_mah_current': 'Esteve Pharmaceuticals S.A.', 'orphan_status': 'h', 'eu_aut_date': '12-17-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/573', 'ema_number_certainty': '0.9154929577464789'}"
EU-1-18-1303,"{'atc_code': 'L03AA13', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Udenyca', 'status_type': 'w', 'eu_pnumber': 'EU/1/18/1303', 'active_substance': 'pegfilgrastim', 'eu_mah_current': 'ERA Consulting GmbH', 'orphan_status': 'h', 'eu_aut_date': '09-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/004413', 'ema_number_certainty': '0.5'}"
EU-1-18-1309,"{'atc_code': 'G03XB02', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Ulipristal Acetate Gedeon Richter', 'status_type': 'w', 'eu_pnumber': 'EU/1/18/1309', 'active_substance': 'Ulipristal Acetate', 'eu_mah_current': 'Gedeon Richter Plc.', 'orphan_status': 'h', 'eu_aut_date': '08-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/A-31/1496', 'ema_number_certainty': '0.6666666666666666'}"
EU-1-20-1522,"{'atc_code': 'L01XC34', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Lumoxiti', 'status_type': 'w', 'eu_pnumber': 'EU/1/20/1522', 'active_substance': 'moxetumomab pasudotox', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'h', 'eu_aut_date': '02-08-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005322', 'ema_number_certainty': '1.0'}"
EU-1-19-1382,"{'atc_code': 'L01BC07', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Azacitidine Celgene', 'status_type': 'w', 'eu_pnumber': 'EU/1/19/1382', 'active_substance': 'azacitidine', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'h', 'eu_aut_date': '08-02-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/005300', 'ema_number_certainty': '1.0'}"
EU-1-21-1563,"{'atc_code': '', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'Skysona', 'status_type': 'w', 'eu_pnumber': 'EU/1/21/1563', 'active_substance': 'elivaldogene autotemcel', 'eu_mah_current': 'bluebird bio (Netherlands) B.V.', 'orphan_status': 'h', 'eu_aut_date': '07-16-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/H/C/003690', 'ema_number_certainty': '1.0'}"
EU-3-00-005,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/00/005', 'status_type': 'a', 'eu_pnumber': 'EU/3/00/005', 'active_substance': 'Gemtuzumab Ozogamicin', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '10-18-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/022/00', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-00-013,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/00/013', 'status_type': 'a', 'eu_pnumber': 'EU/3/00/013', 'active_substance': 'Ethyl Eicosopentaenoate', 'eu_mah_current': 'Amarin Neuroscience Limited', 'orphan_status': 'o', 'eu_aut_date': '12-29-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/021/00', 'ema_number_certainty': '1.0'}"
EU-3-01-026,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/026', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/026', 'active_substance': 'L-Lysine-N-acetyl-L-cysteinate', 'eu_mah_current': 'LABORATOIRES SMB SA', 'orphan_status': 'o', 'eu_aut_date': '02-14-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/032/00', 'ema_number_certainty': '1.0'}"
EU-3-01-028,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/028', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/028', 'active_substance': 'Inolimomab', 'eu_mah_current': 'Elsalys Biotech SA', 'orphan_status': 'o', 'eu_aut_date': '03-05-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/038/00', 'ema_number_certainty': '0.5'}"
EU-3-01-034,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/034', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/034', 'active_substance': 'Gusperimus trihydrochloride', 'eu_mah_current': 'Nordic Group B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-29-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/057/00', 'ema_number_certainty': '1.0'}"
EU-3-01-038,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/038', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/038', 'active_substance': 'Retroviral gamma-c cDNA containing vector', 'eu_mah_current': 'GENOPOIETIC S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '05-30-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/060/00', 'ema_number_certainty': '1.0'}"
EU-3-01-044,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/044', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/044', 'active_substance': 'Human Alpha1-Proteinase Inhibitor (respiratory use)', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-09-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/045/00', 'ema_number_certainty': '1.0'}"
EU-3-01-049,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/049', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/049', 'active_substance': 'Ramoplanin', 'eu_mah_current': 'Vicuron Pharmaceuticals Italy srl,', 'orphan_status': 'o', 'eu_aut_date': '07-09-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/034/00', 'ema_number_certainty': '1.0'}"
EU-3-01-051,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/051', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/051', 'active_substance': '1,3-Propanedisulfonic acid, disodium salt', 'eu_mah_current': 'C.T. Phinco S.&#224;.r.l.', 'orphan_status': 'o', 'eu_aut_date': '07-31-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/054/00', 'ema_number_certainty': '1.0'}"
EU-3-01-056,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/056', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/056', 'active_substance': 'Recombinant human acid sphingomyelinase', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '09-19-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/004/01', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-01-058,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/058', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/058', 'active_substance': 'Repertaxin L-lysine salt', 'eu_mah_current': 'Domp&#233; farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '09-19-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/012/01', 'ema_number_certainty': '0.75'}"
EU-3-01-062,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/062', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/062', 'active_substance': 'Idebenone', 'eu_mah_current': 'Laboratoires Takeda', 'orphan_status': 'o', 'eu_aut_date': '11-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/037/01', 'ema_number_certainty': '1.0'}"
EU-3-01-069,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/069', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/069', 'active_substance': 'Phenylephrine Hydrochloride', 'eu_mah_current': 'S.L.A. Pharma (UK) Limited', 'orphan_status': 'o', 'eu_aut_date': '11-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/043/00', 'ema_number_certainty': '1.0'}"
EU-3-01-075,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/075', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/075', 'active_substance': 'Denileukin diftitox', 'eu_mah_current': 'Clinipace GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-11-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/038/01', 'ema_number_certainty': '0.5'}"
EU-3-01-077,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/077', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/077', 'active_substance': '[gly2]-recombinant human glucagon-like peptide', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'o', 'eu_aut_date': '12-11-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/045/01', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-01-079,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/079', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/079', 'active_substance': 'Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol and palmitic acid', 'eu_mah_current': 'Pharmaceutical Research Associates Group B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-04-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/008/01', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-01-083,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/01/083', 'status_type': 'a', 'eu_pnumber': 'EU/3/01/083', 'active_substance': 'Adenovirus-mediated Herpes simplex Virus-thymidine kinase gene', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '02-06-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/055/01', 'ema_number_certainty': '0.5'}"
EU-3-02-091,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/091', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/091', 'active_substance': 'TGF-beta2 specific phosphorothioate antisense oligodeoxynucleotide', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/073/01', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-02-093,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/093', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/093', 'active_substance': 'Beclomethasone 17, 21-dipropionate (oral use)', 'eu_mah_current': 'Soligenix NE B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-13-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/036/01', 'ema_number_certainty': '0.75'}"
EU-3-02-104,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/104', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/104', 'active_substance': 'Miltefosine', 'eu_mah_current': 'Zentaris GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-12-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/072/01', 'ema_number_certainty': '1.0'}"
EU-3-02-109,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/109', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/109', 'active_substance': 'Oregovomab', 'eu_mah_current': 'ViRexx International Corp. Limited', 'orphan_status': 'o', 'eu_aut_date': '07-30-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/019/02', 'ema_number_certainty': '1.0'}"
EU-3-02-106,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/106', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/106', 'active_substance': 'Antisense NF-K&#223; p65 Oligonucleotide', 'eu_mah_current': 'InDex Pharmaceuticals AB', 'orphan_status': 'o', 'eu_aut_date': '07-30-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/014/02', 'ema_number_certainty': '1.0'}"
EU-3-02-107,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/107', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/107', 'active_substance': 'Purified bromelain', 'eu_mah_current': 'MediWound Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-30-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/012/02', 'ema_number_certainty': '1.0'}"
EU-3-02-110,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/110', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/110', 'active_substance': 'Thymalfasin', 'eu_mah_current': 'SciClone Pharmaceuticals Italy S.r.l', 'orphan_status': 'o', 'eu_aut_date': '07-30-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/015/02', 'ema_number_certainty': '1.0'}"
EU-3-02-111,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/111', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/111', 'active_substance': 'Benzoic acid, sodium salt', 'eu_mah_current': 'Ethicare GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-11-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/017/02', 'ema_number_certainty': '0.5'}"
EU-3-02-116,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/116', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/116', 'active_substance': 'Autologous renal cell tumor vaccine', 'eu_mah_current': 'Liponova GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-21-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/030/02', 'ema_number_certainty': '1.0'}"
EU-3-02-118,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/118', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/118', 'active_substance': 'Recombinant glycoprotein gp350 of Epstein-Barr virus', 'eu_mah_current': 'Henogen S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/043/01', 'ema_number_certainty': '1.0'}"
EU-3-02-120,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/120', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/120', 'active_substance': 'Duramycin', 'eu_mah_current': 'Aop Orphan Pharmaceuticals GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-13-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/038/02', 'ema_number_certainty': '1.0'}"
EU-3-02-122,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/122', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/122', 'active_substance': 'Etilefrin', 'eu_mah_current': 'Laboratoires SERB', 'orphan_status': 'o', 'eu_aut_date': '11-13-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/040/02', 'ema_number_certainty': '1.0'}"
EU-3-02-127,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/127', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/127', 'active_substance': 'Cholic acid', 'eu_mah_current': 'Laboratoires CTRS', 'orphan_status': 'o', 'eu_aut_date': '12-18-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/036/02', 'ema_number_certainty': '1.0'}"
EU-3-02-130,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/130', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/130', 'active_substance': 'G17(9) gastrin-diphtheria toxoid conjugate', 'eu_mah_current': 'Cato Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-28-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/056/02', 'ema_number_certainty': '1.0'}"
EU-3-02-128,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/128', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/128', 'active_substance': 'Carboxypeptidase G2', 'eu_mah_current': 'Serb', 'orphan_status': 'o', 'eu_aut_date': '02-03-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/049/02', 'ema_number_certainty': '0.5'}"
EU-3-02-129,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/02/129', 'status_type': 'a', 'eu_pnumber': 'EU/3/02/129', 'active_substance': 'G17(9) gastrin-diphtheria toxoid conjugate', 'eu_mah_current': 'Cato Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-24-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/055/02', 'ema_number_certainty': '1.0'}"
EU-3-03-135,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/135', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/135', 'active_substance': 'Decitabine', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '02-14-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/059/02', 'ema_number_certainty': '1.0'}"
EU-3-03-140,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/140', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/140', 'active_substance': 'Tobramycin (inhalation powder)', 'eu_mah_current': 'Mylan IRE Healthcare Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-17-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/072/02', 'ema_number_certainty': '0.75'}"
EU-3-03-145,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/145', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/145', 'active_substance': 'Rubitecan', 'eu_mah_current': 'Eurogen Pharmaceuticals Limited', 'orphan_status': 'o', 'eu_aut_date': '06-10-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/068/02', 'ema_number_certainty': '1.0'}"
EU-3-03-149,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/149', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/149', 'active_substance': 'Cytochrome P450 isoform 2B1 gene transfected human embryonic kidney 293 cells encapsulated in polymeric cellulose sulphate', 'eu_mah_current': 'Pharmacyte Biotech Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '06-30-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/005/03', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-03-157,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/157', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/157', 'active_substance': 'Recombinant dog gastric lipase', 'eu_mah_current': 'Meristem Therapeutics S.A.', 'orphan_status': 'o', 'eu_aut_date': '07-09-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/011/03', 'ema_number_certainty': '1.0'}"
EU-3-03-156,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/156', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/156', 'active_substance': 'Prasterone', 'eu_mah_current': 'Medicom Healthcare BV', 'orphan_status': 'o', 'eu_aut_date': '07-28-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/009/03', 'ema_number_certainty': '1.0'}"
EU-3-03-153,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/153', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/153', 'active_substance': 'Herpes simplex virus lacking infected cell protein 34.5', 'eu_mah_current': 'Virttu Biologics Limited', 'orphan_status': 'o', 'eu_aut_date': '07-09-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/026/03', 'ema_number_certainty': '1.0'}"
EU-3-03-160,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/160', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/160', 'active_substance': 'Antisense Oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT)', 'eu_mah_current': 'Gene Signal SAS', 'orphan_status': 'o', 'eu_aut_date': '10-02-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/014/03', 'ema_number_certainty': '1.0'}"
EU-3-03-161,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/161', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/161', 'active_substance': 'Antisense Oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT)', 'eu_mah_current': 'Gene Signal SAS', 'orphan_status': 'o', 'eu_aut_date': '10-02-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/015/03', 'ema_number_certainty': '1.0'}"
EU-3-03-162,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/162', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/162', 'active_substance': 'Yttrium (90Y) antiferritin polyclonal antibodies', 'eu_mah_current': 'Mablife', 'orphan_status': 'o', 'eu_aut_date': '10-02-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/019/03', 'ema_number_certainty': '1.0'}"
EU-3-03-163,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/163', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/163', 'active_substance': '5,6,7,8-Tetrahydrobiopterin', 'eu_mah_current': 'Orphanetics Pharma Entwicklungs GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-02-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/033/03', 'ema_number_certainty': '1.0'}"
EU-3-03-174,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/174', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/174', 'active_substance': 'Gimatecan', 'eu_mah_current': 'Sigma-Tau Industrie Farmaceutiche Riunite S.p.A', 'orphan_status': 'o', 'eu_aut_date': '12-01-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/055/03', 'ema_number_certainty': '1.0'}"
EU-3-03-173,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/173', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/173', 'active_substance': 'Vasoactive Intestinal Peptide', 'eu_mah_current': 'mondoBIOTECH Laboratories AG', 'orphan_status': 'o', 'eu_aut_date': '12-22-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/012/03', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-03-182,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/182', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/182', 'active_substance': '5-methyl-pyridine-2-sulfonic acid {6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-[2-(1H-tetrazol-5-yl)-pyridin-4-yl]-pyrimidin-4-yl}-amide sodium salt', 'eu_mah_current': 'Idorsia Pharmaceuticals Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-12-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/057/03', 'ema_number_certainty': '1.0'}"
EU-3-03-183,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/03/183', 'status_type': 'a', 'eu_pnumber': 'EU/3/03/183', 'active_substance': 'Temocillin sodium', 'eu_mah_current': 'Eumedica N.V.', 'orphan_status': 'o', 'eu_aut_date': '01-14-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/028/03', 'ema_number_certainty': '1.0'}"
EU-3-04-186,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/186', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/186', 'active_substance': 'Treosulfan', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'o', 'eu_aut_date': '02-23-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/075/03', 'ema_number_certainty': '1.0'}"
EU-3-04-188,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/188', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/188', 'active_substance': 'N-3[[4(aminoiminomethyl)benzoyl]amino]propyl]-1-[[2,4-dichloro-3-[[2,4-dimethyl-8-quinolinyl) oxy]methyl] phenyl]sulphonyl]-(2S)-2-pyrrolidinecarboxamide, di(methanesulfonate)', 'eu_mah_current': 'Xytis Pharmaceuticals Limited', 'orphan_status': 'o', 'eu_aut_date': '02-23-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/008/03', 'ema_number_certainty': '1.0'}"
EU-3-04-193,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/193', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/193', 'active_substance': 'Anti-epithelial cell adhesion molecule / anti-CD3 monoclonal antibody', 'eu_mah_current': 'Neovii Biotech GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-08-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/080/03', 'ema_number_certainty': '1.0'}"
EU-3-04-189,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/189', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/189', 'active_substance': 'Idebenone', 'eu_mah_current': 'Santhera Pharmaceuticals (Deutschland) GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-08-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/082/03', 'ema_number_certainty': '1.0'}"
EU-3-04-197,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/197', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/197', 'active_substance': 'Treprostinil sodium (inhalation use)', 'eu_mah_current': 'Unither Therapeutik GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-14-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/002/04', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-04-198,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/198', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/198', 'active_substance': 'Human monoclonal antibody against CD4', 'eu_mah_current': 'TenX Biopharma Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-14-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/001/04', 'ema_number_certainty': '1.0'}"
EU-3-04-201,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/201', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/201', 'active_substance': 'Vascular endothelial growth factor-D gene in an adenoviral vector for use with a collagen collar', 'eu_mah_current': 'Finvector Vision Therapies Limited', 'orphan_status': 'o', 'eu_aut_date': '06-08-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/011/04', 'ema_number_certainty': '1.0'}"
EU-3-04-202,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/202', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/202', 'active_substance': 'HLA-A2 restricted CD8 T-cell line expressing MART-1 T-cell receptor', 'eu_mah_current': 'Cellcure A/S', 'orphan_status': 'o', 'eu_aut_date': '06-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/009/04', 'ema_number_certainty': '1.0'}"
EU-3-04-216,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/216', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/216', 'active_substance': 'Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol and palmitic acid', 'eu_mah_current': 'Pharmaceutical Research Associates Group B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/018/04', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-04-217,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/217', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/217', 'active_substance': 'Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol and palmitic acid', 'eu_mah_current': 'Pharmaceutical Research Associates Group B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/019/04', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-04-214,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/214', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/214', 'active_substance': 'Midostaurin', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/028/04', 'ema_number_certainty': '1.0'}"
EU-3-04-211,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/211', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/211', 'active_substance': 'Defibrotide', 'eu_mah_current': 'Gentium S.r.I.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/025/04', 'ema_number_certainty': '1.0'}"
EU-3-04-212,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/212', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/212', 'active_substance': 'Defibrotide', 'eu_mah_current': 'Gentium S.r.I.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/026/04', 'ema_number_certainty': '1.0'}"
EU-3-04-209,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/209', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/209', 'active_substance': 'Ciclosporin (inhalation use)', 'eu_mah_current': 'Zambon S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/012/04', 'ema_number_certainty': '0.5'}"
EU-3-04-208,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/208', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/208', 'active_substance': 'Acetylsalicylic acid', 'eu_mah_current': 'Bayer HealthCare AG', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/021/04', 'ema_number_certainty': '1.0'}"
EU-3-04-210,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/210', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/210', 'active_substance': 'Ciclosporin (inhalation use)', 'eu_mah_current': 'Zambon S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/022/04', 'ema_number_certainty': '0.6'}"
EU-3-04-219,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/219', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/219', 'active_substance': 'HLA-B27 derived peptide (amino acid 125-138)', 'eu_mah_current': 'Dr Gerhild Wildner', 'orphan_status': 'o', 'eu_aut_date': '09-02-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/037/04', 'ema_number_certainty': '1.0'}"
EU-3-04-220,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/220', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/220', 'active_substance': 'Anti epidermal growth factor receptor antibody h-R3', 'eu_mah_current': 'Oncoscience GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-02-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/038/04', 'ema_number_certainty': '0.5'}"
EU-3-04-222,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/222', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/222', 'active_substance': 'Pancreatic enzymes (cross linked enzyme crystal lipase, protease, amylase)', 'eu_mah_current': 'TRX Services Limited', 'orphan_status': 'o', 'eu_aut_date': '09-02-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/044/02', 'ema_number_certainty': '0.75'}"
EU-3-04-232,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/232', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/232', 'active_substance': 'Biotinylated anti-tenascin monoclonal antibody for use with 90-Yttrium', 'eu_mah_current': 'Sigma-Tau Industrie Farmaceutiche Riunite S.p.A', 'orphan_status': 'o', 'eu_aut_date': '10-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/050/04', 'ema_number_certainty': '1.0'}"
EU-3-04-230,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/230', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/230', 'active_substance': 'Dexamethasone sodium phosphate encapsulated in human erythrocytes', 'eu_mah_current': 'Erydel S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '10-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/039/04', 'ema_number_certainty': '1.0'}"
EU-3-04-243,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/243', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/243', 'active_substance': 'Alpha-1 antitrypsin (inhalation use)', 'eu_mah_current': 'Kamada Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '11-16-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/053/04', 'ema_number_certainty': '0.8571428571428571'}"
EU-3-04-245,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/245', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/245', 'active_substance': 'Aplidine', 'eu_mah_current': 'Pharma Mar S.A.', 'orphan_status': 'o', 'eu_aut_date': '11-16-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/044/04', 'ema_number_certainty': '1.0'}"
EU-3-04-244,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/244', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/244', 'active_substance': 'Alpha-1 antitrypsin (inhalation use)', 'eu_mah_current': 'Kamada Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '11-16-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/054/04', 'ema_number_certainty': '0.7142857142857143'}"
EU-3-04-242,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/242', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/242', 'active_substance': 'N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole', 'eu_mah_current': 'AB Science S.A.', 'orphan_status': 'o', 'eu_aut_date': '11-16-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/062/04', 'ema_number_certainty': '1.0'}"
EU-3-04-248,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/248', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/248', 'active_substance': 'Recombinant histidine-tagged idiotype immunoglobulin Fab fragment of clonal B-cell receptors', 'eu_mah_current': 'CellGenix GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/066/04', 'ema_number_certainty': '1.0'}"
EU-3-04-251,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/251', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/251', 'active_substance': 'N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole', 'eu_mah_current': 'AB Science S.A.', 'orphan_status': 'o', 'eu_aut_date': '12-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/061/04', 'ema_number_certainty': '1.0'}"
EU-3-04-249,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/249', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/249', 'active_substance': 'Recombinant histidine-tagged idiotype immunoglobulin Fab fragment of clonal B-cell receptors', 'eu_mah_current': 'CellGenix GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-23-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/065/04', 'ema_number_certainty': '1.0'}"
EU-3-04-250,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/04/250', 'status_type': 'a', 'eu_pnumber': 'EU/3/04/250', 'active_substance': 'Recombinant histidine-tagged idiotype immunoglobulin Fab fragment of clonal B-cell receptors', 'eu_mah_current': 'CellGenix GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/064/04', 'ema_number_certainty': '1.0'}"
EU-3-05-263,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/263', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/263', 'active_substance': 'dimethyl sulfoxide', 'eu_mah_current': 'Aop Orphan Pharmaceuticals GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-03-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/082/04', 'ema_number_certainty': '1.0'}"
EU-3-05-261,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/261', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/261', 'active_substance': 'Fluocinolone acetonide (prolonged-release intravitreal implant)', 'eu_mah_current': 'Bausch &amp; Lomb Ireland', 'orphan_status': 'o', 'eu_aut_date': '03-07-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/085/04', 'ema_number_certainty': '1.0'}"
EU-3-05-269,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/269', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/269', 'active_substance': 'Tipifarnib', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '03-10-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/098/04', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-05-276,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/276', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/276', 'active_substance': 'Humanized Agonistic Anti-CD28 Monoclonal Antibody', 'eu_mah_current': 'TeGenero AG', 'orphan_status': 'o', 'eu_aut_date': '04-11-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/091/04', 'ema_number_certainty': '1.0'}"
EU-3-05-270,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/270', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/270', 'active_substance': 'Autologous Tumor-Derived gp96 Heat Shock Protein-Peptide Complex', 'eu_mah_current': 'Antigenics Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '04-11-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/096/04', 'ema_number_certainty': '1.0'}"
EU-3-05-275,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/275', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/275', 'active_substance': 'Estradiol Hemihydrate and Progesterone', 'eu_mah_current': 'Dr Frank Pohlandt', 'orphan_status': 'o', 'eu_aut_date': '04-11-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/095/04', 'ema_number_certainty': '1.0'}"
EU-3-05-278,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/278', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/278', 'active_substance': '(3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '05-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/106/04', 'ema_number_certainty': '0.75'}"
EU-3-05-279,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/279', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/279', 'active_substance': '(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/001/05', 'ema_number_certainty': '0.8'}"
EU-3-05-280,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/280', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/280', 'active_substance': 'Acadesine', 'eu_mah_current': 'Advancell - Advanced In Vitro Cell Technologies S.A.', 'orphan_status': 'o', 'eu_aut_date': '05-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/010/05', 'ema_number_certainty': '1.0'}"
EU-3-05-282,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/282', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/282', 'active_substance': 'Miltefosine', 'eu_mah_current': 'Orpha-Devel Handels und Vertriebs GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/007/05', 'ema_number_certainty': '0.75'}"
EU-3-05-284,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/284', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/284', 'active_substance': 'Sodium butyrate (rectal use)', 'eu_mah_current': 'Promefarm srl', 'orphan_status': 'o', 'eu_aut_date': '05-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/003/05', 'ema_number_certainty': '1.0'}"
EU-3-05-285,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/285', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/285', 'active_substance': 'Bimosiamose disodium', 'eu_mah_current': 'Revotar Biopharmaceuticals AG', 'orphan_status': 'o', 'eu_aut_date': '05-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/006/05', 'ema_number_certainty': '1.0'}"
EU-3-05-292,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/292', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/292', 'active_substance': 'H-D-Asp-D-Gln-D-Ser-D-Arg-D-Pro-D-Val-D-Gln-D-Pro-D-Phe-D-Leu-D-Asn-D-Leu-D-Thr-D-Thr-D-Pro-D-Arg-D-Lys-D-Pro-D-Arg-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-NH2', 'eu_mah_current': 'Auris Medical Limited', 'orphan_status': 'o', 'eu_aut_date': '06-16-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/013/05', 'ema_number_certainty': '1.0'}"
EU-3-05-286,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/286', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/286', 'active_substance': 'N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole', 'eu_mah_current': 'Dr Geoffrey Allan', 'orphan_status': 'o', 'eu_aut_date': '06-20-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/012/05', 'ema_number_certainty': '1.0'}"
EU-3-05-287,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/287', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/287', 'active_substance': 'Bovine bile extract', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-20-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/009/05', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-05-289,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/289', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/289', 'active_substance': 'Pegylated arginine deiminase', 'eu_mah_current': 'Dr Francesco Izzo', 'orphan_status': 'o', 'eu_aut_date': '06-20-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/087/04', 'ema_number_certainty': '1.0'}"
EU-3-05-288,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/288', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/288', 'active_substance': '4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine x HCl', 'eu_mah_current': 'Prilenia Therapeutics B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-20-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/011/05', 'ema_number_certainty': '0.42857142857142855'}"
EU-3-05-290,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/290', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/290', 'active_substance': 'Humanised antibody fragment (Ep-CAM)-truncated Pseudomonas exotoxin A fusion protein', 'eu_mah_current': 'Viventia Biotech (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-20-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/099/04', 'ema_number_certainty': '1.0'}"
EU-3-05-294,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/294', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/294', 'active_substance': 'Soluble yeast beta-1,3/1,6-glucan', 'eu_mah_current': 'Biotec Pharmacon ASA', 'orphan_status': 'o', 'eu_aut_date': '06-16-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/005/05', 'ema_number_certainty': '1.0'}"
EU-3-05-295,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/295', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/295', 'active_substance': 'Hepatitis C Immunoglobulin', 'eu_mah_current': 'Biotest Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-08-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/105/04', 'ema_number_certainty': '1.0'}"
EU-3-05-297,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/297', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/297', 'active_substance': 'Adeno-associated viral vector containing a modified U7-snRNA gene', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '07-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/026/05', 'ema_number_certainty': '1.0'}"
EU-3-05-300,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/300', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/300', 'active_substance': 'Nemorubicin hydrochloride', 'eu_mah_current': 'Nerviano Medical Sciences Srl', 'orphan_status': 'o', 'eu_aut_date': '07-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/018/05', 'ema_number_certainty': '1.0'}"
EU-3-05-299,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/299', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/299', 'active_substance': '4-imino-1, 3-diazobicyclo-[3.1.0]-hexan-2-one', 'eu_mah_current': 'ICON Clinical Research (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/028/05', 'ema_number_certainty': '1.0'}"
EU-3-05-301,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/301', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/301', 'active_substance': 'Chimeric monoclonal antibody to shiga-toxin 1 and 2', 'eu_mah_current': 'Taro Pharmaceuticals Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/033/05', 'ema_number_certainty': '0.75'}"
EU-3-05-302,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/302', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/302', 'active_substance': 'Extract of Sorghum bicolour leaf, Pterocarpus osun stem, Piper guineense seed and Caryophylli flower', 'eu_mah_current': 'Xechem UK Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/017/05', 'ema_number_certainty': '1.0'}"
EU-3-05-313,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/313', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/313', 'active_substance': 'Autologous CD34+ cells transfected with retroviral vector containing adenosine deaminase gene', 'eu_mah_current': 'Orchard Therapeutics (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/053/05', 'ema_number_certainty': '0.5'}"
EU-3-05-314,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/314', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/314', 'active_substance': '(1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/024/05', 'ema_number_certainty': '1.0'}"
EU-3-05-315,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/315', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/315', 'active_substance': '(2S)-2-[(4R)-2-oxo-4-propyltetrahydro-1H-pyrrol-1-yl] butanamide', 'eu_mah_current': 'UCB Pharma S.A.', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/044/05', 'ema_number_certainty': '1.0'}"
EU-3-05-317,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/317', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/317', 'active_substance': 'A mixture of anti-CD3 mAb (SPV-T3a)-ricin A chain fusion protein and anti-CD7 mAb (WT1)-ricin A chain fusion protein', 'eu_mah_current': 'Xenikos B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/046/05', 'ema_number_certainty': '1.0'}"
EU-3-05-307,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/307', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/307', 'active_substance': 'Mecasermin', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/025/05', 'ema_number_certainty': '1.0'}"
EU-3-05-310,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/310', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/310', 'active_substance': 'Treprostinil diethanolamine (oral use)', 'eu_mah_current': 'Ferrer Internacional S.A.', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/034/05', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-05-323,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/323', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/323', 'active_substance': 'Bacterial lipase', 'eu_mah_current': 'Nordmark Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-07-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/049/05', 'ema_number_certainty': '0.5'}"
EU-3-05-327,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/327', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/327', 'active_substance': 'Oligonucleotide phosphorothioate (TAAACGTTATAACGTTATGACGTCAT), sodium salt', 'eu_mah_current': 'Oligovax', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/030/05', 'ema_number_certainty': '1.0'}"
EU-3-05-328,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/328', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/328', 'active_substance': '(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/056/05', 'ema_number_certainty': '0.8'}"
EU-3-05-324,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/324', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/324', 'active_substance': 'Levamisol hydrochloride', 'eu_mah_current': 'ACE Pharmaceuticals BV', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/058/05', 'ema_number_certainty': '1.0'}"
EU-3-05-326,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/326', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/326', 'active_substance': 'Peptide 144 TGF- &#223;1 inhibitor (TSLDASIIWAMMQN)', 'eu_mah_current': 'Digna Biotech S.L.', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/035/05', 'ema_number_certainty': '1.0'}"
EU-3-05-329,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/329', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/329', 'active_substance': 'Peptide 144 TGF- &#223;1 inhibitor (TSLDASIIWAMMQN)', 'eu_mah_current': 'Digna Biotech S.L.', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/081/05', 'ema_number_certainty': '1.0'}"
EU-3-05-319,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/319', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/319', 'active_substance': 'Human Staphylococcus aureus immunoglobulin', 'eu_mah_current': 'Biotest Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/057/05', 'ema_number_certainty': '1.0'}"
EU-3-05-341,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/341', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/341', 'active_substance': 'Imexon', 'eu_mah_current': 'ICON Clinical Research (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '12-23-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/065/05', 'ema_number_certainty': '1.0'}"
EU-3-05-343,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/343', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/343', 'active_substance': 'Enzastaurin hydrochloride', 'eu_mah_current': 'Dlrc Pharma Services Limited', 'orphan_status': 'o', 'eu_aut_date': '12-23-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/068/05', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-05-334,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/334', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/334', 'active_substance': 'Human immunoglobulin G1 constant region - human ectodysplasin-A1 receptor-binding domain fusion protein', 'eu_mah_current': 'Florence Porte Thom&#233;', 'orphan_status': 'o', 'eu_aut_date': '12-14-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/064/05', 'ema_number_certainty': '0.75'}"
EU-3-05-346,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/05/346', 'status_type': 'a', 'eu_pnumber': 'EU/3/05/346', 'active_substance': 'E. Coli heat-shock protein 70 with bovine retinal S-antigen', 'eu_mah_current': 'Biotech Tools SA', 'orphan_status': 'o', 'eu_aut_date': '01-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/070/05', 'ema_number_certainty': '1.0'}"
EU-3-06-354,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/354', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/354', 'active_substance': 'Oxalobacter formigenes strain HC-1', 'eu_mah_current': 'OxThera AB', 'orphan_status': 'o', 'eu_aut_date': '02-17-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/095/05', 'ema_number_certainty': '1.0'}"
EU-3-06-355,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/355', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/355', 'active_substance': 'Zosuquidar trihydrochloride', 'eu_mah_current': 'Kanisa Europe Limited, Mofo Notices Limited, C/Morrison &amp; Foerster MNP', 'orphan_status': 'o', 'eu_aut_date': '02-17-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/100/05', 'ema_number_certainty': '1.0'}"
EU-3-06-356,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/356', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/356', 'active_substance': '4-amino-5-oxo-4 (pyridinium-1-ylmethyl) proline', 'eu_mah_current': 'Prodimed S.A.', 'orphan_status': 'o', 'eu_aut_date': '02-16-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/085/05', 'ema_number_certainty': '1.0'}"
EU-3-06-349,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/349', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/349', 'active_substance': 'Apomorphine hydrochloride (inhalation use)', 'eu_mah_current': 'Vectura Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-16-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/086/05', 'ema_number_certainty': '0.5'}"
EU-3-06-362,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/362', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/362', 'active_substance': 'Human heterologous liver cells (for infusion)', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '04-11-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/037/05', 'ema_number_certainty': '0.5'}"
EU-3-06-367,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/367', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/367', 'active_substance': 'Parathyroid hormone (1-34) transglutaminase fusion protein fibrin matrix complex', 'eu_mah_current': 'Kuros Biosurgery International AG', 'orphan_status': 'o', 'eu_aut_date': '04-11-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/107/05', 'ema_number_certainty': '1.0'}"
EU-3-06-363,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/363', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/363', 'active_substance': '4-[131I]iodo-L-phenylalanine', 'eu_mah_current': 'Telix Pharmaceuticals Holdings Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-11-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/110/05', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-06-360,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/360', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/360', 'active_substance': 'Ciclosporin', 'eu_mah_current': 'Santen Oy', 'orphan_status': 'o', 'eu_aut_date': '04-06-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/106/05', 'ema_number_certainty': '0.5'}"
EU-3-06-368,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/368', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/368', 'active_substance': '1-deoxygalactonojirimycin hydrochloride', 'eu_mah_current': 'Amicus Therapeutics Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '05-22-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/105/05', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-06-369,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/369', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/369', 'active_substance': 'Bilayer engineered skin composed of keratinocytes from the patient (autologous) and fibroblasts from a donor (allogeneic) embedded in a plasma matrix', 'eu_mah_current': 'Biodan Yelah S.L.', 'orphan_status': 'o', 'eu_aut_date': '05-22-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/111/05', 'ema_number_certainty': '0.5'}"
EU-3-06-376,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/376', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/376', 'active_substance': 'Recombinant P-selectin glycoprotein immunoglobulin', 'eu_mah_current': 'RJM Consultancy Ltd', 'orphan_status': 'o', 'eu_aut_date': '05-22-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/008/06', 'ema_number_certainty': '1.0'}"
EU-3-06-374,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/374', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/374', 'active_substance': 'Methoxsalen', 'eu_mah_current': 'Therakos Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '05-22-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/009/06', 'ema_number_certainty': '0.75'}"
EU-3-06-370,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/370', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/370', 'active_substance': 'Decitabine', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '06-08-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/004/06', 'ema_number_certainty': '1.0'}"
EU-3-06-371,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/371', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/371', 'active_substance': 'Heparin sodium', 'eu_mah_current': 'Ockham Biotech Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '05-22-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/001/06', 'ema_number_certainty': '0.5'}"
EU-3-06-381,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/381', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/381', 'active_substance': 'Human monoclonal antibody against Pseudomonas aeruginosa serotype O11', 'eu_mah_current': 'Marcello Menapace', 'orphan_status': 'o', 'eu_aut_date': '06-29-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/007/06', 'ema_number_certainty': '0.4'}"
EU-3-06-387,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/387', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/387', 'active_substance': 'Amikacin sulfate (liposomal)', 'eu_mah_current': 'Insmed Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-25-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/024/06', 'ema_number_certainty': '0.8'}"
EU-3-06-384,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/384', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/384', 'active_substance': 'Human telomerase reverse transcriptase peptide (611-626)', 'eu_mah_current': 'Klifo A/S', 'orphan_status': 'o', 'eu_aut_date': '07-25-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/026/06', 'ema_number_certainty': '0.6'}"
EU-3-06-386,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/386', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/386', 'active_substance': '4-[123I]iodo-L-phenylalanine', 'eu_mah_current': 'Therapeia GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '07-25-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/015/06', 'ema_number_certainty': '1.0'}"
EU-3-06-399,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/399', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/399', 'active_substance': 'Mecasermin rinfabate', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/031/06', 'ema_number_certainty': '0.5'}"
EU-3-06-390,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/390', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/390', 'active_substance': '4-amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride', 'eu_mah_current': 'vasopharm GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/035/06', 'ema_number_certainty': '1.0'}"
EU-3-06-400,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/400', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/400', 'active_substance': 'Metastable technetium 99 [99mTc] demogastrin 2', 'eu_mah_current': 'Biomedica Life Sciences SA', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/014/06', 'ema_number_certainty': '1.0'}"
EU-3-06-394,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/394', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/394', 'active_substance': 'Autologous tumor-derived immunoglobulin idiotype coupled to keyhole limpet haemocyanin', 'eu_mah_current': 'Biovest Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/040/06', 'ema_number_certainty': '1.0'}"
EU-3-06-395,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/395', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/395', 'active_substance': 'Aviptadil', 'eu_mah_current': 'mondoBIOTECH Laboratories Anstalt', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/022/06', 'ema_number_certainty': '1.0'}"
EU-3-06-396,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/396', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/396', 'active_substance': 'Cardiotrophin-1', 'eu_mah_current': 'Digna Biotech S.L.', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/037/06', 'ema_number_certainty': '1.0'}"
EU-3-06-405,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/405', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/405', 'active_substance': 'Genetically modified allogeneic (human) tumour cells for the expression of IL-7, GM-CSF, CD80 and CD154, in fixed combination with a DNA-based double stem loop immunomodulator (dSLIM)', 'eu_mah_current': 'MOLOGEN AG', 'orphan_status': 'o', 'eu_aut_date': '10-23-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/021/06', 'ema_number_certainty': '1.0'}"
EU-3-06-404,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/404', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/404', 'active_substance': 'Adenoviral vector containing human p53 gene', 'eu_mah_current': 'Gendux Molecular Limited', 'orphan_status': 'o', 'eu_aut_date': '10-23-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/034/06', 'ema_number_certainty': '1.0'}"
EU-3-06-409,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/409', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/409', 'active_substance': 'L-asparaginase encapsulated in erythrocytes', 'eu_mah_current': 'ERYtech Pharma S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-27-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/033/06', 'ema_number_certainty': '1.0'}"
EU-3-06-410,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/410', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/410', 'active_substance': 'Doxorubicin hydrochloride (liposomal)', 'eu_mah_current': 'GP-Pharm S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-27-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/042/06', 'ema_number_certainty': '1.0'}"
EU-3-06-407,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/407', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/407', 'active_substance': 'Heparin-binding epidermal growth factor-like growth factor (HB-EGF), amino acids 74-148', 'eu_mah_current': 'Dr Michael Moore', 'orphan_status': 'o', 'eu_aut_date': '10-31-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/046/06', 'ema_number_certainty': '1.0'}"
EU-3-06-408,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/408', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/408', 'active_substance': 'Human cytomegalovirus immunoglobulin', 'eu_mah_current': 'Biotest Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-31-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/052/06', 'ema_number_certainty': '1.0'}"
EU-3-06-411,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/411', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/411', 'active_substance': 'Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule', 'eu_mah_current': 'Apogenix AG', 'orphan_status': 'o', 'eu_aut_date': '10-31-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/054/06', 'ema_number_certainty': '0.5'}"
EU-3-06-417,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/417', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/417', 'active_substance': 'Human Interleukin-2 (glycosylated tetrasaccharide, glycosylated trisaccharide and non-glycosylated) (inhalation use)', 'eu_mah_current': 'Immunservice GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-27-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/047/06', 'ema_number_certainty': '1.0'}"
EU-3-06-416,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/416', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/416', 'active_substance': 'Antisense oligonucleotide 5&#39;-d[P-Thio](CCCTG CTCCC CCCTG GCTCC)-3&#39;', 'eu_mah_current': 'EleosInc Limited', 'orphan_status': 'o', 'eu_aut_date': '11-03-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/056/06', 'ema_number_certainty': '1.0'}"
EU-3-06-412,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/412', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/412', 'active_substance': '4,7,10,13,16,19-docosahexaenoic acid', 'eu_mah_current': 'Natac Pharma S.L.', 'orphan_status': 'o', 'eu_aut_date': '11-03-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/057/06', 'ema_number_certainty': '1.0'}"
EU-3-06-413,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/413', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/413', 'active_substance': 'Budesonide (oral use)', 'eu_mah_current': 'Dr Falk Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-03-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/049/06', 'ema_number_certainty': '1.0'}"
EU-3-06-414,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/414', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/414', 'active_substance': 'Catumaxomab', 'eu_mah_current': 'Neovii Biotech GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-03-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/044/06', 'ema_number_certainty': '1.0'}"
EU-3-06-419,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/419', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/419', 'active_substance': 'Paclitaxel (liposomal)', 'eu_mah_current': 'SynCore Biotechnology Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-31-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/063/06', 'ema_number_certainty': '0.5'}"
EU-3-06-421,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/421', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/421', 'active_substance': 'Forodesine hydrochloride', 'eu_mah_current': 'Mundipharma Corporation (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '12-18-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/070/06', 'ema_number_certainty': '0.5'}"
EU-3-06-429,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/429', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/429', 'active_substance': 'Recombinant modified vaccinia Ankara expressing human 5T4', 'eu_mah_current': 'Oxford Biomedica (UK) Ltd', 'orphan_status': 'o', 'eu_aut_date': '01-26-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/084/06', 'ema_number_certainty': '1.0'}"
EU-3-06-428,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/06/428', 'status_type': 'a', 'eu_pnumber': 'EU/3/06/428', 'active_substance': 'Forodesine hydrochloride', 'eu_mah_current': 'Mundipharma Corporation (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '01-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/069/06', 'ema_number_certainty': '0.5'}"
EU-3-07-434,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/434', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/434', 'active_substance': 'Idebenone', 'eu_mah_current': 'Santhera Pharmaceuticals (Deutschland) GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-15-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/076/06', 'ema_number_certainty': '1.0'}"
EU-3-07-435,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/435', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/435', 'active_substance': 'Recombinant human C1-inhibitor', 'eu_mah_current': 'Pharming Group N.V.', 'orphan_status': 'o', 'eu_aut_date': '02-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/086/06', 'ema_number_certainty': '1.0'}"
EU-3-07-431,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/431', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/431', 'active_substance': 'Autologous dendritic cells pulsed with autologous tumour cell lysate', 'eu_mah_current': 'Northwest Biotherapeutics GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-15-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/081/06', 'ema_number_certainty': '1.0'}"
EU-3-07-432,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/432', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/432', 'active_substance': 'Ex-vivo cultured adult human mesenchymal stem cells', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '02-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/068/06', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-07-430,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/430', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/430', 'active_substance': 'artesunate', 'eu_mah_current': 'ACE Pharmaceuticals BV', 'orphan_status': 'o', 'eu_aut_date': '02-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/090/06', 'ema_number_certainty': '1.0'}"
EU-3-07-443,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/443', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/443', 'active_substance': 'Elafin', 'eu_mah_current': 'Proteo Biotech AG', 'orphan_status': 'o', 'eu_aut_date': '03-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/088/06', 'ema_number_certainty': '1.0'}"
EU-3-07-442,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/442', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/442', 'active_substance': 'Enzastaurin hydrochloride', 'eu_mah_current': 'Dlrc Pharma Services Limited', 'orphan_status': 'o', 'eu_aut_date': '03-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/097/06', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-07-437,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/437', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/437', 'active_substance': 'Idebenone', 'eu_mah_current': 'Santhera Pharmaceuticals (Deutschland) GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/077/06', 'ema_number_certainty': '1.0'}"
EU-3-07-438,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/438', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/438', 'active_substance': 'Zanolimumab', 'eu_mah_current': 'TenX Biopharma Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/096/06', 'ema_number_certainty': '1.0'}"
EU-3-07-440,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/440', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/440', 'active_substance': 'Recombinant adeno-associated viral vector containing human alpha-1 antitrypsin gene', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/078/06', 'ema_number_certainty': '0.25'}"
EU-3-07-441,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/441', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/441', 'active_substance': 'Hydrocortisone', 'eu_mah_current': 'Diurnal Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/095/06', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-07-445,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/445', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/445', 'active_substance': 'Antisense Oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT)', 'eu_mah_current': 'Gene Signal SAS', 'orphan_status': 'o', 'eu_aut_date': '04-17-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/091/06', 'ema_number_certainty': '1.0'}"
EU-3-07-446,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/446', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/446', 'active_substance': 'Autologous CD34+ cells transfected with lentiviral vector containing the human arylsulfatase A cDNA', 'eu_mah_current': 'Orchard Therapeutics (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-13-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/102/06', 'ema_number_certainty': '0.5'}"
EU-3-07-444,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/444', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/444', 'active_substance': 'Pralatrexate', 'eu_mah_current': 'TurnKey PharmaConsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '04-13-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/100/06', 'ema_number_certainty': '0.6'}"
EU-3-07-453,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/453', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/453', 'active_substance': 'Recombinant fusion protein consisting of human coagulation factor IX attached to the Fc domain of human IgG1', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'o', 'eu_aut_date': '06-08-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/012/07', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-07-451,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/451', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/451', 'active_substance': 'Cisplatin (liposomal)', 'eu_mah_current': 'Regulon AE', 'orphan_status': 'o', 'eu_aut_date': '06-08-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/103/06', 'ema_number_certainty': '1.0'}"
EU-3-07-452,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/452', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/452', 'active_substance': 'R-1-[2,3-dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1 H -1,4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/014/07', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-07-448,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/448', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/448', 'active_substance': 'Talactoferrinum alfa', 'eu_mah_current': 'Agennix Limited', 'orphan_status': 'o', 'eu_aut_date': '06-05-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/010/07', 'ema_number_certainty': '1.0'}"
EU-3-07-459,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/459', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/459', 'active_substance': '1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride', 'eu_mah_current': 'Bioprojet Pharma', 'orphan_status': 'o', 'eu_aut_date': '07-10-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/087/06', 'ema_number_certainty': '1.0'}"
EU-3-07-463,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/463', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/463', 'active_substance': 'Pyridoxalated haemoglobin polyoxyethylene', 'eu_mah_current': 'Curacyte AG', 'orphan_status': 'o', 'eu_aut_date': '08-02-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/021/07', 'ema_number_certainty': '1.0'}"
EU-3-07-461,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/461', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/461', 'active_substance': 'Human plasminogen', 'eu_mah_current': 'Kedrion S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '08-03-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/022/07', 'ema_number_certainty': '1.0'}"
EU-3-07-470,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/470', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/470', 'active_substance': 'Human heterologous liver cells (for infusion)', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/042/07', 'ema_number_certainty': '0.5'}"
EU-3-07-471,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/471', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/471', 'active_substance': 'Human coagulation factor X', 'eu_mah_current': 'BPL Bioproducts Laboratory GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-17-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/044/07', 'ema_number_certainty': '0.5'}"
EU-3-07-473,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/473', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/473', 'active_substance': 'Aviptadil', 'eu_mah_current': 'mondoBIOTECH Laboratories Anstalt', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/003/07', 'ema_number_certainty': '1.0'}"
EU-3-07-475,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/475', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/475', 'active_substance': 'Alginate oligosaccharide (G-block) fragment', 'eu_mah_current': 'AlgiPharma AS', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/104/06', 'ema_number_certainty': '1.0'}"
EU-3-07-479,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/479', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/479', 'active_substance': 'N-adamantanyl-N&#39;-geranyl-ethylenediamine', 'eu_mah_current': 'RLM Consulting', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/036/07', 'ema_number_certainty': '1.0'}"
EU-3-07-480,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/480', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/480', 'active_substance': 'Naptumomab estafenatox', 'eu_mah_current': 'Active Biotech AB', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/048/07', 'ema_number_certainty': '1.0'}"
EU-3-07-481,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/481', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/481', 'active_substance': 'R-salbutamol sulphate', 'eu_mah_current': 'Astion Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/032/07', 'ema_number_certainty': '1.0'}"
EU-3-07-476,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/476', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/476', 'active_substance': '5&#180;-O-(trans-9&#180;-octadecenoyl)-1-&#223;-D-arabinofuranosyl cytosine', 'eu_mah_current': 'Aqualis ASA', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/049/07', 'ema_number_certainty': '1.0'}"
EU-3-07-477,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/477', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/477', 'active_substance': '4-Amino-1-[5-O-[(2R,4S)-2-oxido-4-(4-pyridinyl)-1,3,2-dioxaphosphorinan-2-yl]-&#223;-D-arabinofuranosyl]-2(1H)-pyrimidinone', 'eu_mah_current': 'Interface International Consultancy Limited', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/045/07', 'ema_number_certainty': '1.0'}"
EU-3-07-495,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/495', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/495', 'active_substance': 'Methotrexate (oral liquid)', 'eu_mah_current': 'Orbona Pharma Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-24-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/064/07', 'ema_number_certainty': '0.5'}"
EU-3-07-496,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/496', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/496', 'active_substance': 'Mercaptopurine (oral liquid)', 'eu_mah_current': 'Orbona Pharma Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/065/07', 'ema_number_certainty': '1.0'}"
EU-3-07-486,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/486', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/486', 'active_substance': 'Adenovirus associated viral vector serotype 4 containing the human RPE65 gene', 'eu_mah_current': 'Coave Therapeutics', 'orphan_status': 'o', 'eu_aut_date': '11-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/043/07', 'ema_number_certainty': '0.5'}"
EU-3-07-487,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/487', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/487', 'active_substance': '4-ethoxy-2-(piperazin-1-yl)-7-(pyridin-4-yl)-5H-pyrimido[5,4-b]indol', 'eu_mah_current': 'BlackSwan Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/057/07', 'ema_number_certainty': '1.0'}"
EU-3-07-498,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/498', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/498', 'active_substance': 'Polihexanide', 'eu_mah_current': 'S.I.F.I. Societ&#224; Industria Farmaceutica Italiana S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '11-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/037/07', 'ema_number_certainty': '1.0'}"
EU-3-07-489,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/489', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/489', 'active_substance': 'Ciclosporin', 'eu_mah_current': 'SANTEN S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '10-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/061/07', 'ema_number_certainty': '1.0'}"
EU-3-07-455,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/455', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/455', 'active_substance': 'Ciclosporin', 'eu_mah_current': 'SANTEN S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '10-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/060/07', 'ema_number_certainty': '1.0'}"
EU-3-07-491,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/491', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/491', 'active_substance': 'Interferon gamma', 'eu_mah_current': 'mondoBIOTECH Laboratories AG', 'orphan_status': 'o', 'eu_aut_date': '10-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/054/07', 'ema_number_certainty': '1.0'}"
EU-3-07-484,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/484', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/484', 'active_substance': 'Adenovirus associated viral vector serotype 4 containing the human RPE65 gene', 'eu_mah_current': 'Coave Therapeutics', 'orphan_status': 'o', 'eu_aut_date': '10-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/072/07', 'ema_number_certainty': '0.5'}"
EU-3-07-485,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/485', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/485', 'active_substance': 'Alvocidib', 'eu_mah_current': 'Labcorp Clinical Development GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-23-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/059/07', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-07-505,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/505', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/505', 'active_substance': 'Interferon beta', 'eu_mah_current': 'Faron Pharmaceuticals Limited', 'orphan_status': 'o', 'eu_aut_date': '11-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/080/07', 'ema_number_certainty': '0.5'}"
EU-3-07-508,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/508', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/508', 'active_substance': 'Chimeric-anti-interleukin-6 monoclonal antibody', 'eu_mah_current': 'EUSA Pharma (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-30-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/078/07', 'ema_number_certainty': '0.75'}"
EU-3-07-511,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/511', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/511', 'active_substance': '3-methoxy-pregnenolone', 'eu_mah_current': 'MAPREG SAS', 'orphan_status': 'o', 'eu_aut_date': '12-04-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/082/07', 'ema_number_certainty': '1.0'}"
EU-3-07-513,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/513', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/513', 'active_substance': '(S)-2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine', 'eu_mah_current': 'Mylan IRE Healthcare Ltd', 'orphan_status': 'o', 'eu_aut_date': '11-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/074/07', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-07-499,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/499', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/499', 'active_substance': 'Terguride', 'eu_mah_current': 'Ergonex Licensing and Regulatory Services AG', 'orphan_status': 'o', 'eu_aut_date': '11-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/083/07', 'ema_number_certainty': '1.0'}"
EU-3-07-514,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/514', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/514', 'active_substance': '(1R, 2R)-Octanoic acid [2-(2,3-dihydro-benzo [1,4] dioxin-6-yl)-2-hydroxy-1-pyrrolidin-1-ylmethyl-ethyl]-amide-L-tartaric acid salt', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-04-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/066/07', 'ema_number_certainty': '1.0'}"
EU-3-07-503,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/503', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/503', 'active_substance': 'Recombinant human hepatitis C monoclonal antibody against C4 region of E1', 'eu_mah_current': 'GENimmune N.V', 'orphan_status': 'o', 'eu_aut_date': '12-06-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/058/07', 'ema_number_certainty': '1.0'}"
EU-3-07-510,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/510', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/510', 'active_substance': 'artesunate', 'eu_mah_current': 'Sigma-Tau Industrie Farmaceutiche Riunite S.p.A', 'orphan_status': 'o', 'eu_aut_date': '12-06-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/084/07', 'ema_number_certainty': '1.0'}"
EU-3-07-506,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/506', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/506', 'active_substance': 'Heterologous human adult liver derived stem cells', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '11-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/039/07', 'ema_number_certainty': '1.0'}"
EU-3-07-521,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/521', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/521', 'active_substance': 'H-Arg-Leu-Phe-Phe-Tyr-Arg-Lys-Ser-Val-OH, acetate salt &amp; H-Tyr-Leu-Phe-Phe-Tyr-Arg-Lys-Ser-Val-OH, acetate salt', 'eu_mah_current': 'Vaxon Biotech', 'orphan_status': 'o', 'eu_aut_date': '12-18-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/081/07', 'ema_number_certainty': '0.5'}"
EU-3-07-516,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/516', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/516', 'active_substance': 'Recombinant human histone H1.3 and recombinant human N-bis-met-histone H1.3', 'eu_mah_current': 'Xenetic Biosciences Plc', 'orphan_status': 'o', 'eu_aut_date': '12-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/087/07', 'ema_number_certainty': '1.0'}"
EU-3-07-519,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/519', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/519', 'active_substance': 'Maribavir', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'o', 'eu_aut_date': '12-18-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/067/07', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-07-520,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/520', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/520', 'active_substance': 'Human papilloma virus type 16 E6/E7 synthetic long peptides', 'eu_mah_current': 'ISA Therapeutics B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/077/07', 'ema_number_certainty': '1.0'}"
EU-3-07-524,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/524', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/524', 'active_substance': '(R)-2-Methyl-6-nitro-2-{4-[4-(4-trifluoromethoxyphenoxy)piperidin-1-yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-b]oxazole', 'eu_mah_current': 'Otsuka Novel Products GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/094/07', 'ema_number_certainty': '1.0'}"
EU-3-07-525,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/525', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/525', 'active_substance': 'Iodine (131I) iobenguane', 'eu_mah_current': 'Excelsior Life Sciences Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '01-31-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/096/07', 'ema_number_certainty': '0.5'}"
EU-3-07-523,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/07/523', 'status_type': 'a', 'eu_pnumber': 'EU/3/07/523', 'active_substance': 'Lutetium (177Lu)-N-[(4,7,10-Tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-L-cysteinyl-L-threonine-cyclic(2-7)disulfide', 'eu_mah_current': 'Advanced Accelerator Applications', 'orphan_status': 'o', 'eu_aut_date': '01-31-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/093/07', 'ema_number_certainty': '1.0'}"
EU-3-08-529,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/529', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/529', 'active_substance': 'Tretazicar', 'eu_mah_current': 'Morvus Technology Limited', 'orphan_status': 'o', 'eu_aut_date': '02-04-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/095/07', 'ema_number_certainty': '1.0'}"
EU-3-08-530,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/530', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/530', 'active_substance': 'Heterologous human adult liver derived stem cells', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '02-04-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/101/07', 'ema_number_certainty': '1.0'}"
EU-3-08-539,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/539', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/539', 'active_substance': 'Ammonium tetrathiomolybdate', 'eu_mah_current': 'JJGConsultancy Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/114/07', 'ema_number_certainty': '1.0'}"
EU-3-08-531,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/531', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/531', 'active_substance': 'ascorbic acid', 'eu_mah_current': 'Murigenetics SAS', 'orphan_status': 'o', 'eu_aut_date': '04-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/100/07', 'ema_number_certainty': '1.0'}"
EU-3-08-532,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/532', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/532', 'active_substance': 'filgrastim', 'eu_mah_current': 'NeuroVision Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/102/07', 'ema_number_certainty': '1.0'}"
EU-3-08-535,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/535', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/535', 'active_substance': 'Humanised monoclonal antibody to the folate receptor alpha', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/110/07', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-08-540,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/540', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/540', 'active_substance': 'Omigapil maleate', 'eu_mah_current': 'Santhera Pharmaceuticals (Deutschland) GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-08-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/104/07', 'ema_number_certainty': '1.0'}"
EU-3-08-541,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/541', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/541', 'active_substance': '[Nle4, D-Phe7]-alpha-melanocyte stimulating hormone', 'eu_mah_current': 'Clinuvel Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '05-08-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/108/07', 'ema_number_certainty': '0.5'}"
EU-3-08-542,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/542', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/542', 'active_substance': 'Ribonucleotide reductase R2 specific phosphorothioate oligonucleotide', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-08-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/118/07', 'ema_number_certainty': '0.5'}"
EU-3-08-544,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/544', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/544', 'active_substance': 'Omigapil maleate', 'eu_mah_current': 'Santhera Pharmaceuticals (Deutschland) GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-08-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/009/08', 'ema_number_certainty': '1.0'}"
EU-3-08-545,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/545', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/545', 'active_substance': '[Nle4, D-Phe7]-alpha-melanocyte stimulating hormone', 'eu_mah_current': 'Clinuvel Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '05-08-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/019/08', 'ema_number_certainty': '0.5'}"
EU-3-08-550,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/550', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/550', 'active_substance': 'Nimotuzumab', 'eu_mah_current': 'Oncoscience GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/006/08', 'ema_number_certainty': '0.5'}"
EU-3-08-553,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/553', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/553', 'active_substance': 'Recombinant fusion protein of circulary-permuted IL-4 and pseudomonas exotoxin A, [IL-4(38-37)-PE38KDEL]', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '06-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/004/08', 'ema_number_certainty': '0.5'}"
EU-3-08-546,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/546', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/546', 'active_substance': 'Alpha-1 proteinase inhibitor (inhalation use)', 'eu_mah_current': 'Grifols Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/001/08', 'ema_number_certainty': '1.0'}"
EU-3-08-548,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/548', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/548', 'active_substance': 'Carfilzomib', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/120/07', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-08-549,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/549', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/549', 'active_substance': 'NGR-human tumour necrosis factor', 'eu_mah_current': 'MolMed S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '06-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/003/08', 'ema_number_certainty': '1.0'}"
EU-3-08-555,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/555', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/555', 'active_substance': 'Vincristine sulphate liposomes', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '07-08-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/002/08', 'ema_number_certainty': '0.75'}"
EU-3-08-557,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/557', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/557', 'active_substance': 'Sapacitabine', 'eu_mah_current': 'Cyclacel Limited', 'orphan_status': 'o', 'eu_aut_date': '07-08-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/014/08', 'ema_number_certainty': '1.0'}"
EU-3-08-558,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/558', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/558', 'active_substance': 'Sapacitabine', 'eu_mah_current': 'Cyclacel Limited', 'orphan_status': 'o', 'eu_aut_date': '07-10-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/015/08', 'ema_number_certainty': '1.0'}"
EU-3-08-563,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/563', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/563', 'active_substance': 'Recombinant derivative of C3 transferase', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '09-05-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/012/08', 'ema_number_certainty': '0.5'}"
EU-3-08-560,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/560', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/560', 'active_substance': '(-)-(2R)-3-(2-hydroxymethylindanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate', 'eu_mah_current': 'KeyNeurotek Pharmaceuticals AG', 'orphan_status': 'o', 'eu_aut_date': '09-05-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/007/07', 'ema_number_certainty': '1.0'}"
EU-3-08-562,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/562', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/562', 'active_substance': 'Topotecan hydrochloride (liposomal)', 'eu_mah_current': 'Dr Matthias Luz', 'orphan_status': 'o', 'eu_aut_date': '09-05-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/023/08', 'ema_number_certainty': '1.0'}"
EU-3-08-564,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/564', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/564', 'active_substance': 'Avian polyclonal IgY antibody against Pseudomonas aeruginosa', 'eu_mah_current': 'Immunsystem I.M.S. AB', 'orphan_status': 'o', 'eu_aut_date': '09-23-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/031/08', 'ema_number_certainty': '1.0'}"
EU-3-08-567,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/567', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/567', 'active_substance': 'Miltefosine', 'eu_mah_current': 'ExperGen Drug Development GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-22-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/030/08', 'ema_number_certainty': '1.0'}"
EU-3-08-568,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/568', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/568', 'active_substance': 'N&#39;-(5-chloro-2-hydroxy-3-methylbenzylidene)-2,4-dihydroxybenzhydrazide', 'eu_mah_current': 'Creative Antibiotics Sweden AB', 'orphan_status': 'o', 'eu_aut_date': '09-22-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/029/08', 'ema_number_certainty': '1.0'}"
EU-3-08-569,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/569', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/569', 'active_substance': 'Pegylated L-asparaginase', 'eu_mah_current': 'Sigma-Tau Rare Diseases, S.A.', 'orphan_status': 'o', 'eu_aut_date': '09-22-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/032/08', 'ema_number_certainty': '1.0'}"
EU-3-08-570,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/570', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/570', 'active_substance': 'Recombinant human CXCL8 mutant', 'eu_mah_current': 'ProtAffin Biotechnologie AG', 'orphan_status': 'o', 'eu_aut_date': '09-22-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/026/08', 'ema_number_certainty': '1.0'}"
EU-3-08-578,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/578', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/578', 'active_substance': 'Cysteamine hydrochloride', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/036/08', 'ema_number_certainty': '1.0'}"
EU-3-08-579,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/579', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/579', 'active_substance': 'Ex-vivo expanded autologous human corneal epithelium containing stem cells', 'eu_mah_current': 'Holostem Terapie Avanzate S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/025/08', 'ema_number_certainty': '0.5'}"
EU-3-08-580,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/580', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/580', 'active_substance': 'Filgrastim', 'eu_mah_current': 'NeuroVision Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/042/08', 'ema_number_certainty': '1.0'}"
EU-3-08-583,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/583', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/583', 'active_substance': 'Gadodiamide (liposomal)', 'eu_mah_current': 'Dr Matthias Luz', 'orphan_status': 'o', 'eu_aut_date': '12-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/034/08', 'ema_number_certainty': '1.0'}"
EU-3-08-585,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/585', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/585', 'active_substance': 'Daunorubicin (liposomal)', 'eu_mah_current': 'Diatos S. A.', 'orphan_status': 'o', 'eu_aut_date': '12-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/048/08', 'ema_number_certainty': '1.0'}"
EU-3-08-587,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/587', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/587', 'active_substance': 'Cenersen', 'eu_mah_current': 'EleosInc Limited', 'orphan_status': 'o', 'eu_aut_date': '12-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/054/08', 'ema_number_certainty': '1.0'}"
EU-3-08-588,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/588', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/588', 'active_substance': 'Recombinant human ADAMTS-13', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/056/08', 'ema_number_certainty': '1.0'}"
EU-3-08-594,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/594', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/594', 'active_substance': 'Recombinant human tissue non-specific alkaline phosphatase - Fc - deca-aspartate fusion protein', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '12-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/071/08', 'ema_number_certainty': '1.0'}"
EU-3-08-595,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/595', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/595', 'active_substance': 'Monoclonal antibody against human CD30 covalently linked to the cytotoxin monomethylauristatin E', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '01-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/072/08', 'ema_number_certainty': '0.75'}"
EU-3-08-596,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/596', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/596', 'active_substance': 'Monoclonal antibody against human CD30 covalently linked to the cytotoxin monomethylauristatin E', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '01-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/073/08', 'ema_number_certainty': '1.0'}"
EU-3-08-598,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/598', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/598', 'active_substance': 'Exon 44 specific phosphorothioate oligonucleotide', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '02-27-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/081/08', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-08-599,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/599', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/599', 'active_substance': 'Exon 51 specific phosphorothioate oligonucleotide', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '02-27-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/082/08', 'ema_number_certainty': '0.75'}"
EU-3-08-600,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/600', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/600', 'active_substance': 'Human anti-intercellular adhesion molecule-1 monoclonal antibody', 'eu_mah_current': 'BioInvent International AB', 'orphan_status': 'o', 'eu_aut_date': '01-20-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/076/08', 'ema_number_certainty': '1.0'}"
EU-3-08-603,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/603', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/603', 'active_substance': 'Pralatrexate', 'eu_mah_current': 'TurnKey PharmaConsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '01-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/074/08', 'ema_number_certainty': '0.5'}"
EU-3-08-607,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/607', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/607', 'active_substance': 'Type I native bovine skin collagen', 'eu_mah_current': 'arGentis Autoimmune Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '02-09-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/079/08', 'ema_number_certainty': '1.0'}"
EU-3-08-610,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/610', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/610', 'active_substance': 'Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide, (L)-malate salt', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'o', 'eu_aut_date': '02-06-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/088/08', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-08-611,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/611', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/611', 'active_substance': 'Recombinant human hepatocarcinoma-intestine-pancreas / pancreatic associated protein', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '02-11-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/085/08', 'ema_number_certainty': '0.5'}"
EU-3-08-612,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/08/612', 'status_type': 'a', 'eu_pnumber': 'EU/3/08/612', 'active_substance': 'Recombinant human proinsulin', 'eu_mah_current': 'ProRetina Therapeutics S.L.', 'orphan_status': 'o', 'eu_aut_date': '02-11-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/087/08', 'ema_number_certainty': '1.0'}"
EU-3-09-614,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/614', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/614', 'active_substance': 'Mifepristone', 'eu_mah_current': 'EXELGYN', 'orphan_status': 'o', 'eu_aut_date': '02-27-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/086/08', 'ema_number_certainty': '1.0'}"
EU-3-09-615,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/615', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/615', 'active_substance': 'N-terminal hexaglutamine-tagged recombinant human N-acetylgalactosamine-6-sulfate sulfatase', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-27-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/097/08', 'ema_number_certainty': '0.75'}"
EU-3-09-616,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/616', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/616', 'active_substance': '(6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine dihydrochloride monohydrate', 'eu_mah_current': 'Knopp Neurosciences Sub Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-27-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/096/08', 'ema_number_certainty': '1.0'}"
EU-3-09-617,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/617', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/617', 'active_substance': '2,2-dimethylbutyric acid, sodium salt', 'eu_mah_current': 'Isabelle Ramirez', 'orphan_status': 'o', 'eu_aut_date': '02-27-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/098/08', 'ema_number_certainty': '1.0'}"
EU-3-09-621,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/621', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/621', 'active_substance': '2,2-dimethylbutyric acid, sodium salt', 'eu_mah_current': 'Isabelle Ramirez', 'orphan_status': 'o', 'eu_aut_date': '03-18-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/107/08', 'ema_number_certainty': '1.0'}"
EU-3-09-622,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/622', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/622', 'active_substance': 'N-(5-tert-Butylisoxazol-3-yl)-N&#39;-{4-[7-(2-(morpholin-4-yl)ethoxy) imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea di-hydrochloride salt', 'eu_mah_current': 'Daiichi Sankyo Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-23-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/105/08', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-09-623,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/623', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/623', 'active_substance': 'Autologous haematopoietic stem cells transduced with lentiviral vector encoding the human beta-globin gene', 'eu_mah_current': 'EGT San Rocco Italia SRL', 'orphan_status': 'o', 'eu_aut_date': '04-29-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/111/08', 'ema_number_certainty': '1.0'}"
EU-3-09-624,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/624', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/624', 'active_substance': 'Autologous tumour-derived gp96 heat shock protein-peptide complex', 'eu_mah_current': 'Antigenics Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '04-29-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/104/08', 'ema_number_certainty': '1.0'}"
EU-3-09-625,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/625', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/625', 'active_substance': 'Guanabenz', 'eu_mah_current': 'Acure Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '04-29-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/116/08', 'ema_number_certainty': '1.0'}"
EU-3-09-629,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/629', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/629', 'active_substance': 'Nanobody directed towards the human A1 domain of von Willebrand factor', 'eu_mah_current': 'Ablynx N.V.', 'orphan_status': 'o', 'eu_aut_date': '04-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/109/08', 'ema_number_certainty': '1.0'}"
EU-3-09-630,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/630', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/630', 'active_substance': 'Skin equivalent graft genetically corrected with a COL7A1-encoding SIN retroviral vector', 'eu_mah_current': 'Prof. Alain Hovnanian', 'orphan_status': 'o', 'eu_aut_date': '04-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/099/08', 'ema_number_certainty': '1.0'}"
EU-3-09-632,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/632', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/632', 'active_substance': 'Adeno-associated viral vector containing porphobilinogen deaminase gene', 'eu_mah_current': 'uniQure Biopharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-29-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/102/08', 'ema_number_certainty': '1.0'}"
EU-3-09-633,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/633', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/633', 'active_substance': 'L-asparaginase encapsulated in erythrocytes', 'eu_mah_current': 'ERYtech Pharma S.A.', 'orphan_status': 'o', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/100/08', 'ema_number_certainty': '1.0'}"
EU-3-09-634,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/634', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/634', 'active_substance': 'S-[2,3-bispalmitoyloxy-(2R)-propyl]-cysteinyl-GNNDESNISFKEK', 'eu_mah_current': 'MBiotec GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/101/08', 'ema_number_certainty': '1.0'}"
EU-3-09-635,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/635', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/635', 'active_substance': 'Treprostinil diethanolamine', 'eu_mah_current': 'Unither Therapeutik GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/106/08', 'ema_number_certainty': '0.5'}"
EU-3-09-637,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/637', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/637', 'active_substance': '2&#39;,3&#39;,5&#39;-tri-O-acetyluridine', 'eu_mah_current': 'Wellstat Therapeutics EU Limited', 'orphan_status': 'o', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/113/08', 'ema_number_certainty': '0.5'}"
EU-3-09-638,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/638', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/638', 'active_substance': 'Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2', 'eu_mah_current': 'Opsona Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/119/08', 'ema_number_certainty': '1.0'}"
EU-3-09-641,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/641', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/641', 'active_substance': 'Alicaforsen', 'eu_mah_current': 'Atlantic Healthcare Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/007/09', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-09-645,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/645', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/645', 'active_substance': 'Octreotide chloride (lipid depot solution)', 'eu_mah_current': 'Camurus AB', 'orphan_status': 'o', 'eu_aut_date': '06-12-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/010/09', 'ema_number_certainty': '0.5'}"
EU-3-09-648,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/648', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/648', 'active_substance': 'Afamelanotide', 'eu_mah_current': 'Clinuvel Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/019/09', 'ema_number_certainty': '0.5'}"
EU-3-09-650,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/650', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/650', 'active_substance': 'Blinatumomab', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/029/09', 'ema_number_certainty': '1.0'}"
EU-3-09-651,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/651', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/651', 'active_substance': 'Ciclosporin (eye drops, solution)', 'eu_mah_current': 'Allergan Pharmaceuticals Ireland', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/014/09', 'ema_number_certainty': '1.0'}"
EU-3-09-652,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/652', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/652', 'active_substance': 'Ciprofloxacin (liposomal)', 'eu_mah_current': 'Savara ApS', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/037/09', 'ema_number_certainty': '0.5'}"
EU-3-09-653,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/653', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/653', 'active_substance': 'Eculizumab', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/027/09', 'ema_number_certainty': '1.0'}"
EU-3-09-654,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/654', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/654', 'active_substance': 'Hypothiocyanite / lactoferrin', 'eu_mah_current': 'Alaxia S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/009/09', 'ema_number_certainty': '1.0'}"
EU-3-09-656,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/656', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/656', 'active_substance': 'Recombinant histidine-tagged idiotype immunoglobulin Fab fragment of clonal B-cell receptors', 'eu_mah_current': 'CellGenix GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/091/08', 'ema_number_certainty': '1.0'}"
EU-3-09-657,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/657', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/657', 'active_substance': 'Recombinant human N-acetylgalactosamine-6-sulfatase', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/017/09', 'ema_number_certainty': '1.0'}"
EU-3-09-660,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/660', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/660', 'active_substance': 'Trabedersen', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/030/09', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-09-661,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/661', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/661', 'active_substance': '(S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate', 'eu_mah_current': 'Serb', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/047/09', 'ema_number_certainty': '0.5'}"
EU-3-09-663,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/663', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/663', 'active_substance': 'Adeno-associated viral vector containing modified U1 snRNA', 'eu_mah_current': 'uniQure Biopharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/044/09', 'ema_number_certainty': '1.0'}"
EU-3-09-666,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/666', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/666', 'active_substance': 'Eicosapentaenoic acid', 'eu_mah_current': 'SLA Pharma (IRE) Limited', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/040/09', 'ema_number_certainty': '0.5'}"
EU-3-09-667,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/667', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/667', 'active_substance': 'Expanded human allogeneic mesenchymal adult stem cells extracted from adipose tissue', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/054/09', 'ema_number_certainty': '1.0'}"
EU-3-09-669,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/669', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/669', 'active_substance': 'Low molecular weight dextran sulfate', 'eu_mah_current': 'TikoMed AB', 'orphan_status': 'o', 'eu_aut_date': '10-09-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/020/09', 'ema_number_certainty': '1.0'}"
EU-3-09-670,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/670', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/670', 'active_substance': 'pasireotide', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/051/09', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-09-672,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/672', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/672', 'active_substance': 'Pomalidomide', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/053/09', 'ema_number_certainty': '0.75'}"
EU-3-09-673,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/673', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/673', 'active_substance': 'Recombinant antibody construct against human CD30 and CD16A', 'eu_mah_current': 'Affimed GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-09-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/046/09', 'ema_number_certainty': '1.0'}"
EU-3-09-677,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/677', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/677', 'active_substance': 'Human tumour necrosis factor alfa-derived peptide Cys-Gly-Gln-Arg-Glu-Thr-Pro-Glu-Gly-Ala-Glu-Ala-Lys-Pro-Trp-Tyr-Cys', 'eu_mah_current': 'Apeptico Forschung und Entwicklung GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/015/09', 'ema_number_certainty': '1.0'}"
EU-3-09-681,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/681', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/681', 'active_substance': '6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide', 'eu_mah_current': 'Aop Orphan Pharmaceuticals GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/066/09', 'ema_number_certainty': '0.5'}"
EU-3-09-684,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/684', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/684', 'active_substance': 'Masitinib mesilate', 'eu_mah_current': 'AB Science S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/063/09', 'ema_number_certainty': '1.0'}"
EU-3-09-686,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/686', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/686', 'active_substance': 'NGR-human tumour necrosis factor', 'eu_mah_current': 'MolMed S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '11-09-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/070/09', 'ema_number_certainty': '1.0'}"
EU-3-09-689,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/689', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/689', 'active_substance': 'Peptides mimicking antigen receptors on autoimmune B cells and autoimmune T cells associated with myasthenia gravis', 'eu_mah_current': 'CuraVac Europe SA', 'orphan_status': 'o', 'eu_aut_date': '11-09-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/078/09', 'ema_number_certainty': '1.0'}"
EU-3-09-692,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/692', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/692', 'active_substance': '16-base single-stranded PNA oligonucleotide linked to a 7-aminoacid peptide', 'eu_mah_current': 'Biogenera SpA', 'orphan_status': 'o', 'eu_aut_date': '11-25-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/093/09', 'ema_number_certainty': '1.0'}"
EU-3-09-694,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/694', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/694', 'active_substance': '6-thioguanine (oral liquid)', 'eu_mah_current': 'Only for Children Pharmaceuticals', 'orphan_status': 'o', 'eu_aut_date': '11-26-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/084/09', 'ema_number_certainty': '1.0'}"
EU-3-09-696,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/696', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/696', 'active_substance': 'Human MHC non-restricted cytotoxic T-cell line', 'eu_mah_current': 'Galileo Research S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '11-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/006/09', 'ema_number_certainty': '1.0'}"
EU-3-09-698,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/698', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/698', 'active_substance': 'Pegylated carboxyhaemoglobin', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '11-26-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/075/09', 'ema_number_certainty': '1.0'}"
EU-3-09-699,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/699', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/699', 'active_substance': 'Recombinant chimeric monoclonal antibody against CD20', 'eu_mah_current': 'CambPharma Solutions (CY) Limited', 'orphan_status': 'o', 'eu_aut_date': '11-26-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/090/09', 'ema_number_certainty': '0.5'}"
EU-3-09-700,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/700', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/700', 'active_substance': 'Vaccinia GM-CSF/TK-deactivated virus', 'eu_mah_current': 'Transgene S.A.', 'orphan_status': 'o', 'eu_aut_date': '11-26-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/076/09', 'ema_number_certainty': '1.0'}"
EU-3-09-701,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/701', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/701', 'active_substance': '2-iminobiotin', 'eu_mah_current': 'Neurophyxia B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/109/09', 'ema_number_certainty': '1.0'}"
EU-3-09-702,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/702', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/702', 'active_substance': 'Beta-artemether / lumefantrine (powder for oral suspension)', 'eu_mah_current': 'Dafra Pharma International NV', 'orphan_status': 'o', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/110/09', 'ema_number_certainty': '1.0'}"
EU-3-09-703,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/703', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/703', 'active_substance': 'Brivudine', 'eu_mah_current': 'RESprotect GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/105/09', 'ema_number_certainty': '1.0'}"
EU-3-09-706,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/706', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/706', 'active_substance': 'Lithium citrate tetrahydrate (in reverse-micelle formulation)', 'eu_mah_current': 'Medesis Pharma', 'orphan_status': 'o', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/095/09', 'ema_number_certainty': '1.0'}"
EU-3-09-707,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/707', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/707', 'active_substance': 'Macitentan', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/104/09', 'ema_number_certainty': '0.5'}"
EU-3-09-708,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/708', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/708', 'active_substance': 'Pegylated recombinant phenylalanine ammonia lyase', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/112/09', 'ema_number_certainty': '0.5'}"
EU-3-09-709,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/709', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/709', 'active_substance': 'Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule', 'eu_mah_current': 'Apogenix AG', 'orphan_status': 'o', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/098/09', 'ema_number_certainty': '0.5'}"
EU-3-09-710,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/710', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/710', 'active_substance': 'Recombinant human elafin', 'eu_mah_current': 'Proteo Biotech AG', 'orphan_status': 'o', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/057/09', 'ema_number_certainty': '1.0'}"
EU-3-09-711,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/711', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/711', 'active_substance': 'Recombinant human vascular endothelial growth factor', 'eu_mah_current': 'Newron Sweden AB', 'orphan_status': 'o', 'eu_aut_date': '01-29-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/108/09', 'ema_number_certainty': '1.0'}"
EU-3-09-712,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/712', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/712', 'active_substance': 'Recombinant kallikrein inhibitor', 'eu_mah_current': 'Dermadis S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '01-29-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/106/09', 'ema_number_certainty': '1.0'}"
EU-3-09-715,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/715', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/715', 'active_substance': 'Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-02-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/122/09', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-09-716,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/716', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/716', 'active_substance': 'Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-02-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/121/09', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-09-717,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/717', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/717', 'active_substance': 'Ecopipam', 'eu_mah_current': 'Dr Alain Munoz', 'orphan_status': 'o', 'eu_aut_date': '02-03-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/102/09', 'ema_number_certainty': '1.0'}"
EU-3-09-719,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/719', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/719', 'active_substance': 'Givinostat', 'eu_mah_current': 'Italfarmaco S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '02-03-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/116/09', 'ema_number_certainty': '1.0'}"
EU-3-09-720,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/720', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/720', 'active_substance': 'Lentiviral vector containing the human ABCA4 gene', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'o', 'eu_aut_date': '02-02-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/127/09', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-09-723,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/09/723', 'status_type': 'a', 'eu_pnumber': 'EU/3/09/723', 'active_substance': 'Recombinant fusion protein linking human coagulation factor IX with human albumin', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-04-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/117/09', 'ema_number_certainty': '1.0'}"
EU-3-10-726,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/726', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/726', 'active_substance': 'Taliglucerase alfa', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '03-23-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/125/09', 'ema_number_certainty': '1.0'}"
EU-3-10-727,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/727', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/727', 'active_substance': 'Lentiviral vector containing the human MYO7A gene', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'o', 'eu_aut_date': '03-23-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/137/09', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-10-730,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/730', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/730', 'active_substance': 'Raloxifene hydrochloride', 'eu_mah_current': 'Consejo Superior de Investigaciones Cientificas (CSIC)', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/138/09', 'ema_number_certainty': '1.0'}"
EU-3-10-732,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/732', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/732', 'active_substance': 'Entinostat', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/150/09', 'ema_number_certainty': '0.25'}"
EU-3-10-733,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/733', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/733', 'active_substance': 'Glyceryl tri-(4-phenylbutyrate)', 'eu_mah_current': 'Immedica Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/124/09', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-10-734,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/734', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/734', 'active_substance': 'Glyceryl tri-(4-phenylbutyrate)', 'eu_mah_current': 'Immedica Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/002/10', 'ema_number_certainty': '1.0'}"
EU-3-10-735,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/735', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/735', 'active_substance': 'Glyceryl tri-(4-phenylbutyrate)', 'eu_mah_current': 'Immedica Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/003/10', 'ema_number_certainty': '1.0'}"
EU-3-10-736,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/736', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/736', 'active_substance': 'Glyceryl tri-(4-phenylbutyrate)', 'eu_mah_current': 'Immedica Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/004/10', 'ema_number_certainty': '1.0'}"
EU-3-10-737,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/737', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/737', 'active_substance': 'Glyceryl tri-(4-phenylbutyrate)', 'eu_mah_current': 'Immedica Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/005/10', 'ema_number_certainty': '1.0'}"
EU-3-10-738,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/738', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/738', 'active_substance': 'Glyceryl tri-(4-phenylbutyrate)', 'eu_mah_current': 'Immedica Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/006/10', 'ema_number_certainty': '1.0'}"
EU-3-10-739,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/739', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/739', 'active_substance': 'Glyceryl tri-(4-phenylbutyrate)', 'eu_mah_current': 'Immedica Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/007/10', 'ema_number_certainty': '1.0'}"
EU-3-10-741,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/741', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/741', 'active_substance': 'Pralatrexate', 'eu_mah_current': 'TurnKey PharmaConsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/135/09', 'ema_number_certainty': '0.5'}"
EU-3-10-742,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/742', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/742', 'active_substance': '2-methoxymethyl-2-hydroxymethyl-1-azabicyclo[2,2,2]octan-3-one', 'eu_mah_current': 'Aprea Therapeutics AB', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/147/09', 'ema_number_certainty': '1.0'}"
EU-3-10-744,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/744', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/744', 'active_substance': 'Adrenomedullin', 'eu_mah_current': 'mondoBIOTECH Laboratories AG', 'orphan_status': 'o', 'eu_aut_date': '06-09-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/139/09', 'ema_number_certainty': '1.0'}"
EU-3-10-748,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/748', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/748', 'active_substance': 'Pravastatin / zoledronic acid', 'eu_mah_current': 'Prenyl BIO SAS', 'orphan_status': 'o', 'eu_aut_date': '06-09-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/154/09', 'ema_number_certainty': '1.0'}"
EU-3-10-749,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/749', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/749', 'active_substance': 'Recombinant human anti-interferon gamma monoclonal antibody', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'o', 'eu_aut_date': '06-09-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/153/09', 'ema_number_certainty': '0.5'}"
EU-3-10-750,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/750', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/750', 'active_substance': 'Rifapentine', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'o', 'eu_aut_date': '06-09-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/145/09', 'ema_number_certainty': '1.0'}"
EU-3-10-753,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/753', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/753', 'active_substance': '6alpha-ethyl-chenodeoxycholic acid', 'eu_mah_current': 'Intercept Pharma International Limited', 'orphan_status': 'o', 'eu_aut_date': '07-27-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/073/09', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-10-755,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/755', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/755', 'active_substance': 'Octenidine dihydrochloride', 'eu_mah_current': 'Sch&#252;lke &amp; Mayr GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-27-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/089/08', 'ema_number_certainty': '1.0'}"
EU-3-10-756,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/756', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/756', 'active_substance': 'Tranilast', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '07-27-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/012/10', 'ema_number_certainty': '0.5'}"
EU-3-10-760,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/760', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/760', 'active_substance': '(3S)-3-{4-[7-(aminocarbonyl)-2H-indazol-2-yl] phenyl} piperidine tosylate monohydrate salt', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-04-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/015/10', 'ema_number_certainty': '0.5'}"
EU-3-10-764,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/764', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/764', 'active_substance': 'Everolimus', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-04-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/010/10', 'ema_number_certainty': '1.0'}"
EU-3-10-765,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/765', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/765', 'active_substance': 'Midostaurin', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-04-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/016/10', 'ema_number_certainty': '1.0'}"
EU-3-10-767,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/767', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/767', 'active_substance': '11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene', 'eu_mah_current': 'CTI Life Sciences Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-25-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/058/10', 'ema_number_certainty': '0.75'}"
EU-3-10-768,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/768', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/768', 'active_substance': '11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene', 'eu_mah_current': 'CTI Life Sciences Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-25-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/019/10', 'ema_number_certainty': '0.75'}"
EU-3-10-769,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/769', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/769', 'active_substance': '11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene', 'eu_mah_current': 'CTI Life Sciences Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-25-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/057/10', 'ema_number_certainty': '0.75'}"
EU-3-10-772,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/772', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/772', 'active_substance': 'Adenovirus-associated viral vector serotype 10 carrying the human N-sulfoglucosamine sulfohydrolase and sulfatase modifying factor 1 cDNAs', 'eu_mah_current': 'LYSOGENE', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/042/10', 'ema_number_certainty': '1.0'}"
EU-3-10-773,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/773', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/773', 'active_substance': 'Allogeneic T cells encoding an exogenous TK gene', 'eu_mah_current': 'LTKFarma', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/044/10', 'ema_number_certainty': '1.0'}"
EU-3-10-774,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/774', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/774', 'active_substance': 'Allogeneic human dermal fibroblasts', 'eu_mah_current': 'Intercytex Ltd', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/061/09', 'ema_number_certainty': '0.5'}"
EU-3-10-775,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/775', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/775', 'active_substance': 'Autologous bone marrow-derived mononuclear cell fraction', 'eu_mah_current': 't2cure GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/041/10', 'ema_number_certainty': '1.0'}"
EU-3-10-776,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/776', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/776', 'active_substance': 'Autologous dendritic cells pulsed with recombinant human-fusion protein (mucin 1 - glutathione S transferase) coupled to oxidised polymannose', 'eu_mah_current': 'Prima Biomed GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/021/10', 'ema_number_certainty': '0.5'}"
EU-3-10-777,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/777', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/777', 'active_substance': 'Cyclic pyranopterin monophosphate', 'eu_mah_current': 'Comharsa Life Sciences Limited', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/025/10', 'ema_number_certainty': '0.5'}"
EU-3-10-778,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/778', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/778', 'active_substance': 'Cysteamine bitartrate (gastroresistant)', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/034/10', 'ema_number_certainty': '1.0'}"
EU-3-10-779,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/779', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/779', 'active_substance': 'Eflornithine', 'eu_mah_current': 'Cancer Prevention Pharma (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/141/09', 'ema_number_certainty': '0.5'}"
EU-3-10-780,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/780', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/780', 'active_substance': 'Forodesine', 'eu_mah_current': 'Mundipharma Corporation (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/032/10', 'ema_number_certainty': '0.5'}"
EU-3-10-782,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/782', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/782', 'active_substance': 'Nafamostat mesilate', 'eu_mah_current': 'Mucokinetica Ltd', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/040/10', 'ema_number_certainty': '1.0'}"
EU-3-10-786,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/786', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/786', 'active_substance': 'Heat-killed Mycobacterium vaccae (whole cell)', 'eu_mah_current': 'Regintel Limited', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/033/10', 'ema_number_certainty': '0.5'}"
EU-3-10-788,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/788', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/788', 'active_substance': '(S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-O-[alpha-(2&#180;&#180;, 4&#180;&#180;, 5&#180;&#180;, 7&#180;&#180;-tetranitro-9&#180;&#180;-fluorenylideneaminooxy)propionyl]-1H-pyrano[3&#180;, 4&#180;, 6&#180;, 7&#180;]indolizino[1,2-beta]-quinoline-3, 14-(4H), 12H)-dione, hydrochloride', 'eu_mah_current': 'TLC Biopharmaceuticals B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/065/10', 'ema_number_certainty': '1.0'}"
EU-3-10-789,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/789', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/789', 'active_substance': '16-base single-stranded peptide nucleic acid oligonucleotide linked to 7-amino acid peptide', 'eu_mah_current': 'Biogenera SpA', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/020/10', 'ema_number_certainty': '1.0'}"
EU-3-10-791,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/791', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/791', 'active_substance': 'Ciclosporin', 'eu_mah_current': 'Abliva AB', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/064/10', 'ema_number_certainty': '1.0'}"
EU-3-10-793,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/793', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/793', 'active_substance': 'N-(6-(2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide', 'eu_mah_current': 'Repligen Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/026/10', 'ema_number_certainty': '1.0'}"
EU-3-10-794,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/794', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/794', 'active_substance': 'N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/069/10', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-10-795,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/795', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/795', 'active_substance': 'Pralatrexate', 'eu_mah_current': 'TurnKey PharmaConsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/061/10', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-10-798,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/798', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/798', 'active_substance': 'Synthetic double-stranded short interfering RNA oligonucleotide directed against proopiomelanocortin', 'eu_mah_current': 'Diurnal Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/038/10', 'ema_number_certainty': '0.75'}"
EU-3-10-802,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/802', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/802', 'active_substance': '2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione', 'eu_mah_current': 'Calliditas Therapeutics France S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/079/10', 'ema_number_certainty': '1.0'}"
EU-3-10-803,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/803', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/803', 'active_substance': 'Chimeric monoclonal antibody against claudin-18 splice variant 2', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/083/10', 'ema_number_certainty': '1.0'}"
EU-3-10-804,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/804', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/804', 'active_substance': 'Methylthioninium', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/076/10', 'ema_number_certainty': '0.75'}"
EU-3-10-805,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/805', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/805', 'active_substance': 'Methylthioninium', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/063/10', 'ema_number_certainty': '0.75'}"
EU-3-10-806,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/806', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/806', 'active_substance': 'Methylthioninium', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/124/10', 'ema_number_certainty': '0.75'}"
EU-3-10-807,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/807', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/807', 'active_substance': 'Methylthioninium', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/125/10', 'ema_number_certainty': '0.75'}"
EU-3-10-808,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/808', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/808', 'active_substance': 'Murine monoclonal antibody against CD26', 'eu_mah_current': 'ADIENNE S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/022/10', 'ema_number_certainty': '1.0'}"
EU-3-10-810,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/810', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/810', 'active_substance': 'N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/084/10', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-10-811,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/811', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/811', 'active_substance': 'N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/092/10', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-10-813,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/813', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/813', 'active_substance': 'Recombinant human arylsulfatase A', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/070/10', 'ema_number_certainty': '0.5'}"
EU-3-10-815,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/815', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/815', 'active_substance': 'Sildenafil citrate', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/068/10', 'ema_number_certainty': '1.0'}"
EU-3-10-816,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/816', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/816', 'active_substance': '7-beta-hydroxycholesteryl-3-beta-oleate', 'eu_mah_current': 'Intsel Chimos SA', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/086/10', 'ema_number_certainty': '1.0'}"
EU-3-10-818,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/818', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/818', 'active_substance': 'Human heterologous liver cells (for infusion)', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/105/10', 'ema_number_certainty': '1.0'}"
EU-3-10-819,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/819', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/819', 'active_substance': 'Human heterologous liver cells (for infusion)', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/106/10', 'ema_number_certainty': '1.0'}"
EU-3-10-820,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/820', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/820', 'active_substance': 'Human heterologous liver cells (for infusion)', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/107/10', 'ema_number_certainty': '1.0'}"
EU-3-10-821,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/821', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/821', 'active_substance': 'Human heterologous liver cells (for infusion)', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/108/10', 'ema_number_certainty': '1.0'}"
EU-3-10-822,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/822', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/822', 'active_substance': 'Lentiviral vector carrying the Fanconi anaemia-A (FANCA) gene', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red M.P.', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/109/10', 'ema_number_certainty': '1.0'}"
EU-3-10-823,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/823', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/823', 'active_substance': 'Lomitapide', 'eu_mah_current': 'Amryt Pharmaceuticals Designated Activity Company', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/089/10', 'ema_number_certainty': '0.75'}"
EU-3-10-825,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/825', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/825', 'active_substance': 'Ovine anti-colchicine polyclonal antibody fragments', 'eu_mah_current': 'Laboratoires SERB', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/075/10', 'ema_number_certainty': '1.0'}"
EU-3-10-826,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/826', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/826', 'active_substance': 'Para-aminosalicylic acid', 'eu_mah_current': 'Eurocept International B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/072/10', 'ema_number_certainty': '1.0'}"
EU-3-10-827,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/827', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/827', 'active_substance': 'Recombinant human lysosomal acid lipase', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/104/10', 'ema_number_certainty': '1.0'}"
EU-3-10-828,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/828', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/828', 'active_substance': 'Silibinin-C-2&#39;,3-dihydrogensuccinate, disodium salt', 'eu_mah_current': 'Rottapharm S.p.A', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/103/10', 'ema_number_certainty': '1.0'}"
EU-3-10-829,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/829', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/829', 'active_substance': 'Tesetaxel', 'eu_mah_current': 'Genta Development Limited', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/101/10', 'ema_number_certainty': '1.0'}"
EU-3-10-830,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/830', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/830', 'active_substance': 'Veliparib', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/110/10', 'ema_number_certainty': '1.0'}"
EU-3-10-831,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/831', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/831', 'active_substance': 'Autologous tumor-derived immunoglobulin idiotype coupled to keyhole limpet haemocyanin', 'eu_mah_current': 'Biovest Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/113/10', 'ema_number_certainty': '1.0'}"
EU-3-10-832,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/832', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/832', 'active_substance': 'Deferiprone', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/077/10', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-10-833,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/833', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/833', 'active_substance': 'Doxorubicin hydrochloride (in heat-sensitive liposomes)', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/096/10', 'ema_number_certainty': '0.5'}"
EU-3-10-836,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/836', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/836', 'active_substance': 'Paquinimod', 'eu_mah_current': 'Active Biotech AB', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/095/10', 'ema_number_certainty': '1.0'}"
EU-3-10-840,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/840', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/840', 'active_substance': 'Recombinant human histone H1.3 and recombinant human N-bis-met-histone H1.3', 'eu_mah_current': 'Xenetic Biosciences Plc', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/097/10', 'ema_number_certainty': '1.0'}"
EU-3-10-841,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/841', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/841', 'active_substance': 'Tasimelteon', 'eu_mah_current': 'Vanda Pharmaceuticals Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/102/10', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-10-842,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/842', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/842', 'active_substance': 'Nimorazole', 'eu_mah_current': 'Azanta A/S', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/093/10', 'ema_number_certainty': '1.0'}"
EU-3-10-845,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/845', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/845', 'active_substance': 'Dry extract from birch bark (DER 5-10 : 1), extraction solvent n-heptane 95% (w/w)', 'eu_mah_current': 'Amryt Pharmaceuticals Designated Activity Company', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/120/10', 'ema_number_certainty': '0.5'}"
EU-3-10-846,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/10/846', 'status_type': 'a', 'eu_pnumber': 'EU/3/10/846', 'active_substance': 'Paclitaxel (aqueous gel)', 'eu_mah_current': 'BTG plc', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/013/10', 'ema_number_certainty': '1.0'}"
EU-3-11-849,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/849', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/849', 'active_substance': '(S)-{8-fluoro-2-2[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)-phenyl]-3,4-dihydro-4-quinazolinyl} acetic acid', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/090/10', 'ema_number_certainty': '1.0'}"
EU-3-11-850,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/850', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/850', 'active_substance': 'Darinaparsin', 'eu_mah_current': 'IDEA Innovative Drug European Associates (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '04-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/112/10', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-11-851,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/851', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/851', 'active_substance': 'Glufosfamide', 'eu_mah_current': 'Theradex (Europe) Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/135/10', 'ema_number_certainty': '1.0'}"
EU-3-11-855,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/855', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/855', 'active_substance': 'Recombinant fusion protein linking human coagulation factor VIIa with human albumin', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/132/10', 'ema_number_certainty': '1.0'}"
EU-3-11-856,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/856', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/856', 'active_substance': 'Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes', 'eu_mah_current': 'St George&#39;s University of London', 'orphan_status': 'o', 'eu_aut_date': '04-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/136/10', 'ema_number_certainty': '1.0'}"
EU-3-11-857,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/857', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/857', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA', 'eu_mah_current': 'Alnylam Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/142/10', 'ema_number_certainty': '1.0'}"
EU-3-11-858,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/858', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/858', 'active_substance': 'R-baclofen', 'eu_mah_current': 'Lakeside Regulatory Consulting Services Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/144/10', 'ema_number_certainty': '1.0'}"
EU-3-11-860,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/860', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/860', 'active_substance': 'Adeno-associated viral vector containing the human NADH dehydrogenase 4 gene', 'eu_mah_current': 'GenSight- Biologics', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/164/10', 'ema_number_certainty': '1.0'}"
EU-3-11-861,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/861', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/861', 'active_substance': '9-cis-Retinyl acetate', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/163/10', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-11-862,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/862', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/862', 'active_substance': 'Apomorphine hydrochloride', 'eu_mah_current': 'Dr Elkan Raphael Gamzu', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/114/10', 'ema_number_certainty': '1.0'}"
EU-3-11-863,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/863', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/863', 'active_substance': 'Recombinant fusion protein linking human coagulation factor VIIa with human albumin', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/133/10', 'ema_number_certainty': '1.0'}"
EU-3-11-864,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/864', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/864', 'active_substance': 'Adeno-associated viral vector containing the human ARSB gene', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/147/10', 'ema_number_certainty': '1.0'}"
EU-3-11-865,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/865', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/865', 'active_substance': '9-cis-Retinyl acetate', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/162/10', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-11-869,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/869', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/869', 'active_substance': 'Lisuride hydrogen maleate', 'eu_mah_current': 'Sinoxa Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/138/10', 'ema_number_certainty': '1.0'}"
EU-3-11-870,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/870', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/870', 'active_substance': 'S-nitrosoglutathione', 'eu_mah_current': 'Salupont Italia S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/145/10', 'ema_number_certainty': '0.5'}"
EU-3-11-872,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/872', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/872', 'active_substance': 'Sulfonated monophosphorylated mannose oligosaccharide', 'eu_mah_current': 'S-cubed Pharmaceutical Services ApS', 'orphan_status': 'o', 'eu_aut_date': '06-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/170/10', 'ema_number_certainty': '0.5'}"
EU-3-11-874,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/874', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/874', 'active_substance': 'Human embryonic stem-cell-derived retinal pigment epithelial cells', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/173/10', 'ema_number_certainty': '1.0'}"
EU-3-11-875,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/875', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/875', 'active_substance': 'Metronidazole', 'eu_mah_current': 'Avivia Projects BV', 'orphan_status': 'o', 'eu_aut_date': '06-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/167/10', 'ema_number_certainty': '1.0'}"
EU-3-11-876,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/876', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/876', 'active_substance': 'Viral vector containing DNA encoding the human SMN protein', 'eu_mah_current': 'University of Sheffield', 'orphan_status': 'o', 'eu_aut_date': '06-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/169/10', 'ema_number_certainty': '1.0'}"
EU-3-11-877,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/877', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/877', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human sulfamidase gene', 'eu_mah_current': 'Esteve Pharmaceuticals, S.A.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/171/10', 'ema_number_certainty': '1.0'}"
EU-3-11-878,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/878', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/878', 'active_substance': 'Allogeneic T cells encoding an exogenous TK gene', 'eu_mah_current': 'LTKFarma', 'orphan_status': 'o', 'eu_aut_date': '06-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/001/11', 'ema_number_certainty': '1.0'}"
EU-3-11-880,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/880', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/880', 'active_substance': 'Genetically modified human adenovirus encoding human PH20 hyaluronidase', 'eu_mah_current': 'VCN Biosciences S.L.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/008/11', 'ema_number_certainty': '1.0'}"
EU-3-11-881,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/881', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/881', 'active_substance': 'Acadesine', 'eu_mah_current': 'Advancell - Advanced In Vitro Cell Technologies S.A.', 'orphan_status': 'o', 'eu_aut_date': '08-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/017/11', 'ema_number_certainty': '1.0'}"
EU-3-11-883,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/883', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/883', 'active_substance': 'Low molecular weight dextran sulfate', 'eu_mah_current': 'TikoMed AB', 'orphan_status': 'o', 'eu_aut_date': '08-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/011/11', 'ema_number_certainty': '1.0'}"
EU-3-11-885,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/885', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/885', 'active_substance': 'Mixture of seven synthetic fragments consisting of p21 RAS peptides', 'eu_mah_current': 'Targovax ASA', 'orphan_status': 'o', 'eu_aut_date': '08-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/007/11', 'ema_number_certainty': '1.0'}"
EU-3-11-886,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/886', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/886', 'active_substance': 'N-(cyanomethyl)-4-(2-{[4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide, dihydrochloride salt', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'o', 'eu_aut_date': '08-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/019/11', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-11-887,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/887', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/887', 'active_substance': 'N-(cyanomethyl)-4-(2-{[4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide, dihydrochloride salt', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'o', 'eu_aut_date': '08-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/020/11', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-11-888,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/888', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/888', 'active_substance': 'N-(cyanomethyl)-4-(2-{[4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide, dihydrochloride salt', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'o', 'eu_aut_date': '08-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/152/10', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-11-889,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/889', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/889', 'active_substance': 'Pegylated recombinant Erwinia chrysanthemi L-asparaginase', 'eu_mah_current': 'Jazz Pharmaceuticals France SAS', 'orphan_status': 'o', 'eu_aut_date': '08-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/168/10', 'ema_number_certainty': '1.0'}"
EU-3-11-890,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/890', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/890', 'active_substance': 'Peretinoin', 'eu_mah_current': 'Kowa Pharmaceutical Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/003/11', 'ema_number_certainty': '1.0'}"
EU-3-11-892,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/892', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/892', 'active_substance': '5-[1-(2,6-dichlorobenzyl)piperidin-4-ylmethoxy]quinazoline-2,4-diamine dihydrochloride', 'eu_mah_current': 'Repligen Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '08-30-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/009/11', 'ema_number_certainty': '1.0'}"
EU-3-11-893,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/893', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/893', 'active_substance': 'Cardiotrophin-1', 'eu_mah_current': 'Digna Biotech S.L.', 'orphan_status': 'o', 'eu_aut_date': '08-30-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/030/11', 'ema_number_certainty': '1.0'}"
EU-3-11-895,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/895', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/895', 'active_substance': 'Hydroxy-propyl-beta-cyclodextrin', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '08-30-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/033/11', 'ema_number_certainty': '0.75'}"
EU-3-11-897,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/897', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/897', 'active_substance': 'N-{[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide', 'eu_mah_current': 'RLM Consulting', 'orphan_status': 'o', 'eu_aut_date': '08-30-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/029/11', 'ema_number_certainty': '1.0'}"
EU-3-11-899,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/899', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/899', 'active_substance': '2,2&#39;-{2-[(1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/048/11', 'ema_number_certainty': '1.0'}"
EU-3-11-900,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/900', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/900', 'active_substance': '20-pentaerythritol poly (oxy-1,2-ethanediyl)-carboxymethyl-glycinate-7-ethyl-10-hydroxycamptothecine 10-[1,4&#39;-bipiperidine]-1&#39;-carboxylate', 'eu_mah_current': 'Nektar Therapeutics UK Ltd', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/054/11', 'ema_number_certainty': '1.0'}"
EU-3-11-902,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/902', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/902', 'active_substance': 'Eflornithine', 'eu_mah_current': 'Cancer Prevention Pharma (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/126/10', 'ema_number_certainty': '0.5'}"
EU-3-11-903,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/903', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/903', 'active_substance': 'Genetically modified Lactococcus lactis bacteria containing the human trefoil factor 1 gene', 'eu_mah_current': 'Intrexon Actobiotics N.V.', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/027/11', 'ema_number_certainty': '1.0'}"
EU-3-11-904,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/904', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/904', 'active_substance': 'Heterologous human adult liver-derived stem cells', 'eu_mah_current': 'Unicyte S.R.L.', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/026/11', 'ema_number_certainty': '0.5'}"
EU-3-11-909,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/909', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/909', 'active_substance': 'Macitentan', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/023/11', 'ema_number_certainty': '1.0'}"
EU-3-11-910,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/910', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/910', 'active_substance': 'NH2-Cys-Ser-Ser-Val-Thr-Ala-Trp-Thr-Thr-Gly-Cys-Gly-CONH2', 'eu_mah_current': 'PHARMAXON', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/025/11', 'ema_number_certainty': '1.0'}"
EU-3-11-912,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/912', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/912', 'active_substance': 'Reparixin', 'eu_mah_current': 'Domp&#233; farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/049/11', 'ema_number_certainty': '1.0'}"
EU-3-11-913,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/913', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/913', 'active_substance': 'Resminostat', 'eu_mah_current': '4SC AG', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/045/11', 'ema_number_certainty': '1.0'}"
EU-3-11-914,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/914', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/914', 'active_substance': 'Smilagenin', 'eu_mah_current': 'Quality Regulatory Clinical Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/043/11', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-11-916,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/916', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/916', 'active_substance': '2-hydroxyoleic acid', 'eu_mah_current': 'Laminar Pharmaceuticals S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/050/11', 'ema_number_certainty': '1.0'}"
EU-3-11-917,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/917', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/917', 'active_substance': 'Adeno-associated viral vector containing the human alpha-N-acetylglucosaminidase gene', 'eu_mah_current': 'Institut Pasteur', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/065/11', 'ema_number_certainty': '1.0'}"
EU-3-11-919,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/919', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/919', 'active_substance': 'Clonidine hydrochloride', 'eu_mah_current': 'Monopar Therapeutics SARL', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/069/11', 'ema_number_certainty': '1.0'}"
EU-3-11-920,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/920', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/920', 'active_substance': 'Gallium (68Ga)-pasireotide tetraxetan', 'eu_mah_current': 'OctreoPharm Sciences GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/072/11', 'ema_number_certainty': '1.0'}"
EU-3-11-921,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/921', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/921', 'active_substance': 'Glycosylation independent lysosomal targeting tagged recombinant human acid alpha glucosidase', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/057/11', 'ema_number_certainty': '0.5'}"
EU-3-11-922,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/922', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/922', 'active_substance': 'Human platelet antigen-1a immunoglobulin', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/076/11', 'ema_number_certainty': '0.5'}"
EU-3-11-925,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/925', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/925', 'active_substance': 'Mifepristone', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/073/11', 'ema_number_certainty': '0.8'}"
EU-3-11-927,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/927', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/927', 'active_substance': 'Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol, sodium salt and palmitic acid', 'eu_mah_current': 'Pharmaceutical Research Associates Group B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/032/11', 'ema_number_certainty': '0.5'}"
EU-3-11-928,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/928', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/928', 'active_substance': 'Cysteamine', 'eu_mah_current': 'NovaBiotics Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/046/11', 'ema_number_certainty': '0.5'}"
EU-3-11-930,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/930', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/930', 'active_substance': 'Resminostat', 'eu_mah_current': '4SC AG', 'orphan_status': 'o', 'eu_aut_date': '12-09-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/083/11', 'ema_number_certainty': '1.0'}"
EU-3-11-933,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/933', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/933', 'active_substance': 'Nanoliposomal irinotecan', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'o', 'eu_aut_date': '12-09-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/051/11', 'ema_number_certainty': '1.0'}"
EU-3-11-935,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/935', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/935', 'active_substance': 'Interferon gamma', 'eu_mah_current': 'Horizon Pharma Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/084/11', 'ema_number_certainty': '1.0'}"
EU-3-11-936,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/936', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/936', 'active_substance': 'Human haptoglobin', 'eu_mah_current': 'BPL Bioproducts Laboratory GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-09-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/092/11', 'ema_number_certainty': '0.5'}"
EU-3-11-937,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/937', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/937', 'active_substance': 'Alpha-tocotrienol quinone', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/071/11', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-11-938,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/938', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/938', 'active_substance': 'Adeno-associated viral vector containing the human factor IX gene', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/090/11', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-11-939,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/939', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/939', 'active_substance': 'Brentuximab vedotin', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/100/11', 'ema_number_certainty': '1.0'}"
EU-3-11-941,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/941', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/941', 'active_substance': 'Lipopolysaccharide of Ochrobactrum intermedium', 'eu_mah_current': 'Diomune S.L.', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/085/11', 'ema_number_certainty': '1.0'}"
EU-3-11-942,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/942', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/942', 'active_substance': 'Liposomal combination of cytarabine and daunorubicin', 'eu_mah_current': 'Jazz Pharmaceuticals Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/070/11', 'ema_number_certainty': '1.0'}"
EU-3-11-943,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/943', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/943', 'active_substance': 'Mogamulizumab', 'eu_mah_current': 'Kyowa Kirin Holdings B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/104/11', 'ema_number_certainty': '1.0'}"
EU-3-11-944,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/944', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/944', 'active_substance': 'N,N&#39;-bis(2-mercaptoethyl)isophthalamide', 'eu_mah_current': 'NBMI Science Limited', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/093/11', 'ema_number_certainty': '1.0'}"
EU-3-11-945,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/11/945', 'status_type': 'a', 'eu_pnumber': 'EU/3/11/945', 'active_substance': 'Ornithine phenylacetate', 'eu_mah_current': 'Mallinckrodt Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/105/11', 'ema_number_certainty': '1.0'}"
EU-3-12-954,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/954', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/954', 'active_substance': 'S[+] apomorphine', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '02-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/106/11', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-955,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/955', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/955', 'active_substance': 'Doxycycline hyclate', 'eu_mah_current': 'Giampaolo Merlini', 'orphan_status': 'o', 'eu_aut_date': '04-02-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/113/11', 'ema_number_certainty': '1.0'}"
EU-3-12-956,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/956', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/956', 'active_substance': 'Human monoclonal antibody against Fas ligand', 'eu_mah_current': 'PinCell s.r.l.', 'orphan_status': 'o', 'eu_aut_date': '02-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/116/11', 'ema_number_certainty': '1.0'}"
EU-3-12-957,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/957', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/957', 'active_substance': 'Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human gp91(phox) gene', 'eu_mah_current': 'Orchard Therapeutics (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/118/11', 'ema_number_certainty': '0.5'}"
EU-3-12-960,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/960', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/960', 'active_substance': 'Glucagon', 'eu_mah_current': 'Biodel UK Limited', 'orphan_status': 'o', 'eu_aut_date': '03-05-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/140/11', 'ema_number_certainty': '1.0'}"
EU-3-12-961,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/961', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/961', 'active_substance': 'Doxycycline hyclate', 'eu_mah_current': 'Giampaolo Merlini', 'orphan_status': 'o', 'eu_aut_date': '03-05-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/120/11', 'ema_number_certainty': '1.0'}"
EU-3-12-963,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/963', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/963', 'active_substance': 'Chlormethine', 'eu_mah_current': 'Helsinn Birex Pharmaceuticals Ltd', 'orphan_status': 'o', 'eu_aut_date': '05-22-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/112/11', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-964,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/964', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/964', 'active_substance': 'Oleylphosphocholine', 'eu_mah_current': 'Oblita Therapeutics', 'orphan_status': 'o', 'eu_aut_date': '04-23-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/135/11', 'ema_number_certainty': '1.0'}"
EU-3-12-965,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/965', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/965', 'active_substance': 'Ketoconazole', 'eu_mah_current': 'HRA Pharma Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '04-23-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/125/11', 'ema_number_certainty': '0.5'}"
EU-3-12-967,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/967', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/967', 'active_substance': 'Sodium nitrite', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-05-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/111/11', 'ema_number_certainty': '1.0'}"
EU-3-12-968,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/968', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/968', 'active_substance': 'Human monoclonal antibody targeting Staphylococcus aureus alpha-toxin', 'eu_mah_current': 'Marcello Menapace', 'orphan_status': 'o', 'eu_aut_date': '03-05-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/128/11', 'ema_number_certainty': '0.5'}"
EU-3-12-969,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/969', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/969', 'active_substance': 'Allogeneic human dendritic cells derived from a CD34+ progenitor cell line', 'eu_mah_current': 'Mendus B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-22-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/101/11', 'ema_number_certainty': '1.0'}"
EU-3-12-970,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/970', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/970', 'active_substance': '6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '03-05-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/138/11', 'ema_number_certainty': '1.0'}"
EU-3-12-971,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/971', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/971', 'active_substance': 'Heterologous human adult liver-derived stem cells', 'eu_mah_current': 'Unicyte S.R.L.', 'orphan_status': 'o', 'eu_aut_date': '03-05-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/124/11', 'ema_number_certainty': '0.5'}"
EU-3-12-973,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/973', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/973', 'active_substance': 'Recombinant human beta-glucuronidase', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-21-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/127/11', 'ema_number_certainty': '1.0'}"
EU-3-12-974,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/974', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/974', 'active_substance': 'Adeno-associated viral vector of serotype 5 containing the human alanine-glyoxylate aminotransferase gene', 'eu_mah_current': 'uniQure Biopharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-21-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/123/11', 'ema_number_certainty': '0.5'}"
EU-3-12-975,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/975', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/975', 'active_substance': 'Carbetocin', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '03-21-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/119/11', 'ema_number_certainty': '1.0'}"
EU-3-12-976,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/976', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/976', 'active_substance': 'Antisense oligonucleotide targeted to the SMN2 gene', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-02-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/141/11', 'ema_number_certainty': '1.0'}"
EU-3-12-978,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/978', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/978', 'active_substance': 'Melatonin', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '04-02-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/133/11', 'ema_number_certainty': '1.0'}"
EU-3-12-979,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/979', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/979', 'active_substance': 'Sodium thiosulfate', 'eu_mah_current': 'Aptiv Solutions (UK) Limited', 'orphan_status': 'o', 'eu_aut_date': '04-02-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/149/11', 'ema_number_certainty': '1.0'}"
EU-3-12-980,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/980', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/980', 'active_substance': 'Genistein sodium salt dihydrate', 'eu_mah_current': 'Axcentua Pharmaceuticals AB', 'orphan_status': 'o', 'eu_aut_date': '04-02-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/130/11', 'ema_number_certainty': '1.0'}"
EU-3-12-981,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/981', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/981', 'active_substance': 'Adenovirus associated viral vector serotype 2 containing the human RPE65 gene', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '04-02-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/150/11', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-982,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/982', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/982', 'active_substance': 'Dipalmitoylphosphatidylcholine, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol, sodium salt, synthetic surfactant protein C analogue and synthetic surfactant protein B analogue', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '04-02-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/148/11', 'ema_number_certainty': '1.0'}"
EU-3-12-983,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/983', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/983', 'active_substance': 'Heterologous human adult liver-derived stem cells', 'eu_mah_current': 'Unicyte S.R.L.', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/153/11', 'ema_number_certainty': '0.5'}"
EU-3-12-985,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/985', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/985', 'active_substance': 'Recombinant human methionine proinsulin', 'eu_mah_current': 'ProRetina Therapeutics S.L.', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/006/12', 'ema_number_certainty': '1.0'}"
EU-3-12-990,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/990', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/990', 'active_substance': 'Vosaroxin', 'eu_mah_current': 'Sunesis Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/158/11', 'ema_number_certainty': '1.0'}"
EU-3-12-991,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/991', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/991', 'active_substance': 'Exon 45 specific phosphorothioate oligonucleotide', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/142/11', 'ema_number_certainty': '1.0'}"
EU-3-12-992,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/992', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/992', 'active_substance': 'Exon 53 specific phosphorothioate oligonucleotide', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/143/11', 'ema_number_certainty': '1.0'}"
EU-3-12-993,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/993', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/993', 'active_substance': 'N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/164/11', 'ema_number_certainty': '0.25'}"
EU-3-12-994,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/994', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/994', 'active_substance': 'Yttrium (90Y)-DTPA-radiolabelled chimeric monoclonal antibody against frizzled homologue 10', 'eu_mah_current': 'Laboratoires OncoTherapy Science France, S.A.R.L', 'orphan_status': 'o', 'eu_aut_date': '05-25-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/155/11', 'ema_number_certainty': '1.0'}"
EU-3-12-996,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/996', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/996', 'active_substance': 'N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/166/11', 'ema_number_certainty': '0.25'}"
EU-3-12-997,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/997', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/997', 'active_substance': 'N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/165/11', 'ema_number_certainty': '0.25'}"
EU-3-12-998,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/998', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/998', 'active_substance': 'Autologous CD34+ cells transfected with lentiviral vector containing the Wiskott-Aldrich syndrome protein gene', 'eu_mah_current': 'Orchard Therapeutics (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/014/12', 'ema_number_certainty': '0.75'}"
EU-3-12-999,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/999', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/999', 'active_substance': 'Letermovir', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/008/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1008,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1008', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1008', 'active_substance': 'Human erythrocytes encapsulating inositol hexaphosphate', 'eu_mah_current': 'ERYtech Pharma S.A.', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/040/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1009,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1009', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1009', 'active_substance': 'Givinostat', 'eu_mah_current': 'Italfarmaco S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/028/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1010,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1010', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1010', 'active_substance': 'Ataluren', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/032/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1011,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1011', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1011', 'active_substance': 'Levoglutamide', 'eu_mah_current': 'Emmaus Medical Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/016/12', 'ema_number_certainty': '0.5'}"
EU-3-12-1012,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1012', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1012', 'active_substance': '2S, 4R ketoconazole', 'eu_mah_current': 'Cortendo AB', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/039/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1013,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1013', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1013', 'active_substance': 'Recombinant human interleukin-7', 'eu_mah_current': 'Inserm-ANRS (Agence Nationale de Recherches sur le Sida et les H&#233;patites Virales)', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/011/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1016,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1016', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1016', 'active_substance': '16-base single-stranded peptide nucleic acid oligonucleotide linked to 7-amino acid peptide', 'eu_mah_current': 'Biogenera SpA', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/020/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1018,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1018', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1018', 'active_substance': 'Recombinant adeno-associated viral vector containing human acid alfa-glucosidase-gene', 'eu_mah_current': 'Sarepta Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/018/12', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-1020,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1020', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1020', 'active_substance': 'Recombinant human pentraxin-2', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/048/12', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-1021,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1021', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1021', 'active_substance': '1-[(2-Chloro-4-methoxyphenoxy)methyl]-4-[(2,6-dichlorophenoxy)methyl]benzene', 'eu_mah_current': 'ViroDefense Ltd', 'orphan_status': 'o', 'eu_aut_date': '07-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/025/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1022,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1022', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1022', 'active_substance': 'Metreleptin', 'eu_mah_current': 'Amryt Pharmaceuticals Designated Activity Company', 'orphan_status': 'o', 'eu_aut_date': '07-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/033/12', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-12-1023,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1023', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1023', 'active_substance': 'Metreleptin', 'eu_mah_current': 'Amryt Pharmaceuticals Designated Activity Company', 'orphan_status': 'o', 'eu_aut_date': '07-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/034/12', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-12-1024,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1024', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1024', 'active_substance': 'Metreleptin', 'eu_mah_current': 'Amryt Pharmaceuticals Designated Activity Company', 'orphan_status': 'o', 'eu_aut_date': '07-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/035/12', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-12-1025,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1025', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1025', 'active_substance': 'Metreleptin', 'eu_mah_current': 'Amryt Pharmaceuticals Designated Activity Company', 'orphan_status': 'o', 'eu_aut_date': '07-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/036/12', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-12-1026,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1026', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1026', 'active_substance': 'Hexasodium phytate', 'eu_mah_current': 'Sanifit Therapeutics S.A.', 'orphan_status': 'o', 'eu_aut_date': '07-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/043/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1027,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1027', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1027', 'active_substance': 'Human apotransferrin', 'eu_mah_current': 'Sanquin Plasma Products B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/045/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1028,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1028', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1028', 'active_substance': '(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid', 'eu_mah_current': 'Albireo AB', 'orphan_status': 'o', 'eu_aut_date': '07-17-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/022/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1031,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1031', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1031', 'active_substance': 'Ketoconazole', 'eu_mah_current': 'Agenzia Industrie Difesa-Stabilimento Chimico Farmaceutico Militare', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/084/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1033,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1033', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1033', 'active_substance': 'N-Butyldeoxygalactonojirimycin', 'eu_mah_current': 'Idorsia Pharmaceuticals Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/042/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1034,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1034', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1034', 'active_substance': 'Humanised monoclonal antibody against P-selectin', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/026/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1038,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1038', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1038', 'active_substance': 'Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein', 'eu_mah_current': 'Aop Orphan Pharmaceuticals GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/047/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1039,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1039', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1039', 'active_substance': 'Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein', 'eu_mah_current': 'Aop Orphan Pharmaceuticals GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/066/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1040,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1040', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1040', 'active_substance': '(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid', 'eu_mah_current': 'Albireo AB', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/023/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1041,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1041', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1041', 'active_substance': '(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid', 'eu_mah_current': 'Albireo AB', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/024/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1045,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1045', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1045', 'active_substance': 'Alpha-1 proteinase inhibitor (for inhalation use)', 'eu_mah_current': 'Grifols Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/058/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1046,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1046', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1046', 'active_substance': 'Mavoglurant', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/059/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1050,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1050', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1050', 'active_substance': '[2-Cyano-3-cyclopropyl-3-hydroxy-N-(3-methyl-4-trifluoromethylphenyl)prop-2-enamide]', 'eu_mah_current': 'Algiax Pharmaceuticals GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/088/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1051,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1051', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1051', 'active_substance': 'Recombinant human lecithin cholesterol acyltransferase', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/091/12', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-1052,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1052', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1052', 'active_substance': 'Humanised monoclonal IgG4 antibody against tissue factor pathway inhibitor', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/095/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1053,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1053', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1053', 'active_substance': 'Lurbinectedin', 'eu_mah_current': 'Pharma Mar S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/099/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1054,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1054', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1054', 'active_substance': 'Obinutuzumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/102/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1055,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1055', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1055', 'active_substance': 'Belinostat', 'eu_mah_current': 'Onxeo DK, Filial af Onxeo S.A., Frankrig', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/103/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1057,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1057', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1057', 'active_substance': 'Naloxone hydrochloride dihydrate', 'eu_mah_current': 'Winston Laboratories Ltd', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/050/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1058,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1058', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1058', 'active_substance': 'IL-12-secreting dendritic cells, loaded with autologous tumour lysate', 'eu_mah_current': 'Activartis Biotech GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/092/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1062,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1062', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1062', 'active_substance': 'Chimeric monoclonal antibody against GD2', 'eu_mah_current': 'EUSA Pharma (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/112/12', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-1063,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1063', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1063', 'active_substance': 'Panobinostat', 'eu_mah_current': 'Secura Bio Limited', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/113/12', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-1066,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1066', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1066', 'active_substance': 'tafamidis', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/115/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1067,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1067', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1067', 'active_substance': 'Erdosteine', 'eu_mah_current': 'Rafifarm SRL', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/119/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1068,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1068', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1068', 'active_substance': 'Melarsoprol', 'eu_mah_current': 'St&#233;phane Gibaud', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/116/12', 'ema_number_certainty': '0.5'}"
EU-3-12-1070,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1070', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1070', 'active_substance': 'Recombinant human dyskerin', 'eu_mah_current': 'Advanced Medical Projects', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/136/11', 'ema_number_certainty': '1.0'}"
EU-3-12-1072,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1072', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1072', 'active_substance': 'Encapsulated human retinal pigment epithelial cell line transfected with plasmid vector expressing human ciliary neurotrophic factor', 'eu_mah_current': 'Le4d Global Regulatory Science Limited', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/160/11', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-1075,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1075', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1075', 'active_substance': 'Cyclo(-gamma-aminobutyryl-L-phenylalanyl-L-tryptophanyl-D-tryptophanyl-L-lysyl-L-threonyl-L phenylalanyl-N-3-carboxypropyl)-glycine amide, acetate salt', 'eu_mah_current': 'Cortendo AB', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/107/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1076,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1076', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1076', 'active_substance': 'Allopurinol sodium', 'eu_mah_current': 'Pharmathen S.A.', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/134/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1077,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1077', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1077', 'active_substance': 'Exon 52 specific phosphorothioate oligonucleotide', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/121/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1078,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1078', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1078', 'active_substance': 'Exon 55 specific phosphorothioate oligonucleotide', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/122/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1079,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1079', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1079', 'active_substance': 'Artesunate', 'eu_mah_current': 'Dafra Pharma International NV', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/123/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1084,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1084', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1084', 'active_substance': 'Erdosteine', 'eu_mah_current': 'Rafifarm SRL', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/131/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1085,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1085', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1085', 'active_substance': 'Voclosporin', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/118/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1086,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1086', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1086', 'active_substance': 'Eflornithine in combination with sulindac', 'eu_mah_current': 'Cancer Prevention Pharma (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/130/12', 'ema_number_certainty': '0.5'}"
EU-3-12-1087,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1087', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1087', 'active_substance': 'Recombinant modified human growth hormone', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/133/12', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-12-1088,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1088', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1088', 'active_substance': 'Allogeneic motor neuron progenitor cells derived from human embryonic stem cells', 'eu_mah_current': 'California Stem Cell (UK) Ltd', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/140/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1089,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1089', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1089', 'active_substance': 'Choline tetrathiomolybdate', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/142/12', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-1093,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1093', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1093', 'active_substance': '1,2:5,6-Dianhydrogalactitol', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/148/12', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-12-1094,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1094', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1094', 'active_substance': 'Modified recombinant human C-type natriuretic peptide', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/149/12', 'ema_number_certainty': '0.5'}"
EU-3-12-1095,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1095', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1095', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human N-acetylglucosaminidase alpha gene', 'eu_mah_current': 'Esteve Pharmaceuticals, S.A.', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/150/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1098,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/12/1098', 'status_type': 'a', 'eu_pnumber': 'EU/3/12/1098', 'active_substance': 'Encapsulated human retinal pigment epithelial cell line transfected with plasmid vector expressing human ciliary neurotrophic factor', 'eu_mah_current': 'Le4d Global Regulatory Science Limited', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/159/11', 'ema_number_certainty': '0.5'}"
EU-3-13-1099,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1099', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1099', 'active_substance': 'Recombinant adeno-associated viral vector containing the human CNGB3 gene', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-08-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/109/12', 'ema_number_certainty': '0.5'}"
EU-3-13-1100,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1100', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1100', 'active_substance': 'Humanised IgG1 kappa antibody against serum amyloid A and AL amyloid', 'eu_mah_current': 'Prothena Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '02-08-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/129/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1102,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1102', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1102', 'active_substance': 'Cyclo-Cys-Gly-Gln-Arg-Glu-Thr-Pro-Glu-Gly-Ala-Glu-Ala-Lys-Pro-Trp-Tyr-Cys', 'eu_mah_current': 'Apeptico Forschung und Entwicklung GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-08-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/144/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1103,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1103', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1103', 'active_substance': 'Treprostinil sodium', 'eu_mah_current': 'SciPharm S&#224;rl', 'orphan_status': 'o', 'eu_aut_date': '02-08-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/154/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1106,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1106', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1106', 'active_substance': 'L-asparaginase encapsulated in erythrocytes', 'eu_mah_current': 'ERYtech Pharma S.A.', 'orphan_status': 'o', 'eu_aut_date': '02-08-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/167/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1107,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1107', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1107', 'active_substance': 'Recombinant adeno-associated viral vector containing the human retinoschisin gene', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/108/12', 'ema_number_certainty': '0.5'}"
EU-3-13-1108,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1108', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1108', 'active_substance': '2-[4-Methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indan-2-carboxylic acid', 'eu_mah_current': 'Horizon Therapeutics Ireland Designated Activity Company', 'orphan_status': 'o', 'eu_aut_date': '03-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/143/12', 'ema_number_certainty': '0.5'}"
EU-3-13-1114,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1114', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1114', 'active_substance': 'Cyclo[L-alanyl-L-seryl-L-isoleucyl-L-prolyl-L-prolyl-L-glutaminyl-L-lysyl-L-tyrosyl-D-prolyl-L-prolyl-(2S)-2-aminodecanoyl-L-alpha-glutamyl-L-threonyl] acetate salt', 'eu_mah_current': 'Santhera Pharmaceuticals (Deutschland) GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-20-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/166/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1117,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1117', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1117', 'active_substance': 'Ramiprilat', 'eu_mah_current': 'Blue-Reg Pharma Consult', 'orphan_status': 'o', 'eu_aut_date': '03-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/175/12', 'ema_number_certainty': '0.5'}"
EU-3-13-1118,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1118', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1118', 'active_substance': 'Recombinant human tripeptidyl-peptidase 1', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '03-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/177/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1122,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1122', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1122', 'active_substance': 'R,S-O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime dihydrochloride', 'eu_mah_current': 'Vudbenk Life Science Kft.', 'orphan_status': 'o', 'eu_aut_date': '04-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/183/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1124,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1124', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1124', 'active_substance': '2-hydroxypropyl-&#223;-cyclodextrin', 'eu_mah_current': 'Rapport Global Strategic Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '04-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/191/12', 'ema_number_certainty': '0.75'}"
EU-3-13-1126,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1126', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1126', 'active_substance': 'Mexiletine hydrochloride', 'eu_mah_current': 'UCL Research Limited', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/182/12', 'ema_number_certainty': '0.5'}"
EU-3-13-1127,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1127', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1127', 'active_substance': 'Inotuzumab ozogamicin', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/194/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1128,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1128', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1128', 'active_substance': 'N-[2,6-bis(1-methylethyl)phenyl]-N-[[1-[4-(dimethylamino) phenyl]cyclopentyl]methyl]urea, hydrochloride salt', 'eu_mah_current': 'Millendo Therapeutics SAS', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/195/12', 'ema_number_certainty': '0.5'}"
EU-3-13-1129,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1129', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1129', 'active_substance': 'Allogeneic bone marrow derived mesenchymal cells expanded ex vivo in synthetic media', 'eu_mah_current': 'Cell2B Advanced Therapeutics, SA', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/197/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1130,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1130', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1130', 'active_substance': 'Recombinant human transglutaminase 1 encapsulated into liposomes', 'eu_mah_current': 'Westf&#228;lische Wilhelms-Universit&#228;t M&#252;nster', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/003/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1131,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1131', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1131', 'active_substance': 'Recombinant human CXCL8 mutant', 'eu_mah_current': 'ProtAffin Biotechnologie AG', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/005/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1133,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1133', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1133', 'active_substance': 'Maribavir', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/013/13', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-13-1134,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1134', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1134', 'active_substance': 'Autologous CD34+ cells transduced with a lentiviral vector containing the human ADA gene', 'eu_mah_current': 'Orchard Therapeutics (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/014/13', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-13-1135,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1135', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1135', 'active_substance': 'Recombinant human nerve growth factor', 'eu_mah_current': 'Domp&#233; farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/015/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1136,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1136', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1136', 'active_substance': '5-[1-(2,6-dichlorobenzyl)piperidin-4-ylmethoxy]quinazoline-2,4-diamine dihydrochloride', 'eu_mah_current': 'Sirius Regulatory Consulting Limited', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/034/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1137,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1137', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1137', 'active_substance': '4,6,4trimethylangelicin', 'eu_mah_current': 'Rare Partners srl Impresa Sociale', 'orphan_status': 'o', 'eu_aut_date': '06-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/017/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1139,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1139', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1139', 'active_substance': 'Sodium chlorite', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/023/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1140,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1140', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1140', 'active_substance': 'Expanded human allogeneic neural retinal progenitor cells extracted from neural retina', 'eu_mah_current': 'Reneuron Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/025/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1141,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1141', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1141', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against the keratin 6a N171K mutation', 'eu_mah_current': 'Alan Irvine', 'orphan_status': 'o', 'eu_aut_date': '06-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/028/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1142,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1142', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1142', 'active_substance': 'Adenovirus associated viral vector serotype 5 containing the human pde6&#223; gene', 'eu_mah_current': 'Coave Therapeutics', 'orphan_status': 'o', 'eu_aut_date': '06-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/031/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1143,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1143', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1143', 'active_substance': 'Immortalised human C3A hepatoblastoma cells', 'eu_mah_current': 'MWB Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '06-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/032/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1145,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1145', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1145', 'active_substance': 'Genetically modified serotype 5/3 adenovirus coding for granulocyte-macrophage colony-stimulating factor', 'eu_mah_current': 'Targovax Oy', 'orphan_status': 'o', 'eu_aut_date': '06-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/041/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1147,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1147', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1147', 'active_substance': 'Granulocyte macrophage colony stimulating factor', 'eu_mah_current': 'Savara ApS', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/106/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1148,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1148', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1148', 'active_substance': 'Autologous bone marrow-derived mesenchymal stromal cells secreting neurotrophic factors', 'eu_mah_current': 'Brainstorm Cell Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/011/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1149,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1149', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1149', 'active_substance': 'Human hemin', 'eu_mah_current': 'Borders Technology Management Ltd', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/018/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1151,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1151', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1151', 'active_substance': 'Belinostat', 'eu_mah_current': 'Onxeo DK, Filial af Onxeo S.A., Frankrig', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/036/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1153,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1153', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1153', 'active_substance': 'Daratumumab', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/038/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1155,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1155', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1155', 'active_substance': 'Allogeneic motor neuron progenitor cells derived from human embryonic stem cells', 'eu_mah_current': 'California Stem Cell (UK) Ltd', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/044/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1156,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1156', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1156', 'active_substance': 'Recombinant human monoclonal antibody against hepatitis B virus', 'eu_mah_current': 'Syneos Health Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/045/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1158,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1158', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1158', 'active_substance': 'Dexamethasone sodium phosphate encapsulated in human autologous erythrocytes', 'eu_mah_current': 'Erydel S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/052/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1161,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1161', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1161', 'active_substance': 'Heterologous human adult liver-derived progenitor cells', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/057/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1162,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1162', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1162', 'active_substance': 'Heterologous human adult liver-derived progenitor cells', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/058/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1163,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1163', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1163', 'active_substance': 'Heterologous human adult liver-derived progenitor cells', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/059/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1164,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1164', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1164', 'active_substance': 'Heterologous human adult liver-derived progenitor cells', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/060/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1165,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1165', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1165', 'active_substance': 'Heterologous human adult liver-derived progenitor cells', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/061/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1166,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1166', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1166', 'active_substance': 'Heterologous human adult liver-derived progenitor cells', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/062/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1167,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1167', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1167', 'active_substance': 'Heterologous human adult liver-derived progenitor cells', 'eu_mah_current': 'Promethera Biosciences', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/063/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1168,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1168', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1168', 'active_substance': 'Ex-vivo expanded autologous human corneal epithelium containing stem cells', 'eu_mah_current': 'University of Newcastle upon Tyne', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/065/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1169,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1169', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1169', 'active_substance': 'Lipid-complexed cisplatin', 'eu_mah_current': 'Richardson Associates Regulatory Affairs Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/020/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1170,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1170', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1170', 'active_substance': 'Octreotide acetate (oral use)', 'eu_mah_current': 'Amryt Pharmaceuticals Designated Activity Company', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/042/13', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-13-1171,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1171', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1171', 'active_substance': 'Autologous regulatory T cells with an immunophenotype of CD4+CD25hiFoxP3+', 'eu_mah_current': 'iReg Medical AB', 'orphan_status': 'o', 'eu_aut_date': '10-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/043/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1174,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1174', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1174', 'active_substance': 'Trans-N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine bis-hydrochloride', 'eu_mah_current': 'Oryzon Genomics SA', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/064/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1176,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1176', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1176', 'active_substance': 'Human allogeneic bone marrow derived osteoblastic-like cells', 'eu_mah_current': 'Bone Therapeutics SA', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/070/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1177,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1177', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1177', 'active_substance': 'Chimeric monoclonal antibody against claudin-18 splice variant 2', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/071/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1181,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1181', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1181', 'active_substance': 'Budesonide', 'eu_mah_current': 'Dr Falk Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/078/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1182,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1182', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1182', 'active_substance': 'Cladribine', 'eu_mah_current': 'Lipomed GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/079/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1183,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1183', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1183', 'active_substance': 'Sacrosidase', 'eu_mah_current': 'QOL Therapeutics Holdings Limited', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/083/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1185,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1185', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1185', 'active_substance': 'Eculizumab', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/087/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1188,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1188', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1188', 'active_substance': 'Recombinant fusion protein linking coagulation factor VIIa with albumin', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/051/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1189,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1189', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1189', 'active_substance': 'Mexiletine hydrochloride', 'eu_mah_current': 'Agenzia Industrie Difesa-Stabilimento Chimico Farmaceutico Militare', 'orphan_status': 'o', 'eu_aut_date': '10-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/069/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1190,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1190', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1190', 'active_substance': 'Recombinant human monoclonal IgM antibody targeting glucose-regulated protein 78', 'eu_mah_current': 'Patrys GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/072/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1191,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1191', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1191', 'active_substance': 'L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser', 'eu_mah_current': 'Araim Pharmaceuticals Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '10-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/081/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1192,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1192', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1192', 'active_substance': 'Zoledronic acid', 'eu_mah_current': 'Axsome Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '10-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/088/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1193,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1193', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1193', 'active_substance': '3,5-diiodothyropropionic acid', 'eu_mah_current': 'CATS Consultants GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/089/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1196,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1196', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1196', 'active_substance': 'Autologous CD34+ cells transduced with a lentiviral vector containing the human Wiskott-Aldrich syndrome gene', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '10-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/104/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1197,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1197', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1197', 'active_substance': 'Autologous ex-vivo-expanded leucocytes treated with 5-aza-2-deoxycytidine', 'eu_mah_current': 'CytoVac A/S', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/086/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1199,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1199', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1199', 'active_substance': 'Sorafenib tosylate', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/092/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1200,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1200', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1200', 'active_substance': 'Sorafenib tosylate', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/093/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1201,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1201', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1201', 'active_substance': 'Defibrotide', 'eu_mah_current': 'Gentium S.r.I.', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/103/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1204,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1204', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1204', 'active_substance': 'Sirolimus', 'eu_mah_current': 'S-cubed Pharmaceutical Services ApS', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/117/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1206,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1206', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1206', 'active_substance': 'Synthetic 12 amino acids peptide designed after subcommissural organ spondin', 'eu_mah_current': 'Axoltis Pharma', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/119/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1207,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1207', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1207', 'active_substance': 'Trebananib', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/122/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1208,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1208', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1208', 'active_substance': 'Soraprazan', 'eu_mah_current': 'Katairo GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/124/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1209,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1209', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1209', 'active_substance': 'Nitric oxide', 'eu_mah_current': 'Novoteris', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/095/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1210,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1210', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1210', 'active_substance': 'Recombinant human parathyroid hormone', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/102/13', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-13-1211,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1211', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1211', 'active_substance': 'Allogeneic and autologous haptenised and irradiated cells and cell lysates derived from glioma', 'eu_mah_current': 'ERC Belgium', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/107/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1213,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1213', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1213', 'active_substance': 'Lactobacillus acidophilus and Bifidobacterium bifidum', 'eu_mah_current': 'Laboratorio Farmaceutico S.I.T. s.r.l.', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/112/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1214,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1214', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1214', 'active_substance': '(4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride', 'eu_mah_current': 'Mirum Pharmaceuticals International B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/120/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1216,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1216', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1216', 'active_substance': '(4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride', 'eu_mah_current': 'Mirum Pharmaceuticals International B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/123/13', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-13-1219,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1219', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1219', 'active_substance': 'Fenfluramine hydrochloride', 'eu_mah_current': 'Zogenix ROI Limited', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/140/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1220,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1220', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1220', 'active_substance': 'Poly[2-[(4-{[1-carboxy-2-(hexadecylcarbamoyl)ethyl]sulfanyl}-2,3-bis({2-[((2S)-2-(2-{[(2R)-2-carbamoyl-(2-{[(2S)-1-ethoxy-3-(3-hydroxy-4oxo-1,4-dihydropyridin-1-yl)-1-oxopropan-2-yl]carbamoyl}ethyl]sulfanyl}-3-{[(2S)-1-ethoxy-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)-1-oxopropan-2-yl]carbamoyl}propanamido)-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)propanoyl Ethyl ester) )-methoxy]acetyl}oxy)butyl)sulfanyl]-3-(hexadecylcarbamoyl)propanoic acid]-poly(ethylene glycol)-ester]', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/142/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1222,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1222', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1222', 'active_substance': 'Amatuximab', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/108/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1223,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1223', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1223', 'active_substance': 'Inecalcitol', 'eu_mah_current': 'Hybrigenics SA', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/109/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1224,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1224', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1224', 'active_substance': 'Sodium nitrite', 'eu_mah_current': 'Hope Pharmaceuticals Limited', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/131/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1225,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1225', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1225', 'active_substance': 'Lonafarnib', 'eu_mah_current': 'EigerBio Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/132/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1226,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1226', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1226', 'active_substance': '(6aS)-1,10-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,9-diol', 'eu_mah_current': 'Valentia BioPharma S.L', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/133/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1229,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1229', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1229', 'active_substance': 'Autologous dendritic cells pulsed with allogeneic tumour cell lysate', 'eu_mah_current': 'Amphera BV', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/138/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1230,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1230', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1230', 'active_substance': '(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl) amino)methyl)tetrahydrofuran-3,4-diol', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/141/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1231,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1231', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1231', 'active_substance': '(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl) amino)methyl)tetrahydrofuran-3,4-diol', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/143/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1233,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/13/1233', 'status_type': 'a', 'eu_pnumber': 'EU/3/13/1233', 'active_substance': 'Allogeneic bone-marrow derived ex-vivo expanded multipotent adult progenitor cells', 'eu_mah_current': 'ReGenesys BVBA', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/146/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1236,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1236', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1236', 'active_substance': 'Diacerein', 'eu_mah_current': 'Diaderm GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/149/13', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1237,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1237', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1237', 'active_substance': 'Gallium [Ga-68]-N-[(4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-Lcysteinyl-L-threonine-cyclic(2-7)disulfide', 'eu_mah_current': 'Advanced Accelerator Applications', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/152/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1239,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1239', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1239', 'active_substance': '11-(4-Dimethylamino-3-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-aza-cyclopentadecane-13,15-dione', 'eu_mah_current': 'Synovo GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/156/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1240,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1240', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1240', 'active_substance': 'Cysteamine', 'eu_mah_current': 'Istituto Europeo per la Ricerca sulla Fibrosi Cistica - ONLUS', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/159/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1241,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1241', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1241', 'active_substance': 'Asp-Arg-Val-Tyr-Ile-His-Pro', 'eu_mah_current': 'Rapport Global Strategic Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/162/13', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1242,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1242', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1242', 'active_substance': '3-Chloro-4-fluorophenyl-[4-fluoro-4-{[(5-methylpyrimidin-2-ylmethyl) amino]methyl}piperidin-1-yl]methanone', 'eu_mah_current': 'Neurolixis SAS', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/163/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1243,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1243', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1243', 'active_substance': 'Recombinant human acid ceramidase', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '02-21-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/167/13', 'ema_number_certainty': '0.6'}"
EU-3-14-1245,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1245', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1245', 'active_substance': 'Pioglitazone', 'eu_mah_current': 'Minoryx Therapeutics S.L.', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/170/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1246,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1246', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1246', 'active_substance': '68Ga-2,2&#39;-(7-(4-((S)-1-((4S,7S,10S,13R,16S,19R)-4-((R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)-10-(4-aminobutyl)-16-(4-((S)-2,6-dioxohexahydropyrimidine-4-carboxamido)benzyl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-13-(4-ureidobenzyl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-ylamino)-3-(4-chlorophenyl)-1-oxopropan-2-ylamino)-1-carboxy-4-oxobutyl)-1,4,7-triazonane-1,4-diyl)diacetic acid', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/173/13', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1247,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1247', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1247', 'active_substance': 'Autologous dendritic cells pulsed with tumour antigen-derived synthetic peptides (MAGE-1, HER-2, AIM-2, TRP-2, gp-100, and interleukin-13 receptor alpha)', 'eu_mah_current': 'Diamond Pharma Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/174/13', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1248,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1248', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1248', 'active_substance': 'N-({Carbamoylmethyl-[3-(2-oxo-pyrrolidin-1-yl)-propyl]-carbamoyl}-methyl)-2-[2-(2-fluoro-phenyl)-ethylamino]-N-isobutyl-acetamide', 'eu_mah_current': 'Accure Therapeutics S.L.', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/175/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1249,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1249', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1249', 'active_substance': 'Phosphorothioate oligonucleotide targeted to apolipoprotein C-III', 'eu_mah_current': 'Akcea Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/180/13', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1250,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1250', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1250', 'active_substance': 'Phosphorothioate oligonucleotide targeted to transthyretin', 'eu_mah_current': 'Akcea Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '03-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/098/13', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1252,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1252', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1252', 'active_substance': 'Cysteamine bitartrate', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '03-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/164/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1253,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1253', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1253', 'active_substance': 'Ex-vivo-cultured human mesenchymal stromal cells', 'eu_mah_current': 'iCell Science AB', 'orphan_status': 'o', 'eu_aut_date': '03-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/168/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1255,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1255', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1255', 'active_substance': 'Volasertib', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/181/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1256,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1256', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1256', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human GUCY2D gene', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '03-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/182/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1257,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1257', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1257', 'active_substance': 'Autologous CD34+ cells transduced with a lentiviral vector containing the human RAG1 gene', 'eu_mah_current': 'Prof. F.J.T.Staal', 'orphan_status': 'o', 'eu_aut_date': '03-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/188/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1258,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1258', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1258', 'active_substance': 'Doxorubicin(6-maleimidocaproyl)hydrazone', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '03-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/190/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1259,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1259', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1259', 'active_substance': 'Amikacin sulfate', 'eu_mah_current': 'Insmed Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-08-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/191/13', 'ema_number_certainty': '0.5'}"
EU-3-14-1260,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1260', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1260', 'active_substance': 'Fixed-dose combination of (R-S) baclofen, naltrexone hydrochloride and D-sorbitol', 'eu_mah_current': 'Pharnext SA', 'orphan_status': 'o', 'eu_aut_date': '03-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/193/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1261,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1261', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1261', 'active_substance': 'Caffeine citrate', 'eu_mah_current': 'Viridian Pharma Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-11-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/161/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1262,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1262', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1262', 'active_substance': 'Recombinant human surfactant protein D', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-11-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/172/13', 'ema_number_certainty': '0.5'}"
EU-3-14-1265,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1265', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1265', 'active_substance': 'Genetically modified serotype 5/3 adenovirus coding for granulocyte macrophage colony-stimulating factor', 'eu_mah_current': 'Targovax Oy', 'orphan_status': 'o', 'eu_aut_date': '04-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/186/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1266,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1266', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1266', 'active_substance': 'Autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '04-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/187/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1269,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1269', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1269', 'active_substance': 'Lutetium (177Lu) edotreotide', 'eu_mah_current': 'ITM Solucin GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/196/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1270,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1270', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1270', 'active_substance': '(5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-Ethylidene]-beta-D-glucopyranosyl]-oxy]-5-(4-({[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl}oxy)-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one', 'eu_mah_current': 'CellAct Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/199/13', 'ema_number_certainty': '0.5'}"
EU-3-14-1271,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1271', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1271', 'active_substance': '177Lu-tetraxetan-tetulomab', 'eu_mah_current': 'Nordic Nanovector AS', 'orphan_status': 'o', 'eu_aut_date': '06-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/200/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1272,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1272', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1272', 'active_substance': 'Recombinant human alpha 1 chain homotrimer of type VII collagen', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '06-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/201/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1273,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1273', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1273', 'active_substance': 'Autologous dendritic cells pulsed with RNA from glioma stem cells', 'eu_mah_current': 'Epitarget AS', 'orphan_status': 'o', 'eu_aut_date': '06-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/001/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1274,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1274', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1274', 'active_substance': 'Paclitaxel-succinate-Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe', 'eu_mah_current': 'Orphit', 'orphan_status': 'o', 'eu_aut_date': '06-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/003/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1275,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1275', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1275', 'active_substance': 'Aganirsen', 'eu_mah_current': 'Gene Signal SAS', 'orphan_status': 'o', 'eu_aut_date': '06-10-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/008/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1276,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1276', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1276', 'active_substance': 'Isavuconazonium sulfate', 'eu_mah_current': 'Basilea Pharmaceutica Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/010/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1277,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1277', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1277', 'active_substance': 'Plasmid DNA encoding the human cystic fibrosis transmembrane conductance regulator gene complexed with a non-viral, cationic lipid based gene transfer agent', 'eu_mah_current': 'Imperial Innovations Limited', 'orphan_status': 'o', 'eu_aut_date': '06-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/013/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1278,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1278', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1278', 'active_substance': 'Adeno-associated viral vector serotype 2 containing the human CHM gene encoding human Rab escort protein 1', 'eu_mah_current': 'Spark Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/015/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1279,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1279', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1279', 'active_substance': '4-(4-Methoxy-phenylamino)-6-methylcarbamyl-quinoline-3-carboxylic acid', 'eu_mah_current': 'Clanotech AB', 'orphan_status': 'o', 'eu_aut_date': '06-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/016/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1280,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1280', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1280', 'active_substance': 'Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene', 'eu_mah_current': 'Orchard Therapeutics (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-10-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/006/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1281,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1281', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1281', 'active_substance': '1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-{1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl}cyclopropanecarboxamide', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/002/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1282,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1282', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1282', 'active_substance': 'Mixture of two adeno-associated viral vectors of serotype 8 containing the 5&#39;-half sequence of human MYO7A gene and the 3&#39;-half sequence of human MYO7A gene', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '07-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/004/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1283,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1283', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1283', 'active_substance': 'Mixture of two adeno-associated viral vectors of serotype 8 containing the 5&#39;-half sequence of human ABCA4 gene and the 3&#39;-half sequence of human ABCA4 gene', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '07-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/005/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1284,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1284', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1284', 'active_substance': 'Isavuconazonium sulfate', 'eu_mah_current': 'Basilea Pharmaceutica Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/009/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1285,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1285', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1285', 'active_substance': 'Afamelanotide', 'eu_mah_current': 'Clinuvel Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '07-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/019/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1286,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1286', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1286', 'active_substance': 'Humanised Fc engineered monoclonal antibody against CD19', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/022/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1288,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1288', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1288', 'active_substance': 'Norursodeoxycholic acid', 'eu_mah_current': 'Dr Falk Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/026/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1290,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1290', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1290', 'active_substance': 'Adeno-associated viral vector serotype 2 containing the human REP1 gene', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/033/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1291,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1291', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1291', 'active_substance': 'Rilotumumab', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/012/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1294,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1294', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1294', 'active_substance': 'Sodium acetate salt of the synthetic peptide H-D-Ala-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-D-Ala-OH', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/028/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1295,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1295', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1295', 'active_substance': 'Marizomib', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/035/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1296,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1296', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1296', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human cardiac calsequestrin gene', 'eu_mah_current': 'Istituti Clinici Scientifici Maugeri', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/037/14', 'ema_number_certainty': '0.6'}"
EU-3-14-1297,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1297', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1297', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against antithrombin mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/039/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1298,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1298', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1298', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against antithrombin mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/041/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1300,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1300', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1300', 'active_substance': 'Recombinant fusion protein consisting of a modified form of the extracellular domain of human activin receptor IIB linked to the human IgG1 Fc domain', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/047/14', 'ema_number_certainty': '0.75'}"
EU-3-14-1302,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1302', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1302', 'active_substance': 'Oxytocin', 'eu_mah_current': 'OT4B', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/054/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1303,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1303', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1303', 'active_substance': 'Cediranib', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/059/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1304,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1304', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1304', 'active_substance': 'Eculizumab', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/062/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1306,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1306', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1306', 'active_substance': 'Cysteamine bitartrate', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/070/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1307,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1307', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1307', 'active_substance': 'Retinol', 'eu_mah_current': 'Orphanix GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/018/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1308,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1308', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1308', 'active_substance': 'Sodium ascorbate and menadione sodium bisulfite', 'eu_mah_current': 'MCA Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/043/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1310,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1310', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1310', 'active_substance': '(3S)-1-azabicyclo[2.2.2]oct-3-yl{2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/052/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1312,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1312', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1312', 'active_substance': 'Recombinant factor VIIa modified with three terminal repeats derived from the &#223; chain of human chorionic gonadotropin', 'eu_mah_current': 'Eirgen Pharma Limited', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/057/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1313,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1313', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1313', 'active_substance': '(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N&#39;-(pyrazin-2-yl)acrylohydrazide', 'eu_mah_current': 'Karyopharm Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/061/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1314,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1314', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1314', 'active_substance': 'Recombinant human apolipoprotein A-I in a complex with phospholipids', 'eu_mah_current': 'Cerenis Therapeutics Holding SA', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/063/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1315,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1315', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1315', 'active_substance': 'Recombinant human apolipoprotein A-I in a complex with phospholipids', 'eu_mah_current': 'Cerenis Therapeutics Holding SA', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/064/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1316,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1316', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1316', 'active_substance': 'Recombinant factor VIIa modified with three terminal repeats derived from the &#223; chain of human chorionic gonadotropin', 'eu_mah_current': 'Eirgen Pharma Limited', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/069/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1317,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1317', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1317', 'active_substance': '(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N&#39;-(pyrazin-2-yl)acrylohydrazide', 'eu_mah_current': 'Karyopharm Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/071/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1318,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1318', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1318', 'active_substance': 'Ulinastatin', 'eu_mah_current': 'BSV BioScience GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/072/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1319,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1319', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1319', 'active_substance': 'Recombinant factor VIIa modified with three terminal repeats derived from the &#223; chain of human chorionic gonadotropin', 'eu_mah_current': 'Eirgen Pharma Limited', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/073/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1320,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1320', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1320', 'active_substance': 'Recombinant human diamine oxidase', 'eu_mah_current': 'Medical University of Vienna', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/075/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1322,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1322', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1322', 'active_substance': 'Humanised IgG1 monoclonal antibody against human KIR3DL2', 'eu_mah_current': 'Innate Pharma S.A.', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/084/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1323,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1323', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1323', 'active_substance': '[5-amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone', 'eu_mah_current': 'Synovo GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/085/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1324,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1324', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1324', 'active_substance': '2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethylsulfamide', 'eu_mah_current': 'DualTpharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/086/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1326,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1326', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1326', 'active_substance': 'Vector based on an adeno-associated virus serotype 2 backbone, pseudo-serotyped with a type 8 capsid, which carries the coding sequence of the human TYMP gene under the control of the human thyroxine binding globulin promoter', 'eu_mah_current': 'Vall d&#39;Hebron Institute of Research', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/093/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1327,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1327', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1327', 'active_substance': 'S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)', 'eu_mah_current': 'Amyndas Pharmaceuticals S.A.', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/098/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1328,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1328', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1328', 'active_substance': '4-{[(2R,3S,4R,5S)-4-(4-chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic acid', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/100/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1329,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1329', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1329', 'active_substance': 'Variant of recombinant human fibroblast growth factor 19', 'eu_mah_current': 'Diamond Pharma Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/101/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1330,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1330', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1330', 'active_substance': 'Lentiviral vector containing the human liver and erythroid pyruvate kinase (PKLR) gene', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red M.P.', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/102/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1331,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1331', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1331', 'active_substance': 'Recombinant fusion protein consisting of a modified form of the extracellular domain of human activin receptor IIB linked to the human IgG1 Fc domain', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/048/14', 'ema_number_certainty': '0.75'}"
EU-3-14-1332,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1332', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1332', 'active_substance': 'Macromolecular conjugate of heparin sodium on a polymer backbone', 'eu_mah_current': 'Corline Biomedical AB', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/090/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1334,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1334', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1334', 'active_substance': '(3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one', 'eu_mah_current': 'Centre National de la Recherche Scientifique (CNRS)', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/105/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1336,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1336', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1336', 'active_substance': '(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride', 'eu_mah_current': 'Khondrion BV', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/068/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1337,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1337', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1337', 'active_substance': 'Acamprosate calcium', 'eu_mah_current': 'ESPL Regulatory Consulting Limited', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/137/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1338,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1338', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1338', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/122/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1339,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1339', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1339', 'active_substance': 'Cannabidiol', 'eu_mah_current': 'GW Pharma (International) B.V', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/083/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1340,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1340', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1340', 'active_substance': 'Cultured allogeneic corneal limbal stem cells', 'eu_mah_current': 'NHS National Services Scotland Trading as Scottish National Blood Transfusion Service', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/109/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1341,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1341', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1341', 'active_substance': 'Cysteamine hydrochloride', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/106/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1342,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1342', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1342', 'active_substance': 'Glucagon', 'eu_mah_current': 'S-cubed Pharmaceutical Services ApS', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/128/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1343,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1343', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1343', 'active_substance': 'Immunoglobulin G1, anti-(human tumour-associated calcium signal transducer 2)(human-Mus musculus monoclonal hRS7 heavy chain), disulfide with human-Mus musculus monoclonal hRS7 k-chain, dimer, hexakis(thioether) with (4S)-4-[[[[4-[[(2S)-2-(4-aminobutyl)-2-[[2-[2-[[26-[4-[[[[4-[(3-mercapto-2,5-dioxo-1-pyrrolidinyl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-3,6,9,12,15,18,21,24-octaoxahexacos-1-yl]amino]-2-oxoethoxy]acetyl]amino]-1-oxoethyl]amino]phenyl]methoxy]carbonyl]oxy]-4,11-diethyl-9-hydroxy-1H-pyrano[3&#39;,4&#39;:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione', 'eu_mah_current': 'Gilead Sciences Ireland Unlimited Company', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/081/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1344,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1344', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1344', 'active_substance': 'Nitric oxide', 'eu_mah_current': 'PD Dr med. Joachim Riethm&#252;ller', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/036/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1345,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1345', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1345', 'active_substance': 'Osilodrostat', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/099/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1346,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1346', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1346', 'active_substance': 'Oxalobacter formigenes strain HC-1', 'eu_mah_current': 'OxThera AB', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/080/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1347,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1347', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1347', 'active_substance': 'Pyridoxal 5&#39;-phosphate', 'eu_mah_current': 'Great Ormond Street Hospital for Children, NHS Foundation Trust', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/104/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1348,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1348', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1348', 'active_substance': 'Recombinant human bone morphogenetic protein 4', 'eu_mah_current': 'Stemgen S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/111/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1350,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1350', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1350', 'active_substance': 'Recombinant human monoclonal antibody of the IgG1 kappa class against human macrophage colony-stimulating factor', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/107/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1351,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1351', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1351', 'active_substance': 'Recombinant human monoclonal IgG1 antibody for fibroblast growth factor 23', 'eu_mah_current': 'Kyowa Kirin Holdings B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/133/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1352,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1352', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1352', 'active_substance': 'Raxibacumab', 'eu_mah_current': 'Emergent Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/134/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1353,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1353', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1353', 'active_substance': 'Mexiletine hydrochloride', 'eu_mah_current': 'Lupin Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/074/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1354,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1354', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1354', 'active_substance': 'Selinexor', 'eu_mah_current': 'Karyopharm Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/078/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1357,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1357', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1357', 'active_substance': 'Imatinib', 'eu_mah_current': 'Exvastat (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/110/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1358,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1358', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1358', 'active_substance': 'Recombinant human pentraxin-2', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/116/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1359,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1359', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1359', 'active_substance': 'Pentosan polysulfate sodium', 'eu_mah_current': 'Paradigm Biopharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/121/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1360,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1360', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1360', 'active_substance': 'A combination of H-Lys-Lys-Gly-Pro-Arg-Cys(SH)-Leu-Thr-Arg-Tyr-Tyr-Ser-Ser-Phe-Val-Asn-Met-Glu-Gly-Lys-Lys-OH and H-Lys-Lys-Gly-Asp-Asn-Ile-Met-Val-Thr-Phe-Arg-Asn-Gln-Ala-Ser-Arg-Pro-Tyr-Gly-Lys-Lys-OH', 'eu_mah_current': 'Apitope International NV', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/123/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1362,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1362', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1362', 'active_substance': '1-(6-benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic acid', 'eu_mah_current': 'Inventiva', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/130/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1363,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1363', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1363', 'active_substance': '4-[[(1S,4S)-5-[[4-[4-(oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]hept-2-yl]methyl]benzoic acid', 'eu_mah_current': 'FarmaStrateegia O&#220;', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/131/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1364,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1364', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1364', 'active_substance': 'Olaptesed pegol', 'eu_mah_current': 'Noxxon Pharma AG', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/132/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1365,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1365', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1365', 'active_substance': 'Recombinant human pentraxin-2', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/139/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1366,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1366', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1366', 'active_substance': 'Recombinant human pentraxin-2', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/140/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1367,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1367', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1367', 'active_substance': 'Bazedoxifene acetate', 'eu_mah_current': 'Consejo Superior de Investigaciones Cientificas (CSIC)', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/144/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1368,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1368', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1368', 'active_substance': 'Palovarotene', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/145/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1371,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1371', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1371', 'active_substance': 'Humanised IgG1 monoclonal antibody against human eotaxin-2', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/148/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1372,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1372', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1372', 'active_substance': '(2R,3S)-2-(4-cyclopentylaminophenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid(4-methyl-3-trifluoromethylphenyl)amide', 'eu_mah_current': 'Vifor Fresenius Medical Care Renal Pharma France', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/149/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1373,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1373', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1373', 'active_substance': '(2R,3S)-2-(4-cyclopentylaminophenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid(4-methyl-3-trifluoromethylphenyl)amide', 'eu_mah_current': 'Vifor Fresenius Medical Care Renal Pharma France', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/150/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1374,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1374', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1374', 'active_substance': '(3S)-1-azabicyclo[2.2.2]oct-3-yl{2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/152/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1375,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1375', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1375', 'active_substance': 'Pro-Pro-Thr-Val-Pro-Thr-Arg', 'eu_mah_current': 'ProGeLife S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/155/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1376,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1376', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1376', 'active_substance': 'Arimoclomol citrate', 'eu_mah_current': 'Orphazyme A/S', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/158/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1377,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1377', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1377', 'active_substance': 'Chloroquine', 'eu_mah_current': 'DualTpharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/159/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1378,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1378', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1378', 'active_substance': 'Diaspirin cross-linked haemoglobin', 'eu_mah_current': 'New Beta Innovation Biopharmaceutical (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/160/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1379,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1379', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1379', 'active_substance': 'Dantrolene sodium', 'eu_mah_current': 'Maxia Strategies-Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/162/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1381,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1381', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1381', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human MD1 gene', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/166/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1383,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1383', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1383', 'active_substance': 'Single-chain urokinase plasminogen activator', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/125/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1384,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1384', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1384', 'active_substance': '((E)-1-(4&#39;-chlorophenyl)-3-(4-hydroxy-3-metoxyphenyl)prop-2-en-1-one)', 'eu_mah_current': 'Centre National de la Recherche Scientifique (CNRS)', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/142/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1385,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1385', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1385', 'active_substance': 'Heat-killed Mycobacterium obuense (whole cell)', 'eu_mah_current': 'Regintel Limited', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/143/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1386,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1386', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1386', 'active_substance': '2-hydroxymethyl-2-methoxymethyl-1-azabicyclo[2,2,2]octan-3-one', 'eu_mah_current': 'Aprea Therapeutics AB', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/157/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1387,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1387', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1387', 'active_substance': 'Exisulind', 'eu_mah_current': 'Firc Institute of Molecular Oncology (IFOM)', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/161/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1388,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1388', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1388', 'active_substance': 'Allogeneic bone marrow derived mesenchymal cells expanded ex vivo in synthetic media', 'eu_mah_current': 'Cell2B Advanced Therapeutics, SA', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/163/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1389,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1389', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1389', 'active_substance': 'Adeno-associated viral vector serotype rh.10 carrying the human N-sulfoglucosamine sulfohydrolase cDNA', 'eu_mah_current': 'LYSOGENE', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/164/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1390,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1390', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1390', 'active_substance': 'Bevacizumab', 'eu_mah_current': 'Dr Sophie Dupuis-Girod', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/167/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1392,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1392', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1392', 'active_substance': '5-bromo-N-(prop-2-yn-1-yl)-2-(1H-1,2,4-triazol-1-yl)pyrimidine-4,6-diamine', 'eu_mah_current': 'Palobiofarma S.L.', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/169/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1393,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1393', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1393', 'active_substance': 'Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3 zeta chimeric antigen receptor', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/171/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1394,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1394', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1394', 'active_substance': 'Pegylated recombinant human hyaluronidase PH20', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/173/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1395,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1395', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1395', 'active_substance': 'Allogeneic ex vivo-generated natural killer cells from CD34+ umbilical cord blood progenitor cells', 'eu_mah_current': 'IPD-Therapeutics BV', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/175/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1396,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1396', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1396', 'active_substance': 'Adenovirus serotype 5 containing partial E1A deletion and an integrin-binding domain', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/176/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1397,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1397', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1397', 'active_substance': 'Amikacin sulfate', 'eu_mah_current': 'PlumeStars s.r.l.', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/177/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1398,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1398', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1398', 'active_substance': 'Genetically modified serotype 5/3 adenovirus coding for granulocyte macrophage colony-stimulating factor', 'eu_mah_current': 'Targovax Oy', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/180/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1399,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1399', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1399', 'active_substance': 'Edaravone', 'eu_mah_current': 'Treeway B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/184/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1400,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1400', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1400', 'active_substance': '(1S,4R,5R,7S)-3,4-dibenzyl-2-oxo-6,8-dioxa-3-azabyciclo[3.2.1]octane-7-carboxylic acid-L-lysine', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/185/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1401,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1401', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1401', 'active_substance': 'Riluzole', 'eu_mah_current': 'Dr Laurent Vinay', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/186/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1402,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1402', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1402', 'active_substance': 'Benserazide hydrochloride', 'eu_mah_current': 'Isabelle Ramirez', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/189/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1403,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1403', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1403', 'active_substance': 'Plerixafor', 'eu_mah_current': 'Groupe d&#39;&#233;tude des neutrop&#233;nies', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/190/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1404,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1404', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1404', 'active_substance': '1-(2-isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d]pyrimidin-4-one', 'eu_mah_current': 'Biohaven Pharmaceutical Ireland DAC', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/193/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1406,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1406', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1406', 'active_substance': 'Chenodeoxycholic acid', 'eu_mah_current': 'Leadiant GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/196/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1407,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1407', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1407', 'active_substance': 'Allogeneic adipose-derived adult mesenchymal stem cells contained in a fibrin-based bioengineered dermis', 'eu_mah_current': 'Biodan Yelah S.L.', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/197/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1408,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1408', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1408', 'active_substance': '5,5&#39;-(4-(trifluromethyl)benzylazanediyl)bis(methylene)diquinolin-8-ol', 'eu_mah_current': 'Prof. Olivier Blin', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/200/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1409,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1409', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1409', 'active_substance': 'Pegylated recombinant arginine deiminase', 'eu_mah_current': 'Polaris Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/076/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1412,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1412', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1412', 'active_substance': 'Herpes simplex type 1 virus containing cellular B-myb gene as tumour-specific promoter', 'eu_mah_current': 'Karcinolys S.A.S', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/187/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1414,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1414', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1414', 'active_substance': 'Sodium thiosulfate', 'eu_mah_current': 'Hope Pharmaceuticals Limited', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/191/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1415,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1415', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1415', 'active_substance': 'Adenoviral vector serotype 5 containing the vascular endothelial growth factor D isoform (preprocessed short form) from a CMV promoter', 'eu_mah_current': 'Magnus Invention Management Ltd', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/198/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1416,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1416', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1416', 'active_substance': 'Chimeric monoclonal antibody to O-acetyl-GD2 antigen', 'eu_mah_current': 'OGD2 Pharma', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/199/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1417,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1417', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1417', 'active_substance': 'A lentiviral vector pseudotyped by the Indiana serotype of the vesicular stomatitis virus G protein encoding an antigen derived from the Tax, HBZ, p12I and p30II HTLV-1 proteins', 'eu_mah_current': 'THERAVECTYS', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/203/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1418,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1418', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1418', 'active_substance': 'A lentiviral vector pseudotyped by the New-Jersey serotype of the vesicular stomatitis virus G protein encoding an antigen derived from the Tax, HBZ, p12I and p30II HTLV-1 proteins', 'eu_mah_current': 'THERAVECTYS', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/204/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1419,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1419', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1419', 'active_substance': 'Tenofovir disoproxil fumarate', 'eu_mah_current': 'Dr Yanick Crow', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/205/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1420,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1420', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1420', 'active_substance': 'Emtricitabine', 'eu_mah_current': 'Dr Yanick Crow', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/206/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1422,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1422', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1422', 'active_substance': 'Chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2', 'eu_mah_current': 'Allievex Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/213/14', 'ema_number_certainty': '0.25'}"
EU-3-14-1423,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1423', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1423', 'active_substance': 'Synthetic signal peptide of human mucin-1 (amino acids 1-21)', 'eu_mah_current': 'Turnkey Pharmaconsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/214/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-14-1424,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1424', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1424', 'active_substance': 'Humanised Fc engineered monoclonal antibody against CD19', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/215/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1425,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1425', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1425', 'active_substance': 'Ceftriaxone', 'eu_mah_current': 'Ospedale San Raffaele s.r.l.', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/216/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1427,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1427', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1427', 'active_substance': 'Recombinant human alkaline phosphatase', 'eu_mah_current': 'AM-Pharma BV', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/218/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1428,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1428', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1428', 'active_substance': 'Sodium valproate', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/222/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1429,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1429', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1429', 'active_substance': 'N-methyl-4-({4-[({3-methyl(methylsulfonyl)aminopyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/223/14', 'ema_number_certainty': '0.5'}"
EU-3-14-1430,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/14/1430', 'status_type': 'a', 'eu_pnumber': 'EU/3/14/1430', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human factor VII gene', 'eu_mah_current': 'UCL Research Limited', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/224/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1432,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1432', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1432', 'active_substance': '2&#39;-O-methyl phosphorothioate RNA oligonucleotide, 5&#39;-m5CUGm5CUGm5CUGm5CUGm5CUGm5CUGm5CUG-3&#39;', 'eu_mah_current': 'Vico Therapeutics B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-18-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/192/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-15-1433,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1433', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1433', 'active_substance': 'Sevuparin sodium', 'eu_mah_current': 'Modus Therapeutics AB', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/210/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1435,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1435', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1435', 'active_substance': 'Nitroglycerin', 'eu_mah_current': 'Covis Pharma S.&#224;.r.l.', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/225/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1436,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1436', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1436', 'active_substance': 'Lactobacillus reuteri', 'eu_mah_current': 'Infant Bacterial Therapeutics AB', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/237/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1437,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1437', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1437', 'active_substance': 'Alvocidib', 'eu_mah_current': 'Labcorp Clinical Development GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/240/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1438,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1438', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1438', 'active_substance': 'Allogeneic CD4+ and CD8+ T lymphocytes ex vivo incubated with synthetic peptides of the viral antigens of cytomegalovirus, adenovirus and Epstein-Barr virus', 'eu_mah_current': 'Miltenyi Biotec GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/245/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1439,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1439', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1439', 'active_substance': 'Allogeneic CD4+ and CD8+ T lymphocytes ex vivo incubated with synthetic peptides of the viral antigens of cytomegalovirus, adenovirus and Epstein-Barr virus', 'eu_mah_current': 'Miltenyi Biotec GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/246/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1440,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1440', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1440', 'active_substance': 'Allogeneic CD4+ and CD8+ T lymphocytes ex vivo incubated with synthetic peptides of the viral antigens of cytomegalovirus, adenovirus and Epstein-Barr virus', 'eu_mah_current': 'Miltenyi Biotec GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/247/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1442,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1442', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1442', 'active_substance': 'Fibrinogen-coated albumin spheres', 'eu_mah_current': 'Fibreu Limitless Research S.L.', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/250/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1446,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1446', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1446', 'active_substance': 'N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine disulphate salt', 'eu_mah_current': 'AlzProtect sas', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/261/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1449,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1449', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1449', 'active_substance': 'Myriocin', 'eu_mah_current': 'Nanovector s.r.l.', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/271/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1450,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1450', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1450', 'active_substance': 'Gallium (68Ga)-edotreotide', 'eu_mah_current': 'Advanced Accelerator Applications', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/219/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1451,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1451', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1451', 'active_substance': '5&#39;-ASCSASTSCSASGSTSCSTSGSASUSASASGSCSTSA-3&#39;', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/238/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1453,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1453', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1453', 'active_substance': 'Chimeric 2&#39;-O-(2-methoxyethyl) modified oligonucleotide targeted to huntingtin RNA', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/256/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1454,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1454', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1454', 'active_substance': '6-ethoxy-7-methoxy-2-(2-methylsulfanylphenyl)-3,1-benzoxazin-4-one', 'eu_mah_current': 'Sixera Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/264/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1455,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1455', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1455', 'active_substance': 'Human plasma-derived alpha-1 proteinase inhibitor', 'eu_mah_current': 'Kamada Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/267/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-15-1456,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1456', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1456', 'active_substance': 'Recombinant human club cell 10 KDa protein', 'eu_mah_current': 'RLM Consulting', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/270/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1458,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1458', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1458', 'active_substance': 'Humanised anti-folate receptor 1 monoclonal antibody conjugated to maytansinoid DM4', 'eu_mah_current': 'ImmunoGen BioPharma (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/281/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1459,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1459', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1459', 'active_substance': 'Enoxacin', 'eu_mah_current': 'Regenold GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/283/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1461,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1461', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1461', 'active_substance': 'Recombinant human monoclonal antibody binding to vascular adhesion protein-1', 'eu_mah_current': 'Biotie Therapies Oy', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/288/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1462,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1462', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1462', 'active_substance': 'Sodium 3-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-bromo-6-phenyl-5H-imidazo[1,2-a]purin-9-one', 'eu_mah_current': 'Universit&#228;tsklinikum T&#252;bingen (UKT)', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/289/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1464,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1464', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1464', 'active_substance': 'Autologous adipose tissue-derived stromal vascular fraction cells', 'eu_mah_current': 'Assistance Publique H&#244;pitaux de Marseille', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/296/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1465,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1465', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1465', 'active_substance': 'Ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a LAMB3-encoding retroviral vector', 'eu_mah_current': 'Holostem Terapie Avanzate S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/297/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1466,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1466', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1466', 'active_substance': 'Ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a COL7A1-encoding retroviral vector', 'eu_mah_current': 'Holostem Terapie Avanzate S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/298/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1467,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1467', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1467', 'active_substance': 'Ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a COL17A1-encoding retroviral vector', 'eu_mah_current': 'Holostem Terapie Avanzate S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/299/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1469,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1469', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1469', 'active_substance': 'Human reovirus type 3 Dearing strain', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/304/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1470,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1470', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1470', 'active_substance': '5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)bacteriochlorin', 'eu_mah_current': 'Luzitin S.A', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/305/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1472,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1472', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1472', 'active_substance': 'Fluciclovine (18F)', 'eu_mah_current': 'Blue Earth Diagnostics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/280/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1475,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1475', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1475', 'active_substance': '1-(4-(N-glycylamido)phenyl)-3-trifluoromethyl-5-(phenanthren-2-yl)-pyrazole-hydrochloride', 'eu_mah_current': 'Arno Therapeutics UK, Limited', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/300/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1476,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1476', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1476', 'active_substance': '1-(4-(N-glycylamido)phenyl)-3-trifluoromethyl-5-(phenanthren-2-yl)-pyrazole-hydrochloride', 'eu_mah_current': 'Arno Therapeutics UK, Limited', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/301/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1477,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1477', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1477', 'active_substance': 'Human reovirus type 3 Dearing strain', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/302/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1478,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1478', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1478', 'active_substance': 'Rimeporide', 'eu_mah_current': 'Florence Porte Thom&#233;', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/307/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1479,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1479', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1479', 'active_substance': 'Recombinant monoclonal IgG1 antibody against T-cell immune response cDNA 7', 'eu_mah_current': 'Nekonal S.a.r.l.', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/308/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1480,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1480', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1480', 'active_substance': 'Rintatolimod', 'eu_mah_current': 'NV Hemispherx BioPharma Europe', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/310/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1482,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1482', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1482', 'active_substance': 'Adeno-associated viral vector serotype 5 containing the human CHM gene', 'eu_mah_current': 'Inserm-Transfert SA', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/312/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1483,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1483', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1483', 'active_substance': 'Xenon', 'eu_mah_current': 'Neuroprotexeon Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/315/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1485,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1485', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1485', 'active_substance': 'Sodium 2-hydroxylinoleate', 'eu_mah_current': 'Ability Pharmaceuticals SL', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/326/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1486,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1486', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1486', 'active_substance': 'Recombinant human mesencephalic astrocyte-derived neurotrophic factor', 'eu_mah_current': 'Regintel Limited', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/327/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1490,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1490', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1490', 'active_substance': 'Triamcinolone acetonide', 'eu_mah_current': 'S-cubed Pharmaceutical Services ApS', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/320/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1491,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1491', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1491', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human HGSNAT gene', 'eu_mah_current': 'Cochamo Pharma Limited', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/322/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1492,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1492', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1492', 'active_substance': 'AASSGVSTPGSAGHDIITEQPRS', 'eu_mah_current': 'Centre National de la Recherche Scientifique (CNRS)', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/325/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1493,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1493', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1493', 'active_substance': 'Allopurinol sodium', 'eu_mah_current': 'ACE Pharmaceuticals BV', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/004/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1496,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1496', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1496', 'active_substance': 'Trehalose', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/008/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1499,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1499', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1499', 'active_substance': 'Adult human bone-marrow-derived, ex-vivo-expanded, pooled allogeneic mesenchymal stromal cells', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/019/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1500,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1500', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1500', 'active_substance': 'Synthetic 47-amino-acid N-myristoylated lipopeptide, derived from the preS region of hepatitis B virus', 'eu_mah_current': 'Gilead Sciences Ireland Unlimited Company', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/329/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1502,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1502', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1502', 'active_substance': 'Trehalose', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/009/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1503,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1503', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1503', 'active_substance': 'Allogeneic ex-vivo-expanded human umbilical cord blood-derived mesenchymal stem cells', 'eu_mah_current': 'PSR Group B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/010/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1504,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1504', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1504', 'active_substance': 'Obinutuzumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/013/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1506,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1506', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1506', 'active_substance': 'Antisense oligonucleotide directed against TGF-beta2 mRNA', 'eu_mah_current': 'Isarna Therapeutics GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/021/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1507,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1507', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1507', 'active_substance': '3-{[2,3,5,6-tetrafluoro-3&#39;-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid', 'eu_mah_current': 'Panoptes Pharma Ges.m.b.H', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/024/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1508,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1508', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1508', 'active_substance': 'Triheptanoin', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/026/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1509,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1509', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1509', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human SMN gene', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/028/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1510,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1510', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1510', 'active_substance': 'Edaravone', 'eu_mah_current': 'Mitsubishi Tanabe Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/032/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1511,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1511', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1511', 'active_substance': 'Human plasminogen', 'eu_mah_current': 'Kedrion S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/313/14', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1512,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1512', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1512', 'active_substance': 'Anti-H5N1 equine immunoglobulin F(ab&#39;)2 fragments', 'eu_mah_current': 'Fab&#39;entech', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/012/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1513,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1513', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1513', 'active_substance': 'Doxorubicin', 'eu_mah_current': 'Double Bond Pharmaceutical AB', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/023/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1514,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1514', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1514', 'active_substance': 'Lanreotide acetate', 'eu_mah_current': 'Prof. Dr R.T.Gansevoort', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/027/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1515,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1515', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1515', 'active_substance': 'Synthetic hypericin', 'eu_mah_current': 'Kinesys Consulting NL B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/033/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1516,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1516', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1516', 'active_substance': 'Modified adenovirus serotype 5/35 containing a CMV promoter-driven transgene cassette with the human transgenes for a membrane-bound CD40 ligand and full length 4-1BBL', 'eu_mah_current': 'Lokon Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/034/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1517,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1517', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1517', 'active_substance': '2-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-N-((5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3&#39;,4&#39;:6,7]naphtho[2,3-d][1,3]dioxol-5-yl)acetamide, tetrahydrochloride', 'eu_mah_current': 'Pierre Fabre M&#233;dicament', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/037/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1518,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1518', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1518', 'active_substance': 'Adenovirus-associated viral vector serotype 2 containing the human RPE65 gene', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/040/15', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-15-1519,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1519', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1519', 'active_substance': 'Allogeneic human adult stem cells, isolated from skeletal muscle and expanded ex vivo', 'eu_mah_current': 'Karl Rouger', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/041/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1520,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1520', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1520', 'active_substance': 'Cannabidiol', 'eu_mah_current': 'GW Pharma (International) B.V', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/042/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1521,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1521', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1521', 'active_substance': 'Artesunate', 'eu_mah_current': 'B And O Pharm', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/043/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1522,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1522', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1522', 'active_substance': 'Humanised IgG4 monoclonal antibody against extracellular tau', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/044/15', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-15-1523,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1523', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1523', 'active_substance': 'Inecalcitol', 'eu_mah_current': 'Hybrigenics SA', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/045/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1524,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1524', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1524', 'active_substance': 'Triheptanoin', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/046/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1525,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1525', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1525', 'active_substance': 'Triheptanoin', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/047/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1526,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1526', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1526', 'active_substance': 'Triheptanoin', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/048/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1527,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1527', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1527', 'active_substance': 'Hydrocinnamate-[Orn-Pro-dCha-Trp-Arg]acetate', 'eu_mah_current': 'PBS Regulatory Consulting Group Limited', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/051/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1529,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1529', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1529', 'active_substance': 'Glycyl-L-2-methylprolyl-L-glutamic acid', 'eu_mah_current': 'DLRC Pharma Services Ltd', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/055/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1531,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1531', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1531', 'active_substance': 'Sarizotan hydrochloride', 'eu_mah_current': 'Newron Pharmaceuticals SpA', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/058/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1532,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1532', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1532', 'active_substance': 'Insulin human', 'eu_mah_current': 'Sirius Regulatory Consulting EU Limited', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/050/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1533,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1533', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1533', 'active_substance': 'Human allogeneic bone-marrow-derived osteoblastic cells', 'eu_mah_current': 'Bone Therapeutics SA', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/053/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1534,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1534', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1534', 'active_substance': 'Glycyl-L-2-methylprolyl-L-glutamic acid', 'eu_mah_current': 'DLRC Pharma Services Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/056/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1535,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1535', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1535', 'active_substance': 'Fibrinogen-coated albumin spheres', 'eu_mah_current': 'Fibreu Limitless Research S.L.', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/060/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1536,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1536', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1536', 'active_substance': 'Recombinant human acid ceramidase', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/061/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1538,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1538', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1538', 'active_substance': 'Fixed-dose combination of fosfomycin disodium and tobramycin', 'eu_mah_current': 'CURx Pharma (UK) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/068/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1539,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1539', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1539', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human MTM1 gene', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/074/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1540,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1540', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1540', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human iduronate-2-sulfatase gene', 'eu_mah_current': 'Esteve Pharmaceuticals, S.A.', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/076/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1543,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1543', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1543', 'active_substance': '(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride', 'eu_mah_current': 'Khondrion BV', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/085/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1544,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1544', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1544', 'active_substance': '2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/087/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1547,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1547', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1547', 'active_substance': 'Mazindol', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/002/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1548,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1548', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1548', 'active_substance': 'Ovine-specific immunoglobulin (Fab) fragments raised against Vipera berus venom', 'eu_mah_current': 'Diamond Pharma Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/062/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1549,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1549', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1549', 'active_substance': 'Synthetic peptide L-cysteine, L-cysteinylglycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-, cyclic (1.fwdarw.17)-disulfide', 'eu_mah_current': 'Apeptico Forschung und Entwicklung GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/071/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1551,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1551', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1551', 'active_substance': 'Recombinant human IgG1 kappa light chain monoclonal antibody targeting plasma kallikrein', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/075/15', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-15-1553,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1553', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1553', 'active_substance': 'Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/078/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1554,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1554', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1554', 'active_substance': 'Nimodipine', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/088/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1556,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1556', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1556', 'active_substance': 'Recombinant adeno-associated viral vector containing human CNGA3 gene', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/096/15', 'ema_number_certainty': '0.25'}"
EU-3-15-1557,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1557', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1557', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Desitin Arzneimittel GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/100/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1559,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1559', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1559', 'active_substance': '2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione', 'eu_mah_current': 'Calliditas Therapeutics France S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/105/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1561,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1561', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1561', 'active_substance': 'Ataluren', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/110/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1562,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1562', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1562', 'active_substance': 'A highly purified formulation of Staphylococcus aureus protein A', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/111/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1563,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1563', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1563', 'active_substance': 'Recombinant human interleukin-3 truncated diphtheria toxin fusion protein', 'eu_mah_current': 'Stemline Therapeutics B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/112/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1565,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1565', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1565', 'active_substance': '2-chloro-N6-(3-iodobenzyl)adenosine-5&#39;-N-methyluronamide', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/118/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1566,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1566', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1566', 'active_substance': 'Autologous human peripheral blood Vdelta1+ T lymphocytes activated in vitro by cytokine and monoclonal antibody treatment', 'eu_mah_current': 'Lymphact - Lymphocyte Activation Technologies S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/006/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1567,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1567', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1567', 'active_substance': 'Recombinant human interleukin-3 truncated diphtheria toxin fusion protein', 'eu_mah_current': 'Stemline Therapeutics B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/064/15', 'ema_number_certainty': '0.75'}"
EU-3-15-1568,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1568', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1568', 'active_substance': 'Interferon alfa-n3', 'eu_mah_current': 'NV Hemispherx BioPharma Europe', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/093/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1573,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1573', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1573', 'active_substance': 'Adeno-associated viral vector serotype 8 encoding the human ATP7B gene under the control of the human alpha-1 antitrypsin promoter', 'eu_mah_current': 'Aligen Therapeutics S.L.', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/114/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1574,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1574', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1574', 'active_substance': '4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2-(ethoxymethyl)-[1,1-biphenyl]-2-sulfonamide', 'eu_mah_current': 'Vifor France S.A.', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/115/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1575,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1575', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1575', 'active_substance': 'Humanised fusion protein consisting of extracellular domain of CD24 linked to IgG1 Fc domain', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/119/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1576,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1576', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1576', 'active_substance': '(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/126/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1577,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1577', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1577', 'active_substance': 'Adenovirus associated viral vector serotype 5 containing the human RPE65 gene', 'eu_mah_current': 'MeiraGTx B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/129/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1578,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1578', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1578', 'active_substance': 'Adenovirus associated viral vector serotype 8 containing the human CNGB3 gene', 'eu_mah_current': 'Janssen-Cilag International N.V.', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/130/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1579,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1579', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1579', 'active_substance': 'Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/135/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1581,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1581', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1581', 'active_substance': 'Sodium phenylbutyrate', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/141/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1582,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1582', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1582', 'active_substance': 'Humanised monoclonal antibody of the IgG4 kappa isotype targeting CD47', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/145/15', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-15-1584,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1584', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1584', 'active_substance': 'Variant of recombinant human fibroblast growth factor 19', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/139/15', 'ema_number_certainty': '0.25'}"
EU-3-15-1585,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1585', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1585', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Rare Partners srl Impresa Sociale', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/142/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1586,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1586', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1586', 'active_substance': 'Recombinant human nerve growth factor', 'eu_mah_current': 'Domp&#233; farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/143/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1587,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1587', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1587', 'active_substance': 'Combretastatin A1 diphosphate', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/144/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1588,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1588', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1588', 'active_substance': '(R)-1-[1-(4-acetoxy-3,3-dimethyl-2-oxo-butyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-3-(3-methylamino-phenyl)-urea', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/147/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-15-1589,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1589', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1589', 'active_substance': 'Glibenclamide', 'eu_mah_current': 'AMMTeK', 'orphan_status': 'o', 'eu_aut_date': '01-15-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/149/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1591,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1591', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1591', 'active_substance': 'Synthetic peptide L-cysteine, L-cysteinylglycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-, cyclic (1.fwdarw.17)-disulfide', 'eu_mah_current': 'Apeptico Forschung und Entwicklung GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/151/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1592,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1592', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1592', 'active_substance': '[4-aminobutanoic acid-glycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-L-aspartyl](cyclo 1-Dgamma17)', 'eu_mah_current': 'Apeptico Forschung und Entwicklung GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/153/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1593,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1593', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1593', 'active_substance': 'Imetelstat sodium', 'eu_mah_current': 'Parexel International GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/154/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1594,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1594', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1594', 'active_substance': 'Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin', 'eu_mah_current': 'Aduro Biotech Holdings, Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/157/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1595,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1595', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1595', 'active_substance': 'Live attenuated Listeria monocytogenes bioengineered with a chimeric human epidermal growth factor receptor 2 fused to a truncated form of the Lm protein listeriolysin O', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/162/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1596,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1596', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1596', 'active_substance': 'Bilayer engineered collagen hydrogel-based skin graft composed of autologous keratinocytes and fibroblasts', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/163/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1598,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1598', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1598', 'active_substance': '2-(2-chlorobenzylidene)hydrazinecarboximidamide acetate', 'eu_mah_current': 'Inflectis Bioscience', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/170/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1600,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1600', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1600', 'active_substance': 'Sodium benzoate', 'eu_mah_current': 'Syri Pharma Limited', 'orphan_status': 'o', 'eu_aut_date': '01-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/123/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1601,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1601', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1601', 'active_substance': 'Sodium benzoate', 'eu_mah_current': 'Syri Pharma Limited', 'orphan_status': 'o', 'eu_aut_date': '01-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/124/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1602,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/15/1602', 'status_type': 'a', 'eu_pnumber': 'EU/3/15/1602', 'active_substance': 'Live attenuated Listeria monocytogenes transfected with plasmids encoding the HPV-16E7 protein fused to a truncated fragment of the Lm protein listeriolysin O', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/161/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1608,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1608', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1608', 'active_substance': 'S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)', 'eu_mah_current': 'Amyndas Pharmaceuticals S.A.', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/104/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1609,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1609', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1609', 'active_substance': 'Humanised IgG4 monoclonal antibody against total complement component 1, subcomponent s', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/177/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-16-1610,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1610', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1610', 'active_substance': 'Arsenic trioxide', 'eu_mah_current': 'Syros Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/180/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1611,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1611', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1611', 'active_substance': 'Ex-vivo-expanded autologous fibroblasts transduced with lentiviral vector containing the COL7A1 gene', 'eu_mah_current': 'Dr Waseem Qasim', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/188/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1613,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1613', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1613', 'active_substance': 'Tolfenamic acid', 'eu_mah_current': 'RV Developpement', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/193/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1614,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1614', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1614', 'active_substance': 'Tolfenamic acid', 'eu_mah_current': 'RV Developpement', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/194/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1615,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1615', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1615', 'active_substance': '2-ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]amino}propanoate', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/197/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1616,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1616', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1616', 'active_substance': 'Diclofenamide', 'eu_mah_current': 'Giampietro Schiavo', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/199/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1618,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1618', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1618', 'active_substance': 'N-(4-methoxyphenyl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-amine', 'eu_mah_current': 'FLAG Therapeutics Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/206/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1620,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1620', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1620', 'active_substance': 'Allogeneic fetal human retinal progenitor cells expanded ex vivo', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/213/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1621,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1621', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1621', 'active_substance': 'Delta-9-tetrahydrocannabinol and cannabidiol from extracts of the Cannabis sativa L. plant', 'eu_mah_current': 'GW Pharma (International) B.V', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/222/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1622,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1622', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1622', 'active_substance': 'Adeno-associated viral vector serotype 5 containing a B-domain deleted variant of human coagulation factor VIII gene', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/230/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1623,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1623', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1623', 'active_substance': 'Adeno-associated viral vector serotype 8 encoding human ornithine transcarbamylase', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/227/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1625,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1625', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1625', 'active_substance': 'Acalabrutinib', 'eu_mah_current': 'Acerta Pharma, BV', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/231/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1626,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1626', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1626', 'active_substance': 'Acalabrutinib', 'eu_mah_current': 'Acerta Pharma, BV', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/237/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1627,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1627', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1627', 'active_substance': 'Allogeneic Epstein-Barr virus specific cytotoxic T lymphocytes', 'eu_mah_current': 'Atara Biotherapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/210/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1628,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1628', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1628', 'active_substance': 'Diaspirin cross-linked haemoglobin', 'eu_mah_current': 'New Beta Innovation Biopharmaceutical (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/192/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1629,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1629', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1629', 'active_substance': 'Exenatide', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/187/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1631,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1631', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1631', 'active_substance': 'Florilglutamic acid (18F)', 'eu_mah_current': 'Piramal Imaging GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/201/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1632,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1632', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1632', 'active_substance': 'Florilglutamic acid (18F)', 'eu_mah_current': 'Piramal Imaging GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/200/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1635,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1635', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1635', 'active_substance': 'N-acetyl-D-mannosamine monohydrate', 'eu_mah_current': 'Leadiant GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/228/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1637,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1637', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1637', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues', 'eu_mah_current': 'Alnylam Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/195/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1638,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1638', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1638', 'active_substance': 'Ubenimex', 'eu_mah_current': 'EigerBio Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/179/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1639,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1639', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1639', 'active_substance': '(1E,6E)-1,7-bis(3,4-dimethoxyphenyl)-4-cyclobutylmethyl-1,6-heptadiene-3,5-dione', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/252/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1640,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1640', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1640', 'active_substance': '2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol methanesulfonate', 'eu_mah_current': 'Bristol Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/253/15', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1641,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1641', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1641', 'active_substance': 'Antisense oligonucleotide complementary to the exonic splicer enhancer sequence at intron 26 of the centrosomal protein 290 pre-mRNA', 'eu_mah_current': 'ProQR Therapeutics IV BV', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/255/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1642,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1642', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1642', 'active_substance': 'Autologous dermal fibroblasts genetically modified ex vivo with a lentiviral vector containing the human COL7A1 gene', 'eu_mah_current': 'Intrexon Actobiotics N.V.', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/218/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1644,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1644', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1644', 'active_substance': 'Brincidofovir', 'eu_mah_current': 'Chimerix IRL Limited', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/234/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1645,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1645', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1645', 'active_substance': 'Cannabidiol', 'eu_mah_current': 'Salzman Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/248/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1646,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1646', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1646', 'active_substance': 'Combination of 4-hydroxyandrostenedione, Serenoa serrulata fruit extract and alpha lipoic acid', 'eu_mah_current': 'Regenold GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/251/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1651,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1651', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1651', 'active_substance': 'Recombinant adeno-associated viral vector serotype 9 carrying the gene for the human E6-AP ubiquitin protein ligase', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/249/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1652,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1652', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1652', 'active_substance': 'Recombinant human cerebral dopamine neurotrophic factor', 'eu_mah_current': 'Herantis Pharma Plc', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/241/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1653,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1653', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1653', 'active_substance': 'Resiquimod', 'eu_mah_current': 'Galderma International', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/254/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1654,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1654', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1654', 'active_substance': 'S-acetyl-(S)-4&#39;-phosphopantetheine, calcium salt', 'eu_mah_current': 'Comet Therapeutics B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/250/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1655,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1655', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1655', 'active_substance': 'Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu, Ser-Gly-Gln-Ala-Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu-Pro-Ser-Cys-Leu-Glu-Ser, Arg-Ser-Asp-Glu-Leu-Val-Arg-His-His-Asn-Met-His-Gln-Arg-Asn-Met-Thr-Lys-Leu and Pro-Gly-Cys-Asn-Lys-Arg-Tyr-Phe-Lys-Leu-Ser-His-Leu-Gln-Met-His-Ser-Arg-Lys-His-Thr-Gly', 'eu_mah_current': 'Sellas Life Sciences Limited', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/233/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1656,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1656', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1656', 'active_substance': 'Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu, Ser-Gly-Gln-Ala-Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu-Pro-Ser-Cys-Leu-Glu-Ser, Arg-Ser-Asp-Glu-Leu-Val-Arg-His-His-Asn-Met-His-Gln-Arg-Asn-Met-Thr-Lys-Leu and Pro-Gly-Cys-Asn-Lys-Arg-Tyr-Phe-Lys-Leu-Ser-His-Leu-Gln-Met-His-Ser-Arg-Lys-His-Thr-Gly', 'eu_mah_current': 'Sellas Life Sciences Limited', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/243/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1657,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1657', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1657', 'active_substance': '(R)-6-(2-fluorophenyl)-N-(3-(2-((2-methoxyethyl)amino)ethyl)phenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine dihydrochloride', 'eu_mah_current': 'Basilea Pharmaceutica Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/245/15', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1660,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1660', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1660', 'active_substance': 'Autologous CD34+ cells transduced with lentiviral vector encoding the human beta globin gene', 'eu_mah_current': 'Fondazione Telethon Ets', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/024/16', 'ema_number_certainty': '0.6'}"
EU-3-16-1662,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1662', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1662', 'active_substance': 'H-Phe-Ser-Arg-Tyr-Ala-Arg-OH acetate', 'eu_mah_current': 'QRC Ireland', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/011/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1663,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1663', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1663', 'active_substance': 'Pentosan polysulfate sodium', 'eu_mah_current': 'Almira Pharma S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/003/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1664,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1664', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1664', 'active_substance': 'Polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase', 'eu_mah_current': 'Travere Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/025/16', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-16-1665,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1665', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1665', 'active_substance': 'Recombinant adeno-associated viral vector containing the human RPGR gene', 'eu_mah_current': 'Diamond Pharma Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/002/16', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-16-1668,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1668', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1668', 'active_substance': 'Sodium nitrite and ethylenediaminetetraacetic acid', 'eu_mah_current': 'Arch Bio Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/013/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1669,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1669', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1669', 'active_substance': 'Temsirolimus', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red M.P.', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/027/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1670,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1670', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1670', 'active_substance': 'Vemurafenib', 'eu_mah_current': 'Groupe d&#39;&#233;tude des histiocytoses', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/026/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1671,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1671', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1671', 'active_substance': '2&#39;-O-(2-methoxyethyl)phosphorothioate antisense oligonucleotide targeting the growth hormone receptor', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/023/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1672,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1672', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1672', 'active_substance': '3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/016/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1673,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1673', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1673', 'active_substance': 'Pyridoxine and L-pyroglutamic acid', 'eu_mah_current': 'FGK Representative Service Ltd', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/034/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1675,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1675', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1675', 'active_substance': 'Citric acid monohydrate', 'eu_mah_current': 'CATS Consultants GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/022/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1677,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1677', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1677', 'active_substance': 'Diclofenamide', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe BV', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/012/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1679,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1679', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1679', 'active_substance': 'Eflornithine', 'eu_mah_current': 'Orbus Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/009/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1680,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1680', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1680', 'active_substance': 'Humanised anti-IL-6 receptor monoclonal antibody', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/014/16', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-16-1681,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1681', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1681', 'active_substance': 'Humanised monoclonal antibody targeting interleukin-15', 'eu_mah_current': 'Calypso Biotech B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/004/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1682,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1682', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1682', 'active_substance': 'Melatonin', 'eu_mah_current': 'Worphmed Srl', 'orphan_status': 'o', 'eu_aut_date': '08-01-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/001/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1683,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1683', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1683', 'active_substance': 'Melatonin', 'eu_mah_current': 'Worphmed Srl', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/007/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1684,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1684', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1684', 'active_substance': 'Modified mRNA encoding the UGT1A1 protein', 'eu_mah_current': 'Moderna Biotech Spain S.L.', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/047/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1685,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1685', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1685', 'active_substance': 'Molgramostim', 'eu_mah_current': 'Savara ApS', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/005/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1686,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1686', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1686', 'active_substance': 'Recombinant humanised monoclonal IgG2 lambda antibody against human sclerostin', 'eu_mah_current': 'Mereo Biopharma Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/052/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1687,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1687', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1687', 'active_substance': 'Recombinant protein derived from the saliva of the Ornithodoros moubata tick', 'eu_mah_current': 'Akari Malta Limited', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/030/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1688,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1688', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1688', 'active_substance': 'Setmelanotide', 'eu_mah_current': 'Rhythm Pharmaceuticals Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/033/16', 'ema_number_certainty': '0.25'}"
EU-3-16-1689,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1689', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1689', 'active_substance': 'Teriparatide', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/031/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1690,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1690', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1690', 'active_substance': '16-base single-stranded peptide nucleic acid oligonucleotide linked to a 7 aminoacid peptide', 'eu_mah_current': 'Biogenera SpA', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/037/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1692,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1692', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1692', 'active_substance': '3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt', 'eu_mah_current': 'Vicore Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/046/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1693,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1693', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1693', 'active_substance': 'Adeno-associated viral vector serotype 2.7m8 containing the ChrimsonR-tdTomato gene', 'eu_mah_current': 'GenSight- Biologics', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/028/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1694,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1694', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1694', 'active_substance': 'Autologous CD4+ and CD8+ T-cells transduced with lentiviral vector containing an affinity-enhanced T-cell receptor targeting the New York esophageal antigen-1', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/064/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1697,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1697', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1697', 'active_substance': 'Brincidofovir', 'eu_mah_current': 'Chimerix IRL Limited', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/070/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1698,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1698', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1698', 'active_substance': 'Dimethyl fumarate', 'eu_mah_current': 'Novalis Investments S.L', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/029/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1699,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1699', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1699', 'active_substance': 'Mifamurtide', 'eu_mah_current': 'Delta Proteomics SAS', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/071/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1700,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1700', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1700', 'active_substance': 'Mifamurtide', 'eu_mah_current': 'Delta Proteomics SAS', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/072/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1701,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1701', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1701', 'active_substance': 'Poly(oxy-1,2-ethanediyl), alpha-(carboxymethyl)-omega-methoxy-,amide with arginase 1 [cobalt cofactor] (synthetic human) (1:10), trimer', 'eu_mah_current': 'Immedica Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/041/16', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-16-1702,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1702', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1702', 'active_substance': 'Recombinant human monoclonal antibody to insulin receptor', 'eu_mah_current': 'Rezolute (Bio) Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/040/16', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-16-1703,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1703', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1703', 'active_substance': 'Setmelanotide', 'eu_mah_current': 'Rhythm Pharmaceuticals Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/063/16', 'ema_number_certainty': '0.25'}"
EU-3-16-1704,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1704', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1704', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Maxia Strategies-Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/045/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1705,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1705', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1705', 'active_substance': 'Sodium benzoate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/053/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1706,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1706', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1706', 'active_substance': 'Sodium benzoate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/057/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1707,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1707', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1707', 'active_substance': 'Sodium benzoate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/058/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1708,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1708', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1708', 'active_substance': 'Sodium benzoate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/060/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1709,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1709', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1709', 'active_substance': 'Sodium hypochlorite', 'eu_mah_current': 'Hypo-Stream Ltd', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/068/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1710,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1710', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1710', 'active_substance': 'Triheptanoin', 'eu_mah_current': 'Vall d&#39;Hebron Institute of Research', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/074/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1711,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1711', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1711', 'active_substance': 'Volanesorsen sodium', 'eu_mah_current': 'Akcea Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/082/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1713,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1713', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1713', 'active_substance': '2-(1,5-dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-{4-[4-(5-fluoro-pyrimidin-2-yl)piperazin-1-yl]-phenyl}-2-oxo-acetamide', 'eu_mah_current': 'F2G Biotech GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/106/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1715,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1715', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1715', 'active_substance': 'Adenovirus associated viral vector serotype 5 containing the human RPGR gene', 'eu_mah_current': 'Janssen-Cilag International N.V.', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/102/16', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-16-1716,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1716', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1716', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/096/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1717,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1717', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1717', 'active_substance': 'Autologous mesenchymal stromal cells on a decellularised tracheal scaffold from a cadaveric donor', 'eu_mah_current': 'Videregen Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/069/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1718,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1718', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1718', 'active_substance': 'Cannabidiol', 'eu_mah_current': 'Salzman Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/110/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1719,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1719', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1719', 'active_substance': 'Cisplatin', 'eu_mah_current': 'PlumeStars s.r.l.', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/101/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1720,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1720', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1720', 'active_substance': 'Fimaporfin', 'eu_mah_current': 'PCI Biotech AS', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/111/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1721,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1721', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1721', 'active_substance': 'L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser', 'eu_mah_current': 'Araim Pharmaceuticals Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/094/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1722,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1722', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1722', 'active_substance': 'Masitinib mesilate', 'eu_mah_current': 'AB Science', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/081/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1723,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1723', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1723', 'active_substance': 'Methotrexate', 'eu_mah_current': 'aimAKU (Associazione Italiana Malati di Alcaptonuria)', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/086/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1725,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1725', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1725', 'active_substance': 'Recombinant protein derived from the saliva of the Ornithodoros moubata tick', 'eu_mah_current': 'Akari Malta Limited', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/077/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1726,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1726', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1726', 'active_substance': 'Recombinant human acid alpha-glucosidase conjugated with mannose-6-phosphate analogues', 'eu_mah_current': 'NanoMedSyn', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/098/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1727,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1727', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1727', 'active_substance': 'Recombinant human interleukin-12', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/116/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1729,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1729', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1729', 'active_substance': 'Sodium benzoate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/055/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1730,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1730', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1730', 'active_substance': 'Sodium benzoate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/056/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1731,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1731', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1731', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against delta-aminolevulinic acid synthase 1 mRNA covalently linked to a ligand containing three N-acetylgalactosamine residues', 'eu_mah_current': 'Alnylam Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/125/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1732,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1732', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1732', 'active_substance': 'Synthetic ribonucleic acid oligonucleotide directed against superoxide dismutase 1 messenger ribonucleic acid', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/120/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1733,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1733', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1733', 'active_substance': 'Temozolomide', 'eu_mah_current': 'Double Bond Pharmaceutical AB', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/085/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1734,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1734', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1734', 'active_substance': 'Valproic Acid', 'eu_mah_current': 'Vall d&#39;Hebron Institute of Research', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/073/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1735,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1735', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1735', 'active_substance': 'Zoledronic acid', 'eu_mah_current': 'Laboratorio Italiano Biochimico Farmaceutico Lisapharma S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/067/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1736,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1736', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1736', 'active_substance': '(6aR,10aR)-3-(1&#39;,1&#39;-dimethylheptyl)-delta-8-tetrahydrocannabinol-9-carboxylic acid', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/100/16', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-16-1737,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1737', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1737', 'active_substance': '(E)-(6-((N-methyl-((3-methylbenzofuran-2-yl)methyl)amino)-3-oxoprop-1-en-1-yl)-2-oxo-3,4-dihydro-1,8-naphthyridin-1(2H)-yl)methyl phosphate, bis ethanolamine salt', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/123/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1738,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1738', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1738', 'active_substance': '2-(1,5-dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-{4-[4-(5-fluoro-pyrimidin-2-yl)piperazin-1-yl]-phenyl}-2-oxo-acetamide', 'eu_mah_current': 'F2G Biotech GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/104/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1739,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1739', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1739', 'active_substance': 'A non-covalent trimer of tumour necrosis factor fused to an antibody specific to the extra-domain B of fibronectin in single-chain variable fragment format', 'eu_mah_current': 'Philogen S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/108/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1741,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1741', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1741', 'active_substance': 'Adeno-associated viral vector serotype 5 containing the human RLBP1 gene', 'eu_mah_current': 'Coave Therapeutics', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/146/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1742,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1742', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1742', 'active_substance': 'Acebutolol hydrochloride', 'eu_mah_current': 'Worphmed Srl', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/128/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1743,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1743', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1743', 'active_substance': 'Autologous mononuclear cells derived from human cord blood', 'eu_mah_current': 'BrainRepair UG (haftungsbeschr&#228;nkt)', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/141/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1744,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1744', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1744', 'active_substance': 'Autologous mononuclear cells derived from human cord blood', 'eu_mah_current': 'BrainRepair UG (haftungsbeschr&#228;nkt)', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/099/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1745,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1745', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1745', 'active_substance': 'Autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/087/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1746,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1746', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1746', 'active_substance': 'Carbamazepine', 'eu_mah_current': 'University of Newcastle upon Tyne', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/148/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1747,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1747', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1747', 'active_substance': 'Chemically modified human recombinant sulfamidase', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/142/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1748,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1748', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1748', 'active_substance': 'Crenolanib besylate', 'eu_mah_current': 'Arog Pharmaceuticals Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/147/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1749,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1749', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1749', 'active_substance': 'Crenolanib besylate', 'eu_mah_current': 'Arog Pharmaceuticals Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/129/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1750,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1750', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1750', 'active_substance': 'Exendin (9-39)', 'eu_mah_current': 'EigerBio Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/065/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1752,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1752', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1752', 'active_substance': 'Human monoclonal IgG1 antibody against tissue factor pathway inhibitor', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/093/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1753,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1753', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1753', 'active_substance': 'Haematopoietic stem cells modified with a lentiviral vector containing the CD18 gene', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red M.P.', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/154/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1754,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1754', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1754', 'active_substance': 'Lutetium-177(3+),S2,S7-cyclo[N-{4,7,10-tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl}-4-chloro-L-phenylalanyl-D-cysteinyl-4-[(4S)-2,6-dioxo-1,3-diazinane-4-carboxamido]-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-D-tyrosinamide]', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/089/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1755,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1755', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1755', 'active_substance': 'Melatonin', 'eu_mah_current': 'Worphmed Srl', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/127/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1756,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1756', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1756', 'active_substance': 'Mogamulizumab', 'eu_mah_current': 'Kyowa Kirin Holdings B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/091/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1757,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1757', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1757', 'active_substance': 'N-[(2S)-5-{[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino}-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(1H-1,2,3-triazol-1-yl)benzamide, bis-tosylate salt', 'eu_mah_current': 'Imago BioSciences B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/115/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1758,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1758', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1758', 'active_substance': 'P-ethoxy growth factor receptor-bound protein 2 antisense oligonucleotide', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/155/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1759,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1759', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1759', 'active_substance': 'Recombinant adeno-associated viral vector encoding a human micro-dystrophin gene under the control of a muscle specific promoter', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/161/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1760,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1760', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1760', 'active_substance': 'Radio-iodinated (131I) anti-CD45 murine monoclonal antibody', 'eu_mah_current': 'Immedica Pharma AB', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/090/16', 'ema_number_certainty': '0.4'}"
EU-3-16-1761,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1761', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1761', 'active_substance': 'Self-complementary adeno-associated viral vector serotype 9 containing the SGSH gene', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/164/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1763,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1763', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1763', 'active_substance': 'Tadekinig alfa', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/150/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1764,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1764', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1764', 'active_substance': 'Tetrofosmin', 'eu_mah_current': 'ProActina', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/143/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1765,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1765', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1765', 'active_substance': 'Ubiquinol', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red M.P.', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/153/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1766,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1766', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1766', 'active_substance': 'Venetoclax', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/122/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1767,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1767', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1767', 'active_substance': 'Venetoclax', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/121/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1768,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1768', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1768', 'active_substance': 'Xenon', 'eu_mah_current': 'Neuroprotexeon Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/109/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1769,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1769', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1769', 'active_substance': '2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde', 'eu_mah_current': 'Global Blood Therapeutics Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/187/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1770,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1770', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1770', 'active_substance': '5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride', 'eu_mah_current': 'Minoryx Therapeutics S.L.', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/132/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1771,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1771', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1771', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human glucose-6-phosphatase gene', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/168/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1775,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1775', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1775', 'active_substance': 'Alpha-tocopherol', 'eu_mah_current': 'Universit&#233; de Montpellier', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/175/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1776,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1776', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1776', 'active_substance': 'Ascorbic acid', 'eu_mah_current': 'Universit&#233; de Montpellier', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/174/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1777,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1777', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1777', 'active_substance': 'Brincidofovir', 'eu_mah_current': 'Chimerix IRL Limited', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/180/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1778,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1778', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1778', 'active_substance': 'Budesonide', 'eu_mah_current': 'STADA Arzneimittel AG', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/139/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1779,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1779', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1779', 'active_substance': 'Human monoclonal antibody against activin A', 'eu_mah_current': 'Regeneron Ireland Designated Activity Company (DAC)', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/186/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1781,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1781', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1781', 'active_substance': 'Live-attenuated non-replicative Pseudomonas aeruginosa strain expressing large T antigen of Merkel cell polyomavirus', 'eu_mah_current': 'APCure SAS', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/160/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1782,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1782', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1782', 'active_substance': 'L-selenomethionine', 'eu_mah_current': 'Universit&#233; de Montpellier', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/173/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1783,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1783', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1783', 'active_substance': 'N-(5-(6-chloro-2,2-difluorobenzo[d][1,3]dioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamide', 'eu_mah_current': 'TurnKey PharmaConsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/138/16', 'ema_number_certainty': '0.75'}"
EU-3-16-1784,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1784', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1784', 'active_substance': 'Particles comprised of methacrylic acid based co-polymer, cross-linked with a bi-functional cross-linker, purified to bind L-phenylalanine and L-phenylalanine containing peptides', 'eu_mah_current': 'MipSalus ApS', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/061/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1785,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1785', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1785', 'active_substance': 'R-azasetron besylate', 'eu_mah_current': 'Sensorion', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/114/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1786,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1786', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1786', 'active_substance': 'Recombinant adeno-associated viral vector serotype 2 carrying the gene for the human aromatic L-amino acid decarboxylase protein', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/183/16', 'ema_number_certainty': '0.75'}"
EU-3-16-1787,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1787', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1787', 'active_substance': 'Sodium benzoate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/184/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1788,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1788', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1788', 'active_substance': 'Sodium benzoate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/185/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1790,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1790', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1790', 'active_substance': 'Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Asp-Leu-Leu-Pro-Arg-Gly-Ser', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/172/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1791,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1791', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1791', 'active_substance': 'Vaccine consisting of 5 survivin peptides with different human leukocyte antigen restrictions', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/159/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1792,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1792', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1792', 'active_substance': 'Valproic acid', 'eu_mah_current': 'Valcuria AB', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/162/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1793,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1793', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1793', 'active_substance': 'Zinc gluconate', 'eu_mah_current': 'Universit&#233; de Montpellier', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/176/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1794,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1794', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1794', 'active_substance': '68Ga-DOTA-pABzA-DIG-dPhe-Gln-Trp-Ala-Val-Gly-His-NHCH[(CH2-CH(CH3)2]2', 'eu_mah_current': 'Advanced Accelerator Applications', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/206/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1795,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1795', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1795', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human CNGA3 gene under the control of a cone arrestin promoter', 'eu_mah_current': 'Universit&#228;tsklinikum T&#252;bingen (UKT)', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/190/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1796,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1796', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1796', 'active_substance': 'Adeno-associated viral vector serotype 8 encoding engineered rhodopsin DNA-binding repressor and human rhodopsin expression cassettes', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/165/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1797,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1797', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1797', 'active_substance': 'Arsenic trioxide', 'eu_mah_current': 'Medsenic', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/208/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1800,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1800', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1800', 'active_substance': 'Dantrolene sodium', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/202/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1801,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1801', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1801', 'active_substance': 'Ibudilast', 'eu_mah_current': 'Medicinova Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/182/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1802,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1802', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1802', 'active_substance': 'Ivosidenib', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/197/16', 'ema_number_certainty': '0.4'}"
EU-3-16-1803,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1803', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1803', 'active_substance': 'Metformin', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red M.P.', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/179/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1804,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1804', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1804', 'active_substance': 'Pegylated recombinant human interleukin-10', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/193/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1805,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1805', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1805', 'active_substance': 'Propranolol', 'eu_mah_current': 'The Anticancer Fund', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/166/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1806,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1806', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1806', 'active_substance': 'Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN3 gene', 'eu_mah_current': 'Abeona Therapeutics Europe SL', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/195/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1807,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1807', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1807', 'active_substance': 'Udenafil', 'eu_mah_current': 'ICON Clinical Research Limited', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/218/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1808,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1808', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1808', 'active_substance': '(6aR, 10aR)-3-(1&#39;,1&#39;-dimethylheptyl)-delta-8-tetrahydro-cannabinol-9-carboxylic acid', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/243/16', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-16-1809,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1809', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1809', 'active_substance': '[5,10,15,20-tetrakis(4-carboxyphenyl)-21H,23H-porphine]manganese(III) chloride', 'eu_mah_current': 'Institut Pasteur', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/205/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1811,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1811', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1811', 'active_substance': '5-aminolevulinic acid', 'eu_mah_current': 'Hemerion Therapeutics', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/215/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1812,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1812', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1812', 'active_substance': 'Antroquinonol', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/241/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1813,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1813', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1813', 'active_substance': 'Autologous dendritic cells incubated ex vivo with zebularine and factor VIII', 'eu_mah_current': 'Idogen AB', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/238/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1814,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1814', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1814', 'active_substance': 'Doxorubicin hydrochloride in a lipid-based pegylated nanoparticle modified with a 31-aminoacid peptide targeting nucleolin', 'eu_mah_current': 'TREAT U, S.A.', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/250/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1815,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1815', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1815', 'active_substance': 'Fluticasone propionate', 'eu_mah_current': 'Ellodi Regulatory Holdings I Limited', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/230/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1816,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1816', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1816', 'active_substance': 'Genetically modified adeno-associated viral vector serotype 9 expressing shRNA as well as a codon-optimized shRNA-insensitive wildtype PABPN1', 'eu_mah_current': 'Clinipace GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/194/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1817,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1817', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1817', 'active_substance': 'Human donor haematopoietic stem and progenitor cells that have been treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/191/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1818,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1818', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1818', 'active_substance': 'Human hepatoma cell line HepaRG in bioartificial liver', 'eu_mah_current': 'Hep-Art Medical Devices BV', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/222/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1819,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1819', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1819', 'active_substance': 'Humanised IgG1 monoclonal antibody against the receptor-binding site of human placental growth factor', 'eu_mah_current': 'Oncurious NV', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/240/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1820,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1820', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1820', 'active_substance': 'Hydroxychloroquine', 'eu_mah_current': 'Cristina Belizna', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/213/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1821,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1821', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1821', 'active_substance': 'Leuprorelin acetate', 'eu_mah_current': 'Stichting Centre for Human Drug Research (CHDR)', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/097/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1822,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1822', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1822', 'active_substance': 'Pentosan polysulfate sodium', 'eu_mah_current': 'HV-Polysaccharides GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/130/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1823,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1823', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1823', 'active_substance': 'Pioglitazone hydrochloride', 'eu_mah_current': 'Regiomedica GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/189/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1824,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1824', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1824', 'active_substance': 'Pr-D-Cys-Met-Pip-Arg-Leu-Arg-Sar-Cys-Lys-Arg-Pro-Tyr-Tle-Leu-OH', 'eu_mah_current': 'VECT-HORUS', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/220/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1825,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1825', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1825', 'active_substance': 'Recombinant adeno-associated viral vector serotype 9 containing the human N-alpha-acetylglucosaminidase gene', 'eu_mah_current': 'Abeona Therapeutics Europe SL', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/226/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1826,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1826', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1826', 'active_substance': 'Recombinant IgG degrading enzyme of Streptococcus pyogenes', 'eu_mah_current': 'Hansa Biopharma AB', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/237/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1827,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/16/1827', 'status_type': 'a', 'eu_pnumber': 'EU/3/16/1827', 'active_substance': 'Trans-resveratrol', 'eu_mah_current': 'Luis Pereira de Almeida', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/209/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1828,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1828', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1828', 'active_substance': '1-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)-N-{1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl}cyclopropane-1-carboxamide and ivacaftor', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/156/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1829,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1829', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1829', 'active_substance': '26 base synthetic single-stranded fully phosphorothioated 2&#39;-O-methyl-RNA and DNA mixmer oligonucleotide-based compound', 'eu_mah_current': 'S-cubed Pharmaceutical Services ApS', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/221/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1830,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1830', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1830', 'active_substance': '5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine', 'eu_mah_current': 'SFL Pharmaceuticals Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/229/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1832,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1832', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1832', 'active_substance': 'Alpha-tocopherol and ascorbic acid', 'eu_mah_current': 'Advanced Medical Projects', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/080/15', 'ema_number_certainty': '1.0'}"
EU-3-17-1833,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1833', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1833', 'active_substance': 'Autologous T cells transduced with lentiviral vector encoding an anti-SLAMF7 CD28/CD3-zeta chimeric antigen receptor', 'eu_mah_current': 'Dr Michael Hudecek', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/274/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1834,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1834', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1834', 'active_substance': 'Cyclo[L-alanyl-L-seryl-L-isoleucyl-L-prolyl-L-prolyl-L-glutaminyl-L-lysyl-L-tyrosyl-D-prolyl-L-prolyl-(2S)-2-aminodecanoyl-L-alpha-glutamyl-L-threonyl]acetate salt', 'eu_mah_current': 'Santhera Pharmaceuticals (Deutschland) GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/244/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1835,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1835', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1835', 'active_substance': 'Ex-vivo-expanded autologous keratinocytes transduced with retroviral vector containing the COL7A1 gene', 'eu_mah_current': 'Abeona Therapeutics Europe SL', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/283/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1836,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1836', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1836', 'active_substance': 'Fenfluramine hydrochloride', 'eu_mah_current': 'Zogenix ROI Limited', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/233/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1837,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1837', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1837', 'active_substance': 'Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2', 'eu_mah_current': 'Opsona Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/272/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1838,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1838', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1838', 'active_substance': 'Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2', 'eu_mah_current': 'Opsona Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/273/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1839,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1839', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1839', 'active_substance': 'Iodine (131I) murine IgG1 monoclonal antibody against CD276', 'eu_mah_current': 'Y-mAbs Therapeutics A/S', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/271/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1840,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1840', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1840', 'active_substance': 'N-(4-(1-cyanocyclopentyl)phenyl)-2-(4-pyridinylmethyl)amino-3-pyridinecarboxamide methanesulfonate', 'eu_mah_current': 'Elevar Therapeutics', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/228/16', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-17-1841,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1841', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1841', 'active_substance': 'Propranolol hydrochloride', 'eu_mah_current': 'Consejo Superior de Investigaciones Cientificas (CSIC)', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/256/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1842,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1842', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1842', 'active_substance': 'Recombinant human club cell 10 KDa protein', 'eu_mah_current': 'EUDRAC GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/247/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1843,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1843', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1843', 'active_substance': 'Soluble recombinant human fibroblast growth factor receptor 3', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/269/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1844,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1844', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1844', 'active_substance': 'Tauroursodeoxycholic acid', 'eu_mah_current': 'Bruschettini s.r.l.', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/242/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1845,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1845', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1845', 'active_substance': 'Thalidomide', 'eu_mah_current': 'PlumeStars s.r.l.', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/268/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1846,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1846', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1846', 'active_substance': 'Vemurafenib', 'eu_mah_current': 'Groupe d&#39;&#233;tude des histiocytoses', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/281/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1847,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1847', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1847', 'active_substance': '(3&#39;R,4&#39;S,5&#39;R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6&#39;&#39;-chloro-4&#39;-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2&#39;&#39;-oxo-1&#39;&#39;,2&#39;&#39;-dihydrodispiro[cyclohexane-1,2&#39;-pyrrolidine-3&#39;,3&#39;&#39;-indole]-5&#39;-carboxamide mono(4-methylbenzenesulfonate) monohydrate', 'eu_mah_current': 'Premier Research Group S.L.', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/201/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1848,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1848', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1848', 'active_substance': 'Acetylleucine', 'eu_mah_current': 'IntraBio Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/276/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1849,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1849', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1849', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human alpha-galactosidase A gene', 'eu_mah_current': 'Freeline Therapeutics (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/277/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1850,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1850', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1850', 'active_substance': 'Adeno-associated viral vector serotype LK03 encoding human ornithine transcarbamylase', 'eu_mah_current': 'Dr Julien Baruteau', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/310/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1851,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1851', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1851', 'active_substance': 'Adeno-associated viral vector serotype rh.10 expressing beta-galactosidase', 'eu_mah_current': 'LYSOGENE', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/265/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1852,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1852', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1852', 'active_substance': 'Allogeneic ex-vivo-expanded umbilical cord blood-derived hematopoietic CD34+ progenitor cells and allogeneic non-expanded umbilical cord blood-derived hematopoietic mature myeloid and lymphoid cells', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/257/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1853,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1853', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1853', 'active_substance': 'Antisense oligonucleotide targeting the USH2A gene', 'eu_mah_current': 'ProQR Therapeutics IV BV', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/280/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1854,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1854', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1854', 'active_substance': 'Autologous adipose tissue-derived mesenchymal stem cells', 'eu_mah_current': 'SPC GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/204/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1855,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1855', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1855', 'active_substance': 'Cannabidiol', 'eu_mah_current': 'GW Pharma (International) B.V', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/275/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1857,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1857', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1857', 'active_substance': 'Ketoconazole', 'eu_mah_current': 'Grupo Espa&#241;ol de Tumores Hu&#233;rfanos e Infrecuentes (GETHI)', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/234/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1858,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1858', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1858', 'active_substance': 'Megestrol acetate', 'eu_mah_current': 'Grupo Espa&#241;ol de Tumores Hu&#233;rfanos e Infrecuentes (GETHI)', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/236/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1859,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1859', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1859', 'active_substance': 'Phosphoinositide 3-kinase gamma peptide', 'eu_mah_current': 'Kither Biotech s.r.l.', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/303/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1860,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1860', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1860', 'active_substance': 'Poly-cyclodextrin-bis-cysteine-PEG3400-camptothecin-conjugate', 'eu_mah_current': 'Viadoc Business Solutions Limited', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/300/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1861,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1861', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1861', 'active_substance': '(S)-8-{2-amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester', 'eu_mah_current': 'Altavant Sciences Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/299/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-17-1862,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1862', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1862', 'active_substance': 'Autologous adult bone marrow-derived non-expanded CD133+ haematopoietic stem cells', 'eu_mah_current': 'Asherman Therapy S.L.U.', 'orphan_status': 'o', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/313/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1863,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1863', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1863', 'active_substance': 'Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human B cell maturation antigen with 4-1BB and CD3-zeta intracellular signalling domains', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/270/16', 'ema_number_certainty': '0.75'}"
EU-3-17-1864,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1864', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1864', 'active_substance': 'Emeramide', 'eu_mah_current': 'NBMI Science Limited', 'orphan_status': 'o', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/329/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1865,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1865', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1865', 'active_substance': 'Estetrol', 'eu_mah_current': 'Mithra Pharmaceuticals S.A.', 'orphan_status': 'o', 'eu_aut_date': '04-28-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/309/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1866,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1866', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1866', 'active_substance': 'Human normal immunoglobulin', 'eu_mah_current': 'H&#244;pital Foch', 'orphan_status': 'o', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/287/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1867,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1867', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1867', 'active_substance': 'Modified messenger ribonucleic acid encoding human ornithine transcarbamylase enzyme encapsulated into lipid nanoparticles', 'eu_mah_current': 'PhaseRx Ireland, Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/326/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1868,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1868', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1868', 'active_substance': 'N-[(1R)-1-phenylethyl]-6-{1H-pyrazolo[3,4-d]pyrimidin-4-yl}quinazolin-2-amine', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/293/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1869,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1869', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1869', 'active_substance': 'Rituximab', 'eu_mah_current': 'H&#244;pital Foch', 'orphan_status': 'o', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/286/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1870,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1870', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1870', 'active_substance': 'Thymidine and deoxycytidine', 'eu_mah_current': 'Zogenix ROI Limited', 'orphan_status': 'o', 'eu_aut_date': '04-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/317/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-17-1871,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1871', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1871', 'active_substance': '225Ac-lintuzumab', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '05-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/319/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1873,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1873', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1873', 'active_substance': 'Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-,15,15&#39;-diester with N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-.alpha.-aspartyl-L-tryptophylglycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threonyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-N6-carboxy-L-lysinamide cyclic (2.fwdarw.12)-(disulfide); where two identical synthetic peptide domains are covalently linked at the ends of the polyethylene glycol chain', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'o', 'eu_aut_date': '05-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/004/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-17-1874,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1874', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1874', 'active_substance': 'Recombinant adeno-associated viral vector serotype 6 encoding the B-domain-deleted human factor VIII', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '05-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/019/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1876,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1876', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1876', 'active_substance': 'Sodium (1R,3R,4R,5S)-3-({2-N-acetylamino-2-deoxy-3-O-[(1S)-1-carboxylato-2-cyclohexylethyl]-beta-D-galactopyranosyl}oxy)-4-({6-deoxy-alpha-L-galactopyranosyl}oxy)-5-ethyl-cyclohexan-1-yl-(38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carboxamide', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/010/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1877,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1877', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1877', 'active_substance': 'Tamoxifen citrate', 'eu_mah_current': 'GB Pharma Srl', 'orphan_status': 'o', 'eu_aut_date': '05-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/006/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1878,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1878', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1878', 'active_substance': 'Ursodeoxycholic acid', 'eu_mah_current': 'IntraBio Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '05-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/316/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1879,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1879', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1879', 'active_substance': 'Asp-Arg-Val-Tyr-Ile-His-Pro', 'eu_mah_current': 'Rapport Global Strategic Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/031/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-17-1880,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1880', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1880', 'active_substance': 'Avacopan', 'eu_mah_current': 'Chemocentryx Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/028/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1881,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1881', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1881', 'active_substance': 'Decitabine and tetrahydrouridine', 'eu_mah_current': 'Ulrich Muehlner', 'orphan_status': 'o', 'eu_aut_date': '06-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/008/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1882,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1882', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1882', 'active_substance': 'Ibutamoren mesilate', 'eu_mah_current': 'Agos Healthcare Limited', 'orphan_status': 'o', 'eu_aut_date': '06-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/013/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-17-1883,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1883', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1883', 'active_substance': 'Pentamer formyl thiophene acetic acid', 'eu_mah_current': 'NeuroScios GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/034/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1884,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1884', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1884', 'active_substance': 'Recombinant human factor IX protein modified with three point mutations', 'eu_mah_current': 'Turnkey Pharmaconsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/018/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-17-1885,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1885', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1885', 'active_substance': 'Sildenafil', 'eu_mah_current': 'Avivia Beheer BV', 'orphan_status': 'o', 'eu_aut_date': '06-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/304/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1886,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1886', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1886', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Desitin Arzneimittel GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/007/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1887,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1887', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1887', 'active_substance': 'Synthetic glucagon analogue modified to contain 7 amino acid substitutions', 'eu_mah_current': 'Zealand Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '06-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/002/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1889,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1889', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1889', 'active_substance': '(S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-yl)pyrimidin-5-yl)ethan-1-amine', 'eu_mah_current': 'Blueprint Medicines (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/037/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1891,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1891', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1891', 'active_substance': 'Bacillus subtilis oxalate decarboxylase', 'eu_mah_current': 'Allena Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/058/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1892,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1892', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1892', 'active_substance': 'Oxymetazoline hydrochloride', 'eu_mah_current': 'RDD Pharma Limited', 'orphan_status': 'o', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/325/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1894,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1894', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1894', 'active_substance': 'Recombinant human antibody directed against misfolded human superoxide dismutase 1', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/030/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1895,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1895', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1895', 'active_substance': 'Retinol', 'eu_mah_current': 'Orphanix GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/051/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1896,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1896', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1896', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/025/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1897,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1897', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1897', 'active_substance': 'Tirapazamine', 'eu_mah_current': 'PhaRA bvba', 'orphan_status': 'o', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/038/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1899,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1899', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1899', 'active_substance': 'Antisense oligonucleotide targeting exon 13 in the USH2A gene', 'eu_mah_current': 'ProQR Therapeutics IV BV', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/094/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1900,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1900', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1900', 'active_substance': 'Asunercept', 'eu_mah_current': 'Apogenix AG', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/050/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1901,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1901', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1901', 'active_substance': 'Itraconazole', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/056/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1902,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1902', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1902', 'active_substance': 'N-{2-[(6-{[(2,6-dichloro-3,5-dimethoxyphenyl)carbamoyl](methyl)amino}pyrimidin-4-yl)amino]-5-(4-ethylpiperazin-1-yl)phenyl}prop-2-enamide', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/052/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1903,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1903', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1903', 'active_substance': 'Odiparcil', 'eu_mah_current': 'Inventiva', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/043/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1904,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1904', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1904', 'active_substance': 'Picropodophyllin', 'eu_mah_current': 'Max Kemikonsult AB', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/068/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1905,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1905', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1905', 'active_substance': 'Purified pasteurised and freeze-dried cell-wall fragments from Mycobacterium tuberculosis strain RUTI', 'eu_mah_current': 'Archivel Farma S.L.', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/098/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1906,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1906', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1906', 'active_substance': 'Recombinant adeno-associated viral vector serotype 5 carrying the gene for the human frataxin protein', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/093/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1907,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1907', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1907', 'active_substance': 'Recombinant fragment of human surfactant protein-D', 'eu_mah_current': 'Premier Research Group S.L.', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/049/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1909,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1909', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1909', 'active_substance': 'Salmonella typhi Ty21a strain transfected with a plasmid vector encoding the human vascular endothelial growth factor receptor 2', 'eu_mah_current': 'Vaximm GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/069/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1910,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1910', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1910', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Plusultra Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/047/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-17-1911,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1911', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1911', 'active_substance': 'Sodium 2-hydroxylinoleate', 'eu_mah_current': 'Ability Pharmaceuticals SL', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/078/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1912,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1912', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1912', 'active_substance': 'Tacrolimus', 'eu_mah_current': 'VIVUS B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/099/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1913,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1913', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1913', 'active_substance': 'Teicoplanin', 'eu_mah_current': 'Neupharma S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/085/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1914,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1914', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1914', 'active_substance': '(S)-3-((S)-2-(2-((2,6-difluorophenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/079/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1915,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1915', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1915', 'active_substance': '2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine', 'eu_mah_current': 'Repositioning SAS', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/055/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1917,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1917', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1917', 'active_substance': 'Adenoviral vector of serotype 5 modified to contain a chimeric sequence consisting of a minimal urokinase-type plasminogen activator receptor promoter preceded by three Notch-responsive elements, and coated with oligopeptide end-modified poly (beta-amino) esters', 'eu_mah_current': 'Sagetis Biotech, S.L.', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/111/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1918,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1918', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1918', 'active_substance': 'Autologous ex-vivo-expanded peripheral polyclonal lymphocytes enriched in activated natural killer cells', 'eu_mah_current': 'CellProtect Nordic Pharmaceuticals AB', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/125/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1920,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1920', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1920', 'active_substance': 'Cannabidiol', 'eu_mah_current': 'GW Pharma (International) B.V', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/076/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1921,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1921', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1921', 'active_substance': 'Cannabidivarin', 'eu_mah_current': 'GW Pharma (International) B.V', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/100/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1922,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1922', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1922', 'active_substance': 'Entospletinib', 'eu_mah_current': 'Rapport Global Strategic Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/040/17', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-17-1923,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1923', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1923', 'active_substance': 'Glasdegib maleate', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/106/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1925,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1925', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1925', 'active_substance': 'Humanised monoclonal antibody targeting B-cell maturation antigen conjugated with maleimidocaproyl monomethyl auristatin F', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/077/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1928,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1928', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1928', 'active_substance': 'Recombinant adeno-associated viral vector serotype 5 encoding Staphylococcus aureus Cas9 endonuclease and two guide RNAs complementary to two regions of intron 26 of the CEP290 gene', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/060/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-17-1929,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1929', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1929', 'active_substance': 'Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8', 'eu_mah_current': 'TurnKey PharmaConsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/087/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1930,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1930', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1930', 'active_substance': 'Seladelpar', 'eu_mah_current': 'Cymabay Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/114/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1931,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1931', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1931', 'active_substance': 'Siplizumab', 'eu_mah_current': 'ITB-MED AB', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/104/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1932,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1932', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1932', 'active_substance': 'Synthetic cyclic 8 amino acid analogue of human unacylated ghrelin', 'eu_mah_current': 'Millendo Therapeutics SAS', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/066/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1933,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1933', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1933', 'active_substance': '(1&#39;R,6&#39;R)-3-(benzylamine)-6-hydroxy-3&#39;-methyl-4-pentyl-6&#39;-(prop-1-en-2-yl)-[1,1&#39;-bi(cyclohexane)]-2&#39;,3,6-triene-2,5-dione', 'eu_mah_current': 'Emerald Health Pharmaceuticals Espa&#241;a, S.L.', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/142/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1934,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1934', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1934', 'active_substance': '(R)-troloxamide quinone', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/136/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1935,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1935', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1935', 'active_substance': '1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene', 'eu_mah_current': 'Edvince AB', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/120/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1936,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1936', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1936', 'active_substance': '1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea', 'eu_mah_current': 'Deciphera Pharmaceuticals (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/119/17', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-17-1937,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1937', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1937', 'active_substance': '4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]pyrimidin-2-one', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/118/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1938,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1938', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1938', 'active_substance': 'Antisense oligonucleotide targeting exon 73 in the COL7A1 gene', 'eu_mah_current': 'IDEA Innovative Drug European Associates (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/140/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1939,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1939', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1939', 'active_substance': 'C1-esterase-inhibitor human', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/105/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1940,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1940', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1940', 'active_substance': 'Concizumab', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/116/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1941,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1941', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1941', 'active_substance': 'Diazoxide choline', 'eu_mah_current': 'Soleno Therapeutics Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/115/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1942,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1942', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1942', 'active_substance': 'N-(2-aminophenyl)-4-(1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin)benzamide', 'eu_mah_current': 'Celleron Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/121/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1943,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1943', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1943', 'active_substance': 'Recombinant adeno-associated viral vector serotype 9 containing human iduronate-2-sulfatase gene', 'eu_mah_current': 'REGENXBIO EU Limited', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/134/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1944,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1944', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1944', 'active_substance': 'Tamoxifen citrate', 'eu_mah_current': 'Quality Regulatory Clinical Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/133/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1945,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1945', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1945', 'active_substance': 'Tiratricol', 'eu_mah_current': 'Rare Thyroid Therapeutics International AB', 'orphan_status': 'o', 'eu_aut_date': '11-08-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/128/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1946,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1946', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1946', 'active_substance': '(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidine-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridine-2-yl)-4-fluoropyrrolidine-2-carboxamide', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '12-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/156/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1947,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1947', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1947', 'active_substance': '2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione', 'eu_mah_current': 'Abliva AB', 'orphan_status': 'o', 'eu_aut_date': '12-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/132/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1948,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1948', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1948', 'active_substance': '4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/135/17', 'ema_number_certainty': '0.25'}"
EU-3-17-1949,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1949', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1949', 'active_substance': 'Acetylleucine', 'eu_mah_current': 'IntraBio Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '12-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/158/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1950,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1950', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1950', 'active_substance': 'Adenovirus associated viral vector serotype 8 containing the human AIPL1 gene', 'eu_mah_current': 'MeiraGTx B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/162/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1952,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1952', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1952', 'active_substance': 'Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles', 'eu_mah_current': 'PhaseRx Ireland, Ltd', 'orphan_status': 'o', 'eu_aut_date': '12-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/153/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1953,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1953', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1953', 'active_substance': 'Pegunigalsidase alfa', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '12-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/138/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1954,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1954', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1954', 'active_substance': 'Venetoclax', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '12-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/131/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1955,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1955', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1955', 'active_substance': 'Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human alpha L-iduronidase gene', 'eu_mah_current': 'Sangamo Therapeutics France S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/167/17', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-17-1956,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1956', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1956', 'active_substance': 'Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human iduronate 2-sulfatase gene', 'eu_mah_current': 'Sangamo Therapeutics France S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/168/17', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-17-1957,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1957', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1957', 'active_substance': 'Adeno-associated viral vector serotype 5 encoding a microRNA targeted to human huntingtin gene', 'eu_mah_current': 'uniQure Biopharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/151/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1959,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1959', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1959', 'active_substance': 'Cannabidiol', 'eu_mah_current': 'GW Pharma (International) B.V', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/165/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1960,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1960', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1960', 'active_substance': 'Ciclopirox', 'eu_mah_current': 'Atlas Molecular Pharma S.L.', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/186/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1961,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1961', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1961', 'active_substance': 'Gilteritinib', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/175/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1962,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1962', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1962', 'active_substance': 'Humanised Fc-engineered monoclonal antibody against CD19', 'eu_mah_current': 'MWB Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/155/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1963,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1963', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1963', 'active_substance': 'Hydroxychloroquine sulphate', 'eu_mah_current': 'Imagine Institut Des Maladies Genetiques Necker Enfants Malades', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/177/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1964,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1964', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1964', 'active_substance': 'Itacitinib', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/169/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1965,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1965', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1965', 'active_substance': 'Metformin and L-citrulline', 'eu_mah_current': 'Quality Regulatory Clinical Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/154/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1966,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1966', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1966', 'active_substance': 'N-(bromoacetyl)-3,3-dinitroazetidine', 'eu_mah_current': 'Sirius Regulatory Consulting EU Limited', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/166/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1967,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1967', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1967', 'active_substance': 'N-[2,6-bis(1-methylethyl)phenyl]-N&#39;-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt', 'eu_mah_current': 'Millendo Therapeutics S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/179/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1968,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1968', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1968', 'active_substance': 'Pyrazolo[1,5-a]pyrimidine, 3-[4-chloro-2-(4-morpholinyl)-5-thiazolyl]-7-(1-ethylpropyl)-2,5-dimethyl-pyrazolo[1,3-a]pyrimidine', 'eu_mah_current': 'Regintel Limited', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/164/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1969,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1969', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1969', 'active_substance': 'Recombinant adeno-associated viral vector serotype 2/1 encoding human beta-hexosaminidase alpha and beta subunits', 'eu_mah_current': 'Maria Livadiotis', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/182/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1970,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1970', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1970', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Rare Partners srl Impresa Sociale', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/184/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1971,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/17/1971', 'status_type': 'a', 'eu_pnumber': 'EU/3/17/1971', 'active_substance': 'Vatiquinone', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/145/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1972,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1972', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1972', 'active_substance': '1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropanamine-dihydrochloride', 'eu_mah_current': 'CATS Consultants GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/202/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1973,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1973', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1973', 'active_substance': '2&#39;-O-(2-methoxyethyl)-modified antisense oligonucleotide targeting exon 13 in the USH2A gene', 'eu_mah_current': 'ProQR Therapeutics IV BV', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/197/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1974,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1974', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1974', 'active_substance': '6-{[(1R,2S)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one monocitrate', 'eu_mah_current': 'Calithera Biosciences Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/193/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1975,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1975', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1975', 'active_substance': 'Adenovirus-associated viral vector serotype 8 containing the human RPGR gene', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/220/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-1976,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1976', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1976', 'active_substance': 'Allogeneic CD4+ and CD25+ T lymphocytes ex vivo incubated with GP120', 'eu_mah_current': 'Actitrexx GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/150/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1977,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1977', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1977', 'active_substance': 'Cannabidivarin', 'eu_mah_current': 'GW Pharma (International) B.V', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/215/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1978,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1978', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1978', 'active_substance': 'Flucytosine', 'eu_mah_current': 'Dlrc Pharma Services Limited', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/198/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-1982,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1982', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1982', 'active_substance': 'N-(tert-butylcarbamoyl)-5-cyano-2-((4&#39;-(difluoromethoxy)-[1,1&#39;-biphenyl]-3-yl)oxy)benzenesulfonamide', 'eu_mah_current': 'ATXA Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/199/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1983,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1983', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1983', 'active_substance': 'Pyridoxal 5&#39;-phosphate', 'eu_mah_current': 'Medicure Pharma Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/201/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1984,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1984', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1984', 'active_substance': 'Recombinant human monoclonal antibody against mannan-binding lectin-associated serine protease-2', 'eu_mah_current': 'Omeros Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/200/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1985,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1985', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1985', 'active_substance': 'Rusalatide acetate', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/221/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1987,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1987', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1987', 'active_substance': 'Vocimagene amiretrorepvec', 'eu_mah_current': 'Dlrc Pharma Services Limited', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/185/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-1988,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1988', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1988', 'active_substance': '(R)-2-(5-cyano-2-(6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidine-5-yl)phenyl)-N,N,N-trimethylethanaminium methanesulfonate dehydrate', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/203/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1989,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1989', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1989', 'active_substance': '(2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidine-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridine-2-yl)-4-fluoropyrrolidine-2-carboxamide', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/208/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1990,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1990', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1990', 'active_substance': 'Dimethyl fumarate', 'eu_mah_current': 'Qualix Pharma S.L.', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/219/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1991,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1991', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1991', 'active_substance': 'Docosahexaenoic acid ethyl ester', 'eu_mah_current': 'TurnKey PharmaConsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/235/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1992,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1992', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1992', 'active_substance': 'Efgartigimod alfa', 'eu_mah_current': 'Argenx', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/245/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1993,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1993', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1993', 'active_substance': 'Gemfibrozil', 'eu_mah_current': 'Premier Research Group S.L.', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/218/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1994,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1994', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1994', 'active_substance': 'Ivosidenib', 'eu_mah_current': 'Les Laboratoires Servier', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/172/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1996,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1996', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1996', 'active_substance': 'Melatonin', 'eu_mah_current': 'Worphmed Srl', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/227/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1997,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1997', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1997', 'active_substance': 'Miransertib', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/226/17', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-18-1998,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1998', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1998', 'active_substance': 'Patidegib', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/206/17', 'ema_number_certainty': '0.5'}"
EU-3-18-1999,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/1999', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/1999', 'active_substance': 'Recombinant adeno-associated viral vector containing a codon-optimized Padua derivative of human coagulation factor IX cDNA', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/232/17', 'ema_number_certainty': '0.5'}"
EU-3-18-2000,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2000', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2000', 'active_substance': 'Recombinant human acid alpha-glucosidase', 'eu_mah_current': 'Amicus Therapeutics Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/230/17', 'ema_number_certainty': '0.5'}"
EU-3-18-2001,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2001', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2001', 'active_substance': 'Recombinant modified ricin toxin A-chain subunit', 'eu_mah_current': 'Soligenix NE B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/242/17', 'ema_number_certainty': '0.5'}"
EU-3-18-2002,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2002', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2002', 'active_substance': 'Ribavirin', 'eu_mah_current': 'Pharmadev Healthcare Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/224/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2003,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2003', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2003', 'active_substance': 'Ribavirin', 'eu_mah_current': 'Pharmadev Healthcare Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/225/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2004,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2004', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2004', 'active_substance': 'Tazemetostat', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/217/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2005,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2005', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2005', 'active_substance': 'Tazemetostat', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/222/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2006,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2006', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2006', 'active_substance': 'Tazemetostat', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/234/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2007,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2007', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2007', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human acid alpha-glucosidase gene', 'eu_mah_current': 'Brainvectis', 'orphan_status': 'o', 'eu_aut_date': '04-16-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/255/17', 'ema_number_certainty': '0.5'}"
EU-3-18-2008,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2008', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2008', 'active_substance': 'Adeno-associated viral vector serotype 9 encoding miRNA against human superoxide dismutase 1', 'eu_mah_current': 'Stolm&#225;r &amp; Partner Patentanw&#228;lte PartG mbB', 'orphan_status': 'o', 'eu_aut_date': '04-16-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/254/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2010,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2010', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2010', 'active_substance': 'Branaplam', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '04-16-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/249/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2011,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2011', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2011', 'active_substance': 'Burosumab', 'eu_mah_current': 'Kyowa Kirin Holdings B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-16-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/026/17', 'ema_number_certainty': '0.5'}"
EU-3-18-2012,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2012', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2012', 'active_substance': 'Genetically modified replication-incompetent herpes simplex virus-1 expressing collagen VII', 'eu_mah_current': 'IDEA Innovative Drug European Associates (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '04-16-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/244/17', 'ema_number_certainty': '0.5'}"
EU-3-18-2013,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2013', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2013', 'active_substance': 'Polatuzumab vedotin', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-16-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/231/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2014,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2014', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2014', 'active_substance': '1-(3-{4-[3,4-difluoro-2-(trifluoromethyl)phenyl]piperidine-1-carbonyl}-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridin-6-yl)ethan-1-one', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/018/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2015,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2015', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2015', 'active_substance': 'Adeno-associated viral vector serotype 8 containing a functional copy of the codon-optimised F8 cDNA encoding the B-domain deleted human coagulation factor VIII', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/010/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2016,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2016', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2016', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human CLN1 gene', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/013/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2017,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2017', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2017', 'active_substance': 'Ambroxol hydrochloride', 'eu_mah_current': 'Spedding Research Solutions SAS', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/236/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2019,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2019', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2019', 'active_substance': 'Bardoxolone methyl', 'eu_mah_current': 'Reata Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/011/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2020,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2020', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2020', 'active_substance': 'Daratumumab', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/207/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2021,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2021', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2021', 'active_substance': 'Equine immunoglobulin F(ab&#39;)2 fragments targeting Shiga toxin', 'eu_mah_current': 'Chemo Research S.L.', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/248/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2022,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2022', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2022', 'active_substance': 'Glucagon analogue linked to a human immunoglobulin Fc fragment', 'eu_mah_current': 'JVM Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/257/17', 'ema_number_certainty': '0.5'}"
EU-3-18-2023,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2023', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2023', 'active_substance': 'H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-2Thi-Gly-Leu-Met(O2)-NH2-DOTA-225-actinium', 'eu_mah_current': 'NovaCurie GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/252/17', 'ema_number_certainty': '0.5'}"
EU-3-18-2024,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2024', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2024', 'active_substance': 'Itraconazole', 'eu_mah_current': 'Laboratoires S.M.B.', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/251/17', 'ema_number_certainty': '0.5'}"
EU-3-18-2025,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2025', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2025', 'active_substance': 'Modified mRNA encoding human methylmalonyl-coenzyme A mutase encapsulated into lipid nanoparticles', 'eu_mah_current': 'Moderna Biotech Spain S.L.', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/017/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2026,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2026', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2026', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide targeted against transthyretin mRNA, with six phosphorothioate linkages in the backbone, and nine 2&#39;-fluoro and thirty-five 2&#39;-O-methyl nucleoside residues in the sequence, which is covalently linked via a phosphodiester group to a ligand containing three N-acetylgalactosamine residues', 'eu_mah_current': 'Alnylam Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/019/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2027,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2027', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2027', 'active_substance': 'Three human monoclonal antibodies against the Ebola virus glycoprotein', 'eu_mah_current': 'Regeneron Ireland Designated Activity Company (DAC)', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/008/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2029,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2029', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2029', 'active_substance': '2-[(2S)-2-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one', 'eu_mah_current': 'Klinikum der Universit&#228;t M&#252;nchen', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/004/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2030,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2030', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2030', 'active_substance': '20-hydroxyecdysone', 'eu_mah_current': 'Biophytis', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/020/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2031,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2031', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2031', 'active_substance': 'Argon', 'eu_mah_current': 'Air Liquide Sant&#233; (International)', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/031/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2032,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2032', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2032', 'active_substance': 'Carmustine', 'eu_mah_current': 'ADIENNE S.r.l.S.U.', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/007/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2034,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2034', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2034', 'active_substance': 'Deferiprone', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/006/18', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-2035,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2035', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2035', 'active_substance': 'Efpegsomatropin', 'eu_mah_current': 'JVM Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/009/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2036,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2036', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2036', 'active_substance': 'L-cystine bis(N&#39;-methylpiperazide)', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/012/18', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-2037,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2037', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2037', 'active_substance': 'Omaveloxolone', 'eu_mah_current': 'Reata Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/033/18', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-2039,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2039', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2039', 'active_substance': 'Recombinant adeno-associated viral vector serotype 9 containing human iduronidase gene', 'eu_mah_current': 'REGENXBIO EU Limited', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/027/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2040,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2040', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2040', 'active_substance': 'Recombinant human placental growth factor', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/035/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2042,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2042', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2042', 'active_substance': 'Adenovirus associated viral vector serotype 2/8 containing the human CNGA3 gene', 'eu_mah_current': 'Janssen-Cilag International N.V.', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/048/18', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-2043,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2043', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2043', 'active_substance': 'Combination of carboplatin and sodium valproate', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/036/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2044,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2044', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2044', 'active_substance': 'Allogeneic bone marrow derived mesenchymal stromal cells, ex-vivo expanded', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/023/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2045,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2045', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2045', 'active_substance': 'Ex-vivo fused autologous human bone marrow-derived mesenchymal stem cell with allogenic human myoblast', 'eu_mah_current': 'Dystrogen Therapeutics S.A.', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/028/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2046,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2046', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2046', 'active_substance': 'Givinostat', 'eu_mah_current': 'Italfarmaco S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/062/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2047,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2047', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2047', 'active_substance': 'Liposomal mannose-1-phosphate', 'eu_mah_current': 'Regintel Limited', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/055/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2048,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2048', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2048', 'active_substance': 'N-acetylgalactosamine-conjugated synthetic double-stranded oligomer specific to serpin family A member 1 gene', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/061/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2049,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2049', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2049', 'active_substance': 'Recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IgG1', 'eu_mah_current': 'Inozyme Pharma Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/053/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2050,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2050', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2050', 'active_substance': 'Selumetinib', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/045/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2051,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2051', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2051', 'active_substance': 'Synthetic antisense oligonucleotide directed against human dystrophin pre-mRNA', 'eu_mah_current': 'Wave life Sciences Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/032/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2052,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2052', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2052', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against lactate dehydrogenase A mRNA and containing four modified nucleosides which form a ligand cluster of four N-acetylgalactosamine residues', 'eu_mah_current': 'Dicerna Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/052/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2053,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2053', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2053', 'active_substance': 'Tamibarotene', 'eu_mah_current': 'Syros Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/026/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2054,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2054', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2054', 'active_substance': 'Tetracosactide', 'eu_mah_current': 'Mallinckrodt Specialty Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-31-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/043/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2063,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2063', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2063', 'active_substance': 'CD34+ haematopoietic stem and progenitor cells with CD3+ T-cells', 'eu_mah_current': 'IQVIA RDS Spain S.L.', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/088/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2064,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2064', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2064', 'active_substance': 'Copanlisib', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/071/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2065,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2065', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2065', 'active_substance': 'Obiltoxaximab', 'eu_mah_current': 'SFL Pharmaceuticals Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/080/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2066,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2066', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2066', 'active_substance': 'Pemigatinib', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/038/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2055,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2055', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2055', 'active_substance': '(3R,3aS,9R,9aS,9bS)-3-((dimethylamino)methyl)-9-hydroxy-6,9-dimethyl-3,3a,4,5,7,8,9,9a-octahydroazuleno[4,5-b]furan-2(9bH)-one fumarate', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/060/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2057,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2057', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2057', 'active_substance': '1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy) phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide fumarate salt', 'eu_mah_current': 'Pharmaceutical Research Associates Group B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/051/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2058,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2058', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2058', 'active_substance': '1-(3-methylbutanoyl)-L-aspartyl-L-threonyl-L-histidyl-L-phenylalanyl-L-prolyl-(L-cystinyl-L-isoleucyl-[(N6-(S)-4-carboxy-4-palmitamidobutanoyl)-L-lysinyl]-L-phenylalanyl-L-glutamyl-L-prolyl-L-arginyl-L-serinyl-L-lysinyl-L-glycinyl-L-cystinyl)-L-lysinamide, disulfide, acetate', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/099/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2059,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2059', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2059', 'active_substance': 'Acetylleucine', 'eu_mah_current': 'IntraBio Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/095/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2067,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2067', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2067', 'active_substance': 'Recombinant human monoclonal antibody against mannan-binding lectin-associated serine protease-2', 'eu_mah_current': 'Omeros Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/044/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2068,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2068', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2068', 'active_substance': 'Somapacitan', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/041/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2069,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2069', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2069', 'active_substance': 'Tilorone', 'eu_mah_current': 'Professor Marjukka Myll&#228;rniemi', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/039/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2061,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2061', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2061', 'active_substance': 'Autologous glioma tumour cells treated with antisense molecule directed against the insulin-like growth factor type 1 receptor', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/049/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2062,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2062', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2062', 'active_substance': 'Bertilimumab', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/098/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2070,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2070', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2070', 'active_substance': '(6aR,10aR)-3-(1,1-dimethylheptyl)-delta8-tetrahydro-cannabinol-9-carboxylic acid', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/114/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2072,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2072', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2072', 'active_substance': '6&#39;-(R)-methyl-5-O-(5-amino-5,6-dideoxy-alpha-L-talofuranosyl)-paromamine sulfate', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/102/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2073,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2073', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2073', 'active_substance': 'Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the alpha-L-iduronidase cDNA', 'eu_mah_current': 'Orchard Therapeutics (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/113/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2074,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2074', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2074', 'active_substance': 'Avapritinib', 'eu_mah_current': 'Blueprint Medicines (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/079/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2075,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2075', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2075', 'active_substance': 'Gefitinib', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red M.P.', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/090/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2076,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2076', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2076', 'active_substance': 'Glycine, L-alanine, L-arginine, L-aspartic acid, L-cysteine, L-cystine, L-glutamic acid, L-histidine, L-lysine monohydrate, L-methionine, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, taurine', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/100/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2077,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2077', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2077', 'active_substance': 'Melatonin', 'eu_mah_current': 'Worphmed Srl', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/077/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2078,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2078', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2078', 'active_substance': 'Peptides YMFPNAPYL, SGQAYMFPNAPYLPSCLES, RSDELVRHHNMHQRNMTKL and PGCNKRYFKLSHLQMHSRKHTG', 'eu_mah_current': 'Sellas Life Sciences Limited', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/091/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2079,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2079', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2079', 'active_substance': 'Recombinant adeno-associated viral vector containing a bioengineered capsid and a codon-optimised expression cassette to drive the expression of the SQ form of a B-domain deleted human coagulation factor VIII', 'eu_mah_current': 'Spark Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/104/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2080,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2080', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2080', 'active_substance': 'Recombinant adeno-associated viral vector serotype S3 containing codon-optimised expression cassette encoding human coagulation factor IX variant', 'eu_mah_current': 'Freeline Therapeutics (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/127/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2081,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2081', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2081', 'active_substance': '3-(3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid', 'eu_mah_current': 'Bridge Bio Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/096/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2082,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2082', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2082', 'active_substance': '5-{(1R,2R)-2-[(cyclopropylmethyl)amino]cyclopropyl}-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide monohydrochloride', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/040/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2083,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2083', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2083', 'active_substance': 'Allogeneic faecal microbiota, pooled', 'eu_mah_current': 'MaaT PHARMA', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/123/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2085,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2085', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2085', 'active_substance': 'Autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand', 'eu_mah_current': 'Rigenerand S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/110/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2086,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2086', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2086', 'active_substance': 'Cyclo[L-alanyl-L-seryl-L-isoleucyl-L-prolyl-L-prolyl-L-glutaminyl-L-lysyl-L-tyrosyl-D-prolyl-L-prolyl-(2S)-2-aminodecanoyl-L-alpha-glutamyl-L-threonyl]acetate', 'eu_mah_current': 'Santhera Pharmaceuticals (Deutschland) GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/106/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2087,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2087', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2087', 'active_substance': 'Etamsylate', 'eu_mah_current': 'Dobecure S.L.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/135/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2088,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2088', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2088', 'active_substance': 'Ex vivo fused normal allogeneic human myoblast with another normal allogeneic human myoblast', 'eu_mah_current': 'Dystrogen Therapeutics S.A.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/134/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2089,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2089', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2089', 'active_substance': 'Ex vivo fused normal allogeneic human myoblast with autologous human myoblast derived from Duchenne muscular dystrophy affected donor', 'eu_mah_current': 'Dystrogen Therapeutics S.A.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/133/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2090,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2090', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2090', 'active_substance': 'Fidanacogene elaparvovec', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/112/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2091,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2091', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2091', 'active_substance': 'Glucagon', 'eu_mah_current': 'S-cubed Pharmaceutical Services ApS', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/108/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2092,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2092', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2092', 'active_substance': 'H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-2Thi-Gly-Leu-Met(O2)-NH2-DOTA-213-bismuth', 'eu_mah_current': 'NovaCurie GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/145/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2093,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2093', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2093', 'active_substance': 'Human apotransferrin', 'eu_mah_current': 'Sanquin Plasma Products B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/109/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2094,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2094', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2094', 'active_substance': 'Anti-GD2 monoclonal antibody 3F8 humanised', 'eu_mah_current': 'Y-mAbs Therapeutics A/S', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/126/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2095,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2095', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2095', 'active_substance': 'Ile-Ser-Ile-Thr-Glu-Ile-Lys-Gly-Val-Ile-Val-His-Arg-Ile-Glu-Thr-Ile-Leu-Phe-Lys-Lys-Lys-Lys-Glu-Met-Pro-Ser-Glu-Glu-Gly-Tyr-Gln-Asp', 'eu_mah_current': 'United Neuroscience Limited', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/146/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2096,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2096', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2096', 'active_substance': 'Imlifidase', 'eu_mah_current': 'Hansa Biopharma AB', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/093/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2100,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2100', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2100', 'active_substance': 'Propagermanium', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/103/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2101,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2101', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2101', 'active_substance': 'Setmelanotide', 'eu_mah_current': 'Rhythm Pharmaceuticals Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/143/18', 'ema_number_certainty': '0.25'}"
EU-3-18-2102,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2102', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2102', 'active_substance': 'Apraglutide', 'eu_mah_current': 'Maxia Strategies-Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/115/18', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-2103,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2103', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2103', 'active_substance': '(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid', 'eu_mah_current': 'Albireo AB', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/165/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2104,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2104', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2104', 'active_substance': '(4-{(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl}benzoic acid-hydrogen chloride(1/1))', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/157/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2105,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2105', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2105', 'active_substance': '6,8-bis(benzylthio)octanoic acid', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/167/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2106,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2106', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2106', 'active_substance': '6-fluoro-9-methyl-9H-pyrido[3,4-b]-indole', 'eu_mah_current': 'AudioCure Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/170/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2107,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2107', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2107', 'active_substance': 'Acetylcysteine', 'eu_mah_current': 'Mucpharm Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/150/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2108,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2108', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2108', 'active_substance': 'Adeno-associated viral vector expressing human 21-hydroxylase', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/140/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2109,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2109', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2109', 'active_substance': 'Adeno-associated virus serotype HSC15 expressing human phenylalanine hydroxylase', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/153/18', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-2110,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2110', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2110', 'active_substance': 'Afatinib', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red M.P.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/141/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2111,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2111', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2111', 'active_substance': 'Allogeneic ABCB5-positive limbal stem cells', 'eu_mah_current': 'Rheacell GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/155/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2113,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2113', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2113', 'active_substance': 'Bromelain', 'eu_mah_current': 'Mucpharm Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/144/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2114,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2114', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2114', 'active_substance': 'C1 esterase inhibitor (human)', 'eu_mah_current': 'Takeda Manufacturing Austria AG', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/173/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2115,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2115', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2115', 'active_substance': 'Human anti-promyostatin monoclonal antibody', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/136/18', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-18-2116,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2116', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2116', 'active_substance': 'Ivacaftor, N-(1,3-dimethyl-1H-pyrazole-4-sulfonyl)-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide, tezacaftor', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/139/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2117,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2117', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2117', 'active_substance': 'Ivacaftor, potassium(benzenesulfonyl)({[6-(3-{2-[1-(trifluoromethyl) cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridin-3-yl]carbonyl})azanide, tezacaftor', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/137/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2118,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2118', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2118', 'active_substance': 'Lonafarnib', 'eu_mah_current': 'EigerBio Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/159/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2119,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2119', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2119', 'active_substance': 'Marizomib', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/161/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2121,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2121', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2121', 'active_substance': 'Sodium 2-hydroxylinoleate', 'eu_mah_current': 'Ability Pharmaceuticals SL', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/142/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2123,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2123', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2123', 'active_substance': '6,8-bis(benzylthio)octanoic acid', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/169/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2124,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2124', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2124', 'active_substance': 'Acetylleucine', 'eu_mah_current': 'IntraBio Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001741', 'ema_number_certainty': '0.5'}"
EU-3-18-2125,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2125', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2125', 'active_substance': 'Benserazide hydrochloride', 'eu_mah_current': 'Isabelle Ramirez', 'orphan_status': 'o', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001719', 'ema_number_certainty': '1.0'}"
EU-3-18-2126,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2126', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2126', 'active_substance': 'Human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment', 'eu_mah_current': 'JVM Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001592', 'ema_number_certainty': '0.5'}"
EU-3-18-2127,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2127', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2127', 'active_substance': 'Melatonin', 'eu_mah_current': 'Worphmed S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001921', 'ema_number_certainty': '0.5'}"
EU-3-18-2128,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2128', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2128', 'active_substance': 'Mercaptamine-pantetheine disulfide', 'eu_mah_current': 'Thiogenesis Therapeutics S.A.R.L', 'orphan_status': 'o', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002209', 'ema_number_certainty': '1.0'}"
EU-3-18-2129,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2129', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2129', 'active_substance': 'Miglustat', 'eu_mah_current': 'Amicus Therapeutics Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002050', 'ema_number_certainty': '0.5'}"
EU-3-18-2130,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2130', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2130', 'active_substance': 'Ralinepag', 'eu_mah_current': 'Unither Therapeutik GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002037', 'ema_number_certainty': '0.5'}"
EU-3-18-2131,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2131', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2131', 'active_substance': 'Rozanolixizumab', 'eu_mah_current': 'UCB Biopharma', 'orphan_status': 'o', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002029', 'ema_number_certainty': '1.0'}"
EU-3-18-2132,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2132', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2132', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues', 'eu_mah_current': 'Silence Therapeutics GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001845', 'ema_number_certainty': '1.0'}"
EU-3-18-2133,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/18/2133', 'status_type': 'a', 'eu_pnumber': 'EU/3/18/2133', 'active_substance': 'Vinorelbine tartrate', 'eu_mah_current': 'TLC Biopharmaceuticals B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-11-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001988', 'ema_number_certainty': '1.0'}"
EU-3-19-2134,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2134', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2134', 'active_substance': '9-cis, 12-cis-11,11-D2-linoleic acid ethyl ester', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002279', 'ema_number_certainty': '1.0'}"
EU-3-19-2135,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2135', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2135', 'active_substance': 'Allogeneic cultured postnatal thymus-derived tissue', 'eu_mah_current': 'Enzyvant Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002975', 'ema_number_certainty': '1.0'}"
EU-3-19-2136,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2136', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2136', 'active_substance': 'Allogeneic cultured postnatal thymus-derived tissue', 'eu_mah_current': 'Enzyvant Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002977', 'ema_number_certainty': '1.0'}"
EU-3-19-2137,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2137', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2137', 'active_substance': 'Allogeneic cultured postnatal thymus-derived tissue', 'eu_mah_current': 'Enzyvant Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002979', 'ema_number_certainty': '1.0'}"
EU-3-19-2139,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2139', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2139', 'active_substance': 'Autologous adult live cultured osteoblasts', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001655', 'ema_number_certainty': '0.5'}"
EU-3-19-2140,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2140', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2140', 'active_substance': 'Humanised IGg1 monoclonal antibody targeting human transferrin receptor conjugated to human iduronate-2-sulfatase', 'eu_mah_current': 'Artemida Pharma Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001793', 'ema_number_certainty': '1.0'}"
EU-3-19-2141,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2141', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2141', 'active_substance': 'Lentiviral vector encoding human coagulation factor IX', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002293', 'ema_number_certainty': '1.0'}"
EU-3-19-2142,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2142', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2142', 'active_substance': 'Losartan', 'eu_mah_current': 'Crowd Pharma Losartan GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002383', 'ema_number_certainty': '0.5'}"
EU-3-19-2143,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2143', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2143', 'active_substance': 'Lurbinectedin', 'eu_mah_current': 'Pharma Mar S.A.', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001317', 'ema_number_certainty': '1.0'}"
EU-3-19-2144,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2144', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2144', 'active_substance': 'Poly(N-acetyl, N-arginyl)glucosamine', 'eu_mah_current': 'Accelsiors CRO And Consultancy Services Ltd.', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002552', 'ema_number_certainty': '1.0'}"
EU-3-19-2145,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2145', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2145', 'active_substance': 'Risdiplam', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001899', 'ema_number_certainty': '1.0'}"
EU-3-19-2146,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2146', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2146', 'active_substance': '1-[(3S)-3-{4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}pyrrolidin-1-yl]-2-propen-1-one', 'eu_mah_current': 'Taiho Pharma Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-01-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002457', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-19-2147,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2147', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2147', 'active_substance': '2-[3-(2-chloro-4-{[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy}phenyl)-3-hydroxyazetidin-1-yl]pyridine-4-carboxylic acid-2-amino-2-(hydroxymethyl)propane-1,3-diol (1/1)', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'o', 'eu_aut_date': '04-01-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002498', 'ema_number_certainty': '1.0'}"
EU-3-19-2149,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2149', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2149', 'active_substance': 'Adeno-associated viral vector serotype rh10 containing the human cholesterol 24-hydroxylase gene', 'eu_mah_current': 'Brainvectis', 'orphan_status': 'o', 'eu_aut_date': '04-01-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002264', 'ema_number_certainty': '1.0'}"
EU-3-19-2150,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2150', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2150', 'active_substance': 'Codon-optimised human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid complexed with lipid-based nanoparticles', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'o', 'eu_aut_date': '04-01-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002333', 'ema_number_certainty': '0.5'}"
EU-3-19-2151,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2151', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2151', 'active_substance': 'Marzeptacog alfa (activated)', 'eu_mah_current': 'Turnkey Pharmaconsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '04-01-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002304', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-19-2152,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2152', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2152', 'active_substance': '3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-pyrazol-1-yl)propanoic acid', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '04-24-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002526', 'ema_number_certainty': '1.0'}"
EU-3-19-2153,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2153', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2153', 'active_substance': 'Autologous human bone marrow-derived haematopoietic and mesenchymal stem cells depleted of erythrocytes, monocytes and lymphocytes', 'eu_mah_current': 'Neuroplast B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-24-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002559', 'ema_number_certainty': '1.0'}"
EU-3-19-2154,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2154', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2154', 'active_substance': 'Balipodect', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '04-24-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002563', 'ema_number_certainty': '1.0'}"
EU-3-19-2155,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2155', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2155', 'active_substance': 'Human culture expanded autologous mesenchymal stromal cells', 'eu_mah_current': 'Parexel International (Irl) Limited', 'orphan_status': 'o', 'eu_aut_date': '04-24-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002775', 'ema_number_certainty': '0.5'}"
EU-3-19-2156,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2156', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2156', 'active_substance': 'Modified messenger ribonucleic acid encoding human propionyl-coenzyme A carboxylase alpha and beta subunits encapsulated into lipid nanoparticle', 'eu_mah_current': 'Moderna Biotech Spain S.L.', 'orphan_status': 'o', 'eu_aut_date': '04-24-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000003207', 'ema_number_certainty': '0.5'}"
EU-3-19-2157,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2157', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2157', 'active_substance': 'Sodium benzoate, sodium phenylacetate', 'eu_mah_current': 'Dipharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-24-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000003216', 'ema_number_certainty': '1.0'}"
EU-3-19-2158,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2158', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2158', 'active_substance': '(S)-3-((3-(1-((6-(3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium', 'eu_mah_current': 'MWB Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004127', 'ema_number_certainty': '1.0'}"
EU-3-19-2159,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2159', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2159', 'active_substance': '(S)-5-(1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile', 'eu_mah_current': 'Clinipace GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000003878', 'ema_number_certainty': '0.5'}"
EU-3-19-2160,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2160', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2160', 'active_substance': 'Allogeneic skin-derived ABCB5-positive mesenchymal stem cells', 'eu_mah_current': 'Rheacell GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000001324', 'ema_number_certainty': '1.0'}"
EU-3-19-2161,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2161', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2161', 'active_substance': 'Diacerein', 'eu_mah_current': 'Worphmed S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000003013', 'ema_number_certainty': '0.5'}"
EU-3-19-2162,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2162', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2162', 'active_substance': 'Emixustat hydrochloride', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000003121', 'ema_number_certainty': '1.0'}"
EU-3-19-2164,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2164', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2164', 'active_substance': 'Relacorilant', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002397', 'ema_number_certainty': '1.0'}"
EU-3-19-2165,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2165', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2165', 'active_substance': 'Sodium benzoate, sodium phenylacetate', 'eu_mah_current': 'Dipharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004137', 'ema_number_certainty': '1.0'}"
EU-3-19-2166,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2166', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2166', 'active_substance': 'Sodium benzoate, sodium phenylacetate', 'eu_mah_current': 'Dipharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004139', 'ema_number_certainty': '1.0'}"
EU-3-19-2168,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2168', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2168', 'active_substance': '(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidine-3-yl)chroman-2-carboxamide hydrochloride', 'eu_mah_current': 'Khondrion BV', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004363', 'ema_number_certainty': '1.0'}"
EU-3-19-2169,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2169', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2169', 'active_substance': 'Reldesemtiv', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004268', 'ema_number_certainty': '1.0'}"
EU-3-19-2170,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2170', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2170', 'active_substance': '2-(2-{[2-(1H-benzimidazol-2-yl)ethyl]amino}ethyl)-N-[(3-fluoropyridine-2-yl)methyl]-1,3-oxazole-4-carboxamide trihydrochloride', 'eu_mah_current': 'Vifor France S.A.', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000005305', 'ema_number_certainty': '1.0'}"
EU-3-19-2171,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2171', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2171', 'active_substance': '5&#39;-cEtG-sp-cEt5MeU-sp-cEt5MeU-sp-dT-sp-dA-sp-dT-sp-dT-sp-dA-sp-dT-sp-dA-sp-dG-sp-dG-sp-dG-sp-cEt5MeC-sp-cEt5MeU-sp-cEt5MeU-3&#39;', 'eu_mah_current': 'Dynacure S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002916', 'ema_number_certainty': '1.0'}"
EU-3-19-2172,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2172', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2172', 'active_substance': 'Gaboxadol monohydrate', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004076', 'ema_number_certainty': '1.0'}"
EU-3-19-2173,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2173', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2173', 'active_substance': 'Imidazolyl ethanamide pentandioic acid', 'eu_mah_current': 'Myelo Therapeutics GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000003591', 'ema_number_certainty': '1.0'}"
EU-3-19-2175,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2175', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2175', 'active_substance': 'Recombinant adeno-associated viral vector containing a bioengineered capsid serotype AAV-rh74 and a codon-optimised expression cassette to drive the expression of a secretable form of human acid alpha-glucosidase', 'eu_mah_current': 'Spark Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004992', 'ema_number_certainty': '1.0'}"
EU-3-19-2176,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2176', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2176', 'active_substance': 'Recombinant human coagulation factor VIII Fc - von Willebrand factor - XTEN fusion protein', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004038', 'ema_number_certainty': '1.0'}"
EU-3-19-2177,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2177', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2177', 'active_substance': 'Regorafenib', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000003987', 'ema_number_certainty': '1.0'}"
EU-3-19-2178,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2178', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2178', 'active_substance': 'Sodium benzoate, sodium phenylacetate', 'eu_mah_current': 'Dipharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000005429', 'ema_number_certainty': '1.0'}"
EU-3-19-2179,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2179', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2179', 'active_substance': 'Sodium benzoate, sodium phenylacetate', 'eu_mah_current': 'Dipharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000005430', 'ema_number_certainty': '1.0'}"
EU-3-19-2180,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2180', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2180', 'active_substance': '2-(hydroxymethyl)-2-(methoxymethyl)-1-azabicyclo[2.2.2]octan-3-one', 'eu_mah_current': 'Aprea Therapeutics AB', 'orphan_status': 'o', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000006186', 'ema_number_certainty': '1.0'}"
EU-3-19-2181,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2181', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2181', 'active_substance': '7-ethyl-10-hydroxycamptothecin', 'eu_mah_current': 'Cebiotex S.L.', 'orphan_status': 'o', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000005124', 'ema_number_certainty': '1.0'}"
EU-3-19-2182,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2182', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2182', 'active_substance': 'Elafibranor', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'o', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000006005', 'ema_number_certainty': '0.5'}"
EU-3-19-2183,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2183', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2183', 'active_substance': 'Mavorixafor', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000006091', 'ema_number_certainty': '1.0'}"
EU-3-19-2184,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2184', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2184', 'active_substance': 'N-((R)-2,3-dihydroxypropoxyl)-3,4-difluro-2-(2-fluoro-4-iodo-phenylamino)-benzamide', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000006043', 'ema_number_certainty': '1.0'}"
EU-3-19-2185,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2185', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2185', 'active_substance': 'Parsaclisib', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000006380', 'ema_number_certainty': '1.0'}"
EU-3-19-2187,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2187', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2187', 'active_substance': 'Recombinant mutated extracellular domain of the human acetylcholine receptor subunit alpha1', 'eu_mah_current': 'Toleranzia AB', 'orphan_status': 'o', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004784', 'ema_number_certainty': '1.0'}"
EU-3-19-2188,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2188', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2188', 'active_substance': 'Temozolomide', 'eu_mah_current': 'ORPHELIA Pharma SAS', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004755', 'ema_number_certainty': '1.0'}"
EU-3-19-2189,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2189', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2189', 'active_substance': 'Gallium citrate', 'eu_mah_current': 'Marcello Menapace', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000005579', 'ema_number_certainty': '0.5'}"
EU-3-19-2190,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2190', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2190', 'active_substance': 'Peginterferon lambda-1a', 'eu_mah_current': 'Eigerbio Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000006379', 'ema_number_certainty': '0.5'}"
EU-3-19-2191,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2191', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2191', 'active_substance': 'Relacorilant', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000005878', 'ema_number_certainty': '1.0'}"
EU-3-19-2192,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2192', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2192', 'active_substance': 'Setmelanotide', 'eu_mah_current': 'Rhythm Pharmaceuticals Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000007359', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-19-2193,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2193', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2193', 'active_substance': 'Acetazolamide', 'eu_mah_current': 'Laboratorios Tillomed Spain, S.L.U', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000007386', 'ema_number_certainty': '1.0'}"
EU-3-19-2194,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2194', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2194', 'active_substance': '4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine', 'eu_mah_current': 'Neurocrine Therapeutics Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000007519', 'ema_number_certainty': '1.0'}"
EU-3-19-2195,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2195', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2195', 'active_substance': '1-(2,2-diphenyltetrahydrofuran-3-yl)-N,N-dimethylmethanamine hydrochloride', 'eu_mah_current': 'Anavex Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000007945', 'ema_number_certainty': '1.0'}"
EU-3-19-2196,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2196', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2196', 'active_substance': 'Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN3 gene', 'eu_mah_current': 'Amicus Therapeutics Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000008395', 'ema_number_certainty': '1.0'}"
EU-3-19-2197,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2197', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2197', 'active_substance': 'Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene', 'eu_mah_current': 'Amicus Therapeutics Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000008785', 'ema_number_certainty': '1.0'}"
EU-3-19-2200,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2200', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2200', 'active_substance': 'Clofazimine', 'eu_mah_current': 'Aclira Consulting GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009964', 'ema_number_certainty': '0.5'}"
EU-3-19-2201,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2201', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2201', 'active_substance': 'Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-hydroxy-,15,15&#39;-diester with N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-alpha-aspartyl-L-tryptophylglycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threonyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-N6-carboxy-L-lysinamide cyclic (2.fwdarw.12)-(disulfide); where two identical synthetic peptide domains are covalently linked at the ends of the polyethylene glycol chain', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000006352', 'ema_number_certainty': '0.5'}"
EU-3-19-2202,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2202', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2202', 'active_substance': '(16E)-14-methyl-20-oxa-5,7,14,26-tetraaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaenecitric acid', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000007659', 'ema_number_certainty': '1.0'}"
EU-3-19-2203,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2203', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2203', 'active_substance': '(S)-2-isobutyrylamino-pentanedioic acid 5-amide 1-{[(2S,5S,8S,11R,12S,15S,18S,21R)-2,8-bis-((S)-sec-butyl)-21-hydroxy-5-(4-hydroxy-benzyl)-15-isobutyl-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentaaza-bicyclo[16.3.1]docos-12-yl]-amide}', 'eu_mah_current': 'MDC RegAffairs GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000012576', 'ema_number_certainty': '1.0'}"
EU-3-19-2204,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2204', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2204', 'active_substance': '18-(p-(131I)-iodophenyl)octadecyl phosphocholine', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009805', 'ema_number_certainty': '0.5'}"
EU-3-19-2205,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2205', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2205', 'active_substance': '2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide-methane sulfonic acid salt', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000012038', 'ema_number_certainty': '0.5'}"
EU-3-19-2206,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2206', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2206', 'active_substance': '2&#39;-O-(2-methoxyethyl)-D-ribose antisense oligonucleotide targeting glial fibrillary acidic protein messenger ribonucleic acid', 'eu_mah_current': 'Ionis Development (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000012628', 'ema_number_certainty': '1.0'}"
EU-3-19-2207,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2207', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2207', 'active_substance': '4-oxo-4H-chromene-2-carboxylic acid (2-(2-4-(2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl)-phenyl-2H-tetrazol-5-yl)-4,5-dimethoxy-phenyl)-amide', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000006325', 'ema_number_certainty': '1.0'}"
EU-3-19-2208,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2208', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2208', 'active_substance': 'Combination of two adeno-associated viral vectors of serotype 8 containing the 5&#39;- and the 3&#39;- half coding sequences of human ABCA4 fused to inteins', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000008501', 'ema_number_certainty': '1.0'}"
EU-3-19-2209,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2209', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2209', 'active_substance': 'Anti-neonatal Fc receptor human monoclonal antibody', 'eu_mah_current': 'Janssen-Cilag International N.V.', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000003541', 'ema_number_certainty': '0.5'}"
EU-3-19-2210,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2210', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2210', 'active_substance': 'Autologous CD34+ haematopoietic stem cells with a CRISPR-edited erythroid enhancer region of the BCL11A gene', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000010152', 'ema_number_certainty': '1.0'}"
EU-3-19-2211,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2211', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2211', 'active_substance': 'Besilesomab', 'eu_mah_current': 'Advanced Nuclear Medicine Ingredients', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004428', 'ema_number_certainty': '0.5'}"
EU-3-19-2212,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2212', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2212', 'active_substance': 'Leriglitazone', 'eu_mah_current': 'Minoryx Therapeutics S.L.', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000012140', 'ema_number_certainty': '1.0'}"
EU-3-19-2213,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2213', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2213', 'active_substance': 'Lonapegsomatropin', 'eu_mah_current': 'Ascendis Pharma Endocrinology Division A/S', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000007487', 'ema_number_certainty': '1.0'}"
EU-3-19-2214,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2214', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2214', 'active_substance': 'Nirogacestat', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009203', 'ema_number_certainty': '1.0'}"
EU-3-19-2215,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2215', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2215', 'active_substance': 'Paclitaxel', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000006386', 'ema_number_certainty': '1.0'}"
EU-3-19-2216,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2216', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2216', 'active_substance': 'Pemigatinib', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000005753', 'ema_number_certainty': '1.0'}"
EU-3-19-2217,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2217', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2217', 'active_substance': 'Propranolol hydrochloride', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '10-17-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000007627', 'ema_number_certainty': '1.0'}"
EU-3-19-2218,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2218', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2218', 'active_substance': '(2S,3R,4R,5S)-2-(hydroxymethyl)-1-pentylpiperidine-3,4,5-triol', 'eu_mah_current': 'Idorsia Pharmaceuticals Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-13-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000013997', 'ema_number_certainty': '1.0'}"
EU-3-19-2219,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2219', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2219', 'active_substance': '4-((E)-(5-(2-(2-((S)-2-((S)-1-(L-threonyl-L-lysyl)pyrrolidine-2-carboxamido)-5-guanidinopentanamido)acetamido)-2-carboxyethyl)-2-hydroxyphenyl)diazenyl)phenyl (2-(trimethylammonio)ethyl) phosphate', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '11-13-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009997', 'ema_number_certainty': '1.0'}"
EU-3-19-2220,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2220', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2220', 'active_substance': 'Autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti CD19 CD28/CD3-zeta chimeric antigen receptor and cultured', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-13-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000013608', 'ema_number_certainty': '1.0'}"
EU-3-19-2221,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2221', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2221', 'active_substance': 'Camsirubicin', 'eu_mah_current': 'Monopar Therapeutics SARL', 'orphan_status': 'o', 'eu_aut_date': '11-13-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000010168', 'ema_number_certainty': '1.0'}"
EU-3-19-2222,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2222', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2222', 'active_substance': 'Chimeric fibril-reactive IgG1k monoclonal antibody 11-1F4', 'eu_mah_current': 'Alexion Europe S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '11-13-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000013909', 'ema_number_certainty': '0.5'}"
EU-3-19-2223,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2223', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2223', 'active_substance': 'Exendin (9-39)', 'eu_mah_current': 'Eigerbio Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-13-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000013234', 'ema_number_certainty': '1.0'}"
EU-3-19-2224,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2224', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2224', 'active_substance': 'Ganaxolone', 'eu_mah_current': 'Marinus Pharmaceuticals Emerald Limited', 'orphan_status': 'o', 'eu_aut_date': '11-13-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000011311', 'ema_number_certainty': '0.5'}"
EU-3-19-2225,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2225', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2225', 'active_substance': 'Replication-incompetent, non-integrating, herpes simplex virus 1 vector expressing the human transglutaminase-1 enzyme', 'eu_mah_current': 'IDEA Innovative Drug European Associates (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '11-13-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009633', 'ema_number_certainty': '1.0'}"
EU-3-19-2226,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2226', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2226', 'active_substance': '(E)-2-((2S,4S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-10-(carboxymethyl)-1-hydroxy-13-(2-(2-(2-((E)-3-(3-((3-hydroxy-3,3 diphosphonopropyl)(methyl)amino)propoxy)benzylidene)hydrazine-1-carbonothioyl)hydrazineyl)-2-oxoethyl)-8-oxo-5-thioxo-3,4,6,7,10,13-hexaazapentadec-2-en-15-oic acid', 'eu_mah_current': 'Atlanthera', 'orphan_status': 'o', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009960', 'ema_number_certainty': '1.0'}"
EU-3-19-2227,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2227', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2227', 'active_substance': '2-(isopropylamino)-3-methyl-5-(6-methyl-5-((2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)oxy)pyridin-2-yl)pyrimidin-4(3H)-one', 'eu_mah_current': 'Deciphera Pharmaceuticals (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000015943', 'ema_number_certainty': '0.5'}"
EU-3-19-2228,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2228', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2228', 'active_substance': '5,7-dichloro-2-((ethylamino)methyl)-8-hydroxy-3-methylquinazolin-4(3H)-one mesilate', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000015485', 'ema_number_certainty': '0.5'}"
EU-3-19-2229,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2229', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2229', 'active_substance': 'Adeno-associated virus vector encoding human phenylalanine hydroxylase', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000016202', 'ema_number_certainty': '1.0'}"
EU-3-19-2230,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2230', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2230', 'active_substance': 'Efgartigimod alfa', 'eu_mah_current': 'Argenx', 'orphan_status': 'o', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000010330', 'ema_number_certainty': '1.0'}"
EU-3-19-2231,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2231', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2231', 'active_substance': 'H-Leu-Pro-Pro-Leu-Pro-Tyr-Pro-OH', 'eu_mah_current': 'AdRes EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000016360', 'ema_number_certainty': '1.0'}"
EU-3-19-2232,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2232', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2232', 'active_substance': 'Lactobacillus plantarum', 'eu_mah_current': 'MDC RegAffairs GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000014060', 'ema_number_certainty': '1.0'}"
EU-3-19-2233,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2233', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2233', 'active_substance': 'Navitoclax', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000016345', 'ema_number_certainty': '1.0'}"
EU-3-19-2234,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2234', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2234', 'active_substance': 'Pamrevlumab', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000012386', 'ema_number_certainty': '1.0'}"
EU-3-19-2235,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2235', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2235', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against SERPINA1 mRNA and containing four modified nucleosides which form a ligand cluster of four N-acetylgalactosamine residues', 'eu_mah_current': 'Dicerna Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '12-16-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000014201', 'ema_number_certainty': '1.0'}"
EU-3-19-2236,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2236', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2236', 'active_substance': 'Dimethyl fumarate', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red, M.P.', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000010028', 'ema_number_certainty': '1.0'}"
EU-3-19-2237,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2237', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2237', 'active_substance': '2-(3,7-dimethyl-octa-2, 6-dienyl)-6-ethylamino-3-hydroxy-5-pentyl-[1,4]benzoquinone', 'eu_mah_current': 'Emerald Health Pharmaceuticals Espa&#241;a, S.L.', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000011265', 'ema_number_certainty': '1.0'}"
EU-3-19-2238,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2238', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2238', 'active_substance': 'Adeno-associated virus serotype 9 vector containing human N-acetylgalactosamine-6-sulfate sulfatase gene', 'eu_mah_current': 'Esteve Pharmaceuticals S.A.', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000013447', 'ema_number_certainty': '1.0'}"
EU-3-19-2239,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2239', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2239', 'active_substance': 'Tripotassium citrate monohydrate and potassium hydrogen carbonate', 'eu_mah_current': 'Advicenne S.A.', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000014361', 'ema_number_certainty': '1.0'}"
EU-3-19-2240,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2240', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2240', 'active_substance': 'Nicardipine', 'eu_mah_current': 'Bit Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000015279', 'ema_number_certainty': '1.0'}"
EU-3-19-2241,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2241', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2241', 'active_substance': 'Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000015678', 'ema_number_certainty': '0.5'}"
EU-3-19-2242,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2242', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2242', 'active_substance': 'Autologous CD34+ hematopoietic stem cells with a CRISPR-edited erythroid enhancer region of the BCL11A gene', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000016302', 'ema_number_certainty': '1.0'}"
EU-3-19-2243,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2243', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2243', 'active_substance': 'Motixafortide', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000016648', 'ema_number_certainty': '1.0'}"
EU-3-19-2245,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/19/2245', 'status_type': 'a', 'eu_pnumber': 'EU/3/19/2245', 'active_substance': 'Setmelanotide', 'eu_mah_current': 'Rhythm Pharmaceuticals Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000018797', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-20-2247,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2247', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2247', 'active_substance': '2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide monohydrate', 'eu_mah_current': 'MorphoSys AG', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000020929', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-20-2248,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2248', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2248', 'active_substance': 'Adeno-associated viral vector serotype S3 encoding human alpha-galactosidase A cDNA', 'eu_mah_current': 'Freeline Therapeutics (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021153', 'ema_number_certainty': '1.0'}"
EU-3-20-2249,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2249', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2249', 'active_substance': 'Adeno-associated virus serotype 8 containing the human RdCVF sequence and the human RdCVFL sequence', 'eu_mah_current': 'SparingVision', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021161', 'ema_number_certainty': '1.0'}"
EU-3-20-2250,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2250', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2250', 'active_substance': 'Adeno-associated virus serotype rh74 containing the human micro-dystrophin gene', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000016347', 'ema_number_certainty': '0.5'}"
EU-3-20-2251,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2251', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2251', 'active_substance': 'Artesunate', 'eu_mah_current': 'Amivas Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000019513', 'ema_number_certainty': '0.5'}"
EU-3-20-2252,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2252', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2252', 'active_substance': 'Autologous human T cells genetically modified ex-vivo with a lentiviral vector encoding a chimeric antigen receptor for B-cell maturation antigen', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000013921', 'ema_number_certainty': '1.0'}"
EU-3-20-2253,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2253', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2253', 'active_substance': 'Autologous skin equivalent graft composed of keratinocytes and fibroblasts genetically corrected by CRISPR/Cas9-mediated excision of mutation-carrying COL7A1 exon 80', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red, M.P.', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000013899', 'ema_number_certainty': '1.0'}"
EU-3-20-2254,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2254', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2254', 'active_substance': 'Combination of three adeno-associated viral vectors of serotype 8 containing the 5&#39;-, the body- and the 3&#39;- coding sequences of human CEP290 fused to inteins', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000018285', 'ema_number_certainty': '1.0'}"
EU-3-20-2255,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2255', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2255', 'active_substance': 'Luspatercept', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000020912', 'ema_number_certainty': '0.5'}"
EU-3-20-2256,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2256', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2256', 'active_substance': 'Reldesemtiv', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000010743', 'ema_number_certainty': '1.0'}"
EU-3-20-2257,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2257', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2257', 'active_substance': 'Sintilimab', 'eu_mah_current': 'Parexel International GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021070', 'ema_number_certainty': '1.0'}"
EU-3-20-2258,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2258', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2258', 'active_substance': 'Sutimlimab', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-28-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021157', 'ema_number_certainty': '0.5'}"
EU-3-20-2259,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2259', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2259', 'active_substance': '2-hydroxy-N,N,N-trimethylethan-1-aminium (Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoate', 'eu_mah_current': 'MWB Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '03-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000020976', 'ema_number_certainty': '1.0'}"
EU-3-20-2260,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2260', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2260', 'active_substance': 'Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein-Barr virus and adenovirus', 'eu_mah_current': 'Allovir International DAC', 'orphan_status': 'o', 'eu_aut_date': '03-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021072', 'ema_number_certainty': '0.5'}"
EU-3-20-2261,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2261', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2261', 'active_substance': 'Asciminib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '03-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000020079', 'ema_number_certainty': '1.0'}"
EU-3-20-2262,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2262', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2262', 'active_substance': 'Fosgemcitabine palabenamide', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '03-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000020924', 'ema_number_certainty': '1.0'}"
EU-3-20-2263,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2263', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2263', 'active_substance': 'Losmapimod', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '03-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000015410', 'ema_number_certainty': '1.0'}"
EU-3-20-2265,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2265', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2265', 'active_substance': 'Cusatuzumab', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000018294', 'ema_number_certainty': '1.0'}"
EU-3-20-2266,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2266', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2266', 'active_substance': 'DNA plasmid encoding IL-12 p35 and p40 genes', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000019167', 'ema_number_certainty': '1.0'}"
EU-3-20-2267,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2267', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2267', 'active_substance': 'Adeno-associated viral vector serotype 3B encoding human multidrug resistance protein 3A', 'eu_mah_current': 'Vivet Therapeutics S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000020387', 'ema_number_certainty': '1.0'}"
EU-3-20-2268,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2268', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2268', 'active_substance': 'Florbetaben (18F)', 'eu_mah_current': 'Life Molecular Imaging GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021576', 'ema_number_certainty': '1.0'}"
EU-3-20-2269,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2269', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2269', 'active_substance': 'Tislelizumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021732', 'ema_number_certainty': '0.5'}"
EU-3-20-2270,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2270', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2270', 'active_substance': 'Mitapivat sulfate', 'eu_mah_current': 'Agios Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000022133', 'ema_number_certainty': '1.0'}"
EU-3-20-2271,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2271', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2271', 'active_substance': 'Haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate', 'eu_mah_current': 'CATS Consultants GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000022351', 'ema_number_certainty': '1.0'}"
EU-3-20-2272,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2272', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2272', 'active_substance': 'Rozanolixizumab', 'eu_mah_current': 'UCB Pharma', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000022918', 'ema_number_certainty': '1.0'}"
EU-3-20-2273,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2273', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2273', 'active_substance': 'Anti-(integrin beta-3) human monoclonal antibody', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000023599', 'ema_number_certainty': '1.0'}"
EU-3-20-2274,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2274', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2274', 'active_substance': 'Adeno-associated virus vector serotype hu37 encoding human factor VIII', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000023893', 'ema_number_certainty': '1.0'}"
EU-3-20-2275,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2275', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2275', 'active_substance': 'Glucagon analogue linked to a human immunoglobulin Fc fragment', 'eu_mah_current': 'JVM Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-22-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000023973', 'ema_number_certainty': '1.0'}"
EU-3-20-2276,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2276', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2276', 'active_substance': 'Methotrexate', 'eu_mah_current': 'Helio Vision Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009482', 'ema_number_certainty': '1.0'}"
EU-3-20-2277,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2277', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2277', 'active_substance': 'Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human B cell maturation antigen with 4-1BB and CD3-zeta intracellular signalling domains', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000020940', 'ema_number_certainty': '1.0'}"
EU-3-20-2278,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2278', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2278', 'active_substance': 'Rilzabrutinib', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021615', 'ema_number_certainty': '0.5'}"
EU-3-20-2279,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2279', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2279', 'active_substance': 'Lumacaftor', 'eu_mah_current': 'Prof. Dr Steffen-Sebastian Bolz', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021857', 'ema_number_certainty': '0.5'}"
EU-3-20-2280,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2280', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2280', 'active_substance': 'Lutetium (177Lu) lilotomab satetraxetan', 'eu_mah_current': 'Nordic Nanovector AS', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000023090', 'ema_number_certainty': '1.0'}"
EU-3-20-2281,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2281', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2281', 'active_substance': '(4-{(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl}benzoic acid-hydrogen chloride(1/1))', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000023613', 'ema_number_certainty': '1.0'}"
EU-3-20-2282,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2282', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2282', 'active_substance': 'Viltolarsen', 'eu_mah_current': 'Medpace Finland Oy', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000025790', 'ema_number_certainty': '1.0'}"
EU-3-20-2283,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2283', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2283', 'active_substance': 'Ile-Ala-Leu-Ile-Leu-Glu-Pro-Ile-Cys-Cys-Gln-Glu-Arg-Ala-Ala-(discrete-polyethylene glycol)24', 'eu_mah_current': 'Clinipace GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000026429', 'ema_number_certainty': '1.0'}"
EU-3-20-2284,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2284', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2284', 'active_substance': 'Sodium phenylbutyrate, tauroursodeoxycholic acid', 'eu_mah_current': 'Amylyx Pharmaceuticals EMEA B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000026509', 'ema_number_certainty': '0.5'}"
EU-3-20-2285,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2285', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2285', 'active_substance': '1-((2S,4S)-2-((((S)-(4-bromophenoxy)(((S)-1-oxo-1-(((S)-pentan-2-yl)oxy)propan-2-yl)amino)phosphoryl)oxy)methyl)-1,3-dioxolan-4-yl)-2-oxo-1,2-dihydropyrimidin-4-aminium chloride', 'eu_mah_current': 'Medivir AB', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000027842', 'ema_number_certainty': '1.0'}"
EU-3-20-2286,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2286', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2286', 'active_substance': 'Autologous CD4+ and CD8+ T cells transduced with a lentiviral vector encoding an affinity enhanced T cell receptor specific to MAGE-A4', 'eu_mah_current': 'Adaptimmune B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000028117', 'ema_number_certainty': '0.5'}"
EU-3-20-2287,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2287', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2287', 'active_substance': 'Adeno-associated virus serotype 9 containing the human ASPA gene', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '06-04-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000028197', 'ema_number_certainty': '0.5'}"
EU-3-20-2288,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2288', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2288', 'active_substance': 'Magrolimab', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'o', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009060', 'ema_number_certainty': '0.5'}"
EU-3-20-2289,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2289', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2289', 'active_substance': 'Nomacopan', 'eu_mah_current': 'Akari Malta Limited', 'orphan_status': 'o', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000020970', 'ema_number_certainty': '1.0'}"
EU-3-20-2290,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2290', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2290', 'active_substance': 'Stiripentol', 'eu_mah_current': 'Biocodex', 'orphan_status': 'o', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021553', 'ema_number_certainty': '1.0'}"
EU-3-20-2291,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2291', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2291', 'active_substance': 'Onfekafusp alfa', 'eu_mah_current': 'Philogen S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000022629', 'ema_number_certainty': '1.0'}"
EU-3-20-2292,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2292', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2292', 'active_substance': 'Anti-CD123 IgG1 humanised monoclonal antibody conjugated to N1-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-N6-((S)-1-(((S)-1-((3-((((S)-8-methoxy-6-oxo-11,12,12a,13-tetrahydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-9-yl)oxy)methyl)-5-((((S)-8-methoxy-6-oxo-12a,13-dihydro-6Hbenzo[5,6][1,4]diazepino[1,2-a]indol-9-yl)oxy)methyl)phenyl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)adipamide', 'eu_mah_current': 'ImmunoGen BioPharma (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000025548', 'ema_number_certainty': '1.0'}"
EU-3-20-2293,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2293', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2293', 'active_substance': '(+)-epicatechin', 'eu_mah_current': 'MWB Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000027959', 'ema_number_certainty': '1.0'}"
EU-3-20-2295,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2295', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2295', 'active_substance': 'Lys40(NODAGA-68Ga)NH2-exendin-4', 'eu_mah_current': 'Stichting Katholieke Universiteit', 'orphan_status': 'o', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000028068', 'ema_number_certainty': '1.0'}"
EU-3-20-2296,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2296', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2296', 'active_substance': 'Axicabtagene ciloleucel', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000030104', 'ema_number_certainty': '1.0'}"
EU-3-20-2297,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2297', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2297', 'active_substance': 'Adeno-associated virus serotype HSC15 expressing human arylsulfatase A gene', 'eu_mah_current': 'Diamond Pharma Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000030202', 'ema_number_certainty': '0.5'}"
EU-3-20-2298,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2298', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2298', 'active_substance': 'Hemopexin, human', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000028172', 'ema_number_certainty': '1.0'}"
EU-3-20-2299,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2299', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2299', 'active_substance': 'C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker', 'eu_mah_current': 'Ascendis Pharma Growth Disorders A/S', 'orphan_status': 'o', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000029070', 'ema_number_certainty': '1.0'}"
EU-3-20-2300,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2300', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2300', 'active_substance': 'Fasudil hydrochloride', 'eu_mah_current': 'Aneuryst (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000029906', 'ema_number_certainty': '1.0'}"
EU-3-20-2301,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2301', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2301', 'active_substance': 'Pegylated adrenomedullin', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000029989', 'ema_number_certainty': '1.0'}"
EU-3-20-2302,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2302', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2302', 'active_substance': 'Triheptanoin', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000030109', 'ema_number_certainty': '1.0'}"
EU-3-20-2303,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2303', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2303', 'active_substance': 'Adeno-associated viral vector expressing acid alpha-glucosidase gene', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000030112', 'ema_number_certainty': '0.5'}"
EU-3-20-2304,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2304', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2304', 'active_substance': 'Maralixibat chloride', 'eu_mah_current': 'Mirum Pharmaceuticals International B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000030237', 'ema_number_certainty': '0.5'}"
EU-3-20-2305,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2305', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2305', 'active_substance': 'Imetelstat sodium', 'eu_mah_current': 'Parexel International GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000031951', 'ema_number_certainty': '1.0'}"
EU-3-20-2306,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2306', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2306', 'active_substance': 'Retinol palmitate', 'eu_mah_current': 'Provepharm S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000032007', 'ema_number_certainty': '1.0'}"
EU-3-20-2307,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2307', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2307', 'active_substance': 'Tinostamustine', 'eu_mah_current': 'Mundipharma Corporation (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-27-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000032028', 'ema_number_certainty': '1.0'}"
EU-3-20-2308,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2308', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2308', 'active_substance': 'Allogeneic umbilical cord tissue-derived mesenchymal stromal cells ex vivo expanded', 'eu_mah_current': 'MDTB Cells GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000016117', 'ema_number_certainty': '1.0'}"
EU-3-20-2309,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2309', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2309', 'active_substance': 'Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-beta-D-galactopyranosyl) sulfane', 'eu_mah_current': 'Galecto Biotech AB', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000023667', 'ema_number_certainty': '1.0'}"
EU-3-20-2310,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2310', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2310', 'active_substance': 'Adeno-associated virus serotype 2/8 vector containing the human PDE6A gene', 'eu_mah_current': 'Institute For Ophthalmic Research', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000024640', 'ema_number_certainty': '1.0'}"
EU-3-20-2311,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2311', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2311', 'active_substance': 'Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000028003', 'ema_number_certainty': '1.0'}"
EU-3-20-2312,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2312', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2312', 'active_substance': 'Allogeneic hepatoblastoma cells encapsulated in alginate, ex vivo expanded', 'eu_mah_current': 'UCL Research Limited', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000028963', 'ema_number_certainty': '0.5'}"
EU-3-20-2313,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2313', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2313', 'active_substance': '2-(2-(18F)fluoropyridin-4-yl)-9H-pyrrolo[2,3-b:4,5-c&#39;]dipyridine', 'eu_mah_current': 'Life Molecular Imaging GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000029150', 'ema_number_certainty': '1.0'}"
EU-3-20-2314,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2314', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2314', 'active_substance': 'Humanised IgG1 monoclonal antibody against human eotaxin-2', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000030305', 'ema_number_certainty': '1.0'}"
EU-3-20-2315,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2315', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2315', 'active_substance': 'Pentosan polysulfate sodium', 'eu_mah_current': 'Paradigm Biopharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000031602', 'ema_number_certainty': '1.0'}"
EU-3-20-2316,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2316', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2316', 'active_substance': 'Protein-based delivery vector carrying a DNA payload encoding an RNA-guided nuclease that targets stx genes of Shiga toxin-producing Escherichia coli', 'eu_mah_current': 'Eligo Bioscience', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000031667', 'ema_number_certainty': '1.0'}"
EU-3-20-2317,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2317', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2317', 'active_substance': 'Allogeneic T-cell precursors, mobilised peripheral blood-derived, ex vivo cultured', 'eu_mah_current': 'Smart Immune', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000031867', 'ema_number_certainty': '1.0'}"
EU-3-20-2318,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2318', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2318', 'active_substance': 'Dextran sulfate low molecular weight', 'eu_mah_current': 'TikoMed AB', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000032154', 'ema_number_certainty': '1.0'}"
EU-3-20-2319,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2319', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2319', 'active_substance': 'Sodium (4-{(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-yl-prop1ynyl)phenyl]allyloxy}-2-methylphenoxy)acetate', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000032752', 'ema_number_certainty': '1.0'}"
EU-3-20-2320,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2320', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2320', 'active_substance': 'Copper histidinate', 'eu_mah_current': 'CambPharma Solutions (CY) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000033614', 'ema_number_certainty': '1.0'}"
EU-3-20-2321,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2321', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2321', 'active_substance': 'Adeno-associated viral vector serotype 3B encoding shortened human ATP7B', 'eu_mah_current': 'Vivet Therapeutics S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000034624', 'ema_number_certainty': '1.0'}"
EU-3-20-2322,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2322', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2322', 'active_substance': '6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000034662', 'ema_number_certainty': '1.0'}"
EU-3-20-2323,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2323', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2323', 'active_substance': 'Trehalose', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000034728', 'ema_number_certainty': '1.0'}"
EU-3-20-2324,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2324', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2324', 'active_substance': '3-(((1S,2S,3R)-2,3-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035036', 'ema_number_certainty': '1.0'}"
EU-3-20-2325,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2325', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2325', 'active_substance': 'Venglustat', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035086', 'ema_number_certainty': '1.0'}"
EU-3-20-2326,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2326', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2326', 'active_substance': 'Autologous CD34+ cells transduced with a lentiviral vector encoding glucosylceramidase beta', 'eu_mah_current': 'PPD Bulgaria EOOD', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035408', 'ema_number_certainty': '0.5'}"
EU-3-20-2327,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2327', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2327', 'active_substance': 'Autologous T cells transduced with lentiviral vector containing a tandem chimeric antigen receptor directed against CD20 and CD19', 'eu_mah_current': 'Miltenyi Biomedicine GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035570', 'ema_number_certainty': '1.0'}"
EU-3-20-2328,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2328', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2328', 'active_substance': 'Human frataxin fused to TAT cell-penetrating peptide', 'eu_mah_current': 'YES Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035595', 'ema_number_certainty': '1.0'}"
EU-3-20-2329,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2329', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2329', 'active_substance': 'Infigratinib', 'eu_mah_current': 'Helsinn Birex Pharmaceuticals Limited', 'orphan_status': 'o', 'eu_aut_date': '08-21-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035662', 'ema_number_certainty': '0.5'}"
EU-3-20-2330,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2330', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2330', 'active_substance': '1-(3-methylbutanoyl)-l-aspartyl-l-threonyl-l-histidyl-l-phenylalanyl-l-prolyl-(l-cystinyl-l-isoleucyl-[(n6-(s)-4-carboxy-4-palmitamidobutanoyl)-l-lysinyl]-l-phenylalanyl-l-glutamyl-l-prolyl-l-arginyl-l-serinyl-l-lysinyl-l-glycinyl-l-cystinyl)-l-lysinamide, disulfide, acetate', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009949', 'ema_number_certainty': '1.0'}"
EU-3-20-2332,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2332', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2332', 'active_substance': 'Retigabine', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000030264', 'ema_number_certainty': '1.0'}"
EU-3-20-2333,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2333', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2333', 'active_substance': 'Tipifarnib', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000030309', 'ema_number_certainty': '1.0'}"
EU-3-20-2334,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2334', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2334', 'active_substance': 'Adeno-associated viral vector serotype 9 encoding a codon-optimised human aspartylglucosaminidase transgene', 'eu_mah_current': 'Real Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000031910', 'ema_number_certainty': '1.0'}"
EU-3-20-2335,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2335', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2335', 'active_substance': '(S)-1-(5-((2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1h)-yl)-3-hydroxy-2-phenylpropan-1-one', 'eu_mah_current': 'Clinipace GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000033107', 'ema_number_certainty': '1.0'}"
EU-3-20-2336,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2336', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2336', 'active_substance': '(4-{(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1h-indol-4-yl)methyl]piperidin-2-yl}benzoic acid-hydrogen chloride(1/1))', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000033552', 'ema_number_certainty': '1.0'}"
EU-3-20-2337,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2337', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2337', 'active_substance': 'Ribitol', 'eu_mah_current': 'Premier Research Group S.L.', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000033863', 'ema_number_certainty': '1.0'}"
EU-3-20-2338,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2338', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2338', 'active_substance': 'Decitabine, tetrahydrouridine', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000034330', 'ema_number_certainty': '1.0'}"
EU-3-20-2339,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2339', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2339', 'active_substance': 'Leniolisib', 'eu_mah_current': 'Pharming Technologies B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000034892', 'ema_number_certainty': '0.5'}"
EU-3-20-2340,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2340', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2340', 'active_substance': '2-(2-(18F)fluoropyridin-4-yl)-9H-pyrrolo[2,3-b:4,5-c&#39;]dipyridine', 'eu_mah_current': 'Life Molecular Imaging GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035180', 'ema_number_certainty': '1.0'}"
EU-3-20-2341,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2341', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2341', 'active_substance': 'Autologous CD34+ cells transduced with a lentiviral vector encoding galactosidase alpha', 'eu_mah_current': 'PPD Bulgaria EOOD', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035407', 'ema_number_certainty': '0.5'}"
EU-3-20-2342,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2342', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2342', 'active_substance': 'Highly branched poly(beta-amino ester) complexed with a nanoplasmid containing the human COL7A1 gene', 'eu_mah_current': 'Amryt Genetics Limited', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035451', 'ema_number_certainty': '1.0'}"
EU-3-20-2343,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2343', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2343', 'active_substance': 'Retifanlimab', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035563', 'ema_number_certainty': '1.0'}"
EU-3-20-2344,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2344', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2344', 'active_substance': 'Autologous peripheral blood T cells CD4 and CD 8 selected and CD 3 and CD 28 activated transduced with retroviral vector expressing anti- CD 19 CD 28/ CD 3-zeta chimeric antigen receptor and cultured', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035618', 'ema_number_certainty': '1.0'}"
EU-3-20-2345,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2345', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2345', 'active_substance': 'Sparsentan', 'eu_mah_current': 'Vifor France S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000036435', 'ema_number_certainty': '0.5'}"
EU-3-20-2346,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2346', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2346', 'active_substance': 'Adeno-associated virus serotype hu68 containing the human GLB1 gene', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037095', 'ema_number_certainty': '1.0'}"
EU-3-20-2347,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2347', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2347', 'active_substance': 'Trehalose', 'eu_mah_current': 'Theranexus S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037166', 'ema_number_certainty': '1.0'}"
EU-3-20-2349,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2349', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2349', 'active_substance': 'Miglustat', 'eu_mah_current': 'Theranexus S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037799', 'ema_number_certainty': '1.0'}"
EU-3-20-2350,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2350', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2350', 'active_substance': 'Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with N-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1)', 'eu_mah_current': 'Ascendis Pharma Bone Diseases A/S', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037830', 'ema_number_certainty': '1.0'}"
EU-3-20-2351,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2351', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2351', 'active_substance': 'Adeno-associated virus serotype 5 containing the human RDH12 gene', 'eu_mah_current': 'MeiraGTx B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000038026', 'ema_number_certainty': '1.0'}"
EU-3-20-2353,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2353', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2353', 'active_substance': 'Zanidatamab', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000032268', 'ema_number_certainty': '1.0'}"
EU-3-20-2354,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2354', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2354', 'active_substance': 'Alisitol, retinol palmitate, zinc gluconate', 'eu_mah_current': 'Vanessa Research Magyarorszag Kft.', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000033691', 'ema_number_certainty': '1.0'}"
EU-3-20-2355,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2355', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2355', 'active_substance': 'Anti-(pancreatic adenocarcinoma upregulated factor) IgG1 humanised monoclonal antibody', 'eu_mah_current': 'Prestige Biopharma Belgium', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000034870', 'ema_number_certainty': '1.0'}"
EU-3-20-2357,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2357', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2357', 'active_substance': 'Tislelizumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000036055', 'ema_number_certainty': '0.5'}"
EU-3-20-2358,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2358', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2358', 'active_substance': 'L-pyroglutamyl-L-asparaginyl-L-prolyl-D-tyrosyl-D-tryptophan amide', 'eu_mah_current': 'Neuropath Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037176', 'ema_number_certainty': '1.0'}"
EU-3-20-2359,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2359', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2359', 'active_substance': 'Adeno-associated viral vector serotype 9 expressing codon-optimized human GRN gene', 'eu_mah_current': 'PPD Bulgaria EOOD', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037822', 'ema_number_certainty': '1.0'}"
EU-3-20-2360,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2360', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2360', 'active_substance': 'Triheptanoin', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037871', 'ema_number_certainty': '1.0'}"
EU-3-20-2361,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2361', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2361', 'active_substance': 'Perflubron', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037899', 'ema_number_certainty': '1.0'}"
EU-3-20-2362,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2362', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2362', 'active_substance': 'Autologous bone marrow derived CD34+ cells transduced ex vivo with a self-inactivating lentiviral vector containing a normal version of the coding region of the IL2RG gene', 'eu_mah_current': 'Real Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000038481', 'ema_number_certainty': '1.0'}"
EU-3-20-2363,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2363', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2363', 'active_substance': '3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)-carbamimidoyl)pyrazine-2-carboxamide, Sodium chloride solution 4.2% (w/v)', 'eu_mah_current': 'EUDRAC GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-16-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000039164', 'ema_number_certainty': '1.0'}"
EU-3-20-2364,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2364', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2364', 'active_substance': 'DNA plasmid encoding human transferrin gene', 'eu_mah_current': 'Eyevensys S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000039389', 'ema_number_certainty': '1.0'}"
EU-3-20-2365,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2365', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2365', 'active_substance': 'Adeno-associated virus serotype rh74 containing the human sarcoglycan beta gene', 'eu_mah_current': 'Sarepta Therapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000007270', 'ema_number_certainty': '1.0'}"
EU-3-20-2367,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2367', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2367', 'active_substance': '(R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea fumarate', 'eu_mah_current': 'Helsinn Birex Pharmaceuticals Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035401', 'ema_number_certainty': '1.0'}"
EU-3-20-2368,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2368', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2368', 'active_substance': 'Human interleukin 12 fused with immunoglobulin G4 C-terminal Fc fragment', 'eu_mah_current': 'VH Regulatory Consulting GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035896', 'ema_number_certainty': '1.0'}"
EU-3-20-2369,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2369', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2369', 'active_substance': 'Sotatercept', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037744', 'ema_number_certainty': '0.5'}"
EU-3-20-2370,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2370', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2370', 'active_substance': 'Tremelimumab', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000038040', 'ema_number_certainty': '1.0'}"
EU-3-20-2371,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2371', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2371', 'active_substance': 'Aspacytarabine', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000039550', 'ema_number_certainty': '1.0'}"
EU-3-20-2372,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2372', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2372', 'active_substance': 'Dabrafenib mesylate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000040009', 'ema_number_certainty': '1.0'}"
EU-3-20-2373,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2373', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2373', 'active_substance': 'Humanised IgG1 monoclonal antibody against the extracellular domain of receptor tyrosine kinase-like orphan receptor 1 coupled via a proteolytically cleavable maleimidocaproyl-valine-citrulline-para-aminobenzoate linker to monomethyl auristatin E', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000040364', 'ema_number_certainty': '0.5'}"
EU-3-20-2374,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2374', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2374', 'active_substance': 'Trametinib dimethyl sulfoxide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000040375', 'ema_number_certainty': '1.0'}"
EU-3-20-2375,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2375', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2375', 'active_substance': '2&#39;-O-(2-methoxyethyl) phosphorothioate antisense oligonucleotide targeting CD49d RNA', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000040669', 'ema_number_certainty': '1.0'}"
EU-3-20-2376,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2376', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2376', 'active_substance': '4-[(3S)-3-aminopyrrolidin-1-yl]-6-cyano-5-(3,5-difluorophenyl)-n-[(2S)-1,1,1-trifluoropropan-2-yl]pyridine-3-carboxamide', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000040890', 'ema_number_certainty': '1.0'}"
EU-3-20-2377,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2377', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2377', 'active_substance': '2-O-(2-methoxyethyl) modified antisense oligonucleotide targeting glycogen synthase 1 pre-mRNA', 'eu_mah_current': 'Ionis Development (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000041239', 'ema_number_certainty': '1.0'}"
EU-3-20-2378,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2378', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2378', 'active_substance': 'Adeno-associated viral vector serotype 9 encoding human ATP7B', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000041492', 'ema_number_certainty': '1.0'}"
EU-3-20-2379,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2379', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2379', 'active_substance': 'Synthetic oligonucleotide selectively targeting UBE3A antisense RNA transcripts', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000041660', 'ema_number_certainty': '1.0'}"
EU-3-20-2380,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2380', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2380', 'active_substance': 'Allogeneic retinal pigment epithelial cells genetically modified with a non-viral vector to express beta-domain deleted human factor VIII', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000041698', 'ema_number_certainty': '1.0'}"
EU-3-20-2381,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2381', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2381', 'active_substance': '(S)-N-(5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-1-yl)-1,3,4-thiadiazol-2-yl)acetamide, hydrochloride salt', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000041855', 'ema_number_certainty': '1.0'}"
EU-3-20-2382,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2382', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2382', 'active_substance': 'Erlotinib', 'eu_mah_current': 'Laboratoires C.T.R.S.', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000042029', 'ema_number_certainty': '0.5'}"
EU-3-20-2384,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2384', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2384', 'active_substance': 'Sulindac', 'eu_mah_current': 'Healx Technology Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000042080', 'ema_number_certainty': '0.5'}"
EU-3-20-2385,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2385', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2385', 'active_substance': 'Rezafungin acetate', 'eu_mah_current': 'Mundipharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000033964', 'ema_number_certainty': '0.5'}"
EU-3-20-2386,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2386', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2386', 'active_substance': 'Calcium oxybate, magnesium oxybate, potassium oxybate, sodium oxybate', 'eu_mah_current': 'Jazz Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000039384', 'ema_number_certainty': '1.0'}"
EU-3-20-2387,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2387', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2387', 'active_substance': 'Setanaxib', 'eu_mah_current': 'Calliditas Therapeutics France S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000040564', 'ema_number_certainty': '1.0'}"
EU-3-20-2388,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2388', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2388', 'active_substance': 'Human laminin-111, recombinant', 'eu_mah_current': 'Maxia Strategies-Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000041257', 'ema_number_certainty': '1.0'}"
EU-3-20-2389,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2389', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2389', 'active_substance': 'Cyclo-L-glycyl-L-2-allylproline', 'eu_mah_current': 'Dlrc Pharma Services Limited', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000041637', 'ema_number_certainty': '1.0'}"
EU-3-20-2390,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2390', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2390', 'active_substance': 'Rilonacept', 'eu_mah_current': 'Blue-Reg Pharma Consult', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000042079', 'ema_number_certainty': '0.5'}"
EU-3-20-2391,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2391', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2391', 'active_substance': 'Idursulfase', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000042795', 'ema_number_certainty': '0.5'}"
EU-3-20-2392,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2392', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2392', 'active_substance': 'Humanised IgG1K monoclonal antibody against interferon beta', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043059', 'ema_number_certainty': '1.0'}"
EU-3-20-2393,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2393', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2393', 'active_substance': 'Cyclo-L-glycyl-L-2-allylproline', 'eu_mah_current': 'Dlrc Pharma Services Limited', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043209', 'ema_number_certainty': '1.0'}"
EU-3-20-2394,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2394', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2394', 'active_substance': 'Cyclo-L-glycyl-L-2-allylproline', 'eu_mah_current': 'Dlrc Pharma Services Limited', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043391', 'ema_number_certainty': '1.0'}"
EU-3-20-2395,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2395', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2395', 'active_substance': 'Celecoxib, ciprofloxacin', 'eu_mah_current': 'Ferenc Tracik', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043612', 'ema_number_certainty': '0.5'}"
EU-3-20-2396,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/20/2396', 'status_type': 'a', 'eu_pnumber': 'EU/3/20/2396', 'active_substance': 'Alpha galactosidase A', 'eu_mah_current': 'Consejo Superior de Investigaciones Cientificas (CSIC)', 'orphan_status': 'o', 'eu_aut_date': '01-06-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043899', 'ema_number_certainty': '1.0'}"
EU-3-21-2397,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2397', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2397', 'active_substance': 'Tebentafusp', 'eu_mah_current': 'Immunocore Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000030272', 'ema_number_certainty': '0.5'}"
EU-3-21-2399,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2399', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2399', 'active_substance': '18-(p-[131I]-iodophenyl)octadecyl phosphocholine', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000041437', 'ema_number_certainty': '1.0'}"
EU-3-21-2400,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2400', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2400', 'active_substance': 'Anti-SIGLEC8 IgG1 humanised monoclonal antibody', 'eu_mah_current': 'Turnkey Pharmaconsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000042924', 'ema_number_certainty': '1.0'}"
EU-3-21-2401,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2401', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2401', 'active_substance': '(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide', 'eu_mah_current': 'Alexion Europe S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043071', 'ema_number_certainty': '1.0'}"
EU-3-21-2402,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2402', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2402', 'active_substance': '2-(2-{[2-(1H-benzimidazol-2-yl)ethyl]amino}ethyl)-N-[(3-fluoropyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide trihydrochloride', 'eu_mah_current': 'Vifor France S.A.', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043114', 'ema_number_certainty': '1.0'}"
EU-3-21-2403,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2403', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2403', 'active_substance': 'Rintatolimod', 'eu_mah_current': 'Hemispherx Biopharma Europe', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043217', 'ema_number_certainty': '1.0'}"
EU-3-21-2404,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2404', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2404', 'active_substance': '(2S)-2-[(2S)-4-cyclohexyl-2-{[(2S)-1-(4-fluorobenzoyl)pyrrolidin-2-yl]formamido}butanamido]-N-(1-{[(1S)-1-{[(1S)-1-({1-[(1-{[2-({1-[(dimethylamino)methyl]cyclobutyl}carbamoyl)ethyl]carbamoyl}-1-methylethyl)carbamoyl]-1-methylethyl}carbamoyl)-3-methylbutyl]carbamoyl}-3-methylbutyl]carbamoyl}-1-methylethyl)-4-methylpentanamide acetate', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043404', 'ema_number_certainty': '0.5'}"
EU-3-21-2405,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2405', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2405', 'active_substance': 'Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human claudin 18.2 antigen with CD28 and CD3-zeta intracellular signalling domains', 'eu_mah_current': 'ICON Clinical Research Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043828', 'ema_number_certainty': '1.0'}"
EU-3-21-2406,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2406', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2406', 'active_substance': 'Autologous CD34+ hematopoietic stem and progenitor cells transfected with zinc finger nuclease mRNAs SB-mRENH1 and SB-mRENH2', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043829', 'ema_number_certainty': '0.5'}"
EU-3-21-2407,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2407', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2407', 'active_substance': 'Autologous CD34+ cells transduced with a lentiviral RNA vector that results in integrated cDNA encoding for functional cystinosin', 'eu_mah_current': 'PPD Bulgaria EOOD', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043857', 'ema_number_certainty': '0.5'}"
EU-3-21-2408,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2408', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2408', 'active_substance': 'Adeno-associated virus serotype 5 containing the human NR2E3 gene', 'eu_mah_current': 'Ocugen Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000043946', 'ema_number_certainty': '1.0'}"
EU-3-21-2409,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2409', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2409', 'active_substance': 'Dodecyl creatine ester, dodecyl creatine ester hydrochloride', 'eu_mah_current': 'Ceres Brain Therapeutics S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000044835', 'ema_number_certainty': '1.0'}"
EU-3-21-2410,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2410', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2410', 'active_substance': '2-[6-(6,7-dimethoxyquinolin-3-yl)pyridin-3-yl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide', 'eu_mah_current': 'Southwood Research Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000045680', 'ema_number_certainty': '1.0'}"
EU-3-21-2411,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2411', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2411', 'active_substance': 'Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Cys-Asp-Met-Ala-Glu-His-Thr-Glu-Arg-Leu-Lys-Ala-Asn-Asp-Ser-Leu-Lys-Leu-Ser-Gln-Glu-Tyr-Glu-Ser-Ile-NH2', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000045713', 'ema_number_certainty': '1.0'}"
EU-3-21-2412,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2412', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2412', 'active_substance': 'Adeno-associated virus serotype 5 containing the human NR2E3 gene', 'eu_mah_current': 'Ocugen Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000046383', 'ema_number_certainty': '1.0'}"
EU-3-21-2413,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2413', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2413', 'active_substance': 'Adeno-associated viral vector serotype 9 expressing codon-optimized human GBA gene', 'eu_mah_current': 'PPD Bulgaria EOOD', 'orphan_status': 'o', 'eu_aut_date': '02-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000046433', 'ema_number_certainty': '1.0'}"
EU-3-21-2414,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2414', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2414', 'active_substance': 'Alpha-L-iduronidase fused to Fab fragment of a humanised monoclonal antibody targeting human transferrin receptor', 'eu_mah_current': 'Artemida Pharma Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000041696', 'ema_number_certainty': '1.0'}"
EU-3-21-2415,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2415', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2415', 'active_substance': 'Lefitolimod', 'eu_mah_current': 'Nucleic Acids To The Rescue GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000041862', 'ema_number_certainty': '0.5'}"
EU-3-21-2417,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2417', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2417', 'active_substance': 'Adeno-associated virus serotype hu68 containing the human GALC gene', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000046077', 'ema_number_certainty': '1.0'}"
EU-3-21-2418,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2418', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2418', 'active_substance': 'Ilixadencel', 'eu_mah_current': 'Mendus AB (publ)', 'orphan_status': 'o', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000046254', 'ema_number_certainty': '1.0'}"
EU-3-21-2419,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2419', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2419', 'active_substance': 'Messenger RNA encoding Cas9, single guide RNA targeting the human TTR gene', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000046448', 'ema_number_certainty': '1.0'}"
EU-3-21-2420,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2420', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2420', 'active_substance': 'Alpelisib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000047280', 'ema_number_certainty': '1.0'}"
EU-3-21-2421,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2421', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2421', 'active_substance': 'Herpes simplex virus 1 expressing the human CFTR gene', 'eu_mah_current': 'IDEA Innovative Drug European Associates (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000047694', 'ema_number_certainty': '1.0'}"
EU-3-21-2422,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2422', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2422', 'active_substance': 'Lorcaserin hydrochloride', 'eu_mah_current': 'Premier Research Group S.L.', 'orphan_status': 'o', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000048780', 'ema_number_certainty': '1.0'}"
EU-3-21-2423,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2423', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2423', 'active_substance': 'Vatiquinone', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '03-26-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000052192', 'ema_number_certainty': '1.0'}"
EU-3-21-2424,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2424', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2424', 'active_substance': 'Cevostamab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-13-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000042673', 'ema_number_certainty': '1.0'}"
EU-3-21-2425,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2425', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2425', 'active_substance': 'S-[5-(omega-methoxypoly(oxyethylene)-2-oxopentyl)]-L-cysteinylglycyl-L-serinylglycylgylcyl-L-isoleucyl-L-lysyl-L-glutamyl-L-phenylalanyl-L-leucyl-L-glutaminyl-L-arginyl-L-phenylalanyl-L-isoleucyl-L-histyl-L-isoleucyl-L-valyl-L-glutaminyl-L-serinyl-L-isoleucyl-L-isoleucyl-L-asparaginyl-L-threonyl-L-serinamide, acetate salt', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-13-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000048121', 'ema_number_certainty': '0.5'}"
EU-3-21-2426,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2426', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2426', 'active_substance': 'Ganglioside GM1', 'eu_mah_current': '3R Pharma Consulting GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-13-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000049973', 'ema_number_certainty': '1.0'}"
EU-3-21-2427,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2427', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2427', 'active_substance': 'Begelomab', 'eu_mah_current': 'Adienne S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037706', 'ema_number_certainty': '1.0'}"
EU-3-21-2428,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2428', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2428', 'active_substance': 'Macitentan', 'eu_mah_current': 'Janssen-Cilag International N.V.', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000042650', 'ema_number_certainty': '1.0'}"
EU-3-21-2429,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2429', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2429', 'active_substance': 'Eflornithine', 'eu_mah_current': 'Norgine B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000044418', 'ema_number_certainty': '0.5'}"
EU-3-21-2430,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2430', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2430', 'active_substance': 'Elamipretide', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000046486', 'ema_number_certainty': '1.0'}"
EU-3-21-2431,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2431', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2431', 'active_substance': 'Human IgG1 monoclonal antibody against alpha-synuclein', 'eu_mah_current': 'H. Lundbeck A/S', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000047784', 'ema_number_certainty': '1.0'}"
EU-3-21-2432,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2432', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2432', 'active_substance': '2-[4-[3-(methylamino)-1-phenylpropoxy]phenyl]ethanol hydrochloride', 'eu_mah_current': 'Connecta Therapeutics S.L.', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000048861', 'ema_number_certainty': '1.0'}"
EU-3-21-2433,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2433', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2433', 'active_substance': 'Adeno-associated viral vector serotype 2.5T encoding the human cystic fibrosis transmembrane conductance regulator with a partial deletion in the R domain', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000049823', 'ema_number_certainty': '1.0'}"
EU-3-21-2434,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2434', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2434', 'active_substance': '6-Amino-5-chloro-N-((1R)-1-(5-(((5-chloro-4-(trifluoromethyl)-2-pyridinyl)amino)carbonyl)-2-thiazolyl)ethyl)-4-pyrimidinecarboxamide', 'eu_mah_current': 'Parexel International (Irl) Limited', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000050198', 'ema_number_certainty': '1.0'}"
EU-3-21-2435,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2435', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2435', 'active_substance': '(S)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3H)-one', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000051718', 'ema_number_certainty': '1.0'}"
EU-3-21-2436,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2436', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2436', 'active_substance': 'Trehalose', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000052176', 'ema_number_certainty': '1.0'}"
EU-3-21-2438,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2438', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2438', 'active_substance': 'Zanubrutinib', 'eu_mah_current': 'BeiGene Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000052449', 'ema_number_certainty': '1.0'}"
EU-3-21-2439,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2439', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2439', 'active_substance': 'Melatonin', 'eu_mah_current': 'Worphmed S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000052825', 'ema_number_certainty': '1.0'}"
EU-3-21-2440,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2440', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2440', 'active_substance': 'Autologous mobilised peripheral blood-derived CD34+ cells transduced ex vivo with a self-inactivating lentiviral vector containing a normal version of the coding region of the IL2RG gene', 'eu_mah_current': 'Real Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000052862', 'ema_number_certainty': '1.0'}"
EU-3-21-2441,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2441', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2441', 'active_substance': 'Adeno-associated viral vector serotype 5 expressing the human Cone-Rod Homeobox gene', 'eu_mah_current': 'Variant', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000052925', 'ema_number_certainty': '1.0'}"
EU-3-21-2443,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2443', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2443', 'active_substance': 'Dantrolene sodium, hemiheptahydrate', 'eu_mah_current': 'Norgine B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000056143', 'ema_number_certainty': '1.0'}"
EU-3-21-2444,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2444', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2444', 'active_substance': 'Humanised IgG2 monoclonal antibody against TNFSF13', 'eu_mah_current': 'Otsuka Pharmaceutical Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000024142', 'ema_number_certainty': '1.0'}"
EU-3-21-2445,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2445', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2445', 'active_substance': 'L-ergothioneine', 'eu_mah_current': 'Averoa', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000037664', 'ema_number_certainty': '0.5'}"
EU-3-21-2446,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2446', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2446', 'active_substance': 'Tislelizumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000045928', 'ema_number_certainty': '0.5'}"
EU-3-21-2447,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2447', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2447', 'active_substance': 'Adeno-associated virus serotype 9 expressing human CLN5', 'eu_mah_current': 'Real Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000047485', 'ema_number_certainty': '1.0'}"
EU-3-21-2448,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2448', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2448', 'active_substance': 'Allogenic placenta-derived mesenchymal stromal cells secretome', 'eu_mah_current': 'Corion Biotech S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000049662', 'ema_number_certainty': '1.0'}"
EU-3-21-2449,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2449', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2449', 'active_substance': 'Imatinib', 'eu_mah_current': 'MDC RegAffairs GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000051869', 'ema_number_certainty': '1.0'}"
EU-3-21-2450,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2450', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2450', 'active_substance': '(S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000052133', 'ema_number_certainty': '1.0'}"
EU-3-21-2451,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2451', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2451', 'active_substance': 'Bomedemstat ditosilate', 'eu_mah_current': 'Imago Biosciences B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000052866', 'ema_number_certainty': '1.0'}"
EU-3-21-2452,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2452', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2452', 'active_substance': 'Hydrocortisone hydrogen succinate', 'eu_mah_current': 'Laboratoire Aguettant', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000053493', 'ema_number_certainty': '1.0'}"
EU-3-21-2453,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2453', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2453', 'active_substance': 'Melatonin', 'eu_mah_current': 'Worphmed S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000053556', 'ema_number_certainty': '1.0'}"
EU-3-21-2454,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2454', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2454', 'active_substance': 'Humanised monoclonal antibody derivative against fibroblast growth factor receptor 3', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000055239', 'ema_number_certainty': '1.0'}"
EU-3-21-2455,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2455', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2455', 'active_substance': 'H-D-valyl1-D-alanyl-D-glutamyl-D-alanyl-D-arginyl5-D-glutamyl-D-glutamyl-D-leucyl-D-glutamyl-D-arginyl10-D-leucyl-D-glutamyl-D-alanyl-D-arginyl-D-leucyl15-glycyl-D-glutaminyl-D-alanyl-D-arginyl-glycyl20-D-glutamyl-D-leucyl-D-lysyl-D-lysyl-D-tryptophyl25-D-lysyl-D-methionyl-D-arginyl-D-arginyl-D-asparaginyl30-D-glutaminyl-D-phenylalanyl-D-tryptophyl-D-leucyl-D-lysyl35-D-leucyl-D-glutaminyl-D-arginine', 'eu_mah_current': 'Sapience Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000055289', 'ema_number_certainty': '1.0'}"
EU-3-21-2457,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2457', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2457', 'active_substance': 'Adeno-associated viral vector LK03 encoding human methylmalonyl-CoA mutase', 'eu_mah_current': 'Parexel International (Irl) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000056297', 'ema_number_certainty': '1.0'}"
EU-3-21-2458,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2458', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2458', 'active_substance': 'Zanidatamab', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000033980', 'ema_number_certainty': '1.0'}"
EU-3-21-2459,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2459', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2459', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against apolipoprotein C-III mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000044658', 'ema_number_certainty': '1.0'}"
EU-3-21-2460,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2460', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2460', 'active_substance': 'Saroglitazar magnesium', 'eu_mah_current': 'Zydus France', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000053160', 'ema_number_certainty': '1.0'}"
EU-3-21-2461,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2461', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2461', 'active_substance': '1-(4-(6-chloropyridazin-3-yl)piperazin-1-yl)-2-(4-cyclopropyl-3-fluorophenyl)ethan-1-one', 'eu_mah_current': 'Bridge Bio Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000053228', 'ema_number_certainty': '0.5'}"
EU-3-21-2462,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2462', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2462', 'active_substance': '1-(4-(6-chloropyridazin-3-yl)piperazin-1-yl)-2-(4-cyclopropyl-3-fluorophenyl)ethan-1-one', 'eu_mah_current': 'Bridge Bio Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000053262', 'ema_number_certainty': '0.5'}"
EU-3-21-2463,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2463', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2463', 'active_substance': 'Itolizumab', 'eu_mah_current': 'Biocon Pharma Malta I Limited', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000053328', 'ema_number_certainty': '0.5'}"
EU-3-21-2464,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2464', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2464', 'active_substance': 'Tisagenlecleucel', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000053899', 'ema_number_certainty': '1.0'}"
EU-3-21-2465,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2465', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2465', 'active_substance': 'Eftansomatropin alfa', 'eu_mah_current': 'Parexel International (Irl) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000055257', 'ema_number_certainty': '1.0'}"
EU-3-21-2466,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2466', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2466', 'active_substance': 'Lutetium (177Lu) omburtamab barzuxetan', 'eu_mah_current': 'Y-Mabs Therapeutics A/S', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000055340', 'ema_number_certainty': '1.0'}"
EU-3-21-2467,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2467', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2467', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000055663', 'ema_number_certainty': '1.0'}"
EU-3-21-2468,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2468', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2468', 'active_substance': 'Melatonin', 'eu_mah_current': 'Worphmed S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000055883', 'ema_number_certainty': '1.0'}"
EU-3-21-2469,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2469', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2469', 'active_substance': 'Vodobatinib', 'eu_mah_current': 'Sun Pharmaceutical Industries Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000055969', 'ema_number_certainty': '1.0'}"
EU-3-21-2470,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2470', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2470', 'active_substance': 'Pridopidine hydrochloride', 'eu_mah_current': 'Prilenia Therapeutics B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000056592', 'ema_number_certainty': '1.0'}"
EU-3-21-2471,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2471', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2471', 'active_substance': 'Humanised IgG2k Fc-modified bispecific monoclonal antibody against CD3 and BCMA', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000057402', 'ema_number_certainty': '1.0'}"
EU-3-21-2472,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2472', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2472', 'active_substance': 'mRNA encoding the human glycogen debranching enzyme', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000057891', 'ema_number_certainty': '1.0'}"
EU-3-21-2473,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2473', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2473', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human SLC13A5 gene', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000057939', 'ema_number_certainty': '1.0'}"
EU-3-21-2474,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2474', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2474', 'active_substance': 'Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector encoding for the human palmitoyl-protein thioesterase 1 gene', 'eu_mah_current': 'University of Padua', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058064', 'ema_number_certainty': '1.0'}"
EU-3-21-2475,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2475', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2475', 'active_substance': 'Infigratinib', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058250', 'ema_number_certainty': '1.0'}"
EU-3-21-2476,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2476', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2476', 'active_substance': '3,5-diiodothyropropionic acid', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058312', 'ema_number_certainty': '1.0'}"
EU-3-21-2477,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2477', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2477', 'active_substance': 'Adeno-associated viral vector serotype Anc80 containing the 3&#39; portion of human OTOF gene, adeno-associated viral vector serotype Anc80 containing the 5&#39; portion of human OTOF gene', 'eu_mah_current': 'Boyd Consultants Limited', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058314', 'ema_number_certainty': '1.0'}"
EU-3-21-2478,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2478', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2478', 'active_substance': 'Adeno-associated virus vector serotype 1 containing the human GRN gene', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058488', 'ema_number_certainty': '1.0'}"
EU-3-21-2479,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2479', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2479', 'active_substance': 'Recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IgG1', 'eu_mah_current': 'Inozyme Pharma Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-19-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058504', 'ema_number_certainty': '1.0'}"
EU-3-21-2480,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2480', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2480', 'active_substance': 'Bardoxolone methyl', 'eu_mah_current': 'Reata Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000054645', 'ema_number_certainty': '0.5'}"
EU-3-21-2481,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2481', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2481', 'active_substance': 'Loncastuximab tesirine', 'eu_mah_current': 'ADC Therapeutics (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000054695', 'ema_number_certainty': '0.5'}"
EU-3-21-2482,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2482', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2482', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human HEXA and HEXB genes', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000057079', 'ema_number_certainty': '1.0'}"
EU-3-21-2483,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2483', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2483', 'active_substance': 'Human keratinocytes', 'eu_mah_current': 'Dizg Deutsches Institut F&#252;r Zell- Und Gewebeersatz gGmbH', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058028', 'ema_number_certainty': '1.0'}"
EU-3-21-2484,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2484', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2484', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human MECP2 gene', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058171', 'ema_number_certainty': '1.0'}"
EU-3-21-2485,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2485', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2485', 'active_substance': 'Humanised IgG1 monoclonal antibody against TfR1 conjugated to double stranded siRNA oligonucleotide against DMPK via a non-cleavable linker', 'eu_mah_current': 'MWB Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058262', 'ema_number_certainty': '1.0'}"
EU-3-21-2486,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2486', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2486', 'active_substance': 'Talquetamab', 'eu_mah_current': 'Janssen-Cilag International N.V.', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000060100', 'ema_number_certainty': '1.0'}"
EU-3-21-2487,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2487', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2487', 'active_substance': 'Adeno-associated virus serotype PTC3 expressing the human UBE3A gene', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000060300', 'ema_number_certainty': '1.0'}"
EU-3-21-2488,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2488', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2488', 'active_substance': 'Autologous CD34+ cells transfected with a lentiviral vector containing codon optimised RPS19 gene', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000060579', 'ema_number_certainty': '0.5'}"
EU-3-21-2489,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2489', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2489', 'active_substance': 'Cemdisiran', 'eu_mah_current': 'Alnylam Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000061148', 'ema_number_certainty': '1.0'}"
EU-3-21-2490,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2490', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2490', 'active_substance': 'Recombinant human apolipoprotein A-I', 'eu_mah_current': 'Abionyx Pharma', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000061524', 'ema_number_certainty': '1.0'}"
EU-3-21-2491,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2491', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2491', 'active_substance': 'Adeno-associated viral vector serotype S3 containing codon-optimised expression cassette encoding human beta-glucocerebrosidase variant', 'eu_mah_current': 'Freeline Therapeutics (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000061847', 'ema_number_certainty': '1.0'}"
EU-3-21-2492,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2492', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2492', 'active_substance': 'Adeno-associated virus serotype 9 encoding human NGLY1 gene', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000062288', 'ema_number_certainty': '1.0'}"
EU-3-21-2493,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2493', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2493', 'active_substance': 'Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector encoding for the human iduronate 2-sulfatase gene', 'eu_mah_current': 'University of Padua', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000062317', 'ema_number_certainty': '1.0'}"
EU-3-21-2494,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2494', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2494', 'active_substance': 'Sabatolimab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000062350', 'ema_number_certainty': '1.0'}"
EU-3-21-2495,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2495', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2495', 'active_substance': 'Lurbinectedin', 'eu_mah_current': 'Pharma Mar S.A.', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000062559', 'ema_number_certainty': '1.0'}"
EU-3-21-2496,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2496', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2496', 'active_substance': 'Autologous CD34+ cell enriched population containing haematopoietic stem and progenitor cells transduced ex vivo with a lentiviral vector encoding the human ADA2 gene', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '08-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000062715', 'ema_number_certainty': '1.0'}"
EU-3-21-2497,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2497', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2497', 'active_substance': 'Glofitamab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000053713', 'ema_number_certainty': '1.0'}"
EU-3-21-2498,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2498', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2498', 'active_substance': 'Human IgG1 monoclonal antibody against sortilin', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000055853', 'ema_number_certainty': '1.0'}"
EU-3-21-2499,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2499', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2499', 'active_substance': 'Devimistat', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000059143', 'ema_number_certainty': '1.0'}"
EU-3-21-2500,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2500', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2500', 'active_substance': 'Adeno-associated virus of serotype rh10 encoding human MLC1 under the control of GFAP promoter', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red, M.P.', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000059436', 'ema_number_certainty': '1.0'}"
EU-3-21-2501,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2501', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2501', 'active_substance': 'Batiraxcept', 'eu_mah_current': 'Kinesys Consulting NL B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000061114', 'ema_number_certainty': '1.0'}"
EU-3-21-2502,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2502', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2502', 'active_substance': 'Humanised IgG1 monoclonal antibody against SEZ6 linked to N-acetyl-calicheamicin', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000061663', 'ema_number_certainty': '1.0'}"
EU-3-21-2503,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2503', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2503', 'active_substance': 'Ganaxolone', 'eu_mah_current': 'Marinus Pharmaceuticals Emerald Limited', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000061671', 'ema_number_certainty': '1.0'}"
EU-3-21-2504,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2504', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2504', 'active_substance': 'Mocravimod', 'eu_mah_current': 'Priothera', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000061869', 'ema_number_certainty': '1.0'}"
EU-3-21-2505,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2505', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2505', 'active_substance': 'Allogeneic retinal pigment epithelial cells genetically modified with a non-viral vector to express human alpha-L-iduronidase', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000063084', 'ema_number_certainty': '1.0'}"
EU-3-21-2506,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2506', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2506', 'active_substance': 'Adeno-associated viral vector serotype 5 expressing the human cone-rod homeobox gene', 'eu_mah_current': 'Variant', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064480', 'ema_number_certainty': '1.0'}"
EU-3-21-2507,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2507', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2507', 'active_substance': 'Autologous haematopoietic stem and progenitor cell population containing CD34+ cells transduced with a lentiviral vector encoding the TCIRG1 cDNA ex vivo expanded', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064944', 'ema_number_certainty': '1.0'}"
EU-3-21-2508,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2508', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2508', 'active_substance': 'Allogeneic umbilical cord mesenchymal cells-derived extracellular vesicles', 'eu_mah_current': 'Exo Biologics', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065116', 'ema_number_certainty': '1.0'}"
EU-3-21-2509,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2509', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2509', 'active_substance': 'Selinexor', 'eu_mah_current': 'Karyopharm Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065221', 'ema_number_certainty': '1.0'}"
EU-3-21-2510,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2510', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2510', 'active_substance': 'Encaleret sulfate', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065287', 'ema_number_certainty': '1.0'}"
EU-3-21-2511,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2511', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2511', 'active_substance': 'Adeno-associated virus serotype rh10 containing the human GALC gene', 'eu_mah_current': 'Diamond Pharma Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065353', 'ema_number_certainty': '1.0'}"
EU-3-21-2512,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2512', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2512', 'active_substance': 'Idursulfase beta', 'eu_mah_current': 'Parexel International (Irl) Limited', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065415', 'ema_number_certainty': '1.0'}"
EU-3-21-2513,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2513', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2513', 'active_substance': 'Psilocybine', 'eu_mah_current': 'Comac Medical Ltd.', 'orphan_status': 'o', 'eu_aut_date': '10-15-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065562', 'ema_number_certainty': '1.0'}"
EU-3-21-2514,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2514', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2514', 'active_substance': 'Anti-CD38 IgG4 human monoclonal antibody', 'eu_mah_current': 'Encefa', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000036998', 'ema_number_certainty': '1.0'}"
EU-3-21-2515,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2515', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2515', 'active_substance': 'Linerixibat', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000057352', 'ema_number_certainty': '1.0'}"
EU-3-21-2516,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2516', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2516', 'active_substance': 'Nadunolimab', 'eu_mah_current': 'Cantargia AB', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058336', 'ema_number_certainty': '1.0'}"
EU-3-21-2517,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2517', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2517', 'active_substance': 'Mosunetuzumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000058552', 'ema_number_certainty': '1.0'}"
EU-3-21-2518,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2518', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2518', 'active_substance': 'Paclitaxel, polyoligo(ethylene glycol)methacrylate-co-poly(vinylbenzyldithiodibutyric acid-gemcitabine)', 'eu_mah_current': 'Duo Oncology Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000060140', 'ema_number_certainty': '0.5'}"
EU-3-21-2519,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2519', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2519', 'active_substance': 'Autologous CD34+ enriched cells transduced with a self-inactivating lentiviral vector containing the codon-optimized RPS19 gene', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red, M.P.', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000060407', 'ema_number_certainty': '1.0'}"
EU-3-21-2520,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2520', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2520', 'active_substance': 'Fingolimod', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red, M.P.', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000062237', 'ema_number_certainty': '1.0'}"
EU-3-21-2521,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2521', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2521', 'active_substance': 'Udonitrectag lysine', 'eu_mah_current': 'Mimetech S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000062364', 'ema_number_certainty': '1.0'}"
EU-3-21-2522,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2522', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2522', 'active_substance': 'Cannabidiol, dronabinol', 'eu_mah_current': 'Tetra Bio-Pharma Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000063093', 'ema_number_certainty': '1.0'}"
EU-3-21-2523,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2523', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2523', 'active_substance': '5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine', 'eu_mah_current': 'Vincerx Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064329', 'ema_number_certainty': '1.0'}"
EU-3-21-2524,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2524', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2524', 'active_substance': 'Rebastinib', 'eu_mah_current': 'Deciphera Pharmaceuticals (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064772', 'ema_number_certainty': '1.0'}"
EU-3-21-2525,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2525', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2525', 'active_substance': 'Ibrexafungerp', 'eu_mah_current': 'Dlrc Pharma Services Limited', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064849', 'ema_number_certainty': '1.0'}"
EU-3-21-2526,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2526', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2526', 'active_substance': '2-[1-(3-{6-[(1E)-(hydroxyimino)methyl]-5-methyl-4-oxo-7-propyl-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-2-yl}-4-propoxybenzenesulfonyl)piperidin-4-yl]ethyl nitrate', 'eu_mah_current': 'Topadur Pharma Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064903', 'ema_number_certainty': '1.0'}"
EU-3-21-2527,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2527', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2527', 'active_substance': '(14S)-8-[3-(2-{dispiro[2.0.24.13]heptan-7-yl}ethoxy)-1H-pyrazol-1-yl]-12,12-dimethyl-2lamba6-thia-3,9,11,18,23-penta-azatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5,7,9,19(23),20-hexaene-2,2,4-trione calcium salt hydrate, deutivacaftor, tezacaftor', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065454', 'ema_number_certainty': '1.0'}"
EU-3-21-2528,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2528', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2528', 'active_substance': 'D-lactic acid, glycolic acid', 'eu_mah_current': 'Neurevo GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065981', 'ema_number_certainty': '1.0'}"
EU-3-21-2530,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2530', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2530', 'active_substance': 'Olverembatinib', 'eu_mah_current': 'Ascentage Pharma Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000066944', 'ema_number_certainty': '1.0'}"
EU-3-21-2531,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2531', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2531', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human SURF1 gene', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '11-12-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000067046', 'ema_number_certainty': '1.0'}"
EU-3-21-2532,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2532', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2532', 'active_substance': 'Garadacimab', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000042546', 'ema_number_certainty': '1.0'}"
EU-3-21-2533,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2533', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2533', 'active_substance': 'Macitentan', 'eu_mah_current': 'Janssen-Cilag International N.V.', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000057224', 'ema_number_certainty': '1.0'}"
EU-3-21-2534,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2534', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2534', 'active_substance': 'Allogeneic fetal mesenchymal stem cells', 'eu_mah_current': 'Boost Pharma ApS', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000061939', 'ema_number_certainty': '1.0'}"
EU-3-21-2535,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2535', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2535', 'active_substance': 'Autologous T cells ex vivo modified with a lentiviral vector encoding a chimeric antigen receptor specific for CD1a', 'eu_mah_current': 'Onechain Immunotherapeutics S.L.', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000062804', 'ema_number_certainty': '1.0'}"
EU-3-21-2536,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2536', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2536', 'active_substance': 'Vatiquinone', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064102', 'ema_number_certainty': '1.0'}"
EU-3-21-2537,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2537', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2537', 'active_substance': 'Retinol palmitate', 'eu_mah_current': 'Real Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064241', 'ema_number_certainty': '1.0'}"
EU-3-21-2538,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2538', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2538', 'active_substance': 'Anti-(endothelin-1 receptor subtype A) IgG4 humanised monoclonal antibody', 'eu_mah_current': 'Gmax Biopharm Belgium', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064736', 'ema_number_certainty': '1.0'}"
EU-3-21-2539,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2539', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2539', 'active_substance': '3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine', 'eu_mah_current': 'Real Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064779', 'ema_number_certainty': '1.0'}"
EU-3-21-2540,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2540', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2540', 'active_substance': '3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine', 'eu_mah_current': 'Real Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064784', 'ema_number_certainty': '1.0'}"
EU-3-21-2541,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2541', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2541', 'active_substance': 'Crofelemer', 'eu_mah_current': 'Napo Therapeutics S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064955', 'ema_number_certainty': '1.0'}"
EU-3-21-2542,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2542', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2542', 'active_substance': 'Atrasentan', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065051', 'ema_number_certainty': '1.0'}"
EU-3-21-2543,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2543', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2543', 'active_substance': 'Copper (64CU) chloride', 'eu_mah_current': 'Advanced Center Oncology Macerata - S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065120', 'ema_number_certainty': '1.0'}"
EU-3-21-2544,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2544', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2544', 'active_substance': 'Ribonucleoprotein complex composed of two sgRNA and a Cas9 nuclease targeting the human COL7A1 gene', 'eu_mah_current': 'Branca Bunus Limited', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065281', 'ema_number_certainty': '1.0'}"
EU-3-21-2545,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2545', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2545', 'active_substance': 'N-[1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide', 'eu_mah_current': 'Neurocrine Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065820', 'ema_number_certainty': '1.0'}"
EU-3-21-2546,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2546', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2546', 'active_substance': '6-(4-(tert-butyl)phenoxy)pyridin-3-amine', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000066191', 'ema_number_certainty': '1.0'}"
EU-3-21-2547,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2547', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2547', 'active_substance': 'Chimeric peptide of human glucagon-like peptide-1, glucagon and gastric inhibitory polypeptide analogues linked to a human immunoglobulin Fc fragment', 'eu_mah_current': 'JVM Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000066630', 'ema_number_certainty': '1.0'}"
EU-3-21-2548,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2548', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2548', 'active_substance': 'Cedazuridine, decitabine', 'eu_mah_current': 'Otsuka Pharmaceutical Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000066742', 'ema_number_certainty': '1.0'}"
EU-3-21-2549,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2549', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2549', 'active_substance': 'Norrin (25-133), Lys86Pro', 'eu_mah_current': 'Maxia Strategies-Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000067316', 'ema_number_certainty': '1.0'}"
EU-3-21-2550,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2550', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2550', 'active_substance': 'Unesbulin', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000068074', 'ema_number_certainty': '1.0'}"
EU-3-21-2551,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2551', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2551', 'active_substance': 'Adeno-associated virus vector serotype 9 encoding the human GRN gene', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000068610', 'ema_number_certainty': '1.0'}"
EU-3-21-2552,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2552', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2552', 'active_substance': '2-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioguanylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioadenylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioadenylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioadenylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioguanoylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioadenylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioguanylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioguanylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioadenylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioadenylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioguanylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-P-thioadenylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3-O->5-O)-2-O-(2-methoxyethyl)-5-methyl-uridine sodium salt', 'eu_mah_current': 'AdRes EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000068887', 'ema_number_certainty': '1.0'}"
EU-3-21-2553,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2553', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2553', 'active_substance': 'Troriluzole hydrochloride', 'eu_mah_current': 'Biohaven Pharmaceutical Ireland DAC', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000069239', 'ema_number_certainty': '1.0'}"
EU-3-21-2554,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2554', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2554', 'active_substance': 'Octreotide acetate', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '12-10-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000069399', 'ema_number_certainty': '1.0'}"
EU-3-21-2555,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2555', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2555', 'active_substance': 'Efgartigimod alfa', 'eu_mah_current': 'Argenx', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064907', 'ema_number_certainty': '1.0'}"
EU-3-21-2556,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2556', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2556', 'active_substance': 'Navtemadlin', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065122', 'ema_number_certainty': '1.0'}"
EU-3-21-2557,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2557', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2557', 'active_substance': 'Insulin human', 'eu_mah_current': 'Sirius Regulatory Consulting EU Limited', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065934', 'ema_number_certainty': '1.0'}"
EU-3-21-2558,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2558', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2558', 'active_substance': 'mRNA encoding human glucose-6-phosphatase variant S298C', 'eu_mah_current': 'Moderna Biotech Spain S.L.', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000067342', 'ema_number_certainty': '1.0'}"
EU-3-21-2559,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2559', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2559', 'active_substance': 'Fasudil hydrochloride', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000068027', 'ema_number_certainty': '1.0'}"
EU-3-21-2560,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2560', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2560', 'active_substance': 'N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting human transferrin receptor', 'eu_mah_current': 'Artemida Pharma Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000068755', 'ema_number_certainty': '1.0'}"
EU-3-21-2561,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2561', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2561', 'active_substance': 'Chimeric peptide of human glucagon-like peptide-1, glucagon and gastric inhibitory polypeptide analogues linked to a human immunoglobulin Fc fragment', 'eu_mah_current': 'JVM Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000069185', 'ema_number_certainty': '1.0'}"
EU-3-21-2562,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2562', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2562', 'active_substance': 'Gadolinium-chelated polysiloxane nanoparticles', 'eu_mah_current': 'NH Theraguix', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000069392', 'ema_number_certainty': '1.0'}"
EU-3-21-2563,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2563', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2563', 'active_substance': 'Olorofim', 'eu_mah_current': 'F2G Biotech GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000070461', 'ema_number_certainty': '1.0'}"
EU-3-21-2564,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2564', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2564', 'active_substance': '5-((4&#39;-(3,3-difluorocyclobutyl)-[1,1&#39;-biphenyl]-4-yl)oxy)-1H-1,2,3-triazole-4-carboxylic acid', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000071191', 'ema_number_certainty': '1.0'}"
EU-3-21-2565,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2565', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2565', 'active_substance': '5&#39;-moemC-(sp)-moemC-(p)-moeA-(p)-moemC-(p)-moeG-(p)-moeA-(p)-dmC-(sp)-dA-(sp)-dT-(sp)-dA-(sp)-dT-(sp)-dT-(sp)-dT-(sp)-dT-(sp)-dT-(sp)-dmC-(sp)-moeT-(p)-moeA-(sp)-moemC-(sp)-moeA 3&#39;', 'eu_mah_current': 'Real Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000071211', 'ema_number_certainty': '1.0'}"
EU-3-21-2566,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2566', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2566', 'active_substance': 'Adeno-associated virus serotype 9 expressing the human fukutin related protein and target sequence of the miR-208a', 'eu_mah_current': 'Atamyo Therapeutics', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000071268', 'ema_number_certainty': '1.0'}"
EU-3-21-2567,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2567', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2567', 'active_substance': 'Melatonin', 'eu_mah_current': 'Worphmed S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000071311', 'ema_number_certainty': '1.0'}"
EU-3-21-2568,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2568', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2568', 'active_substance': 'Azithromycin dihydrate', 'eu_mah_current': 'Vale Pharmaceuticals Limited', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000071547', 'ema_number_certainty': '1.0'}"
EU-3-21-2569,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2569', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2569', 'active_substance': 'Trans N-ethyl-2-((4-(7-((4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide sesquifumarate', 'eu_mah_current': 'Syndax Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000071656', 'ema_number_certainty': '1.0'}"
EU-3-21-2570,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2570', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2570', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Maxia Strategies-Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000071679', 'ema_number_certainty': '1.0'}"
EU-3-21-2571,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/21/2571', 'status_type': 'a', 'eu_pnumber': 'EU/3/21/2571', 'active_substance': 'Adeno-associated virus vector serotype 2 expressing the human MT-ND4 codon-optimised gene', 'eu_mah_current': 'IQVIA RDS Spain S.L.', 'orphan_status': 'o', 'eu_aut_date': '01-14-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000071835', 'ema_number_certainty': '1.0'}"
EU-3-22-2572,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2572', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2572', 'active_substance': 'Valemetostat tosilate', 'eu_mah_current': 'Daiichi Sankyo Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000061188', 'ema_number_certainty': '1.0'}"
EU-3-22-2573,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2573', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2573', 'active_substance': 'Vatiquinone', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000063681', 'ema_number_certainty': '1.0'}"
EU-3-22-2574,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2574', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2574', 'active_substance': 'Pyridoxal 5&#39;-phosphate', 'eu_mah_current': 'Amsterdam UMC', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000069374', 'ema_number_certainty': '1.0'}"
EU-3-22-2575,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2575', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2575', 'active_substance': 'Bovactant', 'eu_mah_current': 'Aerogen Pharma Limited', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000069674', 'ema_number_certainty': '1.0'}"
EU-3-22-2576,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2576', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2576', 'active_substance': 'Gadolinium-chelated polysiloxane nanoparticles', 'eu_mah_current': 'NH Theraguix', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000069751', 'ema_number_certainty': '1.0'}"
EU-3-22-2577,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2577', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2577', 'active_substance': '[Ala1,3,12,Gln10,Arg11,Trp14]PTH(1-14)/[Ala18,22, Lys26]PTHrP(15-36)COOH', 'eu_mah_current': 'Amolyt Pharma', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000069873', 'ema_number_certainty': '1.0'}"
EU-3-22-2578,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2578', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2578', 'active_substance': 'Aldesleukin', 'eu_mah_current': 'Iltoo Pharma', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000070454', 'ema_number_certainty': '1.0'}"
EU-3-22-2580,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2580', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2580', 'active_substance': 'Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene', 'eu_mah_current': 'Consorcio Centro de Investigaci&#243;n Biom&#233;dica en Red, M.P.', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000072308', 'ema_number_certainty': '1.0'}"
EU-3-22-2581,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2581', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2581', 'active_substance': 'Epcoritamab', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000072899', 'ema_number_certainty': '1.0'}"
EU-3-22-2582,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2582', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2582', 'active_substance': 'Enzastaurin hydrochloride', 'eu_mah_current': 'Dlrc Pharma Services Limited', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000073562', 'ema_number_certainty': '1.0'}"
EU-3-22-2583,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2583', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2583', 'active_substance': 'Cannabidiol', 'eu_mah_current': 'EUDRAC GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000073948', 'ema_number_certainty': '1.0'}"
EU-3-22-2584,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2584', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2584', 'active_substance': 'Hymecromone', 'eu_mah_current': 'Ros Lynch', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000064376', 'ema_number_certainty': '1.0'}"
EU-3-22-2585,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2585', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2585', 'active_substance': 'Dersimelagon', 'eu_mah_current': 'Mitsubishi Tanabe Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000065936', 'ema_number_certainty': '1.0'}"
EU-3-22-2586,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2586', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2586', 'active_substance': 'Codergocrine mesilate, oxitriptan', 'eu_mah_current': 'Purposeful I.K.E.', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000066660', 'ema_number_certainty': '1.0'}"
EU-3-22-2587,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2587', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2587', 'active_substance': 'Tropatepine hydrochloride', 'eu_mah_current': 'Laboratoires Delbert', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000068622', 'ema_number_certainty': '1.0'}"
EU-3-22-2588,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2588', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2588', 'active_substance': 'Treprostinil sodium', 'eu_mah_current': 'Unither Therapeutik GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000070626', 'ema_number_certainty': '1.0'}"
EU-3-22-2589,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2589', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2589', 'active_substance': '(S)-12-fluoro-4-(2-methylpyridin-3-yl)-7a,8,13,14-tetrahydro-7H-[1,2,4]triazolo[4&#39;,3&#39;:1,6]pyrido[3,2-b]benzofuro[4,3-fg][1,4]oxazonine', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000072776', 'ema_number_certainty': '1.0'}"
EU-3-22-2590,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2590', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2590', 'active_substance': 'Alisporivir', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000073495', 'ema_number_certainty': '1.0'}"
EU-3-22-2591,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2591', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2591', 'active_substance': 'Emactuzumab', 'eu_mah_current': 'Synox Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000075927', 'ema_number_certainty': '1.0'}"
EU-3-22-2592,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2592', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2592', 'active_substance': 'Adeno-associated virus serotype HSC 15 expressing human iduronate 2-sulfatase', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000075990', 'ema_number_certainty': '0.5'}"
EU-3-22-2593,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2593', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2593', 'active_substance': 'Adeno-associated virus serotype HSC15, containing human homology arms, expressing human phenylalanine hydroxylase', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076117', 'ema_number_certainty': '0.5'}"
EU-3-22-2594,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2594', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2594', 'active_substance': 'Heterologous human adult liver-derived stem cells', 'eu_mah_current': 'Unicyte S.R.L.', 'orphan_status': 'o', 'eu_aut_date': '03-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000071526', 'ema_number_certainty': '1.0'}"
EU-3-22-2595,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2595', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2595', 'active_substance': 'Glofitamab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000070101', 'ema_number_certainty': '1.0'}"
EU-3-22-2596,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2596', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2596', 'active_substance': 'Adeno-associated virus serotype 9 containing human MYBPC3 gene', 'eu_mah_current': 'Yes Pharmaceutical Development Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000071657', 'ema_number_certainty': '1.0'}"
EU-3-22-2597,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2597', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2597', 'active_substance': 'Norucholic acid', 'eu_mah_current': 'Dr Falk Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000072395', 'ema_number_certainty': '1.0'}"
EU-3-22-2598,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2598', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2598', 'active_substance': 'Adeno-associated virus vector serotype 9 encoding human gigaxonin gene', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000074838', 'ema_number_certainty': '1.0'}"
EU-3-22-2599,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2599', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2599', 'active_substance': 'Belzupacap sarotalocan', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000075682', 'ema_number_certainty': '1.0'}"
EU-3-22-2600,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2600', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2600', 'active_substance': 'Cannabidiol', 'eu_mah_current': 'GW Pharma (International) B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000075999', 'ema_number_certainty': '1.0'}"
EU-3-22-2601,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2601', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2601', 'active_substance': 'N-(methoxypolyethylene glycol 5000 carbamoyl)-1,2-dipalmitoyl-sn-glycero-3-phosphatidylethanolamine', 'eu_mah_current': 'Icoat Medical AB', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076085', 'ema_number_certainty': '1.0'}"
EU-3-22-2602,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2602', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2602', 'active_substance': 'Devimistat', 'eu_mah_current': 'IQVIA RDS Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076090', 'ema_number_certainty': '1.0'}"
EU-3-22-2603,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2603', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2603', 'active_substance': 'Tiratricol', 'eu_mah_current': 'Rare Thyroid Therapeutics International AB', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076343', 'ema_number_certainty': '1.0'}"
EU-3-22-2605,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2605', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2605', 'active_substance': 'Obecabtagene autoleucel', 'eu_mah_current': 'Autolus GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077237', 'ema_number_certainty': '1.0'}"
EU-3-22-2606,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2606', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2606', 'active_substance': 'Adeno-associated viral vector serotype 8 encoding B-domain deleted liver specific codon optimized bioengineered chimeric human porcine factor VIII, under a synthetic hepatic combinatorial bundle promoter', 'eu_mah_current': 'Mdc Regaffairs GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077493', 'ema_number_certainty': '1.0'}"
EU-3-22-2607,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2607', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2607', 'active_substance': 'Adeno-associated virus serotype C102 containing the human GLA gene', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '04-13-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077524', 'ema_number_certainty': '1.0'}"
EU-3-22-2608,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2608', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2608', 'active_substance': 'Adeno-associated virus serotype R100 containing the human RPGRorf15 gene isoform', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077548', 'ema_number_certainty': '1.0'}"
EU-3-22-2609,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2609', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2609', 'active_substance': 'Cannabidiol', 'eu_mah_current': 'Tetra Bio-Pharma Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077756', 'ema_number_certainty': '1.0'}"
EU-3-22-2610,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2610', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2610', 'active_substance': 'Autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD123', 'eu_mah_current': 'INSERM UMR 1098', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076679', 'ema_number_certainty': '1.0'}"
EU-3-22-2611,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2611', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2611', 'active_substance': 'Fusion protein composed of the first 2 immunoglobulin-like domains of the human roundabout guidance receptor 2 fused to a human IgG1 crystallised fragment', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000072068', 'ema_number_certainty': '1.0'}"
EU-3-22-2612,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2612', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2612', 'active_substance': 'Elezanumab', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077407', 'ema_number_certainty': '1.0'}"
EU-3-22-2613,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2613', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2613', 'active_substance': 'Streptococcus pyogenes, group A, type 3, strain Su, inactivated', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077676', 'ema_number_certainty': '1.0'}"
EU-3-22-2614,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2614', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2614', 'active_substance': 'Elamipretide', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077720', 'ema_number_certainty': '1.0'}"
EU-3-22-2615,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2615', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2615', 'active_substance': 'Ibudilast', 'eu_mah_current': 'Healx Technology Limited', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000078233', 'ema_number_certainty': '1.0'}"
EU-3-22-2616,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2616', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2616', 'active_substance': 'Adeno-associated virus serotype 8 expressing the human gamma-sarcoglycan gene', 'eu_mah_current': 'Atamyo Therapeutics', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000078678', 'ema_number_certainty': '1.0'}"
EU-3-22-2617,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2617', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2617', 'active_substance': 'Autologous peripheral blood-derived CD4 T-cells CRISPR-edited at the CD40LG locus', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000079230', 'ema_number_certainty': '1.0'}"
EU-3-22-2618,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2618', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2618', 'active_substance': 'Icerguastat acetate', 'eu_mah_current': 'Inflectis Bioscience S.A.S', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000079683', 'ema_number_certainty': '1.0'}"
EU-3-22-2619,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2619', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2619', 'active_substance': 'Chimeric peptide of human glucagon-like peptide-1, glucagon and gastric inhibitory polypeptide analogues linked to a human immunoglobulin Fc fragment', 'eu_mah_current': 'JVM Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000080809', 'ema_number_certainty': '1.0'}"
EU-3-22-2620,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2620', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2620', 'active_substance': 'Pasireotide', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '05-16-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000081138', 'ema_number_certainty': '1.0'}"
EU-3-22-2621,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2621', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2621', 'active_substance': 'Escherichia coli, strain Nissle 1917, expressing high affinity phenylalanine transporter, phenylalanine ammonia lyase and L-amino acid deaminase', 'eu_mah_current': 'Orphix Consulting GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000068847', 'ema_number_certainty': '1.0'}"
EU-3-22-2622,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2622', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2622', 'active_substance': 'Losartan', 'eu_mah_current': '3R Pharma Consulting GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000075685', 'ema_number_certainty': '1.0'}"
EU-3-22-2623,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2623', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2623', 'active_substance': 'Humanised IgG4 monoclonal antibody against A proliferation-inducing ligand', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000075740', 'ema_number_certainty': '1.0'}"
EU-3-22-2624,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2624', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2624', 'active_substance': 'Doxorubicin', 'eu_mah_current': 'Thermosome GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076247', 'ema_number_certainty': '1.0'}"
EU-3-22-2625,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2625', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2625', 'active_substance': 'Sebetralstat', 'eu_mah_current': 'Kalvista Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076332', 'ema_number_certainty': '1.0'}"
EU-3-22-2626,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2626', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2626', 'active_substance': 'Amitriptyline', 'eu_mah_current': 'AlgoTherapeutix', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076571', 'ema_number_certainty': '1.0'}"
EU-3-22-2627,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2627', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2627', 'active_substance': 'Ropeginterferon alfa-2b', 'eu_mah_current': 'Aop Orphan Pharmaceuticals GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077171', 'ema_number_certainty': '1.0'}"
EU-3-22-2628,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2628', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2628', 'active_substance': '3-(1-(2&#39;,3&#39;-dimethoxy-[1,1&#39;-biphenyl]-4-yl)-1H-1,2,3-triazol-4-yl)benzoic acid', 'eu_mah_current': 'ChemIcare S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077417', 'ema_number_certainty': '1.0'}"
EU-3-22-2630,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2630', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2630', 'active_substance': 'Pirfenidone', 'eu_mah_current': 'Regintel Limited', 'orphan_status': 'o', 'eu_aut_date': '06-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000080460', 'ema_number_certainty': '1.0'}"
EU-3-22-2631,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2631', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2631', 'active_substance': 'Sodium (4Z,7Z,10R,11E,13E,15Z,17S,19Z)10,17-dihydroxy-docosa-4,7,11,13,15,19-hexaenoate', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000080709', 'ema_number_certainty': '1.0'}"
EU-3-22-2632,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2632', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2632', 'active_substance': 'Lithium carbonate', 'eu_mah_current': 'Centre Hospitalier Universitaire Dijon Bourgogne', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000080823', 'ema_number_certainty': '1.0'}"
EU-3-22-2633,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2633', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2633', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Raremoon Consulting Esp S.L.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000081767', 'ema_number_certainty': '1.0'}"
EU-3-22-2634,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2634', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2634', 'active_substance': 'Epcoritamab', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000082687', 'ema_number_certainty': '1.0'}"
EU-3-22-2635,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2635', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2635', 'active_substance': 'Tamoxifen citrate', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000082957', 'ema_number_certainty': '1.0'}"
EU-3-22-2636,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2636', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2636', 'active_substance': '2&#39;-O-(2-methoxyethyl) modified antisense oligonucleotide targeting UBE3A antisense transcript RNA', 'eu_mah_current': 'Ionis Development (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000083607', 'ema_number_certainty': '1.0'}"
EU-3-22-2637,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2637', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2637', 'active_substance': 'Human allogeneic keratinocytes', 'eu_mah_current': 'Evomedis GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000083615', 'ema_number_certainty': '1.0'}"
EU-3-22-2638,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2638', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2638', 'active_substance': 'Modified mRNA encoding human methylmalonyl-coenzyme A mutase containing a polymorphism at position 671', 'eu_mah_current': 'Moderna Biotech Spain S.L.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000083787', 'ema_number_certainty': '1.0'}"
EU-3-22-2639,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2639', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2639', 'active_substance': '2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl -(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-P-thioadenylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-P-thioguanylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)- 5-methyl-P-thiouridylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-P-thioguanylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3&#39;-O->5&#39;-O)-2&#39;-O-(2-methoxyethyl)-P-thioadenine, sodium salt', 'eu_mah_current': 'AdRes EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000083789', 'ema_number_certainty': '1.0'}"
EU-3-22-2640,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2640', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2640', 'active_substance': 'Diflunisal', 'eu_mah_current': 'Turnkey Pharmaconsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-24-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000083967', 'ema_number_certainty': '1.0'}"
EU-3-22-2641,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2641', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2641', 'active_substance': 'Eltanexor', 'eu_mah_current': 'Karyopharm Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000084241', 'ema_number_certainty': '1.0'}"
EU-3-22-2642,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2642', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2642', 'active_substance': 'Govorestat', 'eu_mah_current': 'Drug Development and Regulation S.L.', 'orphan_status': 'o', 'eu_aut_date': '06-21-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000084390', 'ema_number_certainty': '1.0'}"
EU-3-22-2643,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2643', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2643', 'active_substance': 'Humanised IgG4 monoclonal antibody against active complement component 1, subcomponent s', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000021158', 'ema_number_certainty': '1.0'}"
EU-3-22-2644,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2644', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2644', 'active_substance': 'Fosmanogepix', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076464', 'ema_number_certainty': '1.0'}"
EU-3-22-2645,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2645', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2645', 'active_substance': 'Fosmanogepix', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076916', 'ema_number_certainty': '1.0'}"
EU-3-22-2646,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2646', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2646', 'active_substance': 'mRNA encoding modified human ornithine transcarbamylase', 'eu_mah_current': 'Arcturus Therapeutics Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000077782', 'ema_number_certainty': '1.0'}"
EU-3-22-2647,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2647', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2647', 'active_substance': 'Autologous naive regulatory T cells transduced with a lentiviral vector encoding for a chimeric antigen receptor to recognise the HLA-A*02 antigen', 'eu_mah_current': 'Sangamo Therapeutics France S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000078610', 'ema_number_certainty': '1.0'}"
EU-3-22-2648,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2648', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2648', 'active_substance': 'Thiostrepton', 'eu_mah_current': 'EMA Regulatory Submissions Expediter Limited', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000079978', 'ema_number_certainty': '1.0'}"
EU-3-22-2649,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2649', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2649', 'active_substance': 'Odronextamab', 'eu_mah_current': 'Regeneron Ireland Designated Activity Company', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000080170', 'ema_number_certainty': '1.0'}"
EU-3-22-2650,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2650', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2650', 'active_substance': 'Zilucoplan', 'eu_mah_current': 'UCB Pharma', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000080529', 'ema_number_certainty': '1.0'}"
EU-3-22-2651,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2651', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2651', 'active_substance': 'Hydroquinidine hydrochloride', 'eu_mah_current': 'Teofarma S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000080688', 'ema_number_certainty': '1.0'}"
EU-3-22-2652,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2652', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2652', 'active_substance': '3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole', 'eu_mah_current': 'Teva B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000081208', 'ema_number_certainty': '1.0'}"
EU-3-22-2653,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2653', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2653', 'active_substance': 'Efgartigimod alfa', 'eu_mah_current': 'Argenx', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000082060', 'ema_number_certainty': '1.0'}"
EU-3-22-2654,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2654', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2654', 'active_substance': '(S)-1-(4-(1-(3,4,5-trimethoxyphenyl)-1H-imidazol-4-ylamino)thieno[2,3-d]pyrimidin-2-yl)pyrrolidine-2-carboxamide', 'eu_mah_current': 'Biocryst Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000082579', 'ema_number_certainty': '1.0'}"
EU-3-22-2655,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2655', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2655', 'active_substance': 'Berzosertib', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000082615', 'ema_number_certainty': '1.0'}"
EU-3-22-2656,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2656', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2656', 'active_substance': 'Odronextamab', 'eu_mah_current': 'Regeneron Ireland Designated Activity Company', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000083083', 'ema_number_certainty': '1.0'}"
EU-3-22-2657,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2657', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2657', 'active_substance': 'Salmonella enterica, subsp. enterica, serovar Typhimurium, strain YS1646, live', 'eu_mah_current': 'Premier Research Group S.L.', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000083166', 'ema_number_certainty': '1.0'}"
EU-3-22-2658,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2658', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2658', 'active_substance': 'Heterologous swine glyco-humanised polyclonal antibody against T lymphocytes', 'eu_mah_current': 'Xenothera', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000083254', 'ema_number_certainty': '1.0'}"
EU-3-22-2659,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2659', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2659', 'active_substance': 'Parsaclisib', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000083733', 'ema_number_certainty': '1.0'}"
EU-3-22-2660,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2660', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2660', 'active_substance': 'Panobinostat', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000085141', 'ema_number_certainty': '1.0'}"
EU-3-22-2661,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2661', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2661', 'active_substance': '2,4,6,7,8,9-hexahydro-4-((2-methylphenyl)methyl)-7-(phenylmethyl)imidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(1H)-one', 'eu_mah_current': 'Chimerix IRL Limited', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000085459', 'ema_number_certainty': '1.0'}"
EU-3-22-2662,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2662', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2662', 'active_substance': 'Vilobelimab', 'eu_mah_current': 'InflaRx GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000085590', 'ema_number_certainty': '1.0'}"
EU-3-22-2663,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2663', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2663', 'active_substance': 'Sodium phenylbutyrate', 'eu_mah_current': 'Renantos Pharmavertriebsgesellschaft mbH', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000085676', 'ema_number_certainty': '1.0'}"
EU-3-22-2664,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2664', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2664', 'active_substance': 'Human decorin fused to the truncated homing peptide CRK', 'eu_mah_current': 'Tampereen Korkeakoulus&#228;&#228;ti&#246; Sr', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000085783', 'ema_number_certainty': '1.0'}"
EU-3-22-2665,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2665', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2665', 'active_substance': 'Pyridoxal 5&#39;-phosphate', 'eu_mah_current': 'Amsterdam UMC', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000085913', 'ema_number_certainty': '1.0'}"
EU-3-22-2666,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2666', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2666', 'active_substance': 'W253R/R275S tissue plasminogen activator', 'eu_mah_current': 'Op2Lysis', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000086046', 'ema_number_certainty': '1.0'}"
EU-3-22-2667,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2667', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2667', 'active_substance': 'Liraglutide', 'eu_mah_current': 'Pietro Maffei', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000086049', 'ema_number_certainty': '1.0'}"
EU-3-22-2668,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2668', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2668', 'active_substance': 'Erlotinib', 'eu_mah_current': 'Imagine Institut Des Maladies Genetiques Necker Enfants Malades', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000086361', 'ema_number_certainty': '1.0'}"
EU-3-22-2670,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2670', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2670', 'active_substance': '(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000086748', 'ema_number_certainty': '0.5'}"
EU-3-22-2671,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2671', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2671', 'active_substance': 'Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with a lentiviral vector encoding for the N-acetylgalactosamine 6-sulfatase cDNA', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000072597', 'ema_number_certainty': '1.0'}"
EU-3-22-2672,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2672', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2672', 'active_substance': 'Toll-like receptor 4 agonist', 'eu_mah_current': 'Hephaistos-Pharma', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000076094', 'ema_number_certainty': '1.0'}"
EU-3-22-2673,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2673', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2673', 'active_substance': 'Nanatinostat, valganciclovir', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000081808', 'ema_number_certainty': '1.0'}"
EU-3-22-2674,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2674', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2674', 'active_substance': 'Lithium carbonate', 'eu_mah_current': 'Amsterdam UMC', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000084294', 'ema_number_certainty': '1.0'}"
EU-3-22-2675,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2675', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2675', 'active_substance': 'Bezafibrate', 'eu_mah_current': 'Amsterdam UMC', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000085853', 'ema_number_certainty': '1.0'}"
EU-3-22-2676,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2676', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2676', 'active_substance': 'Mazindol', 'eu_mah_current': 'Propharma Group The Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000085890', 'ema_number_certainty': '1.0'}"
EU-3-22-2677,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2677', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2677', 'active_substance': 'H-Lys-Lys-Gly-Asp-Asn-Ile-Met-Val-Thr-Phe-Arg-Asn-Gln-Ala-Ser-Arg-Pro-Tyr-Gly-Lys-Lys-OH', 'eu_mah_current': 'S-Cubed Pharmaceutical Services ApS', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000086532', 'ema_number_certainty': '1.0'}"
EU-3-22-2678,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2678', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2678', 'active_substance': 'Calmangafodipir', 'eu_mah_current': 'Egetis Therapeutics AB (publ)', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000086562', 'ema_number_certainty': '1.0'}"
EU-3-22-2679,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2679', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2679', 'active_substance': 'Allogeneic placenta-derived decidual stromal cells', 'eu_mah_current': 'MDC RegAffairs GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000086580', 'ema_number_certainty': '1.0'}"
EU-3-22-2680,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2680', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2680', 'active_substance': 'Epetraborole', 'eu_mah_current': 'Dlrc Pharma Services Limited', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000089012', 'ema_number_certainty': '1.0'}"
EU-3-22-2681,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2681', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2681', 'active_substance': 'Autologous human bone marrow-derived haematopoietic and mesenchymal stem cells depleted of erythrocytes, monocytes and lymphocytes', 'eu_mah_current': 'Neuroplast B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000090545', 'ema_number_certainty': '1.0'}"
EU-3-22-2682,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2682', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2682', 'active_substance': 'Vutrisiran', 'eu_mah_current': 'Alnylam Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000091543', 'ema_number_certainty': '1.0'}"
EU-3-22-2683,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2683', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2683', 'active_substance': 'Sotuletinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000091771', 'ema_number_certainty': '1.0'}"
EU-3-22-2684,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2684', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2684', 'active_substance': 'Batoclimab', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000091878', 'ema_number_certainty': '1.0'}"
EU-3-22-2685,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2685', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2685', 'active_substance': 'Allogeneic adult liver-derived stem cells', 'eu_mah_current': 'Unicyte S.R.L.', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000091899', 'ema_number_certainty': '1.0'}"
EU-3-22-2686,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2686', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2686', 'active_substance': 'Gold', 'eu_mah_current': 'Clene Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000092111', 'ema_number_certainty': '1.0'}"
EU-3-22-2687,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2687', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2687', 'active_substance': 'Clarithromycin, clofazimine, rifabutin', 'eu_mah_current': 'Regintel Limited', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000093202', 'ema_number_certainty': '1.0'}"
EU-3-22-2688,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2688', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2688', 'active_substance': 'Tamibarotene', 'eu_mah_current': 'Syros Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000093305', 'ema_number_certainty': '1.0'}"
EU-3-22-2689,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2689', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2689', 'active_substance': '(7S)-8,8-dimethyl-7-{[(2E)-3-phenyl-2-propen-1-yl]oxy}-7,8-dihydro-2H,6H-pyrano[3,2-g]chromen-2-on', 'eu_mah_current': 'Global Medical Services Sp. z o.o.', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000093471', 'ema_number_certainty': '1.0'}"
EU-3-22-2690,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2690', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2690', 'active_substance': 'Humanised IgG1 tetravalent monoclonal antibody against death receptor 5', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000093683', 'ema_number_certainty': '1.0'}"
EU-3-22-2691,"{'atc_code': 'not applicable', 'eu_aut_status': 'ACTIVE', 'eu_brand_name_current': 'EU/3/22/2691', 'status_type': 'a', 'eu_pnumber': 'EU/3/22/2691', 'active_substance': 'Amphotericin B', 'eu_mah_current': 'Insight Drug Regulatory', 'orphan_status': 'o', 'eu_aut_date': '08-10-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000093873', 'ema_number_certainty': '1.0'}"
EU-3-02-101,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/101', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/101', 'active_substance': 'Pseudomonas exotoxin (domains II/III)-Interleukin 13 chimeric protein', 'eu_mah_current': 'EUDRAC Limited', 'orphan_status': 'o', 'eu_aut_date': '04-30-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/004/02', 'ema_number_certainty': '1.0'}"
EU-3-00-001,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/00/001', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/001', 'active_substance': 'Somatropin', 'eu_mah_current': 'Merck Serono Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '08-08-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/001/00', 'ema_number_certainty': '1.0'}"
EU-3-00-002,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/00/002', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/002', 'active_substance': 'Alpha-Galactosidase A', 'eu_mah_current': 'Shire Human Genetic Therapies AB', 'orphan_status': 'o', 'eu_aut_date': '08-08-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/007/00', 'ema_number_certainty': '1.0'}"
EU-3-00-003,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/00/003', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/003', 'active_substance': 'Alpha-Galactosidase A', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-08-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/010/00', 'ema_number_certainty': '1.0'}"
EU-3-00-004,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/00/004', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/004', 'active_substance': 'Fluorouracil', 'eu_mah_current': 'Ethypharm S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-18-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/012/00', 'ema_number_certainty': '1.0'}"
EU-3-00-006,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/00/006', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/006', 'active_substance': '1,5-(Butylimino)-1,5-dideoxy, D-glucitol', 'eu_mah_current': 'Actelion Registration Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-18-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/023/00', 'ema_number_certainty': '1.0'}"
EU-3-00-007,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/00/007', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/007', 'active_substance': 'N-carbamyl-L-glutamic acid', 'eu_mah_current': 'Orphan Europe S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '10-18-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/002/00', 'ema_number_certainty': '1.0'}"
EU-3-00-008,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/00/008', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/008', 'active_substance': 'Arsenic trioxide', 'eu_mah_current': 'Cephalon Europe', 'orphan_status': 'o', 'eu_aut_date': '10-18-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/008/00', 'ema_number_certainty': '1.0'}"
EU-3-00-009,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/00/009', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/009', 'active_substance': 'Thalidomide', 'eu_mah_current': 'Pharmion France', 'orphan_status': 'o', 'eu_aut_date': '12-29-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/017/00', 'ema_number_certainty': '1.0'}"
EU-3-00-010,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/00/010', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/010', 'active_substance': 'Anagrelide Hydrochloride', 'eu_mah_current': 'Shire Pharmaceutical Development Limited', 'orphan_status': 'o', 'eu_aut_date': '12-29-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/013/00', 'ema_number_certainty': '1.0'}"
EU-3-00-011,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/00/011', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/011', 'active_substance': 'Busulfan (Intravenous use)', 'eu_mah_current': 'Pierre Fabre M&#233;dicament', 'orphan_status': 'o', 'eu_aut_date': '12-29-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/024/00', 'ema_number_certainty': '1.0'}"
EU-3-00-012,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/00/012', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/012', 'active_substance': 'nitisinone', 'eu_mah_current': 'Swedish Orphan Biovitrum International AB', 'orphan_status': 'o', 'eu_aut_date': '12-29-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/011/00', 'ema_number_certainty': '1.0'}"
EU-3-00-014,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/00/014', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/014', 'active_substance': 'Iloprost', 'eu_mah_current': 'Bayer Pharma AG', 'orphan_status': 'o', 'eu_aut_date': '12-29-2000', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/009/00', 'ema_number_certainty': '1.0'}"
EU-3-00-015,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/00/015', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/015', 'active_substance': 'Xaliproden hydrochloride', 'eu_mah_current': 'Sanofi-Aventis', 'orphan_status': 'o', 'eu_aut_date': '01-17-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/029/00', 'ema_number_certainty': '1.0'}"
EU-3-00-016,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/00/016', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/016', 'active_substance': 'Lusupultide', 'eu_mah_current': 'Nycomed GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-17-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/037/00', 'ema_number_certainty': '1.0'}"
EU-3-00-017,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/00/017', 'status_type': 'w', 'eu_pnumber': 'EU/3/00/017', 'active_substance': 'Arsenic trioxide', 'eu_mah_current': 'Agence g&#233;n&#233;rale des &#233;quipements et produits de sant&#233; - Etablissement pharmaceutique des h&#244;pitaux de Paris (AGEPS-EPHP)', 'orphan_status': 'o', 'eu_aut_date': '01-17-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/031/00', 'ema_number_certainty': '1.0'}"
EU-3-01-018,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/018', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/018', 'active_substance': 'Recombinant human acid alpha-glucosidase', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-14-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/033/00', 'ema_number_certainty': '1.0'}"
EU-3-01-019,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/019', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/019', 'active_substance': 'bosentan', 'eu_mah_current': 'Actelion Registration Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-14-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/036/00', 'ema_number_certainty': '1.0'}"
EU-3-01-020,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/020', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/020', 'active_substance': 'Ibuprofen', 'eu_mah_current': 'Orphan Europe S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '02-14-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/004/00', 'ema_number_certainty': '1.0'}"
EU-3-01-021,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/021', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/021', 'active_substance': 'Imatinib mesylate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '02-14-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/049/00', 'ema_number_certainty': '1.0'}"
EU-3-01-022,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/022', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/022', 'active_substance': 'Laronidase', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-14-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/042/00', 'ema_number_certainty': '1.0'}"
EU-3-01-023,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/023', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/023', 'active_substance': 'Pegvisomant', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'o', 'eu_aut_date': '02-14-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/035/00', 'ema_number_certainty': '1.0'}"
EU-3-01-024,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/024', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/024', 'active_substance': 'Ribavirin', 'eu_mah_current': 'ICN Pharmaceuticals Limited', 'orphan_status': 'o', 'eu_aut_date': '02-14-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/041/00', 'ema_number_certainty': '1.0'}"
EU-3-01-025,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/025', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/025', 'active_substance': 'N-acetylgalactosamine-4-sulfatase', 'eu_mah_current': 'BioMarin Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-14-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/051/00', 'ema_number_certainty': '1.0'}"
EU-3-01-027,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/027', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/027', 'active_substance': 'Ibuprofen', 'eu_mah_current': 'Orphan Europe S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '03-05-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/005/00', 'ema_number_certainty': '1.0'}"
EU-3-01-029,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/029', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/029', 'active_substance': 'Ribavirin', 'eu_mah_current': 'Valeant Pharmaceuticals Limited', 'orphan_status': 'o', 'eu_aut_date': '03-08-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/040/00', 'ema_number_certainty': '1.0'}"
EU-3-01-030,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/030', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/030', 'active_substance': '8-cyclopentlyl-1,3-dipropylxanthine', 'eu_mah_current': 'SciClone Pharmaceuticals Italy S.r.l', 'orphan_status': 'o', 'eu_aut_date': '03-29-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/064/00', 'ema_number_certainty': '1.0'}"
EU-3-01-031,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/031', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/031', 'active_substance': 'Arsenic trioxide', 'eu_mah_current': 'Cephalon Europe', 'orphan_status': 'o', 'eu_aut_date': '03-29-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/047/00', 'ema_number_certainty': '1.0'}"
EU-3-01-032,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/032', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/032', 'active_substance': 'Arsenic trioxide', 'eu_mah_current': 'Cephalon Europe', 'orphan_status': 'o', 'eu_aut_date': '03-29-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/048/00', 'ema_number_certainty': '1.0'}"
EU-3-01-033,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/033', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/033', 'active_substance': 'Ranpirnase', 'eu_mah_current': 'MoRa Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-29-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/055/00', 'ema_number_certainty': '1.0'}"
EU-3-01-035,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/035', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/035', 'active_substance': 'Levodopa and Carbidopa (Gastroenteral use)', 'eu_mah_current': 'AbbVie Ltd', 'orphan_status': 'o', 'eu_aut_date': '05-10-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/052/00', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-01-036,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/036', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/036', 'active_substance': 'Recombinant human C1-inhibitor', 'eu_mah_current': 'Pharming Group N.V.', 'orphan_status': 'o', 'eu_aut_date': '05-11-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/053/00', 'ema_number_certainty': '1.0'}"
EU-3-01-037,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/037', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/037', 'active_substance': 'Humanised Anti-HM1.24 Monoclonal Antibody', 'eu_mah_current': 'Chugai Pharma Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '05-10-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/003/01', 'ema_number_certainty': '1.0'}"
EU-3-01-039,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/039', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/039', 'active_substance': 'Ecteinascidin 743', 'eu_mah_current': 'Pharma Mar S.A.', 'orphan_status': 'o', 'eu_aut_date': '05-30-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/001/01', 'ema_number_certainty': '1.0'}"
EU-3-01-040,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/040', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/040', 'active_substance': 'Fomepizole', 'eu_mah_current': 'IDIS Ltd', 'orphan_status': 'o', 'eu_aut_date': '05-30-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/067/00', 'ema_number_certainty': '1.0'}"
EU-3-01-041,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/041', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/041', 'active_substance': 'Recombinant human alpha-1-antitrypsin (respiratory use)', 'eu_mah_current': 'Talecris Biotherapeutics GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-30-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/066/00', 'ema_number_certainty': '1.0'}"
EU-3-01-042,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/042', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/042', 'active_substance': 'Human engineered monoclonal antibody specific for Transforming Growth Factor &#223;2', 'eu_mah_current': 'Cambridge Antibody Technology', 'orphan_status': 'o', 'eu_aut_date': '05-30-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/070/00', 'ema_number_certainty': '1.0'}"
EU-3-01-043,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/043', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/043', 'active_substance': 'Human Milk Fat Globule 1 / Human Milk Fat Globule 1 - S-p-isothiocyanatobenzyl-diethylenetriaminepentaacetic acid for use with 90Yttrium', 'eu_mah_current': 'Antisoma Plc', 'orphan_status': 'o', 'eu_aut_date': '05-30-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/061/00', 'ema_number_certainty': '1.0'}"
EU-3-01-045,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/045', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/045', 'active_substance': 'Betaine anhydrous', 'eu_mah_current': 'Orphan Europe S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '07-09-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/003/00', 'ema_number_certainty': '1.0'}"
EU-3-01-046,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/046', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/046', 'active_substance': 'Thalidomide', 'eu_mah_current': 'Pharmion France', 'orphan_status': 'o', 'eu_aut_date': '07-09-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/020/00', 'ema_number_certainty': '1.0'}"
EU-3-01-047,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/047', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/047', 'active_substance': 'Thalidomide', 'eu_mah_current': 'Pharmion France', 'orphan_status': 'o', 'eu_aut_date': '07-09-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/018/00', 'ema_number_certainty': '1.0'}"
EU-3-01-048,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/048', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/048', 'active_substance': 'Ziconotide (intraspinal use)', 'eu_mah_current': 'Eisai Limited', 'orphan_status': 'o', 'eu_aut_date': '07-09-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/062/00', 'ema_number_certainty': '1.0'}"
EU-3-01-050,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/050', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/050', 'active_substance': 'Zinc acetate dihydrate', 'eu_mah_current': 'Orphan Europe S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '07-31-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/006/00', 'ema_number_certainty': '1.0'}"
EU-3-01-052,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/052', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/052', 'active_substance': 'Seocalcitol', 'eu_mah_current': 'Leo Pharmaceutical Products', 'orphan_status': 'o', 'eu_aut_date': '07-31-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/013/01', 'ema_number_certainty': '1.0'}"
EU-3-01-053,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/053', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/053', 'active_substance': 'Beraprost sodium', 'eu_mah_current': 'Aventis Pharma S.A.', 'orphan_status': 'o', 'eu_aut_date': '09-18-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/015/01', 'ema_number_certainty': '1.0'}"
EU-3-01-054,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/054', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/054', 'active_substance': 'Sinapultide, dipalmitoylfosfatidylcholine, palmitoyloleoyl fosfatidylglycerol and palmitic acid', 'eu_mah_current': 'Discovery Laboratories Inc', 'orphan_status': 'o', 'eu_aut_date': '09-19-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/007/01', 'ema_number_certainty': '1.0'}"
EU-3-01-055,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/055', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/055', 'active_substance': 'Cladribine (subcutaneous use)', 'eu_mah_current': 'Lipomed GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-18-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/006/01', 'ema_number_certainty': '1.0'}"
EU-3-01-057,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/057', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/057', 'active_substance': 'Porcine lung surfactant', 'eu_mah_current': 'Leo Pharmaceutical Products', 'orphan_status': 'o', 'eu_aut_date': '09-19-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/018/01', 'ema_number_certainty': '1.0'}"
EU-3-02-099,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/099', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/099', 'active_substance': 'Bryostatin-1', 'eu_mah_current': 'GPC Biotech AG', 'orphan_status': 'o', 'eu_aut_date': '04-30-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/002/02', 'ema_number_certainty': '1.0'}"
EU-3-01-059,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/059', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/059', 'active_substance': 'Dexrazoxane', 'eu_mah_current': 'Norgine B.V.', 'orphan_status': 'o', 'eu_aut_date': '09-19-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/021/01', 'ema_number_certainty': '0.75'}"
EU-3-01-060,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/060', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/060', 'active_substance': 'Pemetrexed disodium', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'o', 'eu_aut_date': '09-17-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/022/01', 'ema_number_certainty': '1.0'}"
EU-3-01-061,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/061', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/061', 'active_substance': 'Imatinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/039/01', 'ema_number_certainty': '1.0'}"
EU-3-01-063,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/063', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/063', 'active_substance': 'Deoxyribose phosphorothioate (5&#180;-tct-ccc-agc-gtg-cgc-cat-3&#180;)', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '11-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/025/01', 'ema_number_certainty': '1.0'}"
EU-3-01-064,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/064', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/064', 'active_substance': 'Abetimus sodium', 'eu_mah_current': 'La Jolla Limited', 'orphan_status': 'o', 'eu_aut_date': '11-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/023/01', 'ema_number_certainty': '1.0'}"
EU-3-01-065,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/065', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/065', 'active_substance': 'Deoxyribose phosphorothioate (5&#180;-tct-ccc-agc-gtg-cgc-cat-3&#180;)', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '11-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/026/01', 'ema_number_certainty': '1.0'}"
EU-3-01-066,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/066', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/066', 'active_substance': 'Thalidomide', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/041/01', 'ema_number_certainty': '1.0'}"
EU-3-01-067,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/067', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/067', 'active_substance': 'Thalidomide', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/040/01', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-01-068,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/068', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/068', 'active_substance': 'Thalidomide', 'eu_mah_current': 'Kendle International Ltd', 'orphan_status': 'o', 'eu_aut_date': '12-19-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/019/01', 'ema_number_certainty': '1.0'}"
EU-3-01-070,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/070', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/070', 'active_substance': 'Celecoxib', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'o', 'eu_aut_date': '11-20-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/011/01', 'ema_number_certainty': '1.0'}"
EU-3-01-071,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/071', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/071', 'active_substance': 'Stiripentol', 'eu_mah_current': 'Biocodex', 'orphan_status': 'o', 'eu_aut_date': '12-05-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/030/01', 'ema_number_certainty': '1.0'}"
EU-3-01-072,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/072', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/072', 'active_substance': 'Apomorphine (oromucosal use)', 'eu_mah_current': 'Orion Corporation', 'orphan_status': 'o', 'eu_aut_date': '12-05-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/027/01', 'ema_number_certainty': '1.0'}"
EU-3-01-073,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/073', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/073', 'active_substance': 'Recombinant human monoclonal antibody to hsp90', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '12-05-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/014/01', 'ema_number_certainty': '1.0'}"
EU-3-01-074,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/074', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/074', 'active_substance': 'Halofuginone Hydrobromide', 'eu_mah_current': 'PPD Global Ltd', 'orphan_status': 'o', 'eu_aut_date': '12-11-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/032/01', 'ema_number_certainty': '1.0'}"
EU-3-01-076,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/076', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/076', 'active_substance': 'Octovalent Pseudomonas aeruginosa O-polysaccharie-toxin A conjugate vaccine', 'eu_mah_current': 'Orphan Europe S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '12-11-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/042/01', 'ema_number_certainty': '1.0'}"
EU-3-01-078,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/078', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/078', 'active_substance': 'Iduronate-2-sulfatase', 'eu_mah_current': 'Shire Human Genetic Therapies AB', 'orphan_status': 'o', 'eu_aut_date': '12-11-2001', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/056/01', 'ema_number_certainty': '1.0'}"
EU-3-01-080,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/080', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/080', 'active_substance': 'Human engineered monoclonal antibody specific for Transforming Growth Factor &#223;1', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-04-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/051/01', 'ema_number_certainty': '1.0'}"
EU-3-01-081,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/01/081', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/081', 'active_substance': 'Fumagillin', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'o', 'eu_aut_date': '02-04-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/029/01', 'ema_number_certainty': '1.0'}"
EU-3-01-082,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/082', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/082', 'active_substance': '2-chloro-9-[2-deoxy-2-fluoro-&#223;-D-arabinofuranosyl]adenine', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-05-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/046/01', 'ema_number_certainty': '1.0'}"
EU-3-01-084,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/01/084', 'status_type': 'w', 'eu_pnumber': 'EU/3/01/084', 'active_substance': 'Azacitidine', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-06-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/059/01', 'ema_number_certainty': '1.0'}"
EU-3-02-085,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/085', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/085', 'active_substance': 'Carmustine (solution for intratumoral injection)', 'eu_mah_current': 'ICON Clinical Research (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '03-05-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/067/01', 'ema_number_certainty': '1.0'}"
EU-3-02-086,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/086', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/086', 'active_substance': 'Porfimer sodium (for use with photodynamic therapy)', 'eu_mah_current': 'Pinnacle Biologics B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-06-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/065/01', 'ema_number_certainty': '1.0'}"
EU-3-02-087,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/087', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/087', 'active_substance': 'Eflornithine hydrochloride', 'eu_mah_current': 'ILEX Services Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/047/01', 'ema_number_certainty': '1.0'}"
EU-3-02-088,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/088', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/088', 'active_substance': 'Colistimethate sodium', 'eu_mah_current': 'Forest Laboratories UK Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-19-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/057/01', 'ema_number_certainty': '1.0'}"
EU-3-02-089,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/089', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/089', 'active_substance': 'GM-CSF receptor antagonist', 'eu_mah_current': 'British Biotech Pharmaceuticals Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-18-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/075/01', 'ema_number_certainty': '1.0'}"
EU-3-02-090,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/090', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/090', 'active_substance': 'Human transferrin conjugated to mutant diphtheria toxin', 'eu_mah_current': 'Xenova Biomedix Limited', 'orphan_status': 'o', 'eu_aut_date': '03-19-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/074/01', 'ema_number_certainty': '1.0'}"
EU-3-02-092,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/02/092', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/092', 'active_substance': '4-(3,5-bis-(hydroxy-phenyl)-1,2,4) triazol-1-yl)-benzoic acid', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '03-13-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/061/01', 'ema_number_certainty': '1.0'}"
EU-3-02-094,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/094', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/094', 'active_substance': 'Chimeric IgG monoclonal antibody cG250', 'eu_mah_current': 'Heidelberg Pharma AG', 'orphan_status': 'o', 'eu_aut_date': '03-19-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/052/01', 'ema_number_certainty': '1.0'}"
EU-3-02-095,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/095', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/095', 'active_substance': 'Iodine (131I) chimeric IgG monoclonal antibody cG250', 'eu_mah_current': 'Wilex AG', 'orphan_status': 'o', 'eu_aut_date': '03-19-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/053/01', 'ema_number_certainty': '1.0'}"
EU-3-02-096,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/096', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/096', 'active_substance': 'Nitisinone', 'eu_mah_current': 'Swedish Orphan Biovitrum AB (publ)', 'orphan_status': 'o', 'eu_aut_date': '03-13-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/071/01', 'ema_number_certainty': '1.0'}"
EU-3-02-097,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/097', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/097', 'active_substance': 'Humanized anti-KSA monoclonal antibody - human interleukin-2 fusion protein', 'eu_mah_current': 'Merck KGaA', 'orphan_status': 'o', 'eu_aut_date': '03-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/063/01', 'ema_number_certainty': '1.0'}"
EU-3-02-098,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/098', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/098', 'active_substance': 'Epothilone B', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '03-22-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/062/01', 'ema_number_certainty': '1.0'}"
EU-3-02-100,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/100', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/100', 'active_substance': 'Recombinant human alpha-1 antitrypsin', 'eu_mah_current': 'Aptiv Solutions (UK) Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-30-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/048/01', 'ema_number_certainty': '1.0'}"
EU-3-02-102,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/02/102', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/102', 'active_substance': 'Mitotane', 'eu_mah_current': 'Laboratoire HRA Pharma', 'orphan_status': 'o', 'eu_aut_date': '06-12-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/003/02', 'ema_number_certainty': '1.0'}"
EU-3-02-103,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/103', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/103', 'active_substance': 'Recombinant Human Porphobilinogen Deaminase', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '06-12-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/083/01', 'ema_number_certainty': '1.0'}"
EU-3-02-105,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/105', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/105', 'active_substance': 'Carbamic acid, [[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methyl-ethyl]phenoxy]methyl]phenyl]methoxy]-phenyl]iminomethyl]-,ethyl ester', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-26-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/009/02', 'ema_number_certainty': '1.0'}"
EU-3-02-108,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/108', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/108', 'active_substance': 'Myristoylated-peptidyl-recombinant SCR1-3 of human complement receptor type I', 'eu_mah_current': 'Orexo AB', 'orphan_status': 'o', 'eu_aut_date': '07-30-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/013/02', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-02-112,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/112', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/112', 'active_substance': 'Doxorubicin carbon / iron magnetically targeted microparticles', 'eu_mah_current': 'Interface International Consultancy Limited', 'orphan_status': 'o', 'eu_aut_date': '09-11-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/026/02', 'ema_number_certainty': '1.0'}"
EU-3-02-113,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/113', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/113', 'active_substance': 'Mitotane', 'eu_mah_current': 'Agence g&#233;n&#233;rale des &#233;quipements et produits de sant&#233; - Etablissement pharmaceutique des h&#244;pitaux de Paris (AGEPS-EPHP)', 'orphan_status': 'o', 'eu_aut_date': '09-11-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/023/02', 'ema_number_certainty': '1.0'}"
EU-3-02-114,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/114', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/114', 'active_substance': 'Myristoylated-peptidyl-recombinant Human CD59', 'eu_mah_current': 'Orexo AB', 'orphan_status': 'o', 'eu_aut_date': '09-11-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/016/02', 'ema_number_certainty': '1.0'}"
EU-3-02-117,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/117', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/117', 'active_substance': 'Boswellia serrata resin extract', 'eu_mah_current': 'Pharmasan GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-21-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/006/02', 'ema_number_certainty': '1.0'}"
EU-3-02-121,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/02/121', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/121', 'active_substance': '5-aminolevulinic acid hydrochloride', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'o', 'eu_aut_date': '11-13-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/039/02', 'ema_number_certainty': '1.0'}"
EU-3-02-119,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/119', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/119', 'active_substance': 'Iodine (131I) anti-nucleohistone H1 chimeric biotinylated monoclonal antibody', 'eu_mah_current': 'Clinical Network Services (UK) Ltd', 'orphan_status': 'o', 'eu_aut_date': '11-13-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/037/02', 'ema_number_certainty': '0.5'}"
EU-3-02-123,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/123', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/123', 'active_substance': 'anti-CD147 murine monoclonal IgM', 'eu_mah_current': 'SangStat UK Limited', 'orphan_status': 'o', 'eu_aut_date': '11-14-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/045/02', 'ema_number_certainty': '1.0'}"
EU-3-02-126,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/126', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/126', 'active_substance': 'Recombinant inhibitor of human plasma kallikrein', 'eu_mah_current': 'Dyax s.a.', 'orphan_status': 'o', 'eu_aut_date': '12-18-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/043/02', 'ema_number_certainty': '1.0'}"
EU-3-02-125,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/125', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/125', 'active_substance': 'Monoclonal antibody to human interleukin-6', 'eu_mah_current': 'EUSA Pharma SAS', 'orphan_status': 'o', 'eu_aut_date': '12-18-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/052/02', 'ema_number_certainty': '1.0'}"
EU-3-02-124,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/02/124', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/124', 'active_substance': '3,4-diaminopyridine phosphate', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '12-18-2002', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/050/02', 'ema_number_certainty': '0.75'}"
EU-3-02-131,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/02/131', 'status_type': 'w', 'eu_pnumber': 'EU/3/02/131', 'active_substance': 'Sodium oxybate', 'eu_mah_current': 'UCB Pharma Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-03-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/051/02', 'ema_number_certainty': '1.0'}"
EU-3-03-132,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/132', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/132', 'active_substance': 'Caffeine citrate', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '02-17-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/047/02', 'ema_number_certainty': '1.0'}"
EU-3-03-136,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/136', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/136', 'active_substance': 'Iodine (&#185;&#179;&#185;I) tositumomab', 'eu_mah_current': 'GlaxoSmithKline Research &amp; Development Limited', 'orphan_status': 'o', 'eu_aut_date': '02-14-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/061/02', 'ema_number_certainty': '1.0'}"
EU-3-03-137,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/137', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/137', 'active_substance': 'Tositumomab', 'eu_mah_current': 'GlaxoSmithKline Research &amp; Development Limited', 'orphan_status': 'o', 'eu_aut_date': '02-14-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/079/02', 'ema_number_certainty': '1.0'}"
EU-3-03-133,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/03/133', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/133', 'active_substance': 'Icatibant acetate', 'eu_mah_current': 'Shire Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-17-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/054/02', 'ema_number_certainty': '0.5'}"
EU-3-03-134,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/134', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/134', 'active_substance': 'Iodine (123I) Serum Amyloid P', 'eu_mah_current': 'Laboratoire fran&#231;ais du Fractionnement et des Biotechnologies (LFB) S.A.', 'orphan_status': 'o', 'eu_aut_date': '02-14-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/057/02', 'ema_number_certainty': '1.0'}"
EU-3-03-139,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/139', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/139', 'active_substance': 'bosentan', 'eu_mah_current': 'Actelion Registration Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-17-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/069/02', 'ema_number_certainty': '1.0'}"
EU-3-03-138,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/138', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/138', 'active_substance': 'a -1-acid glycoprotein', 'eu_mah_current': 'Bio Products Laboratory Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-20-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/058/02', 'ema_number_certainty': '1.0'}"
EU-3-03-141,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/141', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/141', 'active_substance': '2-chloro-9-[2-deoxy-2-fluoro-&#223;-D-arabinofuranosyl]adenine.', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-08-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/065/02', 'ema_number_certainty': '1.0'}"
EU-3-03-142,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/142', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/142', 'active_substance': 'Iodine (131I) anti-CEA sheep-human chimeric monoclonal antibody monoclonal antibody labeled with iodine-131', 'eu_mah_current': 'Xenova Biomedix Limited', 'orphan_status': 'o', 'eu_aut_date': '05-07-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/070/02', 'ema_number_certainty': '1.0'}"
EU-3-03-144,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/144', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/144', 'active_substance': 'Liarozole', 'eu_mah_current': 'Stiefel Laboratories (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-10-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/073/02', 'ema_number_certainty': '1.0'}"
EU-3-03-143,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/143', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/143', 'active_substance': '5-10-Methylene-tetrahydrofolate', 'eu_mah_current': 'Interface International Consultancy Limited', 'orphan_status': 'o', 'eu_aut_date': '06-11-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/076/02', 'ema_number_certainty': '1.0'}"
EU-3-03-147,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/147', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/147', 'active_substance': 'Amiloride hydrochloride dihydrate', 'eu_mah_current': 'Pulmo Tec GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-30-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/075/02', 'ema_number_certainty': '1.0'}"
EU-3-03-146,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/146', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/146', 'active_substance': 'Aldesleukin (inhalation use)', 'eu_mah_current': 'Chiron Corporation Ltd', 'orphan_status': 'o', 'eu_aut_date': '06-30-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/006/03', 'ema_number_certainty': '1.0'}"
EU-3-03-148,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/148', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/148', 'active_substance': 'Chimeric-anti-interleukin-6 monoclonal antibody', 'eu_mah_current': 'Janssen Biologics B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-30-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/002/03', 'ema_number_certainty': '1.0'}"
EU-3-03-158,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/158', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/158', 'active_substance': 'Recombinant human arylsulfatase A', 'eu_mah_current': 'Shire Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-09-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/024/03', 'ema_number_certainty': '1.0'}"
EU-3-03-159,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/159', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/159', 'active_substance': 'Recombinant human insulin-like growth factor-I / recombinant human insulin-like growth factor binding protein-3', 'eu_mah_current': 'Insmed Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '07-09-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/064/02', 'ema_number_certainty': '1.0'}"
EU-3-03-150,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/150', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/150', 'active_substance': 'Adenovirus-Interferon gamma  coding DNA sequence', 'eu_mah_current': 'Transgene S.A.', 'orphan_status': 'o', 'eu_aut_date': '07-09-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/007/03', 'ema_number_certainty': '1.0'}"
EU-3-03-151,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/151', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/151', 'active_substance': 'Aplidine', 'eu_mah_current': 'Pharma Mar S.A.', 'orphan_status': 'o', 'eu_aut_date': '07-09-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/022/03', 'ema_number_certainty': '1.0'}"
EU-3-03-154,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/03/154', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/154', 'active_substance': 'Hydroxyurea', 'eu_mah_current': 'Addmedica SAS', 'orphan_status': 'o', 'eu_aut_date': '07-09-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/013/03', 'ema_number_certainty': '1.0'}"
EU-3-03-155,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/155', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/155', 'active_substance': 'Murine anti-idiotypic antibody against OC125 antibody against CA125 antigen', 'eu_mah_current': 'Menarini Ricerche S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '07-09-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/016/03', 'ema_number_certainty': '1.0'}"
EU-3-03-152,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/152', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/152', 'active_substance': 'Engineered protein inhibitor of human neutrophil elastase', 'eu_mah_current': 'Debioclinic SA', 'orphan_status': 'o', 'eu_aut_date': '07-09-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/018/03', 'ema_number_certainty': '1.0'}"
EU-3-03-164,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/164', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/164', 'active_substance': 'a-1-acid glycoprotein', 'eu_mah_current': 'Bio Products Laboratory Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-02-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/027/03', 'ema_number_certainty': '1.0'}"
EU-3-03-165,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/165', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/165', 'active_substance': 'Nolatrexed', 'eu_mah_current': 'Scirex Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-02-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/032/03', 'ema_number_certainty': '1.0'}"
EU-3-03-170,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/170', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/170', 'active_substance': 'Human immunoglobulin', 'eu_mah_current': 'Orfagen', 'orphan_status': 'o', 'eu_aut_date': '10-24-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/039/03', 'ema_number_certainty': '1.0'}"
EU-3-03-172,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/172', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/172', 'active_substance': 'Trientine dihydrochloride', 'eu_mah_current': 'Univar BV', 'orphan_status': 'o', 'eu_aut_date': '10-24-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/043/03', 'ema_number_certainty': '1.0'}"
EU-3-03-171,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/03/171', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/171', 'active_substance': 'Trabectedin', 'eu_mah_current': 'Pharma Mar S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-17-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/044/03', 'ema_number_certainty': '1.0'}"
EU-3-03-166,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/03/166', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/166', 'active_substance': 'Eculizumab', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '10-17-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/042/03', 'ema_number_certainty': '1.0'}"
EU-3-03-168,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/168', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/168', 'active_substance': 'Herpes simplex 1 virus-thymidine kinase and truncated low affinity nerve growth factor receptor transfected donor lymphocytes', 'eu_mah_current': 'MolMed S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '10-20-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/041/03', 'ema_number_certainty': '1.0'}"
EU-3-03-169,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/169', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/169', 'active_substance': 'Human immunoglobulin', 'eu_mah_current': 'Orfagen', 'orphan_status': 'o', 'eu_aut_date': '10-20-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/038/03', 'ema_number_certainty': '1.0'}"
EU-3-03-167,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/167', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/167', 'active_substance': 'H-Tyrosine-Glycine-Phenylalanine-Glycine-Glycine-OH', 'eu_mah_current': 'Abiogen Pharma S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '10-20-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/035/03', 'ema_number_certainty': '1.0'}"
EU-3-03-175,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/175', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/175', 'active_substance': 'Recombinant antibody derivative against human CD19 and CD3', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-01-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/053/03', 'ema_number_certainty': '1.0'}"
EU-3-03-176,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/176', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/176', 'active_substance': 'Recombinant antibody derivative against human CD19 and CD3', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-01-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/054/03', 'ema_number_certainty': '1.0'}"
EU-3-03-181,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/181', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/181', 'active_substance': 'N-acetylsarcosyl-glycyl-L-valyl-D-allo-isoleucyl-L-threonyl-L-norvalyl-L-isoleucyl-L-arginyl-L-prolyl-N-ethylamide', 'eu_mah_current': 'Abbott International European Office', 'orphan_status': 'o', 'eu_aut_date': '12-12-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/059/03', 'ema_number_certainty': '1.0'}"
EU-3-03-180,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/180', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/180', 'active_substance': '4,5-dihydro-2-(2,4-dihydroxyphenyl)-4-methylthiazole-4(S)-carboxylic acid', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-12-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/060/03', 'ema_number_certainty': '1.0'}"
EU-3-03-179,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/179', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/179', 'active_substance': 'Recombinant human factor XIII (composed of two A subunits)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '12-12-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/052/03', 'ema_number_certainty': '1.0'}"
EU-3-03-177,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/03/177', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/177', 'active_substance': '3-(4&#39;aminoisoindoline-1&#39;-one)-1-piperidine-2,6-dione', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '12-12-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/063/03', 'ema_number_certainty': '1.0'}"
EU-3-03-185,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/185', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/185', 'active_substance': 'Tacrolimus hydrate', 'eu_mah_current': 'Sucampo Pharma Europa Ltd', 'orphan_status': 'o', 'eu_aut_date': '01-14-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/069/03', 'ema_number_certainty': '1.0'}"
EU-3-03-184,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/03/184', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/184', 'active_substance': 'Cilengitide', 'eu_mah_current': 'Merck KGaA', 'orphan_status': 'o', 'eu_aut_date': '01-14-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/067/03', 'ema_number_certainty': '1.0'}"
EU-3-03-178,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/03/178', 'status_type': 'w', 'eu_pnumber': 'EU/3/03/178', 'active_substance': 'Sildenafil citrate', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'o', 'eu_aut_date': '12-12-2003', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/056/03', 'ema_number_certainty': '1.0'}"
EU-3-04-187,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/187', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/187', 'active_substance': 'Human monoclonal hepatitis B immunoglobulins', 'eu_mah_current': 'ICON Clinical Research (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '02-23-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/074/03', 'ema_number_certainty': '1.0'}"
EU-3-04-190,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/190', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/190', 'active_substance': 'Ethanol (96 per cent ) (gel for injection)', 'eu_mah_current': 'Orfagen', 'orphan_status': 'o', 'eu_aut_date': '03-08-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/078/03', 'ema_number_certainty': '1.0'}"
EU-3-04-194,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/194', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/194', 'active_substance': 'Adeno-associated viral vector expressing lipoprotein lipase', 'eu_mah_current': 'uniQure Biopharma B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-08-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/079/03', 'ema_number_certainty': '1.0'}"
EU-3-04-192,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/192', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/192', 'active_substance': '3-(4&#39;aminoisoindoline-1&#39;-one)-1-piperidine-2,6-dione', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-08-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/083/03', 'ema_number_certainty': '1.0'}"
EU-3-04-191,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/191', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/191', 'active_substance': 'Ethanol (96 per cent ) (gel for injection)', 'eu_mah_current': 'Orfagen', 'orphan_status': 'o', 'eu_aut_date': '03-08-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/076/03', 'ema_number_certainty': '1.0'}"
EU-3-04-196,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/196', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/196', 'active_substance': 'Ciclosporin', 'eu_mah_current': 'Allergan Pharmaceuticals Ireland', 'orphan_status': 'o', 'eu_aut_date': '04-14-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/086/03', 'ema_number_certainty': '1.0'}"
EU-3-04-195,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/195', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/195', 'active_substance': '2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-phenol', 'eu_mah_current': 'Diamond Pharma Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '04-14-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/072/03', 'ema_number_certainty': '0.25'}"
EU-3-04-199,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/04/199', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/199', 'active_substance': 'Tetrahydrobiopterin', 'eu_mah_current': 'BioMarin International Limited', 'orphan_status': 'o', 'eu_aut_date': '06-08-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/077/03', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-04-200,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/200', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/200', 'active_substance': '((2-aminoethyl) carbamic acid (2R,5S,8S,11S,14R,17S,19aS)-11-(4-aminobutyl)-5-benzyl-8-(4-benzyloxy benzyl)-14-(1H-indol-3-ylmethyl)-4,7,10,13,16,19-hexaoxo-17-phenyloctadecahydro-3a,6,9,12,15,18-hexaazacyclopentacyclooctadecen-2-yl ester, di[(S)-2-aminosuccinic acid] salt', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '06-08-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/005/04', 'ema_number_certainty': '1.0'}"
EU-3-04-205,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/205', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/205', 'active_substance': 'Suberoylanilide hydroxamic acid', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'o', 'eu_aut_date': '06-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/003/04', 'ema_number_certainty': '1.0'}"
EU-3-04-204,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/04/204', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/204', 'active_substance': 'Aztreonam lysinate (inhalation use)', 'eu_mah_current': 'Gilead Sciences Ireland UC', 'orphan_status': 'o', 'eu_aut_date': '06-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/006/04', 'ema_number_certainty': '1.0'}"
EU-3-04-203,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/203', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/203', 'active_substance': '5-CTG CCA CGT TCT CCT GC-(2 methoxy)A-(2 methoxy)C-(2 methoxy)C-3', 'eu_mah_current': 'PPD Global Ltd', 'orphan_status': 'o', 'eu_aut_date': '06-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/008/04', 'ema_number_certainty': '1.0'}"
EU-3-04-206,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/04/206', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/206', 'active_substance': 'Muramyl tripeptide phosphatidyl ethanolamine', 'eu_mah_current': 'Takeda France SAS', 'orphan_status': 'o', 'eu_aut_date': '06-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/013/04', 'ema_number_certainty': '1.0'}"
EU-3-04-218,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/218', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/218', 'active_substance': '(R, S)-3-(bromomethyl)-3-butanol-1-yl-diphosphate', 'eu_mah_current': 'Innate Pharma SAS', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/030/04', 'ema_number_certainty': '1.0'}"
EU-3-04-215,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/215', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/215', 'active_substance': 'Porfimer sodium (for use with photodynamic therapy)', 'eu_mah_current': 'Pinnacle Biologics B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/024/04', 'ema_number_certainty': '1.0'}"
EU-3-04-213,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/213', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/213', 'active_substance': 'Mepolizumab', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/027/04', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-04-207,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/04/207', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/207', 'active_substance': 'Sorafenib tosylate', 'eu_mah_current': 'Bayer Pharma AG', 'orphan_status': 'o', 'eu_aut_date': '07-29-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/032/04', 'ema_number_certainty': '1.0'}"
EU-3-04-223,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/223', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/223', 'active_substance': 'Heparin sodium', 'eu_mah_current': 'Prof. Dr Seeger', 'orphan_status': 'o', 'eu_aut_date': '09-02-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/033/04', 'ema_number_certainty': '1.0'}"
EU-3-04-224,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/224', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/224', 'active_substance': 'Homoharringtonine', 'eu_mah_current': 'Teva Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-02-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/041/04', 'ema_number_certainty': '1.0'}"
EU-3-04-221,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/221', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/221', 'active_substance': '5,10-methylene-tetrahydrofolic acid', 'eu_mah_current': 'Interface International Consultancy Limited', 'orphan_status': 'o', 'eu_aut_date': '09-02-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/036/04', 'ema_number_certainty': '1.0'}"
EU-3-04-225,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/225', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/225', 'active_substance': 'Sodium dichloroacetate', 'eu_mah_current': 'Dr Anthony W. Fox', 'orphan_status': 'o', 'eu_aut_date': '09-02-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/066/03', 'ema_number_certainty': '1.0'}"
EU-3-04-226,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/226', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/226', 'active_substance': 'Recombinant human interleukin-21', 'eu_mah_current': 'Bristol-Myers Squibb International Corporation', 'orphan_status': 'o', 'eu_aut_date': '09-02-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/035/04', 'ema_number_certainty': '1.0'}"
EU-3-04-227,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/04/227', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/227', 'active_substance': 'l, 1&#180;-[1,4-phenylenebis (methylene)]-bis-1,4,8,11- tetraazacyclotetradecane', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/045/04', 'ema_number_certainty': '1.0'}"
EU-3-04-228,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/228', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/228', 'active_substance': 'Homoharringtonine', 'eu_mah_current': 'Teva Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/051/04', 'ema_number_certainty': '1.0'}"
EU-3-04-235,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/235', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/235', 'active_substance': 'Recombinant human insulin-like growth factor-I / recombinant human insulin-like growth factor binding protein-3', 'eu_mah_current': 'Insmed Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/071/04', 'ema_number_certainty': '1.0'}"
EU-3-04-236,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/236', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/236', 'active_substance': 'Recombinant human insulin-like growth factor-I / recombinant human insulin-like growth factor binding protein-3', 'eu_mah_current': 'Insmed Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/029/04', 'ema_number_certainty': '1.0'}"
EU-3-04-231,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/231', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/231', 'active_substance': 'Deferoxamine mesilate', 'eu_mah_current': 'SCT Spinal Cord Therapeutics GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/014/04', 'ema_number_certainty': '1.0'}"
EU-3-04-237,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/237', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/237', 'active_substance': 'Recombinant human insulin-like growth factor-I / recombinant human insulin-like growth factor binding protein-3', 'eu_mah_current': 'Insmed Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/073/04', 'ema_number_certainty': '1.0'}"
EU-3-04-238,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/238', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/238', 'active_substance': 'Recombinant human insulin-like growth factor-I / recombinant human insulin-like growth factor binding protein-3', 'eu_mah_current': 'Insmed Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/072/04', 'ema_number_certainty': '1.0'}"
EU-3-04-239,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/239', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/239', 'active_substance': 'Deuterium oxide', 'eu_mah_current': 'BDD Berolina Drug Development GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/040/04', 'ema_number_certainty': '1.0'}"
EU-3-04-240,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/04/240', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/240', 'active_substance': 'Rufinamide', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-20-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/047/04', 'ema_number_certainty': '0.5'}"
EU-3-04-229,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/229', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/229', 'active_substance': 'Doxorubicin polyisohexylcyanoacrylate nanoparticles', 'eu_mah_current': 'Onxeo', 'orphan_status': 'o', 'eu_aut_date': '10-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/048/04', 'ema_number_certainty': '1.0'}"
EU-3-04-233,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/233', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/233', 'active_substance': 'Adeno-associated viral vector containing the human gamma-sarcoglycan gene', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '10-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/049/04', 'ema_number_certainty': '1.0'}"
EU-3-04-234,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/234', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/234', 'active_substance': 'Sitaxentan sodium', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'o', 'eu_aut_date': '10-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/031/04', 'ema_number_certainty': '1.0'}"
EU-3-04-241,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/04/241', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/241', 'active_substance': 'Pirfenidone', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-16-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/052/04', 'ema_number_certainty': '0.8333333333333334'}"
EU-3-04-246,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/246', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/246', 'active_substance': 'Valproic acid, sodium', 'eu_mah_current': 'TopoTarget Germany AG', 'orphan_status': 'o', 'eu_aut_date': '11-30-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/055/04', 'ema_number_certainty': '1.0'}"
EU-3-04-255,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/255', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/255', 'active_substance': 'Sabarubicin', 'eu_mah_current': 'Menarini Ricerche S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '12-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/056/04', 'ema_number_certainty': '1.0'}"
EU-3-04-247,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/247', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/247', 'active_substance': '17-allylamino-17-demethoxygeldanamycin', 'eu_mah_current': 'Bristol-Myers Squibb International Corporation', 'orphan_status': 'o', 'eu_aut_date': '12-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/070/04', 'ema_number_certainty': '1.0'}"
EU-3-04-253,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/253', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/253', 'active_substance': 'Val-Leu-Gln-Glu-Leu-Asn-Val-Thr-Val (Pr1 nanopeptide, sequence 169-177, of proteinase 3)', 'eu_mah_current': 'Accelsiors CRO &amp; Consultancy Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/059/04', 'ema_number_certainty': '1.0'}"
EU-3-04-254,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/254', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/254', 'active_substance': 'Val-Leu-Gln-Glu-Leu-Asn-Val-Thr-Val (Pr1 nanopeptide, sequence 169-177, of proteinase 3)', 'eu_mah_current': 'Accelsiors CRO &amp; Consultancy Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/058/04', 'ema_number_certainty': '1.0'}"
EU-3-04-252,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/252', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/252', 'active_substance': 'Val-Leu-Gln-Glu-Leu-Asn-Val-Thr-Val (Pr1 nanopeptide, sequence 169-177, of proteinase 3)', 'eu_mah_current': 'Accelsiors CRO &amp; Consultancy Services GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-21-2004', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/060/04', 'ema_number_certainty': '1.0'}"
EU-3-04-256,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/256', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/256', 'active_substance': '17-allylamino-17-demethoxygeldanamycin', 'eu_mah_current': 'Bristol-Myers Squibb International Corporation', 'orphan_status': 'o', 'eu_aut_date': '01-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/079/04', 'ema_number_certainty': '1.0'}"
EU-3-04-258,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/258', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/258', 'active_substance': 'L-Asparaginase', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'o', 'eu_aut_date': '01-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/063/04', 'ema_number_certainty': '1.0'}"
EU-3-04-257,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/257', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/257', 'active_substance': 'Recombinant human bile salt-stimulated lipase', 'eu_mah_current': 'Arexis AB', 'orphan_status': 'o', 'eu_aut_date': '01-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/023/04', 'ema_number_certainty': '1.0'}"
EU-3-04-259,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/04/259', 'status_type': 'w', 'eu_pnumber': 'EU/3/04/259', 'active_substance': 'Acetylcysteine', 'eu_mah_current': 'Zambon S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '01-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/075/04', 'ema_number_certainty': '1.0'}"
EU-3-05-262,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/262', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/262', 'active_substance': 'Titanium dioxide and bisoctrizole', 'eu_mah_current': 'Orfagen', 'orphan_status': 'o', 'eu_aut_date': '03-03-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/068/04', 'ema_number_certainty': '1.0'}"
EU-3-05-264,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/264', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/264', 'active_substance': 'Cholest-4-en-3-one, oxime', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-10-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/081/04', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-05-267,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/267', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/267', 'active_substance': '(Z)-N-[2-(Diethylamino)ethyl]-5-[(5-fluoro-2-oxo-1,2-dihydro-3Hindol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (S)-2-hydroxysuccinate', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'o', 'eu_aut_date': '03-10-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/084/04', 'ema_number_certainty': '1.0'}"
EU-3-05-266,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/266', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/266', 'active_substance': 'Ciclosporin (inhalation use)', 'eu_mah_current': 'Right Track Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '03-10-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/089/04', 'ema_number_certainty': '1.0'}"
EU-3-05-268,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/268', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/268', 'active_substance': '(Z)-N-[2-(Diethylamino)ethyl]-5-[(5-fluoro-2-oxo-1,2-dihydro-3Hindol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (S)-2-hydroxysuccinate', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'o', 'eu_aut_date': '03-10-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/083/04', 'ema_number_certainty': '1.0'}"
EU-3-05-265,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/265', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/265', 'active_substance': 'Ciclosporin (inhalation use)', 'eu_mah_current': 'Right Track Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '03-10-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/090/04', 'ema_number_certainty': '1.0'}"
EU-3-05-271,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/271', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/271', 'active_substance': 'Paromomycin sulphate', 'eu_mah_current': 'Sestria Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-11-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/086/04', 'ema_number_certainty': '1.0'}"
EU-3-05-273,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/05/273', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/273', 'active_substance': 'Ambrisentan', 'eu_mah_current': 'Glaxo Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-11-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/103/04', 'ema_number_certainty': '1.0'}"
EU-3-05-272,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/05/272', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/272', 'active_substance': 'Histamine dihydrochloride', 'eu_mah_current': 'Noventia Pharma Srl', 'orphan_status': 'o', 'eu_aut_date': '04-11-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/094/04', 'ema_number_certainty': '1.0'}"
EU-3-05-274,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/274', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/274', 'active_substance': 'Melatonin', 'eu_mah_current': 'ICON Clinical Research (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '04-11-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/101/04', 'ema_number_certainty': '1.0'}"
EU-3-05-277,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/277', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/277', 'active_substance': '(3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '05-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/107/04', 'ema_number_certainty': '0.75'}"
EU-3-05-281,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/281', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/281', 'active_substance': 'Interferon gamma', 'eu_mah_current': 'InterMune Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '05-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/002/05', 'ema_number_certainty': '1.0'}"
EU-3-05-283,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/05/283', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/283', 'active_substance': 'Recombinant megakaryopoeisis-stimulating protein', 'eu_mah_current': 'Amgen Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/008/05', 'ema_number_certainty': '1.0'}"
EU-3-05-291,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/291', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/291', 'active_substance': 'Human monoclonal antibody against HLA-DR', 'eu_mah_current': 'GPC Biotech AG', 'orphan_status': 'o', 'eu_aut_date': '06-16-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/016/05', 'ema_number_certainty': '1.0'}"
EU-3-05-293,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/05/293', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/293', 'active_substance': 'nelarabine', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '06-16-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/013/05', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-05-298,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/298', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/298', 'active_substance': 'Mifepristone', 'eu_mah_current': 'Laboratoire HRA Pharma', 'orphan_status': 'o', 'eu_aut_date': '07-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/022/05', 'ema_number_certainty': '1.0'}"
EU-3-05-296,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/296', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/296', 'active_substance': 'Hydrocortisone', 'eu_mah_current': 'Diurnal Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-27-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/020/05', 'ema_number_certainty': '0.75'}"
EU-3-05-316,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/316', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/316', 'active_substance': '2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide', 'eu_mah_current': 'Actelion Registration Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/043/05', 'ema_number_certainty': '1.0'}"
EU-3-05-303,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/303', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/303', 'active_substance': 'Human autologous mesenchymal adult stem cells extracted from adipose tissue', 'eu_mah_current': 'Tigenix S.A.', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/021/05', 'ema_number_certainty': '1.0'}"
EU-3-05-304,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/304', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/304', 'active_substance': 'Imatinib mesilate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/038/05', 'ema_number_certainty': '1.0'}"
EU-3-05-305,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/305', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/305', 'active_substance': 'Imatinib mesilate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/039/05', 'ema_number_certainty': '1.0'}"
EU-3-05-306,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/306', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/306', 'active_substance': 'Imatinib mesilate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/042/05', 'ema_number_certainty': '1.0'}"
EU-3-05-308,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/308', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/308', 'active_substance': 'Sapropterin', 'eu_mah_current': 'Dr Gunter Schaub', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/032/05', 'ema_number_certainty': '1.0'}"
EU-3-05-309,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/309', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/309', 'active_substance': 'Sodium valproate', 'eu_mah_current': 'The Jennifer Trust for Spinal Muscular Atrophy', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/047/05', 'ema_number_certainty': '1.0'}"
EU-3-05-311,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/311', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/311', 'active_substance': 'Troxacitabine', 'eu_mah_current': 'Pharm Research Associates (UK) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/045/05', 'ema_number_certainty': '1.0'}"
EU-3-05-312,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/312', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/312', 'active_substance': '(1R, 2R, 4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R, 27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetra-cosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxy-cyclohexyldimethyl-phosphinate', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'o', 'eu_aut_date': '08-26-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/050/05', 'ema_number_certainty': '1.0'}"
EU-3-05-321,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/321', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/321', 'active_substance': '(1R, 2R, 4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R, 27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetra-cosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxy-cyclohexyldimethyl-phosphinate', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/055/05', 'ema_number_certainty': '1.0'}"
EU-3-05-322,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/322', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/322', 'active_substance': 'Alfimeprase', 'eu_mah_current': 'Quadramed Limited', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/060/05', 'ema_number_certainty': '1.0'}"
EU-3-05-325,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/05/325', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/325', 'active_substance': 'Mannitolum', 'eu_mah_current': 'Pharmaxis Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-07-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/062/05', 'ema_number_certainty': '0.6'}"
EU-3-05-330,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/330', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/330', 'active_substance': 'Tilarginine acetate', 'eu_mah_current': 'Dr Ulrich Granzer', 'orphan_status': 'o', 'eu_aut_date': '10-18-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/036/05', 'ema_number_certainty': '1.0'}"
EU-3-05-331,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/331', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/331', 'active_substance': 'Recombinant microbial lipase', 'eu_mah_current': 'Abbott Products GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/061/05', 'ema_number_certainty': '1.0'}"
EU-3-05-318,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/318', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/318', 'active_substance': 'Recombinant modified vaccinia virus Ankara expressing tuberculosis antigen 85A', 'eu_mah_current': 'University of Oxford', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/029/05', 'ema_number_certainty': '1.0'}"
EU-3-05-320,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/320', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/320', 'active_substance': 'Imatinib mesilate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '10-28-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/040/05', 'ema_number_certainty': '1.0'}"
EU-3-05-333,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/333', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/333', 'active_substance': 'Eptacog alfa (activated)', 'eu_mah_current': 'Savara ApS', 'orphan_status': 'o', 'eu_aut_date': '12-14-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/063/05', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-05-335,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/335', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/335', 'active_substance': 'Human Staphylococcus aureus polyclonal immunoglobulin and human Staphylococcus epidermidis polyclonal immunoglobulin', 'eu_mah_current': 'Omnicare Clinical Research', 'orphan_status': 'o', 'eu_aut_date': '12-14-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/059/05', 'ema_number_certainty': '1.0'}"
EU-3-05-338,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/05/338', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/338', 'active_substance': 'Dasatinib', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '12-23-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/074/05', 'ema_number_certainty': '1.0'}"
EU-3-05-342,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/342', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/342', 'active_substance': 'Denufosol tetrasodium', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'o', 'eu_aut_date': '12-23-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/072/05', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-05-340,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/340', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/340', 'active_substance': 'Imatinib mesilate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '12-23-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/067/05', 'ema_number_certainty': '1.0'}"
EU-3-05-336,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/336', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/336', 'active_substance': 'Brostallicin', 'eu_mah_current': 'Nuvisan Oncology SA', 'orphan_status': 'o', 'eu_aut_date': '12-23-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/071/05', 'ema_number_certainty': '1.0'}"
EU-3-05-337,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/337', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/337', 'active_substance': 'Heparin sodium (inhalation use)', 'eu_mah_current': 'Vectura Group plc', 'orphan_status': 'o', 'eu_aut_date': '12-23-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/054/05', 'ema_number_certainty': '1.0'}"
EU-3-05-339,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/05/339', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/339', 'active_substance': 'Dasatinib', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '12-23-2005', 'eu_aut_type_initial': 'pre_2006', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/075/05', 'ema_number_certainty': '1.0'}"
EU-3-05-348,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/348', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/348', 'active_substance': 'Purified inactivated Japanese encephalitis SA14-4-2 virus vaccine', 'eu_mah_current': 'Intercell AG', 'orphan_status': 'o', 'eu_aut_date': '01-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/083/05', 'ema_number_certainty': '1.0'}"
EU-3-05-345,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/345', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/345', 'active_substance': 'Lentiviral vector containing the human Wiskott Aldrich syndrome protein gene', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '01-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/087/05', 'ema_number_certainty': '1.0'}"
EU-3-05-344,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/344', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/344', 'active_substance': 'vandetanib', 'eu_mah_current': 'AstraZeneca UK Limited', 'orphan_status': 'o', 'eu_aut_date': '01-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/089/05', 'ema_number_certainty': '1.0'}"
EU-3-05-347,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/05/347', 'status_type': 'w', 'eu_pnumber': 'EU/3/05/347', 'active_substance': 'Human monoclonal antibody against HLA-DR', 'eu_mah_current': 'GPC Biotech AG', 'orphan_status': 'o', 'eu_aut_date': '01-24-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/082/05', 'ema_number_certainty': '1.0'}"
EU-3-06-350,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/350', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/350', 'active_substance': 'Alpha-1 proteinase inhibitor', 'eu_mah_current': 'Octapharma (IP) Limited', 'orphan_status': 'o', 'eu_aut_date': '02-16-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/092/05', 'ema_number_certainty': '1.0'}"
EU-3-06-351,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/06/351', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/351', 'active_substance': 'Miglustat', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '02-16-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/090/05', 'ema_number_certainty': '0.5'}"
EU-3-06-352,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/352', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/352', 'active_substance': '26 base single stranded phosphodiester DNA oligonucleotide', 'eu_mah_current': 'Antisoma Research Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-16-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/097/05', 'ema_number_certainty': '1.0'}"
EU-3-06-357,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/357', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/357', 'active_substance': '2-O-methyl-phosphorothioate oligonucleotide', 'eu_mah_current': 'Prosensa B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-16-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/096/05', 'ema_number_certainty': '1.0'}"
EU-3-06-353,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/353', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/353', 'active_substance': '26 base single stranded phosphodiester DNA oligonucleotide', 'eu_mah_current': 'Antisoma Research Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-16-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/098/05', 'ema_number_certainty': '1.0'}"
EU-3-06-358,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/358', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/358', 'active_substance': 'Human monoclonal antibody against HLA-DR', 'eu_mah_current': 'GPC Biotech AG', 'orphan_status': 'o', 'eu_aut_date': '02-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/093/05', 'ema_number_certainty': '1.0'}"
EU-3-06-365,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/06/365', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/365', 'active_substance': 'Temsirolimus', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'o', 'eu_aut_date': '04-06-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/103/05', 'ema_number_certainty': '1.0'}"
EU-3-06-366,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/366', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/366', 'active_substance': 'Tobramycin (liposomal)', 'eu_mah_current': 'Axentis Pharma Limited', 'orphan_status': 'o', 'eu_aut_date': '04-11-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/112/05', 'ema_number_certainty': '1.0'}"
EU-3-06-359,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/359', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/359', 'active_substance': 'Adeno associated viral vector containing the human calpain 3 gene', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '04-06-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/115/05', 'ema_number_certainty': '1.0'}"
EU-3-06-364,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/06/364', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/364', 'active_substance': 'Sorafenib tosylate', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '04-11-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/109/05', 'ema_number_certainty': '1.0'}"
EU-3-06-361,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/361', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/361', 'active_substance': 'Glutathione', 'eu_mah_current': 'Mukoviszidose e.V.', 'orphan_status': 'o', 'eu_aut_date': '04-11-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/118/05', 'ema_number_certainty': '1.0'}"
EU-3-06-372,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/06/372', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/372', 'active_substance': 'Hydrocortisone (modified release tablet)', 'eu_mah_current': 'Shire Services BVBA', 'orphan_status': 'o', 'eu_aut_date': '05-22-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/108/05', 'ema_number_certainty': '1.0'}"
EU-3-06-375,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/375', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/375', 'active_substance': 'Nilotinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '05-22-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/003/06', 'ema_number_certainty': '0.5'}"
EU-3-06-373,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/06/373', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/373', 'active_substance': 'Mecasermin', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'o', 'eu_aut_date': '05-22-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/104/05', 'ema_number_certainty': '1.0'}"
EU-3-06-377,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/377', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/377', 'active_substance': 'Mecasermin rinfabate', 'eu_mah_current': 'Insmed Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '06-20-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/028/06', 'ema_number_certainty': '1.0'}"
EU-3-06-378,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/378', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/378', 'active_substance': 'Mecasermin rinfabate', 'eu_mah_current': 'Insmed Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '06-20-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/029/06', 'ema_number_certainty': '1.0'}"
EU-3-06-382,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/382', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/382', 'active_substance': 'Pazopanib hydrochloride', 'eu_mah_current': 'Glaxo Group Limited', 'orphan_status': 'o', 'eu_aut_date': '06-29-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/013/06', 'ema_number_certainty': '1.0'}"
EU-3-06-383,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/383', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/383', 'active_substance': 'Siplizumab', 'eu_mah_current': 'MedImmune, LLC', 'orphan_status': 'o', 'eu_aut_date': '06-29-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/012/06', 'ema_number_certainty': '1.0'}"
EU-3-06-379,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/379', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/379', 'active_substance': 'Diphenylcyclopropenone', 'eu_mah_current': 'Orfagen', 'orphan_status': 'o', 'eu_aut_date': '06-29-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/002/06', 'ema_number_certainty': '1.0'}"
EU-3-06-380,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/380', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/380', 'active_substance': 'Diphenylcyclopropenone', 'eu_mah_current': 'Orfagen', 'orphan_status': 'o', 'eu_aut_date': '06-29-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/010/06', 'ema_number_certainty': '1.0'}"
EU-3-06-389,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/389', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/389', 'active_substance': 'Lestaurtinib', 'eu_mah_current': 'Teva Sant&#233;', 'orphan_status': 'o', 'eu_aut_date': '07-25-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/020/06', 'ema_number_certainty': '1.0'}"
EU-3-06-385,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/385', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/385', 'active_substance': '2-(4-(diethylamino) phenyl)-6-methyl-2H-benzo[d][1,2,3] triazol-5-amine', 'eu_mah_current': 'Vastox plc.', 'orphan_status': 'o', 'eu_aut_date': '07-25-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/025/06', 'ema_number_certainty': '1.0'}"
EU-3-06-388,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/388', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/388', 'active_substance': 'Becatecarin', 'eu_mah_current': 'Helsinn Birex Pharmaceuticals Ltd', 'orphan_status': 'o', 'eu_aut_date': '07-25-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/023/06', 'ema_number_certainty': '1.0'}"
EU-3-06-397,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/397', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/397', 'active_substance': 'Cholest-4-en-3-one, oxime', 'eu_mah_current': 'Trophos SA', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/030/06', 'ema_number_certainty': '1.0'}"
EU-3-06-398,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/398', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/398', 'active_substance': 'H-Val-Ile-Val-Lys-Leu-Ile-Pro-Ser-Thr-Ser-Ser-Ala-Val-Asp-Thr-Pro-Tyr-Leu-Asp-Ile-Thr-Tyr-His-Phe-Val-Ala-Gln-Arg-Leu-Pro-Leu-OH', 'eu_mah_current': 'Debioclinic SA', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/036/06', 'ema_number_certainty': '1.0'}"
EU-3-06-401,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/06/401', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/401', 'active_substance': 'N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium; 2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate', 'eu_mah_current': 'Pfizer Specialty UK Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/032/06', 'ema_number_certainty': '0.8'}"
EU-3-06-402,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/402', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/402', 'active_substance': 'Opebacan', 'eu_mah_current': 'XOMA Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/101/05', 'ema_number_certainty': '1.0'}"
EU-3-06-391,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/391', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/391', 'active_substance': 'Amphotericin B (for inhalation use)', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/027/06', 'ema_number_certainty': '0.8'}"
EU-3-06-392,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/392', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/392', 'active_substance': 'Human monoclonal antibody against inhibitory killer cell lg-like receptors', 'eu_mah_current': 'Innate Pharma', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/018/06', 'ema_number_certainty': '1.0'}"
EU-3-06-393,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/393', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/393', 'active_substance': 'Autologous CD34+ cells transfected with retroviral vector containing the human gp91(phox) gene', 'eu_mah_current': 'Vision 7 GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-28-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/017/06', 'ema_number_certainty': '1.0'}"
EU-3-06-403,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/403', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/403', 'active_substance': '5-(2,6-Difluoro-phenoxy)-3(R,S)-{2(S)-[2(S)-(3-methoxycarbonyl-2(S)-{3-methyl-2(S)-[(quinoline-2-carbonyl)-amino]-butyrylamino}-propionylamino)-3-methyl-butyrylamino]-propionylamino}-4-oxo-pentanoic acid methyl ester', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '10-23-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/055/06', 'ema_number_certainty': '1.0'}"
EU-3-06-406,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/406', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/406', 'active_substance': 'Arimoclomol', 'eu_mah_current': 'Orphazyme A/S', 'orphan_status': 'o', 'eu_aut_date': '10-26-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/053/06', 'ema_number_certainty': '1.0'}"
EU-3-06-418,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/418', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/418', 'active_substance': 'Iodine (131I) anti-tenascin monoclonal antibody 81C6', 'eu_mah_current': 'Biological Consulting Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-30-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/050/06', 'ema_number_certainty': '1.0'}"
EU-3-06-415,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/415', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/415', 'active_substance': 'Ciclosporin (implant)', 'eu_mah_current': 'Lux Biosciences GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-03-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/062/06', 'ema_number_certainty': '1.0'}"
EU-3-06-420,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/06/420', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/420', 'active_substance': 'Temsirolimus', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '11-06-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/058/06', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-06-423,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/423', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/423', 'active_substance': 'Tazarotene', 'eu_mah_current': 'Orfagen', 'orphan_status': 'o', 'eu_aut_date': '12-18-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/073/06', 'ema_number_certainty': '1.0'}"
EU-3-06-422,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/422', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/422', 'active_substance': 'Paclitaxel (micellar)', 'eu_mah_current': 'Oasmia Pharmaceutical AB', 'orphan_status': 'o', 'eu_aut_date': '12-18-2006', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/061/06', 'ema_number_certainty': '1.0'}"
EU-3-06-424,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/06/424', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/424', 'active_substance': 'Thiotepa', 'eu_mah_current': 'ADIENNE S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '01-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/060/06', 'ema_number_certainty': '1.0'}"
EU-3-06-427,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/427', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/427', 'active_substance': 'Fenretinide', 'eu_mah_current': 'Cancer Research UK', 'orphan_status': 'o', 'eu_aut_date': '01-30-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/083/06', 'ema_number_certainty': '1.0'}"
EU-3-06-426,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/426', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/426', 'active_substance': 'Fenretinide', 'eu_mah_current': 'Cancer Research UK', 'orphan_status': 'o', 'eu_aut_date': '01-26-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/082/06', 'ema_number_certainty': '1.0'}"
EU-3-06-425,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/06/425', 'status_type': 'w', 'eu_pnumber': 'EU/3/06/425', 'active_substance': 'Complement factor H', 'eu_mah_current': 'Laboratoire fran&#231;ais du Fractionnement et des Biotechnologies (LFB) S.A.', 'orphan_status': 'o', 'eu_aut_date': '01-26-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/080/06', 'ema_number_certainty': '1.0'}"
EU-3-07-433,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/433', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/433', 'active_substance': 'HLA class I/II binding tumour associated peptides (ADF-APO-CCN-GUC-K67-MET- MMP-MUC-RGS)', 'eu_mah_current': 'Immatics Biotechnologies GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-15-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/059/06', 'ema_number_certainty': '1.0'}"
EU-3-07-436,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/436', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/436', 'active_substance': 'Eptacog alfa (activated)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '03-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/089/06', 'ema_number_certainty': '1.0'}"
EU-3-07-439,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/439', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/439', 'active_substance': 'Recombinant human monoclonal antibody to human IL-1beta of the IgG1/K class', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '03-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/071/06', 'ema_number_certainty': '1.0'}"
EU-3-07-447,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/447', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/447', 'active_substance': 'Nilotinib hydrochloride monohydrate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '04-13-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/093/06', 'ema_number_certainty': '1.0'}"
EU-3-07-450,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/450', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/450', 'active_substance': '5(S)-(2&#180;-hydroxy ethoxy)-20(S)- camptothecin', 'eu_mah_current': 'Dr Reddy&#39;s Laboratories (UK) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-08-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/004/07', 'ema_number_certainty': '1.0'}"
EU-3-07-449,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/449', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/449', 'active_substance': 'everolimus', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '06-05-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/005/07', 'ema_number_certainty': '1.0'}"
EU-3-07-454,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/454', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/454', 'active_substance': 'Recombinant adeno-associated viral vector containing human acid alpha-glucosidase-gene', 'eu_mah_current': 'TMC Pharma Services Ltd', 'orphan_status': 'o', 'eu_aut_date': '07-09-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/001/07', 'ema_number_certainty': '1.0'}"
EU-3-07-456,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/456', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/456', 'active_substance': 'Rilonacept', 'eu_mah_current': 'Regeneron UK Limited', 'orphan_status': 'o', 'eu_aut_date': '07-10-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/016/07', 'ema_number_certainty': '1.0'}"
EU-3-07-457,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/457', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/457', 'active_substance': 'Lusupultide', 'eu_mah_current': 'Nycomed GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-10-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/009/06', 'ema_number_certainty': '0.5'}"
EU-3-07-458,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/458', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/458', 'active_substance': 'fampridine', 'eu_mah_current': 'Dr Ulrich Granzer', 'orphan_status': 'o', 'eu_aut_date': '07-10-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/101/06', 'ema_number_certainty': '1.0'}"
EU-3-07-468,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/468', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/468', 'active_substance': 'Dihydroartemisinin, piperaquine', 'eu_mah_current': 'Sigma-Tau Industrie Farmaceutiche Riunite S.p.A', 'orphan_status': 'o', 'eu_aut_date': '08-03-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/019/07', 'ema_number_certainty': '1.0'}"
EU-3-07-469,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/469', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/469', 'active_substance': 'Ciprofloxacin (inhalation use)', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '08-03-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/092/06', 'ema_number_certainty': '1.0'}"
EU-3-07-464,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/464', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/464', 'active_substance': 'Panobinostat lactate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-02-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/015/07', 'ema_number_certainty': '1.0'}"
EU-3-07-465,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/465', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/465', 'active_substance': 'L-threo-3,4-dihydroxyphenylserine', 'eu_mah_current': 'H. Lundbeck A/S', 'orphan_status': 'o', 'eu_aut_date': '08-02-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/026/07', 'ema_number_certainty': '0.75'}"
EU-3-07-462,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/462', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/462', 'active_substance': 'Recombinant human soluble Fc-gamma receptor IIb', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-02-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/028/07', 'ema_number_certainty': '0.5'}"
EU-3-07-466,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/466', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/466', 'active_substance': 'L-threo-3,4-dihydroxyphenylserine', 'eu_mah_current': 'H. Lundbeck A/S', 'orphan_status': 'o', 'eu_aut_date': '08-02-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/025/07', 'ema_number_certainty': '0.75'}"
EU-3-07-467,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/467', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/467', 'active_substance': 'Eltrombopag olamine', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'o', 'eu_aut_date': '08-03-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/031/07', 'ema_number_certainty': '1.0'}"
EU-3-07-460,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/460', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/460', 'active_substance': 'Arsenic trioxide', 'eu_mah_current': 'Cephalon Europe', 'orphan_status': 'o', 'eu_aut_date': '08-02-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/024/07', 'ema_number_certainty': '1.0'}"
EU-3-07-472,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/472', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/472', 'active_substance': 'Cyclo{{(E,Z)-(2s,3r,4r)-3-Hydroxy-4-Methyl-2-(Methylamino)Nona-6,8-Dienoyl}-L-2-Aminobutyryl-N-Methyl-Glycyl-N-Methyl-L-Leucyl-L-Valyl-N-Methyl-L-Leucyl-L-Alanyl-D-Alanyl-N-Methyl-L-Leucyl-N-Methyl-L-Leucyl-N-Methyl-L-Valyl}', 'eu_mah_current': 'Lux Biosciences GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/067/06', 'ema_number_certainty': '1.0'}"
EU-3-07-474,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/474', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/474', 'active_substance': 'Alpha-1 proteinase inhibitor (inhalation use)', 'eu_mah_current': 'CSL Behring GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/041/07', 'ema_number_certainty': '1.0'}"
EU-3-07-478,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/478', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/478', 'active_substance': 'N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide', 'eu_mah_current': 'ICON Clinical Research Limited', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/053/07', 'ema_number_certainty': '0.75'}"
EU-3-07-482,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/482', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/482', 'active_substance': 'Sulfonated monophosphorylated mannose oligosaccharide', 'eu_mah_current': 'Constella Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '09-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/047/07', 'ema_number_certainty': '1.0'}"
EU-3-07-492,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/492', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/492', 'active_substance': 'Iodine (131I) chlorotoxin', 'eu_mah_current': 'Eisai Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '10-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/038/07', 'ema_number_certainty': '1.0'}"
EU-3-07-493,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/493', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/493', 'active_substance': 'Isofagomine tartrate', 'eu_mah_current': 'Amicus Therapeutics UK Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-23-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/062/07', 'ema_number_certainty': '1.0'}"
EU-3-07-497,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/497', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/497', 'active_substance': '4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid', 'eu_mah_current': 'Quintiles Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/046/07', 'ema_number_certainty': '1.0'}"
EU-3-07-488,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/488', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/488', 'active_substance': 'everolimus', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-14-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/040/07', 'ema_number_certainty': '1.0'}"
EU-3-07-490,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/490', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/490', 'active_substance': 'Human autologous bone-forming cells derived from bone marrow stem cells', 'eu_mah_current': 'Bone Therapeutics SA', 'orphan_status': 'o', 'eu_aut_date': '10-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/052/07', 'ema_number_certainty': '1.0'}"
EU-3-07-494,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/494', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/494', 'active_substance': 'Lenalidomide', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/068/07', 'ema_number_certainty': '1.0'}"
EU-3-07-483,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/483', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/483', 'active_substance': 'Amonafide L-malate', 'eu_mah_current': 'Antisoma Research Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-22-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/069/07', 'ema_number_certainty': '1.0'}"
EU-3-07-509,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/07/509', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/509', 'active_substance': 'Azacitidine', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/085/07', 'ema_number_certainty': '1.0'}"
EU-3-07-504,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/504', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/504', 'active_substance': 'Irinotecan hydrochloride (drug eluting beads)', 'eu_mah_current': 'Biocompatibles UK Limited', 'orphan_status': 'o', 'eu_aut_date': '11-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/051/07', 'ema_number_certainty': '1.0'}"
EU-3-07-512,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/512', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/512', 'active_substance': '17-(allylamino)-17-demethoxygeldanamycin hydroquinone hydrochloride', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '11-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/076/07', 'ema_number_certainty': '1.0'}"
EU-3-07-500,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/500', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/500', 'active_substance': 'Recombinant human rod-derived cone viability factor', 'eu_mah_current': 'Fovea Pharmaceuticals SA', 'orphan_status': 'o', 'eu_aut_date': '11-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/075/07', 'ema_number_certainty': '1.0'}"
EU-3-07-501,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/501', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/501', 'active_substance': 'Olaparib', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'o', 'eu_aut_date': '12-06-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/063/07', 'ema_number_certainty': '1.0'}"
EU-3-07-502,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/502', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/502', 'active_substance': 'Picoplatin', 'eu_mah_current': 'Kendle International Ltd', 'orphan_status': 'o', 'eu_aut_date': '12-06-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/055/07', 'ema_number_certainty': '1.0'}"
EU-3-07-507,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/507', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/507', 'active_substance': 'Doxorubicin hydrochloride (drug eluting beads)', 'eu_mah_current': 'Biocompatibles UK Limited', 'orphan_status': 'o', 'eu_aut_date': '11-29-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/050/07', 'ema_number_certainty': '1.0'}"
EU-3-07-517,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/517', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/517', 'active_substance': 'N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N&#180;-(2-fluoro-5-methylphenyl) urea', 'eu_mah_current': 'AbbVie Ltd', 'orphan_status': 'o', 'eu_aut_date': '12-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/090/07', 'ema_number_certainty': '0.5'}"
EU-3-07-518,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/518', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/518', 'active_substance': 'Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carbamate', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '12-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/088/07', 'ema_number_certainty': '1.0'}"
EU-3-07-515,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/515', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/515', 'active_substance': 'Tegafur / gimeracil / oteracil', 'eu_mah_current': 'Taiho Pharma Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '12-20-2007', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/073/07', 'ema_number_certainty': '1.0'}"
EU-3-07-526,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/07/526', 'status_type': 'w', 'eu_pnumber': 'EU/3/07/526', 'active_substance': 'N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide', 'eu_mah_current': 'ICON Clinical Research Limited', 'orphan_status': 'o', 'eu_aut_date': '01-31-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/099/07', 'ema_number_certainty': '0.75'}"
EU-3-08-527,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/527', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/527', 'active_substance': 'Recombinant human monoclonal antibody to human IL-1beta of the IgG1/K class', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '02-04-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/035/07', 'ema_number_certainty': '1.0'}"
EU-3-08-528,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/528', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/528', 'active_substance': 'Lumiliximab', 'eu_mah_current': 'Biogen Idec Limited', 'orphan_status': 'o', 'eu_aut_date': '02-04-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/091/07', 'ema_number_certainty': '1.0'}"
EU-3-08-538,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/538', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/538', 'active_substance': 'Amrubicin hydrochloride', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '04-02-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/113/07', 'ema_number_certainty': '1.0'}"
EU-3-08-536,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/536', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/536', 'active_substance': 'Chimeric antibody to mesothelin', 'eu_mah_current': 'Eisai Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '03-17-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/111/07', 'ema_number_certainty': '1.0'}"
EU-3-08-537,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/537', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/537', 'active_substance': 'Autologous urothelial and smooth muscle cells', 'eu_mah_current': 'European Medical Advisory Services Limited', 'orphan_status': 'o', 'eu_aut_date': '03-17-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/112/07', 'ema_number_certainty': '1.0'}"
EU-3-08-533,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/533', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/533', 'active_substance': 'Recombinant human monoclonal antibody against transforming growth factor beta-1, 2 and 3', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/105/07', 'ema_number_certainty': '1.0'}"
EU-3-08-534,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/534', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/534', 'active_substance': 'Allogeneic human umbilical cord tissue-derived cells', 'eu_mah_current': 'Centocor B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-01-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/106/07', 'ema_number_certainty': '1.0'}"
EU-3-08-543,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/543', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/543', 'active_substance': 'Sarsasapogenin', 'eu_mah_current': 'Phytopharm plc', 'orphan_status': 'o', 'eu_aut_date': '05-08-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/125/07', 'ema_number_certainty': '1.0'}"
EU-3-08-551,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/551', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/551', 'active_substance': 'Pegylated recombinant factor VIIa', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '06-04-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/122/07', 'ema_number_certainty': '1.0'}"
EU-3-08-552,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/552', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/552', 'active_substance': 'Pegylated recombinant factor VIIa', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '06-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/008/08', 'ema_number_certainty': '1.0'}"
EU-3-08-547,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/547', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/547', 'active_substance': 'Anti-von Willebrand Aptamer', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/123/07', 'ema_number_certainty': '1.0'}"
EU-3-08-554,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/554', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/554', 'active_substance': 'Beraprost sodium (modified release tablet)', 'eu_mah_current': 'IDEA Innovative Drug European Associates (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-10-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/018/08', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-08-556,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/08/556', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/556', 'active_substance': 'N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide', 'eu_mah_current': 'Vertex Pharmaceuticals (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-08-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/010/08', 'ema_number_certainty': '0.6'}"
EU-3-08-559,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/559', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/559', 'active_substance': 'bosentan', 'eu_mah_current': 'Actelion Registration Ltd', 'orphan_status': 'o', 'eu_aut_date': '09-05-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/027/08', 'ema_number_certainty': '1.0'}"
EU-3-08-561,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/561', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/561', 'active_substance': 'Donor lymphocyte preparation depleted of functional alloreactive T-cells', 'eu_mah_current': 'Kiadis Pharma Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '09-05-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/121/07', 'ema_number_certainty': '1.0'}"
EU-3-08-565,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/565', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/565', 'active_substance': 'Drotrecogin alfa (activated)', 'eu_mah_current': 'Savara ApS', 'orphan_status': 'o', 'eu_aut_date': '09-22-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/099/06', 'ema_number_certainty': '0.75'}"
EU-3-08-566,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/566', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/566', 'active_substance': 'Levofloxacin hemihydrate', 'eu_mah_current': 'Aptalis Pharma SAS', 'orphan_status': 'o', 'eu_aut_date': '09-23-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/024/08', 'ema_number_certainty': '1.0'}"
EU-3-08-571,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/571', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/571', 'active_substance': 'Recombinant human minibody against complement component C5', 'eu_mah_current': 'ADIENNE S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '09-22-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/035/08', 'ema_number_certainty': '1.0'}"
EU-3-08-572,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/572', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/572', 'active_substance': '(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/039/08', 'ema_number_certainty': '1.0'}"
EU-3-08-573,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/573', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/573', 'active_substance': 'Adeno-associated viral vector containing the human alpha-sarcoglycan gene', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/043/08', 'ema_number_certainty': '1.0'}"
EU-3-08-574,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/574', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/574', 'active_substance': 'Autologous urothelial and smooth muscle cells', 'eu_mah_current': 'European Medical Advisory Services Limited', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/041/08', 'ema_number_certainty': '1.0'}"
EU-3-08-575,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/08/575', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/575', 'active_substance': 'Carglumic acid', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/107/07', 'ema_number_certainty': '1.0'}"
EU-3-08-576,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/08/576', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/576', 'active_substance': 'Carglumic acid', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/045/08', 'ema_number_certainty': '1.0'}"
EU-3-08-577,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/08/577', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/577', 'active_substance': 'Carglumic acid', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/046/08', 'ema_number_certainty': '1.0'}"
EU-3-08-581,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/581', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/581', 'active_substance': 'Ofatumumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/051/08', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-08-582,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/582', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/582', 'active_substance': 'Recombinant human heparan N-sulfatase', 'eu_mah_current': 'Shire Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '11-07-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/052/08', 'ema_number_certainty': '0.5'}"
EU-3-08-584,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/584', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/584', 'active_substance': 'Palifosfamide', 'eu_mah_current': 'Ziopharm Oncology Limited', 'orphan_status': 'o', 'eu_aut_date': '12-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/044/08', 'ema_number_certainty': '1.0'}"
EU-3-08-589,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/589', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/589', 'active_substance': 'Yttrium (90Y) edotreotide', 'eu_mah_current': 'Molecular Insight Limited', 'orphan_status': 'o', 'eu_aut_date': '12-04-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/057/08', 'ema_number_certainty': '0.75'}"
EU-3-08-590,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/590', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/590', 'active_substance': '2-[[3-({4-[(5-{2-[(3-Fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]-quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate trihydrate', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'o', 'eu_aut_date': '12-05-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/060/08', 'ema_number_certainty': '1.0'}"
EU-3-08-591,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/591', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/591', 'active_substance': '5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole', 'eu_mah_current': 'Summit (Oxford) Limited', 'orphan_status': 'o', 'eu_aut_date': '12-04-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/065/08', 'ema_number_certainty': '1.0'}"
EU-3-08-592,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/592', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/592', 'active_substance': 'Murine anti-CD22 antibody variable region fused to truncated Pseudomonas exotoxin 38', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'o', 'eu_aut_date': '12-04-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/066/08', 'ema_number_certainty': '0.5'}"
EU-3-08-593,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/593', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/593', 'active_substance': 'N2&#180;-Deacetyl-N2&#180;-[4-methyl-4-(oxobutyldithio)-1-oxopentyl]-maytansine-chimerised anti-CD138 IgG4 Monoclonal Antibody', 'eu_mah_current': 'Biotest AG', 'orphan_status': 'o', 'eu_aut_date': '12-03-2008', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/068/08', 'ema_number_certainty': '1.0'}"
EU-3-08-597,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/597', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/597', 'active_substance': '2,3,4,5 tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole dihydrochloride', 'eu_mah_current': 'IDEA Innovative Drug European Associates Limited', 'orphan_status': 'o', 'eu_aut_date': '01-20-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/061/08', 'ema_number_certainty': '1.0'}"
EU-3-08-601,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/601', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/601', 'active_substance': 'Milatuzumab', 'eu_mah_current': 'Immunomedics GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/053/08', 'ema_number_certainty': '1.0'}"
EU-3-08-602,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/602', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/602', 'active_substance': 'Milatuzumab', 'eu_mah_current': 'Immunomedics GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/058/08', 'ema_number_certainty': '1.0'}"
EU-3-08-604,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/604', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/604', 'active_substance': 'Recombinant Human minibody against complement component C5 fused with RGD-motif', 'eu_mah_current': 'ADIENNE S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '01-20-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/047/08', 'ema_number_certainty': '1.0'}"
EU-3-08-605,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/605', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/605', 'active_substance': 'Recombinant human monoclonal antibody to human Nogo-A protein of the IgG4/kappa class', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '01-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/059/08', 'ema_number_certainty': '1.0'}"
EU-3-08-606,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/606', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/606', 'active_substance': 'Recombinant human residue 41 glutamic acid to glutamine variant of Interferon-alfa-2b', 'eu_mah_current': 'Creabilis Therapeutics S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '01-19-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/064/08', 'ema_number_certainty': '1.0'}"
EU-3-08-608,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/608', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/608', 'active_substance': 'Yttrium (90Y)-DOTA-radiolabelled humanized monoclonal antibody against mucin 1', 'eu_mah_current': 'Immunomedics GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-06-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/080/08', 'ema_number_certainty': '1.0'}"
EU-3-08-609,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/08/609', 'status_type': 'w', 'eu_pnumber': 'EU/3/08/609', 'active_substance': 'Adeno-associated viral vector serotype 5 containing the human ABCA4 gene', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '02-06-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/084/08', 'ema_number_certainty': '1.0'}"
EU-3-09-613,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/613', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/613', 'active_substance': 'Tobramycin (inhalation use)', 'eu_mah_current': 'PARI Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-27-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/094/08', 'ema_number_certainty': '1.0'}"
EU-3-09-618,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/618', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/618', 'active_substance': 'Allogeneic ex vivo expanded umbilical cord blood cells', 'eu_mah_current': 'Regulatory Resources Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-27-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/067/08', 'ema_number_certainty': '1.0'}"
EU-3-09-619,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/619', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/619', 'active_substance': 'Allogeneic ex vivo expanded umbilical cord blood cells', 'eu_mah_current': 'Regulatory Resources Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-27-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/090/08', 'ema_number_certainty': '1.0'}"
EU-3-09-620,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/620', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/620', 'active_substance': '(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '04-03-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/103/08', 'ema_number_certainty': '1.0'}"
EU-3-09-626,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/626', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/626', 'active_substance': 'Lintuzumab', 'eu_mah_current': 'Seattle Genetics UK Limited', 'orphan_status': 'o', 'eu_aut_date': '04-29-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/117/08', 'ema_number_certainty': '1.0'}"
EU-3-09-627,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/627', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/627', 'active_substance': 'Lintuzumab', 'eu_mah_current': 'Seattle Genetics UK Limited', 'orphan_status': 'o', 'eu_aut_date': '04-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/118/08', 'ema_number_certainty': '1.0'}"
EU-3-09-628,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/09/628', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/628', 'active_substance': 'Mercaptopurine (oral suspension)', 'eu_mah_current': 'Nova Laboratories Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '04-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/114/08', 'ema_number_certainty': '0.5'}"
EU-3-09-631,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/631', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/631', 'active_substance': 'Talampanel', 'eu_mah_current': 'Teva Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-29-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/112/08', 'ema_number_certainty': '1.0'}"
EU-3-09-636,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/636', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/636', 'active_substance': 'Dexamethasone phosphate (iontophoretic solution, ocular use)', 'eu_mah_current': 'IDEA Innovative Drug European Associates Limited', 'orphan_status': 'o', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/110/08', 'ema_number_certainty': '0.75'}"
EU-3-09-639,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/639', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/639', 'active_substance': '4,6,8-trihydroxy-10-(3,7,11-trimethyldodeca-2,6,10-trienyl)-5,10-dihydrodibenzo[b,e][1,4]diazepin-11-one', 'eu_mah_current': 'Albany Regulatory Consulting Limited', 'orphan_status': 'o', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/004/09', 'ema_number_certainty': '1.0'}"
EU-3-09-640,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/640', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/640', 'active_substance': 'Pegylated recombinant human factor IX', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '05-15-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/005/09', 'ema_number_certainty': '1.0'}"
EU-3-09-642,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/642', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/642', 'active_substance': 'Chimeric-anti-interleukin-6 monoclonal antibody', 'eu_mah_current': 'Janssen Biologics B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-12-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/003/09', 'ema_number_certainty': '1.0'}"
EU-3-09-643,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/643', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/643', 'active_substance': 'Desipramine hydrochloride', 'eu_mah_current': 'ORPHELIA Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '06-12-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/001/09', 'ema_number_certainty': '1.0'}"
EU-3-09-644,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/644', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/644', 'active_substance': 'Murine monoclonal antibody to GD2', 'eu_mah_current': 'United Therapeutics Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '06-12-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/013/09', 'ema_number_certainty': '1.0'}"
EU-3-09-646,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/646', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/646', 'active_substance': 'Talampanel', 'eu_mah_current': 'Teva Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-12-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/012/09', 'ema_number_certainty': '1.0'}"
EU-3-09-647,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/647', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/647', 'active_substance': '(S)-3&#180;-(OH)-desazadesferrithiocin-polyether, magnesium salt', 'eu_mah_current': 'Shire Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/008/09', 'ema_number_certainty': '0.75'}"
EU-3-09-649,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/649', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/649', 'active_substance': 'Allogeneic ex vivo expanded umbilical cord blood cells', 'eu_mah_current': 'Regulatory Resources Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/034/09', 'ema_number_certainty': '1.0'}"
EU-3-09-655,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/655', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/655', 'active_substance': 'Octocog alpha (liposomal)', 'eu_mah_current': 'Bayer Pharma AG', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/018/09', 'ema_number_certainty': '1.0'}"
EU-3-09-658,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/658', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/658', 'active_substance': 'Tamibarotene', 'eu_mah_current': 'Eudax Srl', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/002/09', 'ema_number_certainty': '1.0'}"
EU-3-09-659,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/659', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/659', 'active_substance': 'Tosedostat', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '07-24-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/028/09', 'ema_number_certainty': '0.5'}"
EU-3-09-662,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/662', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/662', 'active_substance': '26 base single stranded phosphodiester DNA oligonucleotide', 'eu_mah_current': 'Antisoma Research Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/016/09', 'ema_number_certainty': '1.0'}"
EU-3-09-664,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/664', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/664', 'active_substance': 'Allogeneic ex vivo expanded umbilical cord blood cells', 'eu_mah_current': 'Regulatory Resources Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/033/09', 'ema_number_certainty': '1.0'}"
EU-3-09-665,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/665', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/665', 'active_substance': 'Allogeneic ex vivo expanded umbilical cord blood cells', 'eu_mah_current': 'Regulatory Resources Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/035/09', 'ema_number_certainty': '1.0'}"
EU-3-09-668,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/668', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/668', 'active_substance': 'Human C1-inhibitor', 'eu_mah_current': 'ViroPharma SPRL-BVBA', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/026/09', 'ema_number_certainty': '1.0'}"
EU-3-09-671,"{'atc_code': 'not applicable', 'eu_aut_status': 'EXPIRED', 'eu_brand_name_current': 'EU/3/09/671', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/671', 'active_substance': 'pasireotide', 'eu_mah_current': 'Recordati Rare Diseases', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/052/09', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-09-674,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/674', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/674', 'active_substance': 'Recombinant human serum amyloid P', 'eu_mah_current': 'Appletree Europe S.&#224;.r.l.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/039/09', 'ema_number_certainty': '1.0'}"
EU-3-09-675,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/675', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/675', 'active_substance': 'Sequence-modified recombinant human factor VIIa', 'eu_mah_current': 'Bayer Pharma AG', 'orphan_status': 'o', 'eu_aut_date': '10-09-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/031/09', 'ema_number_certainty': '1.0'}"
EU-3-09-676,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/676', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/676', 'active_substance': 'Sequence-modified recombinant human factor VIIa', 'eu_mah_current': 'Bayer Pharma AG', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/062/09', 'ema_number_certainty': '1.0'}"
EU-3-09-678,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/678', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/678', 'active_substance': '(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1yl)-4-(1H-indol-3-yl) pyrrolidine-2, 5-dione', 'eu_mah_current': 'Gregory Fryer Associates Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-08-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/036/09', 'ema_number_certainty': '1.0'}"
EU-3-09-679,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/679', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/679', 'active_substance': '4-benzyl-2-naphtalen-1-yl-1,2,4-thiadiazolidine-3,5-dione', 'eu_mah_current': 'NOSCIRA, S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/074/09', 'ema_number_certainty': '1.0'}"
EU-3-09-680,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/680', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/680', 'active_substance': '5&#39;-O-(trans-9&#39;&#39;-octadecenoyl)-1-beta-D-2&#39;-deoxy-2&#39;,2&#39;-difluorocytidine', 'eu_mah_current': 'Clovis Oncology UK Limited', 'orphan_status': 'o', 'eu_aut_date': '10-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/067/09', 'ema_number_certainty': '1.0'}"
EU-3-09-682,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/682', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/682', 'active_substance': 'Anti-EphA2 monoclonal antibody conjugated to maleimidocaproyl monomethylauristatin phenylalanine', 'eu_mah_current': 'MedImmune Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/071/09', 'ema_number_certainty': '1.0'}"
EU-3-09-683,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/683', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/683', 'active_substance': 'Cholic acid', 'eu_mah_current': 'Retrophin Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '10-28-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/080/09', 'ema_number_certainty': '0.5'}"
EU-3-09-685,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/685', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/685', 'active_substance': 'N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide hydrochloride', 'eu_mah_current': 'Merck KGaA', 'orphan_status': 'o', 'eu_aut_date': '11-09-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/069/09', 'ema_number_certainty': '1.0'}"
EU-3-09-687,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/687', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/687', 'active_substance': 'Patupilone', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-05-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/049/09', 'ema_number_certainty': '1.0'}"
EU-3-09-688,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/688', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/688', 'active_substance': 'Patupilone', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-05-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/050/09', 'ema_number_certainty': '1.0'}"
EU-3-09-690,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/690', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/690', 'active_substance': 'Human anthrax immunoglobulin', 'eu_mah_current': 'Emergent Sales and Marketing Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-09-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/064/09', 'ema_number_certainty': '1.0'}"
EU-3-09-691,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/691', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/691', 'active_substance': 'Human anthrax immunoglobulin', 'eu_mah_current': 'Emergent Sales and Marketing Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-05-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/065/09', 'ema_number_certainty': '1.0'}"
EU-3-09-693,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/693', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/693', 'active_substance': '1-Cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea', 'eu_mah_current': 'Astex Therapeutics Limited', 'orphan_status': 'o', 'eu_aut_date': '11-26-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/091/09', 'ema_number_certainty': '1.0'}"
EU-3-09-695,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/695', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/695', 'active_substance': '8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-1,2,4-triazolo[3,4-f][1,6]naphthyridin-3(2H)-one mono-hydrochloride', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'o', 'eu_aut_date': '11-30-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/086/09', 'ema_number_certainty': '1.0'}"
EU-3-09-697,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/697', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/697', 'active_substance': 'N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4&#39;-(trifluoromethoxy)[1,1&#39;-biphenyl]-3-carboxamide', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-25-2009', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/048/09', 'ema_number_certainty': '1.0'}"
EU-3-09-704,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/704', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/704', 'active_substance': 'Givinostat', 'eu_mah_current': 'Italfarmaco S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/088/09', 'ema_number_certainty': '1.0'}"
EU-3-09-705,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/705', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/705', 'active_substance': 'Human monoclonal antibody against Pseudomonas aeruginosa IATS-O1', 'eu_mah_current': 'Envestia Limited', 'orphan_status': 'o', 'eu_aut_date': '01-28-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/114/09', 'ema_number_certainty': '1.0'}"
EU-3-09-713,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/713', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/713', 'active_substance': 'Veltuzumab', 'eu_mah_current': 'Immunomedics GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-29-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/100/09', 'ema_number_certainty': '1.0'}"
EU-3-09-714,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/714', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/714', 'active_substance': 'Streptococcus pyogenes Su strain cells treated with benzylpenicillin', 'eu_mah_current': 'Theradex (Europe) Ltd', 'orphan_status': 'o', 'eu_aut_date': '01-29-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/056/09', 'ema_number_certainty': '1.0'}"
EU-3-09-718,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/718', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/718', 'active_substance': 'Fingolimod', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '02-02-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/107/09', 'ema_number_certainty': '1.0'}"
EU-3-09-721,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/721', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/721', 'active_substance': 'Panobinostat', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '02-02-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/096/09', 'ema_number_certainty': '1.0'}"
EU-3-09-722,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/722', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/722', 'active_substance': 'Pixantrone dimaleate', 'eu_mah_current': 'CTI Life Sciences Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-02-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/126/09', 'ema_number_certainty': '1.0'}"
EU-3-09-724,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/09/724', 'status_type': 'w', 'eu_pnumber': 'EU/3/09/724', 'active_substance': 'Recombinant human monoclonal antibody to human interleukin (IL)-17A of the IgG1/k class', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '02-02-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/060/09', 'ema_number_certainty': '1.0'}"
EU-3-10-728,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/728', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/728', 'active_substance': 'Davunetide', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-23-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/129/09', 'ema_number_certainty': '1.0'}"
EU-3-10-729,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/729', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/729', 'active_substance': '(1S, 2S, 3R, 4R)-3-(5-Fluoro-2-(3-methyl-4-(4-methylpiperazin-1-yl)-phenylamino)-pyrimidin-4-ylamino)-bicyclo[2.2.1]hept-5-ene-2-carboxamide benzoate', 'eu_mah_current': 'Merck KGaA', 'orphan_status': 'o', 'eu_aut_date': '03-23-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/132/09', 'ema_number_certainty': '1.0'}"
EU-3-10-731,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/731', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/731', 'active_substance': 'Bafetinib', 'eu_mah_current': 'Eudax Srl', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/143/09', 'ema_number_certainty': '1.0'}"
EU-3-10-740,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/740', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/740', 'active_substance': 'Perifosine', 'eu_mah_current': '&#198;terna Zentaris GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-10-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/130/09', 'ema_number_certainty': '1.0'}"
EU-3-10-743,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/743', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/743', 'active_substance': 'Pagibaximab', 'eu_mah_current': 'Theorem Clinical Research GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-09-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/156/09', 'ema_number_certainty': '1.0'}"
EU-3-10-745,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/745', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/745', 'active_substance': 'Dexamethasone (40 mg tablet)', 'eu_mah_current': 'Laboratoires CTRS', 'orphan_status': 'o', 'eu_aut_date': '06-09-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/133/09', 'ema_number_certainty': '1.0'}"
EU-3-10-746,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/746', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/746', 'active_substance': 'Maytansinoid-conjugated humanised monoclonal antibody against CD56', 'eu_mah_current': 'ImmunoGen Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '06-09-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/155/09', 'ema_number_certainty': '0.5'}"
EU-3-10-747,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/747', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/747', 'active_substance': 'N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N&#180;-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate', 'eu_mah_current': 'EUSA Pharma (UK) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-09-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/148/09', 'ema_number_certainty': '0.5'}"
EU-3-10-751,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/751', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/751', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against p53 mRNA', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-09-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/142/09', 'ema_number_certainty': '0.75'}"
EU-3-10-752,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/752', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/752', 'active_substance': 'Velaglucerase alfa', 'eu_mah_current': 'Takeda Pharmaceuticals International AG Ireland Branch', 'orphan_status': 'o', 'eu_aut_date': '06-09-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/140/09', 'ema_number_certainty': '0.5'}"
EU-3-10-754,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/754', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/754', 'active_substance': 'Heparin-activated recombinant human fibroblast growth factor 1 (on a biodegradable device made from alpha-calcium sulphate hemihydrate)', 'eu_mah_current': 'Bioarctic AB', 'orphan_status': 'o', 'eu_aut_date': '07-27-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/008/10', 'ema_number_certainty': '1.0'}"
EU-3-10-757,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/757', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/757', 'active_substance': 'Pomalidomide', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '07-27-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/161/09', 'ema_number_certainty': '0.5'}"
EU-3-10-758,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/758', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/758', 'active_substance': 'Pomalidomide', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '07-27-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/048/10', 'ema_number_certainty': '1.0'}"
EU-3-10-759,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/759', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/759', 'active_substance': 'Pomalidomide', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '07-27-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/049/10', 'ema_number_certainty': '1.0'}"
EU-3-10-761,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/761', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/761', 'active_substance': '3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid', 'eu_mah_current': 'Vertex Pharmaceuticals (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-04-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/024/10', 'ema_number_certainty': '1.0'}"
EU-3-10-762,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/762', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/762', 'active_substance': 'Bosutinib', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'o', 'eu_aut_date': '08-04-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMEA/OD/160/09', 'ema_number_certainty': '1.0'}"
EU-3-10-763,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/763', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/763', 'active_substance': 'Dexamethasone (intravitreal implant)', 'eu_mah_current': 'Allergan Pharmaceuticals Ireland', 'orphan_status': 'o', 'eu_aut_date': '08-04-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/018/10', 'ema_number_certainty': '1.0'}"
EU-3-10-766,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/766', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/766', 'active_substance': 'Pyr-His-Trp-Ser-Tyr-D-Lys(doxorubicinylglutarate)-Leu-Arg-Pro-Gly-NH2, acetate salt', 'eu_mah_current': '&#198;terna Zentaris GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-04-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/014/10', 'ema_number_certainty': '1.0'}"
EU-3-10-770,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/770', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/770', 'active_substance': '1-[2-(Benzo[1,2,5]thiadiazol-5-ylamino)-6-(2,6-dichloro-phenyl)-pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butyl-urea', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/023/10', 'ema_number_certainty': '1.0'}"
EU-3-10-771,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/771', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/771', 'active_substance': 'Abarelix', 'eu_mah_current': 'Speciality European Pharma Ltd', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/017/10', 'ema_number_certainty': '1.0'}"
EU-3-10-781,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/781', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/781', 'active_substance': 'Glutathione-pegylated liposomal doxorubicin hydrochloride', 'eu_mah_current': 'to-BBB Technologies BV', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/031/10', 'ema_number_certainty': '1.0'}"
EU-3-10-783,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/783', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/783', 'active_substance': 'Recombinant fusion protein consisting of human coagulation factor VIII attached to the Fc domain of human IgG1', 'eu_mah_current': 'Biogen Idec Limited', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/030/10', 'ema_number_certainty': '1.0'}"
EU-3-10-784,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/784', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/784', 'active_substance': 'Recombinant porcine factor VIII (B domain deleted)', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/043/10', 'ema_number_certainty': '1.0'}"
EU-3-10-785,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/785', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/785', 'active_substance': 'Vorinostat', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'o', 'eu_aut_date': '09-20-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/028/10', 'ema_number_certainty': '1.0'}"
EU-3-10-787,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/787', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/787', 'active_substance': '(3S)-3-{4-[7-(aminocarbonyl)-2H-indazol-2-yl] phenyl} piperidine tosylate monohydrate salt', 'eu_mah_current': 'TESARO U.K. Limited', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/059/10', 'ema_number_certainty': '1.0'}"
EU-3-10-790,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/790', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/790', 'active_substance': 'Ambrisentan', 'eu_mah_current': 'Gilead Sciences International Limited', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/029/10', 'ema_number_certainty': '1.0'}"
EU-3-10-792,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/792', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/792', 'active_substance': 'Maytansinoid-conjugated humanised monoclonal antibody against CD56', 'eu_mah_current': 'ImmunoGen Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/056/10', 'ema_number_certainty': '1.0'}"
EU-3-10-796,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/796', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/796', 'active_substance': 'Recombinant humanised anti-human interleukin-1 beta monoclonal antibody', 'eu_mah_current': 'XOMA UK Limited', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/062/10', 'ema_number_certainty': '1.0'}"
EU-3-10-797,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/797', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/797', 'active_substance': 'Recombinant humanised monoclonal antibody to human Nogo-A protein of the IgG1/kappa class', 'eu_mah_current': 'Glaxo Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/060/10', 'ema_number_certainty': '1.0'}"
EU-3-10-799,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/799', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/799', 'active_substance': 'Tecovirimat', 'eu_mah_current': 'SIGA Pharmaceuticals (Europe) Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-01-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/052/10', 'ema_number_certainty': '1.0'}"
EU-3-10-809,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/809', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/809', 'active_substance': 'Nanoparticle albumin-bound paclitaxel', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/087/10', 'ema_number_certainty': '1.0'}"
EU-3-10-812,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/812', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/812', 'active_substance': 'Recombinant fusion protein consisting of the extracellular portion of human activin receptor IIB linked to the human IgG1 Fc domain', 'eu_mah_current': 'Shire Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/085/10', 'ema_number_certainty': '1.0'}"
EU-3-10-814,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/814', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/814', 'active_substance': 'Recombinant human von Willebrand factor', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-26-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/055/10', 'ema_number_certainty': '1.0'}"
EU-3-10-817,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/817', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/817', 'active_substance': 'Adeno-associated viral vector containing DNA encoding an RNAi targeting rhodopsin / adeno-associated viral vector containing a rhodopsin gene', 'eu_mah_current': 'Spark Therapeutics Ireland Ltd', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/098/10', 'ema_number_certainty': '1.0'}"
EU-3-10-824,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/824', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/824', 'active_substance': 'N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl) amino] isonicotinamide hydrochloride', 'eu_mah_current': 'Merck KGaA', 'orphan_status': 'o', 'eu_aut_date': '12-17-2010', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/094/10', 'ema_number_certainty': '1.0'}"
EU-3-10-834,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/834', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/834', 'active_substance': 'Human plasmin', 'eu_mah_current': 'Grifols Deutschland GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/117/10', 'ema_number_certainty': '1.0'}"
EU-3-10-835,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/835', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/835', 'active_substance': 'Maytansinoid-conjugated humanised monoclonal antibody against CD56', 'eu_mah_current': 'ImmunoGen Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/115/10', 'ema_number_certainty': '1.0'}"
EU-3-10-837,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/837', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/837', 'active_substance': 'Plitidepsin', 'eu_mah_current': 'Pharma Mar S.A.', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/123/10', 'ema_number_certainty': '1.0'}"
EU-3-10-838,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/838', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/838', 'active_substance': 'Plitidepsin', 'eu_mah_current': 'Pharma Mar S.A.', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/121/10', 'ema_number_certainty': '1.0'}"
EU-3-10-839,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/839', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/839', 'active_substance': 'Plitidepsin', 'eu_mah_current': 'Pharma Mar S.A.', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/122/10', 'ema_number_certainty': '1.0'}"
EU-3-10-843,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/843', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/843', 'active_substance': 'Allogeneic aortic endothelial cells cultured in a porcine gelatin matrix', 'eu_mah_current': 'Shire Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/134/10', 'ema_number_certainty': '1.0'}"
EU-3-10-844,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/844', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/844', 'active_substance': 'Axitinib', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/119/10', 'ema_number_certainty': '1.0'}"
EU-3-10-847,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/847', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/847', 'active_substance': 'Pegylated B-domain-deleted sequence-modified recombinant human factor VIII', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/128/10', 'ema_number_certainty': '1.0'}"
EU-3-10-848,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/10/848', 'status_type': 'w', 'eu_pnumber': 'EU/3/10/848', 'active_substance': 'Sodium thiosulfate', 'eu_mah_current': 'Dr Franz K&#246;hler Chemie GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-23-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/116/10', 'ema_number_certainty': '1.0'}"
EU-3-11-852,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/852', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/852', 'active_substance': 'Human anthrax monoclonal antibody', 'eu_mah_current': 'Emergent Sales and Marketing Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/139/10', 'ema_number_certainty': '1.0'}"
EU-3-11-853,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/853', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/853', 'active_substance': 'Ombrabulin', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'o', 'eu_aut_date': '04-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/141/10', 'ema_number_certainty': '1.0'}"
EU-3-11-854,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/854', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/854', 'active_substance': 'Vorinostat', 'eu_mah_current': 'Merck Sharp &amp; Dohme Limited', 'orphan_status': 'o', 'eu_aut_date': '04-15-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/137/10', 'ema_number_certainty': '1.0'}"
EU-3-11-859,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/859', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/859', 'active_substance': '[N-((2S,3R,3aS,3&#180;R,4a&#180;R,6S,6a&#180;R,6b&#180;S,7aR,12a&#180;S,12b&#180;S,Z)-3,6,11&#180;,12b&#180;-tetramethyl-2&#180;,3a,3&#180;,4,4&#180;,4a&#180;,5,5&#180;,6,6&#180;,6a&#180;,6b&#180;,7,7a,7&#180;,8&#180;,10&#180;,12&#180;,12a&#180;,12b&#180;-icosahydro-1&#180;H,3H-spiro[furo[3,2-b]pyridine-2,9&#180;-naphtho[2,1-a]azulene]-3&#180;-yl)methanesulfonamide hydrochloride]', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/143/10', 'ema_number_certainty': '1.0'}"
EU-3-11-866,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/866', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/866', 'active_substance': 'Allogeneic bone marrow stem cells treated ex vivo with 16,16-dimethyl prostaglandin E2', 'eu_mah_current': 'Fate Therapeutics, LTD', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/161/10', 'ema_number_certainty': '1.0'}"
EU-3-11-867,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/867', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/867', 'active_substance': 'Allogeneic umbilical cord blood cells treated ex vivo with 16,16-dimethyl prostaglandin E2', 'eu_mah_current': 'Fate Therapeutics, LTD', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/156/10', 'ema_number_certainty': '1.0'}"
EU-3-11-868,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/868', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/868', 'active_substance': 'Lenalidomide', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-13-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/160/10', 'ema_number_certainty': '1.0'}"
EU-3-11-871,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/871', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/871', 'active_substance': 'Salirasib', 'eu_mah_current': 'Kadmon International Ltd', 'orphan_status': 'o', 'eu_aut_date': '06-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/150/10', 'ema_number_certainty': '1.0'}"
EU-3-11-873,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/873', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/873', 'active_substance': 'Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh', 'eu_mah_current': 'Shire Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/172/10', 'ema_number_certainty': '1.0'}"
EU-3-11-879,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/879', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/879', 'active_substance': 'Chimeric monoclonal antibody against GD2', 'eu_mah_current': 'United Therapeutics Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '06-21-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/002/11', 'ema_number_certainty': '1.0'}"
EU-3-11-882,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/882', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/882', 'active_substance': 'Fresolimumab', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/146/10', 'ema_number_certainty': '1.0'}"
EU-3-11-891,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/891', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/891', 'active_substance': 'Human anthrax monoclonal antibody', 'eu_mah_current': 'Emergent Sales and Marketing Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-05-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/140/10', 'ema_number_certainty': '1.0'}"
EU-3-11-894,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/894', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/894', 'active_substance': 'Everolimus', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-30-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/022/11', 'ema_number_certainty': '1.0'}"
EU-3-11-896,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/896', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/896', 'active_substance': 'Multilamellar microvesicle comprising phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, phosphatidylserine, phospatidylinositol and cholesterol', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-30-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/037/11', 'ema_number_certainty': '0.5'}"
EU-3-11-898,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/898', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/898', 'active_substance': 'Sirolimus', 'eu_mah_current': 'Santen Oy', 'orphan_status': 'o', 'eu_aut_date': '08-30-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/021/11', 'ema_number_certainty': '1.0'}"
EU-3-11-901,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/901', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/901', 'active_substance': 'Dinaciclib', 'eu_mah_current': 'Merck Sharp &amp; Dohme B.V.', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/052/11', 'ema_number_certainty': '1.0'}"
EU-3-11-905,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/905', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/905', 'active_substance': 'Kifunensine', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/058/11', 'ema_number_certainty': '1.0'}"
EU-3-11-906,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/906', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/906', 'active_substance': 'Kifunensine', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/059/11', 'ema_number_certainty': '1.0'}"
EU-3-11-907,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/907', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/907', 'active_substance': 'Kifunensine', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/061/11', 'ema_number_certainty': '1.0'}"
EU-3-11-908,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/908', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/908', 'active_substance': 'Kifunensine', 'eu_mah_current': 'G&#233;n&#233;thon', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/060/11', 'ema_number_certainty': '1.0'}"
EU-3-11-911,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/911', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/911', 'active_substance': 'Recombinant human galactocerebrosidase', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '09-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/042/11', 'ema_number_certainty': '1.0'}"
EU-3-11-915,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/915', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/915', 'active_substance': '1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-3-(3-fluorophenyl)urea', 'eu_mah_current': 'AbbVie Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/067/11', 'ema_number_certainty': '1.0'}"
EU-3-11-918,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/918', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/918', 'active_substance': 'Brivanib alaninate', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/075/11', 'ema_number_certainty': '1.0'}"
EU-3-11-924,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/924', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/924', 'active_substance': 'Lenalidomide', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/078/11', 'ema_number_certainty': '1.0'}"
EU-3-11-923,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/923', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/923', 'active_substance': 'L-cysteine, L-leucyl-L-alpha-glutamyl-L-alpha-glutamyl-L-lysyl-L-lysylglycyl-L-asparaginyl-L-tyrosyl-L-valyl-L-valyl-L-threonyl-L-alpha-aspartyl-L-histidyl-S-[1-[(4-carboxycyclohexyl)methyl]-2,5-dioxo-3-pyrrolidinyl]-, complex with keyhole limpet haemocyanin', 'eu_mah_current': 'Orphix Consulting GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/077/11', 'ema_number_certainty': '1.0'}"
EU-3-11-926,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/926', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/926', 'active_substance': 'Recombinant human minibody against complement component C5', 'eu_mah_current': 'ADIENNE S.r.l.', 'orphan_status': 'o', 'eu_aut_date': '10-27-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/053/11', 'ema_number_certainty': '1.0'}"
EU-3-11-929,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/929', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/929', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human AIPL1 gene', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '12-09-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/063/11', 'ema_number_certainty': '1.0'}"
EU-3-11-931,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/931', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/931', 'active_substance': 'Plerixafor', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-09-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/074/11', 'ema_number_certainty': '1.0'}"
EU-3-11-932,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/932', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/932', 'active_substance': 'Pegylated proline-interferon alpha-2b', 'eu_mah_current': 'AOP Orphan Pharmaceuticals AG', 'orphan_status': 'o', 'eu_aut_date': '12-09-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/055/11', 'ema_number_certainty': '1.0'}"
EU-3-11-934,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/934', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/934', 'active_substance': '4-[[9-[(3S)-tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2-yl]amino]-trans-cyclohexanol', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '12-09-2011', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/091/11', 'ema_number_certainty': '1.0'}"
EU-3-11-940,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/940', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/940', 'active_substance': 'Chimeric locked nucleic acid-deoxynucleoside phosphorothioate-linked oligonucleotide directed against microRNA-451', 'eu_mah_current': 'Miragen Therapeutics Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/107/11', 'ema_number_certainty': '1.0'}"
EU-3-11-946,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/946', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/946', 'active_substance': 'Recombinant homodimer of the human annexin V', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/103/11', 'ema_number_certainty': '1.0'}"
EU-3-11-947,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/947', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/947', 'active_substance': 'Recombinant protein consisting of modified human growth hormone releasing hormone and the translocation and endopeptidase domains of botulinum toxin serotype D', 'eu_mah_current': 'Syntaxin Limited', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/108/11', 'ema_number_certainty': '1.0'}"
EU-3-11-948,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/11/948', 'status_type': 'w', 'eu_pnumber': 'EU/3/11/948', 'active_substance': 'Sodium phenylbutyrate', 'eu_mah_current': 'GMP-Orphan SA', 'orphan_status': 'o', 'eu_aut_date': '01-11-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/089/11', 'ema_number_certainty': '1.0'}"
EU-3-12-949,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/949', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/949', 'active_substance': 'Sodium phenylbutyrate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '02-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/096/11', 'ema_number_certainty': '1.0'}"
EU-3-12-950,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/950', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/950', 'active_substance': 'Sodium phenylbutyrate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '02-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/097/11', 'ema_number_certainty': '1.0'}"
EU-3-12-951,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/951', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/951', 'active_substance': 'Sodium phenylbutyrate', 'eu_mah_current': 'Lucane Pharma SA', 'orphan_status': 'o', 'eu_aut_date': '02-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/098/11', 'ema_number_certainty': '1.0'}"
EU-3-12-952,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/952', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/952', 'active_substance': 'Nimorazole maleate', 'eu_mah_current': 'Conventia Medical LLP', 'orphan_status': 'o', 'eu_aut_date': '02-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/099/11', 'ema_number_certainty': '1.0'}"
EU-3-12-953,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/953', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/953', 'active_substance': '(1S,3S)-3-amino-4-(difluoromethylene) cyclopentanecarboxylic acid hydrochloride', 'eu_mah_current': 'Catalent Pharma Solutions Limited', 'orphan_status': 'o', 'eu_aut_date': '02-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/109/11', 'ema_number_certainty': '1.0'}"
EU-3-12-958,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/958', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/958', 'active_substance': 'N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine and folic acid', 'eu_mah_current': 'Endocyte Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/095/11', 'ema_number_certainty': '1.0'}"
EU-3-12-959,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/959', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/959', 'active_substance': 'Vincaleukoblastin-23-oic acid, O4-deacetyl-2-[(2-mercaptoethoxy)carbonyl]hydrazide, disulfide with N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-gamma-glutamyl-L-alpha-aspartyl-L-arginyl-L-alpha-aspartyl-L-alpha-aspartyl-L-cysteine', 'eu_mah_current': 'Endocyte Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/094/11', 'ema_number_certainty': '1.0'}"
EU-3-12-962,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/962', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/962', 'active_substance': 'Chimeric monoclonal antibody against kappa myeloma antigen', 'eu_mah_current': 'Gregory Fryer Associates Ltd', 'orphan_status': 'o', 'eu_aut_date': '05-22-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/137/11', 'ema_number_certainty': '1.0'}"
EU-3-12-966,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/966', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/966', 'active_substance': '(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N&#39;-bis(2-bromoethyl) diamidophosphate', 'eu_mah_current': 'Merck KGaA', 'orphan_status': 'o', 'eu_aut_date': '03-05-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/110/11', 'ema_number_certainty': '1.0'}"
EU-3-12-972,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/972', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/972', 'active_substance': 'Sialic acid', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-05-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/126/11', 'ema_number_certainty': '1.0'}"
EU-3-12-977,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/977', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/977', 'active_substance': 'Linsitinib', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-02-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/145/11', 'ema_number_certainty': '1.0'}"
EU-3-12-984,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/984', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/984', 'active_substance': '1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4 d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/156/11', 'ema_number_certainty': '1.0'}"
EU-3-12-986,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/986', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/986', 'active_substance': 'Pomalidomide', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/163/11', 'ema_number_certainty': '1.0'}"
EU-3-12-987,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/987', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/987', 'active_substance': '(E)-2,4,6-trimethoxystyryl-3-carboxymethylamino-4-methoxybenzyl-sulfone sodium salt', 'eu_mah_current': 'Onconova Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/161/11', 'ema_number_certainty': '1.0'}"
EU-3-12-988,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/988', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/988', 'active_substance': 'Halofuginone Hydrobromide', 'eu_mah_current': 'Biological Consulting Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/162/11', 'ema_number_certainty': '1.0'}"
EU-3-12-989,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/989', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/989', 'active_substance': '2-Allyl-1-[6-(1-hydroxy-1-methylethyl)pyridin-2-yl]-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one', 'eu_mah_current': 'AstraZeneca UK Limited', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/151/11', 'ema_number_certainty': '1.0'}"
EU-3-12-995,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/995', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/995', 'active_substance': 'Pegylated recombinant factor VIII', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '04-26-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/144/11', 'ema_number_certainty': '1.0'}"
EU-3-12-1000,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1000', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1000', 'active_substance': 'Polyinosine-polycytidylic acid coupled with the polycationic polyethyleneimine', 'eu_mah_current': 'Bioncotech Therapeutics S.L.', 'orphan_status': 'o', 'eu_aut_date': '06-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/007/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1001,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1001', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1001', 'active_substance': '1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl] thieno [3,2-c]pyridin-3-yl}phenyl)-3-(3-fluorophenyl)urea', 'eu_mah_current': 'AbbVie Ltd', 'orphan_status': 'o', 'eu_aut_date': '06-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/002/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1002,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1002', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1002', 'active_substance': 'Adenovirus-associated vector containing human Fas-c gene', 'eu_mah_current': 'KCR S.A.', 'orphan_status': 'o', 'eu_aut_date': '06-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/157/11', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-12-1003,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1003', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1003', 'active_substance': 'Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA', 'eu_mah_current': 'bluebird bio (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/009/12', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-1004,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1004', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1004', 'active_substance': 'Ramucirumab', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/030/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1005,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1005', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1005', 'active_substance': 'Talarozole', 'eu_mah_current': 'Stiefel Laboratories (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/005/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1006,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1006', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1006', 'active_substance': 'Doxorubicin (administered after synthetic double-stranded siRNA oligonucleotide directed against claudin-5 complexed with polyethyleneimine)', 'eu_mah_current': 'Avena Therapeutics Ltd', 'orphan_status': 'o', 'eu_aut_date': '11-28-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/019/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1007,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1007', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1007', 'active_substance': '17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (after administration of adeno-associated viral vector encoding an inducible short hairpin RNA targeting claudin-5)', 'eu_mah_current': 'Avena Therapeutics Ltd', 'orphan_status': 'o', 'eu_aut_date': '11-28-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/021/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1014,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1014', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1014', 'active_substance': 'Talarozole', 'eu_mah_current': 'Stiefel Laboratories (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/053/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1015,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1015', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1015', 'active_substance': 'Eculizumab', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/013/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1017,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1017', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1017', 'active_substance': 'Talarozole', 'eu_mah_current': 'Stiefel Laboratories (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-05-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/054/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1019,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1019', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1019', 'active_substance': 'Ramucirumab', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-04-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/031/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1029,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1029', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1029', 'active_substance': 'Humanised monoclonal antibody against epidermal growth factor receptor', 'eu_mah_current': 'AbbVie Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/049/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1030,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1030', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1030', 'active_substance': 'Vatreptacog alfa (activated)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/069/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1032,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1032', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1032', 'active_substance': 'Vatreptacog alfa (activated)', 'eu_mah_current': 'Novo Nordisk A/S', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/070/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1035,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1035', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1035', 'active_substance': 'Recombinant human monoclonal antibody against activin receptor type IIB', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/046/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1036,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1036', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1036', 'active_substance': 'Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl] cyclohexane acetic acid sodium salt', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '09-14-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/071/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1037,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1037', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1037', 'active_substance': 'Elotuzumab', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/061/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1042,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1042', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1042', 'active_substance': 'Covalently closed DNA plasmids coding for cytomegalovirus phosphoprotein 65 and glycoprotein B genes', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-09-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/003/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1043,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1043', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1043', 'active_substance': 'N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine to be used with folic acid', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '09-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/055/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1044,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1044', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1044', 'active_substance': 'Folic acid to be used with N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine', 'eu_mah_current': 'Endocyte Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '09-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/056/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1047,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1047', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1047', 'active_substance': 'Asp-Arg-Val-Tyr-Ile-His-Pro', 'eu_mah_current': 'Gregory Fryer Associates Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/062/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1048,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1048', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1048', 'active_substance': 'Mixture of two allogeneic human pancreatic cancer cell lines stably transduced with a retroviral vector encoding the murine alpha-(1,3)-galactosyltransferase gene', 'eu_mah_current': 'European Medical Advisory Services Limited', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/065/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1049,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1049', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1049', 'active_substance': 'Rucaparib', 'eu_mah_current': 'Clovis Oncology UK Limited', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/085/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1056,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1056', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1056', 'active_substance': 'Liposomal daunorubicin', 'eu_mah_current': 'Galen limited', 'orphan_status': 'o', 'eu_aut_date': '10-10-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/105/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1059,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1059', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1059', 'active_substance': 'Milciclib maleate', 'eu_mah_current': 'Tiziana Life Sciences PLC', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/093/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1060,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1060', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1060', 'active_substance': 'Ixazomib', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/110/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1061,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1061', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1061', 'active_substance': 'Tralokinumab', 'eu_mah_current': 'MedImmune Ltd', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/111/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1064,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1064', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1064', 'active_substance': 'Alisertib', 'eu_mah_current': 'Takeda Development Centre Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/114/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1065,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1065', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1065', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against claudin-5 complexed with polyethyleneimine (prior to administration of doxorubicin)', 'eu_mah_current': 'Avena Therapeutics Ltd', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/136/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1069,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1069', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1069', 'active_substance': 'Adeno-associated viral vector encoding an inducible short hairpin RNA targeting claudin-5 (prior to administration of 17-dimethylaminoethylamino-17-demethoxygeldanamycin)', 'eu_mah_current': 'Avena Therapeutics Ltd', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/135/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1071,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1071', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1071', 'active_substance': 'Canakinumab', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-08-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/060/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1073,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1073', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1073', 'active_substance': 'Maytansinoid-conjugated human monoclonal antibody against mesothelin', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/063/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1074,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1074', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1074', 'active_substance': 'Alisertib', 'eu_mah_current': 'Takeda Development Centre Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/104/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1080,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1080', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1080', 'active_substance': '4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/124/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1081,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1081', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1081', 'active_substance': 'Triheptanoin', 'eu_mah_current': 'B. Braun Melsungen AG', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/126/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1082,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1082', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1082', 'active_substance': 'Triheptanoin', 'eu_mah_current': 'B. Braun Melsungen AG', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/127/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1083,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1083', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1083', 'active_substance': 'Humanised single chain monoclonal antibody against CD37', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '12-06-2012', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/128/12', 'ema_number_certainty': '0.75'}"
EU-3-12-1090,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1090', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1090', 'active_substance': 'Recombinant human monoclonal antibody of the IgG1 kappa class against prostate stem cell antigen', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/145/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1091,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1091', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1091', 'active_substance': 'Autologous CD34+ haematopoietic stem cells transduced with lentiviral vector encoding the human betaA-T87Q-globin gene', 'eu_mah_current': 'bluebird bio (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/146/12', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-12-1092,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1092', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1092', 'active_substance': 'Chimeric monoclonal antibody against claudin 6', 'eu_mah_current': 'Astellas Pharma Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/147/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1096,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1096', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1096', 'active_substance': 'Terguride', 'eu_mah_current': 'medac Gesellschaft f&#252;r klinische Spezialpr&#228;parate mbH', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/153/12', 'ema_number_certainty': '1.0'}"
EU-3-12-1097,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/12/1097', 'status_type': 'w', 'eu_pnumber': 'EU/3/12/1097', 'active_substance': 'Lenalidomide', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-24-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/158/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1101,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1101', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1101', 'active_substance': 'Progesterone', 'eu_mah_current': 'BHR Pharma Belgium', 'orphan_status': 'o', 'eu_aut_date': '02-08-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/141/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1104,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1104', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1104', 'active_substance': 'Terguride', 'eu_mah_current': 'High Tech Participations GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-08-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/156/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1105,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1105', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1105', 'active_substance': 'Humanised monoclonal antibody against myostatin', 'eu_mah_current': 'Pfizer Europe MA EEIG', 'orphan_status': 'o', 'eu_aut_date': '02-08-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/164/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1109,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1109', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1109', 'active_substance': '4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-quinoline-6-carboxamide monohydrate', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/159/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1110,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1110', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1110', 'active_substance': 'Recombinant human heat shock protein 70', 'eu_mah_current': 'Orphazyme ApS', 'orphan_status': 'o', 'eu_aut_date': '03-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/160/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1111,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1111', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1111', 'active_substance': 'Gevokizumab', 'eu_mah_current': 'XOMA UK Limited', 'orphan_status': 'o', 'eu_aut_date': '03-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/161/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1112,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1112', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1112', 'active_substance': 'Poloxamer 188', 'eu_mah_current': 'Theradex (Europe) Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/162/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1113,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1113', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1113', 'active_substance': 'Murine IgM monoclonal antibody binding to alpha beta T-cell receptor', 'eu_mah_current': 'CTI Clinical Trial and Consulting Services Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/165/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1115,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1115', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1115', 'active_substance': '1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '03-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/171/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1116,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1116', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1116', 'active_substance': 'Mepolizumab', 'eu_mah_current': 'GlaxoSmithKline (Ireland) Limited', 'orphan_status': 'o', 'eu_aut_date': '03-12-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/174/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1119,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1119', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1119', 'active_substance': 'Lenvatinib', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/019/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1120,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1120', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1120', 'active_substance': '4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-quinoline-6-carboxamide monohydrate', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/170/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1121,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1121', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1121', 'active_substance': 'Lenvatinib', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/173/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1123,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1123', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1123', 'active_substance': 'Nintedanib', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/186/12', 'ema_number_certainty': '1.0'}"
EU-3-13-1125,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1125', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1125', 'active_substance': '(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one', 'eu_mah_current': 'Verastem Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '04-26-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/196/12', 'ema_number_certainty': '0.75'}"
EU-3-13-1132,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1132', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1132', 'active_substance': 'N-methyl-4-({4-[({3-methyl(methylsulfonyl)aminopyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/012/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1138,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1138', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1138', 'active_substance': 'Copper meso-5,15-bis[3-[(1,2-dicarba-closo-dodecaboranyl)methoxy]phenyl]-meso-10,20-dinitroporphyrin', 'eu_mah_current': 'TurnKey PharmaConsulting Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-27-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/022/13', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-13-1144,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1144', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1144', 'active_substance': 'Recombinant human alpha-N-acetylglucosaminidase', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '06-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/035/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1146,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1146', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1146', 'active_substance': 'Unoprostone isopropyl', 'eu_mah_current': 'Wainwright Associates Limited', 'orphan_status': 'o', 'eu_aut_date': '06-19-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/067/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1150,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1150', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1150', 'active_substance': 'Moxetumomab pasudotox', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/024/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1152,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1152', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1152', 'active_substance': '(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N-bis(2-bromoethyl)diamidophosphate', 'eu_mah_current': 'Chiltern International Limited', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/037/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1154,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1154', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1154', 'active_substance': 'Fosbretabulin tromethamine', 'eu_mah_current': 'Diamond Pharma Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/039/13', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-13-1157,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1157', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1157', 'active_substance': '(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one', 'eu_mah_current': 'Verastem Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/047/13', 'ema_number_certainty': '0.75'}"
EU-3-13-1159,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1159', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1159', 'active_substance': 'Idelalisib', 'eu_mah_current': 'Gilead Sciences International Limited', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/053/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1160,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1160', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1160', 'active_substance': 'Idelalisib', 'eu_mah_current': 'Gilead Sciences International Limited', 'orphan_status': 'o', 'eu_aut_date': '07-17-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/055/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1172,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1172', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1172', 'active_substance': 'Idelalisib', 'eu_mah_current': 'Gilead Sciences International Limited', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/054/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1173,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1173', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1173', 'active_substance': 'Idelalisib', 'eu_mah_current': 'Gilead Sciences International Limited', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/056/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1175,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1175', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1175', 'active_substance': 'Tolvaptan', 'eu_mah_current': 'Otsuka Pharmaceutical Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/066/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1179,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1179', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1179', 'active_substance': 'Recombinant human growth hormone modified by fusion with two hydrophilic polypeptide chains', 'eu_mah_current': 'Larode Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/074/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1180,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1180', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1180', 'active_substance': 'Apremilast', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/076/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1186,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1186', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1186', 'active_substance': 'Idelalisib', 'eu_mah_current': 'Gilead Sciences International Limited', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/105/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1187,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1187', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1187', 'active_substance': 'Idelalisib', 'eu_mah_current': 'Gilead Sciences International Limited', 'orphan_status': 'o', 'eu_aut_date': '08-05-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/106/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1194,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1194', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1194', 'active_substance': 'Naproxcinod', 'eu_mah_current': 'NicOx', 'orphan_status': 'o', 'eu_aut_date': '10-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/090/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1195,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1195', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1195', 'active_substance': 'Antisense oligonucleotide targeting the F508delta mutation of CFTR', 'eu_mah_current': 'ProQR Therapeutics III BV', 'orphan_status': 'o', 'eu_aut_date': '10-07-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/096/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1198,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1198', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1198', 'active_substance': 'Recombinant human insulin receptor monoclonal antibody-fused iduronate 2-sulfatase', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/091/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1202,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1202', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1202', 'active_substance': 'Tivantinib', 'eu_mah_current': 'Daiichi Sankyo Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/115/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1203,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1203', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1203', 'active_substance': 'Ibrutinib', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/116/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1205,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1205', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1205', 'active_substance': 'Human monoclonal antibody against human interleukin 13', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-13-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/118/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1212,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1212', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1212', 'active_substance': 'Ibrutinib', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/111/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1215,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1215', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1215', 'active_substance': '(4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride', 'eu_mah_current': 'Mirum Pharmaceuticals International B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/121/13', 'ema_number_certainty': '0.4'}"
EU-3-13-1217,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1217', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1217', 'active_substance': '(4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride', 'eu_mah_current': 'Mirum Pharmaceuticals International B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/127/13', 'ema_number_certainty': '0.4'}"
EU-3-13-1218,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1218', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1218', 'active_substance': 'Recombinant human type I pancreatic elastase', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/139/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1221,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1221', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1221', 'active_substance': 'Humanised monoclonal modified IgG4 antibody with bispecific structure targeting factors IX, IXa, X and Xa', 'eu_mah_current': 'Roche Registration Limited', 'orphan_status': 'o', 'eu_aut_date': '12-18-2013', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/144/13', 'ema_number_certainty': '1.0'}"
EU-3-13-1227,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1227', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1227', 'active_substance': 'Adenovirus-specific T-cells derived from allogeneic donor leukocytes, expanded ex vivo', 'eu_mah_current': 'Clinical Network Services (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/135/13', 'ema_number_certainty': '0.5'}"
EU-3-13-1228,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1228', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1228', 'active_substance': 'Obeticholic acid', 'eu_mah_current': 'Intercept Pharma International Limited', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/136/13', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-13-1232,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1232', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1232', 'active_substance': 'Allantoin', 'eu_mah_current': 'Amicus Therapeutics Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/145/13', 'ema_number_certainty': '0.75'}"
EU-3-13-1234,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/13/1234', 'status_type': 'w', 'eu_pnumber': 'EU/3/13/1234', 'active_substance': 'N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino) phenyl)acrylamide benzenesulfonic acid salt', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '01-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/151/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1235,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1235', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1235', 'active_substance': 'Mixture of recombinant human IgG1 monoclonal antibodies against human cytomegalovirus envelope glycoproteins', 'eu_mah_current': 'Roche Registration Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/134/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1238,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1238', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1238', 'active_substance': 'Eculizumab', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/154/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1244,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1244', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1244', 'active_substance': 'Ruxolitinib', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '02-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/169/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1251,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1251', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1251', 'active_substance': 'Recombinant human alpha-glucosidase conjugated with multiple copies of synthetic bismannose-6-phosphate-tetra-mannose glycan', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/148/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1254,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1254', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1254', 'active_substance': 'Eculizumab', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '03-26-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/176/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1263,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1263', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1263', 'active_substance': 'Autologous CD34+ haematopoietic stem cells transduced with lentiviral vector encoding the human beta A-T87Q-globin gene', 'eu_mah_current': 'bluebird bio (Netherlands) B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/184/13', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-14-1264,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1264', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1264', 'active_substance': 'Ibrutinib', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '04-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/185/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1267,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1267', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1267', 'active_substance': 'Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues', 'eu_mah_current': 'Alnylam UK Limited', 'orphan_status': 'o', 'eu_aut_date': '04-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/194/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1268,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1268', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1268', 'active_substance': 'Humanised monoclonal antibody against CD38', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'o', 'eu_aut_date': '04-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/198/13', 'ema_number_certainty': '1.0'}"
EU-3-14-1287,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1287', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1287', 'active_substance': 'Beloranib', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/023/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1289,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1289', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1289', 'active_substance': 'Recombinant human alpha-1-microglobulin', 'eu_mah_current': 'Guard Therapeutics International AB', 'orphan_status': 'o', 'eu_aut_date': '07-04-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/027/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1292,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1292', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1292', 'active_substance': 'Carboxy pyrrolidine hexanoyl pyrrolidine carboxylate', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'o', 'eu_aut_date': '07-30-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/020/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1293,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1293', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1293', 'active_substance': 'Recombinant monoclonal antibody to human serum amyloid P component', 'eu_mah_current': 'GlaxoSmithKline Trading Services Limited', 'orphan_status': 'o', 'eu_aut_date': '07-30-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/021/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1299,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1299', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1299', 'active_substance': 'Riociguat', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/044/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1305,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1305', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1305', 'active_substance': 'Humanised recombinant monoclonal antibody against epidermal growth factor receptor conjugated to maleimidocaproyl monomethylauristatin F', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '07-29-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/065/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1311,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1311', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1311', 'active_substance': 'Gevokizumab', 'eu_mah_current': 'XOMA UK Limited', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/053/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1321,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1321', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1321', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene', 'eu_mah_current': 'Fondazione Telethon', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/082/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1325,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1325', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1325', 'active_substance': 'Obinutuzumab', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/092/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1333,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1333', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1333', 'active_substance': 'Lumacaftor / ivacaftor', 'eu_mah_current': 'Vertex Pharmaceuticals (U.K.) Limited', 'orphan_status': 'o', 'eu_aut_date': '08-22-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/032/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1335,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1335', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1335', 'active_substance': '(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile', 'eu_mah_current': 'Almirall, S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-15-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/091/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1355,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1355', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1355', 'active_substance': 'Selinexor', 'eu_mah_current': 'Karyopharm Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/087/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1356,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1356', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1356', 'active_substance': 'Donor T lymphocytes depleted ex vivo of host alloreactive T cells using photodynamic treatment', 'eu_mah_current': 'Kiadis Pharma Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/103/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1361,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1361', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1361', 'active_substance': '1-(6-benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic acid', 'eu_mah_current': 'Inventiva', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/129/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1369,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1369', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1369', 'active_substance': 'Siponimod', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/146/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1370,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1370', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1370', 'active_substance': 'Siponimod', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/147/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1380,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1380', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1380', 'active_substance': 'Ataluren', 'eu_mah_current': 'PTC Therapeutics International Limited', 'orphan_status': 'o', 'eu_aut_date': '11-19-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/165/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1382,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1382', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1382', 'active_substance': 'Allogeneic CD34+ cells expanded ex vivo with an aryl hydrocarbon receptor antagonist', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/120/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1391,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1391', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1391', 'active_substance': '5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-2-pyrimidinamine', 'eu_mah_current': 'TMC Pharma Services Ltd', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/168/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1405,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1405', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1405', 'active_substance': 'Autologous collagen type II-specific regulatory T cells', 'eu_mah_current': 'TxCell', 'orphan_status': 'o', 'eu_aut_date': '12-16-2014', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/195/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1410,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1410', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1410', 'active_substance': 'Recombinant human aspartylglucosaminidase', 'eu_mah_current': 'Chiesi Farmaceutici S.p.A.', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/172/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1411,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1411', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1411', 'active_substance': 'Pentosan polysulfate sodium', 'eu_mah_current': 'bene-Arzneimittel GmbH', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/179/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1413,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1413', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1413', 'active_substance': 'Allogeneic, umbilical cord blood-derived, ex vivo-expanded, haematopoietic CD133+ cells / allogeneic, umbilical cord blood-derived, non-expanded, haematopoietic CD133- cells', 'eu_mah_current': 'Regulatory Resources Group Ltd', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/188/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1421,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1421', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1421', 'active_substance': 'Ponatinib hydrochloride', 'eu_mah_current': 'Incyte Biosciences Distribution B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/212/14', 'ema_number_certainty': '1.0'}"
EU-3-14-1426,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/14/1426', 'status_type': 'w', 'eu_pnumber': 'EU/3/14/1426', 'active_substance': 'Allogeneic peripheral blood mononuclear cells induced to an early apoptotic state', 'eu_mah_current': 'Richardson Associates Regulatory Affairs Ltd', 'orphan_status': 'o', 'eu_aut_date': '01-15-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/217/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1431,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1431', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1431', 'active_substance': '3-[2-(4-carbamimidoyl-phenylcarbamoyl)-5-methoxy-4-vinyl-phenyl]-6-(cyclopropylmethyl-carbamoyl)-pyridine-2-carboxylic acid', 'eu_mah_current': 'BioCryst UK Ltd', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/170/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1434,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1434', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1434', 'active_substance': 'Chimeric group B adenovirus (11p/3) with deletions in the E3 and E4 regions', 'eu_mah_current': 'Regulis Consulting Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/211/14', 'ema_number_certainty': '0.5'}"
EU-3-15-1441,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1441', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1441', 'active_substance': '5-hydroxymethyl-2-furfural', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/249/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1443,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1443', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1443', 'active_substance': 'Recombinant human glutamate oxaloacetate transaminase 1', 'eu_mah_current': 'Dr Regenold GmbH', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/251/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1444,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1444', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1444', 'active_substance': 'Mazindol', 'eu_mah_current': 'HAC Pharma', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/254/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1445,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1445', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1445', 'active_substance': 'Ulocuplumab', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/258/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1447,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1447', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1447', 'active_substance': 'Olaratumab', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/266/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1448,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1448', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1448', 'active_substance': '505 amino acid protein, corresponding to amino acids 2-506 of the wild type human histidyl-tRNA synthetase', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '02-12-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/268/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1452,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1452', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1452', 'active_substance': 'Tideglusib', 'eu_mah_current': 'AMO Pharma Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/253/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1457,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1457', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1457', 'active_substance': '[5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine hydrochloride', 'eu_mah_current': 'Daiichi Sankyo Europe GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/279/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1460,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1460', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1460', 'active_substance': 'Lenvatinib', 'eu_mah_current': 'Eisai GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/287/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1463,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1463', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1463', 'active_substance': 'Melphalan flufenamide', 'eu_mah_current': 'Oncopeptides AB', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/293/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1468,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1468', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1468', 'active_substance': 'Adeno-associated viral vector serotype 9 containing the human glucocerebrosidase gene', 'eu_mah_current': 'Gauchers Association', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/303/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1471,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1471', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1471', 'active_substance': 'Trientine tetrahydrochloride', 'eu_mah_current': 'gmp-orphan SA', 'orphan_status': 'o', 'eu_aut_date': '03-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/001/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1473,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1473', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1473', 'active_substance': 'Lenalidomide', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/284/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1474,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1474', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1474', 'active_substance': 'Ecothiopate iodide', 'eu_mah_current': 'Dorian Regulatory Affairs BV', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/295/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1481,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1481', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1481', 'active_substance': 'Phenol, 4-[2-(aminomethyl)-4-thiazolyl]-2,6-bis(1,1-dimethylethyl)monohydrochloride', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/311/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1484,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1484', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1484', 'active_substance': 'Nitric oxide', 'eu_mah_current': 'Biological Consulting Europe Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-24-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/319/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1487,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1487', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1487', 'active_substance': 'Reduced oxydised N-acetyl heparin', 'eu_mah_current': 'Leadiant GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/277/14', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-15-1488,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1488', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1488', 'active_substance': '{2-amino-8-[4-(pyrrolidinylcarbonyl)phenyl]-(3H-benzo[f]azepin-4-yl)}-N,N-dipropylcarboxamide', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/314/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1489,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1489', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1489', 'active_substance': 'Fusion proteins composed by a genetically modified cholera toxin subunit A1, peptides from the acetylcholine receptor alpha chain and a dimer of the D fragment from Staphylococcus aureus protein A', 'eu_mah_current': 'Toleranzia AB', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/318/14', 'ema_number_certainty': '1.0'}"
EU-3-15-1494,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1494', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1494', 'active_substance': 'Humanised anti-CD37 monoclonal antibody conjugated to maytansinoid DM1', 'eu_mah_current': 'Voisin Consulting Life Sciences', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/005/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1495,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1495', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1495', 'active_substance': 'Triheptanoin', 'eu_mah_current': 'Ultragenyx Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/007/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1497,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1497', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1497', 'active_substance': '5,7-dichloro-2-dimethylaminomethyl-8-hydroxyquinoline hydrochloride', 'eu_mah_current': 'Drug Development and Regulation S.L.', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/017/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1498,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1498', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1498', 'active_substance': '2-(7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2(1H)-yl)-N-methyl-N-(2-methylbenzo[d]oxazol-6-yl)acetamide', 'eu_mah_current': 'Clinical Network Services (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '05-21-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/018/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1501,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1501', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1501', 'active_substance': 'Adeno-associated viral vector containing the human factor IX gene', 'eu_mah_current': 'Baxalta Innovations GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/003/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1505,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1505', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1505', 'active_substance': 'Obinutuzumab', 'eu_mah_current': 'Roche Registration Limited', 'orphan_status': 'o', 'eu_aut_date': '06-19-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/014/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1528,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1528', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1528', 'active_substance': 'Synthetic double-stranded RNA oligonucleotide specific to hydroxyacid oxidase 1 gene', 'eu_mah_current': 'Dicerna EU Limited', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/052/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1530,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1530', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1530', 'active_substance': 'Beloranib', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '07-28-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/057/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1537,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1537', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1537', 'active_substance': 'Verucerfont', 'eu_mah_current': 'Neurocrine Therapeutics Ltd', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/063/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1541,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1541', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1541', 'active_substance': 'Ibrutinib', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/082/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1542,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1542', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1542', 'active_substance': '2&#39;-deoxyguanosylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxythymidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxyguanosylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxyguanosylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidilyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxythymidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxyadenosyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxyguanosylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxyguanosylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxyadenosyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxyguanosylyl-2&#39;-deoxycytidylyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxyadenosyl-(3&#39;,5&#39;-phosphoryl)-2&#39;-deoxycytidine, sodium salt', 'eu_mah_current': 'PhaRA bvba', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/084/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1545,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1545', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1545', 'active_substance': 'CD33-directed antibody-drug conjugate consisting of an antibody conjugated to a DNA cross-linking pyrrolobenzodiazepine dimer drug', 'eu_mah_current': 'Seagen Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/089/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1546,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1546', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1546', 'active_substance': 'Allogeneic umbilical cord blood cells treated ex vivo with 16,16-dimethyl prostaglandin E2', 'eu_mah_current': 'Fate Therapeutics, LTD', 'orphan_status': 'o', 'eu_aut_date': '08-10-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/090/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1550,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1550', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1550', 'active_substance': '3-pentylbenzeneacetic acid sodium salt', 'eu_mah_current': 'Prometic Pharma SMT B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/072/15', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-15-1552,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1552', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1552', 'active_substance': 'Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/077/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1555,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1555', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1555', 'active_substance': 'Synthetic hepcidin', 'eu_mah_current': 'La Jolla Pharmaceutical II B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/092/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1558,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1558', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1558', 'active_substance': 'Three chimeric human/murine monoclonal antibodies against the Ebola (Zaire) surface glycoprotein', 'eu_mah_current': 'Granzer Regulatory Consulting &amp; Services', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/102/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1560,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1560', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1560', 'active_substance': 'N-(2-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenamido)ethyl)-2-hydroxybenzamide', 'eu_mah_current': 'FGK Representative Service GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/109/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1564,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1564', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1564', 'active_substance': 'Dronabinol and cannabidiol', 'eu_mah_current': 'GW Research Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-09-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/113/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1569,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1569', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1569', 'active_substance': 'Pentetrazol', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/097/15', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-15-1570,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1570', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1570', 'active_substance': 'Azacitidine', 'eu_mah_current': 'Celgene Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/098/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1571,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1571', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1571', 'active_substance': 'Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/107/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1572,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1572', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1572', 'active_substance': 'Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor', 'eu_mah_current': 'Kite Pharma EU B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/108/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1580,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1580', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1580', 'active_substance': 'N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4 methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '11-11-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/136/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1583,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1583', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1583', 'active_substance': '2-amino-2-[2-[2-chloro-4-[[3-(phenylmethoxy)phenyl]thio]phenyl]ethyl]-1,3-propanediol hydrochloride', 'eu_mah_current': 'Novartis Europharm Limited', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/131/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1590,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1590', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1590', 'active_substance': 'Recombinant human monoclonal IgG1 antibody against programmed death ligand-1', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/150/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1597,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1597', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1597', 'active_substance': 'Sodium (2R,3S,5R)-5-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)-2-(hydroxymethyl)tetrahydrofuran-3-yl ((2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate', 'eu_mah_current': 'Otsuka Pharmaceutical Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/165/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1599,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1599', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1599', 'active_substance': 'Adeno-associated viral vector serotype rh10 containing the human factor IX gene', 'eu_mah_current': 'Ultragenyx Germany GmbH', 'orphan_status': 'o', 'eu_aut_date': '12-14-2015', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/172/15', 'ema_number_certainty': '0.5'}"
EU-3-15-1603,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1603', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1603', 'active_substance': 'Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin', 'eu_mah_current': 'Aduro Biotech Holdings, Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/168/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1604,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1604', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1604', 'active_substance': 'Two allogenic irradiated pancreatic tumour cell lines', 'eu_mah_current': 'Aduro Biotech Holdings, Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/169/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1605,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1605', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1605', 'active_substance': 'Synthetic double-stranded oligomer specific to the SERPINA1 gene and containing a cholesterol-conjugated, acyclic nucleobase analogue', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '01-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/178/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1606,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1606', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1606', 'active_substance': '(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '01-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/184/15', 'ema_number_certainty': '1.0'}"
EU-3-15-1607,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/15/1607', 'status_type': 'w', 'eu_pnumber': 'EU/3/15/1607', 'active_substance': 'Entolimod', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '01-11-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/191/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1612,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1612', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1612', 'active_substance': 'Methyl 3-((2R)-2-hydroxy-4-(((((S)-1-methoxy-1-oxopropan-2-yl) amino)(phenoxy)phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate', 'eu_mah_current': 'Retrophin Europe Limited', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/189/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1617,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1617', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1617', 'active_substance': 'Venetoclax', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '02-17-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/205/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1624,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1624', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1624', 'active_substance': 'Acalabrutinib', 'eu_mah_current': 'AstraZeneca AB', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/196/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1630,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1630', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1630', 'active_substance': 'Fenretinide', 'eu_mah_current': 'Clinipace GmbH', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/203/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1633,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1633', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1633', 'active_substance': 'Fosbretabulin tromethamine', 'eu_mah_current': 'Diamond Pharma Services Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/211/15', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-16-1634,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1634', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1634', 'active_substance': 'Glucopyranosyl lipid A stable emulsion and recombinant New York esophageal squamous cell carcinoma-1 protein', 'eu_mah_current': 'Immune Design Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/159/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1636,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1636', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1636', 'active_substance': 'Sindbis virus envelope pseudotyped lentiviral vector encoding New York esophageal squamous cell carcinoma-1 protein', 'eu_mah_current': 'Immune Design Ltd', 'orphan_status': 'o', 'eu_aut_date': '03-21-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/238/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1643,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1643', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1643', 'active_substance': 'Autologous stromal vascular cell fraction from adipose tissue', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/257/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1647,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1647', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1647', 'active_substance': 'Fluocinolone acetonide', 'eu_mah_current': 'Campharm Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/219/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1648,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1648', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1648', 'active_substance': 'Human/murine chimeric monoclonal antibody against endoglin', 'eu_mah_current': 'Tracon Pharma International Limited', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/215/15', 'ema_number_certainty': '0.5'}"
EU-3-16-1649,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1649', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1649', 'active_substance': 'Humanised recombinant IgG4 anti-human tau antibody', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/239/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1650,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1650', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1650', 'active_substance': 'N-carboxymethyl-glycyl-L-threonyl-L-histidyl-L-3,3-diphenylalanyl-L-piperidincarboxy-3-yl-L-arginyl-L-S-methylthio-cystyl-L-arginyl-L-tryptophyl-aminohexanyl-N-carboxamidomethyl-glycine N-hexadecylamide', 'eu_mah_current': 'QRC Consultants Ltd', 'orphan_status': 'o', 'eu_aut_date': '04-28-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/242/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1658,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1658', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1658', 'active_substance': '4-[(2E)-1-oxo-3-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-propen-1-yl]-1-piperazinecarboxamide', 'eu_mah_current': 'Shire Pharmaceuticals Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/208/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1659,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1659', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1659', 'active_substance': 'Arimoclomol citrate', 'eu_mah_current': 'Orphazyme A/S', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/256/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1661,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1661', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1661', 'active_substance': 'Fc- and CDR-modified humanised monoclonal antibody against C5', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/246/15', 'ema_number_certainty': '1.0'}"
EU-3-16-1666,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1666', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1666', 'active_substance': 'Rimiducid', 'eu_mah_current': 'Bellicum Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/017/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1667,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1667', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1667', 'active_substance': 'Rovalpituzumab tesirine', 'eu_mah_current': 'AbbVie Deutschland GmbH &amp; Co. KG', 'orphan_status': 'o', 'eu_aut_date': '05-30-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/015/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1674,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1674', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1674', 'active_substance': 'Allogeneic donor-derived ex-vivo expanded T lymphocytes transduced with a retroviral vector containing inducible caspase 9 and truncated CD19', 'eu_mah_current': 'Bellicum Pharma GmbH', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/020/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1676,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1676', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1676', 'active_substance': 'Cyclocreatine', 'eu_mah_current': 'Pharma Gateway AB', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/032/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1678,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1678', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1678', 'active_substance': 'Donor T lymphocytes depleted ex vivo of host alloreactive T cells using photodynamic treatment', 'eu_mah_current': 'Kiadis Pharma Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '06-27-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/008/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1691,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1691', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1691', 'active_substance': '2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid', 'eu_mah_current': 'Pfizer Limited', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/066/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1695,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1695', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1695', 'active_substance': 'Autologous Epstein-Barr virus specific T-cells derived from peripheral blood mononuclear cells, expanded ex vivo', 'eu_mah_current': 'Clinical Network Services (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/075/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1696,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1696', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1696', 'active_substance': 'Autologous Epstein-Barr virus specific T-cells derived from peripheral blood mononuclear cells, expanded ex vivo', 'eu_mah_current': 'Clinical Network Services (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '07-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/076/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1712,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1712', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1712', 'active_substance': '2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)-piperazin-1-yl)-8-methylimidazo[1,2-alpha]pyridin-3-yl)-(methyl)amino)-4-(4-fluorophenyl)-thiazole-5-carbonitrile', 'eu_mah_current': 'Galapagos NV', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/088/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1724,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1724', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1724', 'active_substance': 'Nintedanib', 'eu_mah_current': 'Boehringer Ingelheim International GmbH', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/095/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1728,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1728', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1728', 'active_substance': 'Recombinant humanised monoclonal antibody against human complement component C5a', 'eu_mah_current': 'Alexion Europe SAS', 'orphan_status': 'o', 'eu_aut_date': '08-29-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/118/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1740,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1740', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1740', 'active_substance': 'Adeno-associated viral vector serotype 2/2 containing a gene encoding the channelrhodopsin-2 protein', 'eu_mah_current': 'Allergan Pharmaceuticals International Limited', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/158/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1751,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1751', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1751', 'active_substance': 'Fenretinide', 'eu_mah_current': 'Clinipace GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/131/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1762,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1762', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1762', 'active_substance': 'Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker', 'eu_mah_current': 'UCB Pharma', 'orphan_status': 'o', 'eu_aut_date': '10-14-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/107/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1772,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1772', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1772', 'active_substance': 'Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene', 'eu_mah_current': 'Audentes Therapeutics Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/133/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1773,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1773', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1773', 'active_substance': 'Allogeneic cytomegalovirus-specific cytotoxic T lymphocytes', 'eu_mah_current': 'Atara Biotherapeutics Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/151/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1774,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1774', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1774', 'active_substance': 'Allogeneic peripheral blood mononuclear cells incubated ex vivo with 16, 16-dimethyl prostaglandin E2 and dexamethasone', 'eu_mah_current': 'Fate Therapeutics B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/149/16', 'ema_number_certainty': '0.5'}"
EU-3-16-1780,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1780', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1780', 'active_substance': 'Ibrutinib', 'eu_mah_current': 'Janssen-Cilag International NV', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/178/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1789,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1789', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1789', 'active_substance': 'Synthetic human hepcidin', 'eu_mah_current': 'La Jolla Pharmaceutical II B.V.', 'orphan_status': 'o', 'eu_aut_date': '11-18-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/144/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1798,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1798', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1798', 'active_substance': 'Avelumab', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/170/16', 'ema_number_certainty': '1.0'}"
EU-3-16-1799,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1799', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1799', 'active_substance': 'Cabiralizumab', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '12-12-2016', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/169/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-16-1810,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/16/1810', 'status_type': 'w', 'eu_pnumber': 'EU/3/16/1810', 'active_substance': '3-pentylbenzeneacetic acid sodium salt', 'eu_mah_current': 'Prometic Pharma SMT B.V.', 'orphan_status': 'o', 'eu_aut_date': '01-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/231/16', 'ema_number_certainty': '0.5'}"
EU-3-17-1831,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1831', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1831', 'active_substance': '505 amino acid protein, corresponding to amino acids 2-506 of the wild-type human histidyl-tRNA synthetase', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '02-27-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/279/16', 'ema_number_certainty': '1.0'}"
EU-3-17-1856,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1856', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1856', 'active_substance': 'Inebilizumab', 'eu_mah_current': 'Viela Bio B.V.', 'orphan_status': 'o', 'eu_aut_date': '03-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/267/16', 'ema_number_certainty': '0.6666666666666666'}"
EU-3-17-1872,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1872', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1872', 'active_substance': 'Chimeric locked nucleic acid deoxynucleoside phosphorothioate-linked oligonucleotide inhibitor directed against microRNA-155-5p', 'eu_mah_current': 'Viridian Therapeutics S.&#224;.r.l.', 'orphan_status': 'o', 'eu_aut_date': '05-22-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/011/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1888,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1888', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1888', 'active_substance': 'Tripotassium citrate monohydrate and potassium hydrogen carbonate', 'eu_mah_current': 'Advicenne S.A.', 'orphan_status': 'o', 'eu_aut_date': '06-20-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/016/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1890,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1890', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1890', 'active_substance': 'Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '07-17-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/045/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-17-1898,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1898', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1898', 'active_substance': 'Adeno-associated viral vector serotype Anc80 containing the truncated human ATP7B gene under the control of the human alpha-1 antitrypsin promoter', 'eu_mah_current': 'Vivet Therapeutics S.A.S.', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/084/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1908,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1908', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1908', 'active_substance': 'Recombinant truncated N-terminal fragment of human lens epithelium-derived growth factor', 'eu_mah_current': 'Dorian Regulatory Affairs BV', 'orphan_status': 'o', 'eu_aut_date': '08-23-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/086/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1916,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1916', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1916', 'active_substance': '5-amino-1-(2-methyl-1H-benzo[d]imidazol-5-yl)-1H-pyrazol-4-yl 1H-indol-2-yl ketone mono[(S)-2-hydroxysuccinate]', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/124/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1919,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1919', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1919', 'active_substance': 'Bitopertin', 'eu_mah_current': 'Roche Registration GmbH', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/112/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1924,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1924', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1924', 'active_substance': 'Glucopyranosyl lipid A', 'eu_mah_current': 'Immune Design Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/103/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1926,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1926', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1926', 'active_substance': 'Ofranergene obadenovec', 'eu_mah_current': 'KCR S.A.', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/035/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-17-1927,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1927', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1927', 'active_substance': 'Pracinostat', 'eu_mah_current': 'Helsinn Birex Pharmaceuticals Ltd', 'orphan_status': 'o', 'eu_aut_date': '10-16-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/101/17', 'ema_number_certainty': '1.0'}"
EU-3-17-1951,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1951', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1951', 'active_substance': 'Agammaglobulinaemia tyrosine kinase', 'eu_mah_current': 'Scendea (NL) B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-12-2017', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/157/17', 'ema_number_certainty': '0.5'}"
EU-3-17-1958,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/17/1958', 'status_type': 'w', 'eu_pnumber': 'EU/3/17/1958', 'active_substance': 'Allogeneic umbilical cord blood CD34+ cells cultured ex vivo with Notch ligand Delta1', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '01-17-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/192/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1979,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/1979', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/1979', 'active_substance': 'Human monoclonal IgG2 antibody against tissue factor pathway inhibitor', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/189/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1980,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/1980', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/1980', 'active_substance': 'Levosimendan', 'eu_mah_current': 'Orion Corporation', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/174/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1981,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/1981', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/1981', 'active_substance': 'Mertansine functionalised gold nanoconjugate', 'eu_mah_current': 'Midatech Pharma Espana Sociedad Limitada', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/312/16', 'ema_number_certainty': '0.5'}"
EU-3-18-1986,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/1986', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/1986', 'active_substance': 'Seletalisib', 'eu_mah_current': 'UCB Biopharma', 'orphan_status': 'o', 'eu_aut_date': '02-22-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/205/17', 'ema_number_certainty': '1.0'}"
EU-3-18-1995,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/1995', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/1995', 'active_substance': 'Larotrectinib', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '03-21-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/213/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2009,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2009', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2009', 'active_substance': 'Autologous dendritic cells pulsed with killed ovarian cancer cells and matured by TLR3 ligand ex vivo', 'eu_mah_current': 'Sctbio a.s.', 'orphan_status': 'o', 'eu_aut_date': '04-16-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/246/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2018,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2018', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2018', 'active_substance': 'Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '05-25-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/260/17', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-2028,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2028', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2028', 'active_substance': '(R)-1-(3-(aminomethyl) phenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride', 'eu_mah_current': 'Biocryst Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/003/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2033,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2033', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2033', 'active_substance': 'Codon-optimised human ornithine transcarbamylase mRNA complexed with lipid-based nanoparticles', 'eu_mah_current': 'Real Regulatory Limited', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/022/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2038,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2038', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2038', 'active_substance': 'Palovarotene', 'eu_mah_current': 'Ipsen Pharma', 'orphan_status': 'o', 'eu_aut_date': '06-27-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/025/18', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-2060,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2060', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2060', 'active_substance': 'Adeno-associated viral vector serotype hu68 containing the human SMN1 gene', 'eu_mah_current': 'Biogen Netherlands B.V.', 'orphan_status': 'o', 'eu_aut_date': '08-24-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/065/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2071,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2071', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2071', 'active_substance': '6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile', 'eu_mah_current': 'Eli Lilly Nederland B.V.', 'orphan_status': 'o', 'eu_aut_date': '10-26-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/125/18', 'ema_number_certainty': '0.5'}"
EU-3-18-2084,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2084', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2084', 'active_substance': 'Anetumab ravtansine', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/258/17', 'ema_number_certainty': '1.0'}"
EU-3-18-2097,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2097', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2097', 'active_substance': 'Larotrectinib', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/116/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2098,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2098', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2098', 'active_substance': 'Larotrectinib', 'eu_mah_current': 'Bayer AG', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/117/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2099,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2099', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2099', 'active_substance': 'Lisocabtagene maraleucel', 'eu_mah_current': 'Bristol-Myers Squibb Pharma EEIG', 'orphan_status': 'o', 'eu_aut_date': '11-19-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/124/18', 'ema_number_certainty': '0.3333333333333333'}"
EU-3-18-2112,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2112', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2112', 'active_substance': 'Bifunctional fusion protein composed of two extracellular domains of transforming growth factor beta receptor II fused with a human immunoglobulin G1 monoclonal antibody against programmed death ligand 1', 'eu_mah_current': 'Merck Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/154/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2120,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2120', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2120', 'active_substance': 'Pevonedistat', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/164/18', 'ema_number_certainty': '1.0'}"
EU-3-18-2122,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/18/2122', 'status_type': 'w', 'eu_pnumber': 'EU/3/18/2122', 'active_substance': 'Venglustat', 'eu_mah_current': 'Genzyme Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-14-2018', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/148/18', 'ema_number_certainty': '1.0'}"
EU-3-19-2138,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/19/2138', 'status_type': 'w', 'eu_pnumber': 'EU/3/19/2138', 'active_substance': 'Anti-Epstein Barr virus cytotoxic lymphocytes', 'eu_mah_current': 'Common Services Agency (National Health Services - Scotland)', 'orphan_status': 'o', 'eu_aut_date': '02-26-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002426', 'ema_number_certainty': '1.0'}"
EU-3-19-2148,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/19/2148', 'status_type': 'w', 'eu_pnumber': 'EU/3/19/2148', 'active_substance': '4-hydroxy-6-{2-[4-(trifluoromethyl)phenyl]ethyl}pyridazin-3(2H)-one', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '04-01-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000002821', 'ema_number_certainty': '1.0'}"
EU-3-19-2163,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/19/2163', 'status_type': 'w', 'eu_pnumber': 'EU/3/19/2163', 'active_substance': 'N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide', 'eu_mah_current': 'Voisin Consulting S.A.R.L.', 'orphan_status': 'o', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000003888', 'ema_number_certainty': '1.0'}"
EU-3-19-2167,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/19/2167', 'status_type': 'w', 'eu_pnumber': 'EU/3/19/2167', 'active_substance': 'Zanubrutinib', 'eu_mah_current': 'BeiGene Ireland Limited', 'orphan_status': 'o', 'eu_aut_date': '05-29-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004269', 'ema_number_certainty': '1.0'}"
EU-3-19-2174,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/19/2174', 'status_type': 'w', 'eu_pnumber': 'EU/3/19/2174', 'active_substance': 'Rasagiline', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '06-28-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000003838', 'ema_number_certainty': '1.0'}"
EU-3-19-2186,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/19/2186', 'status_type': 'w', 'eu_pnumber': 'EU/3/19/2186', 'active_substance': 'Pevonedistat', 'eu_mah_current': 'Takeda Pharma A/S', 'orphan_status': 'o', 'eu_aut_date': '07-25-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000004845', 'ema_number_certainty': '1.0'}"
EU-3-19-2198,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/19/2198', 'status_type': 'w', 'eu_pnumber': 'EU/3/19/2198', 'active_substance': 'Adenoviral vector serotype 5 encoding the human interleukin-12 p70 transgene under the control of activator ligand veledimex', 'eu_mah_current': 'Ziopharm Oncology Limited', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009406', 'ema_number_certainty': '1.0'}"
EU-3-19-2199,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/19/2199', 'status_type': 'w', 'eu_pnumber': 'EU/3/19/2199', 'active_substance': 'Veledimex', 'eu_mah_current': 'Ziopharm Oncology Limited', 'orphan_status': 'o', 'eu_aut_date': '08-21-2019', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000009454', 'ema_number_certainty': '1.0'}"
EU-3-19-2244,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/19/2244', 'status_type': 'w', 'eu_pnumber': 'EU/3/19/2244', 'active_substance': 'Ziritaxestat', 'eu_mah_current': 'Galapagos NV', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000017344', 'ema_number_certainty': '1.0'}"
EU-3-19-2246,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/19/2246', 'status_type': 'w', 'eu_pnumber': 'EU/3/19/2246', 'active_substance': 'Romilkimab', 'eu_mah_current': 'Sanofi-Aventis groupe', 'orphan_status': 'o', 'eu_aut_date': '01-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000018998', 'ema_number_certainty': '1.0'}"
EU-3-20-2264,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/20/2264', 'status_type': 'w', 'eu_pnumber': 'EU/3/20/2264', 'active_substance': 'Trifarotene', 'eu_mah_current': 'Premier Research Group S.L.', 'orphan_status': 'o', 'eu_aut_date': '03-24-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000015613', 'ema_number_certainty': '1.0'}"
EU-3-20-2294,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/20/2294', 'status_type': 'w', 'eu_pnumber': 'EU/3/20/2294', 'active_substance': 'Sodium cromoglicate', 'eu_mah_current': 'IQVIA RDS Spain S.L.', 'orphan_status': 'o', 'eu_aut_date': '06-26-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000025945', 'ema_number_certainty': '1.0'}"
EU-3-20-2331,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/20/2331', 'status_type': 'w', 'eu_pnumber': 'EU/3/20/2331', 'active_substance': 'Teclistamab', 'eu_mah_current': 'Janssen-Cilag International N.V.', 'orphan_status': 'o', 'eu_aut_date': '10-19-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000028614', 'ema_number_certainty': '1.0'}"
EU-3-20-2356,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/20/2356', 'status_type': 'w', 'eu_pnumber': 'EU/3/20/2356', 'active_substance': 'Autologous CD34+ cells transduced ex vivo with a lentiviral vector containing a modified gamma-globin gene', 'eu_mah_current': 'PPD Bulgaria EOOD', 'orphan_status': 'o', 'eu_aut_date': '11-13-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000035302', 'ema_number_certainty': '0.5'}"
EU-3-20-2366,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/20/2366', 'status_type': 'w', 'eu_pnumber': 'EU/3/20/2366', 'active_substance': 'Autologous CD4+ and CD8+ T cells genetically modified with a lentiviral vector encoding a B-cell maturation antigen-specific chimeric antigen receptor', 'eu_mah_current': 'Celgene Europe B.V.', 'orphan_status': 'o', 'eu_aut_date': '12-09-2020', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000034375', 'ema_number_certainty': '1.0'}"
EU-3-21-2442,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/21/2442', 'status_type': 'w', 'eu_pnumber': 'EU/3/21/2442', 'active_substance': 'Adeno-associated virus serotype 9 expressing the cDNA for human MECP2', 'eu_mah_current': 'Novartis Gene Therapies EU Limited', 'orphan_status': 'o', 'eu_aut_date': '05-20-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000053087', 'ema_number_certainty': '1.0'}"
EU-3-21-2456,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/21/2456', 'status_type': 'w', 'eu_pnumber': 'EU/3/21/2456', 'active_substance': 'Adeno-associated virus serotype 9 containing the human FXN gene isoform 1', 'eu_mah_current': 'Novartis Gene Therapies EU Limited', 'orphan_status': 'o', 'eu_aut_date': '06-21-2021', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000055345', 'ema_number_certainty': '1.0'}"
EU-3-22-2669,"{'atc_code': 'not applicable', 'eu_aut_status': 'WITHDRAWN', 'eu_brand_name_current': 'EU/3/22/2669', 'status_type': 'w', 'eu_pnumber': 'EU/3/22/2669', 'active_substance': 'Toripalimab', 'eu_mah_current': 'TMC Pharma (EU) Limited', 'orphan_status': 'o', 'eu_aut_date': '07-18-2022', 'eu_aut_type_initial': 'standard', 'eu_aut_type_current': 'standard', 'ema_number': 'EMA/OD/0000086527', 'ema_number_certainty': '1.0'}"
